data_2nwt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nwt _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.484 ' H ' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 29' ' ' LYS . 11.6 mm -93.99 147.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 39.6 mt-10 -113.77 134.75 54.58 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.51 156.54 48.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 11.5 m -110.27 115.16 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.747 0.784 . . . . 0.0 110.577 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.756 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 64.7 t80 -73.62 101.45 3.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.564 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.492 ' OE1' ' HG3' ' A' ' 15' ' ' LYS . 40.2 mt-10 -108.24 119.24 38.91 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.063 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.73 21.13 12.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.632 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 102.73 7.68 44.33 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.367 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.2 t -120.37 142.7 34.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-O 119.588 -0.244 . . . . 0.0 110.436 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 1.073 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 76.1 m-85 -93.0 115.58 28.25 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.976 170.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HG3' ' OE1' ' A' ' 10' ' ' GLU . 29.1 mmtp -107.57 108.75 62.03 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 17.9 Cg_endo -60.84 167.41 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 119.979 1.028 . . . . 0.0 112.501 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.74 -6.05 23.06 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' HG3' HG23 ' A' ' 5' ' ' ILE . 7.9 pt20 -138.41 111.97 8.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.631 173.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 12.7 tmtt? -60.91 133.25 55.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.752 -171.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG13 ' HG ' ' A' ' 22' ' ' LEU . 2.8 t -113.6 140.99 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.114 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -116.33 87.49 2.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.789 1.281 . . . . 0.0 109.047 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 26' ' ' GLU . 76.0 mt -127.11 -158.65 0.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.162 -2.29 . . . . 0.0 110.671 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -85.67 176.75 7.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 2.0 mp0 -89.7 123.31 33.61 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.97 0.891 . . . . 0.0 109.446 168.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.044 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 69.59 64.75 2.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.395 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 22' ' ' LEU . 5.6 tp10 -94.4 144.53 25.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.212 -0.994 . . . . 0.0 108.887 169.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 120.76 34.4 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.568 1.175 . . . . 0.0 114.013 -167.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.78 ' HB ' HG23 ' B' ' 30' ' ' ILE . 30.2 m -138.79 154.64 26.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -115.06 140.01 49.4 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.577 HG13 ' O ' ' B' ' 5' ' ' ILE . 1.8 mt -103.73 140.97 20.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.27 -173.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -125.58 138.06 53.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.773 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp . . . . . 0 C--N 1.309 -1.192 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.472 0.653 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.98 123.65 50.52 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.023 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.45 173.73 13.33 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.585 2.19 . . . . 0.0 112.444 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 pt -116.19 164.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.42 -172.3 2.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 tp -85.48 143.02 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.45 -142.3 5.47 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.866 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.9 161.41 63.54 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.297 . . . . 0.0 111.001 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.15 -174.87 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.827 2.351 . . . . 0.0 112.536 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.56 155.71 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.734 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 p -97.0 -178.43 4.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.53 123.81 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.522 0.677 . . . . 0.0 110.892 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -103.5 179.65 4.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.16 -36.6 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.254 0.55 . . . . 0.0 111.777 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 mt -88.85 1.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.713 0.768 . . . . 0.0 110.361 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.374 -177.215 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.436 HD11 ' N ' ' B' ' 4' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.577 ' O ' HG13 ' A' ' 30' ' ' ILE . 29.7 mt -125.22 153.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -97.57 148.32 23.39 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.06 42.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 1.044 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.6 m -109.6 113.75 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.713 0.768 . . . . 0.0 110.531 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' B' ' 14' ' ' PHE . 37.5 t80 -67.47 100.87 0.9 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.84 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 92.2 mt-10 -102.46 112.59 25.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t30 63.09 13.45 6.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.24 169.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.48 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 119.71 2.36 12.98 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.886 -1.149 . . . . 0.0 112.479 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 10' ' ' GLU . 26.9 m -132.1 142.52 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.105 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 1.073 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 98.2 m-85 -86.85 116.31 24.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.955 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -105.84 111.15 64.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.144 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -44.93 168.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.333 -0.263 0 C-N-CA 123.126 2.55 . . . . 0.0 117.183 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.743 HD12 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -126.15 97.24 5.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.141 -2.299 . . . . 0.0 104.95 163.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.7 pt20 85.53 148.38 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 O-C-N 125.717 1.886 . . . . 0.0 109.326 -167.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.41 157.95 34.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.279 -167.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.545 HG13 ' HG ' ' B' ' 22' ' ' LEU . 5.4 t -116.34 147.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.143 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -88.37 18.58 4.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.796 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.545 ' HG ' HG13 ' B' ' 20' ' ' VAL . 90.8 mt -92.29 162.86 14.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.069 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 175.0 5.91 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.105 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.6 mp0 -65.96 125.0 24.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.482 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.536 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.2 15.11 67.52 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.068 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 mm-40 -69.93 136.24 50.34 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.794 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -100.63 137.35 39.14 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.37 1.081 . . . . 0.0 112.303 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 14' ' ' PHE . 20.3 m -150.12 172.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.135 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 87.0 mttt -125.04 139.23 53.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.345 0.593 . . . . 0.0 109.925 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.78 HG23 ' HB ' ' A' ' 28' ' ' VAL . 4.0 mt -140.48 149.51 21.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.551 -171.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.596 HD23 HG12 ' A' ' 28' ' ' VAL . 42.3 mt . . . . . 0 C--N 1.316 -0.855 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -112.15 169.27 6.52 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.176 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.25 -166.48 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.344 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.43 HD11 ' N ' ' B' ' 39' ' ' ILE . 3.9 mp -93.66 150.45 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.931 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.11 143.34 51.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tt -134.33 132.83 39.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.91 155.44 17.19 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.1 pm0 -70.74 127.67 91.63 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.515 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 26.5 Cg_exo -62.73 160.55 32.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.063 2.509 . . . . 0.0 112.225 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.73 138.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.855 0.836 . . . . 0.0 111.768 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -115.52 177.04 4.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.008 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 51.2 t -79.83 124.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -100.91 160.31 14.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.747 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.96 -25.9 63.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.911 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 tt . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.256 0.55 . . . . 0.0 111.395 -175.189 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.94 150.41 22.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.9 ttt -142.24 124.97 15.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.648 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.3 p -116.06 164.19 14.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -99.53 -5.49 29.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp 45.99 84.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.864 0.727 . . . . 0.0 112.439 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 139.93 42.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -142.87 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -94.09 168.93 10.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 110.905 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -149.63 118.64 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.631 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.82 126.96 29.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -98.32 167.59 10.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.505 175.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 4' ' ' ILE . 3.8 mp . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 122.147 0.975 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' B' ' 30' ' ' ILE . 18.0 mt -110.97 158.26 11.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.042 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HG2' ' CD ' ' B' ' 29' ' ' LYS . 44.5 mt-10 -123.47 134.61 53.89 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.44 165.98 22.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.456 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 4.8 m -110.96 121.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.408 0.623 . . . . 0.0 110.01 171.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.645 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 65.8 t80 -83.18 115.7 22.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.518 1.152 . . . . 0.0 110.677 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.771 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 61.3 mt-10 -86.7 -169.82 2.8 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.064 173.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.21 45.13 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.166 0.986 . . . . 0.0 111.829 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 10' ' ' GLU . . . 122.52 5.16 8.64 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 10' ' ' GLU . 2.4 t -115.67 142.88 27.09 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.481 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 35.2 m-85 -111.72 114.89 28.19 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.846 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -119.95 116.37 32.85 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 122.407 -0.183 . . . . 0.0 111.188 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 20.0 Cg_endo -64.0 168.08 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.818 1.678 . . . . 0.0 112.088 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.65 -14.25 13.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HB2' HG21 ' A' ' 5' ' ' ILE . 63.6 mt-30 -104.24 128.52 51.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.11 -1.405 . . . . 0.0 108.871 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -71.32 140.15 50.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.739 0.781 . . . . 0.0 110.071 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 22' ' ' LEU . 6.0 p -133.17 140.94 45.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.372 -164.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -97.04 85.87 3.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' B' ' 9' ' ' TYR . 0.0 OUTLIER -116.97 173.92 6.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.759 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 5.1 mptp? -114.06 150.34 34.14 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.486 170.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.4 132.52 47.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.211 0.529 . . . . 0.0 111.197 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.03 51.16 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.119 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 25.3 tt0 -74.02 117.97 16.42 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -84.97 126.49 33.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.562 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG12 HD22 ' B' ' 32' ' ' LEU . 35.5 m -132.5 166.89 27.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.25 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 11.4 mmmm -116.37 138.23 51.51 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 2.4 mm -120.84 140.58 44.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.308 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -156.05 149.92 25.17 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.578 HD22 HG11 ' B' ' 28' ' ' VAL . 44.9 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.975 0.417 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.67 151.03 43.43 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.374 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.83 173.68 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.119 1.879 . . . . 0.0 112.095 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.88 136.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.539 ' CG ' ' H ' ' A' ' 41' ' ' LEU . 20.7 t70 56.24 -158.88 0.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.18 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 pp -103.28 167.3 9.91 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.091 -0.381 . . . . 0.0 111.185 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.74 -131.91 5.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.441 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -106.79 108.69 62.35 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-O 120.652 0.263 . . . . 0.0 111.661 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 114.86 3.61 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.889 2.393 . . . . 0.0 111.408 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.21 158.47 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.264 0.554 . . . . 0.0 110.782 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -100.7 162.72 12.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.788 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.83 121.48 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.704 0.764 . . . . 0.0 111.237 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -144.73 -36.77 0.31 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.253 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.76 -25.52 26.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.501 0.667 . . . . 0.0 110.756 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.04 1.69 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.005 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 0.0 110.575 -178.552 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.441 HD12 ' H ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 121.382 0.61 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 15.5 mm -90.48 154.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.561 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.469 ' HG2' ' CD ' ' A' ' 29' ' ' LYS . 45.9 mt-10 -124.79 130.53 52.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.94 163.43 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 3.9 m -128.61 116.87 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 112.013 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -65.31 106.34 1.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.591 0.71 . . . . 0.0 110.398 175.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.572 ' HB2' ' HD3' ' B' ' 15' ' ' LYS . 34.7 mt-10 -129.95 133.79 47.04 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.887 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.91 32.32 22.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.402 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.08 -68.3 0.39 Allowed Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 117.432 -2.318 . . . . 0.0 111.92 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 4.8 m -106.21 155.93 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.153 -156.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -84.85 113.69 21.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' B' ' 10' ' ' GLU . 39.9 mtpt -97.94 113.65 64.04 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.744 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.9 Cg_endo -62.09 167.28 11.0 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.122 1.215 . . . . 0.0 111.931 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.56 -12.13 12.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -120.83 161.67 21.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.176 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -77.83 132.12 37.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.232 0.539 . . . . 0.0 112.035 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.645 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 1.8 t -132.74 144.26 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.044 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.72 87.54 1.5 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.405 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.569 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 87.9 mt -109.91 -2.66 17.05 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.452 172.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 57.6 mttp 77.17 157.77 0.19 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.506 172.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.92 133.49 55.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.102 -164.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.6 64.93 3.5 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.429 -169.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 0.0 OUTLIER -101.47 135.09 43.55 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.56 167.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -77.14 117.21 18.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.107 0.956 . . . . 0.0 111.395 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.578 HG11 HD22 ' A' ' 32' ' ' LEU . 28.2 m -130.2 156.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.694 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.475 ' CD ' ' HG2' ' A' ' 6' ' ' GLU . 33.2 mmtp -109.36 134.75 51.43 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.321 0.581 . . . . 0.0 110.487 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 5' ' ' ILE . 3.5 mm -112.54 143.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.987 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 160.51 39.77 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.319 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.443 HD22 HG12 ' A' ' 28' ' ' VAL . 83.5 mt . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.734 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' B' ' 37' ' ' GLU . 7.1 pt-20 -50.6 110.93 1.91 Allowed Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 123.558 0.536 . . . . 0.0 111.676 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.45 172.89 3.95 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.334 2.022 . . . . 0.0 111.851 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.12 150.0 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -91.44 141.24 28.96 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.521 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.7 mm? -61.16 116.82 4.86 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.326 0.391 . . . . 0.0 110.779 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.63 114.03 4.55 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.498 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.56 147.92 82.34 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 114.621 -0.789 . . . . 0.0 110.37 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.14 130.11 29.51 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.304 2.003 . . . . 0.0 111.833 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -77.99 150.32 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -101.04 169.74 8.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.987 0.423 . . . . 0.0 110.87 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 135.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.51 149.36 22.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -28.73 43.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.682 0.753 . . . . 0.0 109.287 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 pt . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.595 177.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -95.95 134.33 39.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.9 ttt -104.13 146.82 28.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.6 t 75.73 128.62 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 O-C-N 124.218 0.949 . . . . 0.0 110.994 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -97.52 1.59 49.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.057 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp 53.35 83.72 0.06 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.507 0.67 . . . . 0.0 111.417 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 159.71 15.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.006 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -85.72 35.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.562 0.696 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.79 72.4 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.348 0.594 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -77.78 123.48 26.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -100.92 126.58 47.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.836 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.81 136.51 53.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.478 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.023 177.736 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.596 HG23 ' HD3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.891 HD11 HG22 ' A' ' 20' ' ' VAL . 1.4 mt -99.2 145.98 9.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -101.33 132.86 46.67 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.15 155.85 49.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.324 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.33 117.06 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.416 0.626 . . . . 0.0 110.346 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.702 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 77.5 t80 -73.54 119.33 17.62 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.708 176.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 41.3 tt0 -144.96 130.19 18.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.424 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 t30 70.77 22.76 4.72 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.829 0.705 . . . . 0.0 110.802 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.533 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 83.04 17.96 66.14 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.656 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 14.6 t -122.68 149.59 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 82.5 m-85 -97.69 115.28 27.64 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 166.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.0 mmmt -116.38 107.91 46.38 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.7 Cg_endo -59.8 167.89 6.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.213 1.275 . . . . 0.0 112.825 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.66 -8.6 20.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.211 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.601 ' N ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -138.37 140.05 39.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.083 176.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 7.9 tmtt? -76.94 132.4 39.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.558 0.694 . . . . 0.0 110.551 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.891 HG22 HD11 ' A' ' 5' ' ' ILE . 2.9 t -122.49 141.43 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.195 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -100.74 87.94 3.46 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 122.702 1.239 . . . . 0.0 108.148 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 20' ' ' VAL . 69.0 mt -111.25 -175.43 2.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.383 -2.189 . . . . 0.0 110.61 174.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 47.9 mtpt -93.41 165.86 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.559 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.35 129.77 34.79 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.644 0.735 . . . . 0.0 109.589 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.123 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.74 64.65 3.56 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.738 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.945 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 1.9 mm-40 -89.93 150.24 22.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -0.629 . . . . 0.0 110.463 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -89.75 104.48 17.04 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.929 1.347 . . . . 0.0 112.527 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 HG12 HD12 ' B' ' 32' ' ' LEU . 35.3 m -126.99 154.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.41 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.895 ' HD3' HG13 ' B' ' 4' ' ' ILE . 54.8 mttm -111.56 144.68 40.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG22 ' CE1' ' A' ' 14' ' ' PHE . 11.8 mm -104.36 133.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.945 0.878 . . . . 0.0 109.234 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -140.69 161.28 38.13 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.69 ' HG ' HG12 ' B' ' 28' ' ' VAL . 6.8 mp . . . . . 0 C--N 1.302 -1.477 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.9 -166.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.043 0.449 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -118.03 85.0 22.65 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.937 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -90.71 -154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.417 2.744 . . . . 0.0 110.278 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mt -95.79 139.1 19.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.99 116.37 30.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.557 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.734 ' H ' HD22 ' A' ' 41' ' ' LEU . 2.2 pt? -86.24 128.52 34.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.05 114.26 1.24 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.981 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 124.39 30.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.46 125.1 14.37 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.81 2.34 . . . . 0.0 112.266 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.12 148.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.348 0.594 . . . . 0.0 110.863 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.9 m -101.02 173.99 6.22 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.277 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.32 147.8 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.76 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 24.2 mt-10 -86.93 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.342 . . . . 0.0 111.297 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -86.42 -31.35 21.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.693 0.758 . . . . 0.0 109.363 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 pt -84.29 12.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.423 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 41.4 tttp . . . . . 0 C--N 1.326 -0.448 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.895 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 120.789 0.328 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 pt -108.85 134.21 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.515 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 19.8 mp0 -86.08 142.65 28.56 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.532 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -135.05 164.38 27.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.163 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 1.123 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 8.5 m -122.48 130.81 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.276 0.56 . . . . 0.0 110.819 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 91.8 t80 -72.05 112.76 8.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.08 1.419 . . . . 0.0 111.55 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 1.054 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 10.6 tp10 -87.81 -176.48 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.241 -2.254 . . . . 0.0 106.919 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . 0.427 ' H ' ' HG3' ' B' ' 10' ' ' GLU . 1.2 t-20 -66.86 61.28 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.266 1.031 . . . . 0.0 111.93 -172.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.31 8.25 27.33 Favored Glycine 0 C--N 1.299 -1.482 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.023 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 1.054 ' HB ' ' HB3' ' B' ' 10' ' ' GLU . 2.5 t -118.75 156.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 114.769 -0.716 . . . . 0.0 111.419 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 71.1 m-85 -118.37 115.15 24.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 161.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.581 ' HE3' ' HG2' ' B' ' 10' ' ' GLU . 98.2 mttt -108.48 117.49 54.31 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.638 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 26.1 Cg_endo -64.43 168.73 12.31 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.109 1.206 . . . . 0.0 111.701 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.7 HD12 HG12 ' B' ' 8' ' ' VAL . 6.1 mp -110.05 -10.46 14.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -101.67 155.41 18.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.105 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -74.99 141.77 43.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.655 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.434 ' HB ' ' OH ' ' A' ' 9' ' ' TYR . 3.0 t -118.82 146.03 24.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.317 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -126.09 15.27 7.89 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.187 0.994 . . . . 0.0 109.454 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.525 HD12 ' HG2' ' B' ' 26' ' ' GLU . 94.1 mt -83.46 -172.79 4.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.357 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 177.88 6.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.635 0.255 . . . . 0.0 111.016 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 2.5 mp0 -66.08 140.36 58.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.04 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 16.79 70.73 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.606 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' B' ' 22' ' ' LEU . 8.3 tp10 -79.8 126.2 30.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 27' ' ' ARG . 15.3 mmm180 -85.0 129.57 34.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.21 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.69 HG12 ' HG ' ' A' ' 32' ' ' LEU . 30.2 m -142.0 166.36 16.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.724 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.405 ' HD3' HG13 ' A' ' 4' ' ' ILE . 41.8 mttp -116.58 145.21 43.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' B' ' 14' ' ' PHE . 6.6 mm -117.45 143.97 26.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.685 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.596 ' HD3' HG23 ' A' ' 4' ' ' ILE . 29.6 tptp -154.55 128.2 8.66 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.569 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.558 HD12 HG12 ' A' ' 28' ' ' VAL . 3.4 mm? . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -151.36 126.41 4.73 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.971 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 174.13 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.418 2.079 . . . . 0.0 112.75 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 pt -87.41 160.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.15 135.53 36.6 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.16 164.65 33.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.871 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.79 -156.44 22.8 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.41 127.45 15.6 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.698 0.285 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.93 117.48 5.06 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.854 2.369 . . . . 0.0 112.726 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -124.72 152.43 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.54 149.4 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.32 0.581 . . . . 0.0 111.471 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.78 150.16 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.326 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.11 115.09 24.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.225 1.012 . . . . 0.0 112.707 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -86.68 -26.62 24.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.584 171.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.702 -171.021 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m . . . . . 0 CA--C 1.533 0.311 0 CA-C-O 121.229 0.538 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -110.1 134.9 51.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 47.3 ttm -79.36 128.73 33.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -66.83 106.9 2.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.305 0.574 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -99.52 3.44 45.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.368 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 61.48 179.11 0.12 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.528 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.23 144.25 50.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -78.78 88.84 4.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.638 0.732 . . . . 0.0 110.173 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -88.12 117.43 27.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -127.29 127.5 44.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.601 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.592 ' O ' ' HB2' ' B' ' 68' ' ' HIS . 25.7 t-80 -87.13 -103.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . 0.592 ' HB2' ' O ' ' B' ' 67' ' ' HIS . 44.9 t-80 156.65 146.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.402 173.597 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.783 HG13 ' HB ' ' B' ' 30' ' ' ILE . 3.7 pt -90.52 137.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -99.45 142.38 31.0 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.928 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.21 164.31 28.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.168 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 11.8 m -120.0 126.11 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.665 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.784 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.8 t80 -94.65 111.28 23.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.057 -177.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.67 141.29 50.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.785 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.8 t30 60.83 21.4 11.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 87.86 13.08 65.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.863 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 12.5 t -119.53 143.75 30.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.741 -0.23 . . . . 0.0 110.633 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 49.0 m-85 -103.41 115.62 30.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 166.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.67 114.87 61.4 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.7 Cg_endo -62.81 168.69 9.9 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 120.634 0.89 . . . . 0.0 111.939 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -102.43 -4.46 25.42 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.26 127.71 43.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.169 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.53 131.27 40.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -124.2 137.74 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.647 0.737 . . . . 0.0 110.628 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.42 87.82 5.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.38 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HG ' HG13 ' A' ' 20' ' ' VAL . 55.5 mt -121.54 -171.94 2.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.073 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -98.7 -176.18 3.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.956 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 5.3 mp0 -89.22 138.46 31.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.3 0.571 . . . . 0.0 110.162 171.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.717 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.3 65.25 3.05 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.378 -168.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 9.1 tp10 -93.27 128.24 39.18 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.635 -0.783 . . . . 0.0 109.344 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -81.62 114.95 20.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.71 1.243 . . . . 0.0 111.569 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.757 HG11 HD23 ' B' ' 32' ' ' LEU . 35.2 m -131.5 164.23 35.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.059 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HD3' HG13 ' B' ' 4' ' ' ILE . 52.3 mttm -119.92 143.02 48.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.23 0.538 . . . . 0.0 110.08 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.493 HG21 ' CZ ' ' A' ' 14' ' ' PHE . 3.7 mm -110.65 140.46 29.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.144 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -147.4 165.82 29.06 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.667 0.746 . . . . 0.0 110.294 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 HD22 ' B' ' 22' ' ' LEU . 74.9 mt . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.3 mm-40 -85.83 131.47 47.06 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.178 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.6 Cg_exo -79.88 -166.85 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.09 2.527 . . . . 0.0 111.854 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 pt -101.39 168.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.306 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.4 142.42 24.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.991 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.11 153.98 40.67 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.98 -143.29 14.5 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.926 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.0 pt-20 -111.78 147.06 36.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 122.203 0.201 . . . . 0.0 111.001 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 20.0 Cg_exo -67.33 170.96 12.37 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.118 2.545 . . . . 0.0 111.382 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.92 153.29 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 110.158 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p -122.52 162.1 22.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 111.608 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.6 t -131.17 135.57 59.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.669 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.13 133.62 52.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 0.0 111.477 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.86 -21.13 40.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.428 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.63 -13.66 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.705 0.764 . . . . 0.0 110.009 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 30.1 ttmt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.87 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.47 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.099 0 CA-C-O 120.847 0.356 . . . . 0.0 110.058 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 11.2 mt -104.2 144.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.487 ' H ' ' NE2' ' B' ' 18' ' ' GLN . 12.7 mp0 -105.95 130.75 53.83 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.379 0.609 . . . . 0.0 110.422 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.48 154.92 46.78 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.623 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.717 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 3.6 m -110.97 115.37 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 121.507 0.67 . . . . 0.0 110.926 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.784 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 47.4 t80 -75.23 111.46 10.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.274 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.9 tt0 -120.13 116.83 26.45 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.694 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.27 19.59 11.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.876 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 109.59 5.57 29.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.215 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 3.5 t -118.06 142.43 32.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.794 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 74.0 m-85 -97.97 116.63 30.57 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.109 -0.637 . . . . 0.0 109.621 171.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.72 ' HE3' HG11 ' B' ' 13' ' ' VAL . 33.8 mmtp -117.54 111.49 39.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.7 Cg_endo -60.49 167.97 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.299 1.333 . . . . 0.0 111.994 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.663 HD11 HG13 ' B' ' 8' ' ' VAL . 6.7 mp -111.51 -21.92 11.53 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.487 ' NE2' ' H ' ' B' ' 6' ' ' GLU . 5.0 pt20 -115.46 3.72 14.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.053 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 55.65 167.71 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.263 -1.79 . . . . 0.0 113.534 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.616 HG12 ' HG ' ' B' ' 22' ' ' LEU . 3.5 t -144.12 154.22 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.788 -175.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -136.7 86.81 2.24 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 123.139 1.447 . . . . 0.0 109.605 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.616 ' HG ' HG12 ' B' ' 20' ' ' VAL . 0.4 OUTLIER -132.52 104.68 6.81 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 112.132 -2.303 . . . . 0.0 110.196 166.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.707 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 96.0 mttt 33.95 -163.07 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 114.4 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.47 127.12 55.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.697 163.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 53.96 65.19 3.63 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.497 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.707 ' HG2' ' HD2' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -99.03 145.52 27.01 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 167.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -95.71 123.33 39.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.477 1.132 . . . . 0.0 112.391 -168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.604 HG22 ' CE1' ' A' ' 14' ' ' PHE . 34.3 m -131.04 174.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.973 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -112.91 142.22 45.83 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.783 ' HB ' HG13 ' A' ' 5' ' ' ILE . 4.3 mm -119.16 141.08 40.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.224 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.412 ' HD3' HG22 ' A' ' 4' ' ' ILE . 56.5 tptt -143.66 125.91 15.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.492 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.757 HD23 HG11 ' A' ' 28' ' ' VAL . 27.9 mt . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -111.47 119.64 44.63 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 120.917 0.389 . . . . 0.0 111.136 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.32 -176.52 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.96 2.44 . . . . 0.0 111.839 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.407 ' O ' HD12 ' B' ' 39' ' ' ILE . 1.8 pp -103.99 152.59 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.496 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.08 103.99 6.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 50.0 tp -135.04 139.09 44.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.86 114.25 2.58 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -92.26 162.26 30.62 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.739 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.8 142.18 26.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.42 2.747 . . . . 0.0 113.968 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 164.74 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.6 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -78.77 164.08 24.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.234 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.57 164.76 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.519 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.45 110.56 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.41 -29.61 22.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.373 0.606 . . . . 0.0 110.386 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.391 -178.119 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -130.02 146.39 51.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.825 0.345 . . . . 0.0 110.336 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.3 mtt -94.85 178.36 5.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.046 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.7 t -135.04 122.93 22.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -94.22 -6.43 44.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.86 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.304 1.002 . . . . 0.0 112.132 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.43 115.72 16.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 111.087 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -99.24 110.55 23.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.377 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.83 116.93 20.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.831 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 77.19 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.258 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -96.23 94.12 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -81.99 129.62 34.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.697 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.427 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.437 ' H ' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 18' ' ' GLN . 16.9 mt -98.77 155.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.404 ' HB2' HD13 ' A' ' 17' ' ' LEU . 7.0 mp0 -113.1 144.14 43.15 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -144.14 161.04 39.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.454 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.864 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.6 m -121.95 115.22 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.679 0.752 . . . . 0.0 110.493 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 63.8 t80 -75.2 114.74 14.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.737 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.677 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 5.5 pt-20 -105.64 132.24 52.03 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 164.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -74.0 63.55 0.95 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -149.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 13' ' ' VAL . . . -142.96 -7.08 0.62 Allowed Glycine 0 C--N 1.27 -3.094 0 CA-C-N 110.899 -2.864 . . . . 0.0 107.743 149.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 19.0 m -160.76 150.11 5.36 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -155.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.6 m-85 -99.48 116.52 31.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD3' ' HG2' ' A' ' 10' ' ' GLU . 23.3 mtpp -109.18 111.61 60.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.402 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.7 Cg_endo -53.8 165.12 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.592 1.528 . . . . 0.0 113.978 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 6' ' ' GLU . 93.1 mt -93.06 -66.43 0.92 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.436 165.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HB2' HG22 ' A' ' 5' ' ' ILE . 71.0 mt-30 -61.33 132.63 54.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 112.982 -1.917 . . . . 0.0 108.636 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -65.67 139.25 58.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.571 0.701 . . . . 0.0 110.436 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.427 ' CG2' ' H ' ' A' ' 22' ' ' LEU . 2.4 p -106.56 146.82 12.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.575 -167.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -133.85 13.76 3.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.099 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' H ' ' CG2' ' A' ' 20' ' ' VAL . 86.7 mt -72.93 -176.63 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.853 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 14.8 pttp -125.18 165.41 18.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.192 -174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 3.8 mp0 -66.47 143.29 57.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.694 0.759 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.52 65.47 3.39 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.299 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.5 tp10 -106.82 124.39 49.54 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.06 110.36 21.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 123.499 1.619 . . . . 0.0 113.266 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.945 HG11 ' HG ' ' B' ' 32' ' ' LEU . 27.8 m -122.81 149.35 26.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.986 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD3' ' HG3' ' B' ' 6' ' ' GLU . 47.0 mmtm -103.3 138.73 39.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mm -92.6 130.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' B' ' 4' ' ' ILE . 9.7 tttt -136.45 134.67 37.92 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.171 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 HG11 ' B' ' 28' ' ' VAL . 89.5 mt . . . . . 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.396 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.048 0.451 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.04 159.42 65.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.237 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.78 178.21 7.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.709 2.273 . . . . 0.0 112.373 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.1 pt -80.01 174.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.78 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.36 121.57 14.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.556 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -131.95 154.4 49.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.706 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.79 131.83 2.07 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.337 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.26 135.77 44.0 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.884 0.374 . . . . 0.0 111.014 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.3 -173.8 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.047 2.498 . . . . 0.0 112.565 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.07 153.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.687 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -106.09 -171.77 1.96 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.13 157.52 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.989 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.667 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.5 mp0 -61.89 128.0 34.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 110.548 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.18 -35.19 66.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.283 0.563 . . . . 0.0 111.05 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 tt -80.43 -3.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.769 . . . . 0.0 110.742 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.667 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 64.7 tttt . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.472 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.459 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.586 ' HB ' ' HG3' ' B' ' 18' ' ' GLN . 19.6 pt -101.21 134.1 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.469 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -87.4 138.98 31.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.227 0.537 . . . . 0.0 111.079 -175.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.81 152.15 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.308 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.575 HG11 HD12 ' B' ' 17' ' ' LEU . 3.6 m -115.33 118.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.714 0.769 . . . . 0.0 110.621 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 45.6 t80 -70.9 131.42 43.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.72 174.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.525 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 35.1 tt0 -151.75 129.76 11.81 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.469 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 30.6 t30 66.51 20.23 10.87 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.623 0.577 . . . . 0.0 111.907 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' OH ' ' B' ' 9' ' ' TYR . . . 95.26 10.49 57.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.008 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.2 t -122.85 148.51 26.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 92.8 m-85 -102.11 114.38 28.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -110.49 116.55 52.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 31.9 Cg_endo -65.55 168.14 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.233 1.288 . . . . 0.0 112.317 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.575 HD12 HG11 ' B' ' 8' ' ' VAL . 5.6 mp -115.13 -5.59 12.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.586 ' HG3' ' HB ' ' B' ' 5' ' ' ILE . 25.0 mm-40 -94.76 -1.58 52.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.544 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 34.27 123.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 O-C-N 125.311 1.632 . . . . 0.0 114.244 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -125.42 139.92 49.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.599 -164.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.84 88.13 2.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.975 170.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' B' ' 20' ' ' VAL . 71.3 mt -110.81 -161.97 0.78 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 112.639 -2.073 . . . . 0.0 109.967 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -89.27 -174.69 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 35.3 mt-10 -106.3 123.56 48.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 109.653 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.864 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.04 24.53 44.25 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.547 ' HG2' HD12 ' B' ' 22' ' ' LEU . 8.6 tp10 -63.55 132.9 52.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.029 0.531 . . . . 0.0 110.831 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -83.25 113.22 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.847 0.832 . . . . 0.0 111.733 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 14' ' ' PHE . 34.8 m -138.41 161.5 30.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.969 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -115.66 144.51 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.178 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.584 HG21 ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -118.34 126.22 74.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.355 0.598 . . . . 0.0 110.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -134.08 124.65 26.52 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.638 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.945 ' HG ' HG11 ' A' ' 28' ' ' VAL . 3.9 mp . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.15 156.36 35.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 122.616 0.367 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -89.03 -179.32 2.07 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.291 2.661 . . . . 0.0 113.212 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.21 169.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.844 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -125.89 -173.59 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.536 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.5 pt? -125.33 172.44 9.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.42 -150.05 6.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.035 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.769 ' HB2' ' HD2' ' B' ' 44' ' ' PRO . 8.3 pt-20 -98.27 175.07 2.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.769 ' HD2' ' HB2' ' B' ' 43' ' ' GLU . 37.7 Cg_endo -67.18 -162.58 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.266 1.977 . . . . 0.0 111.9 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.41 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -91.82 173.01 8.08 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.89 140.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -169.4 2.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.2 -27.51 63.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.426 ' N ' HD13 ' B' ' 50' ' ' ILE . 3.6 mp . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 121.214 0.531 . . . . 0.0 110.321 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -91.95 133.87 35.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.3 ttt -132.82 137.92 46.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m 67.52 121.01 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.384 1.053 . . . . 0.0 112.386 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -103.44 0.54 31.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.634 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp 52.45 79.74 0.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.795 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.0 136.36 48.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.31 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -89.16 72.53 8.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.672 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.16 128.04 34.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.723 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -93.14 138.46 31.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.061 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -77.56 -156.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.606 174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -145.47 89.05 1.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.635 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.508 177.401 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.328 0.585 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 18' ' ' GLN . 24.8 mm -100.93 156.12 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 28.3 mt-10 -116.0 145.82 42.65 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -147.55 166.27 27.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.101 0.477 . . . . 0.0 110.891 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.04 122.6 65.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.935 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 90.2 t80 -78.33 99.46 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.394 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -120.55 135.79 54.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.968 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.422 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 42.3 m-80 63.25 21.69 12.96 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.587 0.555 . . . . 0.0 111.496 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 86.9 11.48 70.29 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.131 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 16.1 t -125.14 148.67 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.737 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 83.6 m-85 -96.36 114.87 26.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.194 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.451 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 29.9 mtmt -112.5 114.07 50.43 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.74 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 Cg_endo -63.15 168.77 10.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.449 1.433 . . . . 0.0 112.981 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -108.33 -20.62 13.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.52 ' HB2' HG22 ' A' ' 5' ' ' ILE . 42.8 mt-30 -99.6 143.34 29.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.965 -1.471 . . . . 0.0 109.554 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -84.81 124.38 31.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.265 0.555 . . . . 0.0 109.674 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.47 134.87 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.72 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.36 88.63 4.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.365 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.05 171.56 7.47 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.093 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -107.39 158.85 16.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 8.1 mp0 -67.24 114.84 6.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.374 0.606 . . . . 0.0 110.199 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.88 25.92 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.058 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 3.9 mm-40 -74.11 133.96 42.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -100.82 121.88 42.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.968 1.842 . . . . 0.0 113.417 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 HD23 ' B' ' 32' ' ' LEU . 34.7 m -132.93 160.28 42.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.156 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 65.6 mttm -117.26 140.78 49.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.452 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' B' ' 7' ' ' ALA . 1.3 mm -116.57 149.44 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.781 -175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HZ1' HG23 ' B' ' 4' ' ' ILE . 6.4 ptpp? -156.94 164.56 37.89 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 164.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.639 HD22 HD12 ' B' ' 22' ' ' LEU . 9.2 mt . . . . . 0 C--N 1.306 -1.32 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 mt-10 -66.75 120.94 75.09 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-O 120.721 0.296 . . . . 0.0 110.45 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 21.1 Cg_exo -66.35 -175.16 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.383 2.722 . . . . 0.0 112.933 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 pt -70.27 165.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.77 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.42 104.53 10.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.587 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 pp -84.1 176.39 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.402 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.95 -125.21 1.91 Allowed Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.787 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -112.27 127.93 26.19 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.543 0.211 . . . . 0.0 111.142 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.12 173.35 14.05 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.539 2.159 . . . . 0.0 111.433 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 46' ' ' SER . 14.4 p -131.21 166.58 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.217 0.532 . . . . 0.0 110.768 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.44 ' N ' HG23 ' A' ' 45' ' ' VAL . 17.6 m -88.3 170.06 11.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.66 3.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.304 0.574 . . . . 0.0 111.528 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.59 104.03 9.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.464 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -87.28 -30.26 21.01 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.5 tt -69.75 -7.25 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.621 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 tttt . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.831 177.514 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.767 HG23 ' HZ1' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 15.0 mt -109.2 154.31 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 164.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -109.21 135.99 49.41 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.515 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.96 164.24 30.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.679 HG11 HD12 ' B' ' 17' ' ' LEU . 4.4 m -126.49 124.93 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.472 0.653 . . . . 0.0 111.369 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 20.2 t80 -62.15 112.42 2.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.86 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.35 128.83 40.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 120.943 0.401 . . . . 0.0 110.712 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.22 34.32 11.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.794 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.04 -69.33 0.26 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 117.653 -2.213 . . . . 0.0 111.634 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -93.37 154.33 3.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.997 -158.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.737 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -88.23 115.85 26.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -105.67 120.9 47.76 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.583 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 11.3 Cg_endo -58.6 168.71 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.453 1.435 . . . . 0.0 112.391 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.679 HD12 HG11 ' B' ' 8' ' ' VAL . 7.0 mp -102.27 -11.25 18.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' B' ' 16' ' ' PRO . 13.3 pm0 -133.17 143.52 49.26 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.496 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.42 149.25 39.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 112.138 -173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 t -123.76 150.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.353 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.02 25.14 3.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.079 0.942 . . . . 0.0 109.878 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 32' ' ' LEU . 97.9 mt -78.59 -166.23 0.84 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.672 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 10.1 mtmp? -97.1 162.32 13.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.4 mp0 -74.55 136.54 42.11 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.337 0.589 . . . . 0.0 109.416 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.6 65.4 3.2 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.416 -165.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.672 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 1.7 mm-40 -96.34 148.8 22.39 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.618 -0.791 . . . . 0.0 109.551 170.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' B' ' 27' ' ' ARG . 2.1 tpt180 -98.02 105.66 17.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.652 1.215 . . . . 0.0 112.167 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 14' ' ' PHE . 34.0 m -124.68 156.87 33.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 113.045 -1.888 . . . . 0.0 111.408 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.548 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 45.0 mttp -120.79 143.46 48.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.201 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 30' ' ' ILE . 17.1 mt -130.02 147.55 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.884 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -156.88 165.13 37.06 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.867 HD23 HG13 ' A' ' 28' ' ' VAL . 24.2 mt . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.418 HG12 ' HD2' ' B' ' 38' ' ' PRO . 8.6 t . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.437 ' HB2' ' HD3' ' B' ' 38' ' ' PRO . 45.3 mt-10 -81.21 -57.18 0.57 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' B' ' 37' ' ' GLU . 37.9 Cg_endo -65.12 174.6 4.71 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.035 1.823 . . . . 0.0 113.184 -173.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 pp -101.97 172.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.373 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.66 129.61 39.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.245 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 49.3 tp 68.37 112.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.749 0.656 . . . . 0.0 112.04 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.91 114.53 0.49 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.813 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 10.9 mp0 -108.84 130.0 23.25 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 6.0 Cg_exo -78.78 114.38 3.43 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.704 2.269 . . . . 0.0 111.508 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.9 156.6 6.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.185 0.517 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -83.2 160.35 21.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.802 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.85 142.35 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.202 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.0 105.19 4.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.08 0.943 . . . . 0.0 110.879 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.78 -27.73 20.94 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.147 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.525 -172.809 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -124.44 139.99 53.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.584 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.19 31.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -73.73 152.03 40.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.063 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.559 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 11.5 m -93.51 -5.79 48.27 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.075 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 61' ' ' SER . 2.9 pp 46.63 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.032 1.333 . . . . 0.0 114.539 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -119.86 111.74 18.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.347 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -135.4 110.33 8.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.346 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.33 151.3 48.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -75.85 99.64 4.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.735 0.779 . . . . 0.0 110.484 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -84.54 82.17 8.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.613 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -138.54 112.37 8.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.096 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.265 0 CA-C-O 121.062 0.458 . . . . 0.0 111.754 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' CD1' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.56 169.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 164.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.433 ' HB2' HD11 ' A' ' 17' ' ' LEU . 37.0 mt-10 -103.85 158.45 16.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' B' ' 30' ' ' ILE . . . -150.68 154.4 37.38 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 31.1 m -110.08 116.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.841 0.829 . . . . 0.0 110.329 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 57.1 t80 -79.98 102.91 9.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.644 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 13' ' ' VAL . 9.4 pt-20 -118.48 136.95 53.51 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.158 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 65.44 9.25 5.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.836 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 96.5 12.51 50.83 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.905 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 10' ' ' GLU . 2.4 m -124.52 142.67 40.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.371 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.99 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 93.5 m-85 -90.79 116.41 28.62 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.652 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.18 111.82 61.65 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.18 169.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.045 2.496 . . . . 0.0 115.357 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.934 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 63.3 mt -107.02 113.79 27.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 166.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.934 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 1.1 pp0? 77.11 143.21 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 127.99 2.516 . . . . 0.0 111.862 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -60.64 127.83 33.62 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.172 -172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 5' ' ' ILE . 14.7 p -127.26 146.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.652 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.91 86.59 2.75 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.321 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' CE2' ' B' ' 9' ' ' TYR . 67.3 mt -103.45 -176.56 3.12 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.51 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.47 148.83 26.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.41 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 12.4 pt-20 -82.74 121.56 27.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.16 14.97 31.87 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.823 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.84 116.69 17.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.37 119.58 27.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.095 0.95 . . . . 0.0 110.415 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.2 161.15 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.228 -168.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -118.56 134.97 54.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.957 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.723 HG12 HG21 ' B' ' 30' ' ' ILE . 9.8 mt -133.44 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.694 -170.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.66 165.51 27.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.638 172.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.313 -0.999 0 O-C-N 123.445 0.466 . . . . 0.0 111.464 -166.68 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.035 0.445 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -91.03 130.06 41.69 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.588 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 174.06 12.35 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.302 2.001 . . . . 0.0 112.083 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -89.31 150.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.836 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.59 135.56 53.22 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.13 176.11 9.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 111.253 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.29 155.26 16.45 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -67.23 140.79 95.69 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.44 -175.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -63.17 119.73 6.92 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.476 2.117 . . . . 0.0 111.363 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.45 148.03 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.512 0.672 . . . . 0.0 111.32 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 67.2 m -92.98 -171.84 2.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.176 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 46' ' ' SER . 25.0 t 68.37 139.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 111.67 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -93.6 113.51 25.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.7 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.45 -26.28 26.42 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.517 0.675 . . . . 0.0 109.47 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mt -80.33 -15.21 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.002 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.441 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.27 148.59 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.522 ' HB2' HD13 ' B' ' 17' ' ' LEU . 2.4 mp0 -121.81 145.78 47.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.47 165.17 36.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.61 0.243 . . . . 0.0 111.191 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -117.22 122.62 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 69.9 t80 -84.27 102.92 13.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.196 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.42 125.6 50.29 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.741 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 63.34 21.26 12.71 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.012 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.698 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 101.49 4.93 52.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.115 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.6 t -119.69 142.64 34.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.081 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.99 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -98.23 115.59 28.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -102.17 113.2 65.95 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.438 ' HG3' ' CE2' ' A' ' 14' ' ' PHE . 38.6 Cg_exo -56.86 169.72 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.63 1.553 . . . . 0.0 113.041 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' B' ' 6' ' ' GLU . 7.8 mp -83.53 -74.69 0.36 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.782 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -84.69 151.82 24.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -67.95 137.97 55.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.539 . . . . 0.0 111.507 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.476 HG12 ' HG ' ' B' ' 22' ' ' LEU . 2.5 t -122.1 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.597 177.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -110.65 87.81 2.62 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 123.163 1.458 . . . . 0.0 109.012 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.497 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 92.0 mt -111.7 -172.84 2.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.044 -2.344 . . . . 0.0 110.096 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.719 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 92.3 mttt -82.19 159.86 23.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.97 126.31 29.66 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 60.46 65.59 3.25 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.565 -165.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.719 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 0.7 OUTLIER -96.23 149.97 21.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.478 -0.861 . . . . 0.0 108.97 165.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -104.42 131.35 51.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.451 0.644 . . . . 0.0 111.198 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.466 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.2 m -142.15 164.79 17.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.252 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -119.59 134.47 55.21 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.31 0.576 . . . . 0.0 109.717 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 30' ' ' ILE . 3.8 mt -118.39 147.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.581 -172.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.542 ' HB3' HG21 ' A' ' 4' ' ' ILE . 3.0 ptpp? -155.6 166.19 34.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.441 0.638 . . . . 0.0 110.648 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.431 HD23 ' N ' ' B' ' 32' ' ' LEU . 3.2 mm? . . . . . 0 C--N 1.309 -1.173 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.284 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 5.5 pt-20 -77.7 143.75 67.92 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.285 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 11.6 Cg_exo -71.73 -156.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.818 3.012 . . . . 0.0 114.191 -170.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.34 178.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.628 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -92.06 129.67 37.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.502 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.9 144.65 38.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.083 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 -145.27 11.35 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.02 122.24 26.24 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 120.784 0.326 . . . . 0.0 110.692 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 128.38 24.22 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.571 2.181 . . . . 0.0 111.816 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.06 150.77 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.816 0.817 . . . . 0.0 111.444 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -106.12 -176.52 3.1 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.219 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.81 141.76 17.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.538 ' HB2' HG21 ' B' ' 50' ' ' ILE . 1.6 pm0 -66.76 129.76 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.446 0.641 . . . . 0.0 111.628 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.64 -25.08 44.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.423 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' B' ' 48' ' ' GLU . 13.7 tt . . . . . 0 CA--C 1.537 0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -82.11 154.72 25.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.033 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -144.6 154.75 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.241 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -79.74 133.61 36.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 56.4 p -82.85 14.2 3.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.575 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.9 103.08 0.41 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -101.89 155.46 18.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.932 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -84.76 100.26 11.4 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.93 135.12 51.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.978 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -129.8 153.4 48.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.296 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -147.52 130.39 16.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -133.66 140.08 46.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.558 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.568 175.793 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.5 mp . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' B' ' 30' ' ' ILE . 11.7 mt -131.2 150.84 34.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -100.99 126.44 47.66 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.82 166.53 18.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.522 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.26 114.27 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.465 0.65 . . . . 0.0 110.131 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.746 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 68.3 t80 -67.06 119.44 12.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.626 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 22.7 tt0 -148.2 142.57 26.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.395 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.45 18.03 10.76 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 0.0 111.458 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.497 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 83.43 18.99 63.06 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.819 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.746 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 11.6 t -129.09 154.66 40.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 C-N-CA 122.858 0.463 . . . . 0.0 110.048 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 1.042 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.2 m-85 -97.84 115.11 27.42 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.309 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 41.6 mtmt -109.74 113.08 57.99 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.478 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 31.4 Cg_exo -56.87 166.28 4.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.171 1.248 . . . . 0.0 113.593 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.21 -68.5 0.79 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 112.069 -2.332 . . . . 0.0 105.405 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' A' ' 5' ' ' ILE . 57.9 mt-30 -60.04 144.89 48.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.467 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -68.74 149.62 48.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.143 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 22' ' ' LEU . 3.4 p -123.6 155.83 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 122.162 0.982 . . . . 0.0 111.397 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.83 12.63 11.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.834 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.704 HD13 HD21 ' B' ' 32' ' ' LEU . 97.0 mt -90.57 -174.83 4.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.368 -172.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -92.93 -172.96 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.25 -169.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.633 ' HB3' ' H ' ' B' ' 11' ' ' ASN . 0.0 OUTLIER -93.15 -169.89 2.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 164.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.631 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . -21.95 71.66 0.0 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 122.847 1.248 . . . . 0.0 114.686 -152.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 44.3 tt0 -96.65 139.78 32.22 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 111.956 -2.122 . . . . 0.0 108.105 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -93.69 128.44 39.88 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.755 0.788 . . . . 0.0 112.354 -166.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' B' ' 32' ' ' LEU . 16.5 m -145.74 171.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.72 -173.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 58.7 mttm -128.45 138.84 52.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.827 HG22 ' HB ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -119.14 134.32 63.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.0 -171.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HG2' HG22 ' B' ' 4' ' ' ILE . 51.9 mttp -110.24 148.92 30.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.029 0.442 . . . . 0.0 110.075 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.843 -177.235 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -63.76 148.01 95.12 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 122.189 0.196 . . . . 0.0 110.877 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.53 -169.46 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.197 2.598 . . . . 0.0 113.741 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.9 mt -96.51 154.29 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.09 -153.7 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.5 tp -69.47 147.67 50.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.91 -113.62 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.868 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 pm0 -63.99 141.64 98.07 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.286 -0.457 . . . . 0.0 111.196 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 14.8 Cg_exo -68.32 157.11 63.22 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.824 2.349 . . . . 0.0 112.592 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.05 149.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.786 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -117.51 -170.94 1.95 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.862 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.32 147.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.94 169.8 17.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 111.785 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.27 -25.18 62.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.8 -13.37 17.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp . . . . . 0 C--N 1.319 -0.73 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.737 -177.862 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.589 HG22 ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 121.039 0.447 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.829 HD13 HD12 ' B' ' 22' ' ' LEU . 25.1 mt -98.72 160.17 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.533 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 40.6 mt-10 -125.61 136.94 53.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.757 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -151.07 168.37 24.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.845 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.631 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.5 m -128.19 137.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.142 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.523 ' H ' ' HD1' ' B' ' 9' ' ' TYR . 2.8 m-85 -58.05 156.73 8.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.084 0.945 . . . . 0.0 112.075 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 13' ' ' VAL . 16.2 tp10 -144.29 98.05 3.14 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . 0.633 ' H ' ' HB3' ' A' ' 24' ' ' GLU . 1.9 t30 56.14 30.99 17.41 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.115 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.65 -69.56 0.51 Allowed Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 118.279 -1.915 . . . . 0.0 111.708 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' B' ' 10' ' ' GLU . 28.3 m -92.78 141.7 14.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.848 -155.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 1.042 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -88.53 125.39 34.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -165.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.39 112.59 65.44 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.9 Cg_endo -76.23 169.75 21.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 CA-C-O 122.016 0.757 . . . . 0.0 113.428 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.15 -23.61 22.41 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 166.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' B' ' 19' ' ' LYS 0.283 4.2 tt0 43.05 -119.8 0.57 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.343 166.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 47.1 tttp 69.01 -128.05 0.1 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -143.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' B' ' 19' ' ' LYS . 50.9 t 68.82 171.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 119.613 1.097 . . . . 0.0 109.946 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' B' ' 23' ' ' LYS . 30.0 t70 -122.96 17.05 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.226 1.012 . . . . 0.0 111.227 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.829 HD12 HD13 ' B' ' 5' ' ' ILE . 93.6 mt -83.53 169.55 15.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.607 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' B' ' 21' ' ' ASP . 18.9 mttt -136.35 -179.73 5.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -164.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.3 145.17 37.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.348 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 57.9 65.25 3.67 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -164.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 1.4 mm-40 -120.13 139.82 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.497 -0.852 . . . . 0.0 111.05 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' B' ' 27' ' ' ARG . 0.3 OUTLIER -88.95 125.89 35.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.862 -174.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 30' ' ' ILE . 34.3 m -136.99 148.15 26.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.825 -172.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -117.35 138.25 51.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.018 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 3.9 mt -117.26 148.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.289 0.566 . . . . 0.0 111.376 -169.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -137.25 161.76 35.33 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 22' ' ' LEU . 6.6 mp . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.08 110.84 5.22 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.09 173.03 15.17 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.544 2.163 . . . . 0.0 113.439 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.64 173.89 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.953 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -88.68 137.03 32.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.302 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.4 tp -111.41 143.7 41.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.329 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 115.3 3.48 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 125.52 91.65 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 115.319 -0.44 . . . . 0.0 110.92 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.8 172.57 16.02 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.709 2.273 . . . . 0.0 112.356 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.81 152.16 25.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -125.11 168.5 13.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.91 127.34 51.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -102.6 102.78 13.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.67 -25.98 24.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.136 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.316 -178.823 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.575 0.226 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -128.98 141.55 51.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.167 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 49.7 ttm -123.45 124.75 43.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -79.66 140.26 37.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.773 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.3 t -101.89 20.55 16.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.34 0.59 . . . . 0.0 109.689 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.33 -169.16 0.2 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.644 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 169.4 18.77 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -75.13 147.17 40.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 111.17 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.62 156.31 45.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.845 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -132.95 100.71 4.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.004 0.43 . . . . 0.0 111.465 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -106.92 100.12 9.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -51.39 -47.62 62.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.145 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.97 177.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.729 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG22 ' A' ' 20' ' ' VAL . 24.0 mt -85.94 150.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 38.9 mt-10 -124.33 126.12 45.48 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.12 169.5 17.48 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.0 111.406 -171.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.486 HG12 ' HD3' ' B' ' 27' ' ' ARG . 12.1 m -129.66 131.45 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.675 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 70.6 t80 -74.79 118.26 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 34.1 tt0 -155.44 138.47 15.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.905 1.378 . . . . 0.0 108.813 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.06 25.72 12.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.394 0.616 . . . . 0.0 110.35 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 71.01 20.99 78.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.026 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 54.7 t -132.92 159.13 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 9' ' ' TYR . 54.9 m-85 -108.18 115.03 29.37 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -112.97 125.9 29.09 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.908 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 28.0 Cg_endo -64.21 170.01 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.228 1.286 . . . . 0.0 112.112 177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -5.44 21.6 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 17.6 pt20 -135.18 129.33 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.161 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -68.87 129.45 39.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 110.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.557 HG11 ' HG ' ' A' ' 22' ' ' LEU . 13.8 t -117.01 149.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.306 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.74 25.27 11.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.155 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.557 ' HG ' HG11 ' A' ' 20' ' ' VAL . 55.4 mt -66.75 177.69 1.55 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.456 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 8.9 mtpm? -96.13 170.86 8.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 0.6 OUTLIER -77.01 133.86 39.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.289 175.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 76.96 16.78 80.48 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.465 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 6.8 mm-40 -68.68 135.4 51.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.95 0.405 . . . . 0.0 110.585 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 103.68 15.73 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.775 1.274 . . . . 0.0 112.534 -167.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.714 ' HB ' HG23 ' B' ' 30' ' ' ILE . 29.4 m -129.16 152.41 37.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.426 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -129.67 135.26 48.29 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.682 0.753 . . . . 0.0 110.019 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 HG23 HD13 ' B' ' 30' ' ' ILE . 9.1 mt -103.9 143.03 16.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.041 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.795 ' HG3' HG21 ' B' ' 4' ' ' ILE . 10.4 mptt -137.93 157.34 46.59 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.113 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.746 HD13 HD23 ' B' ' 22' ' ' LEU . 94.1 mt . . . . . 0 C--N 1.313 -0.979 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.49 0.662 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.4 mt-10 -101.85 148.88 35.93 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.904 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -75.93 -165.88 0.33 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.982 2.455 . . . . 0.0 111.636 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 pp -70.79 144.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 111.706 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.17 -10.09 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.343 0.592 . . . . 0.0 110.201 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.68 -176.19 3.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.557 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.35 130.7 3.33 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.9 mt-10 -79.1 136.07 57.82 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -67.73 166.03 25.66 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.397 2.731 . . . . 0.0 113.128 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.15 158.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.009 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.6 m -85.16 167.87 15.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.719 0.295 . . . . 0.0 111.102 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.57 134.14 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.252 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 -35.58 18.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.997 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.12 -25.59 67.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.442 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.89 -9.33 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.725 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp . . . . . 0 C--N 1.323 -0.548 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.622 -175.633 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.795 HG21 ' HG3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.432 -1.341 0 CA-C-O 120.84 0.353 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.81 151.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.674 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.22 118.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.0 165.02 25.99 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.568 0.542 . . . . 0.0 110.741 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 m -127.23 133.57 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.598 173.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 1.3 t80 -65.1 100.03 0.41 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.767 ' HB3' ' HD3' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -120.17 119.92 34.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.059 -170.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 52.05 33.58 12.29 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.145 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.85 -70.7 0.44 Allowed Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 117.842 -2.123 . . . . 0.0 112.028 -169.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.547 HG21 ' HG3' ' B' ' 15' ' ' LYS . 32.0 m -100.37 171.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.33 -0.935 . . . . 0.0 112.555 -155.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.669 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 93.7 m-85 -87.76 115.0 24.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.767 ' HD3' ' HB3' ' B' ' 10' ' ' GLU . 50.5 mtpt -115.32 111.18 44.58 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.757 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.3 Cg_endo -64.24 166.67 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.265 1.31 . . . . 0.0 112.113 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.406 HD12 HG11 ' B' ' 8' ' ' VAL . 17.6 mt -129.19 -22.7 3.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.444 -1.707 . . . . 0.0 108.107 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.54 143.82 27.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.959 169.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.52 154.06 33.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.816 0.341 . . . . 0.0 110.35 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.474 HG23 ' H ' ' B' ' 22' ' ' LEU . 4.3 p -98.75 153.74 4.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.994 0.902 . . . . 0.0 110.07 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.3 13.42 7.69 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.906 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.746 HD23 HD13 ' A' ' 32' ' ' LEU . 29.8 mt -106.47 -170.11 1.67 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.08 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 63.5 pttt -120.35 160.84 22.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.049 0.452 . . . . 0.0 110.92 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.29 135.52 42.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.497 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.37 19.51 32.57 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -171.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -94.2 145.01 25.01 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.13 0.49 . . . . 0.0 112.222 -175.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.486 ' HD3' HG12 ' A' ' 8' ' ' VAL . 2.9 mpp_? -98.57 112.92 24.81 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 123.334 1.54 . . . . 0.0 112.787 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.671 HG13 HD22 ' A' ' 32' ' ' LEU . 35.5 m -131.0 162.13 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.228 -173.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.729 ' HE3' HG13 ' A' ' 4' ' ' ILE . 36.3 mtpt -132.78 152.12 51.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.531 0.681 . . . . 0.0 109.632 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.714 HG23 ' HB ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -126.94 139.86 50.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.4 -169.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.664 ' HD3' ' HZ3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.2 165.46 27.78 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.573 171.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.813 -176.739 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.88 151.5 40.8 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.509 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.41 173.75 6.03 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.659 2.239 . . . . 0.0 113.072 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 pt -96.2 172.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.881 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.34 134.27 34.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.661 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.64 169.59 17.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.403 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.22 -146.61 15.88 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.093 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.0 OUTLIER -93.28 142.81 25.77 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 121.049 0.452 . . . . 0.0 111.477 -174.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 5.0 Cg_exo -77.99 130.34 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.932 2.421 . . . . 0.0 111.535 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.86 144.46 12.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.403 0.62 . . . . 0.0 111.443 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -104.92 171.07 7.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.602 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.61 148.31 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -85.22 128.05 34.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.18 -24.99 27.68 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.563 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 CA--C 1.535 0.403 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.289 -176.719 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.248 0.547 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -157.08 135.36 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.241 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.0 ptm -115.11 170.77 8.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -148.89 -174.19 4.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -85.31 5.93 28.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.849 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 85.1 mt 61.17 -166.27 0.21 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.317 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -99.76 145.44 27.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -168.0 110.21 0.6 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.833 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -113.6 132.77 55.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 43.3 t-80 -158.31 98.53 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.262 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 19.4 p-80 178.38 159.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -130.65 -99.92 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.741 0.305 . . . . 0.0 110.302 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 119.149 -0.453 . . . . 0.0 109.973 178.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.608 ' CG2' ' HD3' ' B' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.851 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' HG12 ' B' ' 30' ' ' ILE . 10.2 mt -100.33 156.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 41.3 mt-10 -99.19 154.75 17.9 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.926 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.404 ' CB ' HD12 ' B' ' 30' ' ' ILE . . . -149.67 143.98 25.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.009 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.86 131.86 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.468 0.652 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 47.4 t80 -88.6 113.08 23.8 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.374 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 39.4 mt-10 -138.07 138.29 38.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.388 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 68.25 19.71 8.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.692 0.62 . . . . 0.0 111.136 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.52 16.12 64.73 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.031 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 10.5 t -125.34 148.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 C-N-CA 122.512 0.325 . . . . 0.0 110.598 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 50.5 m-85 -95.29 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 165.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.57 108.32 59.71 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' B' ' 14' ' ' PHE . 47.2 Cg_exo -47.14 168.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.1 2.534 . . . . 0.0 115.707 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.603 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 90.6 mt -114.22 87.36 2.61 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 112.907 -1.951 . . . . 0.0 105.915 165.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 2.5 pp0? 81.58 149.15 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.773 2.429 . . . . 0.0 110.932 -172.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -68.31 152.29 45.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.993 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 5' ' ' ILE . 3.0 t -114.26 135.95 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.039 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.48 87.8 7.21 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 123.07 1.415 . . . . 0.0 108.154 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.69 173.93 9.87 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.838 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.687 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -101.2 153.43 19.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 40.5 mt-10 -61.67 129.9 43.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.806 0.812 . . . . 0.0 110.865 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.789 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 60.55 65.26 3.46 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.72 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.687 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -103.59 142.84 33.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.107 166.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -93.93 127.75 39.87 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 124.036 1.874 . . . . 0.0 113.981 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' B' ' 14' ' ' PHE . 21.4 m -136.08 155.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 111.35 -2.659 . . . . 0.0 108.341 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 38.7 mtpt -118.87 146.24 45.05 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.944 0.878 . . . . 0.0 111.287 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.0 142.85 24.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.804 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HZ3' ' HB2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -155.38 151.52 27.97 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.357 174.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.308 -1.225 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.579 -170.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -88.14 132.49 39.51 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -80.25 -170.83 1.09 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.573 2.849 . . . . 0.0 113.045 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.99 164.5 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.459 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.27 166.58 11.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.03 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.04 166.4 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.912 0.386 . . . . 0.0 111.693 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.72 -145.06 15.81 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.79 156.89 77.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 122.375 0.27 . . . . 0.0 111.147 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.48 -179.16 4.83 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.657 2.238 . . . . 0.0 112.773 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t -104.03 155.97 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.832 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.8 m -101.45 -172.91 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.64 127.83 67.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.297 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.626 ' H ' ' HD2' ' A' ' 51' ' ' LYS . 8.7 mp0 -97.39 171.79 8.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.859 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -85.08 -23.29 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.338 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.18 -15.49 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.399 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HD2' ' H ' ' A' ' 48' ' ' GLU . 87.5 mttt . . . . . 0 N--CA 1.441 -0.893 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.155 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.433 HD11 ' H ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.583 HD12 ' HB ' ' B' ' 20' ' ' VAL . 37.8 pt -101.63 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.487 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 82.9 mt-10 -113.9 157.49 22.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.923 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.84 155.95 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.635 0.255 . . . . 0.0 110.508 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.789 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 12.0 m -114.81 126.55 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.417 0.627 . . . . 0.0 110.571 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.753 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 66.0 t80 -92.1 109.35 20.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.593 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 8.4 pt-20 -130.3 135.24 47.88 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.162 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.48 14.45 9.47 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.486 0.491 . . . . 0.0 111.891 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.545 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 94.84 10.84 57.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.755 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.9 t -114.0 143.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.362 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m-85 -106.01 116.35 31.79 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 167.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -115.99 117.81 39.01 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.863 ' HB2' ' HA ' ' B' ' 19' ' ' LYS . 16.8 Cg_exo -58.37 170.55 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.81 1.674 . . . . 0.0 113.721 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.805 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 6.3 mp -111.04 105.82 14.7 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.805 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.2 pt20 85.44 6.89 0.43 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 126.535 2.397 . . . . 0.0 110.171 -175.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.863 ' HA ' ' HB2' ' B' ' 16' ' ' PRO . 27.6 mtpp 53.56 -159.75 0.14 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.173 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.583 ' HB ' HD12 ' B' ' 5' ' ' ILE . 6.3 p -151.12 164.71 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.85 12.98 35.36 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.738 1.256 . . . . 0.0 109.389 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.629 ' O ' ' HD2' ' B' ' 23' ' ' LYS . 93.6 mt -79.12 156.49 28.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.327 170.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.629 ' HD2' ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -132.57 -170.55 2.46 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.453 -170.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 6.2 mp0 -53.14 137.4 33.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 11.1 83.13 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.737 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' B' ' 22' ' ' LEU . 10.0 tp10 -77.89 134.19 37.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 117.092 0.446 . . . . 0.0 110.068 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -117.84 119.71 35.71 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.835 1.303 . . . . 0.0 112.318 -171.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.15 168.62 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.129 -1.851 . . . . 0.0 109.838 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.541 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 15.3 mtmm -126.45 139.88 52.91 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.586 0.708 . . . . 0.0 111.036 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -91.02 128.03 43.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.224 -170.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.608 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 1.9 tppt? -121.52 124.45 44.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -69.18 131.96 90.27 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.272 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.475 ' O ' ' HB ' ' B' ' 39' ' ' ILE . 63.0 Cg_endo -72.93 -154.24 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.127 2.551 . . . . 0.0 111.652 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' B' ' 38' ' ' PRO . 71.2 mt 74.32 161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.417 ' N ' HG22 ' B' ' 39' ' ' ILE . 27.2 t70 56.16 64.88 1.58 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.291 1.043 . . . . 0.0 110.457 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.97 125.56 41.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.847 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.32 112.75 4.12 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 9.2 pt-20 -85.37 116.89 67.41 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.535 174.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 21.5 Cg_exo -64.36 114.78 2.83 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.655 2.236 . . . . 0.0 112.037 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -72.29 146.75 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.454 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -103.37 159.6 15.43 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.177 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.41 151.86 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.691 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.53 114.15 5.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.767 0.794 . . . . 0.0 111.44 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.2 -25.73 27.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.481 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.815 0.817 . . . . 0.0 110.956 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.146 0.498 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -100.22 -179.46 4.14 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.344 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.41 151.39 6.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.992 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -98.75 132.84 43.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.985 0.421 . . . . 0.0 110.095 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.9 m -105.7 2.36 27.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.57 113.5 18.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.767 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.1 92.25 2.77 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -86.99 71.0 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.536 0.684 . . . . 0.0 111.814 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 131.91 52.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.809 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -90.54 145.52 24.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.648 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -141.99 145.19 34.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -115.6 -168.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 174.279 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 HG22 ' HB2' ' A' ' 18' ' ' GLN . 9.3 mm -108.08 143.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HG3' ' HG2' ' B' ' 29' ' ' LYS . 5.2 mp0 -97.67 121.13 39.22 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -129.81 165.72 21.39 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.056 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.663 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.0 m -117.32 115.05 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.58 0.705 . . . . 0.0 110.69 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.639 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 79.1 t80 -71.88 106.03 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.092 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.65 131.75 54.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.156 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 54.86 24.88 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 99.82 2.04 56.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.059 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.97 143.25 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.252 0.526 . . . . 0.0 111.176 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 1.034 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 96.9 m-85 -94.1 115.62 27.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -105.04 115.25 62.67 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.884 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 36.1 Cg_endo -66.2 167.81 17.41 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.034 1.156 . . . . 0.0 112.352 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 mt -112.91 -17.42 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HB2' HG22 ' A' ' 5' ' ' ILE . 76.5 mt-30 -92.91 171.63 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.058 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -75.94 132.39 40.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 162.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.42 135.45 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 121.519 0.676 . . . . 0.0 110.349 -174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -103.93 14.44 30.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.236 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.501 HD23 ' HG2' ' A' ' 26' ' ' GLU . 91.1 mt -99.27 -174.31 2.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.098 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.55 163.04 34.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 16.5 mp0 -56.49 141.44 42.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.919 0.866 . . . . 0.0 111.524 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.27 65.3 3.45 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.535 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HG2' HD23 ' A' ' 22' ' ' LEU . 10.9 tp10 -116.76 128.5 55.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.403 -0.898 . . . . 0.0 109.634 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -85.97 120.34 27.26 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.603 1.192 . . . . 0.0 111.189 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.762 ' HB ' HG22 ' B' ' 30' ' ' ILE . 31.0 m -137.02 148.74 26.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.129 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -119.76 137.32 54.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.524 0.678 . . . . 0.0 110.374 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 HG21 ' B' ' 30' ' ' ILE . 3.6 mm -102.85 138.02 28.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.362 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.92 165.04 37.67 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.533 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.468 ' N ' HD21 ' A' ' 32' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.868 0.842 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 154.18 37.51 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.317 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.64 173.23 14.24 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.193 1.929 . . . . 0.0 112.012 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -102.55 178.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.341 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.16 137.35 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.95 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.828 ' H ' HD22 ' A' ' 41' ' ' LEU . 1.9 pt? -89.37 -165.04 1.24 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.48 141.03 12.99 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.5 pt-20 -67.09 139.86 95.54 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.04 -0.58 . . . . 0.0 111.511 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 2.3 Cg_endo -84.93 166.88 11.27 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.289 2.659 . . . . 0.0 111.951 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.47 150.71 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -95.89 -168.8 1.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.269 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.46 142.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.5 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.94 126.58 29.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.737 0.78 . . . . 0.0 111.923 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.27 -24.14 23.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.114 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mt -64.92 -12.72 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.547 -169.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.424 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 121.236 0.541 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.83 152.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.469 ' O ' HD12 ' B' ' 17' ' ' LEU . 38.0 mt-10 -124.58 113.02 17.5 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -125.16 169.14 12.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 128.8 73.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 48.5 t80 -82.0 126.86 32.46 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.127 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 25.3 tt0 -152.19 128.28 10.42 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.608 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 67.35 23.16 9.31 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.708 0.63 . . . . 0.0 111.682 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' CE1' ' B' ' 9' ' ' TYR . . . 88.22 15.33 60.81 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.76 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 5.1 t -122.03 150.11 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 1.034 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.0 m-85 -104.56 114.46 28.7 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 165.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.63 113.63 57.69 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 27.5 Cg_endo -63.61 168.51 11.46 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.636 1.557 . . . . 0.0 112.577 -175.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.469 HD12 ' O ' ' B' ' 6' ' ' GLU . 1.3 mt -114.63 -2.43 13.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.778 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.39 159.81 38.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -72.97 130.53 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 3.3 t -107.24 145.58 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.468 -173.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -108.95 14.28 24.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.459 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.443 HD11 ' HG2' ' B' ' 26' ' ' GLU . 85.7 mt -75.51 -175.76 2.95 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.587 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -115.87 168.38 10.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.696 0.284 . . . . 0.0 111.234 -176.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.4 136.31 47.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.487 0.661 . . . . 0.0 110.659 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.663 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.48 65.56 3.08 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.074 -165.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 13.0 tp10 -90.14 134.48 34.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.562 -0.819 . . . . 0.0 109.382 172.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' B' ' 27' ' ' ARG . 3.5 tpt180 -83.75 104.07 13.56 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.441 1.115 . . . . 0.0 110.413 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.611 HG21 ' CD1' ' A' ' 14' ' ' PHE . 30.8 m -129.32 154.84 40.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.685 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.527 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 22.1 mtmm -123.42 138.54 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.277 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.762 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -105.49 121.98 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.116 -172.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' B' ' 31' ' ' LYS . 3.1 tppp? -105.87 124.71 50.01 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.749 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.317 -0.822 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.451 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 10.2 pt-20 -60.68 125.91 83.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 5.1 Cg_exo -74.63 174.93 11.8 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.08 2.52 . . . . 0.0 112.494 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.03 164.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.99 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.28 157.98 30.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -145.85 153.64 41.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.29 115.92 0.68 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.395 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.39 140.14 20.86 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.36 0.124 . . . . 0.0 110.908 -173.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.78 146.88 5.14 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.959 3.106 . . . . 0.0 113.977 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.21 157.27 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.609 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -84.17 -176.58 6.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.572 . . . . 0.0 112.239 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.8 146.99 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.087 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 136.4 37.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.426 0.631 . . . . 0.0 111.284 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.49 -25.56 26.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.009 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.406 ' H ' HD12 ' B' ' 50' ' ' ILE . 4.4 mp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 122.0 0.905 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.383 0.611 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.07 141.24 48.39 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.068 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.4 ttt -133.32 124.52 27.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.285 0.565 . . . . 0.0 111.453 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.3 p -82.72 145.31 29.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 25.3 m -76.76 3.14 12.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.59 0.233 . . . . 0.0 110.848 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt 55.54 41.4 30.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.03 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.84 92.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.819 0.819 . . . . 0.0 110.549 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -75.79 102.5 5.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.29 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -75.57 113.5 13.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.521 0.676 . . . . 0.0 109.717 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -105.85 139.59 40.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -106.99 147.58 29.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.698 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -79.82 112.92 17.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 111.654 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m170 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.087 171.167 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.593 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.643 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.708 HD11 ' HB3' ' A' ' 19' ' ' LYS . 5.0 pt -109.72 155.89 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.728 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.568 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 51.0 mt-10 -103.63 141.3 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.1 161.73 36.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.712 -1.586 . . . . 0.0 108.071 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.88 136.82 58.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.417 0.627 . . . . 0.0 110.286 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 81.2 t80 -81.68 103.97 11.76 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.289 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -122.58 122.65 39.36 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.683 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.76 36.36 27.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.061 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 85.84 16.9 62.54 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.987 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.4 t -134.42 149.29 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 94.2 m-85 -93.04 115.38 28.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 112.81 59.26 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD3' ' HD2' ' B' ' 14' ' ' PHE . 3.1 Cg_endo -61.66 168.64 8.11 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 120.752 0.968 . . . . 0.0 112.154 174.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.52 -71.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.166 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.471 ' HG3' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -141.93 7.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.76 -169.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HB3' HD11 ' A' ' 5' ' ' ILE . 70.5 mmtt -91.25 155.0 18.88 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.292 -159.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 5' ' ' ILE . 40.8 t 61.1 142.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.765 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -145.92 14.74 1.35 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.779 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' B' ' 32' ' ' LEU . 58.2 mt -89.43 5.74 43.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.124 -169.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 83.7 tttt 81.85 163.74 0.15 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.756 156.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -48.91 129.71 17.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.048 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.57 12.47 69.45 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.884 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.587 ' HG2' ' CB ' ' A' ' 22' ' ' LEU . 5.0 tp10 -81.36 134.65 35.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.613 0.244 . . . . 0.0 110.439 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -90.18 115.85 27.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 123.258 1.504 . . . . 0.0 113.419 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG21 ' CE1' ' B' ' 14' ' ' PHE . 31.8 m -123.81 157.43 30.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 112.473 -2.148 . . . . 0.0 108.794 177.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -124.44 135.56 53.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.411 HG23 ' CE1' ' A' ' 14' ' ' PHE . 10.7 mm -90.45 132.06 36.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.073 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.74 ' HD3' ' HZ2' ' B' ' 31' ' ' LYS . 12.6 mptt -121.27 132.5 54.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.288 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.455 HD12 HG11 ' B' ' 28' ' ' VAL . 2.8 mm? . . . . . 0 C--N 1.305 -1.335 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.438 0.637 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.95 103.34 55.24 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.631 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.41 -171.52 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.878 2.385 . . . . 0.0 111.838 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.36 144.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -113.41 123.54 50.31 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.653 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -83.52 154.07 24.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.652 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.87 115.38 2.09 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.957 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.91 122.57 86.45 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.708 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.13 148.03 26.97 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.679 2.253 . . . . 0.0 112.086 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.69 156.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -86.82 171.46 10.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.865 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.93 141.81 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -135.94 -26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.269 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.16 -23.87 66.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -171.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.66 -15.63 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 pttm . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.103 0.477 . . . . 0.0 111.618 -176.421 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.557 HG22 ' CE ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 121.027 0.442 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' B' ' 18' ' ' GLN . 7.1 mt -89.62 148.29 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -102.67 131.08 49.7 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.81 154.34 46.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.604 0.24 . . . . 0.0 110.942 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.704 HG13 HD12 ' B' ' 17' ' ' LEU . 4.4 m -111.4 132.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.843 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 68.3 t80 -82.2 108.37 15.61 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.021 0.915 . . . . 0.0 110.585 176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.693 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 5.6 mt-10 -86.58 -170.68 3.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.391 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.15 62.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 O-C-N 124.342 1.026 . . . . 0.0 111.301 -171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 105.27 5.55 40.09 Favored Glycine 0 C--N 1.304 -1.218 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.677 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.693 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.5 t -112.78 145.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.221 -0.489 . . . . 0.0 111.432 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 55.4 m-85 -115.67 114.67 25.18 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 162.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -121.2 123.62 27.68 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.758 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.4 Cg_endo -65.19 168.0 15.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.708 1.605 . . . . 0.0 112.925 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.704 HD12 HG13 ' B' ' 8' ' ' VAL . 4.2 mp -118.45 -13.66 9.74 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.524 ' HB3' HG23 ' B' ' 5' ' ' ILE . 8.9 tt0 -91.53 164.11 13.91 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.593 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -78.15 142.65 37.88 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.88 139.82 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 122.973 1.368 . . . . 0.0 113.012 -173.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -141.81 87.46 2.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.379 -2.191 . . . . 0.0 108.301 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.3 -179.43 5.14 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.986 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.65 ' HD2' ' OE2' ' B' ' 24' ' ' GLU . 30.0 mmtt -110.06 161.92 15.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.338 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.65 ' OE2' ' HD2' ' B' ' 23' ' ' LYS . 1.1 pm0 -77.16 124.12 27.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.437 0.637 . . . . 0.0 109.532 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 15.28 30.67 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.784 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 7.6 tp10 -78.77 121.22 24.5 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -87.46 122.28 30.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.356 1.074 . . . . 0.0 111.278 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.455 HG11 HD12 ' A' ' 32' ' ' LEU . 29.7 m -129.46 151.15 35.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.219 -173.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.593 ' HE3' HG13 ' A' ' 4' ' ' ILE . 25.9 mtpp -121.57 134.56 55.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 122.443 1.116 . . . . 0.0 111.086 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 7' ' ' ALA . 9.6 mm -106.16 144.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 112.708 -2.042 . . . . 0.0 111.151 -164.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.74 ' HZ2' ' HD3' ' A' ' 31' ' ' LYS . 6.1 ptpp? -156.16 163.98 38.94 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.657 -1.61 . . . . 0.0 107.018 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.592 ' CD2' HD11 ' A' ' 22' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.419 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 7.6 p . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -105.65 104.45 48.54 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.229 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 36' ' ' VAL . 77.2 Cg_endo -92.81 175.29 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.249 2.632 . . . . 0.0 111.528 172.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -124.77 114.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.01 0.433 . . . . 0.0 111.09 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.23 137.33 34.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.52 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 tp -102.75 167.62 9.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.4 -155.18 25.52 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.852 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 40.2 mt-10 -129.44 139.02 34.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.64 165.19 31.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.059 2.506 . . . . 0.0 112.42 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 46' ' ' SER . 10.6 p -95.15 161.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.289 0.566 . . . . 0.0 110.88 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' SER . . . . . 0.567 ' O ' ' HB ' ' B' ' 47' ' ' VAL . 6.4 p -122.62 -164.54 1.19 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.564 -176.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' B' ' 46' ' ' SER . 23.0 t 77.28 137.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.79 0.836 . . . . 0.0 111.915 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.07 138.19 37.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.95 -32.38 21.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.469 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 C--N 1.32 -0.699 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -166.597 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -122.11 134.06 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.898 0.38 . . . . 0.0 110.458 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.52 125.38 54.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.204 0.526 . . . . 0.0 111.232 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t -77.05 160.22 29.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.304 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.9 t -84.29 19.31 1.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 55.66 -176.42 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.551 0.74 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -111.35 167.39 10.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.876 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -152.53 135.66 15.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -143.94 101.42 3.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.984 0.421 . . . . 0.0 110.258 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -103.52 165.46 11.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -135.54 143.28 45.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.53 -75.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.87 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.237 -179.092 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 25.4 mt-10 -124.26 139.45 53.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.073 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.23 165.23 25.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.071 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.577 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 3.1 m -117.08 114.37 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.57 0.7 . . . . 0.0 109.512 170.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.493 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . 19.2 t80 -60.87 124.76 21.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.483 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 28.2 mt-10 -149.4 134.3 17.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.16 0.287 . . . . 0.0 111.167 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 59.03 28.36 17.6 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.152 0.908 . . . . 0.0 111.465 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.23 -69.37 0.32 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 117.406 -2.33 . . . . 0.0 111.626 -167.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 15' ' ' LYS . 22.3 m -95.58 165.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.382 -0.909 . . . . 0.0 113.397 -157.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.3 m-85 -88.68 116.74 27.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.558 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 51.8 mtpt -113.44 112.05 49.13 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.395 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 Cg_endo -60.19 168.13 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.333 1.355 . . . . 0.0 112.527 -175.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 8' ' ' VAL . 97.2 mt -95.84 1.28 53.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 11.5 pt20 -146.89 156.53 43.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.193 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 23.0 mtpp -81.49 145.08 30.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.551 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG13 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -125.0 139.84 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.947 0.88 . . . . 0.0 111.853 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.37 87.44 5.19 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.208 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' HG13 ' A' ' 20' ' ' VAL . 62.2 mt -131.01 -165.59 1.58 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.27 -2.241 . . . . 0.0 109.448 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -129.27 156.79 43.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.042 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 34.2 mt-10 -69.5 128.93 38.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.209 0.528 . . . . 0.0 110.812 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 14.39 57.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.918 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -75.39 139.72 42.54 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -92.53 114.7 27.32 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 123.335 1.541 . . . . 0.0 112.507 -173.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' B' ' 30' ' ' ILE . 28.7 m -124.45 148.63 28.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.216 -2.266 . . . . 0.0 109.825 -175.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -111.59 139.9 46.65 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -105.77 138.89 28.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.304 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -137.32 153.4 50.27 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' O ' ' B' ' 27' ' ' ARG . 17.3 tp . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.835 -156.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 33.8 mt-10 -58.04 129.41 82.47 Favored Pre-proline 0 N--CA 1.446 -0.659 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 46.6 Cg_exo -56.25 174.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.47 2.78 . . . . 0.0 114.028 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 pt -76.4 146.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.845 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.96 95.22 7.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.691 ' H ' HD22 ' A' ' 41' ' ' LEU . 2.5 pt? -95.69 177.77 5.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.038 -173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.71 114.48 5.03 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.8 mt-10 -75.01 138.24 72.73 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 114.526 -0.837 . . . . 0.0 111.338 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 12.6 Cg_exo -70.0 118.06 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.482 2.121 . . . . 0.0 110.594 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.16 147.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.845 0.355 . . . . 0.0 110.612 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 m -98.09 171.78 8.03 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.94 147.34 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.335 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 41.8 mt-10 -74.96 138.03 42.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.807 0.337 . . . . 0.0 110.598 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 -25.19 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.386 0.612 . . . . 0.0 110.05 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.57 -0.4 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.875 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.563 ' HD2' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.05 0.452 . . . . 0.0 110.635 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.436 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 121.476 0.655 . . . . 0.0 110.015 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' B' ' 18' ' ' GLN . 7.6 mt -109.25 142.77 20.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -99.72 138.89 36.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.293 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.15 160.71 39.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.911 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.01 124.35 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.174 0.512 . . . . 0.0 110.626 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 85.6 t80 -80.19 99.74 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.508 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 73.1 mt-10 -122.74 144.75 48.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 66.37 10.72 7.46 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.434 0.458 . . . . 0.0 111.656 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 86.78 18.93 57.43 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.991 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.0 t -122.12 151.39 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.058 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.6 m-85 -98.58 115.62 29.02 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' B' ' 10' ' ' GLU . 49.1 mtmt -118.16 116.48 35.71 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.914 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 15.7 Cg_endo -61.25 165.96 11.85 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 121.688 1.592 . . . . 0.0 113.531 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.0 -66.06 0.96 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.283 -2.689 . . . . 0.0 104.945 162.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.516 ' HB2' ' CG2' ' B' ' 5' ' ' ILE . 14.7 mp0 -59.67 158.63 9.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.276 -1.783 . . . . 0.0 111.134 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.416 ' HZ3' ' HB2' ' B' ' 21' ' ' ASP . 14.1 tmtt? -76.83 128.39 34.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 110.531 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.412 ' HB ' ' OH ' ' A' ' 9' ' ' TYR . 8.7 t -124.44 150.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.374 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . 0.416 ' HB2' ' HZ3' ' B' ' 19' ' ' LYS . 14.2 t70 -127.15 15.2 7.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.916 0.865 . . . . 0.0 110.88 -170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.484 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 94.9 mt -71.25 163.99 26.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.58 -173.63 2.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.354 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 7.2 mp0 -63.15 141.97 58.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.321 0.581 . . . . 0.0 111.806 -175.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 45.9 64.55 2.38 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.218 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 4.1 mm-40 -103.81 134.42 47.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.521 -0.839 . . . . 0.0 110.032 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.468 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.1 mmm-85 -82.64 115.98 21.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.336 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.776 HG23 ' HD1' ' A' ' 14' ' ' PHE . 30.0 m -140.42 152.04 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.585 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 59.4 mttm -115.32 141.83 47.51 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.204 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.605 HG21 ' HB ' ' A' ' 28' ' ' VAL . 1.5 mm -118.94 142.44 33.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.562 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.445 ' HD2' HG22 ' A' ' 4' ' ' ILE . 62.0 tttm -155.3 126.45 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.244 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.578 ' HG ' HG12 ' A' ' 28' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.167 0.508 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.44 171.29 5.8 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.422 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.65 171.87 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.752 1.634 . . . . 0.0 111.873 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.5 176.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.83 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -114.12 147.99 37.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.174 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.606 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.4 pt? -113.32 144.64 42.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.122 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.58 122.04 7.29 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.808 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.1 pt-20 -55.92 141.73 66.29 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.999 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 3.0 Cg_exo -75.18 -170.63 0.82 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.062 2.508 . . . . 0.0 112.269 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.98 156.25 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.297 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -83.32 172.21 12.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.62 148.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.643 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -50.57 119.85 4.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.329 0.585 . . . . 0.0 111.917 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -85.91 -26.04 25.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.179 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.347 -174.122 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.775 0.322 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -129.2 133.22 47.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.216 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 1.2 tpt -114.07 127.45 55.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.767 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -88.68 167.62 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 26.5 t -81.7 20.22 0.96 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.075 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 70.3 mt 62.9 -165.74 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.272 0.629 . . . . 0.0 111.205 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -123.64 134.25 53.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -93.35 120.22 33.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.954 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -57.26 137.58 55.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.491 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -79.79 139.58 37.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.021 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -131.61 117.99 19.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -81.43 123.38 28.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.941 176.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 112.495 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.62 HG23 HG22 ' A' ' 20' ' ' VAL . 22.8 mm -106.14 168.93 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 46.5 mt-10 -124.76 160.03 29.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.318 0.508 . . . . 0.0 110.706 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.65 158.56 34.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.782 0.433 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.5 117.86 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.635 0.731 . . . . 0.0 110.44 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 51.3 t80 -82.69 113.05 20.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.131 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' B' ' 24' ' ' GLU . 0.4 OUTLIER -137.97 146.14 42.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.994 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 57.59 26.31 12.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 80.31 20.96 65.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.008 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.6 t -130.59 152.84 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.227 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 91.4 m-85 -104.64 114.01 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -104.79 106.39 54.78 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.429 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -39.83 168.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.963 3.109 . . . . 0.0 117.758 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.883 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 96.5 mt -131.72 96.99 4.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 111.621 -2.536 . . . . 0.0 105.518 168.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.883 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 4.4 pp0? 77.66 -176.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.476 2.31 . . . . 0.0 112.02 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.88 137.78 44.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -159.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 5' ' ' ILE . 2.5 t -141.6 134.18 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.103 170.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -131.14 87.76 2.51 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.829 1.3 . . . . 0.0 108.6 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 HD12 HD23 ' B' ' 32' ' ' LEU . 57.2 mt -123.11 -179.05 4.15 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 112.178 -2.283 . . . . 0.0 110.967 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 26' ' ' GLU . 18.9 pttp -114.28 162.65 16.31 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 46.3 mt-10 -65.76 133.7 51.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 122.025 0.917 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.61 64.93 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.082 -165.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 2.0 mm-40 -114.82 139.87 49.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.208 -0.996 . . . . 0.0 109.708 168.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -100.17 124.87 46.09 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 123.008 1.385 . . . . 0.0 112.354 -175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' B' ' 30' ' ' ILE . 33.5 m -133.6 150.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.107 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -105.43 138.5 41.53 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.577 0.703 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.47 HG22 ' CE1' ' A' ' 14' ' ' PHE . 20.6 mm -110.2 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.98 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.1 156.29 34.05 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.514 HD11 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.2 pm0 -90.59 148.81 39.5 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 173.43 11.96 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.165 1.91 . . . . 0.0 112.149 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.24 153.18 24.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.67 72.04 0.96 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.6 tp -91.04 135.65 33.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.659 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.7 111.34 3.8 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.5 tt0 -93.42 113.06 59.13 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.525 -0.838 . . . . 0.0 110.469 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 6.3 Cg_exo -73.78 113.82 3.88 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.863 2.375 . . . . 0.0 112.204 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 46' ' ' SER . 8.4 p -114.14 163.15 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.526 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 45' ' ' VAL . 4.3 m -66.67 160.17 26.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.258 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.99 134.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.115 0.483 . . . . 0.0 110.577 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 31.7 mt-10 -126.0 121.57 33.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.966 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.2 -25.57 27.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.695 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -88.43 1.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.669 0.747 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.634 ' HE2' ' HB2' ' A' ' 48' ' ' GLU . 25.1 ttmm . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.986 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.626 0 CA-C-O 121.245 0.545 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' B' ' 18' ' ' GLN . 4.4 mt -114.84 168.07 6.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -132.41 136.4 46.74 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -133.83 155.76 49.25 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.374 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.67 HG13 HD12 ' B' ' 17' ' ' LEU . 7.1 m -110.06 121.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.316 0.579 . . . . 0.0 111.006 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 21.3 t80 -61.02 111.23 1.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.982 171.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -136.11 129.3 31.61 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.969 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . 0.405 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 1.2 t-20 55.02 27.84 9.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.77 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.97 -68.27 0.22 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 117.688 -2.196 . . . . 0.0 111.26 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.67 154.96 3.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.522 -1.339 . . . . 0.0 111.678 -157.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 89.3 m-85 -88.72 122.16 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 0.0 112.031 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.73 119.03 51.64 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 34.1 Cg_endo -66.13 168.71 15.12 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.462 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.67 HD12 HG13 ' B' ' 8' ' ' VAL . 4.9 mp -113.21 -5.72 13.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.528 ' HB2' HG21 ' B' ' 5' ' ' ILE . 18.8 mp0 -116.68 143.35 45.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.356 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -72.57 126.75 30.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.9 t -88.27 145.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.244 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -111.52 14.98 21.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.008 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.539 HD12 ' HG2' ' B' ' 26' ' ' GLU . 80.2 mt -90.57 -168.62 2.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.314 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 15.1 tmtt? -111.81 155.4 23.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.43 ' N ' ' HD3' ' B' ' 23' ' ' LYS . 1.9 mp0 -57.89 133.17 55.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.924 0.869 . . . . 0.0 112.201 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.37 65.5 3.5 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 114.106 -1.407 . . . . 0.0 110.381 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.539 ' HG2' HD12 ' B' ' 22' ' ' LEU . 10.0 tp10 -92.92 149.13 21.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.686 -0.757 . . . . 0.0 110.958 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.55 104.94 17.19 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.532 1.158 . . . . 0.0 111.376 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 32' ' ' LEU . 34.9 m -124.7 154.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.407 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.515 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 41.4 mttp -119.43 148.0 43.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.495 0.664 . . . . 0.0 110.076 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.467 ' CG2' ' HB ' ' A' ' 28' ' ' VAL . 7.8 mt -128.55 153.38 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.129 -170.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -150.88 159.33 44.62 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.582 HD23 HD12 ' A' ' 22' ' ' LEU . 8.3 mt . . . . . 0 C--N 1.315 -0.926 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -173.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.7 mt-10 -60.16 141.93 90.11 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 32.8 Cg_exo -61.88 174.39 2.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.186 2.591 . . . . 0.0 113.773 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.09 171.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.127 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -93.4 -151.57 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.493 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.77 -170.53 2.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.42 141.41 10.4 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.46 155.06 85.82 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 120.573 0.225 . . . . 0.0 110.896 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.25 164.72 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.44 2.093 . . . . 0.0 110.11 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.67 134.99 8.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 122.001 0.905 . . . . 0.0 112.099 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -86.51 172.44 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.021 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.78 131.54 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.97 118.9 20.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.0 110.747 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -85.61 -25.47 26.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.588 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 tt . . . . . 0 C--N 1.317 -0.816 0 CA-C-O 121.616 0.722 . . . . 0.0 110.8 -175.065 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -110.45 135.74 50.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.739 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.39 148.7 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.483 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.1 p -142.54 149.52 39.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.032 0.444 . . . . 0.0 111.207 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 46.1 t -95.3 13.91 24.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.65 94.39 9.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.425 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.07 86.55 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -98.81 58.22 1.16 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.239 0.542 . . . . 0.0 111.624 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -68.92 116.24 9.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.23 102.57 14.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.63 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -78.81 112.94 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -109.94 129.88 55.6 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.055 -174.322 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' HG2' ' B' ' 31' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.615 HD12 HD12 ' A' ' 22' ' ' LEU . 4.6 mt -106.1 148.18 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.926 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' H ' ' NE2' ' A' ' 18' ' ' GLN . 44.9 mt-10 -102.52 123.08 45.61 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -143.07 168.52 19.55 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 10.6 m -129.68 129.73 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.018 0.437 . . . . 0.0 110.785 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.499 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 20.0 t80 -59.77 128.85 38.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 37.7 tt0 -139.79 109.04 6.1 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.496 0.665 . . . . 0.0 111.494 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.0 t30 55.7 27.33 10.5 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.324 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.9 -70.01 0.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 118.158 -1.972 . . . . 0.0 110.731 -165.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' B' ' 13' ' ' VAL . 23.2 m -94.34 145.36 8.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 113.649 -1.276 . . . . 0.0 112.201 -160.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.809 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.5 m-85 -86.82 116.76 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.333 0.587 . . . . 0.0 110.169 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.544 ' HE3' ' CG2' ' A' ' 13' ' ' VAL . 34.5 mmtp -105.12 116.58 60.34 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.153 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 13.6 Cg_endo -59.93 169.0 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.41 1.407 . . . . 0.0 111.997 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.496 HD11 HG11 ' A' ' 8' ' ' VAL . 7.4 mp -102.23 -8.73 21.04 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 6' ' ' GLU . 4.5 pm0 -145.47 170.49 16.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.433 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -63.49 128.01 33.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.061 0.934 . . . . 0.0 112.204 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.479 HG22 HD13 ' A' ' 5' ' ' ILE . 4.9 p -132.87 141.36 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.714 173.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -148.14 87.85 1.63 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.358 -1.746 . . . . 0.0 108.867 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.814 HD13 HD13 ' B' ' 32' ' ' LEU . 67.4 mt -106.63 0.72 24.63 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.853 -1.976 . . . . 0.0 109.647 171.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 85.14 171.99 0.07 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 113.191 173.022 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.7 mp0 -78.43 134.92 37.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.502 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.42 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 51.94 63.87 4.43 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -166.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 22' ' ' LEU . 7.4 tp10 -113.56 137.7 51.21 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.803 -1.199 . . . . 0.0 107.927 170.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -100.53 117.8 35.41 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 123.124 1.44 . . . . 0.0 112.996 -164.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.608 HG12 HD11 ' B' ' 32' ' ' LEU . 16.0 m -134.84 158.07 41.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 112.149 -2.296 . . . . 0.0 109.483 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.701 ' HD3' HG13 ' B' ' 4' ' ' ILE . 87.3 mttt -120.95 138.38 54.16 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 122.047 0.927 . . . . 0.0 111.101 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 14' ' ' PHE . 8.8 mm -103.57 149.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.204 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.658 ' HD2' ' HZ3' ' B' ' 31' ' ' LYS . 7.7 ptpt -156.3 162.37 40.11 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.734 HD22 HG11 ' B' ' 28' ' ' VAL . 52.3 mt . . . . . 0 C--N 1.308 -1.223 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.723 -171.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.94 137.18 22.34 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-O 121.21 0.529 . . . . 0.0 112.152 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.28 177.34 7.23 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.772 2.315 . . . . 0.0 111.117 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.4 pp -87.82 147.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.119 0.485 . . . . 0.0 111.952 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -99.03 172.08 7.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.096 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.8 pt? -98.56 130.57 45.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.41 -154.57 17.65 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.844 -170.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.86 153.65 60.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.718 -173.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.36 171.03 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.736 2.291 . . . . 0.0 112.565 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.71 148.94 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.598 . . . . 0.0 110.465 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.532 ' O ' HG12 ' A' ' 47' ' ' VAL . 45.5 m -120.81 175.92 5.8 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.18 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 64.57 154.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.477 1.111 . . . . 0.0 113.029 177.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.6 mm-40 66.27 -36.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.663 1.185 . . . . 0.0 113.928 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' VAL . 7.4 tp10 -71.75 -26.02 62.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.492 0.663 . . . . 0.0 109.704 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mm -90.24 -4.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.053 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 51' ' ' LYS . 2.2 ttpm? . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.701 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 121.339 0.59 . . . . 0.0 110.457 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.602 HD11 HG21 ' B' ' 20' ' ' VAL . 6.9 mt -101.44 151.8 5.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 42.9 mt-10 -113.55 134.24 54.81 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.27 151.08 40.13 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.538 0.523 . . . . 0.0 109.98 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.7 m -116.19 125.81 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.477 0.656 . . . . 0.0 110.377 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 43.4 t80 -75.99 121.97 23.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.44 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.37 135.98 34.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.57 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t30 63.04 20.61 12.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 91.08 13.06 59.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.743 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 9.1 t -120.69 153.24 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.337 0.255 . . . . 0.0 110.408 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.809 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.4 m-85 -109.0 115.34 29.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.054 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -109.05 115.95 56.18 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.99 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 41.8 Cg_endo -68.81 168.14 21.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.832 1.021 . . . . 0.0 112.186 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.42 HD12 HG12 ' B' ' 8' ' ' VAL . 5.3 mp -112.08 -12.6 13.66 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.486 ' HB2' HG23 ' B' ' 5' ' ' ILE . 0.8 OUTLIER -102.59 139.45 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.484 171.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -80.31 132.76 35.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 110.396 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.602 HG21 HD11 ' B' ' 5' ' ' ILE . 1.5 t -127.47 136.36 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.466 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.77 87.34 2.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.828 1.299 . . . . 0.0 108.186 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.562 ' HG ' HG11 ' B' ' 20' ' ' VAL . 47.2 mt -122.43 -178.44 3.9 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.533 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -102.62 161.96 13.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 mp0 -71.87 119.11 15.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 97.89 14.93 38.22 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.884 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.521 ' HG3' HD23 ' B' ' 22' ' ' LEU . 5.3 mm-40 -71.4 133.42 45.93 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 120.77 35.24 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 123.298 1.523 . . . . 0.0 112.819 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 32' ' ' LEU . 32.8 m -138.95 162.65 28.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 112.291 -2.231 . . . . 0.0 110.489 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -122.3 139.46 53.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.689 0.757 . . . . 0.0 109.246 172.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 28' ' ' VAL . 6.2 mt -102.9 136.34 35.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.98 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.912 ' HG2' HG21 ' A' ' 4' ' ' ILE . 19.8 mttt -137.02 147.14 46.03 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.634 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.814 HD13 HD13 ' A' ' 22' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.372 -169.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.45 114.84 7.35 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.087 0.47 . . . . 0.0 111.917 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.76 -173.12 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.947 2.431 . . . . 0.0 112.128 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.14 155.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.965 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -92.71 159.95 15.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.149 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.65 165.77 26.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.193 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.41 -136.7 5.56 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.557 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -112.9 161.87 24.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 122.282 0.233 . . . . 0.0 110.953 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.88 167.66 24.85 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.402 2.068 . . . . 0.0 111.848 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.05 151.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -98.81 170.18 8.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.016 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.89 138.0 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -119.62 -23.37 6.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.232 0.539 . . . . 0.0 111.123 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.21 -25.23 65.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.983 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 121.194 0.521 . . . . 0.0 111.919 -173.221 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -83.33 171.29 13.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.4 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 19.3 ptp -84.69 169.56 14.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.852 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -73.38 -177.15 2.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.8 m -105.32 4.06 30.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.741 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 67.4 mt 59.01 -171.23 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.392 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.51 136.11 50.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.127 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -118.2 85.1 2.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.786 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.21 127.76 32.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.114 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' B' ' 67' ' ' HIS . 52.5 m80 -96.04 147.67 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' B' ' 66' ' ' HIS . 60.6 m170 72.16 157.61 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.881 0.738 . . . . 0.0 109.465 -168.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -91.29 0.75 57.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.418 0.627 . . . . 0.0 109.781 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 C--O 1.247 0.95 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.888 178.584 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.616 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.182 0.515 . . . . 0.0 111.623 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -105.1 146.76 11.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -103.02 137.2 41.53 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.82 160.33 40.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.838 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.4 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.555 0.693 . . . . 0.0 110.425 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.6 t80 -72.92 110.41 7.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.638 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 36.9 mt-10 -134.2 144.46 48.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.398 177.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 62.62 22.4 13.3 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.441 0.463 . . . . 0.0 111.374 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 79.43 18.55 73.51 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.914 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 9.8 t -127.42 150.72 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.706 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 63.4 m-85 -95.55 115.0 26.81 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.287 168.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 50.8 mtpt -113.99 108.64 50.6 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.594 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 27.7 Cg_endo -62.52 169.22 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.35 1.366 . . . . 0.0 112.781 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.2 -16.29 14.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -107.68 137.37 45.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.558 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -75.96 124.58 27.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.644 0.735 . . . . 0.0 109.98 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.648 ' HB ' ' CE2' ' B' ' 9' ' ' TYR . 3.6 t -103.12 147.48 9.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.591 -175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.76 16.1 13.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.121 0.962 . . . . 0.0 110.345 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 HD22 ' B' ' 32' ' ' LEU . 96.7 mt -73.84 -174.37 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.773 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -110.97 171.86 7.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.341 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -73.29 141.74 47.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.459 0.647 . . . . 0.0 110.575 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.733 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 54.52 64.77 4.02 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.703 -167.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 22' ' ' LEU . 7.8 tp10 -105.98 123.15 47.52 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.478 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -77.88 111.3 13.58 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 122.654 1.216 . . . . 0.0 112.747 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.618 HG11 ' HG ' ' B' ' 32' ' ' LEU . 27.1 m -133.32 155.55 40.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.603 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.96 ' HD3' HG13 ' B' ' 4' ' ' ILE . 64.3 mttm -113.03 149.05 33.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.542 HG23 ' CE1' ' A' ' 14' ' ' PHE . 4.0 mm -104.59 130.25 55.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.277 0.561 . . . . 0.0 109.627 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE3' HG21 ' B' ' 4' ' ' ILE . 75.2 mttt -132.81 134.45 44.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.545 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.694 ' HB3' HG11 ' B' ' 28' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.913 -169.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 mm-40 -81.27 123.05 81.78 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.848 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.3 Cg_exo -77.79 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.543 2.829 . . . . 0.0 113.256 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.2 pt -68.05 165.3 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.89 149.54 52.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.05 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.9 tp -100.52 135.12 42.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 111.379 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 156.38 24.51 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.039 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.44 150.7 73.95 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.36 -0.92 . . . . 0.0 111.868 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 159.03 35.5 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.761 2.307 . . . . 0.0 111.951 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.28 155.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -90.28 174.09 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.43 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.63 164.67 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.37 121.0 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.567 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -85.56 -28.83 24.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.133 0.492 . . . . 0.0 111.088 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.9 tt -93.65 -0.77 10.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.604 0.716 . . . . 0.0 110.774 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 tptm . . . . . 0 C--N 1.319 -0.75 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.726 -176.277 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.96 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.872 0 CA-C-O 120.985 0.421 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.5 HG22 ' HB2' ' B' ' 18' ' ' GLN . 6.6 mt -97.78 144.24 11.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 51.4 mp0 -104.9 141.32 36.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.682 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -139.87 166.26 25.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.108 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.733 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.4 m -121.36 123.48 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.612 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.648 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.2 t80 -61.55 126.16 26.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.831 173.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 81.1 mt-10 -137.09 111.52 8.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.018 0.437 . . . . 0.0 111.294 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 55.5 29.12 12.78 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.032 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.04 -69.78 0.48 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 118.215 -1.945 . . . . 0.0 110.845 -168.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.15 145.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.784 -1.208 . . . . 0.0 111.823 -161.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.706 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -92.83 116.74 29.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.63 120.77 56.68 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.561 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 28.8 Cg_endo -64.82 170.05 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.316 1.344 . . . . 0.0 112.533 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.569 HD12 HG12 ' B' ' 8' ' ' VAL . 6.0 mp -108.92 -10.67 15.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.5 ' HB2' HG22 ' B' ' 5' ' ' ILE . 47.0 mt-30 -115.48 145.26 42.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.866 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -73.42 151.57 41.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.953 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.44 HG11 ' H ' ' B' ' 22' ' ' LEU . 2.5 t -112.54 145.25 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.67 16.61 9.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.36 1.076 . . . . 0.0 109.519 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.533 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 88.6 mt -86.36 -165.93 1.4 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.188 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.532 ' CG ' ' HG2' ' B' ' 26' ' ' GLU . 23.6 pttp -116.32 155.08 29.06 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.379 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.1 132.5 45.16 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.885 0.85 . . . . 0.0 109.836 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.02 65.03 2.75 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.617 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 1.9 mm-40 -112.06 132.96 54.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.254 -0.973 . . . . 0.0 109.221 170.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -90.41 119.48 30.73 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.704 0.764 . . . . 0.0 110.869 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.694 HG11 ' HB3' ' A' ' 32' ' ' LEU . 29.8 m -140.11 166.81 19.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.467 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.616 ' HD3' HG13 ' A' ' 4' ' ' ILE . 60.9 mttm -122.03 153.93 37.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.23 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.417 HG21 ' HB ' ' A' ' 28' ' ' VAL . 5.8 mm -115.44 142.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -151.34 125.05 9.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.618 ' HG ' HG11 ' A' ' 28' ' ' VAL . 3.2 mp . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -143.63 89.08 7.56 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.527 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.65 -161.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.304 2.669 . . . . 0.0 112.712 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.34 156.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -91.81 -51.28 5.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.801 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 45.1 tp 68.8 116.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.278 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.77 -142.5 10.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.969 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.83 158.19 38.39 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 122.252 0.221 . . . . 0.0 111.177 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.09 174.27 12.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.025 2.483 . . . . 0.0 112.253 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.69 154.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 10.4 m -89.32 171.84 9.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.39 138.17 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.405 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.02 -30.67 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.692 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.84 -24.49 66.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.957 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.375 0.607 . . . . 0.0 110.944 -178.444 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' B' ' 59' ' ' MET . 1.3 m-90 -110.56 -168.77 1.35 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.343 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' B' ' 58' ' ' TRP . 66.6 mtt 73.64 172.42 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.831 0.853 . . . . 0.0 110.31 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m 57.09 26.18 11.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.076 0.465 . . . . 0.0 111.735 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.8 p -82.22 16.93 1.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.003 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 45.43 99.89 0.01 OUTLIER 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.119 0.967 . . . . 0.0 113.223 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -82.83 172.4 12.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.09 123.74 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.263 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -97.23 141.22 30.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -71.14 129.92 40.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 111.639 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -71.83 86.78 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -83.77 73.92 10.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.5 0.667 . . . . 0.0 111.167 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.8 m170 . . . . . 0 C--O 1.246 0.891 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.538 177.011 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.249 0.547 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 20' ' ' VAL . 4.6 mt -105.59 152.65 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.109 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 30.1 mt-10 -112.94 108.05 16.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -110.16 167.14 10.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.41 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 3.8 m -118.02 117.39 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.637 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 73.5 t80 -70.38 114.85 8.9 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.868 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 11.6 tt0 -88.05 -170.69 3.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.324 -2.216 . . . . 0.0 107.402 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 10.9 t30 -67.44 49.75 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.713 0.805 . . . . 0.0 112.135 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 10' ' ' GLU . . . 119.69 4.58 11.65 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.2 t -117.32 155.12 19.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.298 -175.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 1.06 ' HB2' ' HB3' ' B' ' 14' ' ' PHE . 81.2 m-85 -122.81 119.15 29.72 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.306 164.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.07 121.02 37.52 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -67.07 167.58 19.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.105 1.203 . . . . 0.0 111.23 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.04 -2.65 14.99 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.52 ' HB2' HG21 ' A' ' 5' ' ' ILE . 40.5 mt-30 -119.24 144.17 46.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.683 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.8 141.19 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 5' ' ' ILE . 4.1 p -132.56 161.77 40.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.843 0.83 . . . . 0.0 112.028 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -104.9 12.84 32.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.198 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.64 HD12 ' CG2' ' A' ' 20' ' ' VAL . 6.9 mp -66.8 135.61 54.2 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.427 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.925 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.7 mmpt? -93.67 -172.26 2.84 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.523 -176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -61.63 160.52 11.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.895 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -19.72 72.63 0.0 OUTLIER Glycine 0 CA--C 1.495 -1.217 0 O-C-N 124.997 1.435 . . . . 0.0 114.132 -151.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.11 147.51 40.49 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 111.526 -2.337 . . . . 0.0 108.602 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HG3' HD21 ' B' ' 32' ' ' LEU . 13.2 tpt180 -88.14 119.17 28.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.866 ' HA ' ' CB ' ' B' ' 32' ' ' LEU . 0.0 OUTLIER -144.61 149.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.255 -174.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HB2' HD13 ' B' ' 32' ' ' LEU . 13.6 mttt -115.21 143.96 44.43 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.365 0.602 . . . . 0.0 110.286 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.693 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 1.5 mt -107.34 135.12 47.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.707 ' HG2' ' HB2' ' B' ' 29' ' ' LYS . 7.5 ptmm? -106.82 143.79 34.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD21 HD23 ' B' ' 22' ' ' LEU . 21.9 tp . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.234 0.253 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.74 138.22 22.91 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.38 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.62 -174.34 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.718 2.279 . . . . 0.0 110.657 171.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.32 151.61 27.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.923 0.392 . . . . 0.0 111.179 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tt -67.99 110.26 3.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.137 0.494 . . . . 0.0 110.902 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.34 114.5 0.71 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -131.89 161.72 60.82 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 122.462 0.305 . . . . 0.0 110.475 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.69 164.84 31.61 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.686 2.257 . . . . 0.0 111.515 173.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.86 148.37 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.4 m -103.59 176.89 5.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.103 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.6 156.92 43.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.03 130.07 39.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.085 0.469 . . . . 0.0 110.227 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -85.43 -25.98 26.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.257 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -70.9 -16.1 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.533 0.682 . . . . 0.0 111.206 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.436 -1.131 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.873 179.087 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' B' ' 18' ' ' GLN . 10.4 mm -113.14 146.43 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -109.39 131.21 55.28 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.616 ' HB3' ' CE2' ' B' ' 14' ' ' PHE . . . -143.12 164.33 30.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 0.0 111.248 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.22 128.87 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.282 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 41.2 t80 -84.76 100.85 11.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -115.12 120.42 39.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.859 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.32 33.29 9.19 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.965 0.79 . . . . 0.0 111.35 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' B' ' 9' ' ' TYR . . . 83.56 14.28 73.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.211 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.5 t -120.12 146.7 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 1.06 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -99.93 114.94 28.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -119.0 108.96 39.91 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.637 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 39.2 Cg_endo -68.85 168.27 20.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.467 1.445 . . . . 0.0 112.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.36 -9.55 17.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.492 ' HB2' HG23 ' B' ' 5' ' ' ILE . 72.4 mt-30 -102.38 145.69 29.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.205 173.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -84.39 124.19 31.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 163.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.637 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.7 t -90.57 148.93 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.431 -161.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.42 16.38 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.027 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.813 HD23 HD21 ' A' ' 32' ' ' LEU . 22.1 mt -99.76 -174.62 2.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.089 -173.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' B' ' 26' ' ' GLU . 37.8 tttm -116.28 155.12 28.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.267 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 1.5 mp0 -62.64 123.46 18.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.049 0.452 . . . . 0.0 109.955 175.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.73 22.92 34.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.036 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.521 ' HG3' HD22 ' B' ' 22' ' ' LEU . 16.9 mm-40 -84.02 143.02 30.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -86.28 120.51 27.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.4 1.095 . . . . 0.0 112.442 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.693 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 34.6 m -136.07 151.55 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.832 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.707 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 47.7 mmtt -117.35 144.63 44.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 18.7 mt -133.12 137.08 54.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.807 0.813 . . . . 0.0 111.967 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -158.16 135.85 10.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.155 169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.866 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 8.8 tp . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -131.34 114.82 16.03 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 120.876 0.37 . . . . 0.0 110.889 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.11 -175.83 2.37 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.158 2.572 . . . . 0.0 112.289 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt 69.27 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.435 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.46 ' OD2' ' HG ' ' B' ' 41' ' ' LEU . 36.2 t70 -155.4 -69.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.862 -173.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.46 ' HG ' ' OD2' ' B' ' 40' ' ' ASP . 94.3 mt -100.04 168.0 10.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.274 0.559 . . . . 0.0 112.147 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 120.93 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.693 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 36.1 mm-40 -97.11 144.18 27.44 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.579 0.228 . . . . 0.0 111.123 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.71 156.15 64.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.98 2.453 . . . . 0.0 112.279 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.49 158.79 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.936 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -87.27 168.24 13.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.88 162.4 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.353 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.36 122.95 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.965 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.13 25.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.023 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 C--N 1.319 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.721 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -95.9 143.14 27.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 120.991 0.424 . . . . 0.0 111.1 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.52 124.65 48.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.61 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.1 t -79.86 148.52 31.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 110.424 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 2.8 p -94.82 -0.09 54.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 61' ' ' SER . 1.0 OUTLIER 39.7 84.58 0.02 OUTLIER 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.651 1.219 . . . . 0.0 112.947 -178.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 100.91 0.16 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.244 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -85.01 57.91 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.17 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -70.29 108.18 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.138 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 134.31 22.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -120.2 117.27 27.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -78.57 142.21 37.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.453 178.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.875 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 CA-C-O 121.262 0.553 . . . . 0.0 112.235 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 mt -93.54 145.54 7.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -99.54 109.72 22.23 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.195 -169.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.933 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -115.68 156.97 24.95 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -166.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.596 HG23 HH12 ' B' ' 27' ' ' ARG . 0.1 OUTLIER -123.31 123.62 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.709 171.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.723 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.5 t80 -80.37 105.63 11.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 50.0 mt-10 -126.83 139.69 52.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.569 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.44 ' H ' ' CG ' ' B' ' 24' ' ' GLU . 4.6 t30 65.36 20.37 11.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 111.554 172.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 84.25 15.62 68.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.5 t -122.48 154.08 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.833 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.7 m-85 -99.43 114.64 27.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 165.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -116.97 108.92 43.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.108 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.933 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 14.4 Cg_endo -72.75 169.17 22.63 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 113.491 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.36 -12.37 59.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.688 ' HG2' ' HG2' ' A' ' 16' ' ' PRO . 6.2 mm-40 75.1 -134.05 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.0 116.731 160.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.0 mttt 59.07 -161.25 0.26 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.454 -141.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' A' ' 22' ' ' LEU . 22.0 t 67.01 147.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.484 0.659 . . . . 0.0 110.435 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.03 26.74 3.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.684 0.754 . . . . 0.0 111.252 -171.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HG ' ' CG1' ' A' ' 20' ' ' VAL . 94.7 mt -56.85 174.81 0.14 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.832 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -103.84 162.68 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 1.5 pm0 -83.62 149.57 26.45 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.82 73.06 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.695 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.687 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 21.5 tt0 -93.1 155.4 17.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -96.33 137.45 35.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.747 0.784 . . . . 0.0 112.465 -171.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' B' ' 32' ' ' LEU . 4.4 m -147.97 171.39 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HD3' HG13 ' B' ' 4' ' ' ILE . 62.5 mttm -127.0 144.74 50.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.188 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.654 HG22 ' HB ' ' B' ' 28' ' ' VAL . 1.3 mm -113.05 131.55 64.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.765 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -121.57 124.29 44.01 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.801 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 12.4 pt-20 41.83 84.23 0.19 Allowed Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 124.298 1.039 . . . . 0.0 111.591 -171.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.24 174.39 8.16 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.465 2.776 . . . . 0.0 113.631 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mt -73.89 149.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.095 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -99.28 101.66 13.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.772 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 19.7 tp -83.13 -177.58 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -172.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.772 ' H ' ' HG ' ' A' ' 41' ' ' LEU . . . -150.05 156.42 26.73 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.7 mp0 -54.6 124.1 47.71 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 123.785 0.344 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.37 128.25 29.28 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.497 2.131 . . . . 0.0 111.521 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.85 143.93 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.886 0.85 . . . . 0.0 111.661 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -114.47 162.15 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.77 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.561 0.696 . . . . 0.0 111.456 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.31 -14.42 25.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.811 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.0 -27.22 68.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.537 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -93.12 -14.84 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -174.635 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.576 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 30' ' ' ILE . 9.0 mm -98.13 143.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -104.86 134.98 47.07 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -137.27 156.29 48.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.536 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.467 HG23 HD12 ' B' ' 17' ' ' LEU . 2.0 m -117.17 114.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 14.1 p90 -103.52 141.88 35.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.186 0.993 . . . . 0.0 113.25 -170.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -87.58 -170.98 3.24 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.582 172.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.7 63.45 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 O-C-N 124.504 1.127 . . . . 0.0 111.722 -171.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 113.06 -5.71 25.46 Favored Glycine 0 C--N 1.301 -1.413 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.382 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' B' ' 9' ' ' TYR . 0.2 OUTLIER -104.37 139.02 26.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.437 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.833 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 42.5 m-85 -118.68 123.87 45.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.188 0.904 . . . . 0.0 111.353 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -122.79 117.32 28.75 Favored Pre-proline 0 N--CA 1.455 -0.184 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.527 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.4 Cg_endo -67.83 169.14 16.83 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.984 1.789 . . . . 0.0 113.74 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.467 HD12 HG23 ' B' ' 8' ' ' VAL . 4.7 mp -120.58 -17.81 7.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.432 171.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.42 146.97 24.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -62.96 148.54 47.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.438 0.637 . . . . 0.0 110.559 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.511 HG12 ' HH ' ' A' ' 9' ' ' TYR . 2.3 p -145.17 134.53 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 122.338 1.066 . . . . 0.0 111.818 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -121.13 15.08 11.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.709 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.417 ' HG ' HG21 ' B' ' 20' ' ' VAL . 85.7 mt -66.39 167.22 10.92 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.09 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -112.68 160.4 17.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -173.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 2.3 mp0 -62.77 120.23 10.87 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.905 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.2 36.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.974 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -75.89 136.4 40.12 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.942 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.596 HH12 HG23 ' A' ' 8' ' ' VAL . 18.3 tpp180 -93.39 117.39 30.02 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.567 1.175 . . . . 0.0 112.522 -171.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.654 ' HB ' HG22 ' A' ' 30' ' ' ILE . 19.8 m -141.79 158.25 21.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.459 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.875 ' HD3' HG13 ' A' ' 4' ' ' ILE . 52.5 mttp -120.76 147.2 45.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.813 HG22 ' CE2' ' B' ' 14' ' ' PHE . 1.3 mm -110.68 132.26 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.145 0.498 . . . . 0.0 110.976 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HG3' HG21 ' A' ' 4' ' ' ILE . 10.5 mtmt -118.56 136.86 53.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 171.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.874 ' HA ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.08 -174.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 122.115 0.959 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -119.75 139.41 28.0 Favored Pre-proline 0 N--CA 1.435 -1.215 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.749 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.4 174.19 12.54 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 111.769 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.522 HD11 ' O ' ' B' ' 39' ' ' ILE . 1.9 pp -81.4 137.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -107.08 119.26 38.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.2 mt -134.32 168.89 18.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.262 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 118.14 2.64 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.93 139.8 31.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 123.174 0.59 . . . . 0.0 111.572 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 130.2 37.33 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.637 2.225 . . . . 0.0 111.761 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.24 151.95 8.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.065 0.459 . . . . 0.0 110.476 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -94.3 169.71 10.03 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.884 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 132.84 65.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.503 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -72.46 120.01 17.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.264 0.554 . . . . 0.0 110.841 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.84 -23.33 48.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.365 -173.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -132.17 135.91 46.69 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.8 ptp -106.18 159.18 16.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.009 0.433 . . . . 0.0 111.066 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -71.14 173.59 7.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.112 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -90.25 -6.51 55.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.828 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 tp 51.1 30.58 5.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.8 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.44 129.62 50.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.03 0.443 . . . . 0.0 110.587 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -133.28 85.87 2.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.546 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -75.05 74.79 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.129 0.966 . . . . 0.0 110.759 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -104.06 111.82 24.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.818 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.55 141.63 51.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.499 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -105.76 137.94 42.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.523 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 9.7 p80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 120.878 0.37 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HB ' HD12 ' B' ' 30' ' ' ILE . 19.4 mt -119.87 152.2 22.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 169.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.57 134.91 48.99 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.678 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.43 165.79 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.44 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.453 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 10.5 m -118.42 127.98 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.27 0.557 . . . . 0.0 110.512 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 86.5 t80 -89.42 105.15 17.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.834 0.826 . . . . 0.0 110.637 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 8.5 pt-20 -91.86 -168.33 1.99 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.79 168.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.78 67.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.436 1.112 . . . . 0.0 112.43 -160.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . 105.38 0.4 40.58 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.012 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 1.9 t -115.16 141.97 29.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.262 -173.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.665 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.5 m-85 -108.31 115.59 30.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 166.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HE3' HG13 ' A' ' 13' ' ' VAL . 96.9 mttt -121.2 119.11 29.78 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.619 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -52.48 166.57 0.75 Allowed 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.382 2.055 . . . . 0.0 114.741 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.3 -67.4 0.99 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 110.215 -3.175 . . . . 0.0 103.655 167.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -71.44 141.73 50.26 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.08 -2.327 . . . . 0.0 108.628 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -60.6 149.63 34.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.697 0.76 . . . . 0.0 112.395 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 m -77.1 166.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.527 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.42 15.21 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.719 0.771 . . . . 0.0 110.148 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.51 HD11 HD21 ' B' ' 32' ' ' LEU . 79.0 mt -122.5 -169.91 1.99 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.378 -172.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 18.3 pttp -124.03 155.12 38.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.974 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.2 pm0 -66.19 134.28 52.41 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.21 0.528 . . . . 0.0 111.002 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.17 10.58 48.22 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.802 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 5.7 tp10 -84.46 146.56 27.56 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.807 -0.231 . . . . 0.0 110.757 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -102.5 125.08 49.1 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.557 1.17 . . . . 0.0 112.334 -175.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.3 m -134.15 156.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.414 -174.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB3' HD13 ' B' ' 4' ' ' ILE . 64.0 mttm -115.33 144.79 43.23 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.0 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.509 HG23 ' CE1' ' A' ' 14' ' ' PHE . 4.5 mm -115.79 144.3 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 -175.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -151.3 123.78 8.41 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.754 ' HB3' HG11 ' B' ' 28' ' ' VAL . 2.7 pt? . . . . . 0 C--N 1.31 -1.126 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.349 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.1 115.6 27.29 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.369 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.86 172.14 11.26 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.211 1.941 . . . . 0.0 112.298 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.57 165.24 32.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.062 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.64 118.37 15.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.903 0.382 . . . . 0.0 110.297 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 41' ' ' LEU . 2.2 pt? -148.82 133.93 18.24 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.875 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.3 -155.07 31.15 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.227 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.13 143.08 32.17 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-O 120.527 0.204 . . . . 0.0 110.704 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.94 142.44 68.8 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.943 2.429 . . . . 0.0 112.112 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.84 146.29 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.914 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -95.73 158.19 15.56 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.054 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.9 t -140.72 132.01 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.234 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -118.99 122.3 41.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.856 0.836 . . . . 0.0 110.954 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.48 -22.98 26.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.104 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 50' ' ' ILE . 25.5 mm -65.07 -3.51 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.532 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 51' ' ' LYS . 6.1 ttpm? . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.441 ' CD1' HG11 ' B' ' 20' ' ' VAL . 1.9 mt -124.45 157.94 31.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . 0.421 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 mt-10 -109.59 139.99 43.93 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.4 157.52 44.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.041 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . 0.633 HG12 HD11 ' B' ' 17' ' ' LEU . 6.0 m -104.26 117.35 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.602 0.715 . . . . 0.0 110.822 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 52.7 t80 -76.57 111.25 11.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.21 1.005 . . . . 0.0 111.181 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.683 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 36.6 mt-10 -88.51 -169.12 2.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.163 170.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.55 55.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.236 1.014 . . . . 0.0 112.349 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.65 6.72 23.01 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.8 t -116.08 149.59 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.885 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.665 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.8 m-85 -119.18 114.87 23.11 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 166.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . 0.443 ' HE2' HG11 ' B' ' 13' ' ' VAL . 65.1 mttm -114.26 113.77 45.93 Favored Pre-proline 0 CA--C 1.506 -0.717 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.23 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -43.56 169.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.318 2.678 . . . . 0.0 116.642 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.941 ' O ' ' HG3' ' B' ' 18' ' ' GLN . 2.5 mt -131.17 103.91 6.76 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.753 167.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.941 ' HG3' ' O ' ' B' ' 17' ' ' LEU . 5.1 pp0? 79.38 178.58 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.068 2.547 . . . . 0.0 112.922 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.23 141.28 35.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -162.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.508 ' HB ' ' HH ' ' A' ' 9' ' ' TYR . 3.2 t -137.79 135.06 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.279 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.511 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -128.08 87.56 2.62 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 123.015 1.388 . . . . 0.0 109.149 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.406 HD13 ' HG2' ' B' ' 26' ' ' GLU . 60.6 mt -129.99 -169.95 2.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.032 -1.894 . . . . 0.0 111.119 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -91.1 -174.72 4.07 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -103.45 122.08 44.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.753 0.787 . . . . 0.0 110.24 170.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 93.02 15.16 53.16 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.409 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.406 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.8 tp10 -60.93 138.46 58.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.604 0.361 . . . . 0.0 110.524 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 0.1 OUTLIER -89.76 115.09 26.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.376 1.084 . . . . 0.0 111.662 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 32' ' ' LEU . 27.4 m -132.33 162.7 39.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.575 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -117.66 147.12 43.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.281 0.562 . . . . 0.0 109.598 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.1 mt -106.7 128.45 61.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.81 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -125.92 134.09 51.67 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 122.556 1.169 . . . . 0.0 108.852 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 22' ' ' LEU . 41.3 tp . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.03 -162.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -86.93 136.02 34.65 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.47 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.91 174.37 9.74 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.415 2.077 . . . . 0.0 111.657 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.22 144.81 8.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.91 -177.07 6.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.5 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.38 143.07 26.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 111.0 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 -123.59 5.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.026 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.3 OUTLIER -101.36 153.47 37.81 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 120.774 0.321 . . . . 0.0 111.055 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 1.8 Cg_endo -87.0 -159.57 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.551 2.834 . . . . 0.0 111.654 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 t -115.04 156.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -75.21 169.68 17.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.844 0.354 . . . . 0.0 111.312 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.04 136.92 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.8 -22.35 21.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.245 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.12 -28.19 67.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.518 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 110.945 -174.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.199 0.523 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.07 178.98 4.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.363 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t 74.91 137.23 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.139 0.899 . . . . 0.0 112.424 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -105.47 18.63 21.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.034 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 67.96 179.05 0.23 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.094 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . 0.512 ' HG2' ' HB2' ' B' ' 65' ' ' HIS . 40.7 tt0 -124.21 121.61 35.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.353 0.596 . . . . 0.0 111.83 -172.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -96.36 74.52 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . 0.512 ' HB2' ' HG2' ' B' ' 63' ' ' GLU . 2.2 t-160 -95.07 -8.91 35.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.736 -170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -99.25 127.49 45.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -139.26 115.57 10.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -73.68 -74.83 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.696 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.897 HG13 ' HD2' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.228 0.537 . . . . 0.0 111.876 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.42 147.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.76 128.51 52.91 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.47 151.57 44.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 6.6 m -115.87 119.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 121.381 0.61 . . . . 0.0 111.063 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 87.2 t80 -72.71 99.71 2.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -119.28 130.95 55.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.397 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.56 23.64 13.89 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.649 0.593 . . . . 0.0 112.035 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 92.1 10.43 61.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.354 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.9 t -122.92 142.83 38.03 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.536 ' CE1' HG22 ' B' ' 28' ' ' VAL . 48.7 m-85 -88.89 114.19 25.24 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 166.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -119.75 116.16 33.23 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.193 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.1 Cg_endo -58.27 166.38 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.33 1.353 . . . . 0.0 111.965 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -98.23 -13.67 20.71 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -122.37 155.36 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.728 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.28 131.85 35.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG12 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -111.26 150.05 13.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.0 14.7 20.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.279 1.038 . . . . 0.0 110.145 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 26' ' ' GLU . 70.4 mt -79.06 176.75 9.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.577 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HG2' ' OE1' ' A' ' 26' ' ' GLU . 17.5 pttm -124.95 163.11 23.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 111.537 -172.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.9 pt-20 -66.24 116.92 7.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.85 14.91 14.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.646 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 3.9 tp10 -80.61 132.49 35.63 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -103.18 127.81 50.35 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 122.356 1.074 . . . . 0.0 111.534 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' B' ' 32' ' ' LEU . 35.7 m -135.19 162.09 38.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.719 -167.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.93 141.88 47.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.793 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 14.7 mt -122.21 137.49 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.569 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -158.04 167.48 29.76 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.108 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 32' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 162.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.75 164.57 9.54 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 122.924 0.489 . . . . 0.0 111.239 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.46 179.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.624 2.216 . . . . 0.0 112.856 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.92 174.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.622 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.84 153.74 43.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.697 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.83 148.04 33.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.92 -144.62 5.93 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.813 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.6 mp0 -53.03 117.91 12.49 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.114 0.538 . . . . 0.0 110.716 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.94 124.31 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.43 2.087 . . . . 0.0 112.258 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.51 150.11 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.26 157.92 16.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.345 0.593 . . . . 0.0 111.481 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.46 96.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.78 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 15.8 pt-20 -84.3 1.07 46.61 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.553 -172.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' LYS . 22.4 mt-10 -52.8 -25.07 10.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.441 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.3 pt -77.77 13.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.365 0.603 . . . . 0.0 111.301 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 32.5 tttt . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.831 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.429 ' N ' HD12 ' B' ' 4' ' ' ILE . 3.3 mp . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.997 0.903 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.573 HD13 HG11 ' B' ' 20' ' ' VAL . 9.9 mt -114.46 151.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.65 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 137.73 52.66 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.66 168.97 18.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.1 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.64 141.58 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.676 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 83.7 t80 -100.3 114.09 27.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.053 0.93 . . . . 0.0 109.958 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.687 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 44.7 mt-10 -87.58 -170.63 3.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.126 -1.852 . . . . 0.0 108.552 169.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 52.64 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.096 0.958 . . . . 0.0 112.07 -172.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.48 4.67 15.26 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.3 t -114.32 145.54 19.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.554 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' B' ' 9' ' ' TYR . 46.5 m-85 -117.68 115.45 25.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 166.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.87 114.33 46.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.709 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' PRO . . . . . 0.504 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 9.5 Cg_endo -59.93 165.47 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-O 123.472 1.363 . . . . 0.0 113.2 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 -66.03 0.93 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.048 -2.796 . . . . 0.0 104.675 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.499 ' HB2' HG22 ' B' ' 5' ' ' ILE . 50.7 mt-30 -65.55 132.13 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.629 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -61.24 124.16 19.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.02 0.914 . . . . 0.0 110.47 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.573 HG11 HD13 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -101.82 132.95 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.177 -176.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.36 88.4 2.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.426 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.523 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 72.5 mt -130.57 -165.0 1.49 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.348 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.401 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 21.0 mttt -92.59 161.58 14.53 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -88.23 128.28 35.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.4 65.11 3.16 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 113.725 -1.579 . . . . 0.0 109.878 -160.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.93 142.8 29.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.646 -0.777 . . . . 0.0 109.864 173.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' B' ' 27' ' ' ARG . 1.0 OUTLIER -100.84 105.57 16.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.684 1.231 . . . . 0.0 111.768 -176.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.536 HG22 ' CE1' ' A' ' 14' ' ' PHE . 33.8 m -123.96 164.83 21.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.979 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.897 ' HD2' HG13 ' A' ' 4' ' ' ILE . 31.7 mtmm -123.44 139.77 53.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.598 0.714 . . . . 0.0 110.935 177.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.457 HG22 ' CE1' ' B' ' 14' ' ' PHE . 10.7 mm -111.11 143.98 19.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.816 -171.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -147.42 161.22 41.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 113.84 -1.527 . . . . 0.0 107.377 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.661 ' HB3' HG13 ' A' ' 28' ' ' VAL . 1.2 pt? . . . . . 0 C--N 1.301 -1.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.75 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.0 112.15 26.88 Favored Pre-proline 0 N--CA 1.433 -1.312 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.876 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.28 173.53 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.416 2.077 . . . . 0.0 111.981 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.1 pt -95.81 155.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.31 123.78 28.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.863 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.36 115.54 28.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.28 113.67 2.39 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.55 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.86 155.51 80.41 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.551 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.21 145.21 77.72 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.474 2.116 . . . . 0.0 111.604 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.99 152.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.095 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -77.36 173.42 11.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.69 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 25.5 t -82.92 116.5 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.339 0.59 . . . . 0.0 110.354 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.73 155.49 18.54 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.924 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.94 -24.36 66.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.798 0.332 . . . . 0.0 111.672 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.425 ' N ' HD13 ' B' ' 50' ' ' ILE . 3.0 mp . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.815 0.817 . . . . 0.0 109.837 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.884 0.373 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -82.75 150.72 26.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.368 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 43.5 tpp -116.13 154.11 30.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.313 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 74.26 -0.58 3.31 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.589 0.556 . . . . 0.0 110.767 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -85.28 5.74 29.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.269 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.93 136.66 52.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.115 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 145.85 26.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -146.73 78.15 1.49 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.675 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -145.19 157.83 43.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -153.68 138.57 17.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -121.02 77.86 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -179.74 97.52 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.499 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.2 t60 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.791 -176.663 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.916 ' HG3' HD12 ' B' ' 34' ' ' LEU . 96.2 Cg_endo -86.7 137.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.954 2.436 . . . . 0.0 113.21 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -97.49 167.22 11.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.695 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.484 ' H ' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -101.86 127.15 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 29' ' ' LYS . 11.6 mm -93.99 147.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 39.6 mt-10 -113.77 134.75 54.58 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.51 156.54 48.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 11.5 m -110.27 115.16 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.747 0.784 . . . . 0.0 110.577 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.756 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 64.7 t80 -73.62 101.45 3.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.564 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.492 ' OE1' ' HG3' ' A' ' 15' ' ' LYS . 40.2 mt-10 -108.24 119.24 38.91 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.063 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.73 21.13 12.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.632 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 102.73 7.68 44.33 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.367 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.2 t -120.37 142.7 34.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-O 119.588 -0.244 . . . . 0.0 110.436 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 1.073 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 76.1 m-85 -93.0 115.58 28.25 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.976 170.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.492 ' HG3' ' OE1' ' A' ' 10' ' ' GLU . 29.1 mmtp -107.57 108.75 62.03 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 17.9 Cg_endo -60.84 167.41 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 119.979 1.028 . . . . 0.0 112.501 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.74 -6.05 23.06 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' HG3' HG23 ' A' ' 5' ' ' ILE . 7.9 pt20 -138.41 111.97 8.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.631 173.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 12.7 tmtt? -60.91 133.25 55.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.752 -171.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG13 ' HG ' ' A' ' 22' ' ' LEU . 2.8 t -113.6 140.99 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.114 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -116.33 87.49 2.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.789 1.281 . . . . 0.0 109.047 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 26' ' ' GLU . 76.0 mt -127.11 -158.65 0.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.162 -2.29 . . . . 0.0 110.671 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -85.67 176.75 7.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 2.0 mp0 -89.7 123.31 33.61 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.97 0.891 . . . . 0.0 109.446 168.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.044 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 69.59 64.75 2.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.395 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 22' ' ' LEU . 5.6 tp10 -94.4 144.53 25.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.212 -0.994 . . . . 0.0 108.887 169.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 120.76 34.4 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.568 1.175 . . . . 0.0 114.013 -167.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.78 ' HB ' HG23 ' B' ' 30' ' ' ILE . 30.2 m -138.79 154.64 26.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -115.06 140.01 49.4 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.577 HG13 ' O ' ' B' ' 5' ' ' ILE . 1.8 mt -103.73 140.97 20.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.27 -173.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -125.58 138.06 53.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.773 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -105.87 119.18 38.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -64.27 126.61 28.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.475 0.655 . . . . 0.0 109.876 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -114.68 160.25 19.57 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.214 -169.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.87 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 10.9 mmpt? -100.86 152.52 20.42 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.582 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.88 141.79 13.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.472 0.653 . . . . 0.0 111.184 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.98 123.65 50.52 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.023 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.45 173.73 13.33 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.585 2.19 . . . . 0.0 112.444 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 pt -116.19 164.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.42 -172.3 2.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 tp -85.48 143.02 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.45 -142.3 5.47 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.866 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.9 161.41 63.54 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.297 . . . . 0.0 111.001 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.15 -174.87 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.827 2.351 . . . . 0.0 112.536 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.56 155.71 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.734 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 p -97.0 -178.43 4.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 53' ' ' ILE . 7.1 p -110.53 123.81 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.522 0.677 . . . . 0.0 110.892 175.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -103.5 179.65 4.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.16 -36.6 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.254 0.55 . . . . 0.0 111.777 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 mt -88.85 1.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.713 0.768 . . . . 0.0 110.361 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -92.47 -4.6 53.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.374 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.16 104.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.976 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.415 ' HA ' HG23 ' A' ' 47' ' ' VAL . 42.3 mt -74.85 -39.07 45.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.73 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -139.67 -166.95 2.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.13 151.51 22.45 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.216 0.532 . . . . 0.0 111.419 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -126.93 47.1 1.04 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.072 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.71 129.39 56.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 110.445 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.62 154.21 48.66 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 ttm -86.01 123.67 31.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.114 0.483 . . . . 0.0 111.613 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.6 t -84.5 133.01 34.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -81.69 1.91 32.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 0.0 110.305 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.4 mt 62.18 -171.67 0.16 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.478 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.61 128.31 43.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.063 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -115.4 -18.32 11.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.23 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 58.09 -159.02 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.819 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -128.99 152.03 49.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -128.43 131.44 48.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -131.27 177.8 7.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.923 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 m80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.633 175.061 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.62 88.17 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.23 1.954 . . . . 0.0 109.329 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -83.59 147.29 27.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -168.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.436 HD11 ' N ' ' B' ' 4' ' ' ILE . 2.7 mp -94.64 139.34 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.224 167.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.577 ' O ' HG13 ' A' ' 30' ' ' ILE . 29.7 mt -125.22 153.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -97.57 148.32 23.39 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.06 42.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 1.044 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.6 m -109.6 113.75 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.713 0.768 . . . . 0.0 110.531 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' B' ' 14' ' ' PHE . 37.5 t80 -67.47 100.87 0.9 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.84 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 92.2 mt-10 -102.46 112.59 25.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t30 63.09 13.45 6.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.24 169.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.48 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 119.71 2.36 12.98 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.886 -1.149 . . . . 0.0 112.479 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 10' ' ' GLU . 26.9 m -132.1 142.52 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.105 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 1.073 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 98.2 m-85 -86.85 116.31 24.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.955 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -105.84 111.15 64.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.144 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -44.93 168.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.333 -0.263 0 C-N-CA 123.126 2.55 . . . . 0.0 117.183 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.743 HD12 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -126.15 97.24 5.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.141 -2.299 . . . . 0.0 104.95 163.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.7 pt20 85.53 148.38 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 O-C-N 125.717 1.886 . . . . 0.0 109.326 -167.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.41 157.95 34.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.279 -167.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.545 HG13 ' HG ' ' B' ' 22' ' ' LEU . 5.4 t -116.34 147.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.143 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -88.37 18.58 4.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.796 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.545 ' HG ' HG13 ' B' ' 20' ' ' VAL . 90.8 mt -92.29 162.86 14.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.069 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 175.0 5.91 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.105 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.6 mp0 -65.96 125.0 24.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.482 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.536 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.2 15.11 67.52 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.068 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 mm-40 -69.93 136.24 50.34 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.794 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -100.63 137.35 39.14 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.37 1.081 . . . . 0.0 112.303 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 14' ' ' PHE . 20.3 m -150.12 172.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.135 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 87.0 mttt -125.04 139.23 53.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.345 0.593 . . . . 0.0 109.925 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.78 HG23 ' HB ' ' A' ' 28' ' ' VAL . 4.0 mt -140.48 149.51 21.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.551 -171.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.596 HD23 HG12 ' A' ' 28' ' ' VAL . 42.3 mt -77.05 124.55 27.95 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.55 145.03 54.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.665 0.745 . . . . 0.0 112.001 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.916 HD12 ' HG3' ' A' ' 2' ' ' PRO . 77.1 mt -109.68 178.36 4.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.696 -171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.542 ' O ' HG12 ' B' ' 36' ' ' VAL . 13.7 mptt -134.76 -170.22 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.007 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.542 HG12 ' O ' ' B' ' 35' ' ' LYS . 0.4 OUTLIER 61.53 161.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.043 1.337 . . . . 0.0 113.899 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -112.15 169.27 6.52 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.176 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.25 -166.48 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.344 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.43 HD11 ' N ' ' B' ' 39' ' ' ILE . 3.9 mp -93.66 150.45 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.931 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.11 143.34 51.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tt -134.33 132.83 39.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.91 155.44 17.19 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.1 pm0 -70.74 127.67 91.63 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.515 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 26.5 Cg_exo -62.73 160.55 32.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.063 2.509 . . . . 0.0 112.225 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.73 138.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.855 0.836 . . . . 0.0 111.768 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -115.52 177.04 4.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.008 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.47 HG13 ' HD2' ' B' ' 51' ' ' LYS . 51.2 t -79.83 124.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -100.91 160.31 14.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.747 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.96 -25.9 63.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.911 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 tt -76.42 -7.46 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.256 0.55 . . . . 0.0 111.395 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.47 ' HD2' HG13 ' B' ' 47' ' ' VAL . 19.2 ttmt -80.71 151.66 28.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.187 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -71.44 106.37 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.363 0.602 . . . . 0.0 110.854 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -112.42 130.95 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.314 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -76.72 144.77 39.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.637 0.256 . . . . 0.0 110.589 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.2 166.12 11.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.111 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.5 61.63 0.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.888 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -82.6 103.26 12.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.94 150.41 22.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.9 ttt -142.24 124.97 15.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.648 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.3 p -116.06 164.19 14.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -99.53 -5.49 29.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp 45.99 84.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.864 0.727 . . . . 0.0 112.439 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 139.93 42.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -142.87 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -94.09 168.93 10.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 110.905 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -149.63 118.64 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.631 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.82 126.96 29.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -98.32 167.59 10.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.505 175.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.13 131.21 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.46 2.106 . . . . 0.0 113.552 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -133.61 143.01 48.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 4' ' ' ILE . 3.8 mp -81.28 127.25 39.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.147 0.975 . . . . 0.0 112.73 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' B' ' 30' ' ' ILE . 18.0 mt -110.97 158.26 11.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.042 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.475 ' HG2' ' CD ' ' B' ' 29' ' ' LYS . 44.5 mt-10 -123.47 134.61 53.89 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.44 165.98 22.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.456 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 4.8 m -110.96 121.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.408 0.623 . . . . 0.0 110.01 171.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.645 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 65.8 t80 -83.18 115.7 22.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.518 1.152 . . . . 0.0 110.677 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.771 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 61.3 mt-10 -86.7 -169.82 2.8 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.064 173.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.21 45.13 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.166 0.986 . . . . 0.0 111.829 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 10' ' ' GLU . . . 122.52 5.16 8.64 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.771 ' HB ' ' HB2' ' A' ' 10' ' ' GLU . 2.4 t -115.67 142.88 27.09 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.481 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 35.2 m-85 -111.72 114.89 28.19 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.846 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -119.95 116.37 32.85 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 122.407 -0.183 . . . . 0.0 111.188 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 20.0 Cg_endo -64.0 168.08 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.818 1.678 . . . . 0.0 112.088 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.65 -14.25 13.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HB2' HG21 ' A' ' 5' ' ' ILE . 63.6 mt-30 -104.24 128.52 51.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.11 -1.405 . . . . 0.0 108.871 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -71.32 140.15 50.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.739 0.781 . . . . 0.0 110.071 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 22' ' ' LEU . 6.0 p -133.17 140.94 45.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.372 -164.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -97.04 85.87 3.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 HD21 ' CD1' ' B' ' 9' ' ' TYR . 0.0 OUTLIER -116.97 173.92 6.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.759 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 5.1 mptp? -114.06 150.34 34.14 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.486 170.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.4 132.52 47.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.211 0.529 . . . . 0.0 111.197 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.03 51.16 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.119 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 25.3 tt0 -74.02 117.97 16.42 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -84.97 126.49 33.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.562 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG12 HD22 ' B' ' 32' ' ' LEU . 35.5 m -132.5 166.89 27.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.25 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.679 ' HG2' ' HG2' ' B' ' 33' ' ' GLU . 11.4 mmmm -116.37 138.23 51.51 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 2.4 mm -120.84 140.58 44.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.308 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' B' ' 2' ' ' PRO . 85.9 tttt -156.05 149.92 25.17 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.578 HD22 HG11 ' B' ' 28' ' ' VAL . 44.9 mt -92.7 118.73 31.37 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.29 -179.83 7.53 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt 56.42 -161.57 0.19 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.235 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -87.81 164.1 16.1 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -97.78 136.48 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.027 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.67 151.03 43.43 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.374 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.83 173.68 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.119 1.879 . . . . 0.0 112.095 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.88 136.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.539 ' CG ' ' H ' ' A' ' 41' ' ' LEU . 20.7 t70 56.24 -158.88 0.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.18 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 pp -103.28 167.3 9.91 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.091 -0.381 . . . . 0.0 111.185 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.74 -131.91 5.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.441 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -106.79 108.69 62.35 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-O 120.652 0.263 . . . . 0.0 111.661 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 114.86 3.61 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.889 2.393 . . . . 0.0 111.408 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.6 p -102.21 158.47 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.264 0.554 . . . . 0.0 110.782 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -100.7 162.72 12.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.788 -176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.83 121.48 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.704 0.764 . . . . 0.0 111.237 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -144.73 -36.77 0.31 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.253 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.76 -25.52 26.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.501 0.667 . . . . 0.0 110.756 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.04 1.69 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.005 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -98.1 135.05 40.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 0.0 110.575 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -123.57 135.24 53.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 tt -105.89 141.93 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -127.53 141.14 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.26 164.38 24.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.904 0.383 . . . . 0.0 111.381 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.34 147.75 16.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.977 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.68 130.61 36.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.758 0.313 . . . . 0.0 111.055 -175.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 59' ' ' MET . 2.2 p-90 -100.46 172.99 6.78 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 44.7 mmm 75.16 161.92 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.725 0.774 . . . . 0.0 112.224 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.0 t -129.81 177.56 7.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.165 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.2 m -81.69 19.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.216 0.322 . . . . 0.0 111.019 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mp 69.57 137.06 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.006 0.922 . . . . 0.0 111.776 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -105.14 113.52 27.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -113.8 117.75 32.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -75.74 100.92 4.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.34 121.6 8.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.067 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -77.92 80.92 4.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.86 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -112.9 130.03 56.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.88 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.162 174.394 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.682 ' H3 ' HD22 ' B' ' 22' ' ' LEU . 1.5 mpt? . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.427 ' O ' ' HE3' ' A' ' 31' ' ' LYS . 43.2 Cg_endo -70.7 -19.79 31.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.311 2.007 . . . . 0.0 111.292 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.87 165.88 24.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.903 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.441 HD12 ' H ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -93.14 128.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.382 0.61 . . . . 0.0 110.43 176.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.553 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 15.5 mm -90.48 154.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.561 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.469 ' HG2' ' CD ' ' A' ' 29' ' ' LYS . 45.9 mt-10 -124.79 130.53 52.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.94 163.43 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 3.9 m -128.61 116.87 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 112.013 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -65.31 106.34 1.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.591 0.71 . . . . 0.0 110.398 175.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.572 ' HB2' ' HD3' ' B' ' 15' ' ' LYS . 34.7 mt-10 -129.95 133.79 47.04 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.887 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.91 32.32 22.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.402 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.08 -68.3 0.39 Allowed Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 117.432 -2.318 . . . . 0.0 111.92 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 4.8 m -106.21 155.93 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.153 -156.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.725 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -84.85 113.69 21.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.572 ' HD3' ' HB2' ' B' ' 10' ' ' GLU . 39.9 mtpt -97.94 113.65 64.04 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.744 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.9 Cg_endo -62.09 167.28 11.0 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.122 1.215 . . . . 0.0 111.931 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.56 -12.13 12.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -120.83 161.67 21.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.176 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -77.83 132.12 37.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.232 0.539 . . . . 0.0 112.035 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.645 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 1.8 t -132.74 144.26 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.044 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.647 ' H ' ' HE2' ' B' ' 1' ' ' MET . 18.6 t70 -149.72 87.54 1.5 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.405 170.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.682 HD22 ' H3 ' ' B' ' 1' ' ' MET . 87.9 mt -109.91 -2.66 17.05 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.452 172.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 57.6 mttp 77.17 157.77 0.19 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.506 172.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.92 133.49 55.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.102 -164.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.572 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.6 64.93 3.5 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.429 -169.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 0.0 OUTLIER -101.47 135.09 43.55 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.56 167.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -77.14 117.21 18.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.107 0.956 . . . . 0.0 111.395 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.578 HG11 HD22 ' A' ' 32' ' ' LEU . 28.2 m -130.2 156.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.694 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.475 ' CD ' ' HG2' ' A' ' 6' ' ' GLU . 33.2 mmtp -109.36 134.75 51.43 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.321 0.581 . . . . 0.0 110.487 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.496 ' HB ' ' HB ' ' A' ' 5' ' ' ILE . 3.5 mm -112.54 143.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.987 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 160.51 39.77 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.319 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.443 HD22 HG12 ' A' ' 28' ' ' VAL . 83.5 mt -99.82 135.75 40.77 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.734 -172.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.679 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 23.0 mm-40 -101.49 145.47 28.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.179 0.99 . . . . 0.0 112.305 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.98 153.73 30.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.489 -1.687 . . . . 0.0 107.737 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.07 154.01 26.03 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.112 0.482 . . . . 0.0 111.008 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.27 160.55 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.317 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' B' ' 37' ' ' GLU . 7.1 pt-20 -50.6 110.93 1.91 Allowed Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 123.558 0.536 . . . . 0.0 111.676 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.45 172.89 3.95 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.334 2.022 . . . . 0.0 111.851 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.12 150.0 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -91.44 141.24 28.96 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.521 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.7 mm? -61.16 116.82 4.86 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.326 0.391 . . . . 0.0 110.779 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.63 114.03 4.55 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.498 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.56 147.92 82.34 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 114.621 -0.789 . . . . 0.0 110.37 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.14 130.11 29.51 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.304 2.003 . . . . 0.0 111.833 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -77.99 150.32 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -101.04 169.74 8.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.987 0.423 . . . . 0.0 110.87 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 135.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' B' ' 51' ' ' LYS . 41.9 mt-10 -98.51 149.36 22.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -28.73 43.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.682 0.753 . . . . 0.0 109.287 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.15 13.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.595 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' B' ' 48' ' ' GLU . 38.5 tptt -72.65 136.58 45.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.071 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' B' ' 52' ' ' LYS . 30.7 mmtp -83.22 162.92 21.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp 57.25 86.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.539 0.685 . . . . 0.0 110.549 -169.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 70.68 94.49 0.08 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.04 150.78 32.68 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.91 124.81 8.25 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.055 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -166.49 175.75 7.86 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -95.95 134.33 39.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.9 ttt -104.13 146.82 28.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.6 t 75.73 128.62 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 O-C-N 124.218 0.949 . . . . 0.0 110.994 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -97.52 1.59 49.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.057 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp 53.35 83.72 0.06 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.507 0.67 . . . . 0.0 111.417 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 159.71 15.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.006 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -85.72 35.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.562 0.696 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.79 72.4 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.348 0.594 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -77.78 123.48 26.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -100.92 126.58 47.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.836 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.81 136.51 53.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.478 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.023 177.736 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.507 0.194 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.15 99.08 1.06 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.791 2.327 . . . . 0.0 111.563 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -146.4 172.9 12.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.019 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.596 HG23 ' HD3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER -113.19 143.56 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.891 HD11 HG22 ' A' ' 20' ' ' VAL . 1.4 mt -99.2 145.98 9.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -101.33 132.86 46.67 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.15 155.85 49.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.324 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.33 117.06 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.416 0.626 . . . . 0.0 110.346 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.702 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 77.5 t80 -73.54 119.33 17.62 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.708 176.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 41.3 tt0 -144.96 130.19 18.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.424 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 t30 70.77 22.76 4.72 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.829 0.705 . . . . 0.0 110.802 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.533 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 83.04 17.96 66.14 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.656 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 14.6 t -122.68 149.59 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 82.5 m-85 -97.69 115.28 27.64 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 166.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.0 mmmt -116.38 107.91 46.38 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.7 Cg_endo -59.8 167.89 6.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.213 1.275 . . . . 0.0 112.825 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.66 -8.6 20.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.211 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.601 ' N ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -138.37 140.05 39.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.083 176.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 7.9 tmtt? -76.94 132.4 39.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.558 0.694 . . . . 0.0 110.551 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.891 HG22 HD11 ' A' ' 5' ' ' ILE . 2.9 t -122.49 141.43 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.195 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -100.74 87.94 3.46 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 122.702 1.239 . . . . 0.0 108.148 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 20' ' ' VAL . 69.0 mt -111.25 -175.43 2.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.383 -2.189 . . . . 0.0 110.61 174.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 47.9 mtpt -93.41 165.86 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.559 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.35 129.77 34.79 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.644 0.735 . . . . 0.0 109.589 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.123 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.74 64.65 3.56 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.738 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.945 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 1.9 mm-40 -89.93 150.24 22.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -0.629 . . . . 0.0 110.463 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -89.75 104.48 17.04 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.929 1.347 . . . . 0.0 112.527 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 HG12 HD12 ' B' ' 32' ' ' LEU . 35.3 m -126.99 154.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.41 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.895 ' HD3' HG13 ' B' ' 4' ' ' ILE . 54.8 mttm -111.56 144.68 40.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG22 ' CE1' ' A' ' 14' ' ' PHE . 11.8 mm -104.36 133.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.945 0.878 . . . . 0.0 109.234 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -140.69 161.28 38.13 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.69 ' HG ' HG12 ' B' ' 28' ' ' VAL . 6.8 mp -112.62 149.45 32.8 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.9 -166.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' CD ' ' HZ2' ' B' ' 29' ' ' LYS . 8.4 mm-40 -66.69 124.74 23.73 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.17 153.17 22.83 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.573 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.55 157.46 16.18 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.18 137.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.29 -172.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -118.03 85.0 22.65 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.937 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -90.71 -154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.417 2.744 . . . . 0.0 110.278 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mt -95.79 139.1 19.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.99 116.37 30.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.557 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.734 ' H ' HD22 ' A' ' 41' ' ' LEU . 2.2 pt? -86.24 128.52 34.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.05 114.26 1.24 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.981 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 124.39 30.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.46 125.1 14.37 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.81 2.34 . . . . 0.0 112.266 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.12 148.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.348 0.594 . . . . 0.0 110.863 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.9 m -101.02 173.99 6.22 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.277 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.32 147.8 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.76 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 24.2 mt-10 -86.93 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.342 . . . . 0.0 111.297 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -86.42 -31.35 21.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.693 0.758 . . . . 0.0 109.363 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 pt -84.29 12.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.423 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 41.4 tttp -71.23 133.0 45.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -141.12 117.74 10.94 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pt -108.14 97.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.255 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -128.78 139.67 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 112.282 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.8 153.89 33.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.482 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.63 134.92 8.27 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.978 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -150.07 140.9 22.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.136 0.493 . . . . 0.0 110.629 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -156.04 135.61 12.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.953 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -160.62 148.26 15.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.157 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -128.39 119.33 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.748 0.309 . . . . 0.0 110.213 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.9 p -105.51 19.11 21.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 110.722 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -73.46 71.48 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.739 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.84 118.91 17.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -160.85 140.46 10.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -112.33 126.83 55.69 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -140.98 116.99 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 112.019 -168.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.47 -55.87 1.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -142.62 -24.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.792 172.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.19 139.94 30.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.498 2.132 . . . . 0.0 110.513 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' B' ' 4' ' ' ILE . 20.3 ttmt -110.52 154.02 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.123 0.487 . . . . 0.0 110.235 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.895 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -79.84 135.91 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.171 172.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 pt -108.85 134.21 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.515 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 19.8 mp0 -86.08 142.65 28.56 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.532 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -135.05 164.38 27.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.163 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 1.123 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 8.5 m -122.48 130.81 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.276 0.56 . . . . 0.0 110.819 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 91.8 t80 -72.05 112.76 8.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.08 1.419 . . . . 0.0 111.55 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 1.054 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 10.6 tp10 -87.81 -176.48 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.241 -2.254 . . . . 0.0 106.919 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.427 ' H ' ' HG3' ' B' ' 10' ' ' GLU . 1.2 t-20 -66.86 61.28 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.266 1.031 . . . . 0.0 111.93 -172.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.31 8.25 27.33 Favored Glycine 0 C--N 1.299 -1.482 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.023 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 1.054 ' HB ' ' HB3' ' B' ' 10' ' ' GLU . 2.5 t -118.75 156.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 114.769 -0.716 . . . . 0.0 111.419 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.6 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 71.1 m-85 -118.37 115.15 24.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 161.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.581 ' HE3' ' HG2' ' B' ' 10' ' ' GLU . 98.2 mttt -108.48 117.49 54.31 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.638 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 26.1 Cg_endo -64.43 168.73 12.31 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.109 1.206 . . . . 0.0 111.701 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.7 HD12 HG12 ' B' ' 8' ' ' VAL . 6.1 mp -110.05 -10.46 14.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -101.67 155.41 18.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.105 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -74.99 141.77 43.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.655 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.434 ' HB ' ' OH ' ' A' ' 9' ' ' TYR . 3.0 t -118.82 146.03 24.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.317 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -126.09 15.27 7.89 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.187 0.994 . . . . 0.0 109.454 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.525 HD12 ' HG2' ' B' ' 26' ' ' GLU . 94.1 mt -83.46 -172.79 4.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.357 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 177.88 6.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.635 0.255 . . . . 0.0 111.016 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 2.5 mp0 -66.08 140.36 58.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.04 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 16.79 70.73 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.606 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' B' ' 22' ' ' LEU . 8.3 tp10 -79.8 126.2 30.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 27' ' ' ARG . 15.3 mmm180 -85.0 129.57 34.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.21 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.69 HG12 ' HG ' ' A' ' 32' ' ' LEU . 30.2 m -142.0 166.36 16.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.724 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.438 ' HZ2' ' CD ' ' A' ' 33' ' ' GLU . 41.8 mttp -116.58 145.21 43.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.425 HG21 ' CE1' ' B' ' 14' ' ' PHE . 6.6 mm -117.45 143.97 26.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.685 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.596 ' HD3' HG23 ' A' ' 4' ' ' ILE . 29.6 tptp -154.55 128.2 8.66 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.569 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.558 HD12 HG12 ' A' ' 28' ' ' VAL . 3.4 mm? -66.14 125.49 25.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.35 153.26 44.09 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.659 0.742 . . . . 0.0 112.757 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' B' ' 35' ' ' LYS . 16.1 tp -128.21 159.77 34.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.456 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' B' ' 34' ' ' LEU . 92.3 mttt -98.16 159.14 15.13 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.909 0.385 . . . . 0.0 110.796 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -111.87 149.78 14.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.071 172.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -151.36 126.41 4.73 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.971 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 174.13 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.418 2.079 . . . . 0.0 112.75 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 pt -87.41 160.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.15 135.53 36.6 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.16 164.65 33.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.871 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.79 -156.44 22.8 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.41 127.45 15.6 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.698 0.285 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.93 117.48 5.06 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.854 2.369 . . . . 0.0 112.726 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -124.72 152.43 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.54 149.4 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.32 0.581 . . . . 0.0 111.471 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.78 150.16 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.326 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.11 115.09 24.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.225 1.012 . . . . 0.0 112.707 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -86.68 -26.62 24.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.584 171.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mm -80.01 -10.38 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.702 -171.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' B' ' 52' ' ' LYS . 5.0 tmtt? -135.93 135.09 39.35 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.045 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.507 ' N ' ' HD3' ' B' ' 51' ' ' LYS . 74.8 tttt -139.27 169.36 17.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.339 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.472 HD11 ' HG2' ' B' ' 52' ' ' LYS . 4.4 mp 54.85 102.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 111.646 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -143.66 124.17 13.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.714 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -84.17 168.95 15.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.243 0.544 . . . . 0.0 111.268 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.435 ' O ' ' HB ' ' B' ' 57' ' ' THR . . . -173.5 -172.61 39.09 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.027 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' B' ' 56' ' ' GLY . 60.4 m 72.09 145.49 0.07 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.229 0.538 . . . . 0.0 111.36 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -110.1 134.9 51.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 47.3 ttm -79.36 128.73 33.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -66.83 106.9 2.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.305 0.574 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -99.52 3.44 45.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.368 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 61.48 179.11 0.12 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.528 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.23 144.25 50.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -78.78 88.84 4.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.638 0.732 . . . . 0.0 110.173 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -88.12 117.43 27.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -127.29 127.5 44.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.601 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.592 ' O ' ' HB2' ' B' ' 68' ' ' HIS . 25.7 t-80 -87.13 -103.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.592 ' HB2' ' O ' ' B' ' 67' ' ' HIS . 44.9 t-80 156.65 146.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.402 173.597 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -74.22 44.83 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.433 2.755 . . . . 0.0 112.832 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -149.5 158.94 44.62 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 111.325 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -127.09 129.36 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.249 166.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.783 HG13 ' HB ' ' B' ' 30' ' ' ILE . 3.7 pt -90.52 137.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -99.45 142.38 31.0 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.928 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.21 164.31 28.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.168 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.579 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 11.8 m -120.0 126.11 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.665 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.784 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.8 t80 -94.65 111.28 23.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.057 -177.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.67 141.29 50.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.785 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.8 t30 60.83 21.4 11.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 87.86 13.08 65.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.863 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 12.5 t -119.53 143.75 30.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.741 -0.23 . . . . 0.0 110.633 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 49.0 m-85 -103.41 115.62 30.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 166.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.67 114.87 61.4 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.7 Cg_endo -62.81 168.69 9.9 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 120.634 0.89 . . . . 0.0 111.939 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -102.43 -4.46 25.42 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.26 127.71 43.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.169 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.53 131.27 40.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -124.2 137.74 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.647 0.737 . . . . 0.0 110.628 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.42 87.82 5.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.38 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HG ' HG13 ' A' ' 20' ' ' VAL . 55.5 mt -121.54 -171.94 2.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.073 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -98.7 -176.18 3.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.956 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 5.3 mp0 -89.22 138.46 31.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.3 0.571 . . . . 0.0 110.162 171.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.717 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.3 65.25 3.05 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.378 -168.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 9.1 tp10 -93.27 128.24 39.18 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.635 -0.783 . . . . 0.0 109.344 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -81.62 114.95 20.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.71 1.243 . . . . 0.0 111.569 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.757 HG11 HD23 ' B' ' 32' ' ' LEU . 35.2 m -131.5 164.23 35.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.059 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.805 ' HE2' ' HG3' ' B' ' 33' ' ' GLU . 52.3 mttm -119.92 143.02 48.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.23 0.538 . . . . 0.0 110.08 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.493 HG21 ' CZ ' ' A' ' 14' ' ' PHE . 3.7 mm -110.65 140.46 29.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.144 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -147.4 165.82 29.06 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.667 0.746 . . . . 0.0 110.294 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD21 HD22 ' B' ' 22' ' ' LEU . 74.9 mt -113.87 129.24 56.61 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 33' ' ' GLU . 4.6 tp10 -64.13 147.46 52.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.667 0.746 . . . . 0.0 112.739 -166.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -147.01 -172.66 4.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.225 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -109.51 170.93 7.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.511 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.66 144.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.332 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.3 mm-40 -85.83 131.47 47.06 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.178 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.6 Cg_exo -79.88 -166.85 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.09 2.527 . . . . 0.0 111.854 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 pt -101.39 168.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.306 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.4 142.42 24.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.991 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.11 153.98 40.67 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.98 -143.29 14.5 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.926 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.0 pt-20 -111.78 147.06 36.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 122.203 0.201 . . . . 0.0 111.001 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 20.0 Cg_exo -67.33 170.96 12.37 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.118 2.545 . . . . 0.0 111.382 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.92 153.29 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 110.158 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p -122.52 162.1 22.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 111.608 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.6 t -131.17 135.57 59.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.669 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.13 133.62 52.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 0.0 111.477 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.86 -21.13 40.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.428 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.63 -13.66 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.705 0.764 . . . . 0.0 110.009 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 30.1 ttmt -93.39 131.82 38.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.87 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 16.3 ptpt -158.75 -165.2 1.59 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.566 0.222 . . . . 0.0 111.51 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 67.2 mt 73.65 100.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -130.53 143.06 50.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.611 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -122.41 153.51 38.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.527 0.68 . . . . 0.0 111.174 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 80.29 0.33 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.338 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 118.83 6.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.108 0.48 . . . . 0.0 111.501 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -147.21 150.21 34.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.212 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.86 -163.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.419 -175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.9 m 62.57 21.4 12.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.367 0.604 . . . . 0.0 111.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -87.47 19.03 3.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.015 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -114.05 154.86 26.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -125.91 136.14 52.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -117.74 93.35 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -130.01 124.16 32.28 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.883 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -108.12 -174.45 2.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.0 31.3 2.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 55.9 t-80 -174.96 -91.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 17.7 t-80 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.403 -1.284 . . . . 0.0 107.933 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.87 -173.48 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.953 2.435 . . . . 0.0 112.852 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -127.38 153.7 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.243 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.47 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -124.04 144.3 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.058 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 11.2 mt -104.2 144.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.487 ' H ' ' NE2' ' B' ' 18' ' ' GLN . 12.7 mp0 -105.95 130.75 53.83 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.379 0.609 . . . . 0.0 110.422 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.48 154.92 46.78 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.623 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.717 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 3.6 m -110.97 115.37 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 121.507 0.67 . . . . 0.0 110.926 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.784 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 47.4 t80 -75.23 111.46 10.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.274 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.9 tt0 -120.13 116.83 26.45 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.694 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.27 19.59 11.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.876 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.542 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 109.59 5.57 29.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.215 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 3.5 t -118.06 142.43 32.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.794 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.838 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 74.0 m-85 -97.97 116.63 30.57 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.109 -0.637 . . . . 0.0 109.621 171.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.72 ' HE3' HG11 ' B' ' 13' ' ' VAL . 33.8 mmtp -117.54 111.49 39.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.7 Cg_endo -60.49 167.97 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.299 1.333 . . . . 0.0 111.994 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.663 HD11 HG13 ' B' ' 8' ' ' VAL . 6.7 mp -111.51 -21.92 11.53 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.487 ' NE2' ' H ' ' B' ' 6' ' ' GLU . 5.0 pt20 -115.46 3.72 14.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.053 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 55.65 167.71 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.263 -1.79 . . . . 0.0 113.534 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.616 HG12 ' HG ' ' B' ' 22' ' ' LEU . 3.5 t -144.12 154.22 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.788 -175.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -136.7 86.81 2.24 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 123.139 1.447 . . . . 0.0 109.605 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.616 ' HG ' HG12 ' B' ' 20' ' ' VAL . 0.4 OUTLIER -132.52 104.68 6.81 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 112.132 -2.303 . . . . 0.0 110.196 166.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.707 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 96.0 mttt 33.95 -163.07 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 114.4 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.47 127.12 55.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.697 163.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 53.96 65.19 3.63 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.497 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.707 ' HG2' ' HD2' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -99.03 145.52 27.01 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 167.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -95.71 123.33 39.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.477 1.132 . . . . 0.0 112.391 -168.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.604 HG22 ' CE1' ' A' ' 14' ' ' PHE . 34.3 m -131.04 174.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.973 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -112.91 142.22 45.83 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.783 ' HB ' HG13 ' A' ' 5' ' ' ILE . 4.3 mm -119.16 141.08 40.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.224 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.412 ' HD3' HG22 ' A' ' 4' ' ' ILE . 56.5 tptt -143.66 125.91 15.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.492 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.757 HD23 HG11 ' A' ' 28' ' ' VAL . 27.9 mt -59.77 135.96 57.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.805 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 41.8 tt0 -61.12 142.55 56.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.955 0.883 . . . . 0.0 113.03 -169.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.66 167.33 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.139 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -124.45 168.82 12.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.328 0.585 . . . . 0.0 110.872 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.36 127.51 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -111.47 119.64 44.63 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 120.917 0.389 . . . . 0.0 111.136 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.32 -176.52 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.96 2.44 . . . . 0.0 111.839 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.407 ' O ' HD12 ' B' ' 39' ' ' ILE . 1.8 pp -103.99 152.59 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.496 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.08 103.99 6.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 50.0 tp -135.04 139.09 44.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.86 114.25 2.58 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -92.26 162.26 30.62 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.739 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.8 142.18 26.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.42 2.747 . . . . 0.0 113.968 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 164.74 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.6 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -78.77 164.08 24.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.234 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.57 164.76 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.519 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.409 ' CB ' ' HB2' ' B' ' 51' ' ' LYS . 13.8 mt-10 -62.45 110.56 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.41 -29.61 22.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.373 0.606 . . . . 0.0 110.386 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.69 13.62 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.391 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' B' ' 48' ' ' GLU . 21.2 tptm -82.07 132.78 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -158.4 147.63 19.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.265 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -81.25 115.34 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -110.12 98.04 7.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.363 0.602 . . . . 0.0 110.617 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.89 163.55 29.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.03 145.86 14.22 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.694 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.2 t -160.65 158.57 29.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -130.02 146.39 51.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.825 0.345 . . . . 0.0 110.336 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.3 mtt -94.85 178.36 5.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.046 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.7 t -135.04 122.93 22.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -94.22 -6.43 44.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.86 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.304 1.002 . . . . 0.0 112.132 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.43 115.72 16.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 111.087 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -99.24 110.55 23.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.377 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.83 116.93 20.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.831 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 77.19 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.258 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -96.23 94.12 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -81.99 129.62 34.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.697 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.427 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.64 112.22 3.32 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.907 2.405 . . . . 0.0 111.429 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -157.22 148.19 21.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.486 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.437 ' H ' HD11 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.35 144.71 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.815 174.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 18' ' ' GLN . 16.9 mt -98.77 155.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' HB2' HD13 ' A' ' 17' ' ' LEU . 7.0 mp0 -113.1 144.14 43.15 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -144.14 161.04 39.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.454 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.864 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.6 m -121.95 115.22 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.679 0.752 . . . . 0.0 110.493 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 63.8 t80 -75.2 114.74 14.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.737 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.677 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 5.5 pt-20 -105.64 132.24 52.03 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 164.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -74.0 63.55 0.95 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -149.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 13' ' ' VAL . . . -142.96 -7.08 0.62 Allowed Glycine 0 C--N 1.27 -3.094 0 CA-C-N 110.899 -2.864 . . . . 0.0 107.743 149.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 19.0 m -160.76 150.11 5.36 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -155.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.6 m-85 -99.48 116.52 31.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD3' ' HG2' ' A' ' 10' ' ' GLU . 23.3 mtpp -109.18 111.61 60.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.402 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.7 Cg_endo -53.8 165.12 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.592 1.528 . . . . 0.0 113.978 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 6' ' ' GLU . 93.1 mt -93.06 -66.43 0.92 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.436 165.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HB2' HG22 ' A' ' 5' ' ' ILE . 71.0 mt-30 -61.33 132.63 54.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 112.982 -1.917 . . . . 0.0 108.636 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -65.67 139.25 58.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.571 0.701 . . . . 0.0 110.436 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.427 ' CG2' ' H ' ' A' ' 22' ' ' LEU . 2.4 p -106.56 146.82 12.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.575 -167.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -133.85 13.76 3.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.099 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' H ' ' CG2' ' A' ' 20' ' ' VAL . 86.7 mt -72.93 -176.63 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.853 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 14.8 pttp -125.18 165.41 18.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.192 -174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 3.8 mp0 -66.47 143.29 57.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.694 0.759 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.52 65.47 3.39 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.299 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.5 tp10 -106.82 124.39 49.54 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.06 110.36 21.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 123.499 1.619 . . . . 0.0 113.266 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.945 HG11 ' HG ' ' B' ' 32' ' ' LEU . 27.8 m -122.81 149.35 26.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.986 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HD3' ' HG3' ' B' ' 6' ' ' GLU . 47.0 mmtm -103.3 138.73 39.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mm -92.6 130.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' B' ' 4' ' ' ILE . 9.7 tttt -136.45 134.67 37.92 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.171 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 HG11 ' B' ' 28' ' ' VAL . 89.5 mt -102.62 128.49 49.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.396 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -69.74 138.18 52.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -165.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 32' ' ' LEU . 5.1 mp -127.82 -172.64 2.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.765 172.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -114.59 164.89 13.38 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.743 0.306 . . . . 0.0 110.743 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.18 154.16 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.04 159.42 65.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.237 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.78 178.21 7.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.709 2.273 . . . . 0.0 112.373 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.1 pt -80.01 174.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.78 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.36 121.57 14.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.556 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -131.95 154.4 49.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.706 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.79 131.83 2.07 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.337 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.26 135.77 44.0 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.884 0.374 . . . . 0.0 111.014 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.3 -173.8 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.047 2.498 . . . . 0.0 112.565 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.07 153.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.687 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -106.09 -171.77 1.96 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.13 157.52 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.989 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.667 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.5 mp0 -61.89 128.0 34.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 110.548 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.18 -35.19 66.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.283 0.563 . . . . 0.0 111.05 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 tt -80.43 -3.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.769 . . . . 0.0 110.742 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.667 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 64.7 tttt -81.69 134.32 35.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.472 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 54' ' ' ARG . 19.3 ptmt -109.91 158.46 18.18 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.339 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.6 110.71 15.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 168.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 3.8 ppt_? -65.7 135.08 54.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 111.132 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.32 144.6 29.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.155 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 57' ' ' THR . . . -153.7 170.3 32.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.904 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 44.8 m 69.89 145.25 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.137 0.551 . . . . 0.0 110.775 -177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -122.78 147.18 46.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.1 mtt -86.43 139.74 30.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -75.34 166.79 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.517 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 m -105.31 19.21 20.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 50.45 82.64 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.955 0.883 . . . . 0.0 110.647 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.1 114.59 2.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.743 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 62.14 69.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.103 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -88.2 36.44 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.805 0.812 . . . . 0.0 110.361 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -136.88 134.26 36.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.171 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.42 105.29 8.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.499 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -100.8 -33.8 10.09 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.709 175.603 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 75.89 4.81 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.638 2.226 . . . . 0.0 112.415 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -79.07 147.95 32.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.738 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.459 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -74.57 126.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.586 ' HB ' ' HG3' ' B' ' 18' ' ' GLN . 19.6 pt -101.21 134.1 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.469 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -87.4 138.98 31.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.227 0.537 . . . . 0.0 111.079 -175.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.81 152.15 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.308 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.575 HG11 HD12 ' B' ' 17' ' ' LEU . 3.6 m -115.33 118.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.714 0.769 . . . . 0.0 110.621 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 45.6 t80 -70.9 131.42 43.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.72 174.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.525 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 35.1 tt0 -151.75 129.76 11.81 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.469 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 30.6 t30 66.51 20.23 10.87 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.623 0.577 . . . . 0.0 111.907 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' OH ' ' B' ' 9' ' ' TYR . . . 95.26 10.49 57.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.008 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.2 t -122.85 148.51 26.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.666 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 92.8 m-85 -102.11 114.38 28.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -110.49 116.55 52.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 31.9 Cg_endo -65.55 168.14 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.233 1.288 . . . . 0.0 112.317 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.575 HD12 HG11 ' B' ' 8' ' ' VAL . 5.6 mp -115.13 -5.59 12.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.586 ' HG3' ' HB ' ' B' ' 5' ' ' ILE . 25.0 mm-40 -94.76 -1.58 52.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.544 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 34.27 123.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 O-C-N 125.311 1.632 . . . . 0.0 114.244 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.651 HG13 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -125.42 139.92 49.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.599 -164.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.84 88.13 2.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.975 170.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.651 ' HG ' HG13 ' B' ' 20' ' ' VAL . 71.3 mt -110.81 -161.97 0.78 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 112.639 -2.073 . . . . 0.0 109.967 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -89.27 -174.69 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 35.3 mt-10 -106.3 123.56 48.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 109.653 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.864 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.04 24.53 44.25 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.547 ' HG2' HD12 ' B' ' 22' ' ' LEU . 8.6 tp10 -63.55 132.9 52.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.029 0.531 . . . . 0.0 110.831 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -83.25 113.22 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.847 0.832 . . . . 0.0 111.733 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 14' ' ' PHE . 34.8 m -138.41 161.5 30.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.969 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -115.66 144.51 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.178 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.584 HG21 ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -118.34 126.22 74.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.355 0.598 . . . . 0.0 110.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -134.08 124.65 26.52 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.638 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.945 ' HG ' HG11 ' A' ' 28' ' ' VAL . 3.9 mp -72.47 113.77 9.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -158.68 162.3 37.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.451 -159.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.08 -150.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.573 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -113.02 155.85 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.991 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.51 163.93 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.239 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.15 156.36 35.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 122.616 0.367 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -89.03 -179.32 2.07 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.291 2.661 . . . . 0.0 113.212 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.21 169.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.844 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -125.89 -173.59 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.536 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.5 pt? -125.33 172.44 9.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.42 -150.05 6.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.035 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.769 ' HB2' ' HD2' ' B' ' 44' ' ' PRO . 8.3 pt-20 -98.27 175.07 2.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.769 ' HD2' ' HB2' ' B' ' 43' ' ' GLU . 37.7 Cg_endo -67.18 -162.58 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.266 1.977 . . . . 0.0 111.9 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.41 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -91.82 173.01 8.08 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.89 140.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.459 ' CD ' ' HG2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -126.61 -169.4 2.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.2 -27.51 63.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.426 ' N ' HD13 ' B' ' 50' ' ' ILE . 3.6 mp -93.54 -15.5 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.214 0.531 . . . . 0.0 110.321 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' B' ' 52' ' ' LYS . 47.0 mmtm -88.33 132.47 34.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.105 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' B' ' 51' ' ' LYS . 12.7 mptt -130.38 135.12 47.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.897 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.456 ' N ' HD11 ' B' ' 53' ' ' ILE . 4.2 mp -93.99 -39.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.09 0.472 . . . . 0.0 110.134 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -79.41 133.6 36.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -104.17 169.66 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.02 172.61 45.23 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t -156.99 165.01 37.37 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -91.95 133.87 35.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.3 ttt -132.82 137.92 46.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m 67.52 121.01 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.384 1.053 . . . . 0.0 112.386 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -103.44 0.54 31.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.634 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp 52.45 79.74 0.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.795 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.0 136.36 48.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.31 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -89.16 72.53 8.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.672 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.16 128.04 34.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.723 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -93.14 138.46 31.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.061 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -77.56 -156.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.606 174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -145.47 89.05 1.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.635 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.508 177.401 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 2.3 mpp? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.7 Cg_exo -75.25 106.39 2.26 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.547 2.165 . . . . 0.0 111.243 174.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.01 144.96 28.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.042 0.449 . . . . 0.0 110.281 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER -91.87 143.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.1 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 18' ' ' GLN . 24.8 mm -100.93 156.12 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 28.3 mt-10 -116.0 145.82 42.65 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -147.55 166.27 27.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.101 0.477 . . . . 0.0 110.891 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.04 122.6 65.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.935 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 90.2 t80 -78.33 99.46 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.394 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -120.55 135.79 54.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.968 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.422 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 42.3 m-80 63.25 21.69 12.96 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.587 0.555 . . . . 0.0 111.496 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 86.9 11.48 70.29 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.131 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 16.1 t -125.14 148.67 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.737 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 83.6 m-85 -96.36 114.87 26.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.194 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.451 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 29.9 mtmt -112.5 114.07 50.43 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.74 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 Cg_endo -63.15 168.77 10.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.449 1.433 . . . . 0.0 112.981 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -108.33 -20.62 13.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.52 ' HB2' HG22 ' A' ' 5' ' ' ILE . 42.8 mt-30 -99.6 143.34 29.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.965 -1.471 . . . . 0.0 109.554 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -84.81 124.38 31.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.265 0.555 . . . . 0.0 109.674 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.47 134.87 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.72 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.36 88.63 4.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.365 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 62.8 mt -113.05 171.56 7.47 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.093 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -107.39 158.85 16.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 8.1 mp0 -67.24 114.84 6.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.374 0.606 . . . . 0.0 110.199 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.88 25.92 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.058 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 3.9 mm-40 -74.11 133.96 42.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -100.82 121.88 42.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.968 1.842 . . . . 0.0 113.417 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 HD23 ' B' ' 32' ' ' LEU . 34.7 m -132.93 160.28 42.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.156 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 65.6 mttm -117.26 140.78 49.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.452 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' B' ' 7' ' ' ALA . 1.3 mm -116.57 149.44 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.781 -175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HZ1' HG23 ' B' ' 4' ' ' ILE . 6.4 ptpp? -156.94 164.56 37.89 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 164.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.639 HD22 HD12 ' B' ' 22' ' ' LEU . 9.2 mt -87.55 114.56 24.27 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.555 ' HG2' ' HD2' ' B' ' 29' ' ' LYS . 3.7 tp10 -69.75 141.86 53.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.845 0.831 . . . . 0.0 111.457 -164.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.08 163.25 22.17 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.921 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -103.66 162.13 13.33 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.108 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.2 138.96 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 mt-10 -66.75 120.94 75.09 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-O 120.721 0.296 . . . . 0.0 110.45 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 21.1 Cg_exo -66.35 -175.16 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.383 2.722 . . . . 0.0 112.933 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 pt -70.27 165.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.77 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.42 104.53 10.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.587 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 pp -84.1 176.39 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.402 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.95 -125.21 1.91 Allowed Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.787 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -112.27 127.93 26.19 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.543 0.211 . . . . 0.0 111.142 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.12 173.35 14.05 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.539 2.159 . . . . 0.0 111.433 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 46' ' ' SER . 14.4 p -131.21 166.58 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.217 0.532 . . . . 0.0 110.768 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.44 ' N ' HG23 ' A' ' 45' ' ' VAL . 17.6 m -88.3 170.06 11.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.66 3.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.304 0.574 . . . . 0.0 111.528 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.59 104.03 9.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.464 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -87.28 -30.26 21.01 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.5 tt -69.75 -7.25 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.621 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -87.35 133.64 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.831 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -101.36 141.23 34.55 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.294 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp -79.23 -45.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -147.38 160.43 42.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.412 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.04 156.16 25.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.21 -50.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.628 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -75.84 138.87 41.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.052 0.453 . . . . 0.0 111.265 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -114.69 134.19 55.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.415 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 97.2 mmm -84.98 161.26 19.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.735 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 m 61.45 25.26 15.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.2 m -79.38 -0.39 32.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.958 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.38 123.34 30.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.916 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.37 113.54 27.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -100.34 -46.87 5.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.285 0.564 . . . . 0.0 110.162 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -99.08 93.51 6.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.585 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -169.93 131.05 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.53 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.8 147.24 52.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.045 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -99.59 148.35 24.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.245 175.384 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.5 86.57 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.789 2.326 . . . . 0.0 111.832 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -92.37 175.02 6.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.007 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.767 HG23 ' HZ1' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -67.29 139.93 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 15.0 mt -109.2 154.31 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 164.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -109.21 135.99 49.41 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.515 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.96 164.24 30.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.679 HG11 HD12 ' B' ' 17' ' ' LEU . 4.4 m -126.49 124.93 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.472 0.653 . . . . 0.0 111.369 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.642 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 20.2 t80 -62.15 112.42 2.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.86 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.35 128.83 40.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 120.943 0.401 . . . . 0.0 110.712 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.22 34.32 11.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.794 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.04 -69.33 0.26 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 117.653 -2.213 . . . . 0.0 111.634 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -93.37 154.33 3.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.997 -158.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.737 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -88.23 115.85 26.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -105.67 120.9 47.76 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.583 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 11.3 Cg_endo -58.6 168.71 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.453 1.435 . . . . 0.0 112.391 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.679 HD12 HG11 ' B' ' 8' ' ' VAL . 7.0 mp -102.27 -11.25 18.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' B' ' 16' ' ' PRO . 13.3 pm0 -133.17 143.52 49.26 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.496 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.42 149.25 39.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 112.138 -173.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 t -123.76 150.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.353 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.02 25.14 3.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.079 0.942 . . . . 0.0 109.878 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.639 HD12 HD22 ' A' ' 32' ' ' LEU . 97.9 mt -78.59 -166.23 0.84 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.672 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 10.1 mtmp? -97.1 162.32 13.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.4 mp0 -74.55 136.54 42.11 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.337 0.589 . . . . 0.0 109.416 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.6 65.4 3.2 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.416 -165.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.672 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 1.7 mm-40 -96.34 148.8 22.39 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.618 -0.791 . . . . 0.0 109.551 170.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' B' ' 27' ' ' ARG . 2.1 tpt180 -98.02 105.66 17.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.652 1.215 . . . . 0.0 112.167 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.468 HG23 ' CD1' ' A' ' 14' ' ' PHE . 34.0 m -124.68 156.87 33.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 113.045 -1.888 . . . . 0.0 111.408 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.555 ' HD2' ' HG2' ' A' ' 33' ' ' GLU . 45.0 mttp -120.79 143.46 48.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.201 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.426 HG12 HG22 ' A' ' 30' ' ' ILE . 17.1 mt -130.02 147.55 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.884 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.625 ' HG3' ' HG3' ' B' ' 33' ' ' GLU . 10.2 ptpt -156.88 165.13 37.06 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.867 HD23 HG13 ' A' ' 28' ' ' VAL . 24.2 mt -89.97 115.11 27.02 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -177.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.625 ' HG3' ' HG3' ' B' ' 31' ' ' LYS . 23.7 mt-10 -125.8 149.25 48.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.38 1.086 . . . . 0.0 113.911 -168.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.36 -169.85 3.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.417 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' B' ' 36' ' ' VAL . 49.4 tptt -123.77 163.55 20.94 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.422 ' N ' ' HG3' ' B' ' 35' ' ' LYS . 8.6 t -86.33 132.27 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.437 ' HB2' ' HD3' ' B' ' 38' ' ' PRO . 45.3 mt-10 -81.21 -57.18 0.57 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' B' ' 37' ' ' GLU . 37.9 Cg_endo -65.12 174.6 4.71 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.035 1.823 . . . . 0.0 113.184 -173.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 pp -101.97 172.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.373 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.66 129.61 39.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.245 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 49.3 tp 68.37 112.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.749 0.656 . . . . 0.0 112.04 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.91 114.53 0.49 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.813 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 10.9 mp0 -108.84 130.0 23.25 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 6.0 Cg_exo -78.78 114.38 3.43 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.704 2.269 . . . . 0.0 111.508 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.9 156.6 6.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.185 0.517 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -83.2 160.35 21.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.802 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.85 142.35 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.202 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.0 105.19 4.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.08 0.943 . . . . 0.0 110.879 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.78 -27.73 20.94 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.147 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tp -76.79 -15.51 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.525 -172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -151.2 137.99 18.92 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.408 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -151.6 158.62 43.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tp -69.87 133.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' B' ' 54' ' ' ARG . 42.0 ttp180 -107.07 133.72 51.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.05 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.6 163.44 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -1.35 49.5 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.11 140.17 45.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.846 0.355 . . . . 0.0 111.342 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -124.44 139.99 53.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.584 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.19 31.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -73.73 152.03 40.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.063 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.559 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 11.5 m -93.51 -5.79 48.27 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.075 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 61' ' ' SER . 2.9 pp 46.63 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.032 1.333 . . . . 0.0 114.539 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -119.86 111.74 18.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.347 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -135.4 110.33 8.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.346 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.33 151.3 48.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -75.85 99.64 4.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.735 0.779 . . . . 0.0 110.484 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -84.54 82.17 8.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.613 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -138.54 112.37 8.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.096 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.27 111.89 2.84 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.414 2.076 . . . . 0.0 111.114 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -71.28 144.05 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.298 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.2 OUTLIER -130.83 146.17 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.754 -175.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' CD1' HG23 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.56 169.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 164.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.433 ' HB2' HD11 ' A' ' 17' ' ' LEU . 37.0 mt-10 -103.85 158.45 16.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HB1' HD11 ' B' ' 30' ' ' ILE . . . -150.68 154.4 37.38 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.644 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 31.1 m -110.08 116.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.841 0.829 . . . . 0.0 110.329 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 57.1 t80 -79.98 102.91 9.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.644 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' O ' HG23 ' A' ' 13' ' ' VAL . 9.4 pt-20 -118.48 136.95 53.51 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.158 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 65.44 9.25 5.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.836 173.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 96.5 12.51 50.83 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.905 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 10' ' ' GLU . 2.4 m -124.52 142.67 40.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.371 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.99 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 93.5 m-85 -90.79 116.41 28.62 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.652 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.18 111.82 61.65 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -46.18 169.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.045 2.496 . . . . 0.0 115.357 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.934 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 63.3 mt -107.02 113.79 27.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 166.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.934 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 1.1 pp0? 77.11 143.21 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 127.99 2.516 . . . . 0.0 111.862 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -60.64 127.83 33.62 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.172 -172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 5' ' ' ILE . 14.7 p -127.26 146.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.652 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.91 86.59 2.75 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.321 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.515 ' HB2' ' CE2' ' B' ' 9' ' ' TYR . 67.3 mt -103.45 -176.56 3.12 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.51 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.47 148.83 26.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.41 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 12.4 pt-20 -82.74 121.56 27.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.16 14.97 31.87 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.823 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.84 116.69 17.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.37 119.58 27.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.095 0.95 . . . . 0.0 110.415 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.2 161.15 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.228 -168.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HG3' ' CD ' ' B' ' 33' ' ' GLU . 13.7 mmmm -118.56 134.97 54.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.957 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.723 HG12 HG21 ' B' ' 30' ' ' ILE . 9.8 mt -133.44 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.694 -170.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.66 165.51 27.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.638 172.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 mt -94.99 146.71 24.07 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 123.445 0.466 . . . . 0.0 111.464 -166.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.17 145.9 55.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.0 mt -71.37 154.57 41.47 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.101 0.953 . . . . 0.0 113.073 -168.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HZ3' ' CD ' ' B' ' 26' ' ' GLU . 15.0 mptt -129.19 175.14 8.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.638 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.63 142.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.035 0.445 . . . . 0.0 110.264 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -91.03 130.06 41.69 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.588 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 174.06 12.35 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.302 2.001 . . . . 0.0 112.083 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -89.31 150.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.836 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.59 135.56 53.22 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.13 176.11 9.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 111.253 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.29 155.26 16.45 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -67.23 140.79 95.69 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.44 -175.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -63.17 119.73 6.92 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.476 2.117 . . . . 0.0 111.363 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.45 148.03 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.512 0.672 . . . . 0.0 111.32 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 67.2 m -92.98 -171.84 2.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.176 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 46' ' ' SER . 25.0 t 68.37 139.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 111.67 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -93.6 113.51 25.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.7 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.45 -26.28 26.42 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.517 0.675 . . . . 0.0 109.47 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mt -80.33 -15.21 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.25 132.51 45.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HG2' HG13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -105.63 -150.24 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.401 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.544 HG13 ' HG2' ' A' ' 52' ' ' LYS . 89.7 mt 76.2 98.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.358 0.663 . . . . 0.0 111.089 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -122.96 123.7 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.336 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.53 173.4 8.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.75 38.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.675 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.5 t -66.52 148.69 51.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.689 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -147.34 144.24 28.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.908 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 24.9 ttt -109.49 124.65 51.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 t -84.14 136.53 33.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.834 0.349 . . . . 0.0 110.914 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -105.8 18.32 22.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.53 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.62 90.92 3.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.54 115.89 28.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.603 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.45 134.17 55.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.603 -174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -121.57 157.74 30.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.646 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -160.78 90.05 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.453 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.8 131.51 35.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.563 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -101.49 -29.5 11.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.828 171.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -90.77 111.48 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.912 2.408 . . . . 0.0 112.372 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.9 152.77 49.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.47 . . . . 0.0 111.427 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.441 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -115.97 144.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.561 174.113 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.27 148.59 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.522 ' HB2' HD13 ' B' ' 17' ' ' LEU . 2.4 mp0 -121.81 145.78 47.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.47 165.17 36.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.61 0.243 . . . . 0.0 111.191 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -117.22 122.62 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.769 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 69.9 t80 -84.27 102.92 13.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.196 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.42 125.6 50.29 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.741 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 63.34 21.26 12.71 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.012 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.698 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 101.49 4.93 52.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.115 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.6 t -119.69 142.64 34.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.081 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.99 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -98.23 115.59 28.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -102.17 113.2 65.95 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.438 ' HG3' ' CE2' ' A' ' 14' ' ' PHE . 38.6 Cg_exo -56.86 169.72 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.63 1.553 . . . . 0.0 113.041 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' B' ' 6' ' ' GLU . 7.8 mp -83.53 -74.69 0.36 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.782 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -84.69 151.82 24.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -67.95 137.97 55.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.539 . . . . 0.0 111.507 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.476 HG12 ' HG ' ' B' ' 22' ' ' LEU . 2.5 t -122.1 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.597 177.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -110.65 87.81 2.62 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 123.163 1.458 . . . . 0.0 109.012 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.497 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 92.0 mt -111.7 -172.84 2.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.044 -2.344 . . . . 0.0 110.096 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.719 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 92.3 mttt -82.19 159.86 23.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.97 126.31 29.66 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.531 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 60.46 65.59 3.25 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.565 -165.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.719 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 0.7 OUTLIER -96.23 149.97 21.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.478 -0.861 . . . . 0.0 108.97 165.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -104.42 131.35 51.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.451 0.644 . . . . 0.0 111.198 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.466 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.2 m -142.15 164.79 17.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.252 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -119.59 134.47 55.21 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.31 0.576 . . . . 0.0 109.717 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.723 HG21 HG12 ' A' ' 30' ' ' ILE . 3.8 mt -118.39 147.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.581 -172.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.542 ' HB3' HG21 ' A' ' 4' ' ' ILE . 3.0 ptpp? -155.6 166.19 34.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.441 0.638 . . . . 0.0 110.648 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.431 HD23 ' N ' ' B' ' 32' ' ' LEU . 3.2 mm? -101.9 128.73 48.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.284 173.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.444 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 68.9 mt-10 -89.18 147.99 23.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.06 -172.24 2.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.741 0.781 . . . . 0.0 112.311 -169.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' B' ' 35' ' ' LYS . 24.4 mtmt -85.36 155.85 21.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.338 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.3 135.7 33.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 164.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 5.5 pt-20 -77.7 143.75 67.92 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.285 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 11.6 Cg_exo -71.73 -156.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.818 3.012 . . . . 0.0 114.191 -170.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.34 178.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.628 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -92.06 129.67 37.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.502 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.9 144.65 38.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.083 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 -145.27 11.35 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -124.02 122.24 26.24 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 120.784 0.326 . . . . 0.0 110.692 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.83 128.38 24.22 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.571 2.181 . . . . 0.0 111.816 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.06 150.77 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.816 0.817 . . . . 0.0 111.444 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -106.12 -176.52 3.1 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.219 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.81 141.76 17.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.538 ' HB2' HG21 ' B' ' 50' ' ' ILE . 1.6 pm0 -66.76 129.76 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.446 0.641 . . . . 0.0 111.628 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.64 -25.08 44.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.423 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' B' ' 48' ' ' GLU . 13.7 tt -69.94 -1.19 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.951 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.472 ' HB2' ' HG2' ' B' ' 48' ' ' GLU . 14.0 tptm -59.15 134.01 56.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.916 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -128.71 138.8 52.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.044 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pp -114.45 162.9 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.107 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -149.83 148.69 29.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.016 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -158.31 -163.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.14 124.39 1.0 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.088 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.75 127.04 43.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -82.11 154.72 25.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.033 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -144.6 154.75 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.241 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -79.74 133.61 36.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 56.4 p -82.85 14.2 3.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.575 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.9 103.08 0.41 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -101.89 155.46 18.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.932 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -84.76 100.26 11.4 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.93 135.12 51.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.978 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -129.8 153.4 48.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.296 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -147.52 130.39 16.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -133.66 140.08 46.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.558 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.568 175.793 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.642 ' HA ' HD11 ' B' ' 32' ' ' LEU . 14.7 Cg_endo -58.47 99.55 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.406 2.071 . . . . 0.0 112.295 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -157.27 154.67 29.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.926 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.5 mp -64.49 135.79 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.744 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HB ' HD12 ' B' ' 30' ' ' ILE . 11.7 mt -131.2 150.84 34.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -100.99 126.44 47.66 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.82 166.53 18.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.522 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.26 114.27 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.465 0.65 . . . . 0.0 110.131 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.746 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 68.3 t80 -67.06 119.44 12.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.626 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 22.7 tt0 -148.2 142.57 26.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.395 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.45 18.03 10.76 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 0.0 111.458 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.497 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 83.43 18.99 63.06 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.819 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.746 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 11.6 t -129.09 154.66 40.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 C-N-CA 122.858 0.463 . . . . 0.0 110.048 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 1.042 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.2 m-85 -97.84 115.11 27.42 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.309 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 41.6 mtmt -109.74 113.08 57.99 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.478 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 31.4 Cg_exo -56.87 166.28 4.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.171 1.248 . . . . 0.0 113.593 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.21 -68.5 0.79 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 112.069 -2.332 . . . . 0.0 105.405 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' A' ' 5' ' ' ILE . 57.9 mt-30 -60.04 144.89 48.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.467 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -68.74 149.62 48.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.143 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 22' ' ' LEU . 3.4 p -123.6 155.83 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 122.162 0.982 . . . . 0.0 111.397 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.83 12.63 11.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.834 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.704 HD13 HD21 ' B' ' 32' ' ' LEU . 97.0 mt -90.57 -174.83 4.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.368 -172.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -92.93 -172.96 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.25 -169.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.633 ' HB3' ' H ' ' B' ' 11' ' ' ASN . 0.0 OUTLIER -93.15 -169.89 2.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 164.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.631 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . -21.95 71.66 0.0 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 122.847 1.248 . . . . 0.0 114.686 -152.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 44.3 tt0 -96.65 139.78 32.22 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 111.956 -2.122 . . . . 0.0 108.105 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -93.69 128.44 39.88 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.755 0.788 . . . . 0.0 112.354 -166.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' B' ' 32' ' ' LEU . 16.5 m -145.74 171.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.72 -173.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 58.7 mttm -128.45 138.84 52.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.827 HG22 ' HB ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -119.14 134.32 63.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.0 -171.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.589 ' HG2' HG22 ' B' ' 4' ' ' ILE . 51.9 mttp -110.24 148.92 30.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.029 0.442 . . . . 0.0 110.075 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.6 146.54 28.01 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.843 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -88.96 154.74 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 ' HG3' ' B' ' 2' ' ' PRO . 34.5 mt -125.85 -174.17 3.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.894 0.854 . . . . 0.0 113.08 -171.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 69.3 tttt -128.33 -137.4 0.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.089 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.43 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 40.3 t -102.05 148.17 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -63.76 148.01 95.12 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 122.189 0.196 . . . . 0.0 110.877 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.53 -169.46 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.197 2.598 . . . . 0.0 113.741 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.9 mt -96.51 154.29 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.09 -153.7 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.5 tp -69.47 147.67 50.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.91 -113.62 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.868 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.2 pm0 -63.99 141.64 98.07 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.286 -0.457 . . . . 0.0 111.196 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 14.8 Cg_exo -68.32 157.11 63.22 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.824 2.349 . . . . 0.0 112.592 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.05 149.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.786 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -117.51 -170.94 1.95 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.862 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.32 147.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.94 169.8 17.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 111.785 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.27 -25.18 62.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.8 -13.37 17.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -82.19 132.45 35.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.737 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.78 156.5 42.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.8 mt -80.12 154.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -71.65 110.47 6.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.007 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -98.95 158.5 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.51 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.95 113.37 0.47 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.448 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -136.8 174.86 10.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -117.43 148.61 41.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.059 0.457 . . . . 0.0 110.879 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.5 ttm -114.75 128.26 56.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.475 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.0 m 62.05 109.34 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 124.196 0.935 . . . . 0.0 112.086 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.826 ' HB2' ' HG3' ' A' ' 63' ' ' GLU . 1.7 m -88.28 18.67 4.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.133 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.8 mt 58.41 30.43 19.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.53 -175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.826 ' HG3' ' HB2' ' A' ' 61' ' ' SER . 34.6 mt-10 -76.14 107.68 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.111 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -111.09 93.7 4.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.392 0.615 . . . . 0.0 109.66 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -95.8 104.92 16.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.477 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -86.15 134.64 33.79 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.011 -173.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -98.97 133.46 43.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.37 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -89.87 108.32 19.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--O 1.242 0.7 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.156 177.454 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.435 ' HG2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.709 ' HG3' HD22 ' A' ' 34' ' ' LEU . 26.9 Cg_endo -89.19 -69.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.519 2.146 . . . . 0.0 112.149 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -123.25 161.81 23.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.641 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.589 HG22 ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -115.22 136.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.039 0.447 . . . . 0.0 110.364 175.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.829 HD13 HD12 ' B' ' 22' ' ' LEU . 25.1 mt -98.72 160.17 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.533 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 40.6 mt-10 -125.61 136.94 53.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.757 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -151.07 168.37 24.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.845 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.631 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.5 m -128.19 137.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.142 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.523 ' H ' ' HD1' ' B' ' 9' ' ' TYR . 2.8 m-85 -58.05 156.73 8.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.084 0.945 . . . . 0.0 112.075 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' B' ' 13' ' ' VAL . 16.2 tp10 -144.29 98.05 3.14 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.633 ' H ' ' HB3' ' A' ' 24' ' ' GLU . 1.9 t30 56.14 30.99 17.41 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.115 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.65 -69.56 0.51 Allowed Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 118.279 -1.915 . . . . 0.0 111.708 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' B' ' 10' ' ' GLU . 28.3 m -92.78 141.7 14.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.848 -155.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 1.042 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -88.53 125.39 34.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -165.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.39 112.59 65.44 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.9 Cg_endo -76.23 169.75 21.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 CA-C-O 122.016 0.757 . . . . 0.0 113.428 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.15 -23.61 22.41 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 166.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' B' ' 19' ' ' LYS 0.283 4.2 tt0 43.05 -119.8 0.57 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.343 166.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 47.1 tttp 69.01 -128.05 0.1 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -143.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' B' ' 19' ' ' LYS . 50.9 t 68.82 171.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 119.613 1.097 . . . . 0.0 109.946 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.407 ' O ' ' HE3' ' B' ' 23' ' ' LYS . 30.0 t70 -122.96 17.05 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.226 1.012 . . . . 0.0 111.227 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.829 HD12 HD13 ' B' ' 5' ' ' ILE . 93.6 mt -83.53 169.55 15.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.607 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' B' ' 21' ' ' ASP . 18.9 mttt -136.35 -179.73 5.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -164.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.3 145.17 37.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.348 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 57.9 65.25 3.67 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -164.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 1.4 mm-40 -120.13 139.82 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.497 -0.852 . . . . 0.0 111.05 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' B' ' 27' ' ' ARG . 0.3 OUTLIER -88.95 125.89 35.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.862 -174.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.827 ' HB ' HG22 ' A' ' 30' ' ' ILE . 34.3 m -136.99 148.15 26.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.825 -172.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -117.35 138.25 51.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.018 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 3.9 mt -117.26 148.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.289 0.566 . . . . 0.0 111.376 -169.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -137.25 161.76 35.33 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 22' ' ' LEU . 6.6 mp -115.05 137.16 52.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -94.94 142.73 27.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 25.6 mt -130.08 162.25 29.2 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -85.91 159.89 19.55 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.178 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.6 150.39 7.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.132 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.08 110.84 5.22 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.09 173.03 15.17 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.544 2.163 . . . . 0.0 113.439 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.64 173.89 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.953 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -88.68 137.03 32.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.302 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.4 tp -111.41 143.7 41.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.329 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 115.3 3.48 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.75 125.52 91.65 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 115.319 -0.44 . . . . 0.0 110.92 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.8 172.57 16.02 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.709 2.273 . . . . 0.0 112.356 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.81 152.16 25.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -125.11 168.5 13.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.91 127.34 51.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -102.6 102.78 13.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.67 -25.98 24.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.136 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt -84.49 0.05 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.316 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.33 131.81 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.598 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -135.84 155.4 50.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.85 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.78 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' B' ' 54' ' ' ARG . 10.1 ptm180 -92.12 155.43 18.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.618 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.24 155.13 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.954 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.12 143.64 15.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.666 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -125.13 168.34 13.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.886 0.343 . . . . 0.0 110.602 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -128.98 141.55 51.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.167 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 49.7 ttm -123.45 124.75 43.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -79.66 140.26 37.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.773 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.3 t -101.89 20.55 16.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.34 0.59 . . . . 0.0 109.689 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.33 -169.16 0.2 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.644 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 169.4 18.77 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -75.13 147.17 40.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 111.17 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.62 156.31 45.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.845 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -132.95 100.71 4.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.004 0.43 . . . . 0.0 111.465 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -106.92 100.12 9.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -51.39 -47.62 62.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.145 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.97 177.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -43.24 119.41 1.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.206 2.604 . . . . 0.0 112.887 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -80.15 162.32 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.447 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.729 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.3 OUTLIER -87.2 143.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 167.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG22 ' A' ' 20' ' ' VAL . 24.0 mt -85.94 150.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.409 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 38.9 mt-10 -124.33 126.12 45.48 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.12 169.5 17.48 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.0 111.406 -171.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.486 HG12 ' HD3' ' B' ' 27' ' ' ARG . 12.1 m -129.66 131.45 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.675 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 70.6 t80 -74.79 118.26 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 34.1 tt0 -155.44 138.47 15.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.905 1.378 . . . . 0.0 108.813 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.06 25.72 12.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.394 0.616 . . . . 0.0 110.35 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 71.01 20.99 78.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.026 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 54.7 t -132.92 159.13 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 9' ' ' TYR . 54.9 m-85 -108.18 115.03 29.37 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -112.97 125.9 29.09 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.908 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.629 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 28.0 Cg_endo -64.21 170.01 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.228 1.286 . . . . 0.0 112.112 177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -5.44 21.6 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 17.6 pt20 -135.18 129.33 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.161 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -68.87 129.45 39.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 110.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.557 HG11 ' HG ' ' A' ' 22' ' ' LEU . 13.8 t -117.01 149.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.306 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.74 25.27 11.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.155 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.557 ' HG ' HG11 ' A' ' 20' ' ' VAL . 55.4 mt -66.75 177.69 1.55 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.456 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 8.9 mtpm? -96.13 170.86 8.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 0.6 OUTLIER -77.01 133.86 39.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.289 175.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 76.96 16.78 80.48 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.465 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 6.8 mm-40 -68.68 135.4 51.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.95 0.405 . . . . 0.0 110.585 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 103.68 15.73 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.775 1.274 . . . . 0.0 112.534 -167.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.714 ' HB ' HG23 ' B' ' 30' ' ' ILE . 29.4 m -129.16 152.41 37.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.426 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.687 ' HE2' ' HG3' ' B' ' 33' ' ' GLU . 46.6 mttm -129.67 135.26 48.29 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.682 0.753 . . . . 0.0 110.019 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 HG23 HD13 ' B' ' 30' ' ' ILE . 9.1 mt -103.9 143.03 16.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.041 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.795 ' HG3' HG21 ' B' ' 4' ' ' ILE . 10.4 mptt -137.93 157.34 46.59 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.113 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.746 HD13 HD23 ' B' ' 22' ' ' LEU . 94.1 mt -86.27 114.18 22.87 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.025 ' HG3' ' HB2' ' B' ' 29' ' ' LYS . 16.7 mm-40 -92.05 144.17 25.71 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -160.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -106.61 -166.16 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.301 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HG2' ' N ' ' A' ' 36' ' ' VAL . 87.5 tttt -125.56 166.11 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' N ' ' HG2' ' A' ' 35' ' ' LYS . 2.1 p -64.48 125.41 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.49 0.662 . . . . 0.0 111.029 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.4 mt-10 -101.85 148.88 35.93 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.904 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -75.93 -165.88 0.33 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.982 2.455 . . . . 0.0 111.636 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.4 pp -70.79 144.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 111.706 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.17 -10.09 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.343 0.592 . . . . 0.0 110.201 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.68 -176.19 3.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.557 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.35 130.7 3.33 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.9 mt-10 -79.1 136.07 57.82 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -67.73 166.03 25.66 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.397 2.731 . . . . 0.0 113.128 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.15 158.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.009 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.6 m -85.16 167.87 15.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.719 0.295 . . . . 0.0 111.102 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.57 134.14 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.252 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 -35.58 18.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.997 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.12 -25.59 67.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.442 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.89 -9.33 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.725 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -88.86 -5.68 57.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.622 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 65.2 157.83 0.1 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.85 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.433 HG12 ' N ' ' A' ' 54' ' ' ARG . 11.4 tt -67.5 165.29 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 122.908 0.483 . . . . 0.0 110.905 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' N ' HG12 ' A' ' 53' ' ' ILE . 57.3 mtt180 -72.19 -67.74 0.52 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.152 0.501 . . . . 0.0 110.936 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.47 176.83 8.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.224 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.34 35.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.461 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -99.51 -166.67 1.37 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -71.04 161.08 31.74 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.154 0.502 . . . . 0.0 111.248 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.4 tpp -131.78 129.46 40.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.714 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.0 t -93.36 144.3 25.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 p -85.71 3.58 40.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.74 106.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.786 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.33 103.25 1.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.278 0.561 . . . . 0.0 110.393 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -82.5 140.23 33.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -64.34 107.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.294 -174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -61.55 139.27 58.28 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -149.59 145.64 26.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.606 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -99.16 15.17 26.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.197 0.522 . . . . 0.0 110.741 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.243 0.757 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.082 177.151 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.684 0.278 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 112.25 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.824 2.35 . . . . 0.0 110.923 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -70.69 152.1 44.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 110.73 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.795 HG21 ' HG3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -103.46 143.34 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.202 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.81 151.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.674 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.22 118.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.0 165.02 25.99 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.568 0.542 . . . . 0.0 110.741 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 m -127.23 133.57 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.598 173.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 1.3 t80 -65.1 100.03 0.41 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.767 ' HB3' ' HD3' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -120.17 119.92 34.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.059 -170.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 52.05 33.58 12.29 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.145 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.85 -70.7 0.44 Allowed Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 117.842 -2.123 . . . . 0.0 112.028 -169.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.547 HG21 ' HG3' ' B' ' 15' ' ' LYS . 32.0 m -100.37 171.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.33 -0.935 . . . . 0.0 112.555 -155.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.669 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 93.7 m-85 -87.76 115.0 24.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.767 ' HD3' ' HB3' ' B' ' 10' ' ' GLU . 50.5 mtpt -115.32 111.18 44.58 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.757 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.3 Cg_endo -64.24 166.67 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.265 1.31 . . . . 0.0 112.113 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.406 HD12 HG11 ' B' ' 8' ' ' VAL . 17.6 mt -129.19 -22.7 3.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.444 -1.707 . . . . 0.0 108.107 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.54 143.82 27.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.959 169.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.52 154.06 33.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.816 0.341 . . . . 0.0 110.35 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.474 HG23 ' H ' ' B' ' 22' ' ' LEU . 4.3 p -98.75 153.74 4.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.994 0.902 . . . . 0.0 110.07 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.3 13.42 7.69 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.906 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.746 HD23 HD13 ' A' ' 32' ' ' LEU . 29.8 mt -106.47 -170.11 1.67 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.08 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 63.5 pttt -120.35 160.84 22.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.049 0.452 . . . . 0.0 110.92 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.29 135.52 42.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.497 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.37 19.51 32.57 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -171.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -94.2 145.01 25.01 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.13 0.49 . . . . 0.0 112.222 -175.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.486 ' HD3' HG12 ' A' ' 8' ' ' VAL . 2.9 mpp_? -98.57 112.92 24.81 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 123.334 1.54 . . . . 0.0 112.787 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.671 HG13 HD22 ' A' ' 32' ' ' LEU . 35.5 m -131.0 162.13 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.228 -173.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 1.025 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 36.3 mtpt -132.78 152.12 51.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.531 0.681 . . . . 0.0 109.632 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.714 HG23 ' HB ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -126.94 139.86 50.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.4 -169.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.664 ' HD3' ' HZ3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -144.2 165.46 27.78 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.573 171.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.97 122.37 37.54 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.813 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.687 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 70.4 mm-40 -72.59 144.12 47.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 -171.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.4 mt -99.89 179.84 4.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.926 0.87 . . . . 0.0 111.892 -173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.1 172.18 14.11 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.834 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.55 149.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.88 151.5 40.8 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.509 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.41 173.75 6.03 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.659 2.239 . . . . 0.0 113.072 -177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 pt -96.2 172.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.881 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.34 134.27 34.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.661 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.64 169.59 17.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.403 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.22 -146.61 15.88 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.093 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.0 OUTLIER -93.28 142.81 25.77 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 121.049 0.452 . . . . 0.0 111.477 -174.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 5.0 Cg_exo -77.99 130.34 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.932 2.421 . . . . 0.0 111.535 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.86 144.46 12.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.403 0.62 . . . . 0.0 111.443 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -104.92 171.07 7.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.602 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.61 148.31 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -85.22 128.05 34.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.18 -24.99 27.68 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.563 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.96 -4.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.289 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -71.36 132.74 45.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.104 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -151.28 103.49 3.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.174 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 67.5 mt -141.33 114.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.344 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -91.6 -52.31 4.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.19 169.84 16.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.53 -104.29 0.99 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.961 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.4 t -158.09 142.9 16.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.248 0.547 . . . . 0.0 110.811 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -157.08 135.36 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.241 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.0 ptm -115.11 170.77 8.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -148.89 -174.19 4.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -85.31 5.93 28.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.849 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 85.1 mt 61.17 -166.27 0.21 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.317 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -99.76 145.44 27.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -168.0 110.21 0.6 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.833 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -113.6 132.77 55.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 43.3 t-80 -158.31 98.53 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.262 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 19.4 p-80 178.38 159.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -130.65 -99.92 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.741 0.305 . . . . 0.0 110.302 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 119.149 -0.453 . . . . 0.0 109.973 178.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.593 0.235 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -89.76 96.82 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.759 2.306 . . . . 0.0 112.059 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -129.77 149.56 51.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.608 ' CG2' ' HD3' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -115.01 139.83 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' HG12 ' B' ' 30' ' ' ILE . 10.2 mt -100.33 156.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 41.3 mt-10 -99.19 154.75 17.9 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.926 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.404 ' CB ' HD12 ' B' ' 30' ' ' ILE . . . -149.67 143.98 25.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.009 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.86 131.86 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.468 0.652 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.73 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 47.4 t80 -88.6 113.08 23.8 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.374 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 39.4 mt-10 -138.07 138.29 38.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.388 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 68.25 19.71 8.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.692 0.62 . . . . 0.0 111.136 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.52 16.12 64.73 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.031 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 10.5 t -125.34 148.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 C-N-CA 122.512 0.325 . . . . 0.0 110.598 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 50.5 m-85 -95.29 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 165.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.57 108.32 59.71 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HG3' ' CE2' ' B' ' 14' ' ' PHE . 47.2 Cg_exo -47.14 168.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.1 2.534 . . . . 0.0 115.707 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.603 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 90.6 mt -114.22 87.36 2.61 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 112.907 -1.951 . . . . 0.0 105.915 165.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 2.5 pp0? 81.58 149.15 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.773 2.429 . . . . 0.0 110.932 -172.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -68.31 152.29 45.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.993 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG12 HD12 ' A' ' 5' ' ' ILE . 3.0 t -114.26 135.95 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.039 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.48 87.8 7.21 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 123.07 1.415 . . . . 0.0 108.154 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.69 173.93 9.87 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.838 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.687 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -101.2 153.43 19.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 40.5 mt-10 -61.67 129.9 43.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.806 0.812 . . . . 0.0 110.865 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.789 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 60.55 65.26 3.46 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.72 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.687 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -103.59 142.84 33.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.107 166.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -93.93 127.75 39.87 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 124.036 1.874 . . . . 0.0 113.981 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' B' ' 14' ' ' PHE . 21.4 m -136.08 155.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 111.35 -2.659 . . . . 0.0 108.341 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.601 ' HD3' ' HB3' ' B' ' 33' ' ' GLU . 38.7 mtpt -118.87 146.24 45.05 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.944 0.878 . . . . 0.0 111.287 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.0 142.85 24.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.804 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HZ3' ' HB2' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -155.38 151.52 27.97 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.357 174.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.56 125.18 42.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.579 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.951 ' HG3' ' HG3' ' B' ' 29' ' ' LYS . 5.2 mm-40 -89.1 150.65 22.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.238 0.542 . . . . 0.0 112.435 -167.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.41 -172.01 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.053 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -92.46 171.9 8.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.094 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.12 156.21 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.778 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -88.14 132.49 39.51 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -80.25 -170.83 1.09 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.573 2.849 . . . . 0.0 113.045 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 pp -84.99 164.5 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.459 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.27 166.58 11.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.03 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.04 166.4 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.912 0.386 . . . . 0.0 111.693 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.72 -145.06 15.81 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.79 156.89 77.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 122.375 0.27 . . . . 0.0 111.147 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.48 -179.16 4.83 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.657 2.238 . . . . 0.0 112.773 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t -104.03 155.97 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.832 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.8 m -101.45 -172.91 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.64 127.83 67.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.297 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.626 ' H ' ' HD2' ' A' ' 51' ' ' LYS . 8.7 mp0 -97.39 171.79 8.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.859 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -85.08 -23.29 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.338 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.18 -15.49 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.399 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.626 ' HD2' ' H ' ' A' ' 48' ' ' GLU . 87.5 mttt -79.67 152.7 29.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.155 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -58.97 122.93 14.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.762 0.791 . . . . 0.0 112.487 -167.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -129.21 142.5 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.017 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -103.64 -175.83 2.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.786 0.327 . . . . 0.0 111.601 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.18 -172.46 0.14 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.389 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.84 -146.64 4.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.055 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.4 t -158.68 173.42 16.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.727 0.299 . . . . 0.0 110.293 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -100.67 142.86 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.879 0.371 . . . . 0.0 110.379 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -109.66 149.33 29.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.93 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -89.51 107.5 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -94.13 19.76 8.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.877 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.4 mt 66.6 174.97 0.24 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 111.503 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.0 -167.51 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.676 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -119.0 108.66 15.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.849 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 62.46 95.56 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.573 0.546 . . . . 0.0 111.638 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -83.1 3.84 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -79.79 88.84 5.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -136.18 113.33 10.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.729 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.954 175.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.59 0.234 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.75 143.36 23.64 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.259 1.973 . . . . 0.0 111.366 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.52 146.44 25.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 110.203 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.433 HD11 ' H ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -91.49 140.12 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.583 HD12 ' HB ' ' B' ' 20' ' ' VAL . 37.8 pt -101.63 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.487 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 82.9 mt-10 -113.9 157.49 22.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.923 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.84 155.95 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.635 0.255 . . . . 0.0 110.508 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.789 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 12.0 m -114.81 126.55 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.417 0.627 . . . . 0.0 110.571 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.753 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 66.0 t80 -92.1 109.35 20.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.593 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 8.4 pt-20 -130.3 135.24 47.88 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.162 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.48 14.45 9.47 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.486 0.491 . . . . 0.0 111.891 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.545 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 94.84 10.84 57.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.755 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.9 t -114.0 143.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.362 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m-85 -106.01 116.35 31.79 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 167.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -115.99 117.81 39.01 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.863 ' HB2' ' HA ' ' B' ' 19' ' ' LYS . 16.8 Cg_exo -58.37 170.55 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.81 1.674 . . . . 0.0 113.721 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.805 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 6.3 mp -111.04 105.82 14.7 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.805 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.2 pt20 85.44 6.89 0.43 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 126.535 2.397 . . . . 0.0 110.171 -175.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.863 ' HA ' ' HB2' ' B' ' 16' ' ' PRO . 27.6 mtpp 53.56 -159.75 0.14 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.173 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.583 ' HB ' HD12 ' B' ' 5' ' ' ILE . 6.3 p -151.12 164.71 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.85 12.98 35.36 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.738 1.256 . . . . 0.0 109.389 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.629 ' O ' ' HD2' ' B' ' 23' ' ' LYS . 93.6 mt -79.12 156.49 28.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.327 170.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.629 ' HD2' ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -132.57 -170.55 2.46 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.453 -170.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 6.2 mp0 -53.14 137.4 33.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 11.1 83.13 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.737 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' B' ' 22' ' ' LEU . 10.0 tp10 -77.89 134.19 37.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 117.092 0.446 . . . . 0.0 110.068 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -117.84 119.71 35.71 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.835 1.303 . . . . 0.0 112.318 -171.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.15 168.62 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.129 -1.851 . . . . 0.0 109.838 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.951 ' HG3' ' HG3' ' A' ' 33' ' ' GLU . 15.3 mtmm -126.45 139.88 52.91 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.586 0.708 . . . . 0.0 111.036 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -91.02 128.03 43.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.224 -170.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.608 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 1.9 tppt? -121.52 124.45 44.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -73.69 111.88 9.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.601 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 14.8 mt-10 -135.72 171.83 13.89 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -160.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.1 176.94 8.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.764 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' B' ' 35' ' ' LYS . 10.5 mtmp? -93.88 159.99 14.94 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.556 0.217 . . . . 0.0 110.473 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.84 152.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -69.18 131.96 90.27 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.272 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.475 ' O ' ' HB ' ' B' ' 39' ' ' ILE . 63.0 Cg_endo -72.93 -154.24 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.127 2.551 . . . . 0.0 111.652 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' B' ' 38' ' ' PRO . 71.2 mt 74.32 161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.417 ' N ' HG22 ' B' ' 39' ' ' ILE . 27.2 t70 56.16 64.88 1.58 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.291 1.043 . . . . 0.0 110.457 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.97 125.56 41.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.847 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.32 112.75 4.12 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 9.2 pt-20 -85.37 116.89 67.41 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.535 174.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 21.5 Cg_exo -64.36 114.78 2.83 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.655 2.236 . . . . 0.0 112.037 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -72.29 146.75 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.454 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -103.37 159.6 15.43 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.177 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.41 151.86 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.691 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.53 114.15 5.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.767 0.794 . . . . 0.0 111.44 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.2 -25.73 27.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.481 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 -15.04 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.815 0.817 . . . . 0.0 110.956 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.18 133.43 42.74 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.871 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' B' ' 52' ' ' LYS . 0.0 OUTLIER -124.79 156.95 36.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.868 0.366 . . . . 0.0 111.272 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 tt -99.28 145.54 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.811 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -72.0 137.96 47.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.261 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.96 -179.25 4.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.451 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.16 6.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.949 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.2 p -90.64 102.08 14.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.146 0.498 . . . . 0.0 111.641 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -100.22 -179.46 4.14 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.344 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.41 151.39 6.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.992 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -98.75 132.84 43.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.985 0.421 . . . . 0.0 110.095 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.9 m -105.7 2.36 27.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.57 113.5 18.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.767 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.1 92.25 2.77 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -86.99 71.0 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.536 0.684 . . . . 0.0 111.814 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 131.91 52.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.809 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -90.54 145.52 24.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.648 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -141.99 145.19 34.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -115.6 -168.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 174.279 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.552 0.215 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' B' ' 31' ' ' LYS . 30.4 Cg_endo -65.71 108.42 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.269 1.979 . . . . 0.0 110.694 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.12 153.09 42.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.521 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.743 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.1 OUTLIER -117.98 138.21 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.273 170.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 HG22 ' HB2' ' A' ' 18' ' ' GLN . 9.3 mm -108.08 143.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' HG3' ' HG2' ' B' ' 29' ' ' LYS . 5.2 mp0 -97.67 121.13 39.22 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -129.81 165.72 21.39 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.056 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.663 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.0 m -117.32 115.05 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.58 0.705 . . . . 0.0 110.69 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.639 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 79.1 t80 -71.88 106.03 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.092 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.65 131.75 54.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.156 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 54.86 24.88 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 172.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 99.82 2.04 56.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.059 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.97 143.25 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.252 0.526 . . . . 0.0 111.176 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 1.034 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 96.9 m-85 -94.1 115.62 27.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -105.04 115.25 62.67 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.884 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 36.1 Cg_endo -66.2 167.81 17.41 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.034 1.156 . . . . 0.0 112.352 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 mt -112.91 -17.42 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HB2' HG22 ' A' ' 5' ' ' ILE . 76.5 mt-30 -92.91 171.63 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.058 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -75.94 132.39 40.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 162.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.42 135.45 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 121.519 0.676 . . . . 0.0 110.349 -174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -103.93 14.44 30.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.236 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.501 HD23 ' HG2' ' A' ' 26' ' ' GLU . 91.1 mt -99.27 -174.31 2.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.098 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.55 163.04 34.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 16.5 mp0 -56.49 141.44 42.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.919 0.866 . . . . 0.0 111.524 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.27 65.3 3.45 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.535 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HG2' HD23 ' A' ' 22' ' ' LEU . 10.9 tp10 -116.76 128.5 55.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.403 -0.898 . . . . 0.0 109.634 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -85.97 120.34 27.26 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.603 1.192 . . . . 0.0 111.189 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.762 ' HB ' HG22 ' B' ' 30' ' ' ILE . 31.0 m -137.02 148.74 26.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.129 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -119.76 137.32 54.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.524 0.678 . . . . 0.0 110.374 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.654 HD11 HG21 ' B' ' 30' ' ' ILE . 3.6 mm -102.85 138.02 28.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.362 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.92 165.04 37.67 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.533 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 ' N ' HD21 ' A' ' 32' ' ' LEU . 2.4 mm? -97.92 127.15 43.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.955 ' HB3' ' HE2' ' B' ' 29' ' ' LYS . 30.0 tt0 -141.81 151.74 43.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.453 0.644 . . . . 0.0 112.516 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.9 mt -127.57 157.88 38.99 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.434 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 68.2 mttm -127.62 -173.16 2.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.362 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 29.8 t 65.7 149.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.868 0.842 . . . . 0.0 112.726 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 154.18 37.51 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.317 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.64 173.23 14.24 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.193 1.929 . . . . 0.0 112.012 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -102.55 178.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.341 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.16 137.35 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.95 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.828 ' H ' HD22 ' A' ' 41' ' ' LEU . 1.9 pt? -89.37 -165.04 1.24 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.48 141.03 12.99 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.5 pt-20 -67.09 139.86 95.54 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.04 -0.58 . . . . 0.0 111.511 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 2.3 Cg_endo -84.93 166.88 11.27 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.289 2.659 . . . . 0.0 111.951 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.47 150.71 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -95.89 -168.8 1.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.269 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.46 142.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.5 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.94 126.58 29.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.737 0.78 . . . . 0.0 111.923 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.27 -24.14 23.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.114 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mt -64.92 -12.72 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.547 -169.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -86.51 133.89 33.71 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 4.5 mptp? -95.46 137.94 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.629 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 tt -80.9 132.93 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -87.34 132.23 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.892 0.377 . . . . 0.0 111.024 -172.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.44 -179.09 3.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.959 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.03 19.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.435 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 p -81.74 97.83 8.14 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.246 0.546 . . . . 0.0 110.793 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -103.27 142.97 33.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.661 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.1 ptm -104.6 136.82 43.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.555 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 m -75.75 96.77 3.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.188 0.518 . . . . 0.0 109.78 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -83.58 10.45 9.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.311 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.02 98.12 6.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.523 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -116.12 112.59 21.93 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -107.25 147.49 30.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -102.58 157.25 17.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.898 0.38 . . . . 0.0 110.579 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -119.26 91.17 3.49 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.392 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -120.31 116.7 26.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 71.31 125.42 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.127 0.892 . . . . 0.0 111.538 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 . . . . . 0 C--O 1.243 0.741 0 CA-C-O 118.091 -0.956 . . . . 0.0 109.74 174.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -94.3 161.86 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.993 2.462 . . . . 0.0 111.934 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -74.48 152.02 39.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.424 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -109.19 137.02 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.236 0.541 . . . . 0.0 109.797 173.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.83 152.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.469 ' O ' HD12 ' B' ' 17' ' ' LEU . 38.0 mt-10 -124.58 113.02 17.5 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -125.16 169.14 12.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 128.8 73.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 48.5 t80 -82.0 126.86 32.46 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.127 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 25.3 tt0 -152.19 128.28 10.42 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.608 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 67.35 23.16 9.31 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.708 0.63 . . . . 0.0 111.682 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' CE1' ' B' ' 9' ' ' TYR . . . 88.22 15.33 60.81 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.76 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 5.1 t -122.03 150.11 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 1.034 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.0 m-85 -104.56 114.46 28.7 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 165.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.63 113.63 57.69 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 27.5 Cg_endo -63.61 168.51 11.46 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.636 1.557 . . . . 0.0 112.577 -175.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.469 HD12 ' O ' ' B' ' 6' ' ' GLU . 1.3 mt -114.63 -2.43 13.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.778 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.39 159.81 38.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.153 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -72.97 130.53 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 3.3 t -107.24 145.58 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.468 -173.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -108.95 14.28 24.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.459 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.443 HD11 ' HG2' ' B' ' 26' ' ' GLU . 85.7 mt -75.51 -175.76 2.95 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.587 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.506 ' HA ' ' HE3' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -115.87 168.38 10.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.696 0.284 . . . . 0.0 111.234 -176.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.4 136.31 47.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.487 0.661 . . . . 0.0 110.659 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.663 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.48 65.56 3.08 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.074 -165.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 13.0 tp10 -90.14 134.48 34.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.562 -0.819 . . . . 0.0 109.382 172.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' B' ' 27' ' ' ARG . 3.5 tpt180 -83.75 104.07 13.56 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.441 1.115 . . . . 0.0 110.413 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.611 HG21 ' CD1' ' A' ' 14' ' ' PHE . 30.8 m -129.32 154.84 40.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.685 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.955 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 22.1 mtmm -123.42 138.54 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.277 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.762 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -105.49 121.98 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.116 -172.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.489 ' HD2' ' HB2' ' A' ' 2' ' ' PRO . 3.1 tppp? -105.87 124.71 50.01 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.749 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.22 111.87 9.81 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.72 155.02 42.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.534 0.683 . . . . 0.0 112.139 -169.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 mt -143.97 161.8 37.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.677 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.41 165.92 11.01 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.387 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -79.27 143.07 13.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.551 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 10.2 pt-20 -60.68 125.91 83.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 5.1 Cg_exo -74.63 174.93 11.8 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.08 2.52 . . . . 0.0 112.494 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pp -85.03 164.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.99 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.28 157.98 30.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -145.85 153.64 41.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.29 115.92 0.68 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.395 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -102.39 140.14 20.86 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.36 0.124 . . . . 0.0 110.908 -173.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -46.78 146.88 5.14 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.959 3.106 . . . . 0.0 113.977 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.21 157.27 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.609 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -84.17 -176.58 6.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.572 . . . . 0.0 112.239 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.8 146.99 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.087 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.856 ' HG2' ' HB2' ' B' ' 51' ' ' LYS . 0.4 OUTLIER -79.12 136.4 37.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.426 0.631 . . . . 0.0 111.284 -173.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.49 -25.56 26.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.009 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.406 ' H ' HD12 ' B' ' 50' ' ' ILE . 4.4 mp -75.85 -4.89 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 122.0 0.905 . . . . 0.0 109.901 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.856 ' HB2' ' HG2' ' B' ' 48' ' ' GLU . 15.7 tptm -59.76 133.72 56.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.159 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -134.27 120.63 20.22 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.451 ' N ' HD11 ' B' ' 53' ' ' ILE . 3.4 mp -116.04 92.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.02 146.64 37.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.276 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -108.17 161.12 15.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.386 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.87 112.22 1.28 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.654 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -105.64 121.68 44.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.383 0.611 . . . . 0.0 111.429 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.07 141.24 48.39 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.068 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.4 ttt -133.32 124.52 27.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.285 0.565 . . . . 0.0 111.453 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.3 p -82.72 145.31 29.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 25.3 m -76.76 3.14 12.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.59 0.233 . . . . 0.0 110.848 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt 55.54 41.4 30.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.03 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -63.84 92.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.819 0.819 . . . . 0.0 110.549 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -75.79 102.5 5.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.29 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -75.57 113.5 13.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.521 0.676 . . . . 0.0 109.717 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -105.85 139.59 40.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -106.99 147.58 29.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.698 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -79.82 112.92 17.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 111.654 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m170 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.087 171.167 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 22.0 ptp . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.221 0.534 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.8 Cg_exo -79.61 146.41 19.04 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.838 2.358 . . . . 0.0 111.863 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.1 160.48 19.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.163 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.593 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER -102.03 120.78 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.708 HD11 ' HB3' ' A' ' 19' ' ' LYS . 5.0 pt -109.72 155.89 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.728 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.568 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 51.0 mt-10 -103.63 141.3 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.1 161.73 36.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.712 -1.586 . . . . 0.0 108.071 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.88 136.82 58.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.417 0.627 . . . . 0.0 110.286 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 81.2 t80 -81.68 103.97 11.76 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.289 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -122.58 122.65 39.36 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.683 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.76 36.36 27.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.061 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 85.84 16.9 62.54 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.987 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.4 t -134.42 149.29 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 94.2 m-85 -93.04 115.38 28.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 112.81 59.26 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD3' ' HD2' ' B' ' 14' ' ' PHE . 3.1 Cg_endo -61.66 168.64 8.11 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 120.752 0.968 . . . . 0.0 112.154 174.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.52 -71.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.166 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.471 ' HG3' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -141.93 7.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.76 -169.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.708 ' HB3' HD11 ' A' ' 5' ' ' ILE . 70.5 mmtt -91.25 155.0 18.88 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.292 -159.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 5' ' ' ILE . 40.8 t 61.1 142.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.765 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -145.92 14.74 1.35 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.779 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' B' ' 32' ' ' LEU . 58.2 mt -89.43 5.74 43.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.124 -169.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 83.7 tttt 81.85 163.74 0.15 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.756 156.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -48.91 129.71 17.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.048 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.57 12.47 69.45 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.884 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.587 ' HG2' ' CB ' ' A' ' 22' ' ' LEU . 5.0 tp10 -81.36 134.65 35.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.613 0.244 . . . . 0.0 110.439 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -90.18 115.85 27.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 123.258 1.504 . . . . 0.0 113.419 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG21 ' CE1' ' B' ' 14' ' ' PHE . 31.8 m -123.81 157.43 30.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 112.473 -2.148 . . . . 0.0 108.794 177.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HB2' ' OE2' ' B' ' 33' ' ' GLU . 59.6 mttm -124.44 135.56 53.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.411 HG23 ' CE1' ' A' ' 14' ' ' PHE . 10.7 mm -90.45 132.06 36.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.073 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.74 ' HD3' ' HZ2' ' B' ' 31' ' ' LYS . 12.6 mptt -121.27 132.5 54.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.288 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.455 HD12 HG11 ' B' ' 28' ' ' VAL . 2.8 mm? -81.81 126.71 32.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -61.22 138.18 58.23 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.748 -176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.0 mt -83.17 155.33 23.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.069 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 148.37 47.07 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.165 178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.8 132.41 38.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.438 0.637 . . . . 0.0 110.157 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.95 103.34 55.24 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.631 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.41 -171.52 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.878 2.385 . . . . 0.0 111.838 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.36 144.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -113.41 123.54 50.31 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.653 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -83.52 154.07 24.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.652 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.87 115.38 2.09 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.957 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.91 122.57 86.45 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.708 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.13 148.03 26.97 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.679 2.253 . . . . 0.0 112.086 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.69 156.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -86.82 171.46 10.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.865 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.93 141.81 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -135.94 -26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.269 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.16 -23.87 66.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -171.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.66 -15.63 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -71.89 133.99 45.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.103 0.477 . . . . 0.0 111.618 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -133.43 163.96 28.19 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.265 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -127.61 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.477 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.18 176.21 6.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 110.495 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -115.73 158.85 22.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.077 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.81 116.61 5.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -96.81 102.49 14.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 120.997 0.427 . . . . 0.0 111.607 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -84.8 152.67 23.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.2 ttm -143.25 165.34 27.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -171.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m 61.78 83.85 0.15 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.113 0.965 . . . . 0.0 112.8 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 m -106.83 16.05 24.8 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.075 172.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.1 tp -88.26 125.9 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.693 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -152.82 109.94 3.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -153.58 142.37 21.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.834 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 71.4 101.94 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.792 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -125.14 -179.15 4.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.835 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -97.35 149.29 22.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -113.33 136.12 53.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.319 0.581 . . . . 0.0 110.855 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.191 -175.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.19 97.5 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.688 2.259 . . . . 0.0 112.881 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -82.66 144.49 30.23 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.456 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.557 HG22 ' CE ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -118.75 144.28 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -177.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' B' ' 18' ' ' GLN . 7.1 mt -89.62 148.29 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -102.67 131.08 49.7 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.81 154.34 46.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.604 0.24 . . . . 0.0 110.942 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.704 HG13 HD12 ' B' ' 17' ' ' LEU . 4.4 m -111.4 132.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.843 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.654 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 68.3 t80 -82.2 108.37 15.61 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.021 0.915 . . . . 0.0 110.585 176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.693 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 5.6 mt-10 -86.58 -170.68 3.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.391 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.15 62.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 O-C-N 124.342 1.026 . . . . 0.0 111.301 -171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 105.27 5.55 40.09 Favored Glycine 0 C--N 1.304 -1.218 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.677 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.693 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.5 t -112.78 145.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.221 -0.489 . . . . 0.0 111.432 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 55.4 m-85 -115.67 114.67 25.18 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 162.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -121.2 123.62 27.68 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.758 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.4 Cg_endo -65.19 168.0 15.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.708 1.605 . . . . 0.0 112.925 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.704 HD12 HG13 ' B' ' 8' ' ' VAL . 4.2 mp -118.45 -13.66 9.74 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.524 ' HB3' HG23 ' B' ' 5' ' ' ILE . 8.9 tt0 -91.53 164.11 13.91 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.593 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -78.15 142.65 37.88 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.88 139.82 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 122.973 1.368 . . . . 0.0 113.012 -173.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -141.81 87.46 2.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.379 -2.191 . . . . 0.0 108.301 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.3 -179.43 5.14 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.986 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.65 ' HD2' ' OE2' ' B' ' 24' ' ' GLU . 30.0 mmtt -110.06 161.92 15.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.338 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.65 ' OE2' ' HD2' ' B' ' 23' ' ' LYS . 1.1 pm0 -77.16 124.12 27.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.437 0.637 . . . . 0.0 109.532 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 15.28 30.67 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.784 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 7.6 tp10 -78.77 121.22 24.5 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -87.46 122.28 30.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.356 1.074 . . . . 0.0 111.278 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.455 HG11 HD12 ' A' ' 32' ' ' LEU . 29.7 m -129.46 151.15 35.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.219 -173.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.593 ' HE3' HG13 ' A' ' 4' ' ' ILE . 25.9 mtpp -121.57 134.56 55.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 122.443 1.116 . . . . 0.0 111.086 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 7' ' ' ALA . 9.6 mm -106.16 144.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 112.708 -2.042 . . . . 0.0 111.151 -164.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.74 ' HZ2' ' HD3' ' A' ' 31' ' ' LYS . 6.1 ptpp? -156.16 163.98 38.94 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.657 -1.61 . . . . 0.0 107.018 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.592 ' CD2' HD11 ' A' ' 22' ' ' LEU . 1.7 mp -107.62 120.53 42.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 29' ' ' LYS . 14.3 mt-10 -117.46 163.84 15.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.718 0.771 . . . . 0.0 112.597 -166.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.95 178.57 5.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.275 -170.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -108.11 162.39 14.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.419 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 7.6 p -95.14 138.69 20.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -105.65 104.45 48.54 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.229 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 36' ' ' VAL . 77.2 Cg_endo -92.81 175.29 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.249 2.632 . . . . 0.0 111.528 172.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -124.77 114.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.01 0.433 . . . . 0.0 111.09 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.23 137.33 34.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.52 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 tp -102.75 167.62 9.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.4 -155.18 25.52 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.852 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 40.2 mt-10 -129.44 139.02 34.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.64 165.19 31.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.059 2.506 . . . . 0.0 112.42 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 46' ' ' SER . 10.6 p -95.15 161.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.289 0.566 . . . . 0.0 110.88 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' SER . . . . . 0.567 ' O ' ' HB ' ' B' ' 47' ' ' VAL . 6.4 p -122.62 -164.54 1.19 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.564 -176.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' B' ' 46' ' ' SER . 23.0 t 77.28 137.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.79 0.836 . . . . 0.0 111.915 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.07 138.19 37.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.95 -32.38 21.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.469 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.31 -12.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -166.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -81.86 129.48 34.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.157 0.504 . . . . 0.0 111.055 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -164.87 170.84 14.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.795 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -83.7 157.73 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -131.76 159.52 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -119.92 -171.56 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.4 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.75 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 m -126.59 144.9 50.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -122.11 134.06 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.898 0.38 . . . . 0.0 110.458 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.52 125.38 54.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.204 0.526 . . . . 0.0 111.232 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t -77.05 160.22 29.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.304 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.9 t -84.29 19.31 1.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 55.66 -176.42 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.551 0.74 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -111.35 167.39 10.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.876 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -152.53 135.66 15.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -143.94 101.42 3.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.984 0.421 . . . . 0.0 110.258 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -103.52 165.46 11.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -135.54 143.28 45.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.53 -75.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.87 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.237 -179.092 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.451 0.167 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.33 131.4 21.76 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.108 1.872 . . . . 0.0 110.738 171.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -70.36 152.03 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.431 0.634 . . . . 0.0 111.929 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.59 142.17 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.4 170.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 25.4 mt-10 -124.26 139.45 53.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.073 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.23 165.23 25.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.071 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.577 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 3.1 m -117.08 114.37 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.57 0.7 . . . . 0.0 109.512 170.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.493 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . 19.2 t80 -60.87 124.76 21.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.483 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 28.2 mt-10 -149.4 134.3 17.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.16 0.287 . . . . 0.0 111.167 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 59.03 28.36 17.6 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.152 0.908 . . . . 0.0 111.465 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.23 -69.37 0.32 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 117.406 -2.33 . . . . 0.0 111.626 -167.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 15' ' ' LYS . 22.3 m -95.58 165.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.382 -0.909 . . . . 0.0 113.397 -157.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.3 m-85 -88.68 116.74 27.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.558 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 51.8 mtpt -113.44 112.05 49.13 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.395 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 Cg_endo -60.19 168.13 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.333 1.355 . . . . 0.0 112.527 -175.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 HD22 HG11 ' A' ' 8' ' ' VAL . 97.2 mt -95.84 1.28 53.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 11.5 pt20 -146.89 156.53 43.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.193 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 23.0 mtpp -81.49 145.08 30.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.551 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG13 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -125.0 139.84 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.947 0.88 . . . . 0.0 111.853 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.37 87.44 5.19 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.208 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' HG ' HG13 ' A' ' 20' ' ' VAL . 62.2 mt -131.01 -165.59 1.58 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.27 -2.241 . . . . 0.0 109.448 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -129.27 156.79 43.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.042 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.724 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 34.2 mt-10 -69.5 128.93 38.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.209 0.528 . . . . 0.0 110.812 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 14.39 57.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.918 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -75.39 139.72 42.54 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -92.53 114.7 27.32 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 123.335 1.541 . . . . 0.0 112.507 -173.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.605 ' HB ' HG21 ' B' ' 30' ' ' ILE . 28.7 m -124.45 148.63 28.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.216 -2.266 . . . . 0.0 109.825 -175.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' B' ' 34' ' ' LEU . 61.1 mttm -111.59 139.9 46.65 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -105.77 138.89 28.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.304 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -137.32 153.4 50.27 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD12 ' O ' ' B' ' 27' ' ' ARG . 17.3 tp -108.4 133.26 52.83 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.835 -156.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -96.67 142.68 28.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.733 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.5 mt -156.62 175.19 14.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.965 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -104.79 167.74 9.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.43 141.79 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 33.8 mt-10 -58.04 129.41 82.47 Favored Pre-proline 0 N--CA 1.446 -0.659 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 46.6 Cg_exo -56.25 174.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.47 2.78 . . . . 0.0 114.028 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 pt -76.4 146.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.845 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.96 95.22 7.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.691 ' H ' HD22 ' A' ' 41' ' ' LEU . 2.5 pt? -95.69 177.77 5.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.038 -173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.71 114.48 5.03 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.8 mt-10 -75.01 138.24 72.73 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 114.526 -0.837 . . . . 0.0 111.338 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 12.6 Cg_exo -70.0 118.06 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.482 2.121 . . . . 0.0 110.594 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.16 147.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.845 0.355 . . . . 0.0 110.612 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 m -98.09 171.78 8.03 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.94 147.34 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.335 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.563 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 41.8 mt-10 -74.96 138.03 42.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.807 0.337 . . . . 0.0 110.598 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 -25.19 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.386 0.612 . . . . 0.0 110.05 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.57 -0.4 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.875 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.563 ' HD2' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -65.62 140.01 58.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.05 0.452 . . . . 0.0 110.635 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 18.4 ptmt -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 51.5 mt 73.27 130.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 124.006 0.816 . . . . 0.0 112.755 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.767 ' HG2' ' H ' ' A' ' 55' ' ' ASP . 37.6 ttp180 -140.93 -168.94 2.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.767 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 7.5 p-10 -64.95 146.1 55.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.566 0.698 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.14 91.15 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.955 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -67.29 130.87 44.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -113.06 134.03 54.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.198 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.5 ttm -83.97 146.5 27.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.671 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.06 111.79 3.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -80.6 -5.4 56.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 110.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.05 -21.64 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.535 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.55 101.68 3.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.338 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -114.64 -171.35 1.91 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.267 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -150.22 137.32 19.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -86.0 154.49 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -130.4 101.82 5.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -168.19 127.53 1.23 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.857 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.7 -179.099 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.15 99.77 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.437 2.091 . . . . 0.0 111.116 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.55 167.37 19.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.249 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.436 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -83.21 131.91 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-O 121.476 0.655 . . . . 0.0 110.015 174.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' B' ' 18' ' ' GLN . 7.6 mt -109.25 142.77 20.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -99.72 138.89 36.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.293 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.15 160.71 39.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.911 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.01 124.35 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.174 0.512 . . . . 0.0 110.626 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.751 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 85.6 t80 -80.19 99.74 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.508 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 73.1 mt-10 -122.74 144.75 48.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 66.37 10.72 7.46 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.434 0.458 . . . . 0.0 111.656 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 86.78 18.93 57.43 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.991 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.0 t -122.12 151.39 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.058 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.943 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.6 m-85 -98.58 115.62 29.02 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' B' ' 10' ' ' GLU . 49.1 mtmt -118.16 116.48 35.71 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.914 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 15.7 Cg_endo -61.25 165.96 11.85 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 121.688 1.592 . . . . 0.0 113.531 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.0 -66.06 0.96 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.283 -2.689 . . . . 0.0 104.945 162.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.516 ' HB2' ' CG2' ' B' ' 5' ' ' ILE . 14.7 mp0 -59.67 158.63 9.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.276 -1.783 . . . . 0.0 111.134 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.416 ' HZ3' ' HB2' ' B' ' 21' ' ' ASP . 14.1 tmtt? -76.83 128.39 34.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 110.531 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.412 ' HB ' ' OH ' ' A' ' 9' ' ' TYR . 8.7 t -124.44 150.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.374 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . 0.416 ' HB2' ' HZ3' ' B' ' 19' ' ' LYS . 14.2 t70 -127.15 15.2 7.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.916 0.865 . . . . 0.0 110.88 -170.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.484 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 94.9 mt -71.25 163.99 26.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.58 -173.63 2.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.354 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 7.2 mp0 -63.15 141.97 58.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.321 0.581 . . . . 0.0 111.806 -175.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.577 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 45.9 64.55 2.38 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.218 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 4.1 mm-40 -103.81 134.42 47.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.521 -0.839 . . . . 0.0 110.032 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.468 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.1 mmm-85 -82.64 115.98 21.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.336 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.776 HG23 ' HD1' ' A' ' 14' ' ' PHE . 30.0 m -140.42 152.04 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.585 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 59.4 mttm -115.32 141.83 47.51 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.204 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.605 HG21 ' HB ' ' A' ' 28' ' ' VAL . 1.5 mm -118.94 142.44 33.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.562 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.445 ' HD2' HG22 ' A' ' 4' ' ' ILE . 62.0 tttm -155.3 126.45 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.244 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.578 ' HG ' HG12 ' A' ' 28' ' ' VAL . 1.3 mp -65.12 113.28 3.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -154.85 146.01 22.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.232 -160.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.49 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 3.4 pp -158.28 171.91 19.32 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.855 -1.521 . . . . 0.0 108.137 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -123.33 147.54 46.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t -94.72 139.32 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.865 -171.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.44 171.29 5.8 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.422 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.65 171.87 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.752 1.634 . . . . 0.0 111.873 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.5 176.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.83 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -114.12 147.99 37.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.174 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.606 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.4 pt? -113.32 144.64 42.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.122 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.58 122.04 7.29 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.808 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.1 pt-20 -55.92 141.73 66.29 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.999 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 3.0 Cg_exo -75.18 -170.63 0.82 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.062 2.508 . . . . 0.0 112.269 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.98 156.25 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.297 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -83.32 172.21 12.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.62 148.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.643 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -50.57 119.85 4.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.329 0.585 . . . . 0.0 111.917 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -85.91 -26.04 25.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.179 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 pt -87.68 0.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.347 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.72 134.01 35.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -105.43 150.51 25.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.407 . . . . 0.0 110.951 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.28 144.46 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.83 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' B' ' 55' ' ' ASP . 87.4 mtm180 -103.16 178.1 4.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.802 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' B' ' 54' ' ' ARG . 12.6 t70 71.02 153.68 0.12 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.907 0.754 . . . . 0.0 110.676 -172.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.68 131.34 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.81 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -60.21 135.33 57.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.775 0.322 . . . . 0.0 110.411 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -129.2 133.22 47.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.216 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 1.2 tpt -114.07 127.45 55.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.767 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -88.68 167.62 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 26.5 t -81.7 20.22 0.96 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.075 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 70.3 mt 62.9 -165.74 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.272 0.629 . . . . 0.0 111.205 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -123.64 134.25 53.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -93.35 120.22 33.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.954 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -57.26 137.58 55.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.491 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -79.79 139.58 37.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.021 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -131.61 117.99 19.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -81.43 123.38 28.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.941 176.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.589 ' HB2' ' HB2' ' B' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.81 -59.81 0.65 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.509 2.806 . . . . 0.0 114.427 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.481 ' HG2' ' HE2' ' A' ' 1' ' ' MET . 11.0 pttp -93.39 171.25 9.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.442 . . . . 0.0 111.247 -171.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.27 145.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.495 -174.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.62 HG23 HG22 ' A' ' 20' ' ' VAL . 22.8 mm -106.14 168.93 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 46.5 mt-10 -124.76 160.03 29.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.318 0.508 . . . . 0.0 110.706 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.65 158.56 34.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.782 0.433 . . . . 0.0 110.259 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.5 117.86 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.635 0.731 . . . . 0.0 110.44 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.732 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 51.3 t80 -82.69 113.05 20.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.131 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' B' ' 24' ' ' GLU . 0.4 OUTLIER -137.97 146.14 42.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.994 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 57.59 26.31 12.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 80.31 20.96 65.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.008 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.732 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.6 t -130.59 152.84 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.227 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 91.4 m-85 -104.64 114.01 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -104.79 106.39 54.78 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.429 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -39.83 168.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.963 3.109 . . . . 0.0 117.758 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.883 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 96.5 mt -131.72 96.99 4.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 111.621 -2.536 . . . . 0.0 105.518 168.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.883 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 4.4 pp0? 77.66 -176.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.476 2.31 . . . . 0.0 112.02 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.88 137.78 44.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -159.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG22 HG23 ' A' ' 5' ' ' ILE . 2.5 t -141.6 134.18 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.103 170.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -131.14 87.76 2.51 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.829 1.3 . . . . 0.0 108.6 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.582 HD12 HD23 ' B' ' 32' ' ' LEU . 57.2 mt -123.11 -179.05 4.15 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 112.178 -2.283 . . . . 0.0 110.967 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 26' ' ' GLU . 18.9 pttp -114.28 162.65 16.31 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 46.3 mt-10 -65.76 133.7 51.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 122.025 0.917 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.61 64.93 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.082 -165.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 2.0 mm-40 -114.82 139.87 49.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.208 -0.996 . . . . 0.0 109.708 168.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -100.17 124.87 46.09 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 123.008 1.385 . . . . 0.0 112.354 -175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' B' ' 30' ' ' ILE . 33.5 m -133.6 150.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.107 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.758 ' HG3' ' HG3' ' B' ' 33' ' ' GLU . 59.5 mttm -105.43 138.5 41.53 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.577 0.703 . . . . 0.0 110.136 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.47 HG22 ' CE1' ' A' ' 14' ' ' PHE . 20.6 mm -110.2 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.98 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.1 156.29 34.05 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 HD11 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? -69.45 148.1 50.03 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.45 124.82 11.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.779 0.8 . . . . 0.0 112.265 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.7 mt 51.47 157.97 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 112.817 -1.992 . . . . 0.0 115.144 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -98.51 175.76 5.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.603 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.33 152.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.691 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.2 pm0 -90.59 148.81 39.5 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 173.43 11.96 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.165 1.91 . . . . 0.0 112.149 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.24 153.18 24.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.67 72.04 0.96 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.6 tp -91.04 135.65 33.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.659 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.7 111.34 3.8 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.5 tt0 -93.42 113.06 59.13 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.525 -0.838 . . . . 0.0 110.469 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 6.3 Cg_exo -73.78 113.82 3.88 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.863 2.375 . . . . 0.0 112.204 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 46' ' ' SER . 8.4 p -114.14 163.15 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.526 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 45' ' ' VAL . 4.3 m -66.67 160.17 26.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.258 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.99 134.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.115 0.483 . . . . 0.0 110.577 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 31.7 mt-10 -126.0 121.57 33.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.966 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -85.2 -25.57 27.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.695 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -88.43 1.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.669 0.747 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.634 ' HE2' ' HB2' ' A' ' 48' ' ' GLU . 25.1 ttmm -72.52 133.87 44.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.986 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 60.19 104.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.804 0.811 . . . . 0.0 112.619 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tp -78.75 127.78 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.62 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -112.52 117.11 31.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.18 153.37 25.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.41 35.66 4.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.325 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -79.46 150.6 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.389 0.614 . . . . 0.0 111.024 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -150.82 134.27 16.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.24 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -88.1 123.85 33.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.015 0.436 . . . . 0.0 110.06 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.9 m -96.39 116.38 28.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 110.29 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m -85.42 21.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.864 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.47 107.58 1.15 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 110.287 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.61 160.2 28.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.911 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -126.12 92.93 3.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.294 0.569 . . . . 0.0 109.706 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -134.5 125.39 27.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.325 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -139.94 -50.5 0.49 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.375 0.607 . . . . 0.0 109.707 171.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.5 m170 58.92 23.11 11.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.872 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -96.11 114.95 26.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.214 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 28.0 ttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 52.1 Cg_exo -55.12 103.45 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.125 2.55 . . . . 0.0 113.34 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.66 159.01 17.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.899 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER -99.76 138.64 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 121.245 0.545 . . . . 0.0 110.605 176.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' B' ' 18' ' ' GLN . 4.4 mt -114.84 168.07 6.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -132.41 136.4 46.74 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -133.83 155.76 49.25 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.374 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.67 HG13 HD12 ' B' ' 17' ' ' LEU . 7.1 m -110.06 121.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.316 0.579 . . . . 0.0 111.006 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 21.3 t80 -61.02 111.23 1.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.982 171.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -136.11 129.3 31.61 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.969 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . 0.405 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 1.2 t-20 55.02 27.84 9.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.77 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.97 -68.27 0.22 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 117.688 -2.196 . . . . 0.0 111.26 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.67 154.96 3.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.522 -1.339 . . . . 0.0 111.678 -157.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 89.3 m-85 -88.72 122.16 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 0.0 112.031 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.73 119.03 51.64 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 34.1 Cg_endo -66.13 168.71 15.12 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.462 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.67 HD12 HG13 ' B' ' 8' ' ' VAL . 4.9 mp -113.21 -5.72 13.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.528 ' HB2' HG21 ' B' ' 5' ' ' ILE . 18.8 mp0 -116.68 143.35 45.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.356 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -72.57 126.75 30.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.61 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.9 t -88.27 145.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.244 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -111.52 14.98 21.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.008 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.539 HD12 ' HG2' ' B' ' 26' ' ' GLU . 80.2 mt -90.57 -168.62 2.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.314 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 15.1 tmtt? -111.81 155.4 23.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.43 ' N ' ' HD3' ' B' ' 23' ' ' LYS . 1.9 mp0 -57.89 133.17 55.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.924 0.869 . . . . 0.0 112.201 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.37 65.5 3.5 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 114.106 -1.407 . . . . 0.0 110.381 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.539 ' HG2' HD12 ' B' ' 22' ' ' LEU . 10.0 tp10 -92.92 149.13 21.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.686 -0.757 . . . . 0.0 110.958 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.55 104.94 17.19 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.532 1.158 . . . . 0.0 111.376 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 32' ' ' LEU . 34.9 m -124.7 154.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.407 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.515 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 41.4 mttp -119.43 148.0 43.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.495 0.664 . . . . 0.0 110.076 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.467 ' CG2' ' HB ' ' A' ' 28' ' ' VAL . 7.8 mt -128.55 153.38 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.129 -170.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -150.88 159.33 44.62 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 8.3 mt -91.25 114.1 26.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -173.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.758 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 4.6 mm-40 -94.62 152.04 18.82 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.175 0.512 . . . . 0.0 111.916 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 -170.55 3.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.771 -175.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -90.96 166.03 13.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.429 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 156.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.7 mt-10 -60.16 141.93 90.11 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 32.8 Cg_exo -61.88 174.39 2.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.186 2.591 . . . . 0.0 113.773 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.09 171.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.127 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -93.4 -151.57 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.493 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.77 -170.53 2.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.42 141.41 10.4 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.46 155.06 85.82 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 120.573 0.225 . . . . 0.0 110.896 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.25 164.72 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.44 2.093 . . . . 0.0 110.11 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.67 134.99 8.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 122.001 0.905 . . . . 0.0 112.099 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -86.51 172.44 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.021 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.78 131.54 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.97 118.9 20.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.0 110.747 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -85.61 -25.47 26.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.588 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 tt -93.29 5.87 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.616 0.722 . . . . 0.0 110.8 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -87.19 148.34 25.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.97 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -80.33 143.82 33.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.944 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.58 -49.36 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 63.43 147.98 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.855 0.862 . . . . 0.0 112.796 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.92 169.69 19.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.45 80.67 0.87 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.057 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -91.79 152.45 20.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -110.45 135.74 50.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.739 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.39 148.7 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.483 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.1 p -142.54 149.52 39.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.032 0.444 . . . . 0.0 111.207 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 46.1 t -95.3 13.91 24.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.65 94.39 9.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.425 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.07 86.55 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -98.81 58.22 1.16 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.239 0.542 . . . . 0.0 111.624 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -68.92 116.24 9.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.23 102.57 14.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.63 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -78.81 112.94 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -109.94 129.88 55.6 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.055 -174.322 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.54 ' HE1' ' HB3' ' A' ' 3' ' ' LYS . 20.6 ptm . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 111.25 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.398 2.065 . . . . 0.0 111.86 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 22.0 ptmt -147.76 173.37 12.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.4 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.912 HG21 ' HG2' ' B' ' 31' ' ' LYS . 0.3 OUTLIER -109.41 144.51 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.778 176.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.615 HD12 HD12 ' A' ' 22' ' ' LEU . 4.6 mt -106.1 148.18 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.926 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' H ' ' NE2' ' A' ' 18' ' ' GLN . 44.9 mt-10 -102.52 123.08 45.61 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -143.07 168.52 19.55 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 10.6 m -129.68 129.73 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.018 0.437 . . . . 0.0 110.785 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.499 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 20.0 t80 -59.77 128.85 38.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 37.7 tt0 -139.79 109.04 6.1 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.496 0.665 . . . . 0.0 111.494 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 31.0 t30 55.7 27.33 10.5 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.324 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.9 -70.01 0.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 118.158 -1.972 . . . . 0.0 110.731 -165.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' B' ' 13' ' ' VAL . 23.2 m -94.34 145.36 8.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 113.649 -1.276 . . . . 0.0 112.201 -160.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.809 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.5 m-85 -86.82 116.76 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.333 0.587 . . . . 0.0 110.169 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.544 ' HE3' ' CG2' ' A' ' 13' ' ' VAL . 34.5 mmtp -105.12 116.58 60.34 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.153 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 13.6 Cg_endo -59.93 169.0 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.41 1.407 . . . . 0.0 111.997 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.496 HD11 HG11 ' A' ' 8' ' ' VAL . 7.4 mp -102.23 -8.73 21.04 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 6' ' ' GLU . 4.5 pm0 -145.47 170.49 16.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.433 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -63.49 128.01 33.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.061 0.934 . . . . 0.0 112.204 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG22 HD13 ' A' ' 5' ' ' ILE . 4.9 p -132.87 141.36 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.714 173.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -148.14 87.85 1.63 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.358 -1.746 . . . . 0.0 108.867 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.814 HD13 HD13 ' B' ' 32' ' ' LEU . 67.4 mt -106.63 0.72 24.63 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.853 -1.976 . . . . 0.0 109.647 171.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 85.14 171.99 0.07 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 113.191 173.022 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.7 mp0 -78.43 134.92 37.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.502 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.42 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 51.94 63.87 4.43 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -166.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 22' ' ' LEU . 7.4 tp10 -113.56 137.7 51.21 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.803 -1.199 . . . . 0.0 107.927 170.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -100.53 117.8 35.41 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 123.124 1.44 . . . . 0.0 112.996 -164.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.608 HG12 HD11 ' B' ' 32' ' ' LEU . 16.0 m -134.84 158.07 41.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 112.149 -2.296 . . . . 0.0 109.483 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.701 ' HD3' HG13 ' B' ' 4' ' ' ILE . 87.3 mttt -120.95 138.38 54.16 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 122.047 0.927 . . . . 0.0 111.101 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 14' ' ' PHE . 8.8 mm -103.57 149.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.204 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.658 ' HD2' ' HZ3' ' B' ' 31' ' ' LYS . 7.7 ptpt -156.3 162.37 40.11 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.734 HD22 HG11 ' B' ' 28' ' ' VAL . 52.3 mt -95.21 117.08 29.63 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.723 -171.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.822 ' HG3' ' HG3' ' B' ' 29' ' ' LYS . 45.2 mm-40 -88.22 132.08 34.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.962 -172.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.25 -167.1 2.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.472 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -117.66 171.75 7.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.425 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.38 130.17 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.94 137.18 22.34 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-O 121.21 0.529 . . . . 0.0 112.152 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.28 177.34 7.23 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.772 2.315 . . . . 0.0 111.117 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.4 pp -87.82 147.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.119 0.485 . . . . 0.0 111.952 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -99.03 172.08 7.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.096 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.8 pt? -98.56 130.57 45.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.41 -154.57 17.65 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.844 -170.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.86 153.65 60.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.718 -173.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.36 171.03 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.736 2.291 . . . . 0.0 112.565 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.71 148.94 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.598 . . . . 0.0 110.465 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.532 ' O ' HG12 ' A' ' 47' ' ' VAL . 45.5 m -120.81 175.92 5.8 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.18 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 64.57 154.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.477 1.111 . . . . 0.0 113.029 177.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.6 mm-40 66.27 -36.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.663 1.185 . . . . 0.0 113.928 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 47' ' ' VAL . 7.4 tp10 -71.75 -26.02 62.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.492 0.663 . . . . 0.0 109.704 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mm -90.24 -4.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.053 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 51' ' ' LYS . 2.2 ttpm? -98.38 176.7 5.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.58 103.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.705 0.764 . . . . 0.0 110.572 -168.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -107.42 148.9 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.581 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -53.36 126.65 21.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.0 110.192 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.81 149.02 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.02 31.1 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.454 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 p -65.16 121.32 14.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.143 0.497 . . . . 0.0 110.902 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -87.35 134.12 33.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.7 tpt -62.83 124.59 21.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.3 m -72.39 108.11 5.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -93.34 15.85 14.71 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.937 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.74 97.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -174.91 2.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.506 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -129.91 116.39 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.1 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -69.72 92.1 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -99.79 4.27 45.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.3 -169.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -103.98 96.88 6.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -175.62 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 t60 . . . . . 0 C--O 1.25 1.118 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.314 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.513 0.197 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.48 106.96 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.444 2.096 . . . . 0.0 112.436 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -115.82 152.2 33.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.554 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.701 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -127.53 143.09 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.457 177.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.602 HD11 HG21 ' B' ' 20' ' ' VAL . 6.9 mt -101.44 151.8 5.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 42.9 mt-10 -113.55 134.24 54.81 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.27 151.08 40.13 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.538 0.523 . . . . 0.0 109.98 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.7 m -116.19 125.81 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.477 0.656 . . . . 0.0 110.377 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 43.4 t80 -75.99 121.97 23.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.44 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.37 135.98 34.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.57 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t30 63.04 20.61 12.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 91.08 13.06 59.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.743 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 9.1 t -120.69 153.24 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.337 0.255 . . . . 0.0 110.408 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.809 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.4 m-85 -109.0 115.34 29.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.054 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -109.05 115.95 56.18 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.99 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 41.8 Cg_endo -68.81 168.14 21.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.832 1.021 . . . . 0.0 112.186 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.42 HD12 HG12 ' B' ' 8' ' ' VAL . 5.3 mp -112.08 -12.6 13.66 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.486 ' HB2' HG23 ' B' ' 5' ' ' ILE . 0.8 OUTLIER -102.59 139.45 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.484 171.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -80.31 132.76 35.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 110.396 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.602 HG21 HD11 ' B' ' 5' ' ' ILE . 1.5 t -127.47 136.36 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.466 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.77 87.34 2.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.828 1.299 . . . . 0.0 108.186 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.562 ' HG ' HG11 ' B' ' 20' ' ' VAL . 47.2 mt -122.43 -178.44 3.9 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.533 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -102.62 161.96 13.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 mp0 -71.87 119.11 15.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 97.89 14.93 38.22 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.884 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.521 ' HG3' HD23 ' B' ' 22' ' ' LEU . 5.3 mm-40 -71.4 133.42 45.93 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 120.77 35.24 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 123.298 1.523 . . . . 0.0 112.819 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 32' ' ' LEU . 32.8 m -138.95 162.65 28.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 112.291 -2.231 . . . . 0.0 110.489 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.822 ' HG3' ' HG3' ' A' ' 33' ' ' GLU . 46.8 mttp -122.3 139.46 53.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.689 0.757 . . . . 0.0 109.246 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 28' ' ' VAL . 6.2 mt -102.9 136.34 35.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.98 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.912 ' HG2' HG21 ' A' ' 4' ' ' ILE . 19.8 mttt -137.02 147.14 46.03 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.634 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.814 HD13 HD13 ' A' ' 22' ' ' LEU . 4.3 mm? -86.59 128.36 34.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.372 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.553 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 38.4 mm-40 -94.46 124.18 38.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -135.37 -169.64 2.43 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.755 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 153.37 29.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.485 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.0 147.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.45 114.84 7.35 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.087 0.47 . . . . 0.0 111.917 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.76 -173.12 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.947 2.431 . . . . 0.0 112.128 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.7 pp -90.14 155.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.965 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -92.71 159.95 15.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.149 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.65 165.77 26.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.193 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.41 -136.7 5.56 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.557 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -112.9 161.87 24.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 122.282 0.233 . . . . 0.0 110.953 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.88 167.66 24.85 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.402 2.068 . . . . 0.0 111.848 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.05 151.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -98.81 170.18 8.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.016 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.89 138.0 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -119.62 -23.37 6.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.232 0.539 . . . . 0.0 111.123 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.21 -25.23 65.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.983 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -84.14 -6.24 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.194 0.521 . . . . 0.0 111.919 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.412 ' HZ2' ' HB2' ' B' ' 51' ' ' LYS . 3.1 ttmp? -74.18 138.55 43.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.824 0.345 . . . . 0.0 110.565 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -85.94 126.94 34.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.72 123.97 42.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.449 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -60.93 115.64 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.316 0.579 . . . . 0.0 111.041 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.54 172.29 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.281 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 128.61 11.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.4 -176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -90.95 144.16 25.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.091 0.472 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -83.33 171.29 13.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.4 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 19.3 ptp -84.69 169.56 14.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.852 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -73.38 -177.15 2.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.8 m -105.32 4.06 30.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.741 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 67.4 mt 59.01 -171.23 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.392 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.51 136.11 50.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.127 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -118.2 85.1 2.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.786 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.21 127.76 32.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.114 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' B' ' 67' ' ' HIS . 52.5 m80 -96.04 147.67 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' B' ' 66' ' ' HIS . 60.6 m170 72.16 157.61 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.881 0.738 . . . . 0.0 109.465 -168.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -91.29 0.75 57.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.418 0.627 . . . . 0.0 109.781 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 C--O 1.247 0.95 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.888 178.584 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.583 0.23 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.5 130.89 23.25 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.814 2.342 . . . . 0.0 111.743 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -136.31 149.03 48.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.616 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER -71.12 144.28 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.182 0.515 . . . . 0.0 111.623 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -105.1 146.76 11.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -103.02 137.2 41.53 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.82 160.33 40.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.838 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.4 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.555 0.693 . . . . 0.0 110.425 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.6 t80 -72.92 110.41 7.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.638 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 36.9 mt-10 -134.2 144.46 48.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.398 177.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 62.62 22.4 13.3 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.441 0.463 . . . . 0.0 111.374 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 79.43 18.55 73.51 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.914 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 9.8 t -127.42 150.72 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.706 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 63.4 m-85 -95.55 115.0 26.81 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.287 168.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 50.8 mtpt -113.99 108.64 50.6 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.594 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 27.7 Cg_endo -62.52 169.22 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.35 1.366 . . . . 0.0 112.781 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.2 -16.29 14.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -107.68 137.37 45.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.558 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -75.96 124.58 27.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.644 0.735 . . . . 0.0 109.98 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.648 ' HB ' ' CE2' ' B' ' 9' ' ' TYR . 3.6 t -103.12 147.48 9.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.591 -175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.76 16.1 13.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.121 0.962 . . . . 0.0 110.345 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 HD22 ' B' ' 32' ' ' LEU . 96.7 mt -73.84 -174.37 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.773 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -110.97 171.86 7.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.341 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -73.29 141.74 47.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.459 0.647 . . . . 0.0 110.575 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.733 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 54.52 64.77 4.02 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.703 -167.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 22' ' ' LEU . 7.8 tp10 -105.98 123.15 47.52 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.478 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -77.88 111.3 13.58 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 122.654 1.216 . . . . 0.0 112.747 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.618 HG11 ' HG ' ' B' ' 32' ' ' LEU . 27.1 m -133.32 155.55 40.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.603 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.96 ' HD3' HG13 ' B' ' 4' ' ' ILE . 64.3 mttm -113.03 149.05 33.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.542 HG23 ' CE1' ' A' ' 14' ' ' PHE . 4.0 mm -104.59 130.25 55.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.277 0.561 . . . . 0.0 109.627 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE3' HG21 ' B' ' 4' ' ' ILE . 75.2 mttt -132.81 134.45 44.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.545 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.694 ' HB3' HG11 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -103.75 141.83 35.42 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.913 -169.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.22 158.3 20.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.255 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt -133.93 160.04 38.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.013 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -96.22 166.94 11.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.653 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.14 138.84 32.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 mm-40 -81.27 123.05 81.78 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.848 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.3 Cg_exo -77.79 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.543 2.829 . . . . 0.0 113.256 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.2 pt -68.05 165.3 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.89 149.54 52.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.05 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.9 tp -100.52 135.12 42.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 111.379 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 156.38 24.51 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.039 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.44 150.7 73.95 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.36 -0.92 . . . . 0.0 111.868 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 159.03 35.5 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.761 2.307 . . . . 0.0 111.951 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.28 155.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -90.28 174.09 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.43 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.63 164.67 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.37 121.0 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.567 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -85.56 -28.83 24.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.133 0.492 . . . . 0.0 111.088 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.9 tt -93.65 -0.77 10.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.604 0.716 . . . . 0.0 110.774 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -73.54 132.94 43.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.726 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -123.92 141.71 51.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 53' ' ' ILE . 4.0 mp -99.63 90.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 0.0 110.197 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -87.56 110.72 20.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.941 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.46 163.21 18.26 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.21 105.2 3.01 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.434 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.3 m -84.94 131.19 34.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -98.24 142.67 29.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -101.13 144.65 29.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.196 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.7 m -77.86 107.18 10.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.439 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.9 m -95.8 3.51 53.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.795 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.3 tp -107.01 123.43 48.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.895 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.59 150.23 21.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -78.03 66.67 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 0.0 109.754 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -86.91 141.54 28.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.648 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 73.14 69.37 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.511 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -117.09 87.09 2.63 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -82.61 115.02 21.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.162 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 -179.298 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.606 0.241 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.05 146.72 20.46 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.319 2.013 . . . . 0.0 111.691 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -121.3 162.78 19.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.729 0.299 . . . . 0.0 110.363 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.96 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -105.71 144.99 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.463 -177.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.5 HG22 ' HB2' ' B' ' 18' ' ' GLN . 6.6 mt -97.78 144.24 11.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.433 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 51.4 mp0 -104.9 141.32 36.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.682 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -139.87 166.26 25.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.108 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.733 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.4 m -121.36 123.48 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.612 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.648 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.2 t80 -61.55 126.16 26.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.831 173.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 81.1 mt-10 -137.09 111.52 8.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.018 0.437 . . . . 0.0 111.294 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 55.5 29.12 12.78 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.032 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.04 -69.78 0.48 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 118.215 -1.945 . . . . 0.0 110.845 -168.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.15 145.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.784 -1.208 . . . . 0.0 111.823 -161.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.706 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -92.83 116.74 29.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.63 120.77 56.68 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.561 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 28.8 Cg_endo -64.82 170.05 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.316 1.344 . . . . 0.0 112.533 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.569 HD12 HG12 ' B' ' 8' ' ' VAL . 6.0 mp -108.92 -10.67 15.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.5 ' HB2' HG22 ' B' ' 5' ' ' ILE . 47.0 mt-30 -115.48 145.26 42.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.866 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -73.42 151.57 41.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.953 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.44 HG11 ' H ' ' B' ' 22' ' ' LEU . 2.5 t -112.54 145.25 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.67 16.61 9.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.36 1.076 . . . . 0.0 109.519 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.533 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 88.6 mt -86.36 -165.93 1.4 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.188 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.532 ' CG ' ' HG2' ' B' ' 26' ' ' GLU . 23.6 pttp -116.32 155.08 29.06 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.379 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.1 132.5 45.16 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.885 0.85 . . . . 0.0 109.836 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.02 65.03 2.75 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.617 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 1.9 mm-40 -112.06 132.96 54.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.254 -0.973 . . . . 0.0 109.221 170.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -90.41 119.48 30.73 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.704 0.764 . . . . 0.0 110.869 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.694 HG11 ' HB3' ' A' ' 32' ' ' LEU . 29.8 m -140.11 166.81 19.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.467 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.616 ' HD3' HG13 ' A' ' 4' ' ' ILE . 60.9 mttm -122.03 153.93 37.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.23 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.417 HG21 ' HB ' ' A' ' 28' ' ' VAL . 5.8 mm -115.44 142.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -151.34 125.05 9.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.618 ' HG ' HG11 ' A' ' 28' ' ' VAL . 3.2 mp -71.14 114.54 9.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -146.12 171.68 14.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.181 0.515 . . . . 0.0 111.594 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.404 ' H ' HD22 ' B' ' 34' ' ' LEU . 1.7 pt? -123.55 165.72 16.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.997 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.498 ' HG2' ' N ' ' B' ' 36' ' ' VAL . 37.6 ttmt -120.64 159.47 25.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.498 ' N ' ' HG2' ' B' ' 35' ' ' LYS . 7.7 p -92.44 138.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.4 0.619 . . . . 0.0 111.018 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -143.63 89.08 7.56 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.527 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.65 -161.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.304 2.669 . . . . 0.0 112.712 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.34 156.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -91.81 -51.28 5.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.801 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 45.1 tp 68.8 116.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.278 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.77 -142.5 10.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.969 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.83 158.19 38.39 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 122.252 0.221 . . . . 0.0 111.177 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.09 174.27 12.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.025 2.483 . . . . 0.0 112.253 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.69 154.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 10.4 m -89.32 171.84 9.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.39 138.17 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.405 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.02 -30.67 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.692 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -66.84 -24.49 66.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.957 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 tt -77.69 -4.03 6.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.375 0.607 . . . . 0.0 110.944 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -70.55 134.24 47.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.178 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -108.21 150.6 27.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -118.23 132.33 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -78.28 120.71 23.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.92 147.97 22.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 0.0 110.89 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.75 76.88 0.41 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.211 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m -70.05 135.56 49.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.683 0.278 . . . . 0.0 110.666 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' B' ' 59' ' ' MET . 1.3 m-90 -110.56 -168.77 1.35 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.343 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' B' ' 58' ' ' TRP . 66.6 mtt 73.64 172.42 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.831 0.853 . . . . 0.0 110.31 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m 57.09 26.18 11.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.076 0.465 . . . . 0.0 111.735 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.8 p -82.22 16.93 1.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.003 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 45.43 99.89 0.01 OUTLIER 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.119 0.967 . . . . 0.0 113.223 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -82.83 172.4 12.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.09 123.74 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.263 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -97.23 141.22 30.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -71.14 129.92 40.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 111.639 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -71.83 86.78 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -83.77 73.92 10.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.5 0.667 . . . . 0.0 111.167 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.8 m170 . . . . . 0 C--O 1.246 0.891 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.538 177.011 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' B' ' 32' ' ' LEU . 74.4 Cg_endo -93.2 108.28 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.097 2.531 . . . . 0.0 115.656 -166.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 4' ' ' ILE . 23.8 ttpp -120.17 158.56 26.67 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 161.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.3 OUTLIER -70.49 127.1 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.451 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 20' ' ' VAL . 4.6 mt -105.59 152.65 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.109 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 30.1 mt-10 -112.94 108.05 16.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -110.16 167.14 10.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.41 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 3.8 m -118.02 117.39 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.637 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 73.5 t80 -70.38 114.85 8.9 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.868 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 11.6 tt0 -88.05 -170.69 3.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.324 -2.216 . . . . 0.0 107.402 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.409 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 10.9 t30 -67.44 49.75 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.713 0.805 . . . . 0.0 112.135 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 10' ' ' GLU . . . 119.69 4.58 11.65 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.2 t -117.32 155.12 19.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.298 -175.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 1.06 ' HB2' ' HB3' ' B' ' 14' ' ' PHE . 81.2 m-85 -122.81 119.15 29.72 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.306 164.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.07 121.02 37.52 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -67.07 167.58 19.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.105 1.203 . . . . 0.0 111.23 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.04 -2.65 14.99 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.52 ' HB2' HG21 ' A' ' 5' ' ' ILE . 40.5 mt-30 -119.24 144.17 46.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.683 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.8 141.19 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 5' ' ' ILE . 4.1 p -132.56 161.77 40.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.843 0.83 . . . . 0.0 112.028 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -104.9 12.84 32.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.198 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD12 ' CG2' ' A' ' 20' ' ' VAL . 6.9 mp -66.8 135.61 54.2 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.427 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.925 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.7 mmpt? -93.67 -172.26 2.84 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.523 -176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -61.63 160.52 11.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.895 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -19.72 72.63 0.0 OUTLIER Glycine 0 CA--C 1.495 -1.217 0 O-C-N 124.997 1.435 . . . . 0.0 114.132 -151.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.11 147.51 40.49 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 111.526 -2.337 . . . . 0.0 108.602 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HG3' HD21 ' B' ' 32' ' ' LEU . 13.2 tpt180 -88.14 119.17 28.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.866 ' HA ' ' CB ' ' B' ' 32' ' ' LEU . 0.0 OUTLIER -144.61 149.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.255 -174.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HB2' HD13 ' B' ' 32' ' ' LEU . 13.6 mttt -115.21 143.96 44.43 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.365 0.602 . . . . 0.0 110.286 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.693 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 1.5 mt -107.34 135.12 47.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.707 ' HG2' ' HB2' ' B' ' 29' ' ' LYS . 7.5 ptmm? -106.82 143.79 34.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD21 HD23 ' B' ' 22' ' ' LEU . 21.9 tp -100.87 128.06 47.07 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.61 ' OE2' ' HE3' ' B' ' 29' ' ' LYS . 3.7 tp10 -72.38 133.64 45.03 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.414 1.102 . . . . 0.0 113.38 -162.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD22 ' HZ1' ' A' ' 31' ' ' LYS . 2.4 pt? -157.07 -179.5 8.27 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.005 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -126.09 158.53 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.03 137.13 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.782 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.74 138.22 22.91 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.38 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.62 -174.34 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.718 2.279 . . . . 0.0 110.657 171.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.32 151.61 27.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.923 0.392 . . . . 0.0 111.179 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tt -67.99 110.26 3.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.137 0.494 . . . . 0.0 110.902 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.34 114.5 0.71 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -131.89 161.72 60.82 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 122.462 0.305 . . . . 0.0 110.475 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.69 164.84 31.61 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.686 2.257 . . . . 0.0 111.515 173.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.86 148.37 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.4 m -103.59 176.89 5.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.103 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.6 156.92 43.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.03 130.07 39.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.085 0.469 . . . . 0.0 110.227 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -85.43 -25.98 26.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.257 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -70.9 -16.1 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.533 0.682 . . . . 0.0 111.206 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.75 132.29 54.11 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.873 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HG2' HG12 ' A' ' 53' ' ' ILE . 85.5 tttt -173.69 149.61 1.62 Allowed 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.091 0.244 . . . . 0.0 110.381 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.753 HG12 ' HG2' ' A' ' 52' ' ' LYS . 43.0 mm 58.98 104.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.93 152.05 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.417 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.51 155.93 40.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.652 0.739 . . . . 0.0 112.835 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.97 75.13 0.24 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.047 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 m -94.29 142.6 27.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.164 0.507 . . . . 0.0 111.922 -172.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -125.89 134.62 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 ttm -94.02 124.95 38.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 t -81.41 150.73 28.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 p -104.32 -6.03 21.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp 38.69 79.56 0.03 OUTLIER 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.09 0.869 . . . . 0.0 112.21 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 156.3 34.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -145.68 82.42 1.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 171.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -108.13 99.75 9.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.212 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -143.33 143.2 31.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.936 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -146.12 138.09 25.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.854 0.359 . . . . 0.0 110.496 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -109.42 108.73 19.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.917 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.376 178.244 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.74 109.91 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.054 2.503 . . . . 0.0 112.659 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' B' ' 3' ' ' LYS . 3.7 mppt? -73.2 156.94 38.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.054 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.22 143.96 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.263 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' B' ' 18' ' ' GLN . 10.4 mm -113.14 146.43 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -109.39 131.21 55.28 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.616 ' HB3' ' CE2' ' B' ' 14' ' ' PHE . . . -143.12 164.33 30.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 0.0 111.248 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.22 128.87 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.282 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 41.2 t80 -84.76 100.85 11.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -115.12 120.42 39.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.859 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.32 33.29 9.19 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.965 0.79 . . . . 0.0 111.35 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' B' ' 9' ' ' TYR . . . 83.56 14.28 73.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.211 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.5 t -120.12 146.7 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 1.06 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -99.93 114.94 28.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -119.0 108.96 39.91 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.637 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 39.2 Cg_endo -68.85 168.27 20.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.467 1.445 . . . . 0.0 112.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.36 -9.55 17.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.492 ' HB2' HG23 ' B' ' 5' ' ' ILE . 72.4 mt-30 -102.38 145.69 29.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.205 173.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -84.39 124.19 31.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 163.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.637 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.7 t -90.57 148.93 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.431 -161.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.42 16.38 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.027 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.813 HD23 HD21 ' A' ' 32' ' ' LEU . 22.1 mt -99.76 -174.62 2.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.089 -173.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' B' ' 26' ' ' GLU . 37.8 tttm -116.28 155.12 28.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.267 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 1.5 mp0 -62.64 123.46 18.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.049 0.452 . . . . 0.0 109.955 175.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.73 22.92 34.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.036 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.521 ' HG3' HD22 ' B' ' 22' ' ' LEU . 16.9 mm-40 -84.02 143.02 30.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -86.28 120.51 27.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.4 1.095 . . . . 0.0 112.442 -175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.693 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 34.6 m -136.07 151.55 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.832 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.707 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 47.7 mmtt -117.35 144.63 44.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 18.7 mt -133.12 137.08 54.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.807 0.813 . . . . 0.0 111.967 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -158.16 135.85 10.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.155 169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.866 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 8.8 tp -153.01 162.22 41.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -164.36 157.22 17.3 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.021 -168.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.73 173.63 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.806 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.823 ' HB3' ' HZ3' ' B' ' 35' ' ' LYS . 9.1 mtpm? -84.12 153.24 23.84 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.491 0.662 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.7 137.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -131.34 114.82 16.03 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 120.876 0.37 . . . . 0.0 110.889 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.11 -175.83 2.37 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.158 2.572 . . . . 0.0 112.289 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt 69.27 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.435 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.46 ' OD2' ' HG ' ' B' ' 41' ' ' LEU . 36.2 t70 -155.4 -69.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.862 -173.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.46 ' HG ' ' OD2' ' B' ' 40' ' ' ASP . 94.3 mt -100.04 168.0 10.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.274 0.559 . . . . 0.0 112.147 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 120.93 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.693 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 36.1 mm-40 -97.11 144.18 27.44 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.579 0.228 . . . . 0.0 111.123 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.71 156.15 64.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.98 2.453 . . . . 0.0 112.279 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.49 158.79 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.936 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -87.27 168.24 13.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.88 162.4 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.353 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.36 122.95 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.965 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.13 25.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.023 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 17.9 tt -72.29 -12.02 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' B' ' 51' ' ' LYS . 6.1 tppt? -79.37 132.38 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -147.42 107.46 4.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.903 0.382 . . . . 0.0 111.574 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tp -100.85 101.86 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.421 0.629 . . . . 0.0 109.449 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -122.73 126.29 47.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.499 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.58 159.28 30.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.112 0.482 . . . . 0.0 110.963 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.48 5.05 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.479 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.7 t -115.98 167.62 10.8 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -95.9 143.14 27.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 120.991 0.424 . . . . 0.0 111.1 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.52 124.65 48.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.61 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.1 t -79.86 148.52 31.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 110.424 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 2.8 p -94.82 -0.09 54.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 61' ' ' SER . 1.0 OUTLIER 39.7 84.58 0.02 OUTLIER 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.651 1.219 . . . . 0.0 112.947 -178.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 100.91 0.16 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.244 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -85.01 57.91 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.17 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -70.29 108.18 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.138 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 134.31 22.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -120.2 117.27 27.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -78.57 142.21 37.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.453 178.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 100.35 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.877 2.385 . . . . 0.0 110.898 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 156.32 21.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.061 0.458 . . . . 0.0 110.906 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.875 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.1 OUTLIER -92.99 144.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.235 -170.028 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 mt -93.54 145.54 7.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -99.54 109.72 22.23 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.195 -169.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.933 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -115.68 156.97 24.95 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -166.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.596 HG23 HH12 ' B' ' 27' ' ' ARG . 0.1 OUTLIER -123.31 123.62 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.709 171.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.723 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.5 t80 -80.37 105.63 11.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 50.0 mt-10 -126.83 139.69 52.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.569 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.44 ' H ' ' CG ' ' B' ' 24' ' ' GLU . 4.6 t30 65.36 20.37 11.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 111.554 172.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 84.25 15.62 68.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.723 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.5 t -122.48 154.08 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.833 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.7 m-85 -99.43 114.64 27.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 165.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -116.97 108.92 43.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.108 -176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.933 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 14.4 Cg_endo -72.75 169.17 22.63 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 113.491 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.36 -12.37 59.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.688 ' HG2' ' HG2' ' A' ' 16' ' ' PRO . 6.2 mm-40 75.1 -134.05 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.0 116.731 160.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.0 mttt 59.07 -161.25 0.26 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.454 -141.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' A' ' 22' ' ' LEU . 22.0 t 67.01 147.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.484 0.659 . . . . 0.0 110.435 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.03 26.74 3.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.684 0.754 . . . . 0.0 111.252 -171.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HG ' ' CG1' ' A' ' 20' ' ' VAL . 94.7 mt -56.85 174.81 0.14 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.832 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -103.84 162.68 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 1.5 pm0 -83.62 149.57 26.45 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.82 73.06 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.695 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.687 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 21.5 tt0 -93.1 155.4 17.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -96.33 137.45 35.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.747 0.784 . . . . 0.0 112.465 -171.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.874 HG12 ' HA ' ' B' ' 32' ' ' LEU . 4.4 m -147.97 171.39 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HD3' HG13 ' B' ' 4' ' ' ILE . 62.5 mttm -127.0 144.74 50.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.188 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.654 HG22 ' HB ' ' B' ' 28' ' ' VAL . 1.3 mm -113.05 131.55 64.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.765 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -121.57 124.29 44.01 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.801 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.0 mp -74.03 117.45 15.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.8 158.13 32.47 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.354 0.597 . . . . 0.0 112.43 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -164.03 1.48 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.756 -173.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -99.03 157.51 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.753 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.5 t -70.14 164.92 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.546 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' GLU . 12.4 pt-20 41.83 84.23 0.19 Allowed Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 124.298 1.039 . . . . 0.0 111.591 -171.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.24 174.39 8.16 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.465 2.776 . . . . 0.0 113.631 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mt -73.89 149.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.095 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -99.28 101.66 13.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.772 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 19.7 tp -83.13 -177.58 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -172.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.772 ' H ' ' HG ' ' A' ' 41' ' ' LEU . . . -150.05 156.42 26.73 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.7 mp0 -54.6 124.1 47.71 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 123.785 0.344 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.37 128.25 29.28 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.497 2.131 . . . . 0.0 111.521 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.85 143.93 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.886 0.85 . . . . 0.0 111.661 -175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -114.47 162.15 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.77 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.561 0.696 . . . . 0.0 111.456 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.31 -14.42 25.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.811 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.0 -27.22 68.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.537 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -93.12 -14.84 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -139.09 130.78 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -151.88 139.3 19.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.669 -173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -92.24 115.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.559 -178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -103.61 104.4 14.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -76.79 148.66 36.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.277 0.56 . . . . 0.0 111.688 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.34 104.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.195 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.1 p -81.83 127.93 33.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.902 0.382 . . . . 0.0 111.404 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -144.65 140.14 28.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.031 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.1 ttm -159.6 145.12 15.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -101.01 159.29 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.169 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -77.39 -0.31 25.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.761 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 tp 57.91 -163.95 0.19 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.19 0.596 . . . . 0.0 111.343 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.95 115.67 5.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -97.04 102.29 14.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.484 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.74 135.78 40.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.359 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -146.5 -179.07 6.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.893 0.377 . . . . 0.0 110.945 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -135.69 164.04 28.78 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -125.95 97.47 5.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.648 0.737 . . . . 0.0 110.3 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.544 -178.703 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -86.48 97.9 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -144.54 161.94 37.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.362 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.576 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -109.21 145.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.658 173.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.467 ' O ' HG12 ' A' ' 30' ' ' ILE . 9.0 mm -98.13 143.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -104.86 134.98 47.07 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -137.27 156.29 48.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.536 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.467 HG23 HD12 ' B' ' 17' ' ' LEU . 2.0 m -117.17 114.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 14.1 p90 -103.52 141.88 35.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.186 0.993 . . . . 0.0 113.25 -170.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -87.58 -170.98 3.24 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.582 172.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.7 63.45 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 O-C-N 124.504 1.127 . . . . 0.0 111.722 -171.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 113.06 -5.71 25.46 Favored Glycine 0 C--N 1.301 -1.413 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.382 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' B' ' 9' ' ' TYR . 0.2 OUTLIER -104.37 139.02 26.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.437 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.833 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 42.5 m-85 -118.68 123.87 45.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.188 0.904 . . . . 0.0 111.353 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -122.79 117.32 28.75 Favored Pre-proline 0 N--CA 1.455 -0.184 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.527 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.4 Cg_endo -67.83 169.14 16.83 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.984 1.789 . . . . 0.0 113.74 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.467 HD12 HG23 ' B' ' 8' ' ' VAL . 4.7 mp -120.58 -17.81 7.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.432 171.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.42 146.97 24.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -62.96 148.54 47.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.438 0.637 . . . . 0.0 110.559 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.511 HG12 ' HH ' ' A' ' 9' ' ' TYR . 2.3 p -145.17 134.53 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 122.338 1.066 . . . . 0.0 111.818 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -121.13 15.08 11.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.709 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.417 ' HG ' HG21 ' B' ' 20' ' ' VAL . 85.7 mt -66.39 167.22 10.92 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.09 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -112.68 160.4 17.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -173.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 2.3 mp0 -62.77 120.23 10.87 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.905 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.2 36.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.974 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -75.89 136.4 40.12 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.942 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.596 HH12 HG23 ' A' ' 8' ' ' VAL . 18.3 tpp180 -93.39 117.39 30.02 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.567 1.175 . . . . 0.0 112.522 -171.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.654 ' HB ' HG22 ' A' ' 30' ' ' ILE . 19.8 m -141.79 158.25 21.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.459 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.875 ' HD3' HG13 ' A' ' 4' ' ' ILE . 52.5 mttp -120.76 147.2 45.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.813 HG22 ' CE2' ' B' ' 14' ' ' PHE . 1.3 mm -110.68 132.26 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.145 0.498 . . . . 0.0 110.976 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.513 ' HG3' HG21 ' A' ' 4' ' ' ILE . 10.5 mtmt -118.56 136.86 53.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 171.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.874 ' HA ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -93.17 113.38 25.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.08 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.552 ' O ' ' HG ' ' B' ' 34' ' ' LEU . 49.6 mm-40 -122.37 135.35 54.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -162.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' B' ' 33' ' ' GLU . 18.3 mt -151.58 144.81 24.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.409 -2.178 . . . . 0.0 106.728 156.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -153.03 179.27 8.85 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.356 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 80.0 t 65.73 143.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.983 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -119.75 139.41 28.0 Favored Pre-proline 0 N--CA 1.435 -1.215 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.749 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.4 174.19 12.54 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 111.769 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.522 HD11 ' O ' ' B' ' 39' ' ' ILE . 1.9 pp -81.4 137.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -107.08 119.26 38.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.2 mt -134.32 168.89 18.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.262 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 118.14 2.64 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.93 139.8 31.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 123.174 0.59 . . . . 0.0 111.572 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 130.2 37.33 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.637 2.225 . . . . 0.0 111.761 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.24 151.95 8.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.065 0.459 . . . . 0.0 110.476 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -94.3 169.71 10.03 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.884 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 132.84 65.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.503 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -72.46 120.01 17.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.264 0.554 . . . . 0.0 110.841 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.84 -23.33 48.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.3 mt -64.2 -15.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.365 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -76.12 131.97 39.75 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.733 ' HG2' HG13 ' B' ' 53' ' ' ILE . 46.6 tttp -160.09 141.73 12.72 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.981 -164.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.733 HG13 ' HG2' ' B' ' 52' ' ' LYS . 77.3 mt 70.11 112.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.868 0.842 . . . . 0.0 112.588 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -99.94 17.29 21.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.794 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.83 175.49 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.075 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 63.46 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.247 -0.501 . . . . 0.0 111.952 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -158.47 164.72 35.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.823 -0.222 . . . . 0.0 110.417 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -132.17 135.91 46.69 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.8 ptp -106.18 159.18 16.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.009 0.433 . . . . 0.0 111.066 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -71.14 173.59 7.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.112 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -90.25 -6.51 55.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.828 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 tp 51.1 30.58 5.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.8 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.44 129.62 50.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.03 0.443 . . . . 0.0 110.587 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -133.28 85.87 2.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.546 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -75.05 74.79 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.129 0.966 . . . . 0.0 110.759 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -104.06 111.82 24.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.818 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.55 141.63 51.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.499 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -105.76 137.94 42.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.523 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 9.7 p80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 ptm . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.77 -41.53 2.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.092 2.528 . . . . 0.0 112.446 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -149.94 160.38 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.347 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.2 OUTLIER -108.08 144.84 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.184 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HB ' HD12 ' B' ' 30' ' ' ILE . 19.4 mt -119.87 152.2 22.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 169.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.57 134.91 48.99 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.678 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.43 165.79 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.44 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 10.5 m -118.42 127.98 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.27 0.557 . . . . 0.0 110.512 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 86.5 t80 -89.42 105.15 17.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.834 0.826 . . . . 0.0 110.637 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 8.5 pt-20 -91.86 -168.33 1.99 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.79 168.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.78 67.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.436 1.112 . . . . 0.0 112.43 -160.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . 105.38 0.4 40.58 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.012 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 1.9 t -115.16 141.97 29.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.262 -173.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.665 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.5 m-85 -108.31 115.59 30.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 166.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.595 ' HE3' HG13 ' A' ' 13' ' ' VAL . 96.9 mttt -121.2 119.11 29.78 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.619 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -52.48 166.57 0.75 Allowed 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.382 2.055 . . . . 0.0 114.741 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.3 -67.4 0.99 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 110.215 -3.175 . . . . 0.0 103.655 167.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -71.44 141.73 50.26 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.08 -2.327 . . . . 0.0 108.628 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -60.6 149.63 34.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.697 0.76 . . . . 0.0 112.395 -173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 m -77.1 166.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.527 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.42 15.21 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.719 0.771 . . . . 0.0 110.148 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.51 HD11 HD21 ' B' ' 32' ' ' LEU . 79.0 mt -122.5 -169.91 1.99 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.378 -172.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 18.3 pttp -124.03 155.12 38.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.974 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.2 pm0 -66.19 134.28 52.41 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.21 0.528 . . . . 0.0 111.002 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.17 10.58 48.22 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.802 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 5.7 tp10 -84.46 146.56 27.56 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.807 -0.231 . . . . 0.0 110.757 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -102.5 125.08 49.1 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.557 1.17 . . . . 0.0 112.334 -175.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.3 m -134.15 156.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.414 -174.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB3' HD13 ' B' ' 4' ' ' ILE . 64.0 mttm -115.33 144.79 43.23 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.0 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.509 HG23 ' CE1' ' A' ' 14' ' ' PHE . 4.5 mm -115.79 144.3 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 -175.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -151.3 123.78 8.41 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.754 ' HB3' HG11 ' B' ' 28' ' ' VAL . 2.7 pt? -89.85 145.67 24.99 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.18 123.93 37.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.405 1.097 . . . . 0.0 110.782 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 34' ' ' LEU . 2.0 mm? -101.48 -164.9 1.14 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.783 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -134.64 160.31 38.51 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.49 127.41 14.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.355 0.598 . . . . 0.0 111.037 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.1 115.6 27.29 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.369 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.86 172.14 11.26 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.211 1.941 . . . . 0.0 112.298 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.57 165.24 32.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.062 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.64 118.37 15.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.903 0.382 . . . . 0.0 110.297 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 41' ' ' LEU . 2.2 pt? -148.82 133.93 18.24 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.875 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.3 -155.07 31.15 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.227 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.13 143.08 32.17 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-O 120.527 0.204 . . . . 0.0 110.704 -177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.94 142.44 68.8 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.943 2.429 . . . . 0.0 112.112 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.84 146.29 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.914 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -95.73 158.19 15.56 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.054 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.9 t -140.72 132.01 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.234 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -118.99 122.3 41.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.856 0.836 . . . . 0.0 110.954 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.48 -22.98 26.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.104 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 50' ' ' ILE . 25.5 mm -65.07 -3.51 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.532 -174.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 51' ' ' LYS . 6.1 ttpm? -78.43 133.19 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 153.15 23.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.961 0.41 . . . . 0.0 111.451 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -105.53 -158.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.123 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.9 ttm105 -107.23 160.47 15.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.905 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.43 153.82 40.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 110.296 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.68 156.42 21.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.855 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 m -68.39 130.76 43.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -119.63 175.17 5.99 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.081 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.0 ttt -63.31 130.56 45.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.022 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 154.88 34.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.402 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -87.11 15.24 6.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp 60.22 -171.03 0.14 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.374 0.67 . . . . 0.0 111.62 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 2.8 mp0 -97.22 -22.92 16.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.249 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 28.6 t-80 72.95 -17.94 0.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.695 0.622 . . . . 0.0 112.66 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.8 m170 68.74 -178.08 0.22 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.735 0.414 . . . . 0.0 110.535 -172.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -109.56 109.97 20.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.509 0.671 . . . . 0.0 110.726 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -94.83 96.74 9.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.356 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -96.52 -7.13 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.294 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.6 p80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.903 170.32 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.67 102.81 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.012 2.475 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -124.16 171.5 9.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.369 0.604 . . . . 0.0 111.894 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.612 HD13 ' HB3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.125 173.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.441 ' CD1' HG11 ' B' ' 20' ' ' VAL . 1.9 mt -124.45 157.94 31.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.421 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 mt-10 -109.59 139.99 43.93 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.4 157.52 44.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.041 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . 0.633 HG12 HD11 ' B' ' 17' ' ' LEU . 6.0 m -104.26 117.35 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.602 0.715 . . . . 0.0 110.822 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.618 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 52.7 t80 -76.57 111.25 11.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.21 1.005 . . . . 0.0 111.181 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.683 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 36.6 mt-10 -88.51 -169.12 2.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.163 170.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.55 55.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.236 1.014 . . . . 0.0 112.349 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.65 6.72 23.01 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.8 t -116.08 149.59 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.885 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.665 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.8 m-85 -119.18 114.87 23.11 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 166.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . 0.443 ' HE2' HG11 ' B' ' 13' ' ' VAL . 65.1 mttm -114.26 113.77 45.93 Favored Pre-proline 0 CA--C 1.506 -0.717 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.23 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -43.56 169.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.318 2.678 . . . . 0.0 116.642 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.941 ' O ' ' HG3' ' B' ' 18' ' ' GLN . 2.5 mt -131.17 103.91 6.76 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.753 167.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.941 ' HG3' ' O ' ' B' ' 17' ' ' LEU . 5.1 pp0? 79.38 178.58 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.068 2.547 . . . . 0.0 112.922 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.23 141.28 35.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -162.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.508 ' HB ' ' HH ' ' A' ' 9' ' ' TYR . 3.2 t -137.79 135.06 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.279 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.511 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -128.08 87.56 2.62 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 123.015 1.388 . . . . 0.0 109.149 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.406 HD13 ' HG2' ' B' ' 26' ' ' GLU . 60.6 mt -129.99 -169.95 2.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.032 -1.894 . . . . 0.0 111.119 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -91.1 -174.72 4.07 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -103.45 122.08 44.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.753 0.787 . . . . 0.0 110.24 170.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . 0.453 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 93.02 15.16 53.16 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.409 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.406 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.8 tp10 -60.93 138.46 58.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.604 0.361 . . . . 0.0 110.524 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 0.1 OUTLIER -89.76 115.09 26.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.376 1.084 . . . . 0.0 111.662 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 32' ' ' LEU . 27.4 m -132.33 162.7 39.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.575 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -117.66 147.12 43.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.281 0.562 . . . . 0.0 109.598 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 2.1 mt -106.7 128.45 61.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.81 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -125.92 134.09 51.67 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 122.556 1.169 . . . . 0.0 108.852 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 22' ' ' LEU . 41.3 tp -103.15 131.17 50.37 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.03 -162.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -97.25 140.08 32.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.943 0.877 . . . . 0.0 112.173 -170.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 18.0 mt -155.59 158.91 39.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.348 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.78 177.3 7.35 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.705 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.17 141.18 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -86.93 136.02 34.65 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.47 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.91 174.37 9.74 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.415 2.077 . . . . 0.0 111.657 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.22 144.81 8.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.91 -177.07 6.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.5 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.38 143.07 26.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 111.0 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 -123.59 5.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.026 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.3 OUTLIER -101.36 153.47 37.81 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 120.774 0.321 . . . . 0.0 111.055 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 1.8 Cg_endo -87.0 -159.57 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.551 2.834 . . . . 0.0 111.654 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 t -115.04 156.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -75.21 169.68 17.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.844 0.354 . . . . 0.0 111.312 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.04 136.92 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.8 -22.35 21.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.245 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.12 -28.19 67.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.518 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.27 2.33 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 110.945 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -111.71 -154.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.136 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' B' ' 52' ' ' LYS . 1.5 ttmt 60.31 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.613 0.721 . . . . 0.0 111.974 -172.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.408 ' N ' HD12 ' B' ' 53' ' ' ILE . 4.3 mp -86.81 102.98 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.696 -174.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -157.56 116.12 3.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.144 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.25 166.02 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.87 93.88 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.783 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 42.6 m 70.0 148.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.292 0.637 . . . . 0.0 111.67 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.07 178.98 4.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.363 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t 74.91 137.23 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.139 0.899 . . . . 0.0 112.424 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -105.47 18.63 21.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.034 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 67.96 179.05 0.23 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.094 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . 0.512 ' HG2' ' HB2' ' B' ' 65' ' ' HIS . 40.7 tt0 -124.21 121.61 35.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.353 0.596 . . . . 0.0 111.83 -172.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -96.36 74.52 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . 0.512 ' HB2' ' HG2' ' B' ' 63' ' ' GLU . 2.2 t-160 -95.07 -8.91 35.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.736 -170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -99.25 127.49 45.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -139.26 115.57 10.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -73.68 -74.83 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.696 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 1' ' ' MET . 20.5 ptm . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.25 0.547 . . . . 0.0 111.503 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -93.43 119.81 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.771 2.314 . . . . 0.0 111.104 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -88.23 143.56 26.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.897 HG13 ' HD2' ' B' ' 29' ' ' LYS . 0.2 OUTLIER -76.12 129.79 36.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.876 -174.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.42 147.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.76 128.51 52.91 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.47 151.57 44.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 6.6 m -115.87 119.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 121.381 0.61 . . . . 0.0 111.063 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.728 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 87.2 t80 -72.71 99.71 2.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -119.28 130.95 55.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.397 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.56 23.64 13.89 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.649 0.593 . . . . 0.0 112.035 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.517 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 92.1 10.43 61.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.354 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.9 t -122.92 142.83 38.03 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.536 ' CE1' HG22 ' B' ' 28' ' ' VAL . 48.7 m-85 -88.89 114.19 25.24 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 166.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -119.75 116.16 33.23 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.193 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.1 Cg_endo -58.27 166.38 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.33 1.353 . . . . 0.0 111.965 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -98.23 -13.67 20.71 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -122.37 155.36 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.728 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.28 131.85 35.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG12 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -111.26 150.05 13.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.0 14.7 20.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.279 1.038 . . . . 0.0 110.145 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 26' ' ' GLU . 70.4 mt -79.06 176.75 9.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.577 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HG2' ' OE1' ' A' ' 26' ' ' GLU . 17.5 pttm -124.95 163.11 23.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 111.537 -172.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.9 pt-20 -66.24 116.92 7.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.85 14.91 14.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.646 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 3.9 tp10 -80.61 132.49 35.63 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -103.18 127.81 50.35 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 122.356 1.074 . . . . 0.0 111.534 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' B' ' 32' ' ' LEU . 35.7 m -135.19 162.09 38.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.719 -167.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HZ1' ' CG ' ' B' ' 33' ' ' GLU . 13.7 mptt -114.93 141.88 47.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.793 177.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 14.7 mt -122.21 137.49 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.569 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -158.04 167.48 29.76 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.108 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 32' ' ' LEU . 2.0 mm? -87.52 114.86 24.52 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 162.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.669 ' HB2' ' HE2' ' B' ' 29' ' ' LYS . 8.5 tp10 -58.14 147.85 28.65 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -154.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 33' ' ' GLU . 85.0 mt 55.23 -166.0 0.11 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.025 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -116.13 171.37 7.85 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.49 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -85.81 164.27 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.75 164.57 9.54 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 122.924 0.489 . . . . 0.0 111.239 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.46 179.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.624 2.216 . . . . 0.0 112.856 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.92 174.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.622 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.84 153.74 43.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.697 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.83 148.04 33.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.92 -144.62 5.93 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.813 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.6 mp0 -53.03 117.91 12.49 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.114 0.538 . . . . 0.0 110.716 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.94 124.31 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.43 2.087 . . . . 0.0 112.258 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.51 150.11 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.26 157.92 16.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.345 0.593 . . . . 0.0 111.481 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.46 96.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.78 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 15.8 pt-20 -84.3 1.07 46.61 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.553 -172.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' LYS . 22.4 mt-10 -52.8 -25.07 10.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.441 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.3 pt -77.77 13.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.365 0.603 . . . . 0.0 111.301 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 32.5 tttt -65.35 140.08 58.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.831 -177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -136.35 147.98 47.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 tt -81.74 132.83 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 120.936 0.398 . . . . 0.0 110.575 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -74.83 85.57 2.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.18 148.27 23.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.751 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.46 116.98 1.61 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.36 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.0 t -129.72 156.78 43.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.667 0.27 . . . . 0.0 110.421 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -77.71 159.23 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.007 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -59.25 159.49 7.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.419 ' O ' HD22 ' A' ' 62' ' ' LEU . 2.3 p -66.63 171.01 5.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 m -76.47 8.19 3.73 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 60' ' ' SER . 2.6 mm? 60.1 142.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.906 0.882 . . . . 0.0 113.133 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.02 111.58 4.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.497 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.85 -16.54 56.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.4 t60 71.91 126.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.879 0.737 . . . . 0.0 110.552 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -85.61 144.79 27.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 74.84 121.53 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 124.412 1.07 . . . . 0.0 111.58 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -60.24 137.33 58.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.071 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.8 p80 . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.557 173.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 139.11 15.18 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.633 2.222 . . . . 0.0 113.665 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -157.25 158.85 36.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.429 ' N ' HD12 ' B' ' 4' ' ' ILE . 3.3 mp -77.93 130.83 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 121.997 0.903 . . . . 0.0 111.734 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.573 HD13 HG11 ' B' ' 20' ' ' VAL . 9.9 mt -114.46 151.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.65 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 137.73 52.66 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.66 168.97 18.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.1 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.64 141.58 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.676 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 83.7 t80 -100.3 114.09 27.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.053 0.93 . . . . 0.0 109.958 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.687 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 44.7 mt-10 -87.58 -170.63 3.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.126 -1.852 . . . . 0.0 108.552 169.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 52.64 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.096 0.958 . . . . 0.0 112.07 -172.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.48 4.67 15.26 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.3 t -114.32 145.54 19.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.554 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' B' ' 9' ' ' TYR . 46.5 m-85 -117.68 115.45 25.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 166.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.87 114.33 46.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.709 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' PRO . . . . . 0.504 ' HD3' ' HD2' ' A' ' 14' ' ' PHE . 9.5 Cg_endo -59.93 165.47 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-O 123.472 1.363 . . . . 0.0 113.2 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 -66.03 0.93 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.048 -2.796 . . . . 0.0 104.675 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.499 ' HB2' HG22 ' B' ' 5' ' ' ILE . 50.7 mt-30 -65.55 132.13 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.629 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -61.24 124.16 19.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.02 0.914 . . . . 0.0 110.47 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.573 HG11 HD13 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -101.82 132.95 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.177 -176.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.36 88.4 2.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.426 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.523 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 72.5 mt -130.57 -165.0 1.49 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.348 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.401 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 21.0 mttt -92.59 161.58 14.53 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -88.23 128.28 35.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.4 65.11 3.16 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 113.725 -1.579 . . . . 0.0 109.878 -160.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.93 142.8 29.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.646 -0.777 . . . . 0.0 109.864 173.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' B' ' 27' ' ' ARG . 1.0 OUTLIER -100.84 105.57 16.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.684 1.231 . . . . 0.0 111.768 -176.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.536 HG22 ' CE1' ' A' ' 14' ' ' PHE . 33.8 m -123.96 164.83 21.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.979 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.897 ' HD2' HG13 ' A' ' 4' ' ' ILE . 31.7 mtmm -123.44 139.77 53.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.598 0.714 . . . . 0.0 110.935 177.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.457 HG22 ' CE1' ' B' ' 14' ' ' PHE . 10.7 mm -111.11 143.98 19.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.816 -171.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -147.42 161.22 41.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 113.84 -1.527 . . . . 0.0 107.377 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.661 ' HB3' HG13 ' A' ' 28' ' ' VAL . 1.2 pt? -121.73 154.05 37.42 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.423 ' CG ' ' HZ1' ' A' ' 29' ' ' LYS . 35.7 mm-40 -68.51 142.49 55.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.511 0.672 . . . . 0.0 112.107 -173.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.57 153.9 30.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.957 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -124.14 147.33 48.04 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.069 0.462 . . . . 0.0 110.423 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.65 130.61 63.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.676 0.75 . . . . 0.0 110.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.0 112.15 26.88 Favored Pre-proline 0 N--CA 1.433 -1.312 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.876 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.28 173.53 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.416 2.077 . . . . 0.0 111.981 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.1 pt -95.81 155.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.31 123.78 28.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.863 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.36 115.54 28.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.28 113.67 2.39 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.55 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.86 155.51 80.41 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.551 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.21 145.21 77.72 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.474 2.116 . . . . 0.0 111.604 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.99 152.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.095 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -77.36 173.42 11.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.69 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 25.5 t -82.92 116.5 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.339 0.59 . . . . 0.0 110.354 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.73 155.49 18.54 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.924 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.94 -24.36 66.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.798 0.332 . . . . 0.0 111.672 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.425 ' N ' HD13 ' B' ' 50' ' ' ILE . 3.0 mp -69.91 -16.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.815 0.817 . . . . 0.0 109.837 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.67 132.98 36.44 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.263 174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' B' ' 52' ' ' LYS . 50.4 tptt -132.71 107.94 8.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.43 0.633 . . . . 0.0 111.228 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -87.31 136.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.34 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.843 ' HG3' ' H ' ' B' ' 55' ' ' ASP . 6.4 tpt180 55.63 -166.73 0.11 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.102 0.561 . . . . 0.0 112.015 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.843 ' H ' ' HG3' ' B' ' 54' ' ' ARG . 11.2 p-10 -108.51 -176.46 3.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.638 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.19 126.85 2.0 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.943 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.38 119.44 31.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.884 0.373 . . . . 0.0 111.06 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -82.75 150.72 26.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.368 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 43.5 tpp -116.13 154.11 30.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.313 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 74.26 -0.58 3.31 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.589 0.556 . . . . 0.0 110.767 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -85.28 5.74 29.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.269 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.93 136.66 52.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.115 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 145.85 26.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -146.73 78.15 1.49 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.675 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -145.19 157.83 43.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -153.68 138.57 17.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -121.02 77.86 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -179.74 97.52 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.499 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.2 t60 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.791 -176.663 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' B' ' 29' ' ' LYS . 11.6 mm -93.99 147.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 39.6 mt-10 -113.77 134.75 54.58 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.51 156.54 48.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 11.5 m -110.27 115.16 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.747 0.784 . . . . 0.0 110.577 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.767 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 64.7 t80 -73.62 101.45 3.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.564 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' OE1' ' HG3' ' A' ' 15' ' ' LYS . 40.2 mt-10 -108.24 119.24 38.91 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.063 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 62.73 21.13 12.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 102.73 7.68 44.33 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.367 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.2 t -120.37 142.7 34.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-O 119.588 -0.244 . . . . 0.0 110.436 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 76.1 m-85 -93.0 115.58 28.25 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.976 170.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HG3' ' OE1' ' A' ' 10' ' ' GLU . 29.1 mmtp -107.57 108.75 62.03 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 17.9 Cg_endo -60.84 167.41 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 119.979 1.028 . . . . 0.0 112.501 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.74 -6.05 23.06 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' A' ' 5' ' ' ILE . 7.9 pt20 -138.41 111.97 8.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.631 173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 12.7 tmtt? -60.91 133.25 55.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.752 -171.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.8 t -113.6 140.99 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.114 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -116.33 87.49 2.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.789 1.281 . . . . 0.0 109.047 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' A' ' 26' ' ' GLU . 76.0 mt -127.11 -158.65 0.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.162 -2.29 . . . . 0.0 110.671 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -85.67 176.75 7.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 2.0 mp0 -89.7 123.31 33.61 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.97 0.891 . . . . 0.0 109.446 168.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.041 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 69.59 64.75 2.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.395 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HG2' HD13 ' A' ' 22' ' ' LEU . 5.6 tp10 -94.4 144.53 25.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.212 -0.994 . . . . 0.0 108.887 169.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 120.76 34.4 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.568 1.175 . . . . 0.0 114.013 -167.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.2 m -138.79 154.64 26.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -115.06 140.01 49.4 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HB ' ' B' ' 5' ' ' ILE . 1.8 mt -103.73 140.97 20.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.27 -173.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -125.58 138.06 53.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.773 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp . . . . . 0 C--N 1.309 -1.192 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.472 0.653 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.98 123.65 50.52 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.023 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.45 173.73 13.33 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.585 2.19 . . . . 0.0 112.444 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 pt -116.19 164.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.42 -172.3 2.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 tp -85.48 143.02 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.45 -142.3 5.47 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.866 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.9 161.41 63.54 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.297 . . . . 0.0 111.001 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.15 -174.87 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.827 2.351 . . . . 0.0 112.536 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.56 155.71 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.734 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 p -97.0 -178.43 4.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.53 123.81 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.522 0.677 . . . . 0.0 110.892 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -103.5 179.65 4.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.16 -36.6 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.254 0.55 . . . . 0.0 111.777 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 mt -88.85 1.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.713 0.768 . . . . 0.0 110.361 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.374 -177.215 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 4' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 30' ' ' ILE . 29.7 mt -125.22 153.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -97.57 148.32 23.39 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.06 42.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 1.041 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.6 m -109.6 113.75 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.713 0.768 . . . . 0.0 110.531 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' B' ' 14' ' ' PHE . 37.5 t80 -67.47 100.87 0.9 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.84 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 92.2 mt-10 -102.46 112.59 25.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t30 63.09 13.45 6.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.24 169.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 119.71 2.36 12.98 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.886 -1.149 . . . . 0.0 112.479 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 15' ' ' LYS . 26.9 m -132.1 142.52 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.105 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 98.2 m-85 -86.85 116.31 24.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.955 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -105.84 111.15 64.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.144 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -44.93 168.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.333 -0.263 0 C-N-CA 123.126 2.55 . . . . 0.0 117.183 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.761 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -126.15 97.24 5.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.141 -2.299 . . . . 0.0 104.95 163.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER 85.53 148.38 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 O-C-N 125.717 1.886 . . . . 0.0 109.326 -167.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.41 157.95 34.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.279 -167.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.565 HG12 ' HG ' ' B' ' 22' ' ' LEU . 5.4 t -116.34 147.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.143 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -88.37 18.58 4.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.796 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.565 ' HG ' HG12 ' B' ' 20' ' ' VAL . 90.8 mt -92.29 162.86 14.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.069 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 175.0 5.91 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.105 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.6 mp0 -65.96 125.0 24.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.482 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.557 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.2 15.11 67.52 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.068 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 mm-40 -69.93 136.24 50.34 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.794 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -100.63 137.35 39.14 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.37 1.081 . . . . 0.0 112.303 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.3 m -150.12 172.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.135 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 87.0 mttt -125.04 139.23 53.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.345 0.593 . . . . 0.0 109.925 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.794 HG22 ' HB ' ' A' ' 28' ' ' VAL . 4.0 mt -140.48 149.51 21.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.551 -171.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 28' ' ' VAL . 42.3 mt . . . . . 0 C--N 1.316 -0.855 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -112.15 169.27 6.52 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.176 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.25 -166.48 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.344 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.436 ' N ' HD12 ' B' ' 39' ' ' ILE . 3.9 mp -93.66 150.45 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.931 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.11 143.34 51.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tt -134.33 132.83 39.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.91 155.44 17.19 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.1 pm0 -70.74 127.67 91.63 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.515 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 26.5 Cg_exo -62.73 160.55 32.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.063 2.509 . . . . 0.0 112.225 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.416 ' H ' HG12 ' B' ' 45' ' ' VAL . 1.5 p -63.73 138.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.855 0.836 . . . . 0.0 111.768 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -115.52 177.04 4.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.008 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 51.2 t -79.83 124.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -100.91 160.31 14.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.747 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.96 -25.9 63.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.911 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 tt . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.256 0.55 . . . . 0.0 111.395 -175.189 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.94 150.41 22.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.9 ttt -142.24 124.97 15.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.648 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.3 p -116.06 164.19 14.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -99.53 -5.49 29.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp 45.99 84.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.864 0.727 . . . . 0.0 112.439 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 139.93 42.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -142.87 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -94.09 168.93 10.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 110.905 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -149.63 118.64 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.631 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.82 126.96 29.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -98.32 167.59 10.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.505 175.939 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 122.147 0.975 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' B' ' 30' ' ' ILE . 18.0 mt -110.97 158.26 11.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.042 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HG2' ' CD ' ' B' ' 29' ' ' LYS . 44.5 mt-10 -123.47 134.61 53.89 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.44 165.98 22.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.456 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.605 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 4.8 m -110.96 121.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.408 0.623 . . . . 0.0 110.01 171.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.652 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 65.8 t80 -83.18 115.7 22.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.518 1.152 . . . . 0.0 110.677 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 61.3 mt-10 -86.7 -169.82 2.8 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.064 173.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.21 45.13 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.166 0.986 . . . . 0.0 111.829 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 122.52 5.16 8.64 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 10' ' ' GLU . 2.4 t -115.67 142.88 27.09 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.481 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 35.2 m-85 -111.72 114.89 28.19 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.846 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -119.95 116.37 32.85 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 122.407 -0.183 . . . . 0.0 111.188 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 20.0 Cg_endo -64.0 168.08 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.818 1.678 . . . . 0.0 112.088 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.65 -14.25 13.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HB2' HG23 ' A' ' 5' ' ' ILE . 63.6 mt-30 -104.24 128.52 51.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.11 -1.405 . . . . 0.0 108.871 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -71.32 140.15 50.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.739 0.781 . . . . 0.0 110.071 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 22' ' ' LEU . 6.0 p -133.17 140.94 45.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.372 -164.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -97.04 85.87 3.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.607 HD21 ' CD1' ' B' ' 9' ' ' TYR . 0.0 OUTLIER -116.97 173.92 6.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.759 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 5.1 mptp? -114.06 150.34 34.14 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.486 170.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.4 132.52 47.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.211 0.529 . . . . 0.0 111.197 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.03 51.16 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.119 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.671 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 25.3 tt0 -74.02 117.97 16.42 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 27' ' ' ARG . 28.4 ttt180 -84.97 126.49 33.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.562 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG12 HD23 ' B' ' 32' ' ' LEU . 35.5 m -132.5 166.89 27.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.25 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 11.4 mmmm -116.37 138.23 51.51 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 2.4 mm -120.84 140.58 44.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.308 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -156.05 149.92 25.17 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD21 HG12 ' B' ' 28' ' ' VAL . 44.9 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.975 0.417 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.67 151.03 43.43 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.374 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.83 173.68 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.119 1.879 . . . . 0.0 112.095 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.88 136.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 41' ' ' LEU . 20.7 t70 56.24 -158.88 0.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.18 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.512 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 pp -103.28 167.3 9.91 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.091 -0.381 . . . . 0.0 111.185 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.74 -131.91 5.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.441 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -106.79 108.69 62.35 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-O 120.652 0.263 . . . . 0.0 111.661 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 114.86 3.61 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.889 2.393 . . . . 0.0 111.408 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 46' ' ' SER . 7.6 p -102.21 158.47 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.264 0.554 . . . . 0.0 110.782 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 45' ' ' VAL . 1.2 m -100.7 162.72 12.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.788 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.83 121.48 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.704 0.764 . . . . 0.0 111.237 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -144.73 -36.77 0.31 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.253 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.76 -25.52 26.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.501 0.667 . . . . 0.0 110.756 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.04 1.69 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.005 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 0.0 110.575 -178.552 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.422 ' O ' HG12 ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 121.382 0.61 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 15.5 mm -90.48 154.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.561 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 29' ' ' LYS . 45.9 mt-10 -124.79 130.53 52.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.94 163.43 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 3.9 m -128.61 116.87 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 112.013 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -65.31 106.34 1.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.591 0.71 . . . . 0.0 110.398 175.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.611 ' HB2' ' HD3' ' B' ' 15' ' ' LYS . 34.7 mt-10 -129.95 133.79 47.04 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.887 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.91 32.32 22.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.402 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.08 -68.3 0.39 Allowed Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 117.432 -2.318 . . . . 0.0 111.92 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 4.8 m -106.21 155.93 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.153 -156.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -84.85 113.69 21.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' B' ' 10' ' ' GLU . 39.9 mtpt -97.94 113.65 64.04 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.744 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.9 Cg_endo -62.09 167.28 11.0 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.122 1.215 . . . . 0.0 111.931 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.56 -12.13 12.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -120.83 161.67 21.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.176 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -77.83 132.12 37.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.232 0.539 . . . . 0.0 112.035 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 1.8 t -132.74 144.26 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.044 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.72 87.54 1.5 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.405 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 87.9 mt -109.91 -2.66 17.05 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.452 172.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 57.6 mttp 77.17 157.77 0.19 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.506 172.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.92 133.49 55.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.102 -164.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.605 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.6 64.93 3.5 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.429 -169.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.602 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 0.0 OUTLIER -101.47 135.09 43.55 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.56 167.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -77.14 117.21 18.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.107 0.956 . . . . 0.0 111.395 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.56 HG12 HD21 ' A' ' 32' ' ' LEU . 28.2 m -130.2 156.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.694 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CD ' ' HG2' ' A' ' 6' ' ' GLU . 33.2 mmtp -109.36 134.75 51.43 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.321 0.581 . . . . 0.0 110.487 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 5' ' ' ILE . 3.5 mm -112.54 143.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.987 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 160.51 39.77 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.319 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.438 HD23 HG12 ' A' ' 28' ' ' VAL . 83.5 mt . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.734 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' B' ' 37' ' ' GLU . 7.1 pt-20 -50.6 110.93 1.91 Allowed Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 123.558 0.536 . . . . 0.0 111.676 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.45 172.89 3.95 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.334 2.022 . . . . 0.0 111.851 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.12 150.0 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -91.44 141.24 28.96 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.56 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.7 mm? -61.16 116.82 4.86 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.326 0.391 . . . . 0.0 110.779 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.63 114.03 4.55 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.498 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.4 pm0 -75.56 147.92 82.34 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 114.621 -0.789 . . . . 0.0 110.37 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.14 130.11 29.51 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.304 2.003 . . . . 0.0 111.833 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -77.99 150.32 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -101.04 169.74 8.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.987 0.423 . . . . 0.0 110.87 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 135.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.51 149.36 22.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -28.73 43.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.682 0.753 . . . . 0.0 109.287 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 pt . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.595 177.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -95.95 134.33 39.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.9 ttt -104.13 146.82 28.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.6 t 75.73 128.62 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 O-C-N 124.218 0.949 . . . . 0.0 110.994 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -97.52 1.59 49.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.057 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp 53.35 83.72 0.06 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.507 0.67 . . . . 0.0 111.417 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 159.71 15.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.006 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -85.72 35.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.562 0.696 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.79 72.4 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.348 0.594 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -77.78 123.48 26.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -100.92 126.58 47.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.836 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.81 136.51 53.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.478 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.023 177.736 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.909 HD13 HG21 ' A' ' 20' ' ' VAL . 1.4 mt -99.2 145.98 9.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -101.33 132.86 46.67 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.15 155.85 49.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.324 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.33 117.06 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.416 0.626 . . . . 0.0 110.346 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 77.5 t80 -73.54 119.33 17.62 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.708 176.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 41.3 tt0 -144.96 130.19 18.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.424 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 t30 70.77 22.76 4.72 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.829 0.705 . . . . 0.0 110.802 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 83.04 17.96 66.14 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.656 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 14.6 t -122.68 149.59 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 82.5 m-85 -97.69 115.28 27.64 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 166.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.0 mmmt -116.38 107.91 46.38 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.7 Cg_endo -59.8 167.89 6.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.213 1.275 . . . . 0.0 112.825 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.66 -8.6 20.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.211 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.0 pm0 -138.37 140.05 39.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.083 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 7.9 tmtt? -76.94 132.4 39.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.558 0.694 . . . . 0.0 110.551 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 5' ' ' ILE . 2.9 t -122.49 141.43 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.195 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -100.74 87.94 3.46 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 122.702 1.239 . . . . 0.0 108.148 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' B' ' 9' ' ' TYR . 69.0 mt -111.25 -175.43 2.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.383 -2.189 . . . . 0.0 110.61 174.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.975 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 47.9 mtpt -93.41 165.86 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.559 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.35 129.77 34.79 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.644 0.735 . . . . 0.0 109.589 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.157 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.74 64.65 3.56 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.738 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.975 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 1.9 mm-40 -89.93 150.24 22.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -0.629 . . . . 0.0 110.463 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -89.75 104.48 17.04 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.929 1.347 . . . . 0.0 112.527 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.611 HG12 HD13 ' B' ' 32' ' ' LEU . 35.3 m -126.99 154.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.41 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.911 ' HD3' HG13 ' B' ' 4' ' ' ILE . 54.8 mttm -111.56 144.68 40.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.516 HG21 ' CE1' ' A' ' 14' ' ' PHE . 11.8 mm -104.36 133.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.945 0.878 . . . . 0.0 109.234 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -140.69 161.28 38.13 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' B' ' 28' ' ' VAL . 6.8 mp . . . . . 0 C--N 1.302 -1.477 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.9 -166.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.043 0.449 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -118.03 85.0 22.65 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.937 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -90.71 -154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.417 2.744 . . . . 0.0 110.278 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mt -95.79 139.1 19.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.99 116.37 30.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.557 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.2 pt? -86.24 128.52 34.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.05 114.26 1.24 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.981 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 124.39 30.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.46 125.1 14.37 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.81 2.34 . . . . 0.0 112.266 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.12 148.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.348 0.594 . . . . 0.0 110.863 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.9 m -101.02 173.99 6.22 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.277 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.32 147.8 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.76 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 24.2 mt-10 -86.93 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.342 . . . . 0.0 111.297 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -86.42 -31.35 21.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.693 0.758 . . . . 0.0 109.363 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 pt -84.29 12.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.423 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 41.4 tttp . . . . . 0 C--N 1.326 -0.448 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.911 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 120.789 0.328 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 pt -108.85 134.21 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 19.8 mp0 -86.08 142.65 28.56 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.532 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -135.05 164.38 27.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.163 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 1.157 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 8.5 m -122.48 130.81 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.276 0.56 . . . . 0.0 110.819 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 91.8 t80 -72.05 112.76 8.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.08 1.419 . . . . 0.0 111.55 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 1.038 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 10.6 tp10 -87.81 -176.48 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.241 -2.254 . . . . 0.0 106.919 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.445 ' H ' ' HG3' ' B' ' 10' ' ' GLU . 1.2 t-20 -66.86 61.28 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.266 1.031 . . . . 0.0 111.93 -172.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 109.31 8.25 27.33 Favored Glycine 0 C--N 1.299 -1.482 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.023 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 1.038 ' HB ' ' HB3' ' B' ' 10' ' ' GLU . 2.5 t -118.75 156.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 114.769 -0.716 . . . . 0.0 111.419 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 71.1 m-85 -118.37 115.15 24.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 161.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.581 ' HE3' ' HG2' ' B' ' 10' ' ' GLU . 98.2 mttt -108.48 117.49 54.31 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.638 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 26.1 Cg_endo -64.43 168.73 12.31 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.109 1.206 . . . . 0.0 111.701 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.723 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -110.05 -10.46 14.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -101.67 155.41 18.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.105 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -74.99 141.77 43.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.655 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.462 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.0 t -118.82 146.03 24.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.317 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -126.09 15.27 7.89 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.187 0.994 . . . . 0.0 109.454 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.562 HD13 ' HG2' ' B' ' 26' ' ' GLU . 94.1 mt -83.46 -172.79 4.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.357 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -128.28 177.88 6.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.635 0.255 . . . . 0.0 111.016 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 2.5 mp0 -66.08 140.36 58.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.04 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 16.79 70.73 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.606 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.562 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.3 tp10 -79.8 126.2 30.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' B' ' 27' ' ' ARG . 15.3 mmm180 -85.0 129.57 34.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.21 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.712 HG12 ' HG ' ' A' ' 32' ' ' LEU . 30.2 m -142.0 166.36 16.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.724 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.419 ' HD3' HG13 ' A' ' 4' ' ' ILE . 41.8 mttp -116.58 145.21 43.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.433 HG21 ' CE1' ' B' ' 14' ' ' PHE . 6.6 mm -117.45 143.97 26.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.685 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' A' ' 4' ' ' ILE . 29.6 tptp -154.55 128.2 8.66 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.569 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.611 HD13 HG12 ' A' ' 28' ' ' VAL . 3.4 mm? . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -151.36 126.41 4.73 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.971 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 174.13 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.418 2.079 . . . . 0.0 112.75 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 pt -87.41 160.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.15 135.53 36.6 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.16 164.65 33.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.871 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.79 -156.44 22.8 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.41 127.45 15.6 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.698 0.285 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.93 117.48 5.06 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.854 2.369 . . . . 0.0 112.726 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -124.72 152.43 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.54 149.4 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.32 0.581 . . . . 0.0 111.471 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.78 150.16 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.326 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.11 115.09 24.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.225 1.012 . . . . 0.0 112.707 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -86.68 -26.62 24.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.584 171.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.702 -171.021 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m . . . . . 0 CA--C 1.533 0.311 0 CA-C-O 121.229 0.538 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -110.1 134.9 51.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 47.3 ttm -79.36 128.73 33.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -66.83 106.9 2.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.305 0.574 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -99.52 3.44 45.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.368 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 61.48 179.11 0.12 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.528 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.23 144.25 50.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -78.78 88.84 4.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.638 0.732 . . . . 0.0 110.173 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -88.12 117.43 27.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -127.29 127.5 44.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.601 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' B' ' 68' ' ' HIS . 25.7 t-80 -87.13 -103.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 67' ' ' HIS . 44.9 t-80 156.65 146.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.402 173.597 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.82 HG13 ' HB ' ' B' ' 30' ' ' ILE . 3.7 pt -90.52 137.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -99.45 142.38 31.0 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.928 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.21 164.31 28.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.168 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 11.8 m -120.0 126.11 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.665 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.8 t80 -94.65 111.28 23.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.057 -177.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 5.9 pt-20 -130.67 141.29 50.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.785 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.8 t30 60.83 21.4 11.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 87.86 13.08 65.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.863 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 12.5 t -119.53 143.75 30.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.741 -0.23 . . . . 0.0 110.633 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 49.0 m-85 -103.41 115.62 30.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 166.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.67 114.87 61.4 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.7 Cg_endo -62.81 168.69 9.9 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 120.634 0.89 . . . . 0.0 111.939 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -102.43 -4.46 25.42 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -128.26 127.71 43.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.169 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.53 131.27 40.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -124.2 137.74 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.647 0.737 . . . . 0.0 110.628 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.42 87.82 5.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.38 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.5 mt -121.54 -171.94 2.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.073 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -98.7 -176.18 3.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.956 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 5.3 mp0 -89.22 138.46 31.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.3 0.571 . . . . 0.0 110.162 171.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.747 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.3 65.25 3.05 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.378 -168.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 9.1 tp10 -93.27 128.24 39.18 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.635 -0.783 . . . . 0.0 109.344 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -81.62 114.95 20.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.71 1.243 . . . . 0.0 111.569 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 HD23 ' B' ' 32' ' ' LEU . 35.2 m -131.5 164.23 35.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.059 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HD3' HG13 ' B' ' 4' ' ' ILE . 52.3 mttm -119.92 143.02 48.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.23 0.538 . . . . 0.0 110.08 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.513 HD12 HD12 ' B' ' 30' ' ' ILE . 3.7 mm -110.65 140.46 29.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.144 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -147.4 165.82 29.06 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.667 0.746 . . . . 0.0 110.294 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.464 HD21 HD22 ' B' ' 22' ' ' LEU . 74.9 mt . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.3 mm-40 -85.83 131.47 47.06 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.178 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.6 Cg_exo -79.88 -166.85 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.09 2.527 . . . . 0.0 111.854 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 pt -101.39 168.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.306 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.4 142.42 24.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.991 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.11 153.98 40.67 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.98 -143.29 14.5 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.926 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.0 pt-20 -111.78 147.06 36.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 122.203 0.201 . . . . 0.0 111.001 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 20.0 Cg_exo -67.33 170.96 12.37 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.118 2.545 . . . . 0.0 111.382 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.92 153.29 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 110.158 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p -122.52 162.1 22.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 111.608 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.6 t -131.17 135.57 59.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.669 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.13 133.62 52.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 0.0 111.477 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.86 -21.13 40.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.428 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.63 -13.66 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.705 0.764 . . . . 0.0 110.009 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 30.1 ttmt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.87 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.477 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.099 0 CA-C-O 120.847 0.356 . . . . 0.0 110.058 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 11.2 mt -104.2 144.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -105.95 130.75 53.83 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.379 0.609 . . . . 0.0 110.422 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.48 154.92 46.78 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.623 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.747 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 3.6 m -110.97 115.37 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 121.507 0.67 . . . . 0.0 110.926 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 47.4 t80 -75.23 111.46 10.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.274 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.9 tt0 -120.13 116.83 26.45 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.694 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.27 19.59 11.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.876 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 109.59 5.57 29.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.215 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 3.5 t -118.06 142.43 32.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.794 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 74.0 m-85 -97.97 116.63 30.57 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.109 -0.637 . . . . 0.0 109.621 171.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.727 ' HE3' HG11 ' B' ' 13' ' ' VAL . 33.8 mmtp -117.54 111.49 39.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.7 Cg_endo -60.49 167.97 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.299 1.333 . . . . 0.0 111.994 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.695 HD11 HG13 ' B' ' 8' ' ' VAL . 6.7 mp -111.51 -21.92 11.53 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -115.46 3.72 14.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.053 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 16' ' ' PRO . 54.8 mtmt 55.65 167.71 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.263 -1.79 . . . . 0.0 113.534 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' B' ' 22' ' ' LEU . 3.5 t -144.12 154.22 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.788 -175.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -136.7 86.81 2.24 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 123.139 1.447 . . . . 0.0 109.605 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' B' ' 20' ' ' VAL . 0.4 OUTLIER -132.52 104.68 6.81 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 112.132 -2.303 . . . . 0.0 110.196 166.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.727 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 96.0 mttt 33.95 -163.07 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 114.4 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -115.47 127.12 55.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.697 163.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.615 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 53.96 65.19 3.63 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.497 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.727 ' HG2' ' HD2' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -99.03 145.52 27.01 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 167.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -95.71 123.33 39.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.477 1.132 . . . . 0.0 112.391 -168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.3 m -131.04 174.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.973 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -112.91 142.22 45.83 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.82 ' HB ' HG13 ' A' ' 5' ' ' ILE . 4.3 mm -119.16 141.08 40.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.224 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.404 ' HD3' HG22 ' A' ' 4' ' ' ILE . 56.5 tptt -143.66 125.91 15.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.492 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.758 HD23 HG12 ' A' ' 28' ' ' VAL . 27.9 mt . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -111.47 119.64 44.63 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 120.917 0.389 . . . . 0.0 111.136 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.32 -176.52 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.96 2.44 . . . . 0.0 111.839 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.4 HD12 ' O ' ' B' ' 39' ' ' ILE . 1.8 pp -103.99 152.59 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.496 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.08 103.99 6.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 50.0 tp -135.04 139.09 44.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.86 114.25 2.58 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' B' ' 44' ' ' PRO . 45.9 mt-10 -92.26 162.26 30.62 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.739 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 43' ' ' GLU . 76.7 Cg_exo -49.8 142.18 26.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.42 2.747 . . . . 0.0 113.968 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 164.74 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.6 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -78.77 164.08 24.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.234 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.57 164.76 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.519 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.45 110.56 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.41 -29.61 22.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.373 0.606 . . . . 0.0 110.386 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.391 -178.119 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -130.02 146.39 51.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.825 0.345 . . . . 0.0 110.336 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.3 mtt -94.85 178.36 5.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.046 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.7 t -135.04 122.93 22.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -94.22 -6.43 44.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.86 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.304 1.002 . . . . 0.0 112.132 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.43 115.72 16.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 111.087 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -99.24 110.55 23.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.377 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.83 116.93 20.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.831 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 77.19 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.258 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -96.23 94.12 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -81.99 129.62 34.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.697 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.427 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 18' ' ' GLN . 16.9 mt -98.77 155.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 17' ' ' LEU . 7.0 mp0 -113.1 144.14 43.15 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -144.14 161.04 39.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.454 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.892 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.6 m -121.95 115.22 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.679 0.752 . . . . 0.0 110.493 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 63.8 t80 -75.2 114.74 14.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.737 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 5.5 pt-20 -105.64 132.24 52.03 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 164.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.493 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 34.3 p-10 -74.0 63.55 0.95 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -149.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . -142.96 -7.08 0.62 Allowed Glycine 0 C--N 1.27 -3.094 0 CA-C-N 110.899 -2.864 . . . . 0.0 107.743 149.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 19.0 m -160.76 150.11 5.36 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -155.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.6 m-85 -99.48 116.52 31.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.701 ' HD3' ' HG2' ' A' ' 10' ' ' GLU . 23.3 mtpp -109.18 111.61 60.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.402 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.7 Cg_endo -53.8 165.12 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.592 1.528 . . . . 0.0 113.978 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 6' ' ' GLU . 93.1 mt -93.06 -66.43 0.92 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.436 165.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.51 ' HB2' HG23 ' A' ' 5' ' ' ILE . 20.3 mt-30 -61.33 132.63 54.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 112.982 -1.917 . . . . 0.0 108.636 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -65.67 139.25 58.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.571 0.701 . . . . 0.0 110.436 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 22' ' ' LEU . 2.4 p -106.56 146.82 12.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.575 -167.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -133.85 13.76 3.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.099 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 20' ' ' VAL . 86.7 mt -72.93 -176.63 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.853 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 14.8 pttp -125.18 165.41 18.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.192 -174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 3.8 mp0 -66.47 143.29 57.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.694 0.759 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.52 65.47 3.39 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.299 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.5 tp10 -106.82 124.39 49.54 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.06 110.36 21.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 123.499 1.619 . . . . 0.0 113.266 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.955 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.8 m -122.81 149.35 26.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.986 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD3' ' HG3' ' B' ' 6' ' ' GLU . 47.0 mmtm -103.3 138.73 39.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mm -92.6 130.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 4' ' ' ILE . 9.7 tttt -136.45 134.67 37.92 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.171 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD21 HG12 ' B' ' 28' ' ' VAL . 89.5 mt . . . . . 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.396 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.048 0.451 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.04 159.42 65.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.237 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.78 178.21 7.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.709 2.273 . . . . 0.0 112.373 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.1 pt -80.01 174.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.78 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.36 121.57 14.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.556 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -131.95 154.4 49.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.706 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.79 131.83 2.07 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.337 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.26 135.77 44.0 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.884 0.374 . . . . 0.0 111.014 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.3 -173.8 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.047 2.498 . . . . 0.0 112.565 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.07 153.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.687 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -106.09 -171.77 1.96 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.13 157.52 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.989 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.704 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.5 mp0 -61.89 128.0 34.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 110.548 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.18 -35.19 66.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.283 0.563 . . . . 0.0 111.05 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 tt -80.43 -3.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.769 . . . . 0.0 110.742 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 64.7 tttt . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.472 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.423 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.581 ' HB ' ' HG3' ' B' ' 18' ' ' GLN . 19.6 pt -101.21 134.1 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.499 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -87.4 138.98 31.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.227 0.537 . . . . 0.0 111.079 -175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.81 152.15 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.308 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.608 HG13 HD11 ' B' ' 17' ' ' LEU . 3.6 m -115.33 118.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.714 0.769 . . . . 0.0 110.621 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.738 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 45.6 t80 -70.9 131.42 43.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.72 174.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.523 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 35.1 tt0 -151.75 129.76 11.81 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.469 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 30.6 t30 66.51 20.23 10.87 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.623 0.577 . . . . 0.0 111.907 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' OH ' ' B' ' 9' ' ' TYR . . . 95.26 10.49 57.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.008 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.2 t -122.85 148.51 26.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 92.8 m-85 -102.11 114.38 28.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' B' ' 15' ' ' LYS . 48.8 mtmt -110.49 116.55 52.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 31.9 Cg_endo -65.55 168.14 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.233 1.288 . . . . 0.0 112.317 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.608 HD11 HG13 ' B' ' 8' ' ' VAL . 5.6 mp -115.13 -5.59 12.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.581 ' HG3' ' HB ' ' B' ' 5' ' ' ILE . 25.0 mm-40 -94.76 -1.58 52.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.544 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 34.27 123.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 O-C-N 125.311 1.632 . . . . 0.0 114.244 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.677 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -125.42 139.92 49.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.599 -164.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.84 88.13 2.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.975 170.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' B' ' 20' ' ' VAL . 71.3 mt -110.81 -161.97 0.78 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 112.639 -2.073 . . . . 0.0 109.967 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -89.27 -174.69 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 35.3 mt-10 -106.3 123.56 48.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 109.653 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.892 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.04 24.53 44.25 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.6 tp10 -63.55 132.9 52.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.029 0.531 . . . . 0.0 110.831 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -83.25 113.22 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.847 0.832 . . . . 0.0 111.733 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.8 m -138.41 161.5 30.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.969 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HG2' ' A' ' 6' ' ' GLU . 33.0 mmtp -115.66 144.51 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.178 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -118.34 126.22 74.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.355 0.598 . . . . 0.0 110.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -134.08 124.65 26.52 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.638 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.955 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.9 mp . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.15 156.36 35.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 122.616 0.367 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -89.03 -179.32 2.07 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.291 2.661 . . . . 0.0 113.212 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.21 169.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.844 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -125.89 -173.59 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.603 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.5 pt? -125.33 172.44 9.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.42 -150.05 6.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.035 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.777 ' HB2' ' HD2' ' B' ' 44' ' ' PRO . 8.3 pt-20 -98.27 175.07 2.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.777 ' HD2' ' HB2' ' B' ' 43' ' ' GLU . 37.7 Cg_endo -67.18 -162.58 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.266 1.977 . . . . 0.0 111.9 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.41 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -91.82 173.01 8.08 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.89 140.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -169.4 2.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.2 -27.51 63.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.437 ' H ' HD12 ' B' ' 50' ' ' ILE . 3.6 mp . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 121.214 0.531 . . . . 0.0 110.321 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -91.95 133.87 35.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.3 ttt -132.82 137.92 46.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m 67.52 121.01 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.384 1.053 . . . . 0.0 112.386 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -103.44 0.54 31.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.634 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp 52.45 79.74 0.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.795 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.0 136.36 48.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.31 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -89.16 72.53 8.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.672 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.16 128.04 34.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.723 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -93.14 138.46 31.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.061 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -77.56 -156.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.606 174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -145.47 89.05 1.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.635 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.508 177.401 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.493 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.328 0.585 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 18' ' ' GLN . 24.8 mm -100.93 156.12 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 28.3 mt-10 -116.0 145.82 42.65 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -147.55 166.27 27.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.101 0.477 . . . . 0.0 110.891 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.04 122.6 65.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.935 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 90.2 t80 -78.33 99.46 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.394 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 32.9 mt-10 -120.55 135.79 54.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.968 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 21.0 m120 63.25 21.69 12.96 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.587 0.555 . . . . 0.0 111.496 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 86.9 11.48 70.29 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.131 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 16.1 t -125.14 148.67 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 83.6 m-85 -96.36 114.87 26.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.194 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 29.9 mtmt -112.5 114.07 50.43 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.74 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 Cg_endo -63.15 168.77 10.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.449 1.433 . . . . 0.0 112.981 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -108.33 -20.62 13.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HB2' HG23 ' A' ' 5' ' ' ILE . 42.8 mt-30 -99.6 143.34 29.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.965 -1.471 . . . . 0.0 109.554 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -84.81 124.38 31.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.265 0.555 . . . . 0.0 109.674 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.3 t -132.47 134.87 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.72 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.36 88.63 4.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.365 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.8 mt -113.05 171.56 7.47 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.093 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -107.39 158.85 16.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 8.1 mp0 -67.24 114.84 6.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.374 0.606 . . . . 0.0 110.199 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.88 25.92 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.058 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 3.9 mm-40 -74.11 133.96 42.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -100.82 121.88 42.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.968 1.842 . . . . 0.0 113.417 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD23 ' B' ' 32' ' ' LEU . 34.7 m -132.93 160.28 42.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.156 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 65.6 mttm -117.26 140.78 49.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.452 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' B' ' 7' ' ' ALA . 1.3 mm -116.57 149.44 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.781 -175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -156.94 164.56 37.89 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 164.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HD13 ' B' ' 22' ' ' LEU . 9.2 mt . . . . . 0 C--N 1.306 -1.32 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 mt-10 -66.75 120.94 75.09 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-O 120.721 0.296 . . . . 0.0 110.45 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 21.1 Cg_exo -66.35 -175.16 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.383 2.722 . . . . 0.0 112.933 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 pt -70.27 165.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.77 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.42 104.53 10.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.587 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 2.8 pp -84.1 176.39 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.402 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.95 -125.21 1.91 Allowed Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.787 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -112.27 127.93 26.19 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.543 0.211 . . . . 0.0 111.142 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.12 173.35 14.05 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.539 2.159 . . . . 0.0 111.433 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' SER . 14.4 p -131.21 166.58 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.217 0.532 . . . . 0.0 110.768 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' VAL . 17.6 m -88.3 170.06 11.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.66 3.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.304 0.574 . . . . 0.0 111.528 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.59 104.03 9.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.464 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -87.28 -30.26 21.01 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.5 tt -69.75 -7.25 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.621 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 tttt . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.831 177.514 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.471 ' CB ' ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 15.0 mt -109.2 154.31 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 164.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -109.21 135.99 49.41 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.515 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.96 164.24 30.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.707 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -126.49 124.93 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.472 0.653 . . . . 0.0 111.369 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 20.2 t80 -62.15 112.42 2.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.86 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.35 128.83 40.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 120.943 0.401 . . . . 0.0 110.712 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.22 34.32 11.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.794 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.04 -69.33 0.26 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 117.653 -2.213 . . . . 0.0 111.634 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -93.37 154.33 3.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.997 -158.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -88.23 115.85 26.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -105.67 120.9 47.76 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.583 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 11.3 Cg_endo -58.6 168.71 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.453 1.435 . . . . 0.0 112.391 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.707 HD11 HG13 ' B' ' 8' ' ' VAL . 7.0 mp -102.27 -11.25 18.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' B' ' 16' ' ' PRO . 13.3 pm0 -133.17 143.52 49.26 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.496 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.42 149.25 39.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 112.138 -173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.451 HG12 ' H ' ' B' ' 22' ' ' LEU . 11.3 t -123.76 150.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.353 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.02 25.14 3.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.079 0.942 . . . . 0.0 109.878 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.658 HD13 HD21 ' A' ' 32' ' ' LEU . 97.9 mt -78.59 -166.23 0.84 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.694 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 10.1 mtmp? -97.1 162.32 13.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.5 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.4 mp0 -74.55 136.54 42.11 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.337 0.589 . . . . 0.0 109.416 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.6 65.4 3.2 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.416 -165.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.694 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 1.7 mm-40 -96.34 148.8 22.39 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.618 -0.791 . . . . 0.0 109.551 170.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 27' ' ' ARG . 2.1 tpt180 -98.02 105.66 17.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.652 1.215 . . . . 0.0 112.167 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.0 m -124.68 156.87 33.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 113.045 -1.888 . . . . 0.0 111.408 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.583 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 45.0 mttp -120.79 143.46 48.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.201 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.476 HG23 HD13 ' A' ' 30' ' ' ILE . 17.1 mt -130.02 147.55 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.884 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -156.88 165.13 37.06 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.877 HD23 HG12 ' A' ' 28' ' ' VAL . 24.2 mt . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.414 HG12 ' HD2' ' B' ' 38' ' ' PRO . 8.6 t . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' B' ' 38' ' ' PRO . 45.3 mt-10 -81.21 -57.18 0.57 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' B' ' 37' ' ' GLU . 37.9 Cg_endo -65.12 174.6 4.71 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.035 1.823 . . . . 0.0 113.184 -173.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 pp -101.97 172.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.373 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.66 129.61 39.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.245 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 49.3 tp 68.37 112.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.749 0.656 . . . . 0.0 112.04 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.91 114.53 0.49 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.813 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 10.9 mp0 -108.84 130.0 23.25 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 6.0 Cg_exo -78.78 114.38 3.43 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.704 2.269 . . . . 0.0 111.508 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.9 156.6 6.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.185 0.517 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -83.2 160.35 21.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.802 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.85 142.35 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.202 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.0 105.19 4.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.08 0.943 . . . . 0.0 110.879 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.78 -27.73 20.94 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.147 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.525 -172.809 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -124.44 139.99 53.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.584 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.19 31.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -73.73 152.03 40.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.063 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 11.5 m -93.51 -5.79 48.27 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.075 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 61' ' ' SER . 2.9 pp 46.63 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.032 1.333 . . . . 0.0 114.539 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -119.86 111.74 18.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.347 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -135.4 110.33 8.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.346 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.33 151.3 48.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -75.85 99.64 4.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.735 0.779 . . . . 0.0 110.484 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -84.54 82.17 8.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.613 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -138.54 112.37 8.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.096 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.265 0 CA-C-O 121.062 0.458 . . . . 0.0 111.754 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.56 169.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 164.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' HD12 ' A' ' 17' ' ' LEU . 37.0 mt-10 -103.85 158.45 16.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB2' HD11 ' B' ' 30' ' ' ILE . . . -150.68 154.4 37.38 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 31.1 m -110.08 116.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.841 0.829 . . . . 0.0 110.329 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 57.1 t80 -79.98 102.91 9.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.644 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.55 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.4 pt-20 -118.48 136.95 53.51 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.158 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 63.5 t30 65.44 9.25 5.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.836 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.537 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 96.5 12.51 50.83 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.905 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.4 m -124.52 142.67 40.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.371 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 93.5 m-85 -90.79 116.41 28.62 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.652 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.18 111.82 61.65 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 41.9 Cg_exo -46.18 169.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.045 2.496 . . . . 0.0 115.357 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.923 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 63.3 mt -107.02 113.79 27.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 166.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.923 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 1.1 pp0? 77.11 143.21 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 127.99 2.516 . . . . 0.0 111.862 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -60.64 127.83 33.62 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.172 -172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 5' ' ' ILE . 14.7 p -127.26 146.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.652 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.91 86.59 2.75 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.321 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.526 ' HB2' ' CE2' ' B' ' 9' ' ' TYR . 67.3 mt -103.45 -176.56 3.12 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.51 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.47 148.83 26.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.41 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 12.4 pt-20 -82.74 121.56 27.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.16 14.97 31.87 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.823 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.84 116.69 17.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.37 119.58 27.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.095 0.95 . . . . 0.0 110.415 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.2 161.15 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.228 -168.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -118.56 134.97 54.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.957 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.742 HG12 HG23 ' B' ' 30' ' ' ILE . 9.8 mt -133.44 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.694 -170.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.66 165.51 27.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.638 172.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.313 -0.999 0 O-C-N 123.445 0.466 . . . . 0.0 111.464 -166.68 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.035 0.445 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -91.03 130.06 41.69 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.588 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 174.06 12.35 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.302 2.001 . . . . 0.0 112.083 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -89.31 150.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.836 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.59 135.56 53.22 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.13 176.11 9.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 111.253 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.29 155.26 16.45 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -67.23 140.79 95.69 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.44 -175.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -63.17 119.73 6.92 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.476 2.117 . . . . 0.0 111.363 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.45 148.03 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.512 0.672 . . . . 0.0 111.32 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 67.2 m -92.98 -171.84 2.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.176 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 46' ' ' SER . 25.0 t 68.37 139.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 111.67 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -93.6 113.51 25.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.7 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.45 -26.28 26.42 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.517 0.675 . . . . 0.0 109.47 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mt -80.33 -15.21 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' NZ ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.002 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.422 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.27 148.59 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.556 ' HB2' HD13 ' B' ' 17' ' ' LEU . 2.4 mp0 -121.81 145.78 47.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -153.47 165.17 36.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.61 0.243 . . . . 0.0 111.191 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -117.22 122.62 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 69.9 t80 -84.27 102.92 13.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.196 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.42 125.6 50.29 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.741 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 63.34 21.26 12.71 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.012 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.692 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 101.49 4.93 52.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.115 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.6 t -119.69 142.64 34.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.081 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -98.23 115.59 28.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -102.17 113.2 65.95 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 38.6 Cg_exo -56.86 169.72 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.63 1.553 . . . . 0.0 113.041 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 6' ' ' GLU . 7.8 mp -83.53 -74.69 0.36 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.782 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -84.69 151.82 24.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -67.95 137.97 55.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.539 . . . . 0.0 111.507 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' HG ' ' B' ' 22' ' ' LEU . 2.5 t -122.1 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.597 177.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -110.65 87.81 2.62 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 123.163 1.458 . . . . 0.0 109.012 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 92.0 mt -111.7 -172.84 2.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.044 -2.344 . . . . 0.0 110.096 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.738 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 92.3 mttt -82.19 159.86 23.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.7 mp0 -72.97 126.31 29.66 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.57 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 60.46 65.59 3.25 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.565 -165.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.738 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 0.7 OUTLIER -96.23 149.97 21.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.478 -0.861 . . . . 0.0 108.97 165.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -104.42 131.35 51.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.451 0.644 . . . . 0.0 111.198 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.2 m -142.15 164.79 17.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.252 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -119.59 134.47 55.21 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.31 0.576 . . . . 0.0 109.717 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 30' ' ' ILE . 3.8 mt -118.39 147.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.581 -172.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 4' ' ' ILE . 3.0 ptpp? -155.6 166.19 34.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.441 0.638 . . . . 0.0 110.648 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.437 ' N ' HD22 ' B' ' 32' ' ' LEU . 3.2 mm? . . . . . 0 C--N 1.309 -1.173 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.284 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 5.5 pt-20 -77.7 143.75 67.92 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.285 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 11.6 Cg_exo -71.73 -156.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.818 3.012 . . . . 0.0 114.191 -170.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.34 178.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.628 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -92.06 129.67 37.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.502 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.9 144.65 38.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.083 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 -145.27 11.35 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 7.2 pt-20 -124.02 122.24 26.24 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 120.784 0.326 . . . . 0.0 110.692 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 38.9 Cg_exo -61.83 128.38 24.22 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.571 2.181 . . . . 0.0 111.816 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.06 150.77 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.816 0.817 . . . . 0.0 111.444 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -106.12 -176.52 3.1 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.219 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.81 141.76 17.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.552 ' HB2' HG22 ' B' ' 50' ' ' ILE . 1.6 pm0 -66.76 129.76 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.446 0.641 . . . . 0.0 111.628 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.64 -25.08 44.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.423 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' B' ' 48' ' ' GLU . 13.7 tt . . . . . 0 CA--C 1.537 0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -82.11 154.72 25.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.033 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -144.6 154.75 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.241 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -79.74 133.61 36.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 56.4 p -82.85 14.2 3.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.575 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.9 103.08 0.41 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -101.89 155.46 18.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.932 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -84.76 100.26 11.4 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -125.93 135.12 51.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.978 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -129.8 153.4 48.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.296 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -147.52 130.39 16.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -133.66 140.08 46.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.558 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.568 175.793 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.5 mp . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 30' ' ' ILE . 11.7 mt -131.2 150.84 34.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -100.99 126.44 47.66 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.82 166.53 18.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.522 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.26 114.27 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.465 0.65 . . . . 0.0 110.131 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 68.3 t80 -67.06 119.44 12.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 22.7 tt0 -148.2 142.57 26.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.395 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.45 18.03 10.76 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 0.0 111.458 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.506 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 83.43 18.99 63.06 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.819 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 11.6 t -129.09 154.66 40.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 C-N-CA 122.858 0.463 . . . . 0.0 110.048 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.2 m-85 -97.84 115.11 27.42 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.309 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 41.6 mtmt -109.74 113.08 57.99 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.478 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 31.4 Cg_exo -56.87 166.28 4.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.171 1.248 . . . . 0.0 113.593 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.21 -68.5 0.79 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 112.069 -2.332 . . . . 0.0 105.405 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 5' ' ' ILE . 57.9 mt-30 -60.04 144.89 48.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.467 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -68.74 149.62 48.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.143 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' LEU . 3.4 p -123.6 155.83 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 122.162 0.982 . . . . 0.0 111.397 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.83 12.63 11.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.834 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.711 HD13 HD21 ' B' ' 32' ' ' LEU . 97.0 mt -90.57 -174.83 4.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.368 -172.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -92.93 -172.96 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.25 -169.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.678 ' HB3' ' H ' ' B' ' 11' ' ' ASN . 0.0 OUTLIER -93.15 -169.89 2.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 164.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . -21.95 71.66 0.0 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 122.847 1.248 . . . . 0.0 114.686 -152.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 44.3 tt0 -96.65 139.78 32.22 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 111.956 -2.122 . . . . 0.0 108.105 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -93.69 128.44 39.88 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.755 0.788 . . . . 0.0 112.354 -166.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' B' ' 32' ' ' LEU . 16.5 m -145.74 171.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.72 -173.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 58.7 mttm -128.45 138.84 52.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.822 HG22 ' HB ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -119.14 134.32 63.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.0 -171.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.623 ' HG2' HG22 ' B' ' 4' ' ' ILE . 51.9 mttp -110.24 148.92 30.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.029 0.442 . . . . 0.0 110.075 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD13 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.843 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.2 pt-20 -63.76 148.01 95.12 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 122.189 0.196 . . . . 0.0 110.877 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 23.2 Cg_exo -65.53 -169.46 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.197 2.598 . . . . 0.0 113.741 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.9 mt -96.51 154.29 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.09 -153.7 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.5 tp -69.47 147.67 50.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.91 -113.62 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.868 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.2 pm0 -63.99 141.64 98.07 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.286 -0.457 . . . . 0.0 111.196 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 14.8 Cg_exo -68.32 157.11 63.22 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.824 2.349 . . . . 0.0 112.592 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.05 149.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.786 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -117.51 -170.94 1.95 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.862 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.32 147.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.94 169.8 17.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 111.785 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.27 -25.18 62.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.8 -13.37 17.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp . . . . . 0 C--N 1.319 -0.73 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.737 -177.862 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.623 HG22 ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 121.039 0.447 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.831 HD11 HD12 ' B' ' 22' ' ' LEU . 25.1 mt -98.72 160.17 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 40.6 mt-10 -125.61 136.94 53.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -151.07 168.37 24.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.845 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.665 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.5 m -128.19 137.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.142 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.574 ' H ' ' HD1' ' B' ' 9' ' ' TYR . 2.8 m-85 -58.05 156.73 8.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.084 0.945 . . . . 0.0 112.075 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' B' ' 13' ' ' VAL . 16.2 tp10 -144.29 98.05 3.14 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.678 ' H ' ' HB3' ' A' ' 24' ' ' GLU . 1.9 t30 56.14 30.99 17.41 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.115 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.65 -69.56 0.51 Allowed Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 118.279 -1.915 . . . . 0.0 111.708 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 13' ' ' VAL . 28.3 m -92.78 141.7 14.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.848 -155.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -88.53 125.39 34.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -165.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.39 112.59 65.44 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.9 Cg_endo -76.23 169.75 21.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 CA-C-O 122.016 0.757 . . . . 0.0 113.428 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 17' ' ' LEU . 4.5 mp -89.15 -23.61 22.41 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 166.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' B' ' 19' ' ' LYS 0.283 4.2 tt0 43.05 -119.8 0.57 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.343 166.195 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.682 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 47.1 tttp 69.01 -128.05 0.1 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -143.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' B' ' 19' ' ' LYS . 50.9 t 68.82 171.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 119.613 1.097 . . . . 0.0 109.946 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . 0.43 ' N ' HG12 ' B' ' 20' ' ' VAL . 30.0 t70 -122.96 17.05 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.226 1.012 . . . . 0.0 111.227 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HD11 ' B' ' 5' ' ' ILE . 93.6 mt -83.53 169.55 15.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.607 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' B' ' 21' ' ' ASP . 18.9 mttt -136.35 -179.73 5.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -164.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.3 145.17 37.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.348 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 57.9 65.25 3.67 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -164.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -120.13 139.82 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.497 -0.852 . . . . 0.0 111.05 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' B' ' 27' ' ' ARG . 0.3 OUTLIER -88.95 125.89 35.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.862 -174.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.822 ' HB ' HG22 ' A' ' 30' ' ' ILE . 34.3 m -136.99 148.15 26.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.825 -172.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -117.35 138.25 51.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.018 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 3.9 mt -117.26 148.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.289 0.566 . . . . 0.0 111.376 -169.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -137.25 161.76 35.33 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 22' ' ' LEU . 6.6 mp . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.08 110.84 5.22 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.09 173.03 15.17 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.544 2.163 . . . . 0.0 113.439 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 39' ' ' ILE . 0.2 OUTLIER -76.64 173.89 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.953 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -88.68 137.03 32.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.302 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.4 tp -111.41 143.7 41.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.329 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 115.3 3.48 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 0.7 OUTLIER -71.75 125.52 91.65 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 115.319 -0.44 . . . . 0.0 110.92 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.8 172.57 16.02 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.709 2.273 . . . . 0.0 112.356 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.81 152.16 25.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -125.11 168.5 13.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.91 127.34 51.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -102.6 102.78 13.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.67 -25.98 24.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.136 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.316 -178.823 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.575 0.226 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -128.98 141.55 51.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.167 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 49.7 ttm -123.45 124.75 43.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -79.66 140.26 37.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.773 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.3 t -101.89 20.55 16.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.34 0.59 . . . . 0.0 109.689 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.33 -169.16 0.2 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.644 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 169.4 18.77 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -75.13 147.17 40.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 111.17 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.62 156.31 45.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.845 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -132.95 100.71 4.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.004 0.43 . . . . 0.0 111.465 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -106.92 100.12 9.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -51.39 -47.62 62.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.145 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.97 177.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.769 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 20' ' ' VAL . 24.0 mt -85.94 150.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 38.9 mt-10 -124.33 126.12 45.48 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.12 169.5 17.48 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.0 111.406 -171.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.522 HG12 ' HD3' ' B' ' 27' ' ' ARG . 12.1 m -129.66 131.45 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.686 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 70.6 t80 -74.79 118.26 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 34.1 tt0 -155.44 138.47 15.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.905 1.378 . . . . 0.0 108.813 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.06 25.72 12.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.394 0.616 . . . . 0.0 110.35 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 71.01 20.99 78.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.026 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 54.7 t -132.92 159.13 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 54.9 m-85 -108.18 115.03 29.37 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -112.97 125.9 29.09 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.908 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 28.0 Cg_endo -64.21 170.01 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.228 1.286 . . . . 0.0 112.112 177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -5.44 21.6 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 2.8 pt20 -135.18 129.33 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.161 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -68.87 129.45 39.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 110.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.571 HG12 ' HG ' ' A' ' 22' ' ' LEU . 13.8 t -117.01 149.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.306 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.74 25.27 11.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.155 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.4 mt -66.75 177.69 1.55 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.456 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 8.9 mtpm? -96.13 170.86 8.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 0.6 OUTLIER -77.01 133.86 39.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.289 175.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 76.96 16.78 80.48 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.465 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 6.8 mm-40 -68.68 135.4 51.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.95 0.405 . . . . 0.0 110.585 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 103.68 15.73 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.775 1.274 . . . . 0.0 112.534 -167.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.731 ' HB ' HG22 ' B' ' 30' ' ' ILE . 29.4 m -129.16 152.41 37.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.426 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -129.67 135.26 48.29 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.682 0.753 . . . . 0.0 110.019 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 HD13 ' B' ' 30' ' ' ILE . 9.1 mt -103.9 143.03 16.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.041 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.829 ' HG3' HG22 ' B' ' 4' ' ' ILE . 10.4 mptt -137.93 157.34 46.59 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.113 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD22 ' B' ' 22' ' ' LEU . 94.1 mt . . . . . 0 C--N 1.313 -0.979 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.49 0.662 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.4 mt-10 -101.85 148.88 35.93 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.904 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -75.93 -165.88 0.33 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.982 2.455 . . . . 0.0 111.636 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 39' ' ' ILE . 1.4 pp -70.79 144.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 111.706 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.17 -10.09 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.343 0.592 . . . . 0.0 110.201 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.68 -176.19 3.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.557 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.35 130.7 3.33 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.9 mt-10 -79.1 136.07 57.82 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -67.73 166.03 25.66 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.397 2.731 . . . . 0.0 113.128 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.15 158.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.009 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.6 m -85.16 167.87 15.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.719 0.295 . . . . 0.0 111.102 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.57 134.14 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.252 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 -35.58 18.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.997 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.12 -25.59 67.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.442 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.89 -9.33 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.725 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp . . . . . 0 C--N 1.323 -0.548 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.622 -175.633 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.829 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.432 -1.341 0 CA-C-O 120.84 0.353 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.403 ' CD1' HG23 ' B' ' 20' ' ' VAL . 10.5 mt -87.81 151.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.674 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.22 118.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.0 165.02 25.99 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.568 0.542 . . . . 0.0 110.741 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 m -127.23 133.57 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.598 173.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 1.3 t80 -65.1 100.03 0.41 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.793 ' HB3' ' HD3' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -120.17 119.92 34.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.059 -170.08 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 52.05 33.58 12.29 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.145 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.85 -70.7 0.44 Allowed Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 117.842 -2.123 . . . . 0.0 112.028 -169.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' HG3' ' B' ' 15' ' ' LYS . 32.0 m -100.37 171.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.33 -0.935 . . . . 0.0 112.555 -155.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 93.7 m-85 -87.76 115.0 24.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.793 ' HD3' ' HB3' ' B' ' 10' ' ' GLU . 50.5 mtpt -115.32 111.18 44.58 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.757 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.3 Cg_endo -64.24 166.67 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.265 1.31 . . . . 0.0 112.113 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.413 HD11 HG13 ' B' ' 8' ' ' VAL . 17.6 mt -129.19 -22.7 3.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.444 -1.707 . . . . 0.0 108.107 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -96.54 143.82 27.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.959 169.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.52 154.06 33.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.816 0.341 . . . . 0.0 110.35 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 ' H ' ' B' ' 22' ' ' LEU . 4.3 p -98.75 153.74 4.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.994 0.902 . . . . 0.0 110.07 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.3 13.42 7.69 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.906 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.784 HD22 HD11 ' A' ' 32' ' ' LEU . 29.8 mt -106.47 -170.11 1.67 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.08 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' B' ' 26' ' ' GLU . 63.5 pttt -120.35 160.84 22.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.049 0.452 . . . . 0.0 110.92 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.29 135.52 42.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.497 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.37 19.51 32.57 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -171.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -94.2 145.01 25.01 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.13 0.49 . . . . 0.0 112.222 -175.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.522 ' HD3' HG12 ' A' ' 8' ' ' VAL . 2.9 mpp_? -98.57 112.92 24.81 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 123.334 1.54 . . . . 0.0 112.787 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.652 HG12 HD23 ' A' ' 32' ' ' LEU . 35.5 m -131.0 162.13 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.228 -173.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.769 ' HE3' HG13 ' A' ' 4' ' ' ILE . 36.3 mtpt -132.78 152.12 51.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.531 0.681 . . . . 0.0 109.632 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.731 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -126.94 139.86 50.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.4 -169.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 165.46 27.78 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.573 171.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.813 -176.739 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 36.5 mt-10 -92.88 151.5 40.8 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.509 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 21.0 Cg_exo -65.41 173.75 6.03 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.659 2.239 . . . . 0.0 113.072 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 pt -96.2 172.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.881 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.34 134.27 34.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.661 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.64 169.59 17.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.403 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.22 -146.61 15.88 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.093 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.0 OUTLIER -93.28 142.81 25.77 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 121.049 0.452 . . . . 0.0 111.477 -174.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 5.0 Cg_exo -77.99 130.34 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.932 2.421 . . . . 0.0 111.535 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.86 144.46 12.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.403 0.62 . . . . 0.0 111.443 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -104.92 171.07 7.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.602 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.61 148.31 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -85.22 128.05 34.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.18 -24.99 27.68 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.563 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 CA--C 1.535 0.403 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.289 -176.719 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.248 0.547 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -157.08 135.36 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.241 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.0 ptm -115.11 170.77 8.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -148.89 -174.19 4.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -85.31 5.93 28.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.849 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 85.1 mt 61.17 -166.27 0.21 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.317 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -99.76 145.44 27.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -168.0 110.21 0.6 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.833 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -113.6 132.77 55.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 43.3 t-80 -158.31 98.53 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.262 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 19.4 p-80 178.38 159.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -130.65 -99.92 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.741 0.305 . . . . 0.0 110.302 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 119.149 -0.453 . . . . 0.0 109.973 178.565 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.625 ' CG2' ' HD3' ' B' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.851 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' O ' HG12 ' B' ' 30' ' ' ILE . 10.2 mt -100.33 156.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 41.3 mt-10 -99.19 154.75 17.9 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.926 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -149.67 143.98 25.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.009 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.86 131.86 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.468 0.652 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 47.4 t80 -88.6 113.08 23.8 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.374 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 39.4 mt-10 -138.07 138.29 38.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.388 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 68.25 19.71 8.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.692 0.62 . . . . 0.0 111.136 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.52 16.12 64.73 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.031 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 10.5 t -125.34 148.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 C-N-CA 122.512 0.325 . . . . 0.0 110.598 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 50.5 m-85 -95.29 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 165.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.57 108.32 59.71 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' B' ' 14' ' ' PHE . 47.2 Cg_exo -47.14 168.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.1 2.534 . . . . 0.0 115.707 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 90.6 mt -114.22 87.36 2.61 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 112.907 -1.951 . . . . 0.0 105.915 165.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 2.5 pp0? 81.58 149.15 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.773 2.429 . . . . 0.0 110.932 -172.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -68.31 152.29 45.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.993 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 HD12 ' A' ' 5' ' ' ILE . 3.0 t -114.26 135.95 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.039 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.48 87.8 7.21 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 123.07 1.415 . . . . 0.0 108.154 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.69 173.93 9.87 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.838 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.732 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -101.2 153.43 19.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 40.5 mt-10 -61.67 129.9 43.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.806 0.812 . . . . 0.0 110.865 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.815 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 60.55 65.26 3.46 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.72 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -103.59 142.84 33.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.107 166.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -93.93 127.75 39.87 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 124.036 1.874 . . . . 0.0 113.981 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' B' ' 14' ' ' PHE . 21.4 m -136.08 155.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 111.35 -2.659 . . . . 0.0 108.341 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 38.7 mtpt -118.87 146.24 45.05 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.944 0.878 . . . . 0.0 111.287 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.0 142.85 24.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.804 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -155.38 151.52 27.97 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.357 174.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.308 -1.225 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.579 -170.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -88.14 132.49 39.51 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -80.25 -170.83 1.09 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.573 2.849 . . . . 0.0 113.045 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 39' ' ' ILE . 2.2 pp -84.99 164.5 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.459 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.27 166.58 11.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.03 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.04 166.4 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.912 0.386 . . . . 0.0 111.693 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.72 -145.06 15.81 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.79 156.89 77.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 122.375 0.27 . . . . 0.0 111.147 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.48 -179.16 4.83 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.657 2.238 . . . . 0.0 112.773 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t -104.03 155.97 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.832 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.8 m -101.45 -172.91 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.64 127.83 67.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.297 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.697 ' H ' ' HD2' ' A' ' 51' ' ' LYS . 8.7 mp0 -97.39 171.79 8.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.859 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -85.08 -23.29 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.338 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.18 -15.49 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.399 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.697 ' HD2' ' H ' ' A' ' 48' ' ' GLU . 87.5 mttt . . . . . 0 N--CA 1.441 -0.893 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.155 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.443 HG13 ' HE3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.63 HD13 ' HB ' ' B' ' 20' ' ' VAL . 37.8 pt -101.63 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 82.9 mt-10 -113.9 157.49 22.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.923 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.84 155.95 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.635 0.255 . . . . 0.0 110.508 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.815 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 12.0 m -114.81 126.55 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.417 0.627 . . . . 0.0 110.571 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 66.0 t80 -92.1 109.35 20.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.593 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 8.4 pt-20 -130.3 135.24 47.88 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.162 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.48 14.45 9.47 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.486 0.491 . . . . 0.0 111.891 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 94.84 10.84 57.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.755 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.9 t -114.0 143.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.362 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m-85 -106.01 116.35 31.79 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 167.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -115.99 117.81 39.01 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.875 ' HB2' ' HA ' ' B' ' 19' ' ' LYS . 16.8 Cg_exo -58.37 170.55 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.81 1.674 . . . . 0.0 113.721 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.804 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 6.3 mp -111.04 105.82 14.7 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.804 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.2 pt20 85.44 6.89 0.43 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 126.535 2.397 . . . . 0.0 110.171 -175.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.875 ' HA ' ' HB2' ' B' ' 16' ' ' PRO . 27.6 mtpp 53.56 -159.75 0.14 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.173 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' B' ' 5' ' ' ILE . 6.3 p -151.12 164.71 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.85 12.98 35.36 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.738 1.256 . . . . 0.0 109.389 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.641 ' O ' ' HD2' ' B' ' 23' ' ' LYS . 93.6 mt -79.12 156.49 28.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.327 170.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -132.57 -170.55 2.46 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.453 -170.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 6.2 mp0 -53.14 137.4 33.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 11.1 83.13 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.737 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' B' ' 22' ' ' LEU . 10.0 tp10 -77.89 134.19 37.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 117.092 0.446 . . . . 0.0 110.068 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -117.84 119.71 35.71 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.835 1.303 . . . . 0.0 112.318 -171.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.15 168.62 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.129 -1.851 . . . . 0.0 109.838 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.566 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 15.3 mtmm -126.45 139.88 52.91 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.586 0.708 . . . . 0.0 111.036 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -91.02 128.03 43.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.224 -170.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 1.9 tppt? -121.52 124.45 44.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -69.18 131.96 90.27 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.272 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' B' ' 39' ' ' ILE . 63.0 Cg_endo -72.93 -154.24 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.127 2.551 . . . . 0.0 111.652 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 38' ' ' PRO . 71.2 mt 74.32 161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.407 ' N ' HG22 ' B' ' 39' ' ' ILE . 27.2 t70 56.16 64.88 1.58 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.291 1.043 . . . . 0.0 110.457 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.97 125.56 41.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.847 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.32 112.75 4.12 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 9.2 pt-20 -85.37 116.89 67.41 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.535 174.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 21.5 Cg_exo -64.36 114.78 2.83 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.655 2.236 . . . . 0.0 112.037 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -72.29 146.75 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.454 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -103.37 159.6 15.43 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.177 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.41 151.86 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.691 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.53 114.15 5.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.767 0.794 . . . . 0.0 111.44 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.2 -25.73 27.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.481 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.815 0.817 . . . . 0.0 110.956 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.146 0.498 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -100.22 -179.46 4.14 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.344 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.41 151.39 6.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.992 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -98.75 132.84 43.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.985 0.421 . . . . 0.0 110.095 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.9 m -105.7 2.36 27.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.57 113.5 18.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.767 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.1 92.25 2.77 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -86.99 71.0 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.536 0.684 . . . . 0.0 111.814 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 131.91 52.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.809 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -90.54 145.52 24.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.648 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -141.99 145.19 34.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -115.6 -168.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 174.279 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.74 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 18' ' ' GLN . 9.3 mm -108.08 143.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HG3' ' HG2' ' B' ' 29' ' ' LYS . 5.2 mp0 -97.67 121.13 39.22 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -129.81 165.72 21.39 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.056 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.694 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.0 m -117.32 115.05 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.58 0.705 . . . . 0.0 110.69 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.641 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 79.1 t80 -71.88 106.03 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.092 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.65 131.75 54.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.156 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.448 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 3.9 m-20 54.86 24.88 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 172.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 99.82 2.04 56.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.059 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.97 143.25 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.252 0.526 . . . . 0.0 111.176 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 96.9 m-85 -94.1 115.62 27.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -105.04 115.25 62.67 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.884 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 36.1 Cg_endo -66.2 167.81 17.41 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.034 1.156 . . . . 0.0 112.352 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 mt -112.91 -17.42 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 5' ' ' ILE . 76.5 mt-30 -92.91 171.63 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.058 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -75.94 132.39 40.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 162.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 22' ' ' LEU . 2.3 t -96.42 135.45 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 121.519 0.676 . . . . 0.0 110.349 -174.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -103.93 14.44 30.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.236 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 26' ' ' GLU . 91.1 mt -99.27 -174.31 2.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.098 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.55 163.04 34.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 16.5 mp0 -56.49 141.44 42.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.919 0.866 . . . . 0.0 111.524 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.27 65.3 3.45 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.535 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HG2' HD22 ' A' ' 22' ' ' LEU . 10.9 tp10 -116.76 128.5 55.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.403 -0.898 . . . . 0.0 109.634 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -85.97 120.34 27.26 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.603 1.192 . . . . 0.0 111.189 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' B' ' 30' ' ' ILE . 31.0 m -137.02 148.74 26.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.129 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -119.76 137.32 54.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.524 0.678 . . . . 0.0 110.374 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.673 HD13 HG23 ' B' ' 30' ' ' ILE . 3.6 mm -102.85 138.02 28.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.362 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.92 165.04 37.67 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.533 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 32' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.868 0.842 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 154.18 37.51 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.317 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.64 173.23 14.24 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.193 1.929 . . . . 0.0 112.012 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -102.55 178.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.341 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.16 137.35 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.95 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.863 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -89.37 -165.04 1.24 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.48 141.03 12.99 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.5 pt-20 -67.09 139.86 95.54 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.04 -0.58 . . . . 0.0 111.511 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 2.3 Cg_endo -84.93 166.88 11.27 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.289 2.659 . . . . 0.0 111.951 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.47 150.71 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -95.89 -168.8 1.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.269 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.46 142.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.5 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.94 126.58 29.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.737 0.78 . . . . 0.0 111.923 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.27 -24.14 23.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.114 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mt -64.92 -12.72 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.547 -169.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 121.236 0.541 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 24.1 mm -94.83 152.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.501 ' O ' HD12 ' B' ' 17' ' ' LEU . 38.0 mt-10 -124.58 113.02 17.5 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -125.16 169.14 12.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 128.8 73.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 48.5 t80 -82.0 126.86 32.46 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.127 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 25.3 tt0 -152.19 128.28 10.42 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.608 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 t30 67.35 23.16 9.31 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.708 0.63 . . . . 0.0 111.682 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' B' ' 9' ' ' TYR . . . 88.22 15.33 60.81 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.76 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 5.1 t -122.03 150.11 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.0 m-85 -104.56 114.46 28.7 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 165.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.63 113.63 57.69 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 27.5 Cg_endo -63.61 168.51 11.46 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.636 1.557 . . . . 0.0 112.577 -175.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' O ' ' B' ' 6' ' ' GLU . 1.3 mt -114.63 -2.43 13.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.778 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.45 ' NE2' ' H ' ' B' ' 6' ' ' GLU . 2.2 pm0 -132.39 159.81 38.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.153 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -72.97 130.53 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.47 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.3 t -107.24 145.58 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.468 -173.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -108.95 14.28 24.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.459 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' B' ' 26' ' ' GLU . 85.7 mt -75.51 -175.76 2.95 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.587 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -115.87 168.38 10.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.696 0.284 . . . . 0.0 111.234 -176.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 3.5 mp0 -71.4 136.31 47.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.487 0.661 . . . . 0.0 110.659 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.48 65.56 3.08 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.074 -165.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 13.0 tp10 -90.14 134.48 34.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.562 -0.819 . . . . 0.0 109.382 172.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' B' ' 27' ' ' ARG . 3.5 tpt180 -83.75 104.07 13.56 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.441 1.115 . . . . 0.0 110.413 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.62 HG21 ' CD1' ' A' ' 14' ' ' PHE . 30.8 m -129.32 154.84 40.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.685 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.557 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 22.1 mtmm -123.42 138.54 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.277 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -105.49 121.98 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.116 -172.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' B' ' 31' ' ' LYS . 3.1 tppp? -105.87 124.71 50.01 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.749 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.317 -0.822 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.451 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 10.2 pt-20 -60.68 125.91 83.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 5.1 Cg_exo -74.63 174.93 11.8 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.08 2.52 . . . . 0.0 112.494 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.44 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -85.03 164.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.99 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.28 157.98 30.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -145.85 153.64 41.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.29 115.92 0.68 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.395 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.428 ' HG3' ' HD2' ' B' ' 44' ' ' PRO . 34.8 tt0 -102.39 140.14 20.86 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.36 0.124 . . . . 0.0 110.908 -173.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' B' ' 43' ' ' GLU . 81.8 Cg_exo -46.78 146.88 5.14 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.959 3.106 . . . . 0.0 113.977 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.21 157.27 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.609 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -84.17 -176.58 6.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.572 . . . . 0.0 112.239 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.8 146.99 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.087 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 136.4 37.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.426 0.631 . . . . 0.0 111.284 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.49 -25.56 26.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.009 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.558 ' H ' HD12 ' B' ' 50' ' ' ILE . 4.4 mp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 122.0 0.905 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.383 0.611 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.07 141.24 48.39 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.068 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.4 ttt -133.32 124.52 27.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.285 0.565 . . . . 0.0 111.453 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.3 p -82.72 145.31 29.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 25.3 m -76.76 3.14 12.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.59 0.233 . . . . 0.0 110.848 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt 55.54 41.4 30.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.03 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' B' ' 63' ' ' GLU . 1.9 pm0 -63.84 92.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.819 0.819 . . . . 0.0 110.549 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -75.79 102.5 5.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.29 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -75.57 113.5 13.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.521 0.676 . . . . 0.0 109.717 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -105.85 139.59 40.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -106.99 147.58 29.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.698 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -79.82 112.92 17.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 111.654 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m170 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.087 171.167 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.638 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.643 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' LYS . 5.0 pt -109.72 155.89 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.728 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.579 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 51.0 mt-10 -103.63 141.3 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.1 161.73 36.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.712 -1.586 . . . . 0.0 108.071 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.88 136.82 58.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.417 0.627 . . . . 0.0 110.286 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 81.2 t80 -81.68 103.97 11.76 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.289 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -122.58 122.65 39.36 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.683 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' B' ' 24' ' ' GLU . 1.1 m-80 55.76 36.36 27.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.061 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 85.84 16.9 62.54 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.987 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.4 t -134.42 149.29 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 94.2 m-85 -93.04 115.38 28.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 112.81 59.26 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.1 Cg_endo -61.66 168.64 8.11 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 120.752 0.968 . . . . 0.0 112.154 174.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.52 -71.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.166 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG3' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -141.93 7.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.76 -169.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.715 ' HB3' HD12 ' A' ' 5' ' ' ILE . 70.5 mmtt -91.25 155.0 18.88 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.292 -159.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 22' ' ' LEU . 40.8 t 61.1 142.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.765 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -145.92 14.74 1.35 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.779 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.616 ' CB ' ' HG2' ' A' ' 26' ' ' GLU . 58.2 mt -89.43 5.74 43.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.124 -169.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 83.7 tttt 81.85 163.74 0.15 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.756 156.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -48.91 129.71 17.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.048 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.57 12.47 69.45 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.884 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' HG2' ' CB ' ' A' ' 22' ' ' LEU . 5.0 tp10 -81.36 134.65 35.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.613 0.244 . . . . 0.0 110.439 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -90.18 115.85 27.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 123.258 1.504 . . . . 0.0 113.419 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' B' ' 14' ' ' PHE . 31.8 m -123.81 157.43 30.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 112.473 -2.148 . . . . 0.0 108.794 177.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -124.44 135.56 53.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.413 HG21 ' CE1' ' A' ' 14' ' ' PHE . 10.7 mm -90.45 132.06 36.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.073 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' CE ' HG21 ' B' ' 4' ' ' ILE . 12.6 mptt -121.27 132.5 54.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.288 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD13 HG12 ' B' ' 28' ' ' VAL . 2.8 mm? . . . . . 0 C--N 1.305 -1.335 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.438 0.637 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.95 103.34 55.24 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.631 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.41 -171.52 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.878 2.385 . . . . 0.0 111.838 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.8 mp -91.36 144.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -113.41 123.54 50.31 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.737 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -83.52 154.07 24.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.652 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.87 115.38 2.09 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.957 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.91 122.57 86.45 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.708 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.13 148.03 26.97 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.679 2.253 . . . . 0.0 112.086 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.69 156.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -86.82 171.46 10.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.865 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.93 141.81 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -135.94 -26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.269 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.16 -23.87 66.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -171.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.66 -15.63 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 pttm . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.103 0.477 . . . . 0.0 111.618 -176.421 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.577 HG21 ' CE ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 121.027 0.442 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.604 HG23 ' HB3' ' B' ' 18' ' ' GLN . 7.1 mt -89.62 148.29 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -102.67 131.08 49.7 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.81 154.34 46.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.604 0.24 . . . . 0.0 110.942 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.715 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -111.4 132.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.843 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 68.3 t80 -82.2 108.37 15.61 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.021 0.915 . . . . 0.0 110.585 176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.721 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 5.6 mt-10 -86.58 -170.68 3.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.391 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.15 62.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 O-C-N 124.342 1.026 . . . . 0.0 111.301 -171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 105.27 5.55 40.09 Favored Glycine 0 C--N 1.304 -1.218 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.677 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.5 t -112.78 145.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.221 -0.489 . . . . 0.0 111.432 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 55.4 m-85 -115.67 114.67 25.18 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 162.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -121.2 123.62 27.68 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.758 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.4 Cg_endo -65.19 168.0 15.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.708 1.605 . . . . 0.0 112.925 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.715 HD11 HG13 ' B' ' 8' ' ' VAL . 4.2 mp -118.45 -13.66 9.74 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' B' ' 5' ' ' ILE . 8.9 tt0 -91.53 164.11 13.91 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.593 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -78.15 142.65 37.88 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.88 139.82 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 122.973 1.368 . . . . 0.0 113.012 -173.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -141.81 87.46 2.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.379 -2.191 . . . . 0.0 108.301 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.3 -179.43 5.14 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.986 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.666 ' HD2' ' OE2' ' B' ' 24' ' ' GLU . 30.0 mmtt -110.06 161.92 15.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.338 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.666 ' OE2' ' HD2' ' B' ' 23' ' ' LYS . 1.1 pm0 -77.16 124.12 27.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.437 0.637 . . . . 0.0 109.532 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 15.28 30.67 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.784 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 7.6 tp10 -78.77 121.22 24.5 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -87.46 122.28 30.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.356 1.074 . . . . 0.0 111.278 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.47 HG12 HD13 ' A' ' 32' ' ' LEU . 29.7 m -129.46 151.15 35.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.219 -173.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.638 ' HE3' HG13 ' A' ' 4' ' ' ILE . 25.9 mtpp -121.57 134.56 55.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 122.443 1.116 . . . . 0.0 111.086 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 7' ' ' ALA . 9.6 mm -106.16 144.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 112.708 -2.042 . . . . 0.0 111.151 -164.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.535 ' HE3' HG22 ' A' ' 4' ' ' ILE . 6.1 ptpp? -156.16 163.98 38.94 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.657 -1.61 . . . . 0.0 107.018 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.603 ' CD2' HD12 ' A' ' 22' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.448 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 7.6 p . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -105.65 104.45 48.54 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.229 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 36' ' ' VAL . 77.2 Cg_endo -92.81 175.29 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.249 2.632 . . . . 0.0 111.528 172.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -124.77 114.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.01 0.433 . . . . 0.0 111.09 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.23 137.33 34.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.52 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 tp -102.75 167.62 9.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.4 -155.18 25.52 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.852 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 40.2 mt-10 -129.44 139.02 34.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.64 165.19 31.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.059 2.506 . . . . 0.0 112.42 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.449 HG22 ' N ' ' B' ' 46' ' ' SER . 10.6 p -95.15 161.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.289 0.566 . . . . 0.0 110.88 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' SER . . . . . 0.57 ' O ' ' HB ' ' B' ' 47' ' ' VAL . 6.4 p -122.62 -164.54 1.19 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.564 -176.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 46' ' ' SER . 23.0 t 77.28 137.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.79 0.836 . . . . 0.0 111.915 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.07 138.19 37.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.95 -32.38 21.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.469 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 C--N 1.32 -0.699 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -166.597 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -122.11 134.06 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.898 0.38 . . . . 0.0 110.458 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.52 125.38 54.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.204 0.526 . . . . 0.0 111.232 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t -77.05 160.22 29.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.304 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.9 t -84.29 19.31 1.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 55.66 -176.42 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.551 0.74 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -111.35 167.39 10.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.876 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -152.53 135.66 15.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -143.94 101.42 3.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.984 0.421 . . . . 0.0 110.258 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -103.52 165.46 11.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -135.54 143.28 45.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.53 -75.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.87 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.237 -179.092 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 25.4 mt-10 -124.26 139.45 53.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.073 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.23 165.23 25.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.071 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 3.1 m -117.08 114.37 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.57 0.7 . . . . 0.0 109.512 170.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . 19.2 t80 -60.87 124.76 21.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.483 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 28.2 mt-10 -149.4 134.3 17.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.16 0.287 . . . . 0.0 111.167 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 59.03 28.36 17.6 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.152 0.908 . . . . 0.0 111.465 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.23 -69.37 0.32 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 117.406 -2.33 . . . . 0.0 111.626 -167.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' HG3' ' A' ' 15' ' ' LYS . 22.3 m -95.58 165.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.382 -0.909 . . . . 0.0 113.397 -157.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.3 m-85 -88.68 116.74 27.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 51.8 mtpt -113.44 112.05 49.13 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.395 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 Cg_endo -60.19 168.13 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.333 1.355 . . . . 0.0 112.527 -175.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 8' ' ' VAL . 97.2 mt -95.84 1.28 53.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 11.5 pt20 -146.89 156.53 43.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.193 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 23.0 mtpp -81.49 145.08 30.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.551 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -125.0 139.84 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.947 0.88 . . . . 0.0 111.853 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.37 87.44 5.19 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.208 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.2 mt -131.01 -165.59 1.58 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.27 -2.241 . . . . 0.0 109.448 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -129.27 156.79 43.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.042 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.743 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 34.2 mt-10 -69.5 128.93 38.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.209 0.528 . . . . 0.0 110.812 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 14.39 57.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.918 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 26' ' ' GLU . 1.5 mm-40 -75.39 139.72 42.54 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -92.53 114.7 27.32 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 123.335 1.541 . . . . 0.0 112.507 -173.014 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' B' ' 30' ' ' ILE . 28.7 m -124.45 148.63 28.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.216 -2.266 . . . . 0.0 109.825 -175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -111.59 139.9 46.65 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -105.77 138.89 28.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.304 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -137.32 153.4 50.27 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 27' ' ' ARG . 17.3 tp . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.835 -156.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 33.8 mt-10 -58.04 129.41 82.47 Favored Pre-proline 0 N--CA 1.446 -0.659 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 46.6 Cg_exo -56.25 174.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.47 2.78 . . . . 0.0 114.028 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 pt -76.4 146.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.845 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.96 95.22 7.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -95.69 177.77 5.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.038 -173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.71 114.48 5.03 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.8 mt-10 -75.01 138.24 72.73 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 114.526 -0.837 . . . . 0.0 111.338 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 12.6 Cg_exo -70.0 118.06 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.482 2.121 . . . . 0.0 110.594 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.16 147.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.845 0.355 . . . . 0.0 110.612 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 m -98.09 171.78 8.03 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.94 147.34 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.335 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 41.8 mt-10 -74.96 138.03 42.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.807 0.337 . . . . 0.0 110.598 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 -25.19 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.386 0.612 . . . . 0.0 110.05 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.57 -0.4 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.875 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.05 0.452 . . . . 0.0 110.635 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.423 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 121.476 0.655 . . . . 0.0 110.015 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.531 ' CG2' ' HB2' ' B' ' 18' ' ' GLN . 7.6 mt -109.25 142.77 20.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -99.72 138.89 36.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.293 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.15 160.71 39.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.911 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.01 124.35 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.174 0.512 . . . . 0.0 110.626 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 85.6 t80 -80.19 99.74 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.543 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 73.1 mt-10 -122.74 144.75 48.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 59.0 t30 66.37 10.72 7.46 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.434 0.458 . . . . 0.0 111.656 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 86.78 18.93 57.43 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.991 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.0 t -122.12 151.39 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.058 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.6 m-85 -98.58 115.62 29.02 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' B' ' 10' ' ' GLU . 49.1 mtmt -118.16 116.48 35.71 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.914 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 15.7 Cg_endo -61.25 165.96 11.85 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 121.688 1.592 . . . . 0.0 113.531 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.0 -66.06 0.96 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.283 -2.689 . . . . 0.0 104.945 162.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.531 ' HB2' ' CG2' ' B' ' 5' ' ' ILE . 14.7 mp0 -59.67 158.63 9.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.276 -1.783 . . . . 0.0 111.134 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -76.83 128.39 34.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 110.531 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.463 HG12 ' H ' ' B' ' 22' ' ' LEU . 8.7 t -124.44 150.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.374 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.15 15.2 7.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.916 0.865 . . . . 0.0 110.88 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.489 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 94.9 mt -71.25 163.99 26.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.58 -173.63 2.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.354 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 7.2 mp0 -63.15 141.97 58.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.321 0.581 . . . . 0.0 111.806 -175.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.584 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 45.9 64.55 2.38 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.218 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 4.1 mm-40 -103.81 134.42 47.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.521 -0.839 . . . . 0.0 110.032 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.1 mmm-85 -82.64 115.98 21.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.336 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 14' ' ' PHE . 30.0 m -140.42 152.04 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.585 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 59.4 mttm -115.32 141.83 47.51 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.204 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.5 mm -118.94 142.44 33.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.562 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.466 ' HD2' HG22 ' A' ' 4' ' ' ILE . 62.0 tttm -155.3 126.45 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.244 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.601 ' HG ' HG12 ' A' ' 28' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.167 0.508 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.44 171.29 5.8 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.422 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.65 171.87 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.752 1.634 . . . . 0.0 111.873 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.5 176.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.83 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -114.12 147.99 37.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.174 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.685 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.4 pt? -113.32 144.64 42.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.122 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.58 122.04 7.29 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.808 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.1 pt-20 -55.92 141.73 66.29 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.999 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 3.0 Cg_exo -75.18 -170.63 0.82 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.062 2.508 . . . . 0.0 112.269 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.98 156.25 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.297 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -83.32 172.21 12.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.62 148.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.643 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -50.57 119.85 4.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.329 0.585 . . . . 0.0 111.917 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -85.91 -26.04 25.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.179 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.347 -174.122 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.775 0.322 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -129.2 133.22 47.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.216 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 1.2 tpt -114.07 127.45 55.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.767 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -88.68 167.62 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 26.5 t -81.7 20.22 0.96 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.075 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 70.3 mt 62.9 -165.74 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.272 0.629 . . . . 0.0 111.205 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -123.64 134.25 53.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -93.35 120.22 33.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.954 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -57.26 137.58 55.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.491 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -79.79 139.58 37.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.021 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -131.61 117.99 19.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -81.43 123.38 28.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.941 176.997 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 112.495 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.623 HG21 HG22 ' A' ' 20' ' ' VAL . 22.8 mm -106.14 168.93 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 46.5 mt-10 -124.76 160.03 29.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.318 0.508 . . . . 0.0 110.706 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' B' ' 30' ' ' ILE . . . -158.65 158.56 34.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.782 0.433 . . . . 0.0 110.259 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.5 117.86 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.635 0.731 . . . . 0.0 110.44 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.733 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 51.3 t80 -82.69 113.05 20.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.131 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HG2' ' HB3' ' B' ' 24' ' ' GLU . 0.4 OUTLIER -137.97 146.14 42.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.994 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 57.59 26.31 12.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 80.31 20.96 65.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.008 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.6 t -130.59 152.84 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.227 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 91.4 m-85 -104.64 114.01 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -104.79 106.39 54.78 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.429 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -39.83 168.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.963 3.109 . . . . 0.0 117.758 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.897 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 96.5 mt -131.72 96.99 4.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 111.621 -2.536 . . . . 0.0 105.518 168.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.897 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 4.4 pp0? 77.66 -176.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.476 2.31 . . . . 0.0 112.02 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.88 137.78 44.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -159.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 5' ' ' ILE . 2.5 t -141.6 134.18 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.103 170.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -131.14 87.76 2.51 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.829 1.3 . . . . 0.0 108.6 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 HD22 ' B' ' 32' ' ' LEU . 57.2 mt -123.11 -179.05 4.15 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 112.178 -2.283 . . . . 0.0 110.967 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.603 ' HG3' ' HG2' ' A' ' 26' ' ' GLU . 18.9 pttp -114.28 162.65 16.31 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 46.3 mt-10 -65.76 133.7 51.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 122.025 0.917 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.61 64.93 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.082 -165.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 2.0 mm-40 -114.82 139.87 49.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.208 -0.996 . . . . 0.0 109.708 168.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -100.17 124.87 46.09 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 123.008 1.385 . . . . 0.0 112.354 -175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' B' ' 30' ' ' ILE . 33.5 m -133.6 150.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.107 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -105.43 138.5 41.53 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.577 0.703 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.476 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.6 mm -110.2 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.98 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.1 156.29 34.05 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.543 HD13 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.2 pm0 -90.59 148.81 39.5 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 173.43 11.96 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.165 1.91 . . . . 0.0 112.149 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.24 153.18 24.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.67 72.04 0.96 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.6 tp -91.04 135.65 33.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.659 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.7 111.34 3.8 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.5 tt0 -93.42 113.06 59.13 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.525 -0.838 . . . . 0.0 110.469 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 6.3 Cg_exo -73.78 113.82 3.88 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.863 2.375 . . . . 0.0 112.204 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 46' ' ' SER . 8.4 p -114.14 163.15 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.526 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 45' ' ' VAL . 4.3 m -66.67 160.17 26.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.258 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.99 134.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.115 0.483 . . . . 0.0 110.577 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.658 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 31.7 mt-10 -126.0 121.57 33.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.966 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 49' ' ' GLU . 6.9 pt-20 -85.2 -25.57 27.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.695 -174.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -88.43 1.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.669 0.747 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.658 ' HE2' ' HB2' ' A' ' 48' ' ' GLU . 25.1 ttmm . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.986 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.626 0 CA-C-O 121.245 0.545 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 18' ' ' GLN . 4.4 mt -114.84 168.07 6.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -132.41 136.4 46.74 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -133.83 155.76 49.25 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.374 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.679 HG13 HD11 ' B' ' 17' ' ' LEU . 7.1 m -110.06 121.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.316 0.579 . . . . 0.0 111.006 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 21.3 t80 -61.02 111.23 1.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.982 171.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -136.11 129.3 31.61 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.969 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 28.8 t30 55.02 27.84 9.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.77 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.97 -68.27 0.22 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 117.688 -2.196 . . . . 0.0 111.26 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.67 154.96 3.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.522 -1.339 . . . . 0.0 111.678 -157.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 89.3 m-85 -88.72 122.16 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 0.0 112.031 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.73 119.03 51.64 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 34.1 Cg_endo -66.13 168.71 15.12 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.462 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.679 HD11 HG13 ' B' ' 8' ' ' VAL . 4.9 mp -113.21 -5.72 13.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' B' ' 5' ' ' ILE . 18.8 mp0 -116.68 143.35 45.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.356 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -72.57 126.75 30.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.9 t -88.27 145.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.244 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -111.52 14.98 21.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.008 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' B' ' 26' ' ' GLU . 80.2 mt -90.57 -168.62 2.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.314 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 15.1 tmtt? -111.81 155.4 23.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.9 mp0 -57.89 133.17 55.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.924 0.869 . . . . 0.0 112.201 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.37 65.5 3.5 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 114.106 -1.407 . . . . 0.0 110.381 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' B' ' 22' ' ' LEU . 10.0 tp10 -92.92 149.13 21.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.686 -0.757 . . . . 0.0 110.958 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.55 104.94 17.19 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.532 1.158 . . . . 0.0 111.376 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 32' ' ' LEU . 34.9 m -124.7 154.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.407 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 41.4 mttp -119.43 148.0 43.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.495 0.664 . . . . 0.0 110.076 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 28' ' ' VAL . 7.8 mt -128.55 153.38 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.129 -170.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -150.88 159.33 44.62 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.584 HD22 HD11 ' A' ' 22' ' ' LEU . 8.3 mt . . . . . 0 C--N 1.315 -0.926 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -173.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.7 mt-10 -60.16 141.93 90.11 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 32.8 Cg_exo -61.88 174.39 2.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.186 2.591 . . . . 0.0 113.773 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.413 HG13 ' H ' ' B' ' 39' ' ' ILE . 2.0 pp -82.09 171.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.127 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -93.4 -151.57 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.493 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.77 -170.53 2.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.42 141.41 10.4 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.46 155.06 85.82 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 120.573 0.225 . . . . 0.0 110.896 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.25 164.72 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.44 2.093 . . . . 0.0 110.11 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.67 134.99 8.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 122.001 0.905 . . . . 0.0 112.099 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -86.51 172.44 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.021 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.78 131.54 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.97 118.9 20.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.0 110.747 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -85.61 -25.47 26.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.588 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 tt . . . . . 0 C--N 1.317 -0.816 0 CA-C-O 121.616 0.722 . . . . 0.0 110.8 -175.065 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -110.45 135.74 50.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.739 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.39 148.7 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.483 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.1 p -142.54 149.52 39.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.032 0.444 . . . . 0.0 111.207 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 46.1 t -95.3 13.91 24.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.65 94.39 9.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.425 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.07 86.55 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -98.81 58.22 1.16 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.239 0.542 . . . . 0.0 111.624 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.92 116.24 9.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.23 102.57 14.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.63 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -78.81 112.94 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -109.94 129.88 55.6 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.055 -174.322 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.946 HG22 ' HG2' ' B' ' 31' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.605 HD11 HD11 ' A' ' 22' ' ' LEU . 4.6 mt -106.1 148.18 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.926 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.52 123.08 45.61 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -143.07 168.52 19.55 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 17' ' ' LEU . 10.6 m -129.68 129.73 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.018 0.437 . . . . 0.0 110.785 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 20.0 t80 -59.77 128.85 38.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 37.7 tt0 -139.79 109.04 6.1 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.496 0.665 . . . . 0.0 111.494 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.455 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 31.0 t30 55.7 27.33 10.5 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.324 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.9 -70.01 0.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 118.158 -1.972 . . . . 0.0 110.731 -165.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' HB ' ' CG1' ' B' ' 13' ' ' VAL . 23.2 m -94.34 145.36 8.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 113.649 -1.276 . . . . 0.0 112.201 -160.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.5 m-85 -86.82 116.76 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.333 0.587 . . . . 0.0 110.169 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HE3' ' CG2' ' A' ' 13' ' ' VAL . 34.5 mmtp -105.12 116.58 60.34 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.153 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 13.6 Cg_endo -59.93 169.0 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.41 1.407 . . . . 0.0 111.997 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.523 HD11 HG13 ' A' ' 8' ' ' VAL . 7.4 mp -102.23 -8.73 21.04 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.47 170.49 16.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.433 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -63.49 128.01 33.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.061 0.934 . . . . 0.0 112.204 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 ' HZ ' ' B' ' 14' ' ' PHE . 4.9 p -132.87 141.36 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.714 173.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -148.14 87.85 1.63 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.358 -1.746 . . . . 0.0 108.867 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.826 HD13 HD11 ' B' ' 32' ' ' LEU . 67.4 mt -106.63 0.72 24.63 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.853 -1.976 . . . . 0.0 109.647 171.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 85.14 171.99 0.07 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 113.191 173.022 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.7 mp0 -78.43 134.92 37.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.502 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 51.94 63.87 4.43 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -166.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.646 ' HG2' ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp10 -113.56 137.7 51.21 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.803 -1.199 . . . . 0.0 107.927 170.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -100.53 117.8 35.41 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 123.124 1.44 . . . . 0.0 112.996 -164.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.622 HG12 HD13 ' B' ' 32' ' ' LEU . 16.0 m -134.84 158.07 41.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 112.149 -2.296 . . . . 0.0 109.483 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.748 ' HD3' HG13 ' B' ' 4' ' ' ILE . 87.3 mttt -120.95 138.38 54.16 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 122.047 0.927 . . . . 0.0 111.101 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 14' ' ' PHE . 8.8 mm -103.57 149.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.204 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -156.3 162.37 40.11 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.742 HD23 HG12 ' B' ' 28' ' ' VAL . 52.3 mt . . . . . 0 C--N 1.308 -1.223 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.723 -171.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.94 137.18 22.34 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-O 121.21 0.529 . . . . 0.0 112.152 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.28 177.34 7.23 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.772 2.315 . . . . 0.0 111.117 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.4 pp -87.82 147.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.119 0.485 . . . . 0.0 111.952 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -99.03 172.08 7.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.096 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.807 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.8 pt? -98.56 130.57 45.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.41 -154.57 17.65 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.844 -170.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.86 153.65 60.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.718 -173.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.36 171.03 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.736 2.291 . . . . 0.0 112.565 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.71 148.94 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.598 . . . . 0.0 110.465 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.537 ' O ' HG12 ' A' ' 47' ' ' VAL . 45.5 m -120.81 175.92 5.8 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.18 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 64.57 154.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.477 1.111 . . . . 0.0 113.029 177.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.6 mm-40 66.27 -36.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.663 1.185 . . . . 0.0 113.928 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.75 -26.02 62.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.492 0.663 . . . . 0.0 109.704 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mm -90.24 -4.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.053 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.329 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.748 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 121.339 0.59 . . . . 0.0 110.457 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.573 HD13 HG21 ' B' ' 20' ' ' VAL . 6.9 mt -101.44 151.8 5.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 42.9 mt-10 -113.55 134.24 54.81 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.27 151.08 40.13 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.538 0.523 . . . . 0.0 109.98 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.7 m -116.19 125.81 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.477 0.656 . . . . 0.0 110.377 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 43.4 t80 -75.99 121.97 23.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.44 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.37 135.98 34.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.57 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t30 63.04 20.61 12.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 91.08 13.06 59.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.743 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 9.1 t -120.69 153.24 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.337 0.255 . . . . 0.0 110.408 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.4 m-85 -109.0 115.34 29.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.054 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -109.05 115.95 56.18 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.99 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 41.8 Cg_endo -68.81 168.14 21.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.832 1.021 . . . . 0.0 112.186 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.436 HD11 HG13 ' B' ' 8' ' ' VAL . 5.3 mp -112.08 -12.6 13.66 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' B' ' 5' ' ' ILE . 0.7 OUTLIER -102.59 139.45 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.484 171.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -80.31 132.76 35.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 110.396 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -127.47 136.36 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.466 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.77 87.34 2.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.828 1.299 . . . . 0.0 108.186 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.581 ' HG ' HG12 ' B' ' 20' ' ' VAL . 47.2 mt -122.43 -178.44 3.9 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.533 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' B' ' 26' ' ' GLU . 29.9 mttp -102.62 161.96 13.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 mp0 -71.87 119.11 15.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 14.93 38.22 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.884 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' B' ' 22' ' ' LEU . 5.3 mm-40 -71.4 133.42 45.93 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 120.77 35.24 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 123.298 1.523 . . . . 0.0 112.819 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 32' ' ' LEU . 32.8 m -138.95 162.65 28.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 112.291 -2.231 . . . . 0.0 110.489 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.414 ' HD3' HG13 ' A' ' 4' ' ' ILE . 46.8 mttp -122.3 139.46 53.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.689 0.757 . . . . 0.0 109.246 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 28' ' ' VAL . 6.2 mt -102.9 136.34 35.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.98 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.946 ' HG2' HG22 ' A' ' 4' ' ' ILE . 19.8 mttt -137.02 147.14 46.03 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.634 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.826 HD11 HD13 ' A' ' 22' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.372 -169.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.45 114.84 7.35 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.087 0.47 . . . . 0.0 111.917 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.76 -173.12 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.947 2.431 . . . . 0.0 112.128 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -90.14 155.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.965 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -92.71 159.95 15.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.149 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.65 165.77 26.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.193 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.41 -136.7 5.56 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.557 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -112.9 161.87 24.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 122.282 0.233 . . . . 0.0 110.953 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.88 167.66 24.85 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.402 2.068 . . . . 0.0 111.848 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.05 151.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -98.81 170.18 8.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.016 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.89 138.0 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -119.62 -23.37 6.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.232 0.539 . . . . 0.0 111.123 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.21 -25.23 65.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.983 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.408 ' O ' HG12 ' B' ' 50' ' ' ILE . 13.1 tt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 121.194 0.521 . . . . 0.0 111.919 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -83.33 171.29 13.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.4 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 19.3 ptp -84.69 169.56 14.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.852 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -73.38 -177.15 2.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.8 m -105.32 4.06 30.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.741 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 67.4 mt 59.01 -171.23 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.392 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.51 136.11 50.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.127 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -118.2 85.1 2.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.786 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.21 127.76 32.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.114 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' B' ' 67' ' ' HIS . 52.5 m80 -96.04 147.67 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 66' ' ' HIS . 60.6 m170 72.16 157.61 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.881 0.738 . . . . 0.0 109.465 -168.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -91.29 0.75 57.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.418 0.627 . . . . 0.0 109.781 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 C--O 1.247 0.95 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.888 178.584 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.629 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.182 0.515 . . . . 0.0 111.623 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -105.1 146.76 11.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -103.02 137.2 41.53 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.82 160.33 40.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.838 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.4 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.555 0.693 . . . . 0.0 110.425 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.6 t80 -72.92 110.41 7.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.668 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 36.9 mt-10 -134.2 144.46 48.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.398 177.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 62.62 22.4 13.3 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.441 0.463 . . . . 0.0 111.374 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 79.43 18.55 73.51 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.914 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 9.8 t -127.42 150.72 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 63.4 m-85 -95.55 115.0 26.81 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.287 168.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 50.8 mtpt -113.99 108.64 50.6 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.594 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 27.7 Cg_endo -62.52 169.22 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.35 1.366 . . . . 0.0 112.781 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.2 -16.29 14.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -107.68 137.37 45.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.558 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -75.96 124.58 27.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.644 0.735 . . . . 0.0 109.98 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.655 ' HB ' ' CE2' ' B' ' 9' ' ' TYR . 3.6 t -103.12 147.48 9.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.591 -175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.76 16.1 13.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.121 0.962 . . . . 0.0 110.345 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD13 ' HG2' ' A' ' 26' ' ' GLU . 96.7 mt -73.84 -174.37 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.773 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -110.97 171.86 7.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.341 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -73.29 141.74 47.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.459 0.647 . . . . 0.0 110.575 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.739 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 54.52 64.77 4.02 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.703 -167.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' HG2' HD13 ' A' ' 22' ' ' LEU . 7.8 tp10 -105.98 123.15 47.52 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.478 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -77.88 111.3 13.58 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 122.654 1.216 . . . . 0.0 112.747 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.641 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.1 m -133.32 155.55 40.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.603 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.964 ' HD3' HG13 ' B' ' 4' ' ' ILE . 64.3 mttm -113.03 149.05 33.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.551 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.0 mm -104.59 130.25 55.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.277 0.561 . . . . 0.0 109.627 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HE3' HG21 ' B' ' 4' ' ' ILE . 75.2 mttt -132.81 134.45 44.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.545 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.707 ' HB3' HG12 ' B' ' 28' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.913 -169.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 mm-40 -81.27 123.05 81.78 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.848 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.3 Cg_exo -77.79 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.543 2.829 . . . . 0.0 113.256 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.2 pt -68.05 165.3 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.89 149.54 52.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.05 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.9 tp -100.52 135.12 42.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 111.379 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 156.38 24.51 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.039 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.44 150.7 73.95 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.36 -0.92 . . . . 0.0 111.868 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 159.03 35.5 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.761 2.307 . . . . 0.0 111.951 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.28 155.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -90.28 174.09 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.43 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.63 164.67 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.37 121.0 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.567 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -85.56 -28.83 24.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.133 0.492 . . . . 0.0 111.088 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.9 tt -93.65 -0.77 10.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.604 0.716 . . . . 0.0 110.774 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 tptm . . . . . 0 C--N 1.319 -0.75 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.726 -176.277 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.964 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.872 0 CA-C-O 120.985 0.421 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB2' ' B' ' 18' ' ' GLN . 6.6 mt -97.78 144.24 11.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 51.4 mp0 -104.9 141.32 36.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -139.87 166.26 25.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.108 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.739 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.4 m -121.36 123.48 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.612 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.655 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.2 t80 -61.55 126.16 26.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.831 173.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 81.1 mt-10 -137.09 111.52 8.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.018 0.437 . . . . 0.0 111.294 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 55.5 29.12 12.78 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.032 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.04 -69.78 0.48 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 118.215 -1.945 . . . . 0.0 110.845 -168.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.15 145.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.784 -1.208 . . . . 0.0 111.823 -161.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -92.83 116.74 29.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.63 120.77 56.68 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.561 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 28.8 Cg_endo -64.82 170.05 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.316 1.344 . . . . 0.0 112.533 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.598 HD11 HG13 ' B' ' 8' ' ' VAL . 6.0 mp -108.92 -10.67 15.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' B' ' 5' ' ' ILE . 47.0 mt-30 -115.48 145.26 42.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.866 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -73.42 151.57 41.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.953 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' B' ' 22' ' ' LEU . 2.5 t -112.54 145.25 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.67 16.61 9.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.36 1.076 . . . . 0.0 109.519 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 88.6 mt -86.36 -165.93 1.4 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.188 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.564 ' HG2' ' HG2' ' B' ' 26' ' ' GLU . 23.6 pttp -116.32 155.08 29.06 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.379 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.1 132.5 45.16 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.885 0.85 . . . . 0.0 109.836 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.02 65.03 2.75 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.617 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 1.9 mm-40 -112.06 132.96 54.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.254 -0.973 . . . . 0.0 109.221 170.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -90.41 119.48 30.73 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.704 0.764 . . . . 0.0 110.869 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 32' ' ' LEU . 29.8 m -140.11 166.81 19.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.467 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HD3' HG13 ' A' ' 4' ' ' ILE . 60.9 mttm -122.03 153.93 37.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.23 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 28' ' ' VAL . 5.8 mm -115.44 142.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -151.34 125.05 9.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.2 mp . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -143.63 89.08 7.56 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.527 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.65 -161.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.304 2.669 . . . . 0.0 112.712 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.34 156.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -91.81 -51.28 5.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.801 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 45.1 tp 68.8 116.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.278 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.77 -142.5 10.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.969 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.83 158.19 38.39 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 122.252 0.221 . . . . 0.0 111.177 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.09 174.27 12.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.025 2.483 . . . . 0.0 112.253 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.69 154.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 10.4 m -89.32 171.84 9.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.39 138.17 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.405 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.02 -30.67 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.692 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' B' ' 49' ' ' GLU . 1.6 pm0 -66.84 -24.49 66.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.957 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.375 0.607 . . . . 0.0 110.944 -178.444 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 58' ' ' TRP . . . . . 0.409 ' O ' ' HB2' ' B' ' 59' ' ' MET . 1.3 m-90 -110.56 -168.77 1.35 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.343 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' B' ' 58' ' ' TRP . 66.6 mtt 73.64 172.42 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.831 0.853 . . . . 0.0 110.31 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m 57.09 26.18 11.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.076 0.465 . . . . 0.0 111.735 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.8 p -82.22 16.93 1.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.003 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 45.43 99.89 0.01 OUTLIER 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.119 0.967 . . . . 0.0 113.223 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -82.83 172.4 12.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.09 123.74 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.263 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -97.23 141.22 30.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -71.14 129.92 40.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 111.639 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -71.83 86.78 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -83.77 73.92 10.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.5 0.667 . . . . 0.0 111.167 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.8 m170 . . . . . 0 C--O 1.246 0.891 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.538 177.011 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.249 0.547 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 20' ' ' VAL . 4.6 mt -105.59 152.65 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.109 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 30.1 mt-10 -112.94 108.05 16.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -110.16 167.14 10.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.41 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 3.8 m -118.02 117.39 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.642 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 73.5 t80 -70.38 114.85 8.9 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.868 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 11.6 tt0 -88.05 -170.69 3.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.324 -2.216 . . . . 0.0 107.402 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 10.9 t30 -67.44 49.75 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.713 0.805 . . . . 0.0 112.135 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.69 4.58 11.65 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.2 t -117.32 155.12 19.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.298 -175.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 1.097 ' HB2' ' HB3' ' B' ' 14' ' ' PHE . 81.2 m-85 -122.81 119.15 29.72 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.306 164.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.07 121.02 37.52 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -67.07 167.58 19.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.105 1.203 . . . . 0.0 111.23 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.04 -2.65 14.99 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' A' ' 5' ' ' ILE . 38.8 mt-30 -119.24 144.17 46.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.683 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.8 141.19 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 5' ' ' ILE . 4.1 p -132.56 161.77 40.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.843 0.83 . . . . 0.0 112.028 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 20' ' ' VAL . 31.0 t70 -104.9 12.84 32.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.198 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 20' ' ' VAL . 6.9 mp -66.8 135.61 54.2 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.427 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.7 mmpt? -93.67 -172.26 2.84 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.523 -176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -61.63 160.52 11.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.895 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -19.72 72.63 0.0 OUTLIER Glycine 0 CA--C 1.495 -1.217 0 O-C-N 124.997 1.435 . . . . 0.0 114.132 -151.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.11 147.51 40.49 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 111.526 -2.337 . . . . 0.0 108.602 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HG3' HD23 ' B' ' 32' ' ' LEU . 13.2 tpt180 -88.14 119.17 28.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.879 ' HA ' ' CB ' ' B' ' 32' ' ' LEU . 0.0 OUTLIER -144.61 149.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.255 -174.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HB2' HD13 ' B' ' 32' ' ' LEU . 13.6 mttt -115.21 143.96 44.43 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.365 0.602 . . . . 0.0 110.286 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.696 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 1.5 mt -107.34 135.12 47.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HG2' ' HB2' ' B' ' 29' ' ' LYS . 7.5 ptmm? -106.82 143.79 34.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.736 HD21 HD21 ' B' ' 22' ' ' LEU . 21.9 tp . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.234 0.253 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.74 138.22 22.91 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.38 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.62 -174.34 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.718 2.279 . . . . 0.0 110.657 171.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.32 151.61 27.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.923 0.392 . . . . 0.0 111.179 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tt -67.99 110.26 3.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.137 0.494 . . . . 0.0 110.902 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.34 114.5 0.71 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -131.89 161.72 60.82 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 122.462 0.305 . . . . 0.0 110.475 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.69 164.84 31.61 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.686 2.257 . . . . 0.0 111.515 173.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.86 148.37 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.4 m -103.59 176.89 5.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.103 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.6 156.92 43.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.03 130.07 39.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.085 0.469 . . . . 0.0 110.227 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -85.43 -25.98 26.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.257 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -70.9 -16.1 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.533 0.682 . . . . 0.0 111.206 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.436 -1.131 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.873 179.087 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 18' ' ' GLN . 10.4 mm -113.14 146.43 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -109.39 131.21 55.28 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' B' ' 14' ' ' PHE . . . -143.12 164.33 30.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 0.0 111.248 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.22 128.87 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.282 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 41.2 t80 -84.76 100.85 11.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -115.12 120.42 39.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.859 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.32 33.29 9.19 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.965 0.79 . . . . 0.0 111.35 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' B' ' 9' ' ' TYR . . . 83.56 14.28 73.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.211 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.5 t -120.12 146.7 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 1.097 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -99.93 114.94 28.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -119.0 108.96 39.91 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.637 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 39.2 Cg_endo -68.85 168.27 20.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.467 1.445 . . . . 0.0 112.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.36 -9.55 17.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.504 ' HB2' HG23 ' B' ' 5' ' ' ILE . 72.4 mt-30 -102.38 145.69 29.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.205 173.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -84.39 124.19 31.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 163.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.7 t -90.57 148.93 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.431 -161.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.42 16.38 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.027 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.736 HD21 HD21 ' A' ' 32' ' ' LEU . 22.1 mt -99.76 -174.62 2.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.089 -173.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 26' ' ' GLU . 37.8 tttm -116.28 155.12 28.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.267 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 1.5 mp0 -62.64 123.46 18.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.049 0.452 . . . . 0.0 109.955 175.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.73 22.92 34.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.036 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' HD22 ' B' ' 22' ' ' LEU . 16.9 mm-40 -84.02 143.02 30.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' B' ' 27' ' ' ARG . 4.3 tpp180 -86.28 120.51 27.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.4 1.095 . . . . 0.0 112.442 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.696 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 34.6 m -136.07 151.55 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.832 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.741 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 47.7 mmtt -117.35 144.63 44.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 18.7 mt -133.12 137.08 54.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.807 0.813 . . . . 0.0 111.967 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -158.16 135.85 10.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.155 169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.879 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 8.8 tp . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -131.34 114.82 16.03 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 120.876 0.37 . . . . 0.0 110.889 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.11 -175.83 2.37 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.158 2.572 . . . . 0.0 112.289 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt 69.27 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.435 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.468 ' OD2' ' HG ' ' B' ' 41' ' ' LEU . 36.2 t70 -155.4 -69.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.862 -173.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' B' ' 40' ' ' ASP . 94.3 mt -100.04 168.0 10.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.274 0.559 . . . . 0.0 112.147 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 120.93 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.693 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 36.1 mm-40 -97.11 144.18 27.44 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.579 0.228 . . . . 0.0 111.123 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.71 156.15 64.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.98 2.453 . . . . 0.0 112.279 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.49 158.79 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.936 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -87.27 168.24 13.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.88 162.4 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.353 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.36 122.95 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.965 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.13 25.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.023 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 C--N 1.319 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.721 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -95.9 143.14 27.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 120.991 0.424 . . . . 0.0 111.1 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.52 124.65 48.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.61 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.1 t -79.86 148.52 31.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 110.424 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 2.8 p -94.82 -0.09 54.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' B' ' 61' ' ' SER . 1.0 OUTLIER 39.7 84.58 0.02 OUTLIER 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.651 1.219 . . . . 0.0 112.947 -178.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 100.91 0.16 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.244 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -85.01 57.91 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.17 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -70.29 108.18 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.138 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.1 134.31 22.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -120.2 117.27 27.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -78.57 142.21 37.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.453 178.968 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.884 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 CA-C-O 121.262 0.553 . . . . 0.0 112.235 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' HZ ' ' B' ' 14' ' ' PHE . 2.0 mt -93.54 145.54 7.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -99.54 109.72 22.23 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.195 -169.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.943 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -115.68 156.97 24.95 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -166.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.623 HG22 HH12 ' B' ' 27' ' ' ARG . 0.1 OUTLIER -123.31 123.62 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.709 171.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.5 t80 -80.37 105.63 11.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 50.0 mt-10 -126.83 139.69 52.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.569 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' CG ' ' B' ' 24' ' ' GLU . 4.6 t30 65.36 20.37 11.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 111.554 172.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 84.25 15.62 68.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.5 t -122.48 154.08 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.7 m-85 -99.43 114.64 27.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 165.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 37.7 mtpt -116.97 108.92 43.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.108 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.943 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 14.4 Cg_endo -72.75 169.17 22.63 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 113.491 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.36 -12.37 59.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.681 ' HG2' ' HG2' ' A' ' 16' ' ' PRO . 6.2 mm-40 75.1 -134.05 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.0 116.731 160.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.0 mttt 59.07 -161.25 0.26 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.454 -141.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' HG ' ' A' ' 22' ' ' LEU . 22.0 t 67.01 147.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.484 0.659 . . . . 0.0 110.435 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.03 26.74 3.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.684 0.754 . . . . 0.0 111.252 -171.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.43 ' HG ' ' CG1' ' A' ' 20' ' ' VAL . 94.7 mt -56.85 174.81 0.14 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.832 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -103.84 162.68 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 1.5 pm0 -83.62 149.57 26.45 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.82 73.06 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.695 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 21.5 tt0 -93.1 155.4 17.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -96.33 137.45 35.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.747 0.784 . . . . 0.0 112.465 -171.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.913 HG12 ' HA ' ' B' ' 32' ' ' LEU . 4.4 m -147.97 171.39 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.601 ' HD3' HG13 ' B' ' 4' ' ' ILE . 62.5 mttm -127.0 144.74 50.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.188 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.66 HG22 ' HB ' ' B' ' 28' ' ' VAL . 1.3 mm -113.05 131.55 64.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.765 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -121.57 124.29 44.01 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.801 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 37' ' ' GLU . 39.5 t . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 36' ' ' VAL . 12.4 pt-20 41.83 84.23 0.19 Allowed Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 124.298 1.039 . . . . 0.0 111.591 -171.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.24 174.39 8.16 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.465 2.776 . . . . 0.0 113.631 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mt -73.89 149.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.095 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -99.28 101.66 13.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.773 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 19.7 tp -83.13 -177.58 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -172.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' ' HG ' ' A' ' 41' ' ' LEU . . . -150.05 156.42 26.73 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.7 mp0 -54.6 124.1 47.71 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 123.785 0.344 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.37 128.25 29.28 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.497 2.131 . . . . 0.0 111.521 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.1 p -70.85 143.93 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.886 0.85 . . . . 0.0 111.661 -175.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -114.47 162.15 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.77 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.561 0.696 . . . . 0.0 111.456 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.31 -14.42 25.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.811 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.0 -27.22 68.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.537 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -93.12 -14.84 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -174.635 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.601 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.479 ' O ' HG12 ' A' ' 30' ' ' ILE . 9.0 mm -98.13 143.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -104.86 134.98 47.07 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.668 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -137.27 156.29 48.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.536 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.487 HG13 HD11 ' B' ' 17' ' ' LEU . 2.0 m -117.17 114.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.688 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 14.1 p90 -103.52 141.88 35.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.186 0.993 . . . . 0.0 113.25 -170.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -87.58 -170.98 3.24 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.582 172.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -65.7 63.45 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 O-C-N 124.504 1.127 . . . . 0.0 111.722 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 113.06 -5.71 25.46 Favored Glycine 0 C--N 1.301 -1.413 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.382 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' B' ' 9' ' ' TYR . 0.2 OUTLIER -104.37 139.02 26.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.437 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 42.5 m-85 -118.68 123.87 45.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.188 0.904 . . . . 0.0 111.353 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -122.79 117.32 28.75 Favored Pre-proline 0 N--CA 1.455 -0.184 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.527 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.4 Cg_endo -67.83 169.14 16.83 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.984 1.789 . . . . 0.0 113.74 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.487 HD11 HG13 ' B' ' 8' ' ' VAL . 4.7 mp -120.58 -17.81 7.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.432 171.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -96.42 146.97 24.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -62.96 148.54 47.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.438 0.637 . . . . 0.0 110.559 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' B' ' 22' ' ' LEU . 2.3 p -145.17 134.53 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 122.338 1.066 . . . . 0.0 111.818 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -121.13 15.08 11.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.709 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 32' ' ' LEU . 85.7 mt -66.39 167.22 10.92 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.09 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -112.68 160.4 17.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -173.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 2.3 mp0 -62.77 120.23 10.87 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.905 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.2 36.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.974 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -75.89 136.4 40.12 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.942 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.623 HH12 HG22 ' A' ' 8' ' ' VAL . 18.3 tpp180 -93.39 117.39 30.02 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.567 1.175 . . . . 0.0 112.522 -171.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 30' ' ' ILE . 19.8 m -141.79 158.25 21.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.459 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.884 ' HD3' HG13 ' A' ' 4' ' ' ILE . 52.5 mttp -120.76 147.2 45.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.823 HG21 ' CE2' ' B' ' 14' ' ' PHE . 1.3 mm -110.68 132.26 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.145 0.498 . . . . 0.0 110.976 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 4' ' ' ILE . 10.5 mtmt -118.56 136.86 53.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 171.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HA ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.08 -174.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 122.115 0.959 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -119.75 139.41 28.0 Favored Pre-proline 0 N--CA 1.435 -1.215 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.749 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.4 174.19 12.54 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 111.769 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.508 ' O ' HD12 ' B' ' 39' ' ' ILE . 1.9 pp -81.4 137.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -107.08 119.26 38.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.2 mt -134.32 168.89 18.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.262 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 118.14 2.64 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.7 mp0 -51.93 139.8 31.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 123.174 0.59 . . . . 0.0 111.572 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 130.2 37.33 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.637 2.225 . . . . 0.0 111.761 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.24 151.95 8.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.065 0.459 . . . . 0.0 110.476 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -94.3 169.71 10.03 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.884 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 132.84 65.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.503 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -72.46 120.01 17.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.264 0.554 . . . . 0.0 110.841 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.84 -23.33 48.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.365 -173.401 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -132.17 135.91 46.69 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.8 ptp -106.18 159.18 16.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.009 0.433 . . . . 0.0 111.066 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -71.14 173.59 7.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.112 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -90.25 -6.51 55.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.828 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 tp 51.1 30.58 5.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.8 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.44 129.62 50.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.03 0.443 . . . . 0.0 110.587 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -133.28 85.87 2.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.546 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -75.05 74.79 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.129 0.966 . . . . 0.0 110.759 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -104.06 111.82 24.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.818 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -127.55 141.63 51.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.499 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -105.76 137.94 42.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.523 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 9.7 p80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 120.878 0.37 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.574 ' HB ' HD12 ' B' ' 30' ' ' ILE . 19.4 mt -119.87 152.2 22.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 169.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.57 134.91 48.99 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.678 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.43 165.79 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.44 -175.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.474 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 10.5 m -118.42 127.98 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.27 0.557 . . . . 0.0 110.512 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.687 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 86.5 t80 -89.42 105.15 17.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.834 0.826 . . . . 0.0 110.637 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 8.5 pt-20 -91.86 -168.33 1.99 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.79 168.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.78 67.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.436 1.112 . . . . 0.0 112.43 -160.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . 105.38 0.4 40.58 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.012 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 1.9 t -115.16 141.97 29.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.262 -173.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.5 m-85 -108.31 115.59 30.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 166.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HE3' HG11 ' A' ' 13' ' ' VAL . 96.9 mttt -121.2 119.11 29.78 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.619 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -52.48 166.57 0.75 Allowed 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.382 2.055 . . . . 0.0 114.741 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.3 -67.4 0.99 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 110.215 -3.175 . . . . 0.0 103.655 167.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -71.44 141.73 50.26 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.08 -2.327 . . . . 0.0 108.628 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 13.8 mtpt -60.6 149.63 34.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.697 0.76 . . . . 0.0 112.395 -173.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 m -77.1 166.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.527 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.42 15.21 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.719 0.771 . . . . 0.0 110.148 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.527 HD11 HD22 ' B' ' 32' ' ' LEU . 79.0 mt -122.5 -169.91 1.99 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.378 -172.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 18.3 pttp -124.03 155.12 38.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.974 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.2 pm0 -66.19 134.28 52.41 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.21 0.528 . . . . 0.0 111.002 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.17 10.58 48.22 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.802 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 5.7 tp10 -84.46 146.56 27.56 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.807 -0.231 . . . . 0.0 110.757 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -102.5 125.08 49.1 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.557 1.17 . . . . 0.0 112.334 -175.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.512 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.3 m -134.15 156.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.414 -174.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.627 ' HB3' HD12 ' B' ' 4' ' ' ILE . 64.0 mttm -115.33 144.79 43.23 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.0 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.514 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.5 mm -115.79 144.3 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 -175.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -151.3 123.78 8.41 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' B' ' 28' ' ' VAL . 2.7 pt? . . . . . 0 C--N 1.31 -1.126 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.349 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.1 115.6 27.29 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.369 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.86 172.14 11.26 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.211 1.941 . . . . 0.0 112.298 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.57 165.24 32.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.062 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.64 118.37 15.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.903 0.382 . . . . 0.0 110.297 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 pt? -148.82 133.93 18.24 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.875 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.3 -155.07 31.15 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.227 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 49.0 mt-10 -118.13 143.08 32.17 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-O 120.527 0.204 . . . . 0.0 110.704 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 21.5 Cg_exo -65.94 142.44 68.8 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.943 2.429 . . . . 0.0 112.112 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.84 146.29 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.914 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -95.73 158.19 15.56 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.054 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.9 t -140.72 132.01 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.234 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -118.99 122.3 41.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.856 0.836 . . . . 0.0 110.954 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.48 -22.98 26.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.104 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.07 -3.51 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.532 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.713 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' B' ' 20' ' ' VAL . 1.9 mt -124.45 157.94 31.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 mt-10 -109.59 139.99 43.93 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.4 157.52 44.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.041 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' VAL . . . . . 0.659 HG13 HD11 ' B' ' 17' ' ' LEU . 6.0 m -104.26 117.35 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.602 0.715 . . . . 0.0 110.822 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 52.7 t80 -76.57 111.25 11.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.21 1.005 . . . . 0.0 111.181 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.696 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 36.6 mt-10 -88.51 -169.12 2.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.163 170.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.55 55.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.236 1.014 . . . . 0.0 112.349 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 112.65 6.72 23.01 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.8 t -116.08 149.59 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.885 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.8 m-85 -119.18 114.87 23.11 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 166.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.468 ' HE2' HG11 ' B' ' 13' ' ' VAL . 65.1 mttm -114.26 113.77 45.93 Favored Pre-proline 0 CA--C 1.506 -0.717 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.23 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -43.56 169.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.318 2.678 . . . . 0.0 116.642 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.946 ' O ' ' HG3' ' B' ' 18' ' ' GLN . 2.5 mt -131.17 103.91 6.76 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.753 167.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.946 ' HG3' ' O ' ' B' ' 17' ' ' LEU . 5.1 pp0? 79.38 178.58 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.068 2.547 . . . . 0.0 112.922 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.23 141.28 35.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -162.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' B' ' 5' ' ' ILE . 3.2 t -137.79 135.06 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.279 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.511 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -128.08 87.56 2.62 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 123.015 1.388 . . . . 0.0 109.149 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.434 HD13 ' HG2' ' B' ' 26' ' ' GLU . 60.6 mt -129.99 -169.95 2.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.032 -1.894 . . . . 0.0 111.119 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -91.1 -174.72 4.07 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -103.45 122.08 44.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.753 0.787 . . . . 0.0 110.24 170.279 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 25' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 93.02 15.16 53.16 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.409 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.434 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.8 tp10 -60.93 138.46 58.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.604 0.361 . . . . 0.0 110.524 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 0.1 OUTLIER -89.76 115.09 26.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.376 1.084 . . . . 0.0 111.662 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 32' ' ' LEU . 27.4 m -132.33 162.7 39.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.575 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -117.66 147.12 43.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.281 0.562 . . . . 0.0 109.598 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.574 HD12 ' HB ' ' A' ' 5' ' ' ILE . 2.1 mt -106.7 128.45 61.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.81 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -125.92 134.09 51.67 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 122.556 1.169 . . . . 0.0 108.852 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 22' ' ' LEU . 41.3 tp . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.03 -162.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -86.93 136.02 34.65 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.47 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.91 174.37 9.74 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.415 2.077 . . . . 0.0 111.657 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.22 144.81 8.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.91 -177.07 6.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.5 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.38 143.07 26.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 111.0 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 -123.59 5.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.026 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.3 OUTLIER -101.36 153.47 37.81 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 120.774 0.321 . . . . 0.0 111.055 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 1.8 Cg_endo -87.0 -159.57 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.551 2.834 . . . . 0.0 111.654 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 t -115.04 156.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -75.21 169.68 17.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.844 0.354 . . . . 0.0 111.312 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.04 136.92 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.8 -22.35 21.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.245 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.12 -28.19 67.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.518 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 110.945 -174.678 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.199 0.523 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.07 178.98 4.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.363 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t 74.91 137.23 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.139 0.899 . . . . 0.0 112.424 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -105.47 18.63 21.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.034 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 67.96 179.05 0.23 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.094 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 65' ' ' HIS . 40.7 tt0 -124.21 121.61 35.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.353 0.596 . . . . 0.0 111.83 -172.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -96.36 74.52 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' HIS . . . . . 0.513 ' HB2' ' HG2' ' B' ' 63' ' ' GLU . 2.2 t-160 -95.07 -8.91 35.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.736 -170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -99.25 127.49 45.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -139.26 115.57 10.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -73.68 -74.83 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.696 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.937 HG13 ' HD2' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.228 0.537 . . . . 0.0 111.876 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.42 147.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.76 128.51 52.91 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.47 151.57 44.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 6.6 m -115.87 119.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 121.381 0.61 . . . . 0.0 111.063 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.724 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 87.2 t80 -72.71 99.71 2.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -119.28 130.95 55.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.397 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.56 23.64 13.89 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.649 0.593 . . . . 0.0 112.035 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.515 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 92.1 10.43 61.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.354 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.9 t -122.92 142.83 38.03 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' B' ' 28' ' ' VAL . 48.7 m-85 -88.89 114.19 25.24 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 166.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -119.75 116.16 33.23 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.193 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.1 Cg_endo -58.27 166.38 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.33 1.353 . . . . 0.0 111.965 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -98.23 -13.67 20.71 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -122.37 155.36 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.728 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.28 131.85 35.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -111.26 150.05 13.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.0 14.7 20.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.279 1.038 . . . . 0.0 110.145 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.53 HD13 ' HG2' ' A' ' 26' ' ' GLU . 70.4 mt -79.06 176.75 9.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.577 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HG2' ' OE1' ' A' ' 26' ' ' GLU . 17.5 pttm -124.95 163.11 23.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 111.537 -172.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.9 pt-20 -66.24 116.92 7.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.85 14.91 14.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.646 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 3.9 tp10 -80.61 132.49 35.63 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -103.18 127.81 50.35 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 122.356 1.074 . . . . 0.0 111.534 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' B' ' 32' ' ' LEU . 35.7 m -135.19 162.09 38.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.719 -167.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.93 141.88 47.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.793 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 14.7 mt -122.21 137.49 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.569 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -158.04 167.48 29.76 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.108 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 162.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 37' ' ' GLU . 7.5 p . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 36' ' ' VAL . 1.4 mp0 -61.75 164.57 9.54 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 122.924 0.489 . . . . 0.0 111.239 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.46 179.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.624 2.216 . . . . 0.0 112.856 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.92 174.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.622 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.84 153.74 43.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.697 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.83 148.04 33.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.92 -144.62 5.93 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.813 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.6 mp0 -53.03 117.91 12.49 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.114 0.538 . . . . 0.0 110.716 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.94 124.31 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.43 2.087 . . . . 0.0 112.258 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.51 150.11 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.26 157.92 16.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.345 0.593 . . . . 0.0 111.481 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.46 96.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.78 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 15.8 pt-20 -84.3 1.07 46.61 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.553 -172.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.8 -25.07 10.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.441 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.3 pt -77.77 13.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.365 0.603 . . . . 0.0 111.301 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 32.5 tttt . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.831 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.416 ' N ' HD12 ' B' ' 4' ' ' ILE . 3.3 mp . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.997 0.903 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.594 HD13 HG12 ' B' ' 20' ' ' VAL . 9.9 mt -114.46 151.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.65 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 137.73 52.66 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.66 168.97 18.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.1 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.64 141.58 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 83.7 t80 -100.3 114.09 27.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.053 0.93 . . . . 0.0 109.958 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.714 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 44.7 mt-10 -87.58 -170.63 3.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.126 -1.852 . . . . 0.0 108.552 169.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 52.64 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.096 0.958 . . . . 0.0 112.07 -172.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 117.48 4.67 15.26 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.3 t -114.32 145.54 19.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.554 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' B' ' 9' ' ' TYR . 46.5 m-85 -117.68 115.45 25.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 166.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.87 114.33 46.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.709 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 9.5 Cg_endo -59.93 165.47 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-O 123.472 1.363 . . . . 0.0 113.2 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 -66.03 0.93 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.048 -2.796 . . . . 0.0 104.675 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.508 ' HB2' HG23 ' B' ' 5' ' ' ILE . 50.7 mt-30 -65.55 132.13 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.629 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -61.24 124.16 19.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.02 0.914 . . . . 0.0 110.47 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.594 HG12 HD13 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -101.82 132.95 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.177 -176.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.36 88.4 2.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.426 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.555 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 72.5 mt -130.57 -165.0 1.49 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.348 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -92.59 161.58 14.53 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -88.23 128.28 35.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.4 65.11 3.16 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 113.725 -1.579 . . . . 0.0 109.878 -160.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.93 142.8 29.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.646 -0.777 . . . . 0.0 109.864 173.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' B' ' 27' ' ' ARG . 1.0 OUTLIER -100.84 105.57 16.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.684 1.231 . . . . 0.0 111.768 -176.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 14' ' ' PHE . 33.8 m -123.96 164.83 21.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.979 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.937 ' HD2' HG13 ' A' ' 4' ' ' ILE . 31.7 mtmm -123.44 139.77 53.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.598 0.714 . . . . 0.0 110.935 177.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.465 HG21 ' CE1' ' B' ' 14' ' ' PHE . 10.7 mm -111.11 143.98 19.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.816 -171.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -147.42 161.22 41.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 113.84 -1.527 . . . . 0.0 107.377 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.67 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.2 pt? . . . . . 0 C--N 1.301 -1.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.75 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.0 112.15 26.88 Favored Pre-proline 0 N--CA 1.433 -1.312 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.876 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.28 173.53 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.416 2.077 . . . . 0.0 111.981 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.1 pt -95.81 155.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.31 123.78 28.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.863 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.36 115.54 28.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.28 113.67 2.39 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.55 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.86 155.51 80.41 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.551 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.21 145.21 77.72 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.474 2.116 . . . . 0.0 111.604 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.99 152.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.095 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -77.36 173.42 11.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.69 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 25.5 t -82.92 116.5 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.339 0.59 . . . . 0.0 110.354 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.73 155.49 18.54 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.924 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.94 -24.36 66.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.798 0.332 . . . . 0.0 111.672 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.41 ' N ' HD12 ' B' ' 50' ' ' ILE . 3.0 mp . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.815 0.817 . . . . 0.0 109.837 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.884 0.373 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -82.75 150.72 26.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.368 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 43.5 tpp -116.13 154.11 30.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.313 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 74.26 -0.58 3.31 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.589 0.556 . . . . 0.0 110.767 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -85.28 5.74 29.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.269 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.93 136.66 52.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.115 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 145.85 26.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -146.73 78.15 1.49 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.675 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -145.19 157.83 43.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -153.68 138.57 17.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -121.02 77.86 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -179.74 97.52 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.499 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.2 t60 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.791 -176.663 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.918 ' HG3' HD11 ' B' ' 34' ' ' LEU . 96.2 Cg_endo -86.7 137.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.954 2.436 . . . . 0.0 113.21 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -97.49 167.22 11.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.695 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.614 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -101.86 127.15 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' B' ' 29' ' ' LYS . 11.6 mm -93.99 147.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 39.6 mt-10 -113.77 134.75 54.58 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.51 156.54 48.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 11.5 m -110.27 115.16 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.747 0.784 . . . . 0.0 110.577 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.767 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 64.7 t80 -73.62 101.45 3.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.564 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' OE1' ' HG3' ' A' ' 15' ' ' LYS . 40.2 mt-10 -108.24 119.24 38.91 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.063 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 62.73 21.13 12.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 102.73 7.68 44.33 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.367 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.2 t -120.37 142.7 34.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-O 119.588 -0.244 . . . . 0.0 110.436 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 76.1 m-85 -93.0 115.58 28.25 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.976 170.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HG3' ' OE1' ' A' ' 10' ' ' GLU . 29.1 mmtp -107.57 108.75 62.03 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 17.9 Cg_endo -60.84 167.41 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 119.979 1.028 . . . . 0.0 112.501 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.74 -6.05 23.06 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' A' ' 5' ' ' ILE . 7.9 pt20 -138.41 111.97 8.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.631 173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 12.7 tmtt? -60.91 133.25 55.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.752 -171.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.8 t -113.6 140.99 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.114 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -116.33 87.49 2.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.789 1.281 . . . . 0.0 109.047 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' A' ' 26' ' ' GLU . 76.0 mt -127.11 -158.65 0.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.162 -2.29 . . . . 0.0 110.671 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -85.67 176.75 7.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 2.0 mp0 -89.7 123.31 33.61 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.97 0.891 . . . . 0.0 109.446 168.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.041 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 69.59 64.75 2.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.395 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HG2' HD13 ' A' ' 22' ' ' LEU . 5.6 tp10 -94.4 144.53 25.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.212 -0.994 . . . . 0.0 108.887 169.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 120.76 34.4 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.568 1.175 . . . . 0.0 114.013 -167.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.2 m -138.79 154.64 26.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -115.06 140.01 49.4 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HB ' ' B' ' 5' ' ' ILE . 1.8 mt -103.73 140.97 20.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.27 -173.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -125.58 138.06 53.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.773 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -105.87 119.18 38.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -64.27 126.61 28.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.475 0.655 . . . . 0.0 109.876 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.3 pt? -114.68 160.25 19.57 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.214 -169.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.872 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 10.9 mmpt? -100.86 152.52 20.42 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.582 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.88 141.79 13.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.472 0.653 . . . . 0.0 111.184 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.98 123.65 50.52 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.023 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.45 173.73 13.33 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.585 2.19 . . . . 0.0 112.444 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 pt -116.19 164.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.42 -172.3 2.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 tp -85.48 143.02 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.45 -142.3 5.47 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.866 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.9 161.41 63.54 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.297 . . . . 0.0 111.001 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.15 -174.87 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.827 2.351 . . . . 0.0 112.536 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.56 155.71 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.734 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 p -97.0 -178.43 4.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 53' ' ' ILE . 7.1 p -110.53 123.81 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.522 0.677 . . . . 0.0 110.892 175.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -103.5 179.65 4.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.16 -36.6 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.254 0.55 . . . . 0.0 111.777 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 mt -88.85 1.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.713 0.768 . . . . 0.0 110.361 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -92.47 -4.6 53.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.374 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.16 104.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.976 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 ' HA ' HG21 ' A' ' 47' ' ' VAL . 42.3 mt -74.85 -39.07 45.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.73 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -139.67 -166.95 2.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.13 151.51 22.45 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.216 0.532 . . . . 0.0 111.419 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -126.93 47.1 1.04 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.072 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.71 129.39 56.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 110.445 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.62 154.21 48.66 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 ttm -86.01 123.67 31.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.114 0.483 . . . . 0.0 111.613 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.6 t -84.5 133.01 34.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -81.69 1.91 32.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 0.0 110.305 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.4 mt 62.18 -171.67 0.16 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.478 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.61 128.31 43.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.063 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -115.4 -18.32 11.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.23 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' HB3' ' H ' ' A' ' 66' ' ' HIS . 6.0 m-70 58.09 -159.02 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.819 177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 65' ' ' HIS . 48.1 m80 -128.99 152.03 49.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -128.43 131.44 48.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -131.27 177.8 7.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.923 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 m80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.633 175.061 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.411 ' HG2' HD13 ' A' ' 34' ' ' LEU . 14.3 Cg_exo -69.62 88.17 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.23 1.954 . . . . 0.0 109.329 167.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -83.59 147.29 27.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -168.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 4' ' ' ILE . 2.7 mp -94.64 139.34 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.224 167.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 30' ' ' ILE . 29.7 mt -125.22 153.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -97.57 148.32 23.39 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.06 42.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 1.041 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.6 m -109.6 113.75 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.713 0.768 . . . . 0.0 110.531 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' B' ' 14' ' ' PHE . 37.5 t80 -67.47 100.87 0.9 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.84 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 92.2 mt-10 -102.46 112.59 25.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t30 63.09 13.45 6.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.24 169.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 119.71 2.36 12.98 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.886 -1.149 . . . . 0.0 112.479 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 15' ' ' LYS . 26.9 m -132.1 142.52 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.105 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 98.2 m-85 -86.85 116.31 24.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.955 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -105.84 111.15 64.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.144 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -44.93 168.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.333 -0.263 0 C-N-CA 123.126 2.55 . . . . 0.0 117.183 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.761 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -126.15 97.24 5.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.141 -2.299 . . . . 0.0 104.95 163.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 0.3 OUTLIER 85.53 148.38 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 O-C-N 125.717 1.886 . . . . 0.0 109.326 -167.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.41 157.95 34.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.279 -167.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.565 HG12 ' HG ' ' B' ' 22' ' ' LEU . 5.4 t -116.34 147.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.143 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -88.37 18.58 4.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.796 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.565 ' HG ' HG12 ' B' ' 20' ' ' VAL . 90.8 mt -92.29 162.86 14.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.069 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 175.0 5.91 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.105 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.6 mp0 -65.96 125.0 24.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.482 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.557 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.2 15.11 67.52 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.068 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 mm-40 -69.93 136.24 50.34 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.794 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -100.63 137.35 39.14 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.37 1.081 . . . . 0.0 112.303 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.3 m -150.12 172.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.135 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 87.0 mttt -125.04 139.23 53.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.345 0.593 . . . . 0.0 109.925 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.794 HG22 ' HB ' ' A' ' 28' ' ' VAL . 4.0 mt -140.48 149.51 21.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.551 -171.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 28' ' ' VAL . 42.3 mt -77.05 124.55 27.95 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.55 145.03 54.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.665 0.745 . . . . 0.0 112.001 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 2' ' ' PRO . 77.1 mt -109.68 178.36 4.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.696 -171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.559 ' O ' HG12 ' B' ' 36' ' ' VAL . 13.7 mptt -134.76 -170.22 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.007 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.559 HG12 ' O ' ' B' ' 35' ' ' LYS . 0.4 OUTLIER 61.53 161.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.043 1.337 . . . . 0.0 113.899 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -112.15 169.27 6.52 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.176 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.25 -166.48 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.344 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.436 ' N ' HD12 ' B' ' 39' ' ' ILE . 3.9 mp -93.66 150.45 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.931 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.11 143.34 51.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tt -134.33 132.83 39.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.91 155.44 17.19 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.1 pm0 -70.74 127.67 91.63 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.515 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 26.5 Cg_exo -62.73 160.55 32.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.063 2.509 . . . . 0.0 112.225 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.416 ' H ' HG12 ' B' ' 45' ' ' VAL . 1.5 p -63.73 138.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.855 0.836 . . . . 0.0 111.768 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -115.52 177.04 4.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.008 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' B' ' 51' ' ' LYS . 51.2 t -79.83 124.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -100.91 160.31 14.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.747 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.96 -25.9 63.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.911 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 tt -76.42 -7.46 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.256 0.55 . . . . 0.0 111.395 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.487 ' HD2' HG13 ' B' ' 47' ' ' VAL . 19.2 ttmt -80.71 151.66 28.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.187 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -71.44 106.37 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.363 0.602 . . . . 0.0 110.854 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -112.42 130.95 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.314 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -76.72 144.77 39.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.637 0.256 . . . . 0.0 110.589 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.2 166.12 11.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.111 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.5 61.63 0.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.888 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -82.6 103.26 12.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.94 150.41 22.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.9 ttt -142.24 124.97 15.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.648 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.3 p -116.06 164.19 14.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -99.53 -5.49 29.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp 45.99 84.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.864 0.727 . . . . 0.0 112.439 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 139.93 42.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -142.87 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -94.09 168.93 10.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 110.905 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -149.63 118.64 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.631 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.82 126.96 29.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -98.32 167.59 10.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.505 175.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.13 131.21 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.46 2.106 . . . . 0.0 113.552 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -133.61 143.01 48.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp -81.28 127.25 39.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.147 0.975 . . . . 0.0 112.73 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' B' ' 30' ' ' ILE . 18.0 mt -110.97 158.26 11.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.042 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HG2' ' CD ' ' B' ' 29' ' ' LYS . 44.5 mt-10 -123.47 134.61 53.89 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.44 165.98 22.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.456 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.605 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 4.8 m -110.96 121.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.408 0.623 . . . . 0.0 110.01 171.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.652 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 65.8 t80 -83.18 115.7 22.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.518 1.152 . . . . 0.0 110.677 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 61.3 mt-10 -86.7 -169.82 2.8 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.064 173.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.21 45.13 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.166 0.986 . . . . 0.0 111.829 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 122.52 5.16 8.64 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 10' ' ' GLU . 2.4 t -115.67 142.88 27.09 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.481 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 35.2 m-85 -111.72 114.89 28.19 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.846 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -119.95 116.37 32.85 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 122.407 -0.183 . . . . 0.0 111.188 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 20.0 Cg_endo -64.0 168.08 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.818 1.678 . . . . 0.0 112.088 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.65 -14.25 13.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HB2' HG23 ' A' ' 5' ' ' ILE . 63.6 mt-30 -104.24 128.52 51.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.11 -1.405 . . . . 0.0 108.871 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -71.32 140.15 50.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.739 0.781 . . . . 0.0 110.071 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 22' ' ' LEU . 6.0 p -133.17 140.94 45.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.372 -164.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -97.04 85.87 3.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.607 HD21 ' CD1' ' B' ' 9' ' ' TYR . 0.0 OUTLIER -116.97 173.92 6.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.759 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 5.1 mptp? -114.06 150.34 34.14 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.486 170.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.4 132.52 47.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.211 0.529 . . . . 0.0 111.197 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.03 51.16 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.119 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.671 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 25.3 tt0 -74.02 117.97 16.42 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 27' ' ' ARG . 28.4 ttt180 -84.97 126.49 33.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.562 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG12 HD23 ' B' ' 32' ' ' LEU . 35.5 m -132.5 166.89 27.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.25 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.713 ' HG2' ' HG2' ' B' ' 33' ' ' GLU . 11.4 mmmm -116.37 138.23 51.51 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 2.4 mm -120.84 140.58 44.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.308 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' B' ' 2' ' ' PRO . 85.9 tttt -156.05 149.92 25.17 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD21 HG12 ' B' ' 28' ' ' VAL . 44.9 mt -92.7 118.73 31.37 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.29 -179.83 7.53 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt 56.42 -161.57 0.19 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.235 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -87.81 164.1 16.1 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -97.78 136.48 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.027 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.67 151.03 43.43 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.374 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.83 173.68 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.119 1.879 . . . . 0.0 112.095 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.88 136.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 41' ' ' LEU . 20.7 t70 56.24 -158.88 0.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.18 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.512 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 pp -103.28 167.3 9.91 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.091 -0.381 . . . . 0.0 111.185 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.74 -131.91 5.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.441 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -106.79 108.69 62.35 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-O 120.652 0.263 . . . . 0.0 111.661 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 114.86 3.61 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.889 2.393 . . . . 0.0 111.408 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 46' ' ' SER . 7.6 p -102.21 158.47 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.264 0.554 . . . . 0.0 110.782 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 45' ' ' VAL . 1.2 m -100.7 162.72 12.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.788 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.83 121.48 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.704 0.764 . . . . 0.0 111.237 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -144.73 -36.77 0.31 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.253 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.76 -25.52 26.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.501 0.667 . . . . 0.0 110.756 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.04 1.69 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.005 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -98.1 135.05 40.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 0.0 110.575 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -123.57 135.24 53.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 tt -105.89 141.93 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 54' ' ' ARG . 42.0 ttm180 -127.53 141.14 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.26 164.38 24.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.904 0.383 . . . . 0.0 111.381 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.34 147.75 16.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.977 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.68 130.61 36.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.758 0.313 . . . . 0.0 111.055 -175.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' MET . 2.2 p-90 -100.46 172.99 6.78 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 44.7 mmm 75.16 161.92 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.725 0.774 . . . . 0.0 112.224 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.0 t -129.81 177.56 7.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.165 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 50.2 m -81.69 19.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.216 0.322 . . . . 0.0 111.019 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 61' ' ' SER . 7.7 mp 69.57 137.06 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.006 0.922 . . . . 0.0 111.776 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -105.14 113.52 27.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -113.8 117.75 32.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -75.74 100.92 4.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.34 121.6 8.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.067 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -77.92 80.92 4.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.86 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -112.9 130.03 56.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.88 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.162 174.394 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.58 ' N ' HD21 ' B' ' 22' ' ' LEU . 1.5 mpt? . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.44 ' O ' ' HE3' ' A' ' 31' ' ' LYS . 43.2 Cg_endo -70.7 -19.79 31.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.311 2.007 . . . . 0.0 111.292 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.87 165.88 24.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.903 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.78 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -93.14 128.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.382 0.61 . . . . 0.0 110.43 176.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 15.5 mm -90.48 154.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.561 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 29' ' ' LYS . 45.9 mt-10 -124.79 130.53 52.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.94 163.43 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 3.9 m -128.61 116.87 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 112.013 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -65.31 106.34 1.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.591 0.71 . . . . 0.0 110.398 175.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.611 ' HB2' ' HD3' ' B' ' 15' ' ' LYS . 34.7 mt-10 -129.95 133.79 47.04 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.887 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.91 32.32 22.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.402 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.08 -68.3 0.39 Allowed Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 117.432 -2.318 . . . . 0.0 111.92 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 4.8 m -106.21 155.93 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.153 -156.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -84.85 113.69 21.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' B' ' 10' ' ' GLU . 39.9 mtpt -97.94 113.65 64.04 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.744 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.9 Cg_endo -62.09 167.28 11.0 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.122 1.215 . . . . 0.0 111.931 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.56 -12.13 12.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -120.83 161.67 21.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.176 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -77.83 132.12 37.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.232 0.539 . . . . 0.0 112.035 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 1.8 t -132.74 144.26 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.044 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.72 87.54 1.5 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.405 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 87.9 mt -109.91 -2.66 17.05 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.452 172.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 57.6 mttp 77.17 157.77 0.19 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.506 172.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.92 133.49 55.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.102 -164.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.605 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.6 64.93 3.5 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.429 -169.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.602 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 0.0 OUTLIER -101.47 135.09 43.55 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.56 167.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -77.14 117.21 18.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.107 0.956 . . . . 0.0 111.395 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.56 HG12 HD21 ' A' ' 32' ' ' LEU . 28.2 m -130.2 156.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.694 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CD ' ' HG2' ' A' ' 6' ' ' GLU . 33.2 mmtp -109.36 134.75 51.43 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.321 0.581 . . . . 0.0 110.487 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 5' ' ' ILE . 3.5 mm -112.54 143.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.987 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 160.51 39.77 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.319 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.438 HD23 HG12 ' A' ' 28' ' ' VAL . 83.5 mt -99.82 135.75 40.77 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.734 -172.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.713 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 23.0 mm-40 -101.49 145.47 28.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.179 0.99 . . . . 0.0 112.305 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.98 153.73 30.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.489 -1.687 . . . . 0.0 107.737 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.07 154.01 26.03 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.112 0.482 . . . . 0.0 111.008 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.27 160.55 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.317 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' B' ' 37' ' ' GLU . 7.1 pt-20 -50.6 110.93 1.91 Allowed Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 123.558 0.536 . . . . 0.0 111.676 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.45 172.89 3.95 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.334 2.022 . . . . 0.0 111.851 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.12 150.0 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -91.44 141.24 28.96 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.56 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.7 mm? -61.16 116.82 4.86 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.326 0.391 . . . . 0.0 110.779 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.63 114.03 4.55 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.498 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.4 pm0 -75.56 147.92 82.34 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 114.621 -0.789 . . . . 0.0 110.37 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.14 130.11 29.51 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.304 2.003 . . . . 0.0 111.833 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -77.99 150.32 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -101.04 169.74 8.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.987 0.423 . . . . 0.0 110.87 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 135.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' B' ' 51' ' ' LYS . 41.9 mt-10 -98.51 149.36 22.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -28.73 43.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.682 0.753 . . . . 0.0 109.287 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.15 13.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.595 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' B' ' 48' ' ' GLU . 38.5 tptt -72.65 136.58 45.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.071 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' B' ' 52' ' ' LYS . 30.7 mmtp -83.22 162.92 21.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp 57.25 86.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.539 0.685 . . . . 0.0 110.549 -169.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 70.68 94.49 0.08 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.04 150.78 32.68 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.91 124.81 8.25 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.055 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -166.49 175.75 7.86 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -95.95 134.33 39.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.9 ttt -104.13 146.82 28.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.6 t 75.73 128.62 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 O-C-N 124.218 0.949 . . . . 0.0 110.994 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -97.52 1.59 49.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.057 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp 53.35 83.72 0.06 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.507 0.67 . . . . 0.0 111.417 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 159.71 15.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.006 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -85.72 35.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.562 0.696 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.79 72.4 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.348 0.594 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -77.78 123.48 26.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -100.92 126.58 47.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.836 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.81 136.51 53.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.478 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.023 177.736 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.507 0.194 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.15 99.08 1.06 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.791 2.327 . . . . 0.0 111.563 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -146.4 172.9 12.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.019 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER -113.19 143.56 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.909 HD13 HG21 ' A' ' 20' ' ' VAL . 1.4 mt -99.2 145.98 9.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -101.33 132.86 46.67 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.15 155.85 49.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.324 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.33 117.06 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.416 0.626 . . . . 0.0 110.346 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 77.5 t80 -73.54 119.33 17.62 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.708 176.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 41.3 tt0 -144.96 130.19 18.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.424 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 t30 70.77 22.76 4.72 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.829 0.705 . . . . 0.0 110.802 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 83.04 17.96 66.14 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.656 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 14.6 t -122.68 149.59 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 82.5 m-85 -97.69 115.28 27.64 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 166.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.0 mmmt -116.38 107.91 46.38 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.7 Cg_endo -59.8 167.89 6.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.213 1.275 . . . . 0.0 112.825 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.66 -8.6 20.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.211 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.0 pm0 -138.37 140.05 39.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.083 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 7.9 tmtt? -76.94 132.4 39.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.558 0.694 . . . . 0.0 110.551 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 5' ' ' ILE . 2.9 t -122.49 141.43 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.195 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -100.74 87.94 3.46 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 122.702 1.239 . . . . 0.0 108.148 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' B' ' 9' ' ' TYR . 69.0 mt -111.25 -175.43 2.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.383 -2.189 . . . . 0.0 110.61 174.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.975 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 47.9 mtpt -93.41 165.86 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.559 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.35 129.77 34.79 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.644 0.735 . . . . 0.0 109.589 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.157 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.74 64.65 3.56 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.738 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.975 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 1.9 mm-40 -89.93 150.24 22.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -0.629 . . . . 0.0 110.463 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -89.75 104.48 17.04 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.929 1.347 . . . . 0.0 112.527 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.611 HG12 HD13 ' B' ' 32' ' ' LEU . 35.3 m -126.99 154.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.41 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.911 ' HD3' HG13 ' B' ' 4' ' ' ILE . 54.8 mttm -111.56 144.68 40.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.516 HG21 ' CE1' ' A' ' 14' ' ' PHE . 11.8 mm -104.36 133.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.945 0.878 . . . . 0.0 109.234 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -140.69 161.28 38.13 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' B' ' 28' ' ' VAL . 6.8 mp -112.62 149.45 32.8 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.9 -166.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -66.69 124.74 23.73 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.17 153.17 22.83 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.573 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.55 157.46 16.18 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.18 137.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.29 -172.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -118.03 85.0 22.65 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.937 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -90.71 -154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.417 2.744 . . . . 0.0 110.278 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mt -95.79 139.1 19.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.99 116.37 30.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.557 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.2 pt? -86.24 128.52 34.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.05 114.26 1.24 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.981 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 124.39 30.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.46 125.1 14.37 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.81 2.34 . . . . 0.0 112.266 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.12 148.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.348 0.594 . . . . 0.0 110.863 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.9 m -101.02 173.99 6.22 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.277 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.32 147.8 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.76 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 24.2 mt-10 -86.93 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.342 . . . . 0.0 111.297 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -86.42 -31.35 21.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.693 0.758 . . . . 0.0 109.363 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 pt -84.29 12.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.423 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 41.4 tttp -71.23 133.0 45.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -141.12 117.74 10.94 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pt -108.14 97.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.255 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -128.78 139.67 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 112.282 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.8 153.89 33.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.482 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.63 134.92 8.27 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.978 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -150.07 140.9 22.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.136 0.493 . . . . 0.0 110.629 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -156.04 135.61 12.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.953 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -160.62 148.26 15.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.157 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -128.39 119.33 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.748 0.309 . . . . 0.0 110.213 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.9 p -105.51 19.11 21.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 110.722 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -73.46 71.48 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.739 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.84 118.91 17.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -160.85 140.46 10.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -112.33 126.83 55.69 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -140.98 116.99 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 112.019 -168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.47 -55.87 1.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -142.62 -24.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 p80 . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.792 172.987 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 39.2 mtt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 8.7 Cg_exo -73.19 139.94 30.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.498 2.132 . . . . 0.0 110.513 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' B' ' 4' ' ' ILE . 20.3 ttmt -110.52 154.02 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.123 0.487 . . . . 0.0 110.235 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.911 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -79.84 135.91 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.171 172.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 pt -108.85 134.21 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 19.8 mp0 -86.08 142.65 28.56 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.532 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -135.05 164.38 27.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.163 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 1.157 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 8.5 m -122.48 130.81 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.276 0.56 . . . . 0.0 110.819 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 91.8 t80 -72.05 112.76 8.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.08 1.419 . . . . 0.0 111.55 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 1.038 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 10.6 tp10 -87.81 -176.48 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.241 -2.254 . . . . 0.0 106.919 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.445 ' H ' ' HG3' ' B' ' 10' ' ' GLU . 1.2 t-20 -66.86 61.28 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.266 1.031 . . . . 0.0 111.93 -172.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 109.31 8.25 27.33 Favored Glycine 0 C--N 1.299 -1.482 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.023 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 1.038 ' HB ' ' HB3' ' B' ' 10' ' ' GLU . 2.5 t -118.75 156.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 114.769 -0.716 . . . . 0.0 111.419 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 71.1 m-85 -118.37 115.15 24.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 161.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.581 ' HE3' ' HG2' ' B' ' 10' ' ' GLU . 98.2 mttt -108.48 117.49 54.31 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.638 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 26.1 Cg_endo -64.43 168.73 12.31 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.109 1.206 . . . . 0.0 111.701 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.723 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -110.05 -10.46 14.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -101.67 155.41 18.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.105 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -74.99 141.77 43.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.655 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.462 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.0 t -118.82 146.03 24.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.317 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -126.09 15.27 7.89 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.187 0.994 . . . . 0.0 109.454 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.562 HD13 ' HG2' ' B' ' 26' ' ' GLU . 94.1 mt -83.46 -172.79 4.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.357 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -128.28 177.88 6.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.635 0.255 . . . . 0.0 111.016 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 2.5 mp0 -66.08 140.36 58.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.04 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 16.79 70.73 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.606 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.562 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.3 tp10 -79.8 126.2 30.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' B' ' 27' ' ' ARG . 15.3 mmm180 -85.0 129.57 34.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.21 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.712 HG12 ' HG ' ' A' ' 32' ' ' LEU . 30.2 m -142.0 166.36 16.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.724 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.419 ' HD3' HG13 ' A' ' 4' ' ' ILE . 41.8 mttp -116.58 145.21 43.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.433 HG21 ' CE1' ' B' ' 14' ' ' PHE . 6.6 mm -117.45 143.97 26.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.685 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' A' ' 4' ' ' ILE . 29.6 tptp -154.55 128.2 8.66 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.569 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.611 HD13 HG12 ' A' ' 28' ' ' VAL . 3.4 mm? -66.14 125.49 25.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.35 153.26 44.09 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.659 0.742 . . . . 0.0 112.757 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' B' ' 35' ' ' LYS . 16.1 tp -128.21 159.77 34.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.456 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.442 ' N ' ' HG ' ' B' ' 34' ' ' LEU . 92.3 mttt -98.16 159.14 15.13 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.909 0.385 . . . . 0.0 110.796 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -111.87 149.78 14.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.071 172.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -151.36 126.41 4.73 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.971 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 174.13 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.418 2.079 . . . . 0.0 112.75 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 pt -87.41 160.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.15 135.53 36.6 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.16 164.65 33.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.871 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.79 -156.44 22.8 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.41 127.45 15.6 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.698 0.285 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.93 117.48 5.06 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.854 2.369 . . . . 0.0 112.726 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -124.72 152.43 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.54 149.4 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.32 0.581 . . . . 0.0 111.471 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.78 150.16 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.326 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.11 115.09 24.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.225 1.012 . . . . 0.0 112.707 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -86.68 -26.62 24.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.584 171.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mm -80.01 -10.38 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.702 -171.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' B' ' 52' ' ' LYS . 5.0 tmtt? -135.93 135.09 39.35 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.045 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.527 ' N ' ' HD3' ' B' ' 51' ' ' LYS . 74.8 tttt -139.27 169.36 17.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.339 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.472 HD12 ' HG2' ' B' ' 52' ' ' LYS . 4.4 mp 54.85 102.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 111.646 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -143.66 124.17 13.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.714 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -84.17 168.95 15.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.243 0.544 . . . . 0.0 111.268 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' B' ' 57' ' ' THR . . . -173.5 -172.61 39.09 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.027 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' B' ' 56' ' ' GLY . 60.4 m 72.09 145.49 0.07 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.229 0.538 . . . . 0.0 111.36 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -110.1 134.9 51.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 47.3 ttm -79.36 128.73 33.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -66.83 106.9 2.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.305 0.574 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -99.52 3.44 45.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.368 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 61.48 179.11 0.12 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.528 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.23 144.25 50.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -78.78 88.84 4.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.638 0.732 . . . . 0.0 110.173 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -88.12 117.43 27.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -127.29 127.5 44.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.601 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' B' ' 68' ' ' HIS . 25.7 t-80 -87.13 -103.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 67' ' ' HIS . 44.9 t-80 156.65 146.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.402 173.597 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -74.22 44.83 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.433 2.755 . . . . 0.0 112.832 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -149.5 158.94 44.62 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 111.325 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -127.09 129.36 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.249 166.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.82 HG13 ' HB ' ' B' ' 30' ' ' ILE . 3.7 pt -90.52 137.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -99.45 142.38 31.0 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.928 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.21 164.31 28.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.168 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 11.8 m -120.0 126.11 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.665 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.8 t80 -94.65 111.28 23.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.057 -177.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 5.9 pt-20 -130.67 141.29 50.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.785 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.8 t30 60.83 21.4 11.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 87.86 13.08 65.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.863 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 12.5 t -119.53 143.75 30.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.741 -0.23 . . . . 0.0 110.633 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 49.0 m-85 -103.41 115.62 30.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 166.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.67 114.87 61.4 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.7 Cg_endo -62.81 168.69 9.9 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 120.634 0.89 . . . . 0.0 111.939 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -102.43 -4.46 25.42 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -128.26 127.71 43.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.169 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.53 131.27 40.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -124.2 137.74 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.647 0.737 . . . . 0.0 110.628 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.42 87.82 5.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.38 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.5 mt -121.54 -171.94 2.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.073 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -98.7 -176.18 3.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.956 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 5.3 mp0 -89.22 138.46 31.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.3 0.571 . . . . 0.0 110.162 171.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.747 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.3 65.25 3.05 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.378 -168.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 9.1 tp10 -93.27 128.24 39.18 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.635 -0.783 . . . . 0.0 109.344 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -81.62 114.95 20.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.71 1.243 . . . . 0.0 111.569 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 HD23 ' B' ' 32' ' ' LEU . 35.2 m -131.5 164.23 35.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.059 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.817 ' HE2' ' HG3' ' B' ' 33' ' ' GLU . 52.3 mttm -119.92 143.02 48.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.23 0.538 . . . . 0.0 110.08 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.513 HD12 HD12 ' B' ' 30' ' ' ILE . 3.7 mm -110.65 140.46 29.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.144 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -147.4 165.82 29.06 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.667 0.746 . . . . 0.0 110.294 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD21 HD22 ' B' ' 22' ' ' LEU . 74.9 mt -113.87 129.24 56.61 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 33' ' ' GLU . 4.6 tp10 -64.13 147.46 52.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.667 0.746 . . . . 0.0 112.739 -166.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -147.01 -172.66 4.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.225 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -109.51 170.93 7.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.511 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.66 144.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.332 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.3 mm-40 -85.83 131.47 47.06 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.178 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.6 Cg_exo -79.88 -166.85 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.09 2.527 . . . . 0.0 111.854 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 pt -101.39 168.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.306 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.4 142.42 24.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.991 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.11 153.98 40.67 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.98 -143.29 14.5 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.926 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.0 pt-20 -111.78 147.06 36.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 122.203 0.201 . . . . 0.0 111.001 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 20.0 Cg_exo -67.33 170.96 12.37 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.118 2.545 . . . . 0.0 111.382 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.92 153.29 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 110.158 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p -122.52 162.1 22.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 111.608 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.6 t -131.17 135.57 59.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.669 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.13 133.62 52.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 0.0 111.477 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.86 -21.13 40.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.428 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.63 -13.66 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.705 0.764 . . . . 0.0 110.009 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 30.1 ttmt -93.39 131.82 38.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.87 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 16.3 ptpt -158.75 -165.2 1.59 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.566 0.222 . . . . 0.0 111.51 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 67.2 mt 73.65 100.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -130.53 143.06 50.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.611 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -122.41 153.51 38.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.527 0.68 . . . . 0.0 111.174 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 80.29 0.33 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.338 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 118.83 6.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.108 0.48 . . . . 0.0 111.501 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -147.21 150.21 34.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.212 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.86 -163.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.419 -175.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.9 m 62.57 21.4 12.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.367 0.604 . . . . 0.0 111.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -87.47 19.03 3.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.015 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -114.05 154.86 26.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -125.91 136.14 52.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -117.74 93.35 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -130.01 124.16 32.28 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.883 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -108.12 -174.45 2.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.0 31.3 2.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 55.9 t-80 -174.96 -91.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 17.7 t-80 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.403 -1.284 . . . . 0.0 107.933 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.87 -173.48 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.953 2.435 . . . . 0.0 112.852 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -127.38 153.7 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.243 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.485 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -124.04 144.3 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.058 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 11.2 mt -104.2 144.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -105.95 130.75 53.83 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.379 0.609 . . . . 0.0 110.422 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.48 154.92 46.78 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.623 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.747 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 3.6 m -110.97 115.37 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 121.507 0.67 . . . . 0.0 110.926 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 47.4 t80 -75.23 111.46 10.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.274 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.9 tt0 -120.13 116.83 26.45 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.694 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.27 19.59 11.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.876 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 109.59 5.57 29.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.215 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 3.5 t -118.06 142.43 32.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.794 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 74.0 m-85 -97.97 116.63 30.57 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.109 -0.637 . . . . 0.0 109.621 171.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.727 ' HE3' HG11 ' B' ' 13' ' ' VAL . 33.8 mmtp -117.54 111.49 39.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.7 Cg_endo -60.49 167.97 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.299 1.333 . . . . 0.0 111.994 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.695 HD11 HG13 ' B' ' 8' ' ' VAL . 6.7 mp -111.51 -21.92 11.53 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -115.46 3.72 14.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.053 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 16' ' ' PRO . 54.8 mtmt 55.65 167.71 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.263 -1.79 . . . . 0.0 113.534 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' B' ' 22' ' ' LEU . 3.5 t -144.12 154.22 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.788 -175.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -136.7 86.81 2.24 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 123.139 1.447 . . . . 0.0 109.605 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' B' ' 20' ' ' VAL . 0.4 OUTLIER -132.52 104.68 6.81 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 112.132 -2.303 . . . . 0.0 110.196 166.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.727 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 96.0 mttt 33.95 -163.07 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 114.4 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -115.47 127.12 55.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.697 163.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.615 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 53.96 65.19 3.63 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.497 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.727 ' HG2' ' HD2' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -99.03 145.52 27.01 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 167.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -95.71 123.33 39.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.477 1.132 . . . . 0.0 112.391 -168.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.3 m -131.04 174.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.973 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -112.91 142.22 45.83 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.82 ' HB ' HG13 ' A' ' 5' ' ' ILE . 4.3 mm -119.16 141.08 40.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.224 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.404 ' HD3' HG22 ' A' ' 4' ' ' ILE . 56.5 tptt -143.66 125.91 15.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.492 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.758 HD23 HG12 ' A' ' 28' ' ' VAL . 27.9 mt -59.77 135.96 57.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.817 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 41.8 tt0 -61.12 142.55 56.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.955 0.883 . . . . 0.0 113.03 -169.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.66 167.33 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.139 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -124.45 168.82 12.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.328 0.585 . . . . 0.0 110.872 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.36 127.51 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -111.47 119.64 44.63 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 120.917 0.389 . . . . 0.0 111.136 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.32 -176.52 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.96 2.44 . . . . 0.0 111.839 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.4 HD12 ' O ' ' B' ' 39' ' ' ILE . 1.8 pp -103.99 152.59 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.496 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.08 103.99 6.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 50.0 tp -135.04 139.09 44.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.86 114.25 2.58 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' B' ' 44' ' ' PRO . 45.9 mt-10 -92.26 162.26 30.62 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.739 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 43' ' ' GLU . 76.7 Cg_exo -49.8 142.18 26.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.42 2.747 . . . . 0.0 113.968 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 164.74 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.6 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -78.77 164.08 24.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.234 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.57 164.76 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.519 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 51' ' ' LYS . 13.8 mt-10 -62.45 110.56 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.41 -29.61 22.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.373 0.606 . . . . 0.0 110.386 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.69 13.62 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.391 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' B' ' 48' ' ' GLU . 21.2 tptm -82.07 132.78 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -158.4 147.63 19.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.265 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -81.25 115.34 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -110.12 98.04 7.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.363 0.602 . . . . 0.0 110.617 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.89 163.55 29.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.03 145.86 14.22 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.694 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.2 t -160.65 158.57 29.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -130.02 146.39 51.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.825 0.345 . . . . 0.0 110.336 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.3 mtt -94.85 178.36 5.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.046 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.7 t -135.04 122.93 22.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -94.22 -6.43 44.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.86 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.304 1.002 . . . . 0.0 112.132 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.43 115.72 16.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 111.087 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -99.24 110.55 23.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.377 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.83 116.93 20.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.831 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 77.19 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.258 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -96.23 94.12 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -81.99 129.62 34.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.697 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.427 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.64 112.22 3.32 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.907 2.405 . . . . 0.0 111.429 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -157.22 148.19 21.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.486 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.35 144.71 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.815 174.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 18' ' ' GLN . 16.9 mt -98.77 155.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 17' ' ' LEU . 7.0 mp0 -113.1 144.14 43.15 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -144.14 161.04 39.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.454 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.892 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.6 m -121.95 115.22 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.679 0.752 . . . . 0.0 110.493 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 63.8 t80 -75.2 114.74 14.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.737 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 5.5 pt-20 -105.64 132.24 52.03 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 164.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.493 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 34.3 p-10 -74.0 63.55 0.95 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -149.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . -142.96 -7.08 0.62 Allowed Glycine 0 C--N 1.27 -3.094 0 CA-C-N 110.899 -2.864 . . . . 0.0 107.743 149.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 19.0 m -160.76 150.11 5.36 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -155.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.6 m-85 -99.48 116.52 31.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.701 ' HD3' ' HG2' ' A' ' 10' ' ' GLU . 23.3 mtpp -109.18 111.61 60.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.402 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.7 Cg_endo -53.8 165.12 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.592 1.528 . . . . 0.0 113.978 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 6' ' ' GLU . 93.1 mt -93.06 -66.43 0.92 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.436 165.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.51 ' HB2' HG23 ' A' ' 5' ' ' ILE . 71.0 mt-30 -61.33 132.63 54.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 112.982 -1.917 . . . . 0.0 108.636 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -65.67 139.25 58.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.571 0.701 . . . . 0.0 110.436 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 22' ' ' LEU . 2.4 p -106.56 146.82 12.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.575 -167.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -133.85 13.76 3.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.099 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 20' ' ' VAL . 86.7 mt -72.93 -176.63 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.853 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 14.8 pttp -125.18 165.41 18.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.192 -174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 3.8 mp0 -66.47 143.29 57.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.694 0.759 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.52 65.47 3.39 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.299 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.5 tp10 -106.82 124.39 49.54 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.06 110.36 21.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 123.499 1.619 . . . . 0.0 113.266 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.955 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.8 m -122.81 149.35 26.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.986 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD3' ' HG3' ' B' ' 6' ' ' GLU . 47.0 mmtm -103.3 138.73 39.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mm -92.6 130.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 4' ' ' ILE . 9.7 tttt -136.45 134.67 37.92 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.171 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD21 HG12 ' B' ' 28' ' ' VAL . 89.5 mt -102.62 128.49 49.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.396 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 33' ' ' GLU . 7.7 pt-20 -69.74 138.18 52.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -165.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 32' ' ' LEU . 5.1 mp -127.82 -172.64 2.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.765 172.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -114.59 164.89 13.38 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.743 0.306 . . . . 0.0 110.743 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.18 154.16 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.04 159.42 65.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.237 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.78 178.21 7.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.709 2.273 . . . . 0.0 112.373 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.1 pt -80.01 174.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.78 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.36 121.57 14.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.556 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -131.95 154.4 49.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.706 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.79 131.83 2.07 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.337 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.26 135.77 44.0 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.884 0.374 . . . . 0.0 111.014 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.3 -173.8 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.047 2.498 . . . . 0.0 112.565 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.07 153.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.687 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -106.09 -171.77 1.96 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.13 157.52 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.989 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.704 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.5 mp0 -61.89 128.0 34.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 110.548 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.18 -35.19 66.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.283 0.563 . . . . 0.0 111.05 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 tt -80.43 -3.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.769 . . . . 0.0 110.742 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 64.7 tttt -81.69 134.32 35.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.472 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 54' ' ' ARG . 19.3 ptmt -109.91 158.46 18.18 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.339 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.6 110.71 15.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 168.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.489 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 3.8 ppt_? -65.7 135.08 54.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 111.132 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.32 144.6 29.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.155 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' THR . . . -153.7 170.3 32.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.904 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 44.8 m 69.89 145.25 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.137 0.551 . . . . 0.0 110.775 -177.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -122.78 147.18 46.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.1 mtt -86.43 139.74 30.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -75.34 166.79 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.517 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 m -105.31 19.21 20.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 50.45 82.64 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.955 0.883 . . . . 0.0 110.647 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.1 114.59 2.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.743 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 62.14 69.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.103 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -88.2 36.44 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.805 0.812 . . . . 0.0 110.361 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -136.88 134.26 36.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.171 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.42 105.29 8.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.499 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -100.8 -33.8 10.09 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.709 175.603 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 75.89 4.81 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.638 2.226 . . . . 0.0 112.415 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -79.07 147.95 32.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.738 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.563 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -74.57 126.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.581 ' HB ' ' HG3' ' B' ' 18' ' ' GLN . 19.6 pt -101.21 134.1 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.499 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -87.4 138.98 31.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.227 0.537 . . . . 0.0 111.079 -175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.81 152.15 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.308 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.608 HG13 HD11 ' B' ' 17' ' ' LEU . 3.6 m -115.33 118.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.714 0.769 . . . . 0.0 110.621 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.738 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 45.6 t80 -70.9 131.42 43.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.72 174.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.523 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 35.1 tt0 -151.75 129.76 11.81 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.469 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 30.6 t30 66.51 20.23 10.87 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.623 0.577 . . . . 0.0 111.907 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' OH ' ' B' ' 9' ' ' TYR . . . 95.26 10.49 57.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.008 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.2 t -122.85 148.51 26.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 92.8 m-85 -102.11 114.38 28.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' B' ' 15' ' ' LYS . 48.8 mtmt -110.49 116.55 52.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 31.9 Cg_endo -65.55 168.14 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.233 1.288 . . . . 0.0 112.317 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.608 HD11 HG13 ' B' ' 8' ' ' VAL . 5.6 mp -115.13 -5.59 12.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.581 ' HG3' ' HB ' ' B' ' 5' ' ' ILE . 25.0 mm-40 -94.76 -1.58 52.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.544 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 34.27 123.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 O-C-N 125.311 1.632 . . . . 0.0 114.244 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.677 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -125.42 139.92 49.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.599 -164.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.84 88.13 2.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.975 170.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' B' ' 20' ' ' VAL . 71.3 mt -110.81 -161.97 0.78 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 112.639 -2.073 . . . . 0.0 109.967 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -89.27 -174.69 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 35.3 mt-10 -106.3 123.56 48.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 109.653 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.892 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.04 24.53 44.25 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.6 tp10 -63.55 132.9 52.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.029 0.531 . . . . 0.0 110.831 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -83.25 113.22 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.847 0.832 . . . . 0.0 111.733 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.8 m -138.41 161.5 30.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.969 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HG2' ' A' ' 6' ' ' GLU . 33.0 mmtp -115.66 144.51 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.178 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -118.34 126.22 74.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.355 0.598 . . . . 0.0 110.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -134.08 124.65 26.52 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.638 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.955 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.9 mp -72.47 113.77 9.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -158.68 162.3 37.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.451 -159.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.08 -150.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.573 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -113.02 155.85 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.991 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.51 163.93 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.239 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.15 156.36 35.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 122.616 0.367 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -89.03 -179.32 2.07 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.291 2.661 . . . . 0.0 113.212 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.21 169.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.844 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -125.89 -173.59 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.603 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.5 pt? -125.33 172.44 9.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.42 -150.05 6.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.035 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.777 ' HB2' ' HD2' ' B' ' 44' ' ' PRO . 8.3 pt-20 -98.27 175.07 2.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.777 ' HD2' ' HB2' ' B' ' 43' ' ' GLU . 37.7 Cg_endo -67.18 -162.58 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.266 1.977 . . . . 0.0 111.9 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.41 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -91.82 173.01 8.08 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.89 140.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.477 ' CD ' ' HG2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -126.61 -169.4 2.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.2 -27.51 63.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.437 ' H ' HD12 ' B' ' 50' ' ' ILE . 3.6 mp -93.54 -15.5 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.214 0.531 . . . . 0.0 110.321 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.582 ' O ' ' HD2' ' B' ' 52' ' ' LYS . 47.0 mmtm -88.33 132.47 34.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.105 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' B' ' 51' ' ' LYS . 12.7 mptt -130.38 135.12 47.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.897 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 53' ' ' ILE . 4.2 mp -93.99 -39.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.09 0.472 . . . . 0.0 110.134 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -79.41 133.6 36.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -104.17 169.66 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.02 172.61 45.23 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t -156.99 165.01 37.37 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -91.95 133.87 35.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.3 ttt -132.82 137.92 46.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m 67.52 121.01 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.384 1.053 . . . . 0.0 112.386 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -103.44 0.54 31.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.634 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp 52.45 79.74 0.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.795 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.0 136.36 48.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.31 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -89.16 72.53 8.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.672 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.16 128.04 34.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.723 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -93.14 138.46 31.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.061 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -77.56 -156.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.606 174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -145.47 89.05 1.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.635 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.508 177.401 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.25 106.39 2.26 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.547 2.165 . . . . 0.0 111.243 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.01 144.96 28.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.042 0.449 . . . . 0.0 110.281 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.669 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -91.87 143.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.1 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 18' ' ' GLN . 24.8 mm -100.93 156.12 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 28.3 mt-10 -116.0 145.82 42.65 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -147.55 166.27 27.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.101 0.477 . . . . 0.0 110.891 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.04 122.6 65.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.935 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 90.2 t80 -78.33 99.46 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.394 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 32.9 mt-10 -120.55 135.79 54.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.968 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 21.0 m120 63.25 21.69 12.96 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.587 0.555 . . . . 0.0 111.496 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 86.9 11.48 70.29 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.131 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 16.1 t -125.14 148.67 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 83.6 m-85 -96.36 114.87 26.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.194 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 29.9 mtmt -112.5 114.07 50.43 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.74 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 Cg_endo -63.15 168.77 10.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.449 1.433 . . . . 0.0 112.981 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -108.33 -20.62 13.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HB2' HG23 ' A' ' 5' ' ' ILE . 42.8 mt-30 -99.6 143.34 29.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.965 -1.471 . . . . 0.0 109.554 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -84.81 124.38 31.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.265 0.555 . . . . 0.0 109.674 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.3 t -132.47 134.87 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.72 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.36 88.63 4.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.365 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.8 mt -113.05 171.56 7.47 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.093 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -107.39 158.85 16.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 8.1 mp0 -67.24 114.84 6.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.374 0.606 . . . . 0.0 110.199 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.88 25.92 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.058 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 3.9 mm-40 -74.11 133.96 42.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -100.82 121.88 42.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.968 1.842 . . . . 0.0 113.417 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD23 ' B' ' 32' ' ' LEU . 34.7 m -132.93 160.28 42.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.156 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 65.6 mttm -117.26 140.78 49.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.452 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' B' ' 7' ' ' ALA . 1.3 mm -116.57 149.44 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.781 -175.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -156.94 164.56 37.89 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 164.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HD13 ' B' ' 22' ' ' LEU . 9.2 mt -87.55 114.56 24.27 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HG2' ' HD2' ' B' ' 29' ' ' LYS . 3.7 tp10 -69.75 141.86 53.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.845 0.831 . . . . 0.0 111.457 -164.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.08 163.25 22.17 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.921 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -103.66 162.13 13.33 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.108 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.2 138.96 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 mt-10 -66.75 120.94 75.09 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-O 120.721 0.296 . . . . 0.0 110.45 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 21.1 Cg_exo -66.35 -175.16 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.383 2.722 . . . . 0.0 112.933 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 pt -70.27 165.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.77 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.42 104.53 10.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.587 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 2.8 pp -84.1 176.39 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.402 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.95 -125.21 1.91 Allowed Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.787 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -112.27 127.93 26.19 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.543 0.211 . . . . 0.0 111.142 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.12 173.35 14.05 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.539 2.159 . . . . 0.0 111.433 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' SER . 14.4 p -131.21 166.58 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.217 0.532 . . . . 0.0 110.768 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' VAL . 17.6 m -88.3 170.06 11.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.66 3.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.304 0.574 . . . . 0.0 111.528 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.59 104.03 9.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.464 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -87.28 -30.26 21.01 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.5 tt -69.75 -7.25 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.621 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -87.35 133.64 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.831 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -101.36 141.23 34.55 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.294 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.5 mp -79.23 -45.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -147.38 160.43 42.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.412 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.04 156.16 25.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.21 -50.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.628 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -75.84 138.87 41.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.052 0.453 . . . . 0.0 111.265 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -114.69 134.19 55.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.415 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 97.2 mmm -84.98 161.26 19.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.735 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 m 61.45 25.26 15.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.2 m -79.38 -0.39 32.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.958 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.38 123.34 30.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.916 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.37 113.54 27.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -100.34 -46.87 5.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.285 0.564 . . . . 0.0 110.162 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -99.08 93.51 6.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.585 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -169.93 131.05 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.53 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.8 147.24 52.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.045 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -99.59 148.35 24.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.245 175.384 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.457 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 7.2 Cg_exo -73.5 86.57 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.789 2.326 . . . . 0.0 111.832 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -92.37 175.02 6.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.007 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.539 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -67.29 139.93 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 15.0 mt -109.2 154.31 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 164.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -109.21 135.99 49.41 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.515 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.96 164.24 30.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.707 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -126.49 124.93 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.472 0.653 . . . . 0.0 111.369 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 20.2 t80 -62.15 112.42 2.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.86 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.35 128.83 40.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 120.943 0.401 . . . . 0.0 110.712 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.22 34.32 11.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.794 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.04 -69.33 0.26 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 117.653 -2.213 . . . . 0.0 111.634 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -93.37 154.33 3.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.997 -158.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -88.23 115.85 26.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -105.67 120.9 47.76 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.583 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 11.3 Cg_endo -58.6 168.71 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.453 1.435 . . . . 0.0 112.391 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.707 HD11 HG13 ' B' ' 8' ' ' VAL . 7.0 mp -102.27 -11.25 18.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' B' ' 16' ' ' PRO . 13.3 pm0 -133.17 143.52 49.26 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.496 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.42 149.25 39.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 112.138 -173.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.451 HG12 ' H ' ' B' ' 22' ' ' LEU . 11.3 t -123.76 150.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.353 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.02 25.14 3.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.079 0.942 . . . . 0.0 109.878 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.658 HD13 HD21 ' A' ' 32' ' ' LEU . 97.9 mt -78.59 -166.23 0.84 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.694 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 10.1 mtmp? -97.1 162.32 13.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.5 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.4 mp0 -74.55 136.54 42.11 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.337 0.589 . . . . 0.0 109.416 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.6 65.4 3.2 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.416 -165.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.694 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 1.7 mm-40 -96.34 148.8 22.39 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.618 -0.791 . . . . 0.0 109.551 170.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 27' ' ' ARG . 2.1 tpt180 -98.02 105.66 17.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.652 1.215 . . . . 0.0 112.167 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.0 m -124.68 156.87 33.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 113.045 -1.888 . . . . 0.0 111.408 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.583 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 45.0 mttp -120.79 143.46 48.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.201 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.476 HG23 HD13 ' A' ' 30' ' ' ILE . 17.1 mt -130.02 147.55 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.884 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.663 ' HG3' ' HG3' ' B' ' 33' ' ' GLU . 10.2 ptpt -156.88 165.13 37.06 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.877 HD23 HG12 ' A' ' 28' ' ' VAL . 24.2 mt -89.97 115.11 27.02 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -177.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.663 ' HG3' ' HG3' ' B' ' 31' ' ' LYS . 23.7 mt-10 -125.8 149.25 48.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.38 1.086 . . . . 0.0 113.911 -168.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.36 -169.85 3.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.417 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' B' ' 36' ' ' VAL . 49.4 tptt -123.77 163.55 20.94 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.414 ' N ' ' HG3' ' B' ' 35' ' ' LYS . 8.6 t -86.33 132.27 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' B' ' 38' ' ' PRO . 45.3 mt-10 -81.21 -57.18 0.57 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' B' ' 37' ' ' GLU . 37.9 Cg_endo -65.12 174.6 4.71 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.035 1.823 . . . . 0.0 113.184 -173.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 pp -101.97 172.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.373 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.66 129.61 39.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.245 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 49.3 tp 68.37 112.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.749 0.656 . . . . 0.0 112.04 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.91 114.53 0.49 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.813 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 10.9 mp0 -108.84 130.0 23.25 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 6.0 Cg_exo -78.78 114.38 3.43 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.704 2.269 . . . . 0.0 111.508 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.9 156.6 6.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.185 0.517 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -83.2 160.35 21.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.802 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.85 142.35 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.202 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.0 105.19 4.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.08 0.943 . . . . 0.0 110.879 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.78 -27.73 20.94 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.147 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tp -76.79 -15.51 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.525 -172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -151.2 137.99 18.92 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.408 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -151.6 158.62 43.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tp -69.87 133.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' B' ' 54' ' ' ARG . 42.0 ttp180 -107.07 133.72 51.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.05 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.6 163.44 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -1.35 49.5 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.11 140.17 45.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.846 0.355 . . . . 0.0 111.342 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -124.44 139.99 53.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.584 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.19 31.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -73.73 152.03 40.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.063 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 11.5 m -93.51 -5.79 48.27 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.075 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 61' ' ' SER . 2.9 pp 46.63 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.032 1.333 . . . . 0.0 114.539 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -119.86 111.74 18.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.347 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -135.4 110.33 8.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.346 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.33 151.3 48.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -75.85 99.64 4.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.735 0.779 . . . . 0.0 110.484 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -84.54 82.17 8.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.613 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -138.54 112.37 8.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.096 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.27 111.89 2.84 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.414 2.076 . . . . 0.0 111.114 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -71.28 144.05 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.298 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER -130.83 146.17 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.754 -175.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.56 169.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 164.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' HD12 ' A' ' 17' ' ' LEU . 37.0 mt-10 -103.85 158.45 16.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB2' HD11 ' B' ' 30' ' ' ILE . . . -150.68 154.4 37.38 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 31.1 m -110.08 116.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.841 0.829 . . . . 0.0 110.329 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 57.1 t80 -79.98 102.91 9.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.644 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.55 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.4 pt-20 -118.48 136.95 53.51 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.158 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 63.5 t30 65.44 9.25 5.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.836 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.537 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 96.5 12.51 50.83 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.905 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.4 m -124.52 142.67 40.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.371 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 93.5 m-85 -90.79 116.41 28.62 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.652 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.18 111.82 61.65 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 41.9 Cg_exo -46.18 169.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.045 2.496 . . . . 0.0 115.357 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.923 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 63.3 mt -107.02 113.79 27.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 166.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.923 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 1.1 pp0? 77.11 143.21 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 127.99 2.516 . . . . 0.0 111.862 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -60.64 127.83 33.62 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.172 -172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 5' ' ' ILE . 14.7 p -127.26 146.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.652 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.91 86.59 2.75 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.321 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.526 ' HB2' ' CE2' ' B' ' 9' ' ' TYR . 67.3 mt -103.45 -176.56 3.12 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.51 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.47 148.83 26.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.41 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 12.4 pt-20 -82.74 121.56 27.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.16 14.97 31.87 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.823 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.84 116.69 17.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.37 119.58 27.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.095 0.95 . . . . 0.0 110.415 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.2 161.15 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.228 -168.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HG3' ' CD ' ' B' ' 33' ' ' GLU . 13.7 mmmm -118.56 134.97 54.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.957 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.742 HG12 HG23 ' B' ' 30' ' ' ILE . 9.8 mt -133.44 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.694 -170.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.66 165.51 27.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.638 172.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 mt -94.99 146.71 24.07 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 123.445 0.466 . . . . 0.0 111.464 -166.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.17 145.9 55.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.0 mt -71.37 154.57 41.47 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.101 0.953 . . . . 0.0 113.073 -168.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mptt -129.19 175.14 8.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.638 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.63 142.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.035 0.445 . . . . 0.0 110.264 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -91.03 130.06 41.69 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.588 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 174.06 12.35 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.302 2.001 . . . . 0.0 112.083 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -89.31 150.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.836 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.59 135.56 53.22 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.13 176.11 9.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 111.253 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.29 155.26 16.45 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -67.23 140.79 95.69 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.44 -175.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -63.17 119.73 6.92 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.476 2.117 . . . . 0.0 111.363 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.45 148.03 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.512 0.672 . . . . 0.0 111.32 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 67.2 m -92.98 -171.84 2.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.176 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 46' ' ' SER . 25.0 t 68.37 139.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 111.67 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -93.6 113.51 25.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.7 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.45 -26.28 26.42 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.517 0.675 . . . . 0.0 109.47 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mt -80.33 -15.21 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' NZ ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.25 132.51 45.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.57 ' HG2' HG13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -105.63 -150.24 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.401 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.57 HG13 ' HG2' ' A' ' 52' ' ' LYS . 89.7 mt 76.2 98.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.358 0.663 . . . . 0.0 111.089 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -122.96 123.7 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.336 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.53 173.4 8.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.75 38.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.675 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.5 t -66.52 148.69 51.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.689 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -147.34 144.24 28.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.908 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 24.9 ttt -109.49 124.65 51.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 t -84.14 136.53 33.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.834 0.349 . . . . 0.0 110.914 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -105.8 18.32 22.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.53 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.62 90.92 3.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.54 115.89 28.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.603 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.45 134.17 55.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.603 -174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -121.57 157.74 30.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.646 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -160.78 90.05 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.453 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.8 131.51 35.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.563 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -101.49 -29.5 11.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.828 171.862 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -90.77 111.48 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.912 2.408 . . . . 0.0 112.372 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.9 152.77 49.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.47 . . . . 0.0 111.427 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.746 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -115.97 144.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.561 174.113 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.27 148.59 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.556 ' HB2' HD13 ' B' ' 17' ' ' LEU . 2.4 mp0 -121.81 145.78 47.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -153.47 165.17 36.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.61 0.243 . . . . 0.0 111.191 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -117.22 122.62 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 69.9 t80 -84.27 102.92 13.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.196 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.42 125.6 50.29 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.741 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 63.34 21.26 12.71 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.012 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.692 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 101.49 4.93 52.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.115 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.6 t -119.69 142.64 34.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.081 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -98.23 115.59 28.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -102.17 113.2 65.95 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 38.6 Cg_exo -56.86 169.72 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.63 1.553 . . . . 0.0 113.041 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 6' ' ' GLU . 7.8 mp -83.53 -74.69 0.36 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.782 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -84.69 151.82 24.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -67.95 137.97 55.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.539 . . . . 0.0 111.507 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' HG ' ' B' ' 22' ' ' LEU . 2.5 t -122.1 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.597 177.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -110.65 87.81 2.62 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 123.163 1.458 . . . . 0.0 109.012 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 92.0 mt -111.7 -172.84 2.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.044 -2.344 . . . . 0.0 110.096 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.738 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 92.3 mttt -82.19 159.86 23.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.7 mp0 -72.97 126.31 29.66 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.57 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 60.46 65.59 3.25 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.565 -165.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.738 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 0.7 OUTLIER -96.23 149.97 21.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.478 -0.861 . . . . 0.0 108.97 165.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -104.42 131.35 51.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.451 0.644 . . . . 0.0 111.198 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.2 m -142.15 164.79 17.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.252 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -119.59 134.47 55.21 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.31 0.576 . . . . 0.0 109.717 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 30' ' ' ILE . 3.8 mt -118.39 147.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.581 -172.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 4' ' ' ILE . 3.0 ptpp? -155.6 166.19 34.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.441 0.638 . . . . 0.0 110.648 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.437 ' N ' HD22 ' B' ' 32' ' ' LEU . 3.2 mm? -101.9 128.73 48.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.284 173.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.461 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 68.9 mt-10 -89.18 147.99 23.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.06 -172.24 2.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.741 0.781 . . . . 0.0 112.311 -169.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' B' ' 35' ' ' LYS . 24.4 mtmt -85.36 155.85 21.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.338 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.3 135.7 33.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 164.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 5.5 pt-20 -77.7 143.75 67.92 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.285 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 11.6 Cg_exo -71.73 -156.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.818 3.012 . . . . 0.0 114.191 -170.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.34 178.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.628 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -92.06 129.67 37.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.502 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.9 144.65 38.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.083 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 -145.27 11.35 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 7.2 pt-20 -124.02 122.24 26.24 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 120.784 0.326 . . . . 0.0 110.692 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 38.9 Cg_exo -61.83 128.38 24.22 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.571 2.181 . . . . 0.0 111.816 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.06 150.77 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.816 0.817 . . . . 0.0 111.444 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -106.12 -176.52 3.1 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.219 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.81 141.76 17.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.552 ' HB2' HG22 ' B' ' 50' ' ' ILE . 1.6 pm0 -66.76 129.76 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.446 0.641 . . . . 0.0 111.628 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.64 -25.08 44.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.423 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' B' ' 48' ' ' GLU . 13.7 tt -69.94 -1.19 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.951 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.486 ' HB2' ' HG2' ' B' ' 48' ' ' GLU . 14.0 tptm -59.15 134.01 56.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.916 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -128.71 138.8 52.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.044 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pp -114.45 162.9 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.107 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -149.83 148.69 29.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.016 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -158.31 -163.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.14 124.39 1.0 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.088 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.75 127.04 43.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -82.11 154.72 25.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.033 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -144.6 154.75 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.241 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -79.74 133.61 36.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 56.4 p -82.85 14.2 3.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.575 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.9 103.08 0.41 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -101.89 155.46 18.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.932 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -84.76 100.26 11.4 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -125.93 135.12 51.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.978 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -129.8 153.4 48.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.296 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -147.52 130.39 16.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -133.66 140.08 46.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.558 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.568 175.793 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.68 ' HA ' HD13 ' B' ' 32' ' ' LEU . 14.7 Cg_endo -58.47 99.55 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.406 2.071 . . . . 0.0 112.295 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -157.27 154.67 29.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.926 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.5 mp -64.49 135.79 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.744 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 30' ' ' ILE . 11.7 mt -131.2 150.84 34.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -100.99 126.44 47.66 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.82 166.53 18.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.522 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.26 114.27 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.465 0.65 . . . . 0.0 110.131 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 68.3 t80 -67.06 119.44 12.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 22.7 tt0 -148.2 142.57 26.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.395 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.45 18.03 10.76 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 0.0 111.458 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.506 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 83.43 18.99 63.06 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.819 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 11.6 t -129.09 154.66 40.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 C-N-CA 122.858 0.463 . . . . 0.0 110.048 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.2 m-85 -97.84 115.11 27.42 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.309 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 41.6 mtmt -109.74 113.08 57.99 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.478 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 31.4 Cg_exo -56.87 166.28 4.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.171 1.248 . . . . 0.0 113.593 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.21 -68.5 0.79 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 112.069 -2.332 . . . . 0.0 105.405 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 5' ' ' ILE . 57.9 mt-30 -60.04 144.89 48.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.467 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -68.74 149.62 48.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.143 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' LEU . 3.4 p -123.6 155.83 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 122.162 0.982 . . . . 0.0 111.397 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.83 12.63 11.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.834 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.711 HD13 HD21 ' B' ' 32' ' ' LEU . 97.0 mt -90.57 -174.83 4.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.368 -172.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -92.93 -172.96 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.25 -169.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.678 ' HB3' ' H ' ' B' ' 11' ' ' ASN . 0.0 OUTLIER -93.15 -169.89 2.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 164.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . -21.95 71.66 0.0 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 122.847 1.248 . . . . 0.0 114.686 -152.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 44.3 tt0 -96.65 139.78 32.22 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 111.956 -2.122 . . . . 0.0 108.105 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -93.69 128.44 39.88 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.755 0.788 . . . . 0.0 112.354 -166.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' B' ' 32' ' ' LEU . 16.5 m -145.74 171.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.72 -173.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 58.7 mttm -128.45 138.84 52.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.822 HG22 ' HB ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -119.14 134.32 63.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.0 -171.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.623 ' HG2' HG22 ' B' ' 4' ' ' ILE . 51.9 mttp -110.24 148.92 30.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.029 0.442 . . . . 0.0 110.075 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' HB2' ' HD2' ' B' ' 2' ' ' PRO . 3.5 mm? -102.6 146.54 28.01 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.843 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -88.96 154.74 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.694 HD21 ' HG3' ' B' ' 2' ' ' PRO . 34.5 mt -125.85 -174.17 3.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.894 0.854 . . . . 0.0 113.08 -171.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 69.3 tttt -128.33 -137.4 0.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.089 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.416 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 40.3 t -102.05 148.17 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.2 pt-20 -63.76 148.01 95.12 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 122.189 0.196 . . . . 0.0 110.877 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 23.2 Cg_exo -65.53 -169.46 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.197 2.598 . . . . 0.0 113.741 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.9 mt -96.51 154.29 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.09 -153.7 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.5 tp -69.47 147.67 50.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.91 -113.62 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.868 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.2 pm0 -63.99 141.64 98.07 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.286 -0.457 . . . . 0.0 111.196 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 14.8 Cg_exo -68.32 157.11 63.22 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.824 2.349 . . . . 0.0 112.592 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.05 149.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.786 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -117.51 -170.94 1.95 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.862 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.32 147.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.94 169.8 17.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 111.785 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.27 -25.18 62.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.8 -13.37 17.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -82.19 132.45 35.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.737 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.78 156.5 42.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.8 mt -80.12 154.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -71.65 110.47 6.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.007 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -98.95 158.5 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.51 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.95 113.37 0.47 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.448 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -136.8 174.86 10.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -117.43 148.61 41.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.059 0.457 . . . . 0.0 110.879 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.5 ttm -114.75 128.26 56.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.475 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.0 m 62.05 109.34 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 124.196 0.935 . . . . 0.0 112.086 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.844 ' HB2' ' HG3' ' A' ' 63' ' ' GLU . 1.7 m -88.28 18.67 4.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.133 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.8 mt 58.41 30.43 19.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.53 -175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.844 ' HG3' ' HB2' ' A' ' 61' ' ' SER . 34.6 mt-10 -76.14 107.68 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.111 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -111.09 93.7 4.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.392 0.615 . . . . 0.0 109.66 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -95.8 104.92 16.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.477 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -86.15 134.64 33.79 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.011 -173.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -98.97 133.46 43.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.37 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -89.87 108.32 19.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--O 1.242 0.7 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.156 177.454 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.431 ' HG2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.694 ' HG3' HD21 ' A' ' 34' ' ' LEU . 26.9 Cg_endo -89.19 -69.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.519 2.146 . . . . 0.0 112.149 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -123.25 161.81 23.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.641 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.623 HG22 ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -115.22 136.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.039 0.447 . . . . 0.0 110.364 175.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.831 HD11 HD12 ' B' ' 22' ' ' LEU . 25.1 mt -98.72 160.17 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 40.6 mt-10 -125.61 136.94 53.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -151.07 168.37 24.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.845 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.665 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.5 m -128.19 137.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.142 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.574 ' H ' ' HD1' ' B' ' 9' ' ' TYR . 2.8 m-85 -58.05 156.73 8.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.084 0.945 . . . . 0.0 112.075 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' B' ' 13' ' ' VAL . 16.2 tp10 -144.29 98.05 3.14 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.678 ' H ' ' HB3' ' A' ' 24' ' ' GLU . 1.9 t30 56.14 30.99 17.41 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.115 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.65 -69.56 0.51 Allowed Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 118.279 -1.915 . . . . 0.0 111.708 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 13' ' ' VAL . 28.3 m -92.78 141.7 14.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.848 -155.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -88.53 125.39 34.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -165.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.39 112.59 65.44 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.9 Cg_endo -76.23 169.75 21.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 CA-C-O 122.016 0.757 . . . . 0.0 113.428 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 17' ' ' LEU . 4.5 mp -89.15 -23.61 22.41 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 166.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' B' ' 19' ' ' LYS 0.283 4.2 tt0 43.05 -119.8 0.57 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.343 166.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.682 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 47.1 tttp 69.01 -128.05 0.1 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -143.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' B' ' 19' ' ' LYS . 50.9 t 68.82 171.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 119.613 1.097 . . . . 0.0 109.946 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . 0.43 ' N ' HG12 ' B' ' 20' ' ' VAL . 30.0 t70 -122.96 17.05 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.226 1.012 . . . . 0.0 111.227 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HD11 ' B' ' 5' ' ' ILE . 93.6 mt -83.53 169.55 15.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.607 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' B' ' 21' ' ' ASP . 18.9 mttt -136.35 -179.73 5.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -164.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.3 145.17 37.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.348 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 57.9 65.25 3.67 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -164.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -120.13 139.82 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.497 -0.852 . . . . 0.0 111.05 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' B' ' 27' ' ' ARG . 0.3 OUTLIER -88.95 125.89 35.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.862 -174.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.822 ' HB ' HG22 ' A' ' 30' ' ' ILE . 34.3 m -136.99 148.15 26.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.825 -172.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -117.35 138.25 51.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.018 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 3.9 mt -117.26 148.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.289 0.566 . . . . 0.0 111.376 -169.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -137.25 161.76 35.33 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 22' ' ' LEU . 6.6 mp -115.05 137.16 52.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -94.94 142.73 27.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 25.6 mt -130.08 162.25 29.2 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -85.91 159.89 19.55 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.178 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.6 150.39 7.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.132 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.08 110.84 5.22 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.09 173.03 15.17 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.544 2.163 . . . . 0.0 113.439 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 39' ' ' ILE . 0.2 OUTLIER -76.64 173.89 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.953 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -88.68 137.03 32.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.302 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.4 tp -111.41 143.7 41.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.329 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 115.3 3.48 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 0.7 OUTLIER -71.75 125.52 91.65 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 115.319 -0.44 . . . . 0.0 110.92 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.8 172.57 16.02 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.709 2.273 . . . . 0.0 112.356 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.81 152.16 25.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -125.11 168.5 13.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.91 127.34 51.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -102.6 102.78 13.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.67 -25.98 24.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.136 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt -84.49 0.05 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.316 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.33 131.81 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.598 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -135.84 155.4 50.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.85 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.78 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 54' ' ' ARG . 10.1 ptm180 -92.12 155.43 18.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.618 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.24 155.13 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.954 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.12 143.64 15.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.666 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -125.13 168.34 13.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.886 0.343 . . . . 0.0 110.602 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -128.98 141.55 51.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.167 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 49.7 ttm -123.45 124.75 43.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -79.66 140.26 37.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.773 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.3 t -101.89 20.55 16.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.34 0.59 . . . . 0.0 109.689 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.33 -169.16 0.2 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.644 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 169.4 18.77 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -75.13 147.17 40.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 111.17 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.62 156.31 45.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.845 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -132.95 100.71 4.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.004 0.43 . . . . 0.0 111.465 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -106.92 100.12 9.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -51.39 -47.62 62.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.145 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.97 177.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 28.0 ttt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 1' ' ' MET . 79.8 Cg_exo -43.24 119.41 1.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.206 2.604 . . . . 0.0 112.887 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -80.15 162.32 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.447 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.769 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.3 OUTLIER -87.2 143.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 167.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 20' ' ' VAL . 24.0 mt -85.94 150.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 38.9 mt-10 -124.33 126.12 45.48 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.12 169.5 17.48 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.0 111.406 -171.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.522 HG12 ' HD3' ' B' ' 27' ' ' ARG . 12.1 m -129.66 131.45 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.686 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 70.6 t80 -74.79 118.26 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 34.1 tt0 -155.44 138.47 15.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.905 1.378 . . . . 0.0 108.813 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.06 25.72 12.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.394 0.616 . . . . 0.0 110.35 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 71.01 20.99 78.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.026 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 54.7 t -132.92 159.13 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 54.9 m-85 -108.18 115.03 29.37 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -112.97 125.9 29.09 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.908 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 28.0 Cg_endo -64.21 170.01 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.228 1.286 . . . . 0.0 112.112 177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -5.44 21.6 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 2.8 pt20 -135.18 129.33 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.161 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -68.87 129.45 39.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 110.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.571 HG12 ' HG ' ' A' ' 22' ' ' LEU . 13.8 t -117.01 149.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.306 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.74 25.27 11.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.155 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.4 mt -66.75 177.69 1.55 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.456 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 8.9 mtpm? -96.13 170.86 8.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 0.6 OUTLIER -77.01 133.86 39.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.289 175.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 76.96 16.78 80.48 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.465 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 6.8 mm-40 -68.68 135.4 51.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.95 0.405 . . . . 0.0 110.585 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 103.68 15.73 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.775 1.274 . . . . 0.0 112.534 -167.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.731 ' HB ' HG22 ' B' ' 30' ' ' ILE . 29.4 m -129.16 152.41 37.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.426 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.69 ' HE2' ' HG3' ' B' ' 33' ' ' GLU . 46.6 mttm -129.67 135.26 48.29 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.682 0.753 . . . . 0.0 110.019 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 HD13 ' B' ' 30' ' ' ILE . 9.1 mt -103.9 143.03 16.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.041 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.829 ' HG3' HG22 ' B' ' 4' ' ' ILE . 10.4 mptt -137.93 157.34 46.59 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.113 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD22 ' B' ' 22' ' ' LEU . 94.1 mt -86.27 114.18 22.87 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 1.062 ' HG3' ' HB2' ' B' ' 29' ' ' LYS . 16.7 mm-40 -92.05 144.17 25.71 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -160.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -106.61 -166.16 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.301 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 36' ' ' VAL . 87.5 tttt -125.56 166.11 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 35' ' ' LYS . 2.1 p -64.48 125.41 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.49 0.662 . . . . 0.0 111.029 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.4 mt-10 -101.85 148.88 35.93 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.904 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -75.93 -165.88 0.33 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.982 2.455 . . . . 0.0 111.636 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 39' ' ' ILE . 1.4 pp -70.79 144.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 111.706 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.17 -10.09 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.343 0.592 . . . . 0.0 110.201 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.68 -176.19 3.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.557 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.35 130.7 3.33 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.9 mt-10 -79.1 136.07 57.82 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -67.73 166.03 25.66 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.397 2.731 . . . . 0.0 113.128 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.15 158.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.009 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.6 m -85.16 167.87 15.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.719 0.295 . . . . 0.0 111.102 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.57 134.14 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.252 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 -35.58 18.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.997 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.12 -25.59 67.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.442 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.89 -9.33 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.725 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -88.86 -5.68 57.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.622 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 65.2 157.83 0.1 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.85 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.446 HG12 ' N ' ' A' ' 54' ' ' ARG . 11.4 tt -67.5 165.29 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 122.908 0.483 . . . . 0.0 110.905 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' N ' HG12 ' A' ' 53' ' ' ILE . 57.3 mtt180 -72.19 -67.74 0.52 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.152 0.501 . . . . 0.0 110.936 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.47 176.83 8.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.224 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.34 35.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.461 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -99.51 -166.67 1.37 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -71.04 161.08 31.74 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.154 0.502 . . . . 0.0 111.248 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.4 tpp -131.78 129.46 40.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.714 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.0 t -93.36 144.3 25.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 p -85.71 3.58 40.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.74 106.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.786 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.33 103.25 1.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.278 0.561 . . . . 0.0 110.393 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -82.5 140.23 33.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -64.34 107.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.294 -174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -61.55 139.27 58.28 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -149.59 145.64 26.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.606 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -99.16 15.17 26.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.197 0.522 . . . . 0.0 110.741 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.243 0.757 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.082 177.151 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.684 0.278 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 112.25 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.824 2.35 . . . . 0.0 110.923 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -70.69 152.1 44.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 110.73 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.829 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -103.46 143.34 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.202 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.403 ' CD1' HG23 ' B' ' 20' ' ' VAL . 10.5 mt -87.81 151.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.674 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.22 118.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.0 165.02 25.99 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.568 0.542 . . . . 0.0 110.741 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 m -127.23 133.57 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.598 173.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 1.3 t80 -65.1 100.03 0.41 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.793 ' HB3' ' HD3' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -120.17 119.92 34.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.059 -170.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 52.05 33.58 12.29 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.145 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.85 -70.7 0.44 Allowed Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 117.842 -2.123 . . . . 0.0 112.028 -169.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' HG3' ' B' ' 15' ' ' LYS . 32.0 m -100.37 171.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.33 -0.935 . . . . 0.0 112.555 -155.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 93.7 m-85 -87.76 115.0 24.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.793 ' HD3' ' HB3' ' B' ' 10' ' ' GLU . 50.5 mtpt -115.32 111.18 44.58 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.757 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.3 Cg_endo -64.24 166.67 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.265 1.31 . . . . 0.0 112.113 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.413 HD11 HG13 ' B' ' 8' ' ' VAL . 17.6 mt -129.19 -22.7 3.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.444 -1.707 . . . . 0.0 108.107 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.54 143.82 27.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.959 169.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.52 154.06 33.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.816 0.341 . . . . 0.0 110.35 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 ' H ' ' B' ' 22' ' ' LEU . 4.3 p -98.75 153.74 4.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.994 0.902 . . . . 0.0 110.07 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.3 13.42 7.69 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.906 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.784 HD22 HD11 ' A' ' 32' ' ' LEU . 29.8 mt -106.47 -170.11 1.67 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.08 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' B' ' 26' ' ' GLU . 63.5 pttt -120.35 160.84 22.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.049 0.452 . . . . 0.0 110.92 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.29 135.52 42.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.497 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.37 19.51 32.57 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -171.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -94.2 145.01 25.01 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.13 0.49 . . . . 0.0 112.222 -175.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.522 ' HD3' HG12 ' A' ' 8' ' ' VAL . 2.9 mpp_? -98.57 112.92 24.81 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 123.334 1.54 . . . . 0.0 112.787 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.652 HG12 HD23 ' A' ' 32' ' ' LEU . 35.5 m -131.0 162.13 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.228 -173.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 1.062 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 36.3 mtpt -132.78 152.12 51.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.531 0.681 . . . . 0.0 109.632 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.731 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -126.94 139.86 50.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.4 -169.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 165.46 27.78 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.573 171.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.97 122.37 37.54 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.813 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.69 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 70.4 mm-40 -72.59 144.12 47.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 -171.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.4 mt -99.89 179.84 4.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.926 0.87 . . . . 0.0 111.892 -173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.1 172.18 14.11 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.834 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.55 149.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 36.5 mt-10 -92.88 151.5 40.8 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.509 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 21.0 Cg_exo -65.41 173.75 6.03 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.659 2.239 . . . . 0.0 113.072 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 pt -96.2 172.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.881 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.34 134.27 34.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.661 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.64 169.59 17.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.403 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.22 -146.61 15.88 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.093 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.0 OUTLIER -93.28 142.81 25.77 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 121.049 0.452 . . . . 0.0 111.477 -174.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 5.0 Cg_exo -77.99 130.34 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.932 2.421 . . . . 0.0 111.535 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.86 144.46 12.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.403 0.62 . . . . 0.0 111.443 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -104.92 171.07 7.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.602 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.61 148.31 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -85.22 128.05 34.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.18 -24.99 27.68 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.563 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.96 -4.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.289 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -71.36 132.74 45.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.104 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -151.28 103.49 3.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.174 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 67.5 mt -141.33 114.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.344 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' B' ' 54' ' ' ARG . 7.2 tpt180 -91.6 -52.31 4.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.19 169.84 16.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.53 -104.29 0.99 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.961 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.4 t -158.09 142.9 16.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.248 0.547 . . . . 0.0 110.811 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -157.08 135.36 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.241 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.0 ptm -115.11 170.77 8.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -148.89 -174.19 4.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -85.31 5.93 28.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.849 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 85.1 mt 61.17 -166.27 0.21 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.317 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -99.76 145.44 27.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -168.0 110.21 0.6 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.833 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -113.6 132.77 55.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 43.3 t-80 -158.31 98.53 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.262 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 19.4 p-80 178.38 159.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -130.65 -99.92 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.741 0.305 . . . . 0.0 110.302 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 119.149 -0.453 . . . . 0.0 109.973 178.565 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.593 0.235 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -89.76 96.82 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.759 2.306 . . . . 0.0 112.059 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -129.77 149.56 51.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.625 ' CG2' ' HD3' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -115.01 139.83 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' O ' HG12 ' B' ' 30' ' ' ILE . 10.2 mt -100.33 156.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 41.3 mt-10 -99.19 154.75 17.9 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.926 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -149.67 143.98 25.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.009 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.86 131.86 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.468 0.652 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 47.4 t80 -88.6 113.08 23.8 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.374 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 39.4 mt-10 -138.07 138.29 38.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.388 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 68.25 19.71 8.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.692 0.62 . . . . 0.0 111.136 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.52 16.12 64.73 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.031 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 10.5 t -125.34 148.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 C-N-CA 122.512 0.325 . . . . 0.0 110.598 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 50.5 m-85 -95.29 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 165.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.57 108.32 59.71 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' B' ' 14' ' ' PHE . 47.2 Cg_exo -47.14 168.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.1 2.534 . . . . 0.0 115.707 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 90.6 mt -114.22 87.36 2.61 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 112.907 -1.951 . . . . 0.0 105.915 165.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 2.5 pp0? 81.58 149.15 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.773 2.429 . . . . 0.0 110.932 -172.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -68.31 152.29 45.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.993 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 HD12 ' A' ' 5' ' ' ILE . 3.0 t -114.26 135.95 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.039 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.48 87.8 7.21 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 123.07 1.415 . . . . 0.0 108.154 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.69 173.93 9.87 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.838 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.732 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -101.2 153.43 19.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 40.5 mt-10 -61.67 129.9 43.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.806 0.812 . . . . 0.0 110.865 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.815 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 60.55 65.26 3.46 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.72 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -103.59 142.84 33.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.107 166.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -93.93 127.75 39.87 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 124.036 1.874 . . . . 0.0 113.981 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' B' ' 14' ' ' PHE . 21.4 m -136.08 155.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 111.35 -2.659 . . . . 0.0 108.341 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' B' ' 33' ' ' GLU . 38.7 mtpt -118.87 146.24 45.05 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.944 0.878 . . . . 0.0 111.287 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.0 142.85 24.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.804 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -155.38 151.52 27.97 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.357 174.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.56 125.18 42.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.579 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.958 ' HG3' ' HG3' ' B' ' 29' ' ' LYS . 5.2 mm-40 -89.1 150.65 22.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.238 0.542 . . . . 0.0 112.435 -167.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.41 -172.01 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.053 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -92.46 171.9 8.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.094 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.12 156.21 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.778 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -88.14 132.49 39.51 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -80.25 -170.83 1.09 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.573 2.849 . . . . 0.0 113.045 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 39' ' ' ILE . 2.2 pp -84.99 164.5 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.459 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.27 166.58 11.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.03 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.04 166.4 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.912 0.386 . . . . 0.0 111.693 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.72 -145.06 15.81 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.79 156.89 77.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 122.375 0.27 . . . . 0.0 111.147 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.48 -179.16 4.83 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.657 2.238 . . . . 0.0 112.773 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t -104.03 155.97 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.832 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.8 m -101.45 -172.91 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.64 127.83 67.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.297 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.697 ' H ' ' HD2' ' A' ' 51' ' ' LYS . 8.7 mp0 -97.39 171.79 8.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.859 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -85.08 -23.29 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.338 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.18 -15.49 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.399 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.697 ' HD2' ' H ' ' A' ' 48' ' ' GLU . 87.5 mttt -79.67 152.7 29.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.155 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -58.97 122.93 14.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.762 0.791 . . . . 0.0 112.487 -167.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -129.21 142.5 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.017 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -103.64 -175.83 2.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.786 0.327 . . . . 0.0 111.601 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.18 -172.46 0.14 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.389 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.84 -146.64 4.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.055 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.4 t -158.68 173.42 16.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.727 0.299 . . . . 0.0 110.293 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -100.67 142.86 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.879 0.371 . . . . 0.0 110.379 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -109.66 149.33 29.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.93 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -89.51 107.5 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -94.13 19.76 8.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.877 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.4 mt 66.6 174.97 0.24 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 111.503 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.0 -167.51 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.676 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -119.0 108.66 15.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.849 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 62.46 95.56 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.573 0.546 . . . . 0.0 111.638 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -83.1 3.84 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -79.79 88.84 5.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -136.18 113.33 10.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.729 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.954 175.65 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.59 0.234 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.75 143.36 23.64 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.259 1.973 . . . . 0.0 111.366 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.52 146.44 25.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 110.203 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.793 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -91.49 140.12 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.63 HD13 ' HB ' ' B' ' 20' ' ' VAL . 37.8 pt -101.63 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 82.9 mt-10 -113.9 157.49 22.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.923 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.84 155.95 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.635 0.255 . . . . 0.0 110.508 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.815 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 12.0 m -114.81 126.55 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.417 0.627 . . . . 0.0 110.571 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 66.0 t80 -92.1 109.35 20.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.593 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 8.4 pt-20 -130.3 135.24 47.88 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.162 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.48 14.45 9.47 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.486 0.491 . . . . 0.0 111.891 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 94.84 10.84 57.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.755 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.9 t -114.0 143.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.362 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m-85 -106.01 116.35 31.79 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 167.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -115.99 117.81 39.01 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.875 ' HB2' ' HA ' ' B' ' 19' ' ' LYS . 16.8 Cg_exo -58.37 170.55 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.81 1.674 . . . . 0.0 113.721 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.804 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 6.3 mp -111.04 105.82 14.7 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.804 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.2 pt20 85.44 6.89 0.43 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 126.535 2.397 . . . . 0.0 110.171 -175.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.875 ' HA ' ' HB2' ' B' ' 16' ' ' PRO . 27.6 mtpp 53.56 -159.75 0.14 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.173 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' B' ' 5' ' ' ILE . 6.3 p -151.12 164.71 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.85 12.98 35.36 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.738 1.256 . . . . 0.0 109.389 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.641 ' O ' ' HD2' ' B' ' 23' ' ' LYS . 93.6 mt -79.12 156.49 28.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.327 170.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -132.57 -170.55 2.46 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.453 -170.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 6.2 mp0 -53.14 137.4 33.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 11.1 83.13 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.737 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' B' ' 22' ' ' LEU . 10.0 tp10 -77.89 134.19 37.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 117.092 0.446 . . . . 0.0 110.068 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -117.84 119.71 35.71 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.835 1.303 . . . . 0.0 112.318 -171.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.15 168.62 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.129 -1.851 . . . . 0.0 109.838 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.958 ' HG3' ' HG3' ' A' ' 33' ' ' GLU . 15.3 mtmm -126.45 139.88 52.91 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.586 0.708 . . . . 0.0 111.036 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -91.02 128.03 43.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.224 -170.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 1.9 tppt? -121.52 124.45 44.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -73.69 111.88 9.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 14.8 mt-10 -135.72 171.83 13.89 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -160.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.465 HD23 ' H ' ' B' ' 34' ' ' LEU . 2.6 pt? -136.1 176.94 8.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -93.88 159.99 14.94 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.556 0.217 . . . . 0.0 110.473 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.84 152.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -69.18 131.96 90.27 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.272 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' B' ' 39' ' ' ILE . 63.0 Cg_endo -72.93 -154.24 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.127 2.551 . . . . 0.0 111.652 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 38' ' ' PRO . 71.2 mt 74.32 161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.407 ' N ' HG22 ' B' ' 39' ' ' ILE . 27.2 t70 56.16 64.88 1.58 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.291 1.043 . . . . 0.0 110.457 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.97 125.56 41.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.847 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.32 112.75 4.12 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 9.2 pt-20 -85.37 116.89 67.41 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.535 174.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 21.5 Cg_exo -64.36 114.78 2.83 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.655 2.236 . . . . 0.0 112.037 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -72.29 146.75 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.454 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -103.37 159.6 15.43 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.177 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.41 151.86 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.691 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.53 114.15 5.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.767 0.794 . . . . 0.0 111.44 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.2 -25.73 27.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.481 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 -15.04 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.815 0.817 . . . . 0.0 110.956 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.18 133.43 42.74 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.871 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 52' ' ' LYS . 0.0 OUTLIER -124.79 156.95 36.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.868 0.366 . . . . 0.0 111.272 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 tt -99.28 145.54 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.811 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 54' ' ' ARG . 12.8 mmt180 -72.0 137.96 47.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.261 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.96 -179.25 4.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.451 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.16 6.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.949 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.2 p -90.64 102.08 14.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.146 0.498 . . . . 0.0 111.641 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -100.22 -179.46 4.14 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.344 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.41 151.39 6.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.992 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -98.75 132.84 43.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.985 0.421 . . . . 0.0 110.095 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.9 m -105.7 2.36 27.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.57 113.5 18.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.767 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.1 92.25 2.77 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -86.99 71.0 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.536 0.684 . . . . 0.0 111.814 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.66 131.91 52.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.809 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -90.54 145.52 24.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.648 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -141.99 145.19 34.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -115.6 -168.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 174.279 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.552 0.215 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' HB2' ' HD2' ' B' ' 31' ' ' LYS . 30.4 Cg_endo -65.71 108.42 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.269 1.979 . . . . 0.0 110.694 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.12 153.09 42.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.521 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.74 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.1 OUTLIER -117.98 138.21 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.273 170.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 18' ' ' GLN . 9.3 mm -108.08 143.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HG3' ' HG2' ' B' ' 29' ' ' LYS . 5.2 mp0 -97.67 121.13 39.22 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -129.81 165.72 21.39 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.056 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.694 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.0 m -117.32 115.05 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.58 0.705 . . . . 0.0 110.69 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.641 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 79.1 t80 -71.88 106.03 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.092 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.65 131.75 54.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.156 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.448 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 3.9 m-20 54.86 24.88 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 172.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 99.82 2.04 56.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.059 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.97 143.25 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.252 0.526 . . . . 0.0 111.176 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 96.9 m-85 -94.1 115.62 27.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -105.04 115.25 62.67 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.884 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 36.1 Cg_endo -66.2 167.81 17.41 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.034 1.156 . . . . 0.0 112.352 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 mt -112.91 -17.42 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 5' ' ' ILE . 76.5 mt-30 -92.91 171.63 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.058 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -75.94 132.39 40.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 162.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 22' ' ' LEU . 2.3 t -96.42 135.45 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 121.519 0.676 . . . . 0.0 110.349 -174.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -103.93 14.44 30.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.236 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 26' ' ' GLU . 91.1 mt -99.27 -174.31 2.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.098 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.55 163.04 34.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 16.5 mp0 -56.49 141.44 42.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.919 0.866 . . . . 0.0 111.524 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.27 65.3 3.45 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.535 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HG2' HD22 ' A' ' 22' ' ' LEU . 10.9 tp10 -116.76 128.5 55.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.403 -0.898 . . . . 0.0 109.634 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -85.97 120.34 27.26 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.603 1.192 . . . . 0.0 111.189 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' B' ' 30' ' ' ILE . 31.0 m -137.02 148.74 26.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.129 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -119.76 137.32 54.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.524 0.678 . . . . 0.0 110.374 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.673 HD13 HG23 ' B' ' 30' ' ' ILE . 3.6 mm -102.85 138.02 28.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.362 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.92 165.04 37.67 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.533 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 32' ' ' LEU . 2.4 mm? -97.92 127.15 43.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.98 ' HB3' ' HE2' ' B' ' 29' ' ' LYS . 30.0 tt0 -141.81 151.74 43.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.453 0.644 . . . . 0.0 112.516 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.9 mt -127.57 157.88 38.99 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.434 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 68.2 mttm -127.62 -173.16 2.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.362 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 29.8 t 65.7 149.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.868 0.842 . . . . 0.0 112.726 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 154.18 37.51 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.317 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.64 173.23 14.24 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.193 1.929 . . . . 0.0 112.012 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -102.55 178.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.341 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.16 137.35 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.95 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.863 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -89.37 -165.04 1.24 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.48 141.03 12.99 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.5 pt-20 -67.09 139.86 95.54 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.04 -0.58 . . . . 0.0 111.511 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 2.3 Cg_endo -84.93 166.88 11.27 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.289 2.659 . . . . 0.0 111.951 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.47 150.71 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -95.89 -168.8 1.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.269 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.46 142.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.5 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.94 126.58 29.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.737 0.78 . . . . 0.0 111.923 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.27 -24.14 23.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.114 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mt -64.92 -12.72 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.547 -169.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 133.89 33.71 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.46 137.94 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.629 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 tt -80.9 132.93 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -87.34 132.23 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.892 0.377 . . . . 0.0 111.024 -172.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.44 -179.09 3.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.959 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.03 19.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.435 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 p -81.74 97.83 8.14 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.246 0.546 . . . . 0.0 110.793 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -103.27 142.97 33.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.661 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.1 ptm -104.6 136.82 43.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.555 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 m -75.75 96.77 3.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.188 0.518 . . . . 0.0 109.78 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -83.58 10.45 9.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.311 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.02 98.12 6.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.523 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -116.12 112.59 21.93 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -107.25 147.49 30.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -102.58 157.25 17.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.898 0.38 . . . . 0.0 110.579 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -119.26 91.17 3.49 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.392 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -120.31 116.7 26.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 71.31 125.42 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.127 0.892 . . . . 0.0 111.538 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 . . . . . 0 C--O 1.243 0.741 0 CA-C-O 118.091 -0.956 . . . . 0.0 109.74 174.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -94.3 161.86 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.993 2.462 . . . . 0.0 111.934 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -74.48 152.02 39.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.706 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -109.19 137.02 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.236 0.541 . . . . 0.0 109.797 173.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 24.1 mm -94.83 152.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.501 ' O ' HD12 ' B' ' 17' ' ' LEU . 38.0 mt-10 -124.58 113.02 17.5 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -125.16 169.14 12.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 128.8 73.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 48.5 t80 -82.0 126.86 32.46 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.127 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 25.3 tt0 -152.19 128.28 10.42 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.608 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 t30 67.35 23.16 9.31 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.708 0.63 . . . . 0.0 111.682 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' B' ' 9' ' ' TYR . . . 88.22 15.33 60.81 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.76 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 5.1 t -122.03 150.11 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.0 m-85 -104.56 114.46 28.7 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 165.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.63 113.63 57.69 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 27.5 Cg_endo -63.61 168.51 11.46 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.636 1.557 . . . . 0.0 112.577 -175.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' O ' ' B' ' 6' ' ' GLU . 1.3 mt -114.63 -2.43 13.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.778 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.45 ' NE2' ' H ' ' B' ' 6' ' ' GLU . 2.2 pm0 -132.39 159.81 38.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.153 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -72.97 130.53 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.47 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.3 t -107.24 145.58 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.468 -173.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -108.95 14.28 24.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.459 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' B' ' 26' ' ' GLU . 85.7 mt -75.51 -175.76 2.95 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.587 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -115.87 168.38 10.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.696 0.284 . . . . 0.0 111.234 -176.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 3.5 mp0 -71.4 136.31 47.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.487 0.661 . . . . 0.0 110.659 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.48 65.56 3.08 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.074 -165.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 13.0 tp10 -90.14 134.48 34.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.562 -0.819 . . . . 0.0 109.382 172.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' B' ' 27' ' ' ARG . 3.5 tpt180 -83.75 104.07 13.56 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.441 1.115 . . . . 0.0 110.413 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.62 HG21 ' CD1' ' A' ' 14' ' ' PHE . 30.8 m -129.32 154.84 40.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.685 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.98 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 22.1 mtmm -123.42 138.54 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.277 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -105.49 121.98 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.116 -172.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 2' ' ' PRO . 3.1 tppp? -105.87 124.71 50.01 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.749 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.22 111.87 9.81 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.72 155.02 42.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.534 0.683 . . . . 0.0 112.139 -169.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 mt -143.97 161.8 37.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.677 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.41 165.92 11.01 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.387 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -79.27 143.07 13.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.551 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 10.2 pt-20 -60.68 125.91 83.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 5.1 Cg_exo -74.63 174.93 11.8 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.08 2.52 . . . . 0.0 112.494 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.44 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -85.03 164.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.99 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.28 157.98 30.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -145.85 153.64 41.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.29 115.92 0.68 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.395 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.428 ' HG3' ' HD2' ' B' ' 44' ' ' PRO . 34.8 tt0 -102.39 140.14 20.86 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.36 0.124 . . . . 0.0 110.908 -173.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' B' ' 43' ' ' GLU . 81.8 Cg_exo -46.78 146.88 5.14 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.959 3.106 . . . . 0.0 113.977 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.21 157.27 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.609 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -84.17 -176.58 6.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.572 . . . . 0.0 112.239 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.8 146.99 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.087 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.881 ' HG2' ' HB2' ' B' ' 51' ' ' LYS . 0.4 OUTLIER -79.12 136.4 37.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.426 0.631 . . . . 0.0 111.284 -173.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.49 -25.56 26.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.009 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.558 ' H ' HD12 ' B' ' 50' ' ' ILE . 4.4 mp -75.85 -4.89 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 122.0 0.905 . . . . 0.0 109.901 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.881 ' HB2' ' HG2' ' B' ' 48' ' ' GLU . 15.7 tptm -59.76 133.72 56.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.159 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -134.27 120.63 20.22 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.456 ' N ' HD12 ' B' ' 53' ' ' ILE . 3.4 mp -116.04 92.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.02 146.64 37.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.276 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -108.17 161.12 15.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.386 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.87 112.22 1.28 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.654 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -105.64 121.68 44.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.383 0.611 . . . . 0.0 111.429 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.07 141.24 48.39 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.068 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.4 ttt -133.32 124.52 27.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.285 0.565 . . . . 0.0 111.453 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.3 p -82.72 145.31 29.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 25.3 m -76.76 3.14 12.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.59 0.233 . . . . 0.0 110.848 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt 55.54 41.4 30.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.03 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' B' ' 63' ' ' GLU . 1.9 pm0 -63.84 92.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.819 0.819 . . . . 0.0 110.549 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -75.79 102.5 5.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.29 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -75.57 113.5 13.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.521 0.676 . . . . 0.0 109.717 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -105.85 139.59 40.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -106.99 147.58 29.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.698 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -79.82 112.92 17.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 111.654 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m170 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.087 171.167 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 22.0 ptp . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.221 0.534 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.8 Cg_exo -79.61 146.41 19.04 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.838 2.358 . . . . 0.0 111.863 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.1 160.48 19.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.163 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -102.03 120.78 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' LYS . 5.0 pt -109.72 155.89 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.728 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.579 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 51.0 mt-10 -103.63 141.3 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.1 161.73 36.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.712 -1.586 . . . . 0.0 108.071 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.88 136.82 58.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.417 0.627 . . . . 0.0 110.286 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 81.2 t80 -81.68 103.97 11.76 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.289 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -122.58 122.65 39.36 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.683 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' B' ' 24' ' ' GLU . 1.1 m-80 55.76 36.36 27.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.061 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 85.84 16.9 62.54 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.987 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.4 t -134.42 149.29 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 94.2 m-85 -93.04 115.38 28.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 112.81 59.26 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.1 Cg_endo -61.66 168.64 8.11 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 120.752 0.968 . . . . 0.0 112.154 174.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.52 -71.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.166 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG3' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -141.93 7.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.76 -169.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.715 ' HB3' HD12 ' A' ' 5' ' ' ILE . 70.5 mmtt -91.25 155.0 18.88 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.292 -159.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 22' ' ' LEU . 40.8 t 61.1 142.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.765 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -145.92 14.74 1.35 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.779 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.616 ' CB ' ' HG2' ' A' ' 26' ' ' GLU . 58.2 mt -89.43 5.74 43.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.124 -169.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 83.7 tttt 81.85 163.74 0.15 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.756 156.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -48.91 129.71 17.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.048 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.57 12.47 69.45 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.884 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' HG2' ' CB ' ' A' ' 22' ' ' LEU . 5.0 tp10 -81.36 134.65 35.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.613 0.244 . . . . 0.0 110.439 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -90.18 115.85 27.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 123.258 1.504 . . . . 0.0 113.419 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' B' ' 14' ' ' PHE . 31.8 m -123.81 157.43 30.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 112.473 -2.148 . . . . 0.0 108.794 177.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' ' OE2' ' B' ' 33' ' ' GLU . 59.6 mttm -124.44 135.56 53.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.413 HG21 ' CE1' ' A' ' 14' ' ' PHE . 10.7 mm -90.45 132.06 36.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.073 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' CE ' HG21 ' B' ' 4' ' ' ILE . 12.6 mptt -121.27 132.5 54.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.288 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD13 HG12 ' B' ' 28' ' ' VAL . 2.8 mm? -81.81 126.71 32.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -61.22 138.18 58.23 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.748 -176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.0 mt -83.17 155.33 23.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.069 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' H ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -124.02 148.37 47.07 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.165 178.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.8 132.41 38.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.438 0.637 . . . . 0.0 110.157 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.95 103.34 55.24 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.631 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.41 -171.52 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.878 2.385 . . . . 0.0 111.838 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.8 mp -91.36 144.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -113.41 123.54 50.31 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.737 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -83.52 154.07 24.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.652 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.87 115.38 2.09 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.957 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.91 122.57 86.45 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.708 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.13 148.03 26.97 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.679 2.253 . . . . 0.0 112.086 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.69 156.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -86.82 171.46 10.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.865 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.93 141.81 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -135.94 -26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.269 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.16 -23.87 66.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -171.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.66 -15.63 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -71.89 133.99 45.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.103 0.477 . . . . 0.0 111.618 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -133.43 163.96 28.19 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.265 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -127.61 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.477 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.18 176.21 6.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 110.495 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -115.73 158.85 22.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.077 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.81 116.61 5.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -96.81 102.49 14.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 120.997 0.427 . . . . 0.0 111.607 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -84.8 152.67 23.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.2 ttm -143.25 165.34 27.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -171.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m 61.78 83.85 0.15 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.113 0.965 . . . . 0.0 112.8 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 m -106.83 16.05 24.8 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.075 172.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.1 tp -88.26 125.9 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.693 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -152.82 109.94 3.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -153.58 142.37 21.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.834 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 71.4 101.94 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.792 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -125.14 -179.15 4.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.835 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -97.35 149.29 22.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -113.33 136.12 53.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.319 0.581 . . . . 0.0 110.855 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.191 -175.439 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.19 97.5 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.688 2.259 . . . . 0.0 112.881 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -82.66 144.49 30.23 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.456 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.577 HG21 ' CE ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -118.75 144.28 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -177.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.604 HG23 ' HB3' ' B' ' 18' ' ' GLN . 7.1 mt -89.62 148.29 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -102.67 131.08 49.7 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.81 154.34 46.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.604 0.24 . . . . 0.0 110.942 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.715 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -111.4 132.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.843 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 68.3 t80 -82.2 108.37 15.61 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.021 0.915 . . . . 0.0 110.585 176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.721 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 5.6 mt-10 -86.58 -170.68 3.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.391 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.15 62.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 O-C-N 124.342 1.026 . . . . 0.0 111.301 -171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 105.27 5.55 40.09 Favored Glycine 0 C--N 1.304 -1.218 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.677 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.5 t -112.78 145.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.221 -0.489 . . . . 0.0 111.432 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 55.4 m-85 -115.67 114.67 25.18 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 162.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -121.2 123.62 27.68 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.758 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.4 Cg_endo -65.19 168.0 15.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.708 1.605 . . . . 0.0 112.925 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.715 HD11 HG13 ' B' ' 8' ' ' VAL . 4.2 mp -118.45 -13.66 9.74 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' B' ' 5' ' ' ILE . 8.9 tt0 -91.53 164.11 13.91 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.593 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -78.15 142.65 37.88 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.88 139.82 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 122.973 1.368 . . . . 0.0 113.012 -173.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -141.81 87.46 2.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.379 -2.191 . . . . 0.0 108.301 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.3 -179.43 5.14 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.986 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.666 ' HD2' ' OE2' ' B' ' 24' ' ' GLU . 30.0 mmtt -110.06 161.92 15.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.338 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.666 ' OE2' ' HD2' ' B' ' 23' ' ' LYS . 1.1 pm0 -77.16 124.12 27.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.437 0.637 . . . . 0.0 109.532 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 15.28 30.67 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.784 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 7.6 tp10 -78.77 121.22 24.5 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -87.46 122.28 30.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.356 1.074 . . . . 0.0 111.278 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.47 HG12 HD13 ' A' ' 32' ' ' LEU . 29.7 m -129.46 151.15 35.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.219 -173.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.638 ' HE3' HG13 ' A' ' 4' ' ' ILE . 25.9 mtpp -121.57 134.56 55.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 122.443 1.116 . . . . 0.0 111.086 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 7' ' ' ALA . 9.6 mm -106.16 144.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 112.708 -2.042 . . . . 0.0 111.151 -164.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.535 ' HE3' HG22 ' A' ' 4' ' ' ILE . 6.1 ptpp? -156.16 163.98 38.94 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.657 -1.61 . . . . 0.0 107.018 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.603 ' CD2' HD12 ' A' ' 22' ' ' LEU . 1.7 mp -107.62 120.53 42.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.575 ' OE2' ' HB2' ' A' ' 29' ' ' LYS . 14.3 mt-10 -117.46 163.84 15.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.718 0.771 . . . . 0.0 112.597 -166.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.95 178.57 5.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.275 -170.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -108.11 162.39 14.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.448 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 7.6 p -95.14 138.69 20.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -105.65 104.45 48.54 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.229 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 36' ' ' VAL . 77.2 Cg_endo -92.81 175.29 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.249 2.632 . . . . 0.0 111.528 172.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -124.77 114.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.01 0.433 . . . . 0.0 111.09 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.23 137.33 34.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.52 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 tp -102.75 167.62 9.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.4 -155.18 25.52 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.852 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 40.2 mt-10 -129.44 139.02 34.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.64 165.19 31.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.059 2.506 . . . . 0.0 112.42 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.449 HG22 ' N ' ' B' ' 46' ' ' SER . 10.6 p -95.15 161.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.289 0.566 . . . . 0.0 110.88 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' SER . . . . . 0.57 ' O ' ' HB ' ' B' ' 47' ' ' VAL . 6.4 p -122.62 -164.54 1.19 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.564 -176.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 46' ' ' SER . 23.0 t 77.28 137.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.79 0.836 . . . . 0.0 111.915 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.07 138.19 37.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.95 -32.38 21.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.469 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.31 -12.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -166.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -81.86 129.48 34.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.157 0.504 . . . . 0.0 111.055 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -164.87 170.84 14.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.795 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -83.7 157.73 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -131.76 159.52 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -119.92 -171.56 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.4 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.75 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 m -126.59 144.9 50.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -122.11 134.06 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.898 0.38 . . . . 0.0 110.458 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.52 125.38 54.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.204 0.526 . . . . 0.0 111.232 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t -77.05 160.22 29.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.304 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.9 t -84.29 19.31 1.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 55.66 -176.42 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.551 0.74 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -111.35 167.39 10.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.876 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -152.53 135.66 15.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -143.94 101.42 3.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.984 0.421 . . . . 0.0 110.258 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -103.52 165.46 11.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -135.54 143.28 45.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.53 -75.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.87 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.237 -179.092 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.451 0.167 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.33 131.4 21.76 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.108 1.872 . . . . 0.0 110.738 171.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -70.36 152.03 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.431 0.634 . . . . 0.0 111.929 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.786 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.59 142.17 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.4 170.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 25.4 mt-10 -124.26 139.45 53.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.073 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.23 165.23 25.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.071 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 3.1 m -117.08 114.37 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.57 0.7 . . . . 0.0 109.512 170.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . 19.2 t80 -60.87 124.76 21.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.483 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 28.2 mt-10 -149.4 134.3 17.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.16 0.287 . . . . 0.0 111.167 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 59.03 28.36 17.6 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.152 0.908 . . . . 0.0 111.465 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.23 -69.37 0.32 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 117.406 -2.33 . . . . 0.0 111.626 -167.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' HG3' ' A' ' 15' ' ' LYS . 22.3 m -95.58 165.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.382 -0.909 . . . . 0.0 113.397 -157.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.3 m-85 -88.68 116.74 27.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 51.8 mtpt -113.44 112.05 49.13 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.395 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 Cg_endo -60.19 168.13 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.333 1.355 . . . . 0.0 112.527 -175.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 8' ' ' VAL . 97.2 mt -95.84 1.28 53.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 11.5 pt20 -146.89 156.53 43.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.193 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 23.0 mtpp -81.49 145.08 30.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.551 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -125.0 139.84 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.947 0.88 . . . . 0.0 111.853 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.37 87.44 5.19 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.208 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.2 mt -131.01 -165.59 1.58 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.27 -2.241 . . . . 0.0 109.448 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -129.27 156.79 43.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.042 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.743 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 34.2 mt-10 -69.5 128.93 38.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.209 0.528 . . . . 0.0 110.812 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 14.39 57.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.918 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 26' ' ' GLU . 1.5 mm-40 -75.39 139.72 42.54 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -92.53 114.7 27.32 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 123.335 1.541 . . . . 0.0 112.507 -173.014 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' B' ' 30' ' ' ILE . 28.7 m -124.45 148.63 28.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.216 -2.266 . . . . 0.0 109.825 -175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' B' ' 34' ' ' LEU . 61.1 mttm -111.59 139.9 46.65 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -105.77 138.89 28.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.304 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -137.32 153.4 50.27 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 27' ' ' ARG . 17.3 tp -108.4 133.26 52.83 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.835 -156.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -96.67 142.68 28.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.733 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.5 mt -156.62 175.19 14.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.965 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -104.79 167.74 9.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.43 141.79 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 33.8 mt-10 -58.04 129.41 82.47 Favored Pre-proline 0 N--CA 1.446 -0.659 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 46.6 Cg_exo -56.25 174.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.47 2.78 . . . . 0.0 114.028 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 pt -76.4 146.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.845 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.96 95.22 7.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -95.69 177.77 5.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.038 -173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.71 114.48 5.03 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.8 mt-10 -75.01 138.24 72.73 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 114.526 -0.837 . . . . 0.0 111.338 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 12.6 Cg_exo -70.0 118.06 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.482 2.121 . . . . 0.0 110.594 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.16 147.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.845 0.355 . . . . 0.0 110.612 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 m -98.09 171.78 8.03 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.94 147.34 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.335 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 41.8 mt-10 -74.96 138.03 42.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.807 0.337 . . . . 0.0 110.598 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 -25.19 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.386 0.612 . . . . 0.0 110.05 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.57 -0.4 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.875 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -65.62 140.01 58.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.05 0.452 . . . . 0.0 110.635 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 18.4 ptmt -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 51.5 mt 73.27 130.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 124.006 0.816 . . . . 0.0 112.755 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.764 ' HG2' ' H ' ' A' ' 55' ' ' ASP . 37.6 ttp180 -140.93 -168.94 2.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.764 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 7.5 p-10 -64.95 146.1 55.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.566 0.698 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.14 91.15 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.955 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -67.29 130.87 44.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -113.06 134.03 54.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.198 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.5 ttm -83.97 146.5 27.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.671 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.06 111.79 3.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -80.6 -5.4 56.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 110.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.05 -21.64 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.535 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.55 101.68 3.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.338 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -114.64 -171.35 1.91 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.267 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -150.22 137.32 19.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -86.0 154.49 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -130.4 101.82 5.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -168.19 127.53 1.23 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.857 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.7 -179.099 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.15 99.77 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.437 2.091 . . . . 0.0 111.116 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.55 167.37 19.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.249 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.777 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -83.21 131.91 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-O 121.476 0.655 . . . . 0.0 110.015 174.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.531 ' CG2' ' HB2' ' B' ' 18' ' ' GLN . 7.6 mt -109.25 142.77 20.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -99.72 138.89 36.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.293 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.15 160.71 39.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.911 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.01 124.35 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.174 0.512 . . . . 0.0 110.626 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 85.6 t80 -80.19 99.74 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.543 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 73.1 mt-10 -122.74 144.75 48.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 59.0 t30 66.37 10.72 7.46 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.434 0.458 . . . . 0.0 111.656 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 86.78 18.93 57.43 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.991 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.0 t -122.12 151.39 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.058 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.6 m-85 -98.58 115.62 29.02 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' B' ' 10' ' ' GLU . 49.1 mtmt -118.16 116.48 35.71 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.914 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 15.7 Cg_endo -61.25 165.96 11.85 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 121.688 1.592 . . . . 0.0 113.531 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.0 -66.06 0.96 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.283 -2.689 . . . . 0.0 104.945 162.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.531 ' HB2' ' CG2' ' B' ' 5' ' ' ILE . 14.7 mp0 -59.67 158.63 9.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.276 -1.783 . . . . 0.0 111.134 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -76.83 128.39 34.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 110.531 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.463 HG12 ' H ' ' B' ' 22' ' ' LEU . 8.7 t -124.44 150.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.374 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.15 15.2 7.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.916 0.865 . . . . 0.0 110.88 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.489 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 94.9 mt -71.25 163.99 26.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.58 -173.63 2.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.354 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 7.2 mp0 -63.15 141.97 58.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.321 0.581 . . . . 0.0 111.806 -175.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.584 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 45.9 64.55 2.38 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.218 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 4.1 mm-40 -103.81 134.42 47.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.521 -0.839 . . . . 0.0 110.032 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.1 mmm-85 -82.64 115.98 21.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.336 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 14' ' ' PHE . 30.0 m -140.42 152.04 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.585 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 59.4 mttm -115.32 141.83 47.51 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.204 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.5 mm -118.94 142.44 33.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.562 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.466 ' HD2' HG22 ' A' ' 4' ' ' ILE . 62.0 tttm -155.3 126.45 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.244 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.601 ' HG ' HG12 ' A' ' 28' ' ' VAL . 1.3 mp -65.12 113.28 3.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -154.85 146.01 22.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.232 -160.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.507 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 3.4 pp -158.28 171.91 19.32 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.855 -1.521 . . . . 0.0 108.137 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -123.33 147.54 46.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t -94.72 139.32 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.865 -171.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.44 171.29 5.8 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.422 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.65 171.87 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.752 1.634 . . . . 0.0 111.873 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.5 176.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.83 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -114.12 147.99 37.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.174 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.685 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.4 pt? -113.32 144.64 42.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.122 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.58 122.04 7.29 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.808 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.1 pt-20 -55.92 141.73 66.29 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.999 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 3.0 Cg_exo -75.18 -170.63 0.82 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.062 2.508 . . . . 0.0 112.269 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.98 156.25 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.297 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -83.32 172.21 12.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.62 148.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.643 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -50.57 119.85 4.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.329 0.585 . . . . 0.0 111.917 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -85.91 -26.04 25.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.179 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 pt -87.68 0.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.347 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.72 134.01 35.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -105.43 150.51 25.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.407 . . . . 0.0 110.951 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.28 144.46 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.83 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' B' ' 55' ' ' ASP . 87.4 mtm180 -103.16 178.1 4.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.802 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' B' ' 54' ' ' ARG . 12.6 t70 71.02 153.68 0.12 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.907 0.754 . . . . 0.0 110.676 -172.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.68 131.34 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.81 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -60.21 135.33 57.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.775 0.322 . . . . 0.0 110.411 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -129.2 133.22 47.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.216 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 1.2 tpt -114.07 127.45 55.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.767 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -88.68 167.62 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 26.5 t -81.7 20.22 0.96 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.075 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 70.3 mt 62.9 -165.74 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.272 0.629 . . . . 0.0 111.205 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -123.64 134.25 53.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -93.35 120.22 33.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.954 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -57.26 137.58 55.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.491 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -79.79 139.58 37.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.021 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -131.61 117.99 19.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -81.43 123.38 28.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.941 176.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HB2' ' HB2' ' B' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.81 -59.81 0.65 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.509 2.806 . . . . 0.0 114.427 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -93.39 171.25 9.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.442 . . . . 0.0 111.247 -171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.27 145.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.495 -174.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.623 HG21 HG22 ' A' ' 20' ' ' VAL . 22.8 mm -106.14 168.93 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 46.5 mt-10 -124.76 160.03 29.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.318 0.508 . . . . 0.0 110.706 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' B' ' 30' ' ' ILE . . . -158.65 158.56 34.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.782 0.433 . . . . 0.0 110.259 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.5 117.86 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.635 0.731 . . . . 0.0 110.44 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.733 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 51.3 t80 -82.69 113.05 20.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.131 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HG2' ' HB3' ' B' ' 24' ' ' GLU . 0.4 OUTLIER -137.97 146.14 42.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.994 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 57.59 26.31 12.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 80.31 20.96 65.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.008 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.6 t -130.59 152.84 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.227 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 91.4 m-85 -104.64 114.01 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -104.79 106.39 54.78 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.429 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -39.83 168.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.963 3.109 . . . . 0.0 117.758 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.897 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 96.5 mt -131.72 96.99 4.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 111.621 -2.536 . . . . 0.0 105.518 168.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.897 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 4.4 pp0? 77.66 -176.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.476 2.31 . . . . 0.0 112.02 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.88 137.78 44.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -159.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 5' ' ' ILE . 2.5 t -141.6 134.18 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.103 170.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -131.14 87.76 2.51 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.829 1.3 . . . . 0.0 108.6 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 HD22 ' B' ' 32' ' ' LEU . 57.2 mt -123.11 -179.05 4.15 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 112.178 -2.283 . . . . 0.0 110.967 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.603 ' HG3' ' HG2' ' A' ' 26' ' ' GLU . 18.9 pttp -114.28 162.65 16.31 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 46.3 mt-10 -65.76 133.7 51.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 122.025 0.917 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.61 64.93 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.082 -165.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 2.0 mm-40 -114.82 139.87 49.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.208 -0.996 . . . . 0.0 109.708 168.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -100.17 124.87 46.09 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 123.008 1.385 . . . . 0.0 112.354 -175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' B' ' 30' ' ' ILE . 33.5 m -133.6 150.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.107 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HG3' ' HG3' ' B' ' 33' ' ' GLU . 59.5 mttm -105.43 138.5 41.53 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.577 0.703 . . . . 0.0 110.136 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.476 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.6 mm -110.2 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.98 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.1 156.29 34.05 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.543 HD13 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? -69.45 148.1 50.03 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.45 124.82 11.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.779 0.8 . . . . 0.0 112.265 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.7 mt 51.47 157.97 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 112.817 -1.992 . . . . 0.0 115.144 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -98.51 175.76 5.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.603 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.33 152.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.691 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.2 pm0 -90.59 148.81 39.5 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 173.43 11.96 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.165 1.91 . . . . 0.0 112.149 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.24 153.18 24.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.67 72.04 0.96 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.6 tp -91.04 135.65 33.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.659 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.7 111.34 3.8 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.5 tt0 -93.42 113.06 59.13 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.525 -0.838 . . . . 0.0 110.469 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 6.3 Cg_exo -73.78 113.82 3.88 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.863 2.375 . . . . 0.0 112.204 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 46' ' ' SER . 8.4 p -114.14 163.15 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.526 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 45' ' ' VAL . 4.3 m -66.67 160.17 26.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.258 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.99 134.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.115 0.483 . . . . 0.0 110.577 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.658 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 31.7 mt-10 -126.0 121.57 33.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.966 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 49' ' ' GLU . 6.9 pt-20 -85.2 -25.57 27.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.695 -174.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -88.43 1.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.669 0.747 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.658 ' HE2' ' HB2' ' A' ' 48' ' ' GLU . 25.1 ttmm -72.52 133.87 44.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.986 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 60.19 104.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.804 0.811 . . . . 0.0 112.619 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tp -78.75 127.78 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.62 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -112.52 117.11 31.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.18 153.37 25.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.41 35.66 4.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.325 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -79.46 150.6 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.389 0.614 . . . . 0.0 111.024 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -150.82 134.27 16.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.24 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -88.1 123.85 33.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.015 0.436 . . . . 0.0 110.06 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.9 m -96.39 116.38 28.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 110.29 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m -85.42 21.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.864 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.47 107.58 1.15 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 110.287 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.61 160.2 28.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.911 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -126.12 92.93 3.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.294 0.569 . . . . 0.0 109.706 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -134.5 125.39 27.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.325 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -139.94 -50.5 0.49 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.375 0.607 . . . . 0.0 109.707 171.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.5 m170 58.92 23.11 11.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.872 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -96.11 114.95 26.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.214 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 28.0 ttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 52.1 Cg_exo -55.12 103.45 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.125 2.55 . . . . 0.0 113.34 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.66 159.01 17.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.899 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.647 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -99.76 138.64 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 121.245 0.545 . . . . 0.0 110.605 176.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 18' ' ' GLN . 4.4 mt -114.84 168.07 6.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -132.41 136.4 46.74 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -133.83 155.76 49.25 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.374 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.679 HG13 HD11 ' B' ' 17' ' ' LEU . 7.1 m -110.06 121.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.316 0.579 . . . . 0.0 111.006 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 21.3 t80 -61.02 111.23 1.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.982 171.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -136.11 129.3 31.61 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.969 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 28.8 t30 55.02 27.84 9.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.77 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.97 -68.27 0.22 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 117.688 -2.196 . . . . 0.0 111.26 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.67 154.96 3.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.522 -1.339 . . . . 0.0 111.678 -157.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 89.3 m-85 -88.72 122.16 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 0.0 112.031 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.73 119.03 51.64 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 34.1 Cg_endo -66.13 168.71 15.12 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.462 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.679 HD11 HG13 ' B' ' 8' ' ' VAL . 4.9 mp -113.21 -5.72 13.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' B' ' 5' ' ' ILE . 18.8 mp0 -116.68 143.35 45.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.356 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -72.57 126.75 30.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.9 t -88.27 145.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.244 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -111.52 14.98 21.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.008 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' B' ' 26' ' ' GLU . 80.2 mt -90.57 -168.62 2.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.314 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 15.1 tmtt? -111.81 155.4 23.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.9 mp0 -57.89 133.17 55.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.924 0.869 . . . . 0.0 112.201 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.37 65.5 3.5 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 114.106 -1.407 . . . . 0.0 110.381 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' B' ' 22' ' ' LEU . 10.0 tp10 -92.92 149.13 21.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.686 -0.757 . . . . 0.0 110.958 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.55 104.94 17.19 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.532 1.158 . . . . 0.0 111.376 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 32' ' ' LEU . 34.9 m -124.7 154.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.407 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 41.4 mttp -119.43 148.0 43.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.495 0.664 . . . . 0.0 110.076 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 28' ' ' VAL . 7.8 mt -128.55 153.38 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.129 -170.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -150.88 159.33 44.62 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 8.3 mt -91.25 114.1 26.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -173.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.754 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 4.6 mm-40 -94.62 152.04 18.82 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.175 0.512 . . . . 0.0 111.916 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 -170.55 3.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.771 -175.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -90.96 166.03 13.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.429 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 156.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.7 mt-10 -60.16 141.93 90.11 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 32.8 Cg_exo -61.88 174.39 2.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.186 2.591 . . . . 0.0 113.773 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.413 HG13 ' H ' ' B' ' 39' ' ' ILE . 2.0 pp -82.09 171.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.127 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -93.4 -151.57 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.493 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.77 -170.53 2.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.42 141.41 10.4 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.46 155.06 85.82 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 120.573 0.225 . . . . 0.0 110.896 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.25 164.72 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.44 2.093 . . . . 0.0 110.11 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.67 134.99 8.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 122.001 0.905 . . . . 0.0 112.099 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -86.51 172.44 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.021 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.78 131.54 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.97 118.9 20.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.0 110.747 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -85.61 -25.47 26.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.588 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 tt -93.29 5.87 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.616 0.722 . . . . 0.0 110.8 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -87.19 148.34 25.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.97 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -80.33 143.82 33.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.944 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.58 -49.36 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 63.43 147.98 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.855 0.862 . . . . 0.0 112.796 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.92 169.69 19.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.45 80.67 0.87 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.057 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -91.79 152.45 20.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -110.45 135.74 50.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.739 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.39 148.7 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.483 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.1 p -142.54 149.52 39.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.032 0.444 . . . . 0.0 111.207 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 46.1 t -95.3 13.91 24.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.65 94.39 9.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.425 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.07 86.55 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -98.81 58.22 1.16 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.239 0.542 . . . . 0.0 111.624 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -68.92 116.24 9.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.23 102.57 14.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.63 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -78.81 112.94 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -109.94 129.88 55.6 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.055 -174.322 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptm . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 111.25 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.398 2.065 . . . . 0.0 111.86 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -147.76 173.37 12.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.4 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.946 HG22 ' HG2' ' B' ' 31' ' ' LYS . 0.3 OUTLIER -109.41 144.51 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.778 176.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.605 HD11 HD11 ' A' ' 22' ' ' LEU . 4.6 mt -106.1 148.18 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.926 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.52 123.08 45.61 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -143.07 168.52 19.55 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 17' ' ' LEU . 10.6 m -129.68 129.73 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.018 0.437 . . . . 0.0 110.785 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 20.0 t80 -59.77 128.85 38.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 37.7 tt0 -139.79 109.04 6.1 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.496 0.665 . . . . 0.0 111.494 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.455 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 31.0 t30 55.7 27.33 10.5 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.324 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.9 -70.01 0.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 118.158 -1.972 . . . . 0.0 110.731 -165.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' HB ' ' CG1' ' B' ' 13' ' ' VAL . 23.2 m -94.34 145.36 8.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 113.649 -1.276 . . . . 0.0 112.201 -160.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.5 m-85 -86.82 116.76 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.333 0.587 . . . . 0.0 110.169 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HE3' ' CG2' ' A' ' 13' ' ' VAL . 34.5 mmtp -105.12 116.58 60.34 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.153 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 13.6 Cg_endo -59.93 169.0 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.41 1.407 . . . . 0.0 111.997 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.523 HD11 HG13 ' A' ' 8' ' ' VAL . 7.4 mp -102.23 -8.73 21.04 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.47 170.49 16.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.433 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -63.49 128.01 33.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.061 0.934 . . . . 0.0 112.204 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 ' HZ ' ' B' ' 14' ' ' PHE . 4.9 p -132.87 141.36 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.714 173.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -148.14 87.85 1.63 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.358 -1.746 . . . . 0.0 108.867 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.826 HD13 HD11 ' B' ' 32' ' ' LEU . 67.4 mt -106.63 0.72 24.63 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.853 -1.976 . . . . 0.0 109.647 171.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 85.14 171.99 0.07 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 113.191 173.022 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.7 mp0 -78.43 134.92 37.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.502 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 51.94 63.87 4.43 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -166.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.646 ' HG2' ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp10 -113.56 137.7 51.21 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.803 -1.199 . . . . 0.0 107.927 170.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -100.53 117.8 35.41 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 123.124 1.44 . . . . 0.0 112.996 -164.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.622 HG12 HD13 ' B' ' 32' ' ' LEU . 16.0 m -134.84 158.07 41.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 112.149 -2.296 . . . . 0.0 109.483 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.748 ' HD3' HG13 ' B' ' 4' ' ' ILE . 87.3 mttt -120.95 138.38 54.16 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 122.047 0.927 . . . . 0.0 111.101 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 14' ' ' PHE . 8.8 mm -103.57 149.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.204 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -156.3 162.37 40.11 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.742 HD23 HG12 ' B' ' 28' ' ' VAL . 52.3 mt -95.21 117.08 29.63 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.723 -171.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.811 ' HG3' ' HG3' ' B' ' 29' ' ' LYS . 45.2 mm-40 -88.22 132.08 34.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.962 -172.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.25 -167.1 2.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.472 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -117.66 171.75 7.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.425 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.38 130.17 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.94 137.18 22.34 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-O 121.21 0.529 . . . . 0.0 112.152 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.28 177.34 7.23 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.772 2.315 . . . . 0.0 111.117 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.4 pp -87.82 147.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.119 0.485 . . . . 0.0 111.952 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -99.03 172.08 7.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.096 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.807 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.8 pt? -98.56 130.57 45.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.41 -154.57 17.65 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.844 -170.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.86 153.65 60.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.718 -173.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.36 171.03 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.736 2.291 . . . . 0.0 112.565 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.71 148.94 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.598 . . . . 0.0 110.465 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.537 ' O ' HG12 ' A' ' 47' ' ' VAL . 45.5 m -120.81 175.92 5.8 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.18 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 64.57 154.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.477 1.111 . . . . 0.0 113.029 177.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.6 mm-40 66.27 -36.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.663 1.185 . . . . 0.0 113.928 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.75 -26.02 62.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.492 0.663 . . . . 0.0 109.704 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mm -90.24 -4.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.053 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -98.38 176.7 5.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.58 103.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.705 0.764 . . . . 0.0 110.572 -168.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -107.42 148.9 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.581 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -53.36 126.65 21.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.0 110.192 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.81 149.02 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.02 31.1 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.454 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 p -65.16 121.32 14.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.143 0.497 . . . . 0.0 110.902 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -87.35 134.12 33.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.7 tpt -62.83 124.59 21.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.3 m -72.39 108.11 5.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -93.34 15.85 14.71 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.937 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.74 97.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -174.91 2.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.506 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -129.91 116.39 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.1 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -69.72 92.1 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -99.79 4.27 45.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.3 -169.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -103.98 96.88 6.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -175.62 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 t60 . . . . . 0 C--O 1.25 1.118 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.314 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.513 0.197 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.48 106.96 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.444 2.096 . . . . 0.0 112.436 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -115.82 152.2 33.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.554 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.748 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -127.53 143.09 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.457 177.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.573 HD13 HG21 ' B' ' 20' ' ' VAL . 6.9 mt -101.44 151.8 5.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 42.9 mt-10 -113.55 134.24 54.81 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.27 151.08 40.13 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.538 0.523 . . . . 0.0 109.98 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.7 m -116.19 125.81 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.477 0.656 . . . . 0.0 110.377 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 43.4 t80 -75.99 121.97 23.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.44 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.37 135.98 34.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.57 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t30 63.04 20.61 12.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 91.08 13.06 59.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.743 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 9.1 t -120.69 153.24 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.337 0.255 . . . . 0.0 110.408 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.4 m-85 -109.0 115.34 29.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.054 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -109.05 115.95 56.18 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.99 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 41.8 Cg_endo -68.81 168.14 21.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.832 1.021 . . . . 0.0 112.186 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.436 HD11 HG13 ' B' ' 8' ' ' VAL . 5.3 mp -112.08 -12.6 13.66 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' B' ' 5' ' ' ILE . 0.7 OUTLIER -102.59 139.45 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.484 171.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -80.31 132.76 35.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 110.396 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -127.47 136.36 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.466 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.77 87.34 2.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.828 1.299 . . . . 0.0 108.186 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.581 ' HG ' HG12 ' B' ' 20' ' ' VAL . 47.2 mt -122.43 -178.44 3.9 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.533 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' B' ' 26' ' ' GLU . 29.9 mttp -102.62 161.96 13.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 mp0 -71.87 119.11 15.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 14.93 38.22 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.884 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' B' ' 22' ' ' LEU . 5.3 mm-40 -71.4 133.42 45.93 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 120.77 35.24 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 123.298 1.523 . . . . 0.0 112.819 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 32' ' ' LEU . 32.8 m -138.95 162.65 28.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 112.291 -2.231 . . . . 0.0 110.489 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.811 ' HG3' ' HG3' ' A' ' 33' ' ' GLU . 46.8 mttp -122.3 139.46 53.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.689 0.757 . . . . 0.0 109.246 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 28' ' ' VAL . 6.2 mt -102.9 136.34 35.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.98 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.946 ' HG2' HG22 ' A' ' 4' ' ' ILE . 19.8 mttt -137.02 147.14 46.03 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.634 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.826 HD11 HD13 ' A' ' 22' ' ' LEU . 4.3 mm? -86.59 128.36 34.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.372 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.549 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 38.4 mm-40 -94.46 124.18 38.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -135.37 -169.64 2.43 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.755 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 153.37 29.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.485 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.0 147.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.45 114.84 7.35 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.087 0.47 . . . . 0.0 111.917 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.76 -173.12 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.947 2.431 . . . . 0.0 112.128 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -90.14 155.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.965 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -92.71 159.95 15.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.149 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.65 165.77 26.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.193 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.41 -136.7 5.56 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.557 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -112.9 161.87 24.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 122.282 0.233 . . . . 0.0 110.953 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.88 167.66 24.85 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.402 2.068 . . . . 0.0 111.848 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.05 151.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -98.81 170.18 8.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.016 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.89 138.0 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -119.62 -23.37 6.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.232 0.539 . . . . 0.0 111.123 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.21 -25.23 65.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.983 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.408 ' O ' HG12 ' B' ' 50' ' ' ILE . 13.1 tt -84.14 -6.24 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.194 0.521 . . . . 0.0 111.919 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -74.18 138.55 43.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.824 0.345 . . . . 0.0 110.565 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -85.94 126.94 34.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.72 123.97 42.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.449 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -60.93 115.64 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.316 0.579 . . . . 0.0 111.041 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.54 172.29 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.281 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 128.61 11.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.4 -176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -90.95 144.16 25.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.091 0.472 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -83.33 171.29 13.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.4 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 19.3 ptp -84.69 169.56 14.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.852 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -73.38 -177.15 2.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.8 m -105.32 4.06 30.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.741 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 67.4 mt 59.01 -171.23 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.392 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.51 136.11 50.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.127 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -118.2 85.1 2.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.786 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.21 127.76 32.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.114 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' B' ' 67' ' ' HIS . 52.5 m80 -96.04 147.67 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 66' ' ' HIS . 60.6 m170 72.16 157.61 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.881 0.738 . . . . 0.0 109.465 -168.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -91.29 0.75 57.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.418 0.627 . . . . 0.0 109.781 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 C--O 1.247 0.95 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.888 178.584 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.583 0.23 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.5 130.89 23.25 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.814 2.342 . . . . 0.0 111.743 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -136.31 149.03 48.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.831 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -71.12 144.28 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.182 0.515 . . . . 0.0 111.623 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -105.1 146.76 11.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -103.02 137.2 41.53 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.82 160.33 40.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.838 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.4 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.555 0.693 . . . . 0.0 110.425 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.6 t80 -72.92 110.41 7.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.668 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 36.9 mt-10 -134.2 144.46 48.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.398 177.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 62.62 22.4 13.3 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.441 0.463 . . . . 0.0 111.374 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 79.43 18.55 73.51 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.914 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 9.8 t -127.42 150.72 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 63.4 m-85 -95.55 115.0 26.81 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.287 168.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 50.8 mtpt -113.99 108.64 50.6 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.594 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 27.7 Cg_endo -62.52 169.22 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.35 1.366 . . . . 0.0 112.781 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.2 -16.29 14.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -107.68 137.37 45.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.558 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -75.96 124.58 27.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.644 0.735 . . . . 0.0 109.98 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.655 ' HB ' ' CE2' ' B' ' 9' ' ' TYR . 3.6 t -103.12 147.48 9.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.591 -175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.76 16.1 13.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.121 0.962 . . . . 0.0 110.345 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD13 ' HG2' ' A' ' 26' ' ' GLU . 96.7 mt -73.84 -174.37 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.773 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -110.97 171.86 7.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.341 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -73.29 141.74 47.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.459 0.647 . . . . 0.0 110.575 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.739 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 54.52 64.77 4.02 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.703 -167.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' HG2' HD13 ' A' ' 22' ' ' LEU . 7.8 tp10 -105.98 123.15 47.52 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.478 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -77.88 111.3 13.58 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 122.654 1.216 . . . . 0.0 112.747 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.1 m -133.32 155.55 40.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.603 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.964 ' HD3' HG13 ' B' ' 4' ' ' ILE . 64.3 mttm -113.03 149.05 33.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.551 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.0 mm -104.59 130.25 55.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.277 0.561 . . . . 0.0 109.627 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HE3' HG21 ' B' ' 4' ' ' ILE . 75.2 mttt -132.81 134.45 44.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.545 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.707 ' HB3' HG12 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -103.75 141.83 35.42 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.913 -169.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.22 158.3 20.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.255 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt -133.93 160.04 38.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.013 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -96.22 166.94 11.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.653 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.14 138.84 32.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 mm-40 -81.27 123.05 81.78 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.848 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.3 Cg_exo -77.79 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.543 2.829 . . . . 0.0 113.256 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.2 pt -68.05 165.3 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.89 149.54 52.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.05 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.9 tp -100.52 135.12 42.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 111.379 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 156.38 24.51 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.039 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.44 150.7 73.95 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.36 -0.92 . . . . 0.0 111.868 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 159.03 35.5 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.761 2.307 . . . . 0.0 111.951 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.28 155.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -90.28 174.09 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.43 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.63 164.67 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.37 121.0 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.567 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -85.56 -28.83 24.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.133 0.492 . . . . 0.0 111.088 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.9 tt -93.65 -0.77 10.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.604 0.716 . . . . 0.0 110.774 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -73.54 132.94 43.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.726 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -123.92 141.71 51.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -99.63 90.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 0.0 110.197 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -87.56 110.72 20.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.941 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.46 163.21 18.26 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.21 105.2 3.01 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.434 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.3 m -84.94 131.19 34.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -98.24 142.67 29.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -101.13 144.65 29.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.196 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.7 m -77.86 107.18 10.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.439 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.9 m -95.8 3.51 53.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.795 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.3 tp -107.01 123.43 48.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.895 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.59 150.23 21.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -78.03 66.67 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 0.0 109.754 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -86.91 141.54 28.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.648 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 73.14 69.37 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.511 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -117.09 87.09 2.63 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -82.61 115.02 21.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.162 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 -179.298 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.606 0.241 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.05 146.72 20.46 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.319 2.013 . . . . 0.0 111.691 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -121.3 162.78 19.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.729 0.299 . . . . 0.0 110.363 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.964 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -105.71 144.99 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.463 -177.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB2' ' B' ' 18' ' ' GLN . 6.6 mt -97.78 144.24 11.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 51.4 mp0 -104.9 141.32 36.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -139.87 166.26 25.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.108 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.739 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.4 m -121.36 123.48 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.612 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.655 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.2 t80 -61.55 126.16 26.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.831 173.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 81.1 mt-10 -137.09 111.52 8.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.018 0.437 . . . . 0.0 111.294 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 55.5 29.12 12.78 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.032 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.04 -69.78 0.48 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 118.215 -1.945 . . . . 0.0 110.845 -168.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.15 145.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.784 -1.208 . . . . 0.0 111.823 -161.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -92.83 116.74 29.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.63 120.77 56.68 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.561 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 28.8 Cg_endo -64.82 170.05 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.316 1.344 . . . . 0.0 112.533 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.598 HD11 HG13 ' B' ' 8' ' ' VAL . 6.0 mp -108.92 -10.67 15.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' B' ' 5' ' ' ILE . 47.0 mt-30 -115.48 145.26 42.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.866 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -73.42 151.57 41.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.953 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' B' ' 22' ' ' LEU . 2.5 t -112.54 145.25 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.67 16.61 9.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.36 1.076 . . . . 0.0 109.519 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 88.6 mt -86.36 -165.93 1.4 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.188 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.564 ' HG2' ' HG2' ' B' ' 26' ' ' GLU . 23.6 pttp -116.32 155.08 29.06 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.379 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.1 132.5 45.16 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.885 0.85 . . . . 0.0 109.836 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.02 65.03 2.75 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.617 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 1.9 mm-40 -112.06 132.96 54.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.254 -0.973 . . . . 0.0 109.221 170.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -90.41 119.48 30.73 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.704 0.764 . . . . 0.0 110.869 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 32' ' ' LEU . 29.8 m -140.11 166.81 19.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.467 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HD3' HG13 ' A' ' 4' ' ' ILE . 60.9 mttm -122.03 153.93 37.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.23 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 28' ' ' VAL . 5.8 mm -115.44 142.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -151.34 125.05 9.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.2 mp -71.14 114.54 9.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -146.12 171.68 14.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.181 0.515 . . . . 0.0 111.594 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.471 HD23 ' H ' ' B' ' 34' ' ' LEU . 1.7 pt? -123.55 165.72 16.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.997 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.507 ' HG2' ' N ' ' B' ' 36' ' ' VAL . 37.6 ttmt -120.64 159.47 25.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.507 ' N ' ' HG2' ' B' ' 35' ' ' LYS . 7.7 p -92.44 138.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.4 0.619 . . . . 0.0 111.018 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -143.63 89.08 7.56 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.527 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.65 -161.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.304 2.669 . . . . 0.0 112.712 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.34 156.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -91.81 -51.28 5.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.801 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 45.1 tp 68.8 116.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.278 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.77 -142.5 10.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.969 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.83 158.19 38.39 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 122.252 0.221 . . . . 0.0 111.177 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.09 174.27 12.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.025 2.483 . . . . 0.0 112.253 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.69 154.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 10.4 m -89.32 171.84 9.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.39 138.17 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.405 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.02 -30.67 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.692 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' B' ' 49' ' ' GLU . 1.6 pm0 -66.84 -24.49 66.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.957 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 tt -77.69 -4.03 6.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.375 0.607 . . . . 0.0 110.944 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -70.55 134.24 47.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.178 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -108.21 150.6 27.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -118.23 132.33 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -78.28 120.71 23.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.92 147.97 22.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 0.0 110.89 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.75 76.88 0.41 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.211 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m -70.05 135.56 49.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.683 0.278 . . . . 0.0 110.666 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' TRP . . . . . 0.409 ' O ' ' HB2' ' B' ' 59' ' ' MET . 1.3 m-90 -110.56 -168.77 1.35 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.343 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' B' ' 58' ' ' TRP . 66.6 mtt 73.64 172.42 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.831 0.853 . . . . 0.0 110.31 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m 57.09 26.18 11.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.076 0.465 . . . . 0.0 111.735 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.8 p -82.22 16.93 1.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.003 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 45.43 99.89 0.01 OUTLIER 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.119 0.967 . . . . 0.0 113.223 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -82.83 172.4 12.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.09 123.74 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.263 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -97.23 141.22 30.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -71.14 129.92 40.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 111.639 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -71.83 86.78 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -83.77 73.92 10.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.5 0.667 . . . . 0.0 111.167 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.8 m170 . . . . . 0 C--O 1.246 0.891 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.538 177.011 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' B' ' 32' ' ' LEU . 74.4 Cg_endo -93.2 108.28 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.097 2.531 . . . . 0.0 115.656 -166.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.452 ' HG2' HD13 ' A' ' 4' ' ' ILE . 23.8 ttpp -120.17 158.56 26.67 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 161.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.3 OUTLIER -70.49 127.1 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.451 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 20' ' ' VAL . 4.6 mt -105.59 152.65 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.109 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 30.1 mt-10 -112.94 108.05 16.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -110.16 167.14 10.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.41 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 3.8 m -118.02 117.39 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.642 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 73.5 t80 -70.38 114.85 8.9 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.868 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 11.6 tt0 -88.05 -170.69 3.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.324 -2.216 . . . . 0.0 107.402 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 10.9 t30 -67.44 49.75 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.713 0.805 . . . . 0.0 112.135 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.69 4.58 11.65 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.2 t -117.32 155.12 19.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.298 -175.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 1.097 ' HB2' ' HB3' ' B' ' 14' ' ' PHE . 81.2 m-85 -122.81 119.15 29.72 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.306 164.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.07 121.02 37.52 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -67.07 167.58 19.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.105 1.203 . . . . 0.0 111.23 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.04 -2.65 14.99 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' A' ' 5' ' ' ILE . 40.5 mt-30 -119.24 144.17 46.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.683 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.8 141.19 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 5' ' ' ILE . 4.1 p -132.56 161.77 40.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.843 0.83 . . . . 0.0 112.028 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 20' ' ' VAL . 31.0 t70 -104.9 12.84 32.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.198 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 20' ' ' VAL . 6.9 mp -66.8 135.61 54.2 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.427 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.7 mmpt? -93.67 -172.26 2.84 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.523 -176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -61.63 160.52 11.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.895 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -19.72 72.63 0.0 OUTLIER Glycine 0 CA--C 1.495 -1.217 0 O-C-N 124.997 1.435 . . . . 0.0 114.132 -151.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.11 147.51 40.49 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 111.526 -2.337 . . . . 0.0 108.602 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HG3' HD23 ' B' ' 32' ' ' LEU . 13.2 tpt180 -88.14 119.17 28.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.879 ' HA ' ' CB ' ' B' ' 32' ' ' LEU . 0.0 OUTLIER -144.61 149.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.255 -174.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HB2' HD13 ' B' ' 32' ' ' LEU . 13.6 mttt -115.21 143.96 44.43 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.365 0.602 . . . . 0.0 110.286 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.696 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 1.5 mt -107.34 135.12 47.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HG2' ' HB2' ' B' ' 29' ' ' LYS . 7.5 ptmm? -106.82 143.79 34.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.736 HD21 HD21 ' B' ' 22' ' ' LEU . 21.9 tp -100.87 128.06 47.07 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' OE2' ' HE3' ' B' ' 29' ' ' LYS . 3.7 tp10 -72.38 133.64 45.03 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.414 1.102 . . . . 0.0 113.38 -162.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -157.07 -179.5 8.27 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.005 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -126.09 158.53 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.03 137.13 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.782 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.74 138.22 22.91 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.38 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.62 -174.34 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.718 2.279 . . . . 0.0 110.657 171.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.32 151.61 27.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.923 0.392 . . . . 0.0 111.179 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tt -67.99 110.26 3.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.137 0.494 . . . . 0.0 110.902 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.34 114.5 0.71 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -131.89 161.72 60.82 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 122.462 0.305 . . . . 0.0 110.475 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.69 164.84 31.61 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.686 2.257 . . . . 0.0 111.515 173.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.86 148.37 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.4 m -103.59 176.89 5.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.103 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.6 156.92 43.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.03 130.07 39.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.085 0.469 . . . . 0.0 110.227 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -85.43 -25.98 26.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.257 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -70.9 -16.1 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.533 0.682 . . . . 0.0 111.206 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.75 132.29 54.11 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.873 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.773 ' HG2' HG12 ' A' ' 53' ' ' ILE . 85.5 tttt -173.69 149.61 1.62 Allowed 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.091 0.244 . . . . 0.0 110.381 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.773 HG12 ' HG2' ' A' ' 52' ' ' LYS . 43.0 mm 58.98 104.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.93 152.05 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.417 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.51 155.93 40.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.652 0.739 . . . . 0.0 112.835 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.97 75.13 0.24 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.047 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 m -94.29 142.6 27.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.164 0.507 . . . . 0.0 111.922 -172.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -125.89 134.62 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 ttm -94.02 124.95 38.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 t -81.41 150.73 28.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 p -104.32 -6.03 21.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp 38.69 79.56 0.03 OUTLIER 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.09 0.869 . . . . 0.0 112.21 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 156.3 34.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -145.68 82.42 1.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 171.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -108.13 99.75 9.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.212 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -143.33 143.2 31.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.936 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -146.12 138.09 25.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.854 0.359 . . . . 0.0 110.496 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -109.42 108.73 19.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.917 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.376 178.244 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.421 ' O ' ' HD3' ' B' ' 3' ' ' LYS . 27.0 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.74 109.91 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.054 2.503 . . . . 0.0 112.659 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 3' ' ' LYS . 3.7 mppt? -73.2 156.94 38.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.054 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.577 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -89.22 143.96 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.263 170.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 18' ' ' GLN . 10.4 mm -113.14 146.43 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -109.39 131.21 55.28 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' B' ' 14' ' ' PHE . . . -143.12 164.33 30.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 0.0 111.248 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.22 128.87 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.282 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 41.2 t80 -84.76 100.85 11.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -115.12 120.42 39.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.859 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.32 33.29 9.19 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.965 0.79 . . . . 0.0 111.35 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' B' ' 9' ' ' TYR . . . 83.56 14.28 73.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.211 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.5 t -120.12 146.7 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 1.097 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -99.93 114.94 28.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -119.0 108.96 39.91 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.637 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 39.2 Cg_endo -68.85 168.27 20.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.467 1.445 . . . . 0.0 112.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.36 -9.55 17.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.504 ' HB2' HG23 ' B' ' 5' ' ' ILE . 72.4 mt-30 -102.38 145.69 29.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.205 173.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -84.39 124.19 31.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 163.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.7 t -90.57 148.93 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.431 -161.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.42 16.38 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.027 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.736 HD21 HD21 ' A' ' 32' ' ' LEU . 22.1 mt -99.76 -174.62 2.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.089 -173.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 26' ' ' GLU . 37.8 tttm -116.28 155.12 28.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.267 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 1.5 mp0 -62.64 123.46 18.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.049 0.452 . . . . 0.0 109.955 175.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.73 22.92 34.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.036 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' HD22 ' B' ' 22' ' ' LEU . 16.9 mm-40 -84.02 143.02 30.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' B' ' 27' ' ' ARG . 4.3 tpp180 -86.28 120.51 27.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.4 1.095 . . . . 0.0 112.442 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.696 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 34.6 m -136.07 151.55 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.832 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.741 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 47.7 mmtt -117.35 144.63 44.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 18.7 mt -133.12 137.08 54.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.807 0.813 . . . . 0.0 111.967 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -158.16 135.85 10.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.155 169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.879 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 8.8 tp -153.01 162.22 41.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -164.36 157.22 17.3 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.021 -168.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' B' ' 34' ' ' LEU . 2.9 pp -78.73 173.63 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.806 177.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.481 ' HB3' ' NZ ' ' B' ' 35' ' ' LYS . 9.1 mtpm? -84.12 153.24 23.84 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.491 0.662 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.7 137.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -131.34 114.82 16.03 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 120.876 0.37 . . . . 0.0 110.889 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.11 -175.83 2.37 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.158 2.572 . . . . 0.0 112.289 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt 69.27 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.435 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.468 ' OD2' ' HG ' ' B' ' 41' ' ' LEU . 36.2 t70 -155.4 -69.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.862 -173.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' B' ' 40' ' ' ASP . 94.3 mt -100.04 168.0 10.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.274 0.559 . . . . 0.0 112.147 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 120.93 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.693 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 36.1 mm-40 -97.11 144.18 27.44 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.579 0.228 . . . . 0.0 111.123 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.71 156.15 64.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.98 2.453 . . . . 0.0 112.279 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.49 158.79 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.936 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -87.27 168.24 13.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.88 162.4 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.353 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.36 122.95 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.965 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.13 25.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.023 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 17.9 tt -72.29 -12.02 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.445 ' HB2' ' HE2' ' B' ' 51' ' ' LYS . 6.1 tppt? -79.37 132.38 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -147.42 107.46 4.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.903 0.382 . . . . 0.0 111.574 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tp -100.85 101.86 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.421 0.629 . . . . 0.0 109.449 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -122.73 126.29 47.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.499 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.58 159.28 30.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.112 0.482 . . . . 0.0 110.963 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.48 5.05 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.479 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.7 t -115.98 167.62 10.8 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -95.9 143.14 27.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 120.991 0.424 . . . . 0.0 111.1 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.52 124.65 48.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.61 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.1 t -79.86 148.52 31.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 110.424 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 2.8 p -94.82 -0.09 54.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' B' ' 61' ' ' SER . 1.0 OUTLIER 39.7 84.58 0.02 OUTLIER 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.651 1.219 . . . . 0.0 112.947 -178.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 100.91 0.16 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.244 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -85.01 57.91 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.17 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -70.29 108.18 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.138 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.1 134.31 22.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -120.2 117.27 27.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -78.57 142.21 37.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.453 178.968 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 100.35 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.877 2.385 . . . . 0.0 110.898 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 156.32 21.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.061 0.458 . . . . 0.0 110.906 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.884 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.1 OUTLIER -92.99 144.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.235 -170.028 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' HZ ' ' B' ' 14' ' ' PHE . 2.0 mt -93.54 145.54 7.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -99.54 109.72 22.23 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.195 -169.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.943 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -115.68 156.97 24.95 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -166.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.623 HG22 HH12 ' B' ' 27' ' ' ARG . 0.1 OUTLIER -123.31 123.62 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.709 171.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.5 t80 -80.37 105.63 11.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 50.0 mt-10 -126.83 139.69 52.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.569 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' CG ' ' B' ' 24' ' ' GLU . 4.6 t30 65.36 20.37 11.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 111.554 172.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 84.25 15.62 68.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.5 t -122.48 154.08 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.7 m-85 -99.43 114.64 27.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 165.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 37.7 mtpt -116.97 108.92 43.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.108 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.943 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 14.4 Cg_endo -72.75 169.17 22.63 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 113.491 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.36 -12.37 59.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.681 ' HG2' ' HG2' ' A' ' 16' ' ' PRO . 6.2 mm-40 75.1 -134.05 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.0 116.731 160.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.0 mttt 59.07 -161.25 0.26 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.454 -141.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' HG ' ' A' ' 22' ' ' LEU . 22.0 t 67.01 147.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.484 0.659 . . . . 0.0 110.435 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.03 26.74 3.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.684 0.754 . . . . 0.0 111.252 -171.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.43 ' HG ' ' CG1' ' A' ' 20' ' ' VAL . 94.7 mt -56.85 174.81 0.14 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.832 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -103.84 162.68 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 1.5 pm0 -83.62 149.57 26.45 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.82 73.06 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.695 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 21.5 tt0 -93.1 155.4 17.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -96.33 137.45 35.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.747 0.784 . . . . 0.0 112.465 -171.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.913 HG12 ' HA ' ' B' ' 32' ' ' LEU . 4.4 m -147.97 171.39 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.601 ' HD3' HG13 ' B' ' 4' ' ' ILE . 62.5 mttm -127.0 144.74 50.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.188 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.66 HG22 ' HB ' ' B' ' 28' ' ' VAL . 1.3 mm -113.05 131.55 64.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.765 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -121.57 124.29 44.01 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.801 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.0 mp -74.03 117.45 15.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.8 158.13 32.47 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.354 0.597 . . . . 0.0 112.43 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -164.03 1.48 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.756 -173.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -99.03 157.51 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.753 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 37' ' ' GLU . 39.5 t -70.14 164.92 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.546 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 36' ' ' VAL . 12.4 pt-20 41.83 84.23 0.19 Allowed Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 124.298 1.039 . . . . 0.0 111.591 -171.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.24 174.39 8.16 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.465 2.776 . . . . 0.0 113.631 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mt -73.89 149.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.095 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -99.28 101.66 13.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.773 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 19.7 tp -83.13 -177.58 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -172.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' ' HG ' ' A' ' 41' ' ' LEU . . . -150.05 156.42 26.73 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.7 mp0 -54.6 124.1 47.71 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 123.785 0.344 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.37 128.25 29.28 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.497 2.131 . . . . 0.0 111.521 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.1 p -70.85 143.93 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.886 0.85 . . . . 0.0 111.661 -175.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -114.47 162.15 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.77 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.561 0.696 . . . . 0.0 111.456 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.31 -14.42 25.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.811 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.0 -27.22 68.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.537 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -93.12 -14.84 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -139.09 130.78 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -151.88 139.3 19.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.669 -173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -92.24 115.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.559 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -103.61 104.4 14.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -76.79 148.66 36.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.277 0.56 . . . . 0.0 111.688 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.34 104.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.195 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.1 p -81.83 127.93 33.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.902 0.382 . . . . 0.0 111.404 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -144.65 140.14 28.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.031 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.1 ttm -159.6 145.12 15.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -101.01 159.29 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.169 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -77.39 -0.31 25.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.761 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 tp 57.91 -163.95 0.19 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.19 0.596 . . . . 0.0 111.343 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.95 115.67 5.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -97.04 102.29 14.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.484 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.74 135.78 40.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.359 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -146.5 -179.07 6.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.893 0.377 . . . . 0.0 110.945 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -135.69 164.04 28.78 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -125.95 97.47 5.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.648 0.737 . . . . 0.0 110.3 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.544 -178.703 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 6.2 Cg_endo -86.48 97.9 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -144.54 161.94 37.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.362 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.601 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -109.21 145.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.658 173.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.479 ' O ' HG12 ' A' ' 30' ' ' ILE . 9.0 mm -98.13 143.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -104.86 134.98 47.07 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.668 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -137.27 156.29 48.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.536 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.487 HG13 HD11 ' B' ' 17' ' ' LEU . 2.0 m -117.17 114.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.688 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 14.1 p90 -103.52 141.88 35.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.186 0.993 . . . . 0.0 113.25 -170.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -87.58 -170.98 3.24 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.582 172.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -65.7 63.45 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 O-C-N 124.504 1.127 . . . . 0.0 111.722 -171.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 113.06 -5.71 25.46 Favored Glycine 0 C--N 1.301 -1.413 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.382 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' B' ' 9' ' ' TYR . 0.2 OUTLIER -104.37 139.02 26.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.437 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 42.5 m-85 -118.68 123.87 45.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.188 0.904 . . . . 0.0 111.353 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -122.79 117.32 28.75 Favored Pre-proline 0 N--CA 1.455 -0.184 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.527 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.4 Cg_endo -67.83 169.14 16.83 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.984 1.789 . . . . 0.0 113.74 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.487 HD11 HG13 ' B' ' 8' ' ' VAL . 4.7 mp -120.58 -17.81 7.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.432 171.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -96.42 146.97 24.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -62.96 148.54 47.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.438 0.637 . . . . 0.0 110.559 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' B' ' 22' ' ' LEU . 2.3 p -145.17 134.53 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 122.338 1.066 . . . . 0.0 111.818 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -121.13 15.08 11.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.709 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 32' ' ' LEU . 85.7 mt -66.39 167.22 10.92 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.09 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -112.68 160.4 17.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -173.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 2.3 mp0 -62.77 120.23 10.87 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.905 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.2 36.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.974 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -75.89 136.4 40.12 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.942 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.623 HH12 HG22 ' A' ' 8' ' ' VAL . 18.3 tpp180 -93.39 117.39 30.02 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.567 1.175 . . . . 0.0 112.522 -171.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 30' ' ' ILE . 19.8 m -141.79 158.25 21.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.459 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.884 ' HD3' HG13 ' A' ' 4' ' ' ILE . 52.5 mttp -120.76 147.2 45.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.823 HG21 ' CE2' ' B' ' 14' ' ' PHE . 1.3 mm -110.68 132.26 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.145 0.498 . . . . 0.0 110.976 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 4' ' ' ILE . 10.5 mtmt -118.56 136.86 53.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 171.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HA ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -93.17 113.38 25.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.08 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.561 ' O ' ' HG ' ' B' ' 34' ' ' LEU . 49.6 mm-40 -122.37 135.35 54.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -162.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 33' ' ' GLU . 18.3 mt -151.58 144.81 24.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.409 -2.178 . . . . 0.0 106.728 156.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -153.03 179.27 8.85 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.356 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 80.0 t 65.73 143.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.983 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -119.75 139.41 28.0 Favored Pre-proline 0 N--CA 1.435 -1.215 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.749 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.4 174.19 12.54 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 111.769 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.508 ' O ' HD12 ' B' ' 39' ' ' ILE . 1.9 pp -81.4 137.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -107.08 119.26 38.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.2 mt -134.32 168.89 18.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.262 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 118.14 2.64 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.7 mp0 -51.93 139.8 31.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 123.174 0.59 . . . . 0.0 111.572 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 130.2 37.33 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.637 2.225 . . . . 0.0 111.761 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.24 151.95 8.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.065 0.459 . . . . 0.0 110.476 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -94.3 169.71 10.03 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.884 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 132.84 65.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.503 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -72.46 120.01 17.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.264 0.554 . . . . 0.0 110.841 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.84 -23.33 48.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.3 mt -64.2 -15.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.365 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -76.12 131.97 39.75 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.745 ' HG2' HG13 ' B' ' 53' ' ' ILE . 46.6 tttp -160.09 141.73 12.72 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.981 -164.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.745 HG13 ' HG2' ' B' ' 52' ' ' LYS . 77.3 mt 70.11 112.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.868 0.842 . . . . 0.0 112.588 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -99.94 17.29 21.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.794 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.83 175.49 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.075 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 63.46 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.247 -0.501 . . . . 0.0 111.952 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -158.47 164.72 35.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.823 -0.222 . . . . 0.0 110.417 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -132.17 135.91 46.69 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.8 ptp -106.18 159.18 16.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.009 0.433 . . . . 0.0 111.066 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -71.14 173.59 7.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.112 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -90.25 -6.51 55.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.828 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 tp 51.1 30.58 5.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.8 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.44 129.62 50.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.03 0.443 . . . . 0.0 110.587 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -133.28 85.87 2.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.546 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -75.05 74.79 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.129 0.966 . . . . 0.0 110.759 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -104.06 111.82 24.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.818 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -127.55 141.63 51.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.499 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -105.76 137.94 42.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.523 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 9.7 p80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' B' ' 32' ' ' LEU . 15.7 ptm . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.77 -41.53 2.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.092 2.528 . . . . 0.0 112.446 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -149.94 160.38 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.347 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.747 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.08 144.84 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.184 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.574 ' HB ' HD12 ' B' ' 30' ' ' ILE . 19.4 mt -119.87 152.2 22.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 169.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.57 134.91 48.99 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.678 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.43 165.79 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.44 -175.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.474 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 10.5 m -118.42 127.98 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.27 0.557 . . . . 0.0 110.512 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.687 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 86.5 t80 -89.42 105.15 17.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.834 0.826 . . . . 0.0 110.637 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 8.5 pt-20 -91.86 -168.33 1.99 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.79 168.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.78 67.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.436 1.112 . . . . 0.0 112.43 -160.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . 105.38 0.4 40.58 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.012 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 1.9 t -115.16 141.97 29.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.262 -173.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.5 m-85 -108.31 115.59 30.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 166.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HE3' HG11 ' A' ' 13' ' ' VAL . 96.9 mttt -121.2 119.11 29.78 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.619 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -52.48 166.57 0.75 Allowed 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.382 2.055 . . . . 0.0 114.741 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.3 -67.4 0.99 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 110.215 -3.175 . . . . 0.0 103.655 167.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -71.44 141.73 50.26 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.08 -2.327 . . . . 0.0 108.628 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 13.8 mtpt -60.6 149.63 34.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.697 0.76 . . . . 0.0 112.395 -173.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 m -77.1 166.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.527 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.42 15.21 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.719 0.771 . . . . 0.0 110.148 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.527 HD11 HD22 ' B' ' 32' ' ' LEU . 79.0 mt -122.5 -169.91 1.99 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.378 -172.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 18.3 pttp -124.03 155.12 38.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.974 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.2 pm0 -66.19 134.28 52.41 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.21 0.528 . . . . 0.0 111.002 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.17 10.58 48.22 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.802 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 5.7 tp10 -84.46 146.56 27.56 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.807 -0.231 . . . . 0.0 110.757 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -102.5 125.08 49.1 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.557 1.17 . . . . 0.0 112.334 -175.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.512 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.3 m -134.15 156.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.414 -174.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.627 ' HB3' HD12 ' B' ' 4' ' ' ILE . 64.0 mttm -115.33 144.79 43.23 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.0 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.514 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.5 mm -115.79 144.3 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 -175.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -151.3 123.78 8.41 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' B' ' 28' ' ' VAL . 2.7 pt? -89.85 145.67 24.99 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.18 123.93 37.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.405 1.097 . . . . 0.0 110.782 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 34' ' ' LEU . 2.0 mm? -101.48 -164.9 1.14 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.783 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -134.64 160.31 38.51 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.49 127.41 14.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.355 0.598 . . . . 0.0 111.037 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.1 115.6 27.29 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.369 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.86 172.14 11.26 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.211 1.941 . . . . 0.0 112.298 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.57 165.24 32.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.062 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.64 118.37 15.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.903 0.382 . . . . 0.0 110.297 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 pt? -148.82 133.93 18.24 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.875 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.3 -155.07 31.15 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.227 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 49.0 mt-10 -118.13 143.08 32.17 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-O 120.527 0.204 . . . . 0.0 110.704 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 21.5 Cg_exo -65.94 142.44 68.8 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.943 2.429 . . . . 0.0 112.112 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.84 146.29 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.914 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -95.73 158.19 15.56 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.054 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.9 t -140.72 132.01 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.234 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -118.99 122.3 41.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.856 0.836 . . . . 0.0 110.954 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.48 -22.98 26.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.104 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.07 -3.51 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.532 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -78.43 133.19 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 153.15 23.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.961 0.41 . . . . 0.0 111.451 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -105.53 -158.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.123 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' H ' ' HB ' ' A' ' 53' ' ' ILE . 27.9 ttm105 -107.23 160.47 15.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.905 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.43 153.82 40.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 110.296 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.68 156.42 21.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.855 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 m -68.39 130.76 43.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -119.63 175.17 5.99 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.081 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.0 ttt -63.31 130.56 45.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.022 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 154.88 34.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.402 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -87.11 15.24 6.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp 60.22 -171.03 0.14 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.374 0.67 . . . . 0.0 111.62 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 2.8 mp0 -97.22 -22.92 16.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.249 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 28.6 t-80 72.95 -17.94 0.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.695 0.622 . . . . 0.0 112.66 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.8 m170 68.74 -178.08 0.22 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.735 0.414 . . . . 0.0 110.535 -172.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -109.56 109.97 20.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.509 0.671 . . . . 0.0 110.726 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -94.83 96.74 9.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.356 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -96.52 -7.13 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.294 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.903 170.32 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.67 102.81 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.012 2.475 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -124.16 171.5 9.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.369 0.604 . . . . 0.0 111.894 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.125 173.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' B' ' 20' ' ' VAL . 1.9 mt -124.45 157.94 31.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 mt-10 -109.59 139.99 43.93 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.4 157.52 44.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.041 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.659 HG13 HD11 ' B' ' 17' ' ' LEU . 6.0 m -104.26 117.35 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.602 0.715 . . . . 0.0 110.822 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 52.7 t80 -76.57 111.25 11.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.21 1.005 . . . . 0.0 111.181 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.696 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 36.6 mt-10 -88.51 -169.12 2.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.163 170.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.55 55.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.236 1.014 . . . . 0.0 112.349 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 112.65 6.72 23.01 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.8 t -116.08 149.59 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.885 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.8 m-85 -119.18 114.87 23.11 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 166.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.468 ' HE2' HG11 ' B' ' 13' ' ' VAL . 65.1 mttm -114.26 113.77 45.93 Favored Pre-proline 0 CA--C 1.506 -0.717 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.23 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -43.56 169.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.318 2.678 . . . . 0.0 116.642 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.946 ' O ' ' HG3' ' B' ' 18' ' ' GLN . 2.5 mt -131.17 103.91 6.76 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.753 167.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.946 ' HG3' ' O ' ' B' ' 17' ' ' LEU . 5.1 pp0? 79.38 178.58 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.068 2.547 . . . . 0.0 112.922 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.23 141.28 35.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -162.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' B' ' 5' ' ' ILE . 3.2 t -137.79 135.06 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.279 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.511 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -128.08 87.56 2.62 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 123.015 1.388 . . . . 0.0 109.149 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.434 HD13 ' HG2' ' B' ' 26' ' ' GLU . 60.6 mt -129.99 -169.95 2.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.032 -1.894 . . . . 0.0 111.119 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -91.1 -174.72 4.07 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -103.45 122.08 44.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.753 0.787 . . . . 0.0 110.24 170.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 25' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 93.02 15.16 53.16 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.409 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.434 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.8 tp10 -60.93 138.46 58.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.604 0.361 . . . . 0.0 110.524 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 0.1 OUTLIER -89.76 115.09 26.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.376 1.084 . . . . 0.0 111.662 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 32' ' ' LEU . 27.4 m -132.33 162.7 39.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.575 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -117.66 147.12 43.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.281 0.562 . . . . 0.0 109.598 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.574 HD12 ' HB ' ' A' ' 5' ' ' ILE . 2.1 mt -106.7 128.45 61.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.81 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -125.92 134.09 51.67 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 122.556 1.169 . . . . 0.0 108.852 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 22' ' ' LEU . 41.3 tp -103.15 131.17 50.37 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.03 -162.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -97.25 140.08 32.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.943 0.877 . . . . 0.0 112.173 -170.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 18.0 mt -155.59 158.91 39.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.348 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.78 177.3 7.35 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.705 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.17 141.18 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -86.93 136.02 34.65 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.47 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.91 174.37 9.74 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.415 2.077 . . . . 0.0 111.657 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.22 144.81 8.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.91 -177.07 6.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.5 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.38 143.07 26.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 111.0 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 -123.59 5.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.026 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.3 OUTLIER -101.36 153.47 37.81 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 120.774 0.321 . . . . 0.0 111.055 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 1.8 Cg_endo -87.0 -159.57 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.551 2.834 . . . . 0.0 111.654 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 t -115.04 156.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -75.21 169.68 17.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.844 0.354 . . . . 0.0 111.312 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.04 136.92 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.8 -22.35 21.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.245 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.12 -28.19 67.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.518 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.27 2.33 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 110.945 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -111.71 -154.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.136 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' B' ' 52' ' ' LYS . 1.5 ttmt 60.31 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.613 0.721 . . . . 0.0 111.974 -172.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.4 ' N ' HD12 ' B' ' 53' ' ' ILE . 4.3 mp -86.81 102.98 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.696 -174.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -157.56 116.12 3.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.144 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.25 166.02 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.87 93.88 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.783 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 42.6 m 70.0 148.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.292 0.637 . . . . 0.0 111.67 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.07 178.98 4.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.363 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t 74.91 137.23 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.139 0.899 . . . . 0.0 112.424 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -105.47 18.63 21.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.034 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 67.96 179.05 0.23 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.094 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 65' ' ' HIS . 40.7 tt0 -124.21 121.61 35.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.353 0.596 . . . . 0.0 111.83 -172.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -96.36 74.52 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' HIS . . . . . 0.513 ' HB2' ' HG2' ' B' ' 63' ' ' GLU . 2.2 t-160 -95.07 -8.91 35.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.736 -170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -99.25 127.49 45.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -139.26 115.57 10.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -73.68 -74.83 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.696 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 1' ' ' MET . 20.5 ptm . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.25 0.547 . . . . 0.0 111.503 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -93.43 119.81 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.771 2.314 . . . . 0.0 111.104 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -88.23 143.56 26.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.937 HG13 ' HD2' ' B' ' 29' ' ' LYS . 0.2 OUTLIER -76.12 129.79 36.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.876 -174.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.42 147.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.76 128.51 52.91 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.47 151.57 44.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 6.6 m -115.87 119.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 121.381 0.61 . . . . 0.0 111.063 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.724 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 87.2 t80 -72.71 99.71 2.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -119.28 130.95 55.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.397 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.56 23.64 13.89 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.649 0.593 . . . . 0.0 112.035 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.515 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 92.1 10.43 61.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.354 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.9 t -122.92 142.83 38.03 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' B' ' 28' ' ' VAL . 48.7 m-85 -88.89 114.19 25.24 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 166.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -119.75 116.16 33.23 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.193 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.1 Cg_endo -58.27 166.38 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.33 1.353 . . . . 0.0 111.965 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -98.23 -13.67 20.71 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -122.37 155.36 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.728 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.28 131.85 35.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -111.26 150.05 13.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.0 14.7 20.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.279 1.038 . . . . 0.0 110.145 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.53 HD13 ' HG2' ' A' ' 26' ' ' GLU . 70.4 mt -79.06 176.75 9.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.577 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HG2' ' OE1' ' A' ' 26' ' ' GLU . 17.5 pttm -124.95 163.11 23.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 111.537 -172.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.9 pt-20 -66.24 116.92 7.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.85 14.91 14.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.646 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 3.9 tp10 -80.61 132.49 35.63 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -103.18 127.81 50.35 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 122.356 1.074 . . . . 0.0 111.534 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' B' ' 32' ' ' LEU . 35.7 m -135.19 162.09 38.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.719 -167.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.93 141.88 47.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.793 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 14.7 mt -122.21 137.49 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.569 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -158.04 167.48 29.76 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.108 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.52 114.86 24.52 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 162.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.705 ' HB2' ' HE2' ' B' ' 29' ' ' LYS . 8.5 tp10 -58.14 147.85 28.65 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -154.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.689 ' HG ' ' HG3' ' A' ' 33' ' ' GLU . 85.0 mt 55.23 -166.0 0.11 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.025 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -116.13 171.37 7.85 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.49 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 37' ' ' GLU . 7.5 p -85.81 164.27 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 36' ' ' VAL . 1.4 mp0 -61.75 164.57 9.54 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 122.924 0.489 . . . . 0.0 111.239 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.46 179.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.624 2.216 . . . . 0.0 112.856 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.92 174.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.622 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.84 153.74 43.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.697 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.83 148.04 33.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.92 -144.62 5.93 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.813 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.6 mp0 -53.03 117.91 12.49 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.114 0.538 . . . . 0.0 110.716 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.94 124.31 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.43 2.087 . . . . 0.0 112.258 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.51 150.11 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.26 157.92 16.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.345 0.593 . . . . 0.0 111.481 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.46 96.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.78 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 15.8 pt-20 -84.3 1.07 46.61 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.553 -172.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.8 -25.07 10.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.441 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.3 pt -77.77 13.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.365 0.603 . . . . 0.0 111.301 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 32.5 tttt -65.35 140.08 58.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.831 -177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -136.35 147.98 47.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 tt -81.74 132.83 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 120.936 0.398 . . . . 0.0 110.575 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 54' ' ' ARG . 22.6 ttt85 -74.83 85.57 2.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.18 148.27 23.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.751 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.46 116.98 1.61 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.36 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.0 t -129.72 156.78 43.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.667 0.27 . . . . 0.0 110.421 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -77.71 159.23 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.007 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -59.25 159.49 7.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.434 ' O ' HD22 ' A' ' 62' ' ' LEU . 2.3 p -66.63 171.01 5.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 m -76.47 8.19 3.73 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 60' ' ' SER . 2.6 mm? 60.1 142.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.906 0.882 . . . . 0.0 113.133 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.02 111.58 4.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.497 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.85 -16.54 56.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.4 t60 71.91 126.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.879 0.737 . . . . 0.0 110.552 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -85.61 144.79 27.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 74.84 121.53 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 124.412 1.07 . . . . 0.0 111.58 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -60.24 137.33 58.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.071 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.8 p80 . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.557 173.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 139.11 15.18 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.633 2.222 . . . . 0.0 113.665 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -157.25 158.85 36.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.416 ' N ' HD12 ' B' ' 4' ' ' ILE . 3.3 mp -77.93 130.83 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 121.997 0.903 . . . . 0.0 111.734 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.594 HD13 HG12 ' B' ' 20' ' ' VAL . 9.9 mt -114.46 151.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.65 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 137.73 52.66 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.66 168.97 18.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.1 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.64 141.58 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 83.7 t80 -100.3 114.09 27.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.053 0.93 . . . . 0.0 109.958 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.714 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 44.7 mt-10 -87.58 -170.63 3.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.126 -1.852 . . . . 0.0 108.552 169.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 52.64 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.096 0.958 . . . . 0.0 112.07 -172.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 117.48 4.67 15.26 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.3 t -114.32 145.54 19.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.554 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' B' ' 9' ' ' TYR . 46.5 m-85 -117.68 115.45 25.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 166.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.87 114.33 46.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.709 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 9.5 Cg_endo -59.93 165.47 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-O 123.472 1.363 . . . . 0.0 113.2 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 -66.03 0.93 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.048 -2.796 . . . . 0.0 104.675 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.508 ' HB2' HG23 ' B' ' 5' ' ' ILE . 50.7 mt-30 -65.55 132.13 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.629 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -61.24 124.16 19.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.02 0.914 . . . . 0.0 110.47 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.594 HG12 HD13 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -101.82 132.95 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.177 -176.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.36 88.4 2.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.426 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.555 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 72.5 mt -130.57 -165.0 1.49 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.348 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -92.59 161.58 14.53 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -88.23 128.28 35.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.4 65.11 3.16 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 113.725 -1.579 . . . . 0.0 109.878 -160.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.93 142.8 29.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.646 -0.777 . . . . 0.0 109.864 173.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' B' ' 27' ' ' ARG . 1.0 OUTLIER -100.84 105.57 16.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.684 1.231 . . . . 0.0 111.768 -176.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 14' ' ' PHE . 33.8 m -123.96 164.83 21.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.979 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.937 ' HD2' HG13 ' A' ' 4' ' ' ILE . 31.7 mtmm -123.44 139.77 53.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.598 0.714 . . . . 0.0 110.935 177.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.465 HG21 ' CE1' ' B' ' 14' ' ' PHE . 10.7 mm -111.11 143.98 19.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.816 -171.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -147.42 161.22 41.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 113.84 -1.527 . . . . 0.0 107.377 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.67 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.2 pt? -121.73 154.05 37.42 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.51 142.49 55.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.511 0.672 . . . . 0.0 112.107 -173.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.57 153.9 30.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.957 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -124.14 147.33 48.04 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.069 0.462 . . . . 0.0 110.423 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.65 130.61 63.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.676 0.75 . . . . 0.0 110.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.0 112.15 26.88 Favored Pre-proline 0 N--CA 1.433 -1.312 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.876 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.28 173.53 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.416 2.077 . . . . 0.0 111.981 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.1 pt -95.81 155.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.31 123.78 28.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.863 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.36 115.54 28.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.28 113.67 2.39 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.55 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.86 155.51 80.41 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.551 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.21 145.21 77.72 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.474 2.116 . . . . 0.0 111.604 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.99 152.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.095 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -77.36 173.42 11.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.69 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 25.5 t -82.92 116.5 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.339 0.59 . . . . 0.0 110.354 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.73 155.49 18.54 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.924 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.94 -24.36 66.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.798 0.332 . . . . 0.0 111.672 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.41 ' N ' HD12 ' B' ' 50' ' ' ILE . 3.0 mp -69.91 -16.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.815 0.817 . . . . 0.0 109.837 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.67 132.98 36.44 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.263 174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' B' ' 52' ' ' LYS . 50.4 tptt -132.71 107.94 8.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.43 0.633 . . . . 0.0 111.228 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -87.31 136.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.34 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.849 ' HG3' ' H ' ' B' ' 55' ' ' ASP . 6.4 tpt180 55.63 -166.73 0.11 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.102 0.561 . . . . 0.0 112.015 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.849 ' H ' ' HG3' ' B' ' 54' ' ' ARG . 11.2 p-10 -108.51 -176.46 3.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.638 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.19 126.85 2.0 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.943 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.38 119.44 31.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.884 0.373 . . . . 0.0 111.06 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -82.75 150.72 26.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.368 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 43.5 tpp -116.13 154.11 30.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.313 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 74.26 -0.58 3.31 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.589 0.556 . . . . 0.0 110.767 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -85.28 5.74 29.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.269 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.93 136.66 52.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.115 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 145.85 26.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -146.73 78.15 1.49 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.675 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -145.19 157.83 43.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -153.68 138.57 17.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -121.02 77.86 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -179.74 97.52 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.499 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.2 t60 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.791 -176.663 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.451 ' O ' HG12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' B' ' 29' ' ' LYS . 11.6 mm -93.99 147.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 39.6 mt-10 -113.77 134.75 54.58 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.51 156.54 48.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 11.5 m -110.27 115.16 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.747 0.784 . . . . 0.0 110.577 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.767 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 64.7 t80 -73.62 101.45 3.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.564 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' OE1' ' HG3' ' A' ' 15' ' ' LYS . 40.2 mt-10 -108.24 119.24 38.91 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.063 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.73 21.13 12.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 102.73 7.68 44.33 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.367 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.2 t -120.37 142.7 34.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-O 119.588 -0.244 . . . . 0.0 110.436 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 76.1 m-85 -93.0 115.58 28.25 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.976 170.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HG3' ' OE1' ' A' ' 10' ' ' GLU . 29.1 mmtp -107.57 108.75 62.03 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 17.9 Cg_endo -60.84 167.41 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 119.979 1.028 . . . . 0.0 112.501 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.74 -6.05 23.06 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' A' ' 5' ' ' ILE . 7.9 pt20 -138.41 111.97 8.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.631 173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 12.7 tmtt? -60.91 133.25 55.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.752 -171.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.8 t -113.6 140.99 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.114 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -116.33 87.49 2.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.789 1.281 . . . . 0.0 109.047 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' A' ' 26' ' ' GLU . 76.0 mt -127.11 -158.65 0.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.162 -2.29 . . . . 0.0 110.671 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -85.67 176.75 7.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 2.0 mp0 -89.7 123.31 33.61 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.97 0.891 . . . . 0.0 109.446 168.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.041 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 69.59 64.75 2.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.395 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HG2' HD13 ' A' ' 22' ' ' LEU . 5.6 tp10 -94.4 144.53 25.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.212 -0.994 . . . . 0.0 108.887 169.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 120.76 34.4 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.568 1.175 . . . . 0.0 114.013 -167.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.2 m -138.79 154.64 26.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -115.06 140.01 49.4 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HB ' ' B' ' 5' ' ' ILE . 1.8 mt -103.73 140.97 20.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.27 -173.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -125.58 138.06 53.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.773 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp . . . . . 0 C--N 1.309 -1.192 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.472 0.653 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.98 123.65 50.52 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.023 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.45 173.73 13.33 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.585 2.19 . . . . 0.0 112.444 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 pt -116.19 164.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.42 -172.3 2.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 tp -85.48 143.02 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.45 -142.3 5.47 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.866 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.9 161.41 63.54 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.297 . . . . 0.0 111.001 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.15 -174.87 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.827 2.351 . . . . 0.0 112.536 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.56 155.71 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.734 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 p -97.0 -178.43 4.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.53 123.81 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.522 0.677 . . . . 0.0 110.892 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -103.5 179.65 4.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.16 -36.6 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.254 0.55 . . . . 0.0 111.777 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 mt -88.85 1.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.713 0.768 . . . . 0.0 110.361 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.374 -177.215 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 4' ' ' ILE . 2.7 mp . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 30' ' ' ILE . 29.7 mt -125.22 153.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -97.57 148.32 23.39 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.06 42.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 1.041 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.6 m -109.6 113.75 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.713 0.768 . . . . 0.0 110.531 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' B' ' 14' ' ' PHE . 37.5 t80 -67.47 100.87 0.9 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.84 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 92.2 mt-10 -102.46 112.59 25.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t30 63.09 13.45 6.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.24 169.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 119.71 2.36 12.98 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.886 -1.149 . . . . 0.0 112.479 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 15' ' ' LYS . 26.9 m -132.1 142.52 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.105 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 98.2 m-85 -86.85 116.31 24.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.955 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -105.84 111.15 64.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.144 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -44.93 168.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.333 -0.263 0 C-N-CA 123.126 2.55 . . . . 0.0 117.183 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.761 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -126.15 97.24 5.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.141 -2.299 . . . . 0.0 104.95 163.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.7 pt20 85.53 148.38 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 O-C-N 125.717 1.886 . . . . 0.0 109.326 -167.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.41 157.95 34.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.279 -167.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.565 HG12 ' HG ' ' B' ' 22' ' ' LEU . 5.4 t -116.34 147.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.143 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -88.37 18.58 4.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.796 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.565 ' HG ' HG12 ' B' ' 20' ' ' VAL . 90.8 mt -92.29 162.86 14.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.069 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 175.0 5.91 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.105 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.6 mp0 -65.96 125.0 24.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.482 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.557 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.2 15.11 67.52 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.068 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 mm-40 -69.93 136.24 50.34 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.794 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -100.63 137.35 39.14 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.37 1.081 . . . . 0.0 112.303 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.3 m -150.12 172.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.135 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 87.0 mttt -125.04 139.23 53.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.345 0.593 . . . . 0.0 109.925 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.794 HG22 ' HB ' ' A' ' 28' ' ' VAL . 4.0 mt -140.48 149.51 21.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.551 -171.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 28' ' ' VAL . 42.3 mt . . . . . 0 C--N 1.316 -0.855 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -112.15 169.27 6.52 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.176 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.25 -166.48 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.344 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.436 ' N ' HD12 ' B' ' 39' ' ' ILE . 3.9 mp -93.66 150.45 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.931 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.11 143.34 51.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tt -134.33 132.83 39.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.91 155.44 17.19 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.1 pm0 -70.74 127.67 91.63 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.515 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 26.5 Cg_exo -62.73 160.55 32.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.063 2.509 . . . . 0.0 112.225 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.416 ' H ' HG12 ' B' ' 45' ' ' VAL . 1.5 p -63.73 138.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.855 0.836 . . . . 0.0 111.768 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -115.52 177.04 4.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.008 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 51.2 t -79.83 124.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -100.91 160.31 14.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.747 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.96 -25.9 63.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.911 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 tt . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.256 0.55 . . . . 0.0 111.395 -175.189 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.442 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.94 150.41 22.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.9 ttt -142.24 124.97 15.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.648 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.3 p -116.06 164.19 14.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -99.53 -5.49 29.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp 45.99 84.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.864 0.727 . . . . 0.0 112.439 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 139.93 42.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -142.87 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -94.09 168.93 10.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 110.905 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -149.63 118.64 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.631 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.82 126.96 29.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -98.32 167.59 10.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.505 175.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 122.147 0.975 . . . . 0.0 112.73 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' B' ' 30' ' ' ILE . 18.0 mt -110.97 158.26 11.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.042 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HG2' ' CD ' ' B' ' 29' ' ' LYS . 44.5 mt-10 -123.47 134.61 53.89 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.44 165.98 22.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.456 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.605 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 4.8 m -110.96 121.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.408 0.623 . . . . 0.0 110.01 171.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.652 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 65.8 t80 -83.18 115.7 22.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.518 1.152 . . . . 0.0 110.677 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 61.3 mt-10 -86.7 -169.82 2.8 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.064 173.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.21 45.13 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.166 0.986 . . . . 0.0 111.829 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 122.52 5.16 8.64 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 10' ' ' GLU . 2.4 t -115.67 142.88 27.09 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.481 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 35.2 m-85 -111.72 114.89 28.19 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.846 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -119.95 116.37 32.85 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 122.407 -0.183 . . . . 0.0 111.188 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 20.0 Cg_endo -64.0 168.08 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.818 1.678 . . . . 0.0 112.088 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.65 -14.25 13.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HB2' HG23 ' A' ' 5' ' ' ILE . 63.6 mt-30 -104.24 128.52 51.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.11 -1.405 . . . . 0.0 108.871 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -71.32 140.15 50.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.739 0.781 . . . . 0.0 110.071 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 22' ' ' LEU . 6.0 p -133.17 140.94 45.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.372 -164.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -97.04 85.87 3.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.607 HD21 ' CD1' ' B' ' 9' ' ' TYR . 0.0 OUTLIER -116.97 173.92 6.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.759 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 5.1 mptp? -114.06 150.34 34.14 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.486 170.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.4 132.52 47.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.211 0.529 . . . . 0.0 111.197 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.03 51.16 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.119 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.671 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 25.3 tt0 -74.02 117.97 16.42 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 27' ' ' ARG . 28.4 ttt180 -84.97 126.49 33.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.562 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG12 HD23 ' B' ' 32' ' ' LEU . 35.5 m -132.5 166.89 27.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.25 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 11.4 mmmm -116.37 138.23 51.51 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 2.4 mm -120.84 140.58 44.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.308 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -156.05 149.92 25.17 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD21 HG12 ' B' ' 28' ' ' VAL . 44.9 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.975 0.417 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.67 151.03 43.43 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.374 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.83 173.68 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.119 1.879 . . . . 0.0 112.095 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.88 136.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 41' ' ' LEU . 20.7 t70 56.24 -158.88 0.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.18 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.512 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 pp -103.28 167.3 9.91 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.091 -0.381 . . . . 0.0 111.185 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.74 -131.91 5.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.441 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -106.79 108.69 62.35 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-O 120.652 0.263 . . . . 0.0 111.661 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 114.86 3.61 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.889 2.393 . . . . 0.0 111.408 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 46' ' ' SER . 7.6 p -102.21 158.47 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.264 0.554 . . . . 0.0 110.782 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 45' ' ' VAL . 1.2 m -100.7 162.72 12.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.788 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.83 121.48 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.704 0.764 . . . . 0.0 111.237 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -144.73 -36.77 0.31 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.253 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.76 -25.52 26.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.501 0.667 . . . . 0.0 110.756 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.04 1.69 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.005 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 0.0 110.575 -178.552 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.422 ' O ' HG12 ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.035 0 CA-C-O 121.382 0.61 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 15.5 mm -90.48 154.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.561 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 29' ' ' LYS . 45.9 mt-10 -124.79 130.53 52.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.94 163.43 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 3.9 m -128.61 116.87 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 112.013 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -65.31 106.34 1.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.591 0.71 . . . . 0.0 110.398 175.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.611 ' HB2' ' HD3' ' B' ' 15' ' ' LYS . 34.7 mt-10 -129.95 133.79 47.04 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.887 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.91 32.32 22.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.402 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.08 -68.3 0.39 Allowed Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 117.432 -2.318 . . . . 0.0 111.92 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 4.8 m -106.21 155.93 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.153 -156.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -84.85 113.69 21.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' B' ' 10' ' ' GLU . 39.9 mtpt -97.94 113.65 64.04 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.744 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.9 Cg_endo -62.09 167.28 11.0 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.122 1.215 . . . . 0.0 111.931 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.56 -12.13 12.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -120.83 161.67 21.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.176 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -77.83 132.12 37.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.232 0.539 . . . . 0.0 112.035 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 1.8 t -132.74 144.26 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.044 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.72 87.54 1.5 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.405 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 87.9 mt -109.91 -2.66 17.05 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.452 172.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 57.6 mttp 77.17 157.77 0.19 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.506 172.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.92 133.49 55.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.102 -164.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.605 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.6 64.93 3.5 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.429 -169.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.602 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 0.0 OUTLIER -101.47 135.09 43.55 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.56 167.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -77.14 117.21 18.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.107 0.956 . . . . 0.0 111.395 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.56 HG12 HD21 ' A' ' 32' ' ' LEU . 28.2 m -130.2 156.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.694 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CD ' ' HG2' ' A' ' 6' ' ' GLU . 33.2 mmtp -109.36 134.75 51.43 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.321 0.581 . . . . 0.0 110.487 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 5' ' ' ILE . 3.5 mm -112.54 143.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.987 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 160.51 39.77 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.319 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.438 HD23 HG12 ' A' ' 28' ' ' VAL . 83.5 mt . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.734 -172.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' B' ' 37' ' ' GLU . 7.1 pt-20 -50.6 110.93 1.91 Allowed Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 123.558 0.536 . . . . 0.0 111.676 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.45 172.89 3.95 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.334 2.022 . . . . 0.0 111.851 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.12 150.0 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -91.44 141.24 28.96 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.56 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.7 mm? -61.16 116.82 4.86 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.326 0.391 . . . . 0.0 110.779 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.63 114.03 4.55 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.498 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.4 pm0 -75.56 147.92 82.34 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 114.621 -0.789 . . . . 0.0 110.37 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.14 130.11 29.51 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.304 2.003 . . . . 0.0 111.833 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -77.99 150.32 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -101.04 169.74 8.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.987 0.423 . . . . 0.0 110.87 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 135.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -98.51 149.36 22.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -175.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -28.73 43.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.682 0.753 . . . . 0.0 109.287 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 pt . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.595 177.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -95.95 134.33 39.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.9 ttt -104.13 146.82 28.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.6 t 75.73 128.62 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 O-C-N 124.218 0.949 . . . . 0.0 110.994 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -97.52 1.59 49.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.057 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp 53.35 83.72 0.06 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.507 0.67 . . . . 0.0 111.417 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 159.71 15.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.006 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -85.72 35.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.562 0.696 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.79 72.4 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.348 0.594 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -77.78 123.48 26.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -100.92 126.58 47.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.836 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.81 136.51 53.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.478 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.023 177.736 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.909 HD13 HG21 ' A' ' 20' ' ' VAL . 1.4 mt -99.2 145.98 9.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -101.33 132.86 46.67 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.15 155.85 49.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.324 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.33 117.06 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.416 0.626 . . . . 0.0 110.346 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 77.5 t80 -73.54 119.33 17.62 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.708 176.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 41.3 tt0 -144.96 130.19 18.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.424 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 t30 70.77 22.76 4.72 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.829 0.705 . . . . 0.0 110.802 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 83.04 17.96 66.14 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.656 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 14.6 t -122.68 149.59 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 82.5 m-85 -97.69 115.28 27.64 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 166.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.0 mmmt -116.38 107.91 46.38 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.7 Cg_endo -59.8 167.89 6.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.213 1.275 . . . . 0.0 112.825 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.66 -8.6 20.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.211 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.622 ' N ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -138.37 140.05 39.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.083 176.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 7.9 tmtt? -76.94 132.4 39.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.558 0.694 . . . . 0.0 110.551 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 5' ' ' ILE . 2.9 t -122.49 141.43 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.195 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -100.74 87.94 3.46 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 122.702 1.239 . . . . 0.0 108.148 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' B' ' 9' ' ' TYR . 69.0 mt -111.25 -175.43 2.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.383 -2.189 . . . . 0.0 110.61 174.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.975 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 47.9 mtpt -93.41 165.86 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.559 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.35 129.77 34.79 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.644 0.735 . . . . 0.0 109.589 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.157 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.74 64.65 3.56 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.738 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.975 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 1.9 mm-40 -89.93 150.24 22.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -0.629 . . . . 0.0 110.463 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -89.75 104.48 17.04 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.929 1.347 . . . . 0.0 112.527 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.611 HG12 HD13 ' B' ' 32' ' ' LEU . 35.3 m -126.99 154.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.41 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.911 ' HD3' HG13 ' B' ' 4' ' ' ILE . 54.8 mttm -111.56 144.68 40.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.516 HG21 ' CE1' ' A' ' 14' ' ' PHE . 11.8 mm -104.36 133.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.945 0.878 . . . . 0.0 109.234 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -140.69 161.28 38.13 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' B' ' 28' ' ' VAL . 6.8 mp . . . . . 0 C--N 1.302 -1.477 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.9 -166.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.043 0.449 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -118.03 85.0 22.65 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.937 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -90.71 -154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.417 2.744 . . . . 0.0 110.278 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mt -95.79 139.1 19.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.99 116.37 30.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.557 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.2 pt? -86.24 128.52 34.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.05 114.26 1.24 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.981 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 124.39 30.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.46 125.1 14.37 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.81 2.34 . . . . 0.0 112.266 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.12 148.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.348 0.594 . . . . 0.0 110.863 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.9 m -101.02 173.99 6.22 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.277 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.32 147.8 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.76 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 24.2 mt-10 -86.93 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.342 . . . . 0.0 111.297 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -86.42 -31.35 21.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.693 0.758 . . . . 0.0 109.363 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 pt -84.29 12.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.423 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 41.4 tttp . . . . . 0 C--N 1.326 -0.448 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.911 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 120.789 0.328 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 pt -108.85 134.21 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 19.8 mp0 -86.08 142.65 28.56 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.532 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -135.05 164.38 27.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.163 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 1.157 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 8.5 m -122.48 130.81 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.276 0.56 . . . . 0.0 110.819 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 91.8 t80 -72.05 112.76 8.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.08 1.419 . . . . 0.0 111.55 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 1.038 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 10.6 tp10 -87.81 -176.48 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.241 -2.254 . . . . 0.0 106.919 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.445 ' H ' ' HG3' ' B' ' 10' ' ' GLU . 1.2 t-20 -66.86 61.28 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.266 1.031 . . . . 0.0 111.93 -172.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 109.31 8.25 27.33 Favored Glycine 0 C--N 1.299 -1.482 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.023 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 1.038 ' HB ' ' HB3' ' B' ' 10' ' ' GLU . 2.5 t -118.75 156.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 114.769 -0.716 . . . . 0.0 111.419 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 71.1 m-85 -118.37 115.15 24.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 161.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.581 ' HE3' ' HG2' ' B' ' 10' ' ' GLU . 98.2 mttt -108.48 117.49 54.31 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.638 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 26.1 Cg_endo -64.43 168.73 12.31 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.109 1.206 . . . . 0.0 111.701 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.723 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -110.05 -10.46 14.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -101.67 155.41 18.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.105 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -74.99 141.77 43.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.655 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.462 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.0 t -118.82 146.03 24.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.317 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -126.09 15.27 7.89 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.187 0.994 . . . . 0.0 109.454 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.562 HD13 ' HG2' ' B' ' 26' ' ' GLU . 94.1 mt -83.46 -172.79 4.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.357 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -128.28 177.88 6.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.635 0.255 . . . . 0.0 111.016 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 2.5 mp0 -66.08 140.36 58.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.04 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 16.79 70.73 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.606 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.562 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.3 tp10 -79.8 126.2 30.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' B' ' 27' ' ' ARG . 15.3 mmm180 -85.0 129.57 34.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.21 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.712 HG12 ' HG ' ' A' ' 32' ' ' LEU . 30.2 m -142.0 166.36 16.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.724 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.419 ' HD3' HG13 ' A' ' 4' ' ' ILE . 41.8 mttp -116.58 145.21 43.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.433 HG21 ' CE1' ' B' ' 14' ' ' PHE . 6.6 mm -117.45 143.97 26.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.685 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' A' ' 4' ' ' ILE . 29.6 tptp -154.55 128.2 8.66 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.569 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.611 HD13 HG12 ' A' ' 28' ' ' VAL . 3.4 mm? . . . . . 0 C--N 1.324 -0.533 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.042 0.449 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -151.36 126.41 4.73 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.971 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 174.13 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.418 2.079 . . . . 0.0 112.75 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 pt -87.41 160.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.15 135.53 36.6 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.16 164.65 33.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.871 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.79 -156.44 22.8 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.41 127.45 15.6 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.698 0.285 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.93 117.48 5.06 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.854 2.369 . . . . 0.0 112.726 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -124.72 152.43 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.54 149.4 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.32 0.581 . . . . 0.0 111.471 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.78 150.16 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.326 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.11 115.09 24.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.225 1.012 . . . . 0.0 112.707 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -86.68 -26.62 24.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.584 171.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.702 -171.021 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 60.4 m . . . . . 0 CA--C 1.533 0.311 0 CA-C-O 121.229 0.538 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -110.1 134.9 51.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 47.3 ttm -79.36 128.73 33.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -66.83 106.9 2.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.305 0.574 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -99.52 3.44 45.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.368 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 61.48 179.11 0.12 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.528 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.23 144.25 50.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -78.78 88.84 4.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.638 0.732 . . . . 0.0 110.173 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -88.12 117.43 27.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -127.29 127.5 44.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.601 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' B' ' 68' ' ' HIS . 25.7 t-80 -87.13 -103.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 67' ' ' HIS . 44.9 t-80 156.65 146.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.402 173.597 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.82 HG13 ' HB ' ' B' ' 30' ' ' ILE . 3.7 pt -90.52 137.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -99.45 142.38 31.0 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.928 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.21 164.31 28.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.168 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 11.8 m -120.0 126.11 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.665 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.8 t80 -94.65 111.28 23.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.057 -177.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 5.9 pt-20 -130.67 141.29 50.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.785 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.8 t30 60.83 21.4 11.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 87.86 13.08 65.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.863 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 12.5 t -119.53 143.75 30.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.741 -0.23 . . . . 0.0 110.633 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 49.0 m-85 -103.41 115.62 30.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 166.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.67 114.87 61.4 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.7 Cg_endo -62.81 168.69 9.9 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 120.634 0.89 . . . . 0.0 111.939 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -102.43 -4.46 25.42 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.26 127.71 43.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.169 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.53 131.27 40.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -124.2 137.74 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.647 0.737 . . . . 0.0 110.628 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.42 87.82 5.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.38 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.5 mt -121.54 -171.94 2.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.073 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -98.7 -176.18 3.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.956 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 5.3 mp0 -89.22 138.46 31.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.3 0.571 . . . . 0.0 110.162 171.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.747 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.3 65.25 3.05 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.378 -168.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 9.1 tp10 -93.27 128.24 39.18 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.635 -0.783 . . . . 0.0 109.344 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -81.62 114.95 20.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.71 1.243 . . . . 0.0 111.569 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 HD23 ' B' ' 32' ' ' LEU . 35.2 m -131.5 164.23 35.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.059 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HD3' HG13 ' B' ' 4' ' ' ILE . 52.3 mttm -119.92 143.02 48.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.23 0.538 . . . . 0.0 110.08 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.513 HD12 HD12 ' B' ' 30' ' ' ILE . 3.7 mm -110.65 140.46 29.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.144 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -147.4 165.82 29.06 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.667 0.746 . . . . 0.0 110.294 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.464 HD21 HD22 ' B' ' 22' ' ' LEU . 74.9 mt . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 121.021 0.439 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.3 mm-40 -85.83 131.47 47.06 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.178 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.6 Cg_exo -79.88 -166.85 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.09 2.527 . . . . 0.0 111.854 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 pt -101.39 168.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.306 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.4 142.42 24.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.991 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.11 153.98 40.67 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.98 -143.29 14.5 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.926 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.0 pt-20 -111.78 147.06 36.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 122.203 0.201 . . . . 0.0 111.001 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 20.0 Cg_exo -67.33 170.96 12.37 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.118 2.545 . . . . 0.0 111.382 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.92 153.29 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 110.158 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p -122.52 162.1 22.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 111.608 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.6 t -131.17 135.57 59.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.669 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.13 133.62 52.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 0.0 111.477 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.86 -21.13 40.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.428 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.63 -13.66 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.705 0.764 . . . . 0.0 110.009 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 30.1 ttmt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.87 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.477 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.099 0 CA-C-O 120.847 0.356 . . . . 0.0 110.058 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 11.2 mt -104.2 144.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.573 ' H ' HE21 ' B' ' 18' ' ' GLN . 12.7 mp0 -105.95 130.75 53.83 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.379 0.609 . . . . 0.0 110.422 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.48 154.92 46.78 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.623 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.747 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 3.6 m -110.97 115.37 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 121.507 0.67 . . . . 0.0 110.926 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 47.4 t80 -75.23 111.46 10.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.274 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.9 tt0 -120.13 116.83 26.45 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.694 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.27 19.59 11.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.876 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 109.59 5.57 29.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.215 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 3.5 t -118.06 142.43 32.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.794 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 74.0 m-85 -97.97 116.63 30.57 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.109 -0.637 . . . . 0.0 109.621 171.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.727 ' HE3' HG11 ' B' ' 13' ' ' VAL . 33.8 mmtp -117.54 111.49 39.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.7 Cg_endo -60.49 167.97 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.299 1.333 . . . . 0.0 111.994 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.695 HD11 HG13 ' B' ' 8' ' ' VAL . 6.7 mp -111.51 -21.92 11.53 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.573 HE21 ' H ' ' B' ' 6' ' ' GLU . 5.0 pt20 -115.46 3.72 14.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.053 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 16' ' ' PRO . 54.8 mtmt 55.65 167.71 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.263 -1.79 . . . . 0.0 113.534 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' B' ' 22' ' ' LEU . 3.5 t -144.12 154.22 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.788 -175.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -136.7 86.81 2.24 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 123.139 1.447 . . . . 0.0 109.605 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' B' ' 20' ' ' VAL . 0.4 OUTLIER -132.52 104.68 6.81 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 112.132 -2.303 . . . . 0.0 110.196 166.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.727 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 96.0 mttt 33.95 -163.07 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 114.4 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -115.47 127.12 55.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.697 163.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.615 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 53.96 65.19 3.63 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.497 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.727 ' HG2' ' HD2' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -99.03 145.52 27.01 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 167.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -95.71 123.33 39.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.477 1.132 . . . . 0.0 112.391 -168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.3 m -131.04 174.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.973 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -112.91 142.22 45.83 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.82 ' HB ' HG13 ' A' ' 5' ' ' ILE . 4.3 mm -119.16 141.08 40.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.224 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.404 ' HD3' HG22 ' A' ' 4' ' ' ILE . 56.5 tptt -143.66 125.91 15.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.492 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.758 HD23 HG12 ' A' ' 28' ' ' VAL . 27.9 mt . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -111.47 119.64 44.63 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 120.917 0.389 . . . . 0.0 111.136 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.32 -176.52 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.96 2.44 . . . . 0.0 111.839 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.4 HD12 ' O ' ' B' ' 39' ' ' ILE . 1.8 pp -103.99 152.59 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.496 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.08 103.99 6.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 50.0 tp -135.04 139.09 44.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.86 114.25 2.58 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' B' ' 44' ' ' PRO . 45.9 mt-10 -92.26 162.26 30.62 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.739 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 43' ' ' GLU . 76.7 Cg_exo -49.8 142.18 26.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.42 2.747 . . . . 0.0 113.968 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 164.74 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.6 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -78.77 164.08 24.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.234 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.57 164.76 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.519 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.45 110.56 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.41 -29.61 22.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.373 0.606 . . . . 0.0 110.386 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.391 -178.119 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -130.02 146.39 51.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.825 0.345 . . . . 0.0 110.336 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.3 mtt -94.85 178.36 5.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.046 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.7 t -135.04 122.93 22.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -94.22 -6.43 44.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.86 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.304 1.002 . . . . 0.0 112.132 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.43 115.72 16.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 111.087 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -99.24 110.55 23.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.377 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.83 116.93 20.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.831 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 77.19 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.258 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -96.23 94.12 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -81.99 129.62 34.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.697 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.427 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 18' ' ' GLN . 16.9 mt -98.77 155.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 17' ' ' LEU . 7.0 mp0 -113.1 144.14 43.15 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -144.14 161.04 39.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.454 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.892 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.6 m -121.95 115.22 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.679 0.752 . . . . 0.0 110.493 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 63.8 t80 -75.2 114.74 14.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.737 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 5.5 pt-20 -105.64 132.24 52.03 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 164.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.529 ' H ' HD22 ' A' ' 11' ' ' ASN . 0.1 OUTLIER -74.0 63.55 0.95 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -149.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . -142.96 -7.08 0.62 Allowed Glycine 0 C--N 1.27 -3.094 0 CA-C-N 110.899 -2.864 . . . . 0.0 107.743 149.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 19.0 m -160.76 150.11 5.36 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -155.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.6 m-85 -99.48 116.52 31.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.701 ' HD3' ' HG2' ' A' ' 10' ' ' GLU . 23.3 mtpp -109.18 111.61 60.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.402 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.7 Cg_endo -53.8 165.12 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.592 1.528 . . . . 0.0 113.978 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 6' ' ' GLU . 93.1 mt -93.06 -66.43 0.92 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.436 165.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.51 ' HB2' HG23 ' A' ' 5' ' ' ILE . 71.0 mt-30 -61.33 132.63 54.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 112.982 -1.917 . . . . 0.0 108.636 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -65.67 139.25 58.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.571 0.701 . . . . 0.0 110.436 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 22' ' ' LEU . 2.4 p -106.56 146.82 12.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.575 -167.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -133.85 13.76 3.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.099 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 20' ' ' VAL . 86.7 mt -72.93 -176.63 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.853 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 14.8 pttp -125.18 165.41 18.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.192 -174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 3.8 mp0 -66.47 143.29 57.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.694 0.759 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.52 65.47 3.39 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.299 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.5 tp10 -106.82 124.39 49.54 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.06 110.36 21.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 123.499 1.619 . . . . 0.0 113.266 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.955 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.8 m -122.81 149.35 26.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.986 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD3' ' HG3' ' B' ' 6' ' ' GLU . 47.0 mmtm -103.3 138.73 39.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mm -92.6 130.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 4' ' ' ILE . 9.7 tttt -136.45 134.67 37.92 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.171 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD21 HG12 ' B' ' 28' ' ' VAL . 89.5 mt . . . . . 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.396 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.234 0.261 0 CA-C-O 121.048 0.451 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.04 159.42 65.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.237 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.78 178.21 7.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.709 2.273 . . . . 0.0 112.373 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.1 pt -80.01 174.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.78 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.36 121.57 14.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.556 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -131.95 154.4 49.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.706 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.79 131.83 2.07 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.337 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.26 135.77 44.0 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.884 0.374 . . . . 0.0 111.014 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.3 -173.8 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.047 2.498 . . . . 0.0 112.565 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.07 153.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.687 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -106.09 -171.77 1.96 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.13 157.52 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.989 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.704 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.5 mp0 -61.89 128.0 34.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 110.548 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.18 -35.19 66.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.283 0.563 . . . . 0.0 111.05 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 tt -80.43 -3.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.769 . . . . 0.0 110.742 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 64.7 tttt . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.472 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.423 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.059 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.581 ' HB ' ' HG3' ' B' ' 18' ' ' GLN . 19.6 pt -101.21 134.1 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.499 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -87.4 138.98 31.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.227 0.537 . . . . 0.0 111.079 -175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.81 152.15 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.308 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.608 HG13 HD11 ' B' ' 17' ' ' LEU . 3.6 m -115.33 118.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.714 0.769 . . . . 0.0 110.621 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.738 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 45.6 t80 -70.9 131.42 43.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.72 174.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.523 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 35.1 tt0 -151.75 129.76 11.81 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.469 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 30.6 t30 66.51 20.23 10.87 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.623 0.577 . . . . 0.0 111.907 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' OH ' ' B' ' 9' ' ' TYR . . . 95.26 10.49 57.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.008 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.2 t -122.85 148.51 26.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 92.8 m-85 -102.11 114.38 28.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' B' ' 15' ' ' LYS . 48.8 mtmt -110.49 116.55 52.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 31.9 Cg_endo -65.55 168.14 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.233 1.288 . . . . 0.0 112.317 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.608 HD11 HG13 ' B' ' 8' ' ' VAL . 5.6 mp -115.13 -5.59 12.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.581 ' HG3' ' HB ' ' B' ' 5' ' ' ILE . 25.0 mm-40 -94.76 -1.58 52.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.544 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 34.27 123.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 O-C-N 125.311 1.632 . . . . 0.0 114.244 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.677 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -125.42 139.92 49.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.599 -164.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.84 88.13 2.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.975 170.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' B' ' 20' ' ' VAL . 71.3 mt -110.81 -161.97 0.78 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 112.639 -2.073 . . . . 0.0 109.967 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -89.27 -174.69 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 35.3 mt-10 -106.3 123.56 48.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 109.653 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.892 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.04 24.53 44.25 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.6 tp10 -63.55 132.9 52.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.029 0.531 . . . . 0.0 110.831 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -83.25 113.22 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.847 0.832 . . . . 0.0 111.733 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.8 m -138.41 161.5 30.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.969 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HG2' ' A' ' 6' ' ' GLU . 33.0 mmtp -115.66 144.51 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.178 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -118.34 126.22 74.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.355 0.598 . . . . 0.0 110.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -134.08 124.65 26.52 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.638 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.955 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.9 mp . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.15 156.36 35.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 122.616 0.367 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -89.03 -179.32 2.07 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.291 2.661 . . . . 0.0 113.212 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.21 169.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.844 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -125.89 -173.59 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.603 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.5 pt? -125.33 172.44 9.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.42 -150.05 6.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.035 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.777 ' HB2' ' HD2' ' B' ' 44' ' ' PRO . 8.3 pt-20 -98.27 175.07 2.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.777 ' HD2' ' HB2' ' B' ' 43' ' ' GLU . 37.7 Cg_endo -67.18 -162.58 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.266 1.977 . . . . 0.0 111.9 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.41 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -91.82 173.01 8.08 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.89 140.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.61 -169.4 2.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.2 -27.51 63.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.437 ' H ' HD12 ' B' ' 50' ' ' ILE . 3.6 mp . . . . . 0 C--N 1.315 -0.925 0 CA-C-O 121.214 0.531 . . . . 0.0 110.321 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -91.95 133.87 35.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.3 ttt -132.82 137.92 46.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m 67.52 121.01 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.384 1.053 . . . . 0.0 112.386 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -103.44 0.54 31.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.634 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp 52.45 79.74 0.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.795 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.0 136.36 48.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.31 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -89.16 72.53 8.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.672 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.16 128.04 34.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.723 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -93.14 138.46 31.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.061 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -77.56 -156.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.606 174.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -145.47 89.05 1.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.635 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.508 177.401 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.493 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.083 0 CA-C-O 121.328 0.585 . . . . 0.0 111.1 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 18' ' ' GLN . 24.8 mm -100.93 156.12 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 28.3 mt-10 -116.0 145.82 42.65 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -147.55 166.27 27.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.101 0.477 . . . . 0.0 110.891 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.04 122.6 65.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.935 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 90.2 t80 -78.33 99.46 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.394 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 32.9 mt-10 -120.55 135.79 54.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.968 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 42.3 m-80 63.25 21.69 12.96 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.587 0.555 . . . . 0.0 111.496 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 86.9 11.48 70.29 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.131 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 16.1 t -125.14 148.67 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 83.6 m-85 -96.36 114.87 26.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.194 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 29.9 mtmt -112.5 114.07 50.43 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.74 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 Cg_endo -63.15 168.77 10.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.449 1.433 . . . . 0.0 112.981 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -108.33 -20.62 13.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HB2' HG23 ' A' ' 5' ' ' ILE . 42.8 mt-30 -99.6 143.34 29.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.965 -1.471 . . . . 0.0 109.554 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -84.81 124.38 31.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.265 0.555 . . . . 0.0 109.674 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.3 t -132.47 134.87 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.72 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.36 88.63 4.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.365 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.8 mt -113.05 171.56 7.47 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.093 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -107.39 158.85 16.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 8.1 mp0 -67.24 114.84 6.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.374 0.606 . . . . 0.0 110.199 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.88 25.92 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.058 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 3.9 mm-40 -74.11 133.96 42.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -100.82 121.88 42.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.968 1.842 . . . . 0.0 113.417 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD23 ' B' ' 32' ' ' LEU . 34.7 m -132.93 160.28 42.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.156 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 65.6 mttm -117.26 140.78 49.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.452 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' B' ' 7' ' ' ALA . 1.3 mm -116.57 149.44 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.781 -175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -156.94 164.56 37.89 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 164.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HD13 ' B' ' 22' ' ' LEU . 9.2 mt . . . . . 0 C--N 1.306 -1.32 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 mt-10 -66.75 120.94 75.09 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-O 120.721 0.296 . . . . 0.0 110.45 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 21.1 Cg_exo -66.35 -175.16 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.383 2.722 . . . . 0.0 112.933 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 pt -70.27 165.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.77 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.42 104.53 10.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.587 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 2.8 pp -84.1 176.39 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.402 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.95 -125.21 1.91 Allowed Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.787 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -112.27 127.93 26.19 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.543 0.211 . . . . 0.0 111.142 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.12 173.35 14.05 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.539 2.159 . . . . 0.0 111.433 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' SER . 14.4 p -131.21 166.58 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.217 0.532 . . . . 0.0 110.768 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' VAL . 17.6 m -88.3 170.06 11.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.66 3.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.304 0.574 . . . . 0.0 111.528 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.59 104.03 9.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.464 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -87.28 -30.26 21.01 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.5 tt -69.75 -7.25 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.621 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 tttt . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.831 177.514 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.471 ' CB ' ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 15.0 mt -109.2 154.31 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 164.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -109.21 135.99 49.41 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.515 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.96 164.24 30.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.707 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -126.49 124.93 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.472 0.653 . . . . 0.0 111.369 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 20.2 t80 -62.15 112.42 2.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.86 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.35 128.83 40.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 120.943 0.401 . . . . 0.0 110.712 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.22 34.32 11.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.794 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.04 -69.33 0.26 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 117.653 -2.213 . . . . 0.0 111.634 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -93.37 154.33 3.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.997 -158.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -88.23 115.85 26.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -105.67 120.9 47.76 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.583 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 11.3 Cg_endo -58.6 168.71 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.453 1.435 . . . . 0.0 112.391 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.707 HD11 HG13 ' B' ' 8' ' ' VAL . 7.0 mp -102.27 -11.25 18.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' B' ' 16' ' ' PRO . 13.3 pm0 -133.17 143.52 49.26 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.496 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.42 149.25 39.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 112.138 -173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.451 HG12 ' H ' ' B' ' 22' ' ' LEU . 11.3 t -123.76 150.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.353 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.02 25.14 3.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.079 0.942 . . . . 0.0 109.878 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.658 HD13 HD21 ' A' ' 32' ' ' LEU . 97.9 mt -78.59 -166.23 0.84 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.694 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 10.1 mtmp? -97.1 162.32 13.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.5 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.4 mp0 -74.55 136.54 42.11 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.337 0.589 . . . . 0.0 109.416 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.6 65.4 3.2 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.416 -165.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.694 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 1.7 mm-40 -96.34 148.8 22.39 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.618 -0.791 . . . . 0.0 109.551 170.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 27' ' ' ARG . 2.1 tpt180 -98.02 105.66 17.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.652 1.215 . . . . 0.0 112.167 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.0 m -124.68 156.87 33.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 113.045 -1.888 . . . . 0.0 111.408 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.583 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 45.0 mttp -120.79 143.46 48.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.201 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.476 HG23 HD13 ' A' ' 30' ' ' ILE . 17.1 mt -130.02 147.55 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.884 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -156.88 165.13 37.06 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.877 HD23 HG12 ' A' ' 28' ' ' VAL . 24.2 mt . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.414 HG12 ' HD2' ' B' ' 38' ' ' PRO . 8.6 t . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' B' ' 38' ' ' PRO . 45.3 mt-10 -81.21 -57.18 0.57 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' B' ' 37' ' ' GLU . 37.9 Cg_endo -65.12 174.6 4.71 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.035 1.823 . . . . 0.0 113.184 -173.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 pp -101.97 172.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.373 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.66 129.61 39.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.245 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 49.3 tp 68.37 112.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.749 0.656 . . . . 0.0 112.04 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.91 114.53 0.49 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.813 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 10.9 mp0 -108.84 130.0 23.25 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 6.0 Cg_exo -78.78 114.38 3.43 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.704 2.269 . . . . 0.0 111.508 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.9 156.6 6.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.185 0.517 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -83.2 160.35 21.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.802 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.85 142.35 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.202 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.0 105.19 4.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.08 0.943 . . . . 0.0 110.879 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.78 -27.73 20.94 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.147 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.525 -172.809 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -124.44 139.99 53.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.584 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.19 31.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -73.73 152.03 40.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.063 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 11.5 m -93.51 -5.79 48.27 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.075 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 61' ' ' SER . 2.9 pp 46.63 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.032 1.333 . . . . 0.0 114.539 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -119.86 111.74 18.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.347 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -135.4 110.33 8.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.346 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.33 151.3 48.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -75.85 99.64 4.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.735 0.779 . . . . 0.0 110.484 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -84.54 82.17 8.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.613 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -138.54 112.37 8.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.096 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.265 0 CA-C-O 121.062 0.458 . . . . 0.0 111.754 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.56 169.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 164.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' HD12 ' A' ' 17' ' ' LEU . 37.0 mt-10 -103.85 158.45 16.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB2' HD11 ' B' ' 30' ' ' ILE . . . -150.68 154.4 37.38 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 31.1 m -110.08 116.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.841 0.829 . . . . 0.0 110.329 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 57.1 t80 -79.98 102.91 9.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.644 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.55 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.4 pt-20 -118.48 136.95 53.51 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.158 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 3.3 t-20 65.44 9.25 5.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.836 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.537 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 96.5 12.51 50.83 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.905 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.4 m -124.52 142.67 40.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.371 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 93.5 m-85 -90.79 116.41 28.62 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.652 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.18 111.82 61.65 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 41.9 Cg_exo -46.18 169.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.045 2.496 . . . . 0.0 115.357 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.923 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 63.3 mt -107.02 113.79 27.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 166.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.923 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 1.1 pp0? 77.11 143.21 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 127.99 2.516 . . . . 0.0 111.862 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -60.64 127.83 33.62 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.172 -172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 5' ' ' ILE . 14.7 p -127.26 146.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.652 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.91 86.59 2.75 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.321 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.526 ' HB2' ' CE2' ' B' ' 9' ' ' TYR . 67.3 mt -103.45 -176.56 3.12 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.51 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.47 148.83 26.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.41 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 12.4 pt-20 -82.74 121.56 27.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.16 14.97 31.87 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.823 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.84 116.69 17.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.37 119.58 27.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.095 0.95 . . . . 0.0 110.415 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.2 161.15 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.228 -168.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -118.56 134.97 54.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.957 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.742 HG12 HG23 ' B' ' 30' ' ' ILE . 9.8 mt -133.44 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.694 -170.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.66 165.51 27.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.638 172.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--N 1.313 -0.999 0 O-C-N 123.445 0.466 . . . . 0.0 111.464 -166.68 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.035 0.445 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -91.03 130.06 41.69 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.588 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 174.06 12.35 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.302 2.001 . . . . 0.0 112.083 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -89.31 150.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.836 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.59 135.56 53.22 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.13 176.11 9.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 111.253 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.29 155.26 16.45 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -67.23 140.79 95.69 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.44 -175.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -63.17 119.73 6.92 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.476 2.117 . . . . 0.0 111.363 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.45 148.03 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.512 0.672 . . . . 0.0 111.32 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 67.2 m -92.98 -171.84 2.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.176 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 46' ' ' SER . 25.0 t 68.37 139.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 111.67 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -93.6 113.51 25.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.7 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.45 -26.28 26.42 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.517 0.675 . . . . 0.0 109.47 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mt -80.33 -15.21 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' NZ ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.002 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.422 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.27 148.59 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.556 ' HB2' HD13 ' B' ' 17' ' ' LEU . 2.4 mp0 -121.81 145.78 47.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -153.47 165.17 36.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.61 0.243 . . . . 0.0 111.191 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -117.22 122.62 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 69.9 t80 -84.27 102.92 13.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.196 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.42 125.6 50.29 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.741 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 63.34 21.26 12.71 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.012 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.692 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 101.49 4.93 52.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.115 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.6 t -119.69 142.64 34.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.081 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -98.23 115.59 28.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -102.17 113.2 65.95 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 38.6 Cg_exo -56.86 169.72 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.63 1.553 . . . . 0.0 113.041 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 6' ' ' GLU . 7.8 mp -83.53 -74.69 0.36 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.782 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -84.69 151.82 24.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -67.95 137.97 55.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.539 . . . . 0.0 111.507 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' HG ' ' B' ' 22' ' ' LEU . 2.5 t -122.1 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.597 177.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -110.65 87.81 2.62 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 123.163 1.458 . . . . 0.0 109.012 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 92.0 mt -111.7 -172.84 2.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.044 -2.344 . . . . 0.0 110.096 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.738 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 92.3 mttt -82.19 159.86 23.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.7 mp0 -72.97 126.31 29.66 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.57 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 60.46 65.59 3.25 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.565 -165.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.738 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 0.7 OUTLIER -96.23 149.97 21.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.478 -0.861 . . . . 0.0 108.97 165.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -104.42 131.35 51.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.451 0.644 . . . . 0.0 111.198 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.2 m -142.15 164.79 17.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.252 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -119.59 134.47 55.21 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.31 0.576 . . . . 0.0 109.717 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 30' ' ' ILE . 3.8 mt -118.39 147.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.581 -172.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 4' ' ' ILE . 3.0 ptpp? -155.6 166.19 34.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.441 0.638 . . . . 0.0 110.648 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.437 ' N ' HD22 ' B' ' 32' ' ' LEU . 3.2 mm? . . . . . 0 C--N 1.309 -1.173 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.284 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 5.5 pt-20 -77.7 143.75 67.92 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.285 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 11.6 Cg_exo -71.73 -156.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.818 3.012 . . . . 0.0 114.191 -170.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.34 178.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.628 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -92.06 129.67 37.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.502 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.9 144.65 38.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.083 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 -145.27 11.35 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 7.2 pt-20 -124.02 122.24 26.24 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 120.784 0.326 . . . . 0.0 110.692 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 38.9 Cg_exo -61.83 128.38 24.22 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.571 2.181 . . . . 0.0 111.816 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.06 150.77 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.816 0.817 . . . . 0.0 111.444 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -106.12 -176.52 3.1 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.219 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.81 141.76 17.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.552 ' HB2' HG22 ' B' ' 50' ' ' ILE . 1.6 pm0 -66.76 129.76 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.446 0.641 . . . . 0.0 111.628 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.64 -25.08 44.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.423 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' B' ' 48' ' ' GLU . 13.7 tt . . . . . 0 CA--C 1.537 0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -82.11 154.72 25.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.033 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -144.6 154.75 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.241 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -79.74 133.61 36.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 56.4 p -82.85 14.2 3.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.575 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.9 103.08 0.41 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -101.89 155.46 18.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.932 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -84.76 100.26 11.4 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.93 135.12 51.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.978 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -129.8 153.4 48.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.296 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -147.52 130.39 16.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -133.66 140.08 46.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.558 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.568 175.793 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.5 mp . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 30' ' ' ILE . 11.7 mt -131.2 150.84 34.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -100.99 126.44 47.66 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.82 166.53 18.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.522 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.26 114.27 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.465 0.65 . . . . 0.0 110.131 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 68.3 t80 -67.06 119.44 12.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 22.7 tt0 -148.2 142.57 26.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.395 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.45 18.03 10.76 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 0.0 111.458 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.506 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 83.43 18.99 63.06 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.819 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 11.6 t -129.09 154.66 40.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 C-N-CA 122.858 0.463 . . . . 0.0 110.048 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.2 m-85 -97.84 115.11 27.42 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.309 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 41.6 mtmt -109.74 113.08 57.99 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.478 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 31.4 Cg_exo -56.87 166.28 4.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.171 1.248 . . . . 0.0 113.593 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.21 -68.5 0.79 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 112.069 -2.332 . . . . 0.0 105.405 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 5' ' ' ILE . 57.9 mt-30 -60.04 144.89 48.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.467 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -68.74 149.62 48.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.143 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' LEU . 3.4 p -123.6 155.83 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 122.162 0.982 . . . . 0.0 111.397 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.83 12.63 11.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.834 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.711 HD13 HD21 ' B' ' 32' ' ' LEU . 97.0 mt -90.57 -174.83 4.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.368 -172.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -92.93 -172.96 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.25 -169.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.678 ' HB3' ' H ' ' B' ' 11' ' ' ASN . 0.0 OUTLIER -93.15 -169.89 2.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 164.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . -21.95 71.66 0.0 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 122.847 1.248 . . . . 0.0 114.686 -152.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 44.3 tt0 -96.65 139.78 32.22 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 111.956 -2.122 . . . . 0.0 108.105 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -93.69 128.44 39.88 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.755 0.788 . . . . 0.0 112.354 -166.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' B' ' 32' ' ' LEU . 16.5 m -145.74 171.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.72 -173.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 58.7 mttm -128.45 138.84 52.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.822 HG22 ' HB ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -119.14 134.32 63.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.0 -171.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.623 ' HG2' HG22 ' B' ' 4' ' ' ILE . 51.9 mttp -110.24 148.92 30.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.029 0.442 . . . . 0.0 110.075 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD13 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? . . . . . 0 C--N 1.306 -1.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.843 -177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.235 0.338 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.2 pt-20 -63.76 148.01 95.12 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 122.189 0.196 . . . . 0.0 110.877 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 23.2 Cg_exo -65.53 -169.46 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.197 2.598 . . . . 0.0 113.741 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.9 mt -96.51 154.29 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.09 -153.7 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.5 tp -69.47 147.67 50.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.91 -113.62 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.868 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.2 pm0 -63.99 141.64 98.07 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.286 -0.457 . . . . 0.0 111.196 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 14.8 Cg_exo -68.32 157.11 63.22 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.824 2.349 . . . . 0.0 112.592 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.05 149.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.786 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -117.51 -170.94 1.95 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.862 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.32 147.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.94 169.8 17.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 111.785 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.27 -25.18 62.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.8 -13.37 17.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp . . . . . 0 C--N 1.319 -0.73 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.737 -177.862 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.623 HG22 ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 121.039 0.447 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.831 HD11 HD12 ' B' ' 22' ' ' LEU . 25.1 mt -98.72 160.17 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 40.6 mt-10 -125.61 136.94 53.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -151.07 168.37 24.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.845 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.665 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.5 m -128.19 137.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.142 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.574 ' H ' ' HD1' ' B' ' 9' ' ' TYR . 2.8 m-85 -58.05 156.73 8.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.084 0.945 . . . . 0.0 112.075 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' B' ' 13' ' ' VAL . 16.2 tp10 -144.29 98.05 3.14 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.678 ' H ' ' HB3' ' A' ' 24' ' ' GLU . 1.9 t30 56.14 30.99 17.41 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.115 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.65 -69.56 0.51 Allowed Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 118.279 -1.915 . . . . 0.0 111.708 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 13' ' ' VAL . 28.3 m -92.78 141.7 14.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.848 -155.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -88.53 125.39 34.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -165.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.39 112.59 65.44 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.9 Cg_endo -76.23 169.75 21.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 CA-C-O 122.016 0.757 . . . . 0.0 113.428 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 17' ' ' LEU . 4.5 mp -89.15 -23.61 22.41 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 166.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' B' ' 19' ' ' LYS 0.283 4.2 tt0 43.05 -119.8 0.57 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.343 166.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.682 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 47.1 tttp 69.01 -128.05 0.1 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -143.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' B' ' 19' ' ' LYS . 50.9 t 68.82 171.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 119.613 1.097 . . . . 0.0 109.946 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . 0.43 ' N ' HG12 ' B' ' 20' ' ' VAL . 30.0 t70 -122.96 17.05 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.226 1.012 . . . . 0.0 111.227 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HD11 ' B' ' 5' ' ' ILE . 93.6 mt -83.53 169.55 15.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.607 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' B' ' 21' ' ' ASP . 18.9 mttt -136.35 -179.73 5.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -164.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.3 145.17 37.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.348 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 57.9 65.25 3.67 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -164.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -120.13 139.82 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.497 -0.852 . . . . 0.0 111.05 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' B' ' 27' ' ' ARG . 0.3 OUTLIER -88.95 125.89 35.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.862 -174.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.822 ' HB ' HG22 ' A' ' 30' ' ' ILE . 34.3 m -136.99 148.15 26.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.825 -172.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -117.35 138.25 51.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.018 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 3.9 mt -117.26 148.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.289 0.566 . . . . 0.0 111.376 -169.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -137.25 161.76 35.33 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 22' ' ' LEU . 6.6 mp . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.08 110.84 5.22 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.09 173.03 15.17 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.544 2.163 . . . . 0.0 113.439 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 39' ' ' ILE . 0.2 OUTLIER -76.64 173.89 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.953 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -88.68 137.03 32.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.302 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.4 tp -111.41 143.7 41.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.329 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 115.3 3.48 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 0.7 OUTLIER -71.75 125.52 91.65 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 115.319 -0.44 . . . . 0.0 110.92 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.8 172.57 16.02 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.709 2.273 . . . . 0.0 112.356 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.81 152.16 25.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -125.11 168.5 13.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.91 127.34 51.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -102.6 102.78 13.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.67 -25.98 24.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.136 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.316 -178.823 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.575 0.226 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -128.98 141.55 51.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.167 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 49.7 ttm -123.45 124.75 43.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -79.66 140.26 37.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.773 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.3 t -101.89 20.55 16.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.34 0.59 . . . . 0.0 109.689 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.33 -169.16 0.2 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.644 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 169.4 18.77 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -75.13 147.17 40.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 111.17 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.62 156.31 45.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.845 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -132.95 100.71 4.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.004 0.43 . . . . 0.0 111.465 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -106.92 100.12 9.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -51.39 -47.62 62.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.145 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.97 177.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.769 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 20' ' ' VAL . 24.0 mt -85.94 150.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 38.9 mt-10 -124.33 126.12 45.48 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.12 169.5 17.48 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.0 111.406 -171.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.522 HG12 ' HD3' ' B' ' 27' ' ' ARG . 12.1 m -129.66 131.45 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.686 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 70.6 t80 -74.79 118.26 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 34.1 tt0 -155.44 138.47 15.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.905 1.378 . . . . 0.0 108.813 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.06 25.72 12.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.394 0.616 . . . . 0.0 110.35 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 71.01 20.99 78.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.026 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 54.7 t -132.92 159.13 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 54.9 m-85 -108.18 115.03 29.37 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -112.97 125.9 29.09 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.908 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 28.0 Cg_endo -64.21 170.01 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.228 1.286 . . . . 0.0 112.112 177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -5.44 21.6 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 17.6 pt20 -135.18 129.33 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.161 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -68.87 129.45 39.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 110.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.571 HG12 ' HG ' ' A' ' 22' ' ' LEU . 13.8 t -117.01 149.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.306 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.74 25.27 11.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.155 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.4 mt -66.75 177.69 1.55 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.456 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 8.9 mtpm? -96.13 170.86 8.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 0.6 OUTLIER -77.01 133.86 39.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.289 175.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 76.96 16.78 80.48 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.465 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 6.8 mm-40 -68.68 135.4 51.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.95 0.405 . . . . 0.0 110.585 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 103.68 15.73 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.775 1.274 . . . . 0.0 112.534 -167.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.731 ' HB ' HG22 ' B' ' 30' ' ' ILE . 29.4 m -129.16 152.41 37.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.426 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -129.67 135.26 48.29 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.682 0.753 . . . . 0.0 110.019 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 HD13 ' B' ' 30' ' ' ILE . 9.1 mt -103.9 143.03 16.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.041 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.829 ' HG3' HG22 ' B' ' 4' ' ' ILE . 10.4 mptt -137.93 157.34 46.59 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.113 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD22 ' B' ' 22' ' ' LEU . 94.1 mt . . . . . 0 C--N 1.313 -0.979 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.49 0.662 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.4 mt-10 -101.85 148.88 35.93 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.904 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -75.93 -165.88 0.33 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.982 2.455 . . . . 0.0 111.636 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 39' ' ' ILE . 1.4 pp -70.79 144.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 111.706 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.17 -10.09 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.343 0.592 . . . . 0.0 110.201 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.68 -176.19 3.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.557 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.35 130.7 3.33 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.9 mt-10 -79.1 136.07 57.82 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -67.73 166.03 25.66 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.397 2.731 . . . . 0.0 113.128 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.15 158.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.009 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.6 m -85.16 167.87 15.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.719 0.295 . . . . 0.0 111.102 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.57 134.14 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.252 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 -35.58 18.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.997 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.12 -25.59 67.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.442 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.89 -9.33 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.725 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp . . . . . 0 C--N 1.323 -0.548 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.622 -175.633 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.829 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.432 -1.341 0 CA-C-O 120.84 0.353 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.403 ' CD1' HG23 ' B' ' 20' ' ' VAL . 10.5 mt -87.81 151.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.674 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.22 118.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.0 165.02 25.99 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.568 0.542 . . . . 0.0 110.741 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 m -127.23 133.57 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.598 173.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 1.3 t80 -65.1 100.03 0.41 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.793 ' HB3' ' HD3' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -120.17 119.92 34.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.059 -170.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 52.05 33.58 12.29 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.145 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.85 -70.7 0.44 Allowed Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 117.842 -2.123 . . . . 0.0 112.028 -169.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' HG3' ' B' ' 15' ' ' LYS . 32.0 m -100.37 171.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.33 -0.935 . . . . 0.0 112.555 -155.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 93.7 m-85 -87.76 115.0 24.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.793 ' HD3' ' HB3' ' B' ' 10' ' ' GLU . 50.5 mtpt -115.32 111.18 44.58 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.757 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.3 Cg_endo -64.24 166.67 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.265 1.31 . . . . 0.0 112.113 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.413 HD11 HG13 ' B' ' 8' ' ' VAL . 17.6 mt -129.19 -22.7 3.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.444 -1.707 . . . . 0.0 108.107 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.54 143.82 27.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.959 169.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.52 154.06 33.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.816 0.341 . . . . 0.0 110.35 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 ' H ' ' B' ' 22' ' ' LEU . 4.3 p -98.75 153.74 4.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.994 0.902 . . . . 0.0 110.07 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.3 13.42 7.69 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.906 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.784 HD22 HD11 ' A' ' 32' ' ' LEU . 29.8 mt -106.47 -170.11 1.67 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.08 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' B' ' 26' ' ' GLU . 63.5 pttt -120.35 160.84 22.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.049 0.452 . . . . 0.0 110.92 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.29 135.52 42.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.497 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.37 19.51 32.57 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -171.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -94.2 145.01 25.01 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.13 0.49 . . . . 0.0 112.222 -175.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.522 ' HD3' HG12 ' A' ' 8' ' ' VAL . 2.9 mpp_? -98.57 112.92 24.81 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 123.334 1.54 . . . . 0.0 112.787 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.652 HG12 HD23 ' A' ' 32' ' ' LEU . 35.5 m -131.0 162.13 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.228 -173.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.769 ' HE3' HG13 ' A' ' 4' ' ' ILE . 36.3 mtpt -132.78 152.12 51.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.531 0.681 . . . . 0.0 109.632 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.731 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -126.94 139.86 50.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.4 -169.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 165.46 27.78 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.573 171.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.813 -176.739 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 36.5 mt-10 -92.88 151.5 40.8 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.509 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 21.0 Cg_exo -65.41 173.75 6.03 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.659 2.239 . . . . 0.0 113.072 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 pt -96.2 172.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.881 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.34 134.27 34.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.661 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.64 169.59 17.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.403 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.22 -146.61 15.88 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.093 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.0 OUTLIER -93.28 142.81 25.77 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 121.049 0.452 . . . . 0.0 111.477 -174.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 5.0 Cg_exo -77.99 130.34 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.932 2.421 . . . . 0.0 111.535 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.86 144.46 12.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.403 0.62 . . . . 0.0 111.443 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -104.92 171.07 7.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.602 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.61 148.31 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -85.22 128.05 34.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.18 -24.99 27.68 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.563 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.0 tt . . . . . 0 CA--C 1.535 0.403 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.289 -176.719 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.248 0.547 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -157.08 135.36 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.241 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.0 ptm -115.11 170.77 8.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -148.89 -174.19 4.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -85.31 5.93 28.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.849 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 85.1 mt 61.17 -166.27 0.21 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.317 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -99.76 145.44 27.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -168.0 110.21 0.6 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.833 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -113.6 132.77 55.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 43.3 t-80 -158.31 98.53 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.262 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 19.4 p-80 178.38 159.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -130.65 -99.92 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.741 0.305 . . . . 0.0 110.302 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 119.149 -0.453 . . . . 0.0 109.973 178.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.625 ' CG2' ' HD3' ' B' ' 31' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.851 0 CA-C-O 120.865 0.364 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' O ' HG12 ' B' ' 30' ' ' ILE . 10.2 mt -100.33 156.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 41.3 mt-10 -99.19 154.75 17.9 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.926 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -149.67 143.98 25.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.009 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.86 131.86 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.468 0.652 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 47.4 t80 -88.6 113.08 23.8 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.374 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 39.4 mt-10 -138.07 138.29 38.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.388 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 68.25 19.71 8.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.692 0.62 . . . . 0.0 111.136 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.52 16.12 64.73 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.031 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 10.5 t -125.34 148.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 C-N-CA 122.512 0.325 . . . . 0.0 110.598 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 50.5 m-85 -95.29 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 165.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.57 108.32 59.71 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' B' ' 14' ' ' PHE . 47.2 Cg_exo -47.14 168.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.1 2.534 . . . . 0.0 115.707 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 90.6 mt -114.22 87.36 2.61 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 112.907 -1.951 . . . . 0.0 105.915 165.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 2.5 pp0? 81.58 149.15 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.773 2.429 . . . . 0.0 110.932 -172.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -68.31 152.29 45.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.993 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 HD12 ' A' ' 5' ' ' ILE . 3.0 t -114.26 135.95 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.039 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.48 87.8 7.21 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 123.07 1.415 . . . . 0.0 108.154 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.69 173.93 9.87 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.838 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.732 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -101.2 153.43 19.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 40.5 mt-10 -61.67 129.9 43.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.806 0.812 . . . . 0.0 110.865 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.815 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 60.55 65.26 3.46 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.72 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -103.59 142.84 33.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.107 166.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -93.93 127.75 39.87 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 124.036 1.874 . . . . 0.0 113.981 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' B' ' 14' ' ' PHE . 21.4 m -136.08 155.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 111.35 -2.659 . . . . 0.0 108.341 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 38.7 mtpt -118.87 146.24 45.05 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.944 0.878 . . . . 0.0 111.287 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.0 142.85 24.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.804 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -155.38 151.52 27.97 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.357 174.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--N 1.308 -1.225 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.579 -170.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -88.14 132.49 39.51 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -80.25 -170.83 1.09 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.573 2.849 . . . . 0.0 113.045 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 39' ' ' ILE . 2.2 pp -84.99 164.5 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.459 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.27 166.58 11.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.03 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.04 166.4 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.912 0.386 . . . . 0.0 111.693 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.72 -145.06 15.81 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.79 156.89 77.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 122.375 0.27 . . . . 0.0 111.147 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.48 -179.16 4.83 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.657 2.238 . . . . 0.0 112.773 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t -104.03 155.97 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.832 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.8 m -101.45 -172.91 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.64 127.83 67.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.297 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.697 ' H ' ' HD2' ' A' ' 51' ' ' LYS . 8.7 mp0 -97.39 171.79 8.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.859 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -85.08 -23.29 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.338 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.18 -15.49 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.399 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.697 ' HD2' ' H ' ' A' ' 48' ' ' GLU . 87.5 mttt . . . . . 0 N--CA 1.441 -0.893 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.155 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.443 HG13 ' HE3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 120.894 0.378 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.63 HD13 ' HB ' ' B' ' 20' ' ' VAL . 37.8 pt -101.63 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 82.9 mt-10 -113.9 157.49 22.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.923 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.84 155.95 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.635 0.255 . . . . 0.0 110.508 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.815 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 12.0 m -114.81 126.55 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.417 0.627 . . . . 0.0 110.571 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 66.0 t80 -92.1 109.35 20.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.593 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 8.4 pt-20 -130.3 135.24 47.88 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.162 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.48 14.45 9.47 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.486 0.491 . . . . 0.0 111.891 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 94.84 10.84 57.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.755 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.9 t -114.0 143.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.362 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m-85 -106.01 116.35 31.79 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 167.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -115.99 117.81 39.01 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.875 ' HB2' ' HA ' ' B' ' 19' ' ' LYS . 16.8 Cg_exo -58.37 170.55 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.81 1.674 . . . . 0.0 113.721 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.804 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 6.3 mp -111.04 105.82 14.7 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.804 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.2 pt20 85.44 6.89 0.43 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 126.535 2.397 . . . . 0.0 110.171 -175.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.875 ' HA ' ' HB2' ' B' ' 16' ' ' PRO . 27.6 mtpp 53.56 -159.75 0.14 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.173 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' B' ' 5' ' ' ILE . 6.3 p -151.12 164.71 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.85 12.98 35.36 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.738 1.256 . . . . 0.0 109.389 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.641 ' O ' ' HD2' ' B' ' 23' ' ' LYS . 93.6 mt -79.12 156.49 28.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.327 170.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -132.57 -170.55 2.46 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.453 -170.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 6.2 mp0 -53.14 137.4 33.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 11.1 83.13 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.737 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' B' ' 22' ' ' LEU . 10.0 tp10 -77.89 134.19 37.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 117.092 0.446 . . . . 0.0 110.068 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -117.84 119.71 35.71 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.835 1.303 . . . . 0.0 112.318 -171.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.15 168.62 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.129 -1.851 . . . . 0.0 109.838 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.566 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 15.3 mtmm -126.45 139.88 52.91 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.586 0.708 . . . . 0.0 111.036 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -91.02 128.03 43.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.224 -170.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 1.9 tppt? -121.52 124.45 44.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--O 1.234 0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -69.18 131.96 90.27 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.272 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' B' ' 39' ' ' ILE . 63.0 Cg_endo -72.93 -154.24 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.127 2.551 . . . . 0.0 111.652 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 38' ' ' PRO . 71.2 mt 74.32 161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.407 ' N ' HG22 ' B' ' 39' ' ' ILE . 27.2 t70 56.16 64.88 1.58 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.291 1.043 . . . . 0.0 110.457 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.97 125.56 41.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.847 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.32 112.75 4.12 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 9.2 pt-20 -85.37 116.89 67.41 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.535 174.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 21.5 Cg_exo -64.36 114.78 2.83 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.655 2.236 . . . . 0.0 112.037 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -72.29 146.75 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.454 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -103.37 159.6 15.43 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.177 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.41 151.86 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.691 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.53 114.15 5.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.767 0.794 . . . . 0.0 111.44 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.2 -25.73 27.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.481 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.815 0.817 . . . . 0.0 110.956 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 121.146 0.498 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -100.22 -179.46 4.14 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.344 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.41 151.39 6.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.992 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -98.75 132.84 43.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.985 0.421 . . . . 0.0 110.095 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.9 m -105.7 2.36 27.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.57 113.5 18.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.767 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.1 92.25 2.77 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -86.99 71.0 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.536 0.684 . . . . 0.0 111.814 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 131.91 52.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.809 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -90.54 145.52 24.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.648 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -141.99 145.19 34.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -115.6 -168.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 174.279 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.74 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 18' ' ' GLN . 9.3 mm -108.08 143.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HG3' ' HG2' ' B' ' 29' ' ' LYS . 5.2 mp0 -97.67 121.13 39.22 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -129.81 165.72 21.39 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.056 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.694 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.0 m -117.32 115.05 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.58 0.705 . . . . 0.0 110.69 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.641 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 79.1 t80 -71.88 106.03 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.092 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.65 131.75 54.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.156 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.448 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 3.9 m-20 54.86 24.88 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 172.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 99.82 2.04 56.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.059 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.97 143.25 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.252 0.526 . . . . 0.0 111.176 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 96.9 m-85 -94.1 115.62 27.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -105.04 115.25 62.67 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.884 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 36.1 Cg_endo -66.2 167.81 17.41 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.034 1.156 . . . . 0.0 112.352 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 mt -112.91 -17.42 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 5' ' ' ILE . 76.5 mt-30 -92.91 171.63 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.058 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -75.94 132.39 40.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 162.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 22' ' ' LEU . 2.3 t -96.42 135.45 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 121.519 0.676 . . . . 0.0 110.349 -174.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -103.93 14.44 30.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.236 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 26' ' ' GLU . 91.1 mt -99.27 -174.31 2.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.098 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.55 163.04 34.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 16.5 mp0 -56.49 141.44 42.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.919 0.866 . . . . 0.0 111.524 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.27 65.3 3.45 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.535 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HG2' HD22 ' A' ' 22' ' ' LEU . 10.9 tp10 -116.76 128.5 55.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.403 -0.898 . . . . 0.0 109.634 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -85.97 120.34 27.26 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.603 1.192 . . . . 0.0 111.189 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' B' ' 30' ' ' ILE . 31.0 m -137.02 148.74 26.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.129 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -119.76 137.32 54.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.524 0.678 . . . . 0.0 110.374 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.673 HD13 HG23 ' B' ' 30' ' ' ILE . 3.6 mm -102.85 138.02 28.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.362 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.92 165.04 37.67 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.533 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 32' ' ' LEU . 2.4 mm? . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 t . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 121.868 0.842 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 154.18 37.51 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.317 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.64 173.23 14.24 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.193 1.929 . . . . 0.0 112.012 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -102.55 178.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.341 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.16 137.35 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.95 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.863 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -89.37 -165.04 1.24 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.48 141.03 12.99 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.5 pt-20 -67.09 139.86 95.54 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.04 -0.58 . . . . 0.0 111.511 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 2.3 Cg_endo -84.93 166.88 11.27 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.289 2.659 . . . . 0.0 111.951 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.47 150.71 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -95.89 -168.8 1.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.269 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.46 142.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.5 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.94 126.58 29.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.737 0.78 . . . . 0.0 111.923 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.27 -24.14 23.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.114 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mt -64.92 -12.72 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.547 -169.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 121.236 0.541 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 24.1 mm -94.83 152.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.501 ' O ' HD12 ' B' ' 17' ' ' LEU . 38.0 mt-10 -124.58 113.02 17.5 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -125.16 169.14 12.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 128.8 73.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 48.5 t80 -82.0 126.86 32.46 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.127 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 25.3 tt0 -152.19 128.28 10.42 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.608 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 67.35 23.16 9.31 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.708 0.63 . . . . 0.0 111.682 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' B' ' 9' ' ' TYR . . . 88.22 15.33 60.81 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.76 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 5.1 t -122.03 150.11 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.0 m-85 -104.56 114.46 28.7 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 165.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.63 113.63 57.69 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 27.5 Cg_endo -63.61 168.51 11.46 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.636 1.557 . . . . 0.0 112.577 -175.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' O ' ' B' ' 6' ' ' GLU . 1.3 mt -114.63 -2.43 13.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.778 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.45 ' NE2' ' H ' ' B' ' 6' ' ' GLU . 2.2 pm0 -132.39 159.81 38.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.153 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -72.97 130.53 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.47 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.3 t -107.24 145.58 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.468 -173.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -108.95 14.28 24.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.459 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' B' ' 26' ' ' GLU . 85.7 mt -75.51 -175.76 2.95 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.587 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -115.87 168.38 10.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.696 0.284 . . . . 0.0 111.234 -176.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 3.5 mp0 -71.4 136.31 47.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.487 0.661 . . . . 0.0 110.659 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.48 65.56 3.08 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.074 -165.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 13.0 tp10 -90.14 134.48 34.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.562 -0.819 . . . . 0.0 109.382 172.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' B' ' 27' ' ' ARG . 3.5 tpt180 -83.75 104.07 13.56 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.441 1.115 . . . . 0.0 110.413 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.62 HG21 ' CD1' ' A' ' 14' ' ' PHE . 30.8 m -129.32 154.84 40.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.685 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.557 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 22.1 mtmm -123.42 138.54 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.277 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -105.49 121.98 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.116 -172.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' B' ' 31' ' ' LYS . 3.1 tppp? -105.87 124.71 50.01 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.749 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.317 -0.822 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.451 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 10.2 pt-20 -60.68 125.91 83.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 5.1 Cg_exo -74.63 174.93 11.8 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.08 2.52 . . . . 0.0 112.494 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.44 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -85.03 164.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.99 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.28 157.98 30.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -145.85 153.64 41.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.29 115.92 0.68 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.395 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.428 ' HG3' ' HD2' ' B' ' 44' ' ' PRO . 34.8 tt0 -102.39 140.14 20.86 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.36 0.124 . . . . 0.0 110.908 -173.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' B' ' 43' ' ' GLU . 81.8 Cg_exo -46.78 146.88 5.14 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.959 3.106 . . . . 0.0 113.977 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.21 157.27 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.609 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -84.17 -176.58 6.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.572 . . . . 0.0 112.239 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.8 146.99 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.087 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.12 136.4 37.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.426 0.631 . . . . 0.0 111.284 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.49 -25.56 26.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.009 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.558 ' H ' HD12 ' B' ' 50' ' ' ILE . 4.4 mp . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 122.0 0.905 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 121.383 0.611 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.07 141.24 48.39 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.068 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.4 ttt -133.32 124.52 27.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.285 0.565 . . . . 0.0 111.453 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.3 p -82.72 145.31 29.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 25.3 m -76.76 3.14 12.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.59 0.233 . . . . 0.0 110.848 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt 55.54 41.4 30.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.03 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' B' ' 63' ' ' GLU . 1.9 pm0 -63.84 92.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.819 0.819 . . . . 0.0 110.549 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -75.79 102.5 5.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.29 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -75.57 113.5 13.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.521 0.676 . . . . 0.0 109.717 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -105.85 139.59 40.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -106.99 147.58 29.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.698 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -79.82 112.92 17.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 111.654 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m170 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.087 171.167 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.638 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.643 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' LYS . 5.0 pt -109.72 155.89 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.728 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.579 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 51.0 mt-10 -103.63 141.3 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.1 161.73 36.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.712 -1.586 . . . . 0.0 108.071 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.88 136.82 58.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.417 0.627 . . . . 0.0 110.286 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 81.2 t80 -81.68 103.97 11.76 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.289 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -122.58 122.65 39.36 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.683 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' B' ' 24' ' ' GLU . 1.1 m-80 55.76 36.36 27.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.061 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 85.84 16.9 62.54 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.987 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.4 t -134.42 149.29 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 94.2 m-85 -93.04 115.38 28.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 112.81 59.26 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.1 Cg_endo -61.66 168.64 8.11 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 120.752 0.968 . . . . 0.0 112.154 174.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.52 -71.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.166 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG3' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -141.93 7.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.76 -169.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.715 ' HB3' HD12 ' A' ' 5' ' ' ILE . 70.5 mmtt -91.25 155.0 18.88 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.292 -159.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 22' ' ' LEU . 40.8 t 61.1 142.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.765 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -145.92 14.74 1.35 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.779 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.616 ' CB ' ' HG2' ' A' ' 26' ' ' GLU . 58.2 mt -89.43 5.74 43.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.124 -169.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 83.7 tttt 81.85 163.74 0.15 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.756 156.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -48.91 129.71 17.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.048 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.57 12.47 69.45 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.884 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.616 ' HG2' ' CB ' ' A' ' 22' ' ' LEU . 5.0 tp10 -81.36 134.65 35.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.613 0.244 . . . . 0.0 110.439 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -90.18 115.85 27.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 123.258 1.504 . . . . 0.0 113.419 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' B' ' 14' ' ' PHE . 31.8 m -123.81 157.43 30.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 112.473 -2.148 . . . . 0.0 108.794 177.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -124.44 135.56 53.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.413 HG21 ' CE1' ' A' ' 14' ' ' PHE . 10.7 mm -90.45 132.06 36.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.073 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' CE ' HG21 ' B' ' 4' ' ' ILE . 12.6 mptt -121.27 132.5 54.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.288 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD13 HG12 ' B' ' 28' ' ' VAL . 2.8 mm? . . . . . 0 C--N 1.305 -1.335 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.438 0.637 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.95 103.34 55.24 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.631 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.41 -171.52 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.878 2.385 . . . . 0.0 111.838 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.8 mp -91.36 144.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -113.41 123.54 50.31 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.737 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -83.52 154.07 24.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.652 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.87 115.38 2.09 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.957 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.91 122.57 86.45 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.708 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.13 148.03 26.97 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.679 2.253 . . . . 0.0 112.086 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.69 156.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -86.82 171.46 10.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.865 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.93 141.81 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -135.94 -26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.269 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.16 -23.87 66.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -171.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.66 -15.63 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 pttm . . . . . 0 C--N 1.319 -0.736 0 CA-C-O 121.103 0.477 . . . . 0.0 111.618 -176.421 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.577 HG21 ' CE ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 121.027 0.442 . . . . 0.0 111.053 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.604 HG23 ' HB3' ' B' ' 18' ' ' GLN . 7.1 mt -89.62 148.29 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -102.67 131.08 49.7 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.81 154.34 46.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.604 0.24 . . . . 0.0 110.942 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.715 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -111.4 132.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.843 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 68.3 t80 -82.2 108.37 15.61 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.021 0.915 . . . . 0.0 110.585 176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.721 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 5.6 mt-10 -86.58 -170.68 3.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.391 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.15 62.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 O-C-N 124.342 1.026 . . . . 0.0 111.301 -171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 105.27 5.55 40.09 Favored Glycine 0 C--N 1.304 -1.218 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.677 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.5 t -112.78 145.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.221 -0.489 . . . . 0.0 111.432 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 55.4 m-85 -115.67 114.67 25.18 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 162.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -121.2 123.62 27.68 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.758 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.4 Cg_endo -65.19 168.0 15.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.708 1.605 . . . . 0.0 112.925 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.715 HD11 HG13 ' B' ' 8' ' ' VAL . 4.2 mp -118.45 -13.66 9.74 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' B' ' 5' ' ' ILE . 8.9 tt0 -91.53 164.11 13.91 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.593 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -78.15 142.65 37.88 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.88 139.82 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 122.973 1.368 . . . . 0.0 113.012 -173.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -141.81 87.46 2.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.379 -2.191 . . . . 0.0 108.301 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.3 -179.43 5.14 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.986 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.666 ' HD2' ' OE2' ' B' ' 24' ' ' GLU . 30.0 mmtt -110.06 161.92 15.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.338 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.666 ' OE2' ' HD2' ' B' ' 23' ' ' LYS . 1.1 pm0 -77.16 124.12 27.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.437 0.637 . . . . 0.0 109.532 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 15.28 30.67 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.784 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 7.6 tp10 -78.77 121.22 24.5 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -87.46 122.28 30.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.356 1.074 . . . . 0.0 111.278 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.47 HG12 HD13 ' A' ' 32' ' ' LEU . 29.7 m -129.46 151.15 35.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.219 -173.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.638 ' HE3' HG13 ' A' ' 4' ' ' ILE . 25.9 mtpp -121.57 134.56 55.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 122.443 1.116 . . . . 0.0 111.086 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 7' ' ' ALA . 9.6 mm -106.16 144.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 112.708 -2.042 . . . . 0.0 111.151 -164.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.535 ' HE3' HG22 ' A' ' 4' ' ' ILE . 6.1 ptpp? -156.16 163.98 38.94 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.657 -1.61 . . . . 0.0 107.018 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.603 ' CD2' HD12 ' A' ' 22' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.448 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 7.6 p . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -105.65 104.45 48.54 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.229 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 36' ' ' VAL . 77.2 Cg_endo -92.81 175.29 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.249 2.632 . . . . 0.0 111.528 172.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -124.77 114.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.01 0.433 . . . . 0.0 111.09 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.23 137.33 34.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.52 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 tp -102.75 167.62 9.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.4 -155.18 25.52 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.852 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 40.2 mt-10 -129.44 139.02 34.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.64 165.19 31.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.059 2.506 . . . . 0.0 112.42 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.449 HG22 ' N ' ' B' ' 46' ' ' SER . 10.6 p -95.15 161.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.289 0.566 . . . . 0.0 110.88 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . 0.57 ' O ' ' HB ' ' B' ' 47' ' ' VAL . 6.4 p -122.62 -164.54 1.19 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.564 -176.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 46' ' ' SER . 23.0 t 77.28 137.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.79 0.836 . . . . 0.0 111.915 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.07 138.19 37.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.95 -32.38 21.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.469 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 C--N 1.32 -0.699 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -166.597 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 C--O 1.234 0.247 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -122.11 134.06 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.898 0.38 . . . . 0.0 110.458 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.52 125.38 54.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.204 0.526 . . . . 0.0 111.232 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t -77.05 160.22 29.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.304 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.9 t -84.29 19.31 1.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 55.66 -176.42 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.551 0.74 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -111.35 167.39 10.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.876 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -152.53 135.66 15.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -143.94 101.42 3.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.984 0.421 . . . . 0.0 110.258 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -103.52 165.46 11.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -135.54 143.28 45.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.53 -75.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.87 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.237 -179.092 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.466 HG22 ' HD2' ' B' ' 31' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.3 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 25.4 mt-10 -124.26 139.45 53.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.073 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.23 165.23 25.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.071 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 3.1 m -117.08 114.37 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.57 0.7 . . . . 0.0 109.512 170.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . 19.2 t80 -60.87 124.76 21.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.483 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 28.2 mt-10 -149.4 134.3 17.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.16 0.287 . . . . 0.0 111.167 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 59.03 28.36 17.6 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.152 0.908 . . . . 0.0 111.465 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.23 -69.37 0.32 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 117.406 -2.33 . . . . 0.0 111.626 -167.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' HG3' ' A' ' 15' ' ' LYS . 22.3 m -95.58 165.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.382 -0.909 . . . . 0.0 113.397 -157.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.3 m-85 -88.68 116.74 27.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 51.8 mtpt -113.44 112.05 49.13 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.395 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 Cg_endo -60.19 168.13 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.333 1.355 . . . . 0.0 112.527 -175.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 8' ' ' VAL . 97.2 mt -95.84 1.28 53.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 11.5 pt20 -146.89 156.53 43.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.193 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 23.0 mtpp -81.49 145.08 30.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.551 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -125.0 139.84 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.947 0.88 . . . . 0.0 111.853 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.37 87.44 5.19 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.208 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.2 mt -131.01 -165.59 1.58 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.27 -2.241 . . . . 0.0 109.448 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -129.27 156.79 43.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.042 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.743 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 34.2 mt-10 -69.5 128.93 38.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.209 0.528 . . . . 0.0 110.812 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 14.39 57.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.918 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 26' ' ' GLU . 1.5 mm-40 -75.39 139.72 42.54 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -92.53 114.7 27.32 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 123.335 1.541 . . . . 0.0 112.507 -173.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' B' ' 30' ' ' ILE . 28.7 m -124.45 148.63 28.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.216 -2.266 . . . . 0.0 109.825 -175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -111.59 139.9 46.65 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -105.77 138.89 28.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.304 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -137.32 153.4 50.27 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 27' ' ' ARG . 17.3 tp . . . . . 0 C--N 1.298 -1.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.835 -156.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 33.8 mt-10 -58.04 129.41 82.47 Favored Pre-proline 0 N--CA 1.446 -0.659 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 46.6 Cg_exo -56.25 174.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.47 2.78 . . . . 0.0 114.028 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 pt -76.4 146.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.845 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.96 95.22 7.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -95.69 177.77 5.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.038 -173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.71 114.48 5.03 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.8 mt-10 -75.01 138.24 72.73 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 114.526 -0.837 . . . . 0.0 111.338 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 12.6 Cg_exo -70.0 118.06 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.482 2.121 . . . . 0.0 110.594 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.16 147.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.845 0.355 . . . . 0.0 110.612 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 m -98.09 171.78 8.03 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.94 147.34 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.335 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 41.8 mt-10 -74.96 138.03 42.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.807 0.337 . . . . 0.0 110.598 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 -25.19 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.386 0.612 . . . . 0.0 110.05 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.57 -0.4 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.875 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.05 0.452 . . . . 0.0 110.635 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.423 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.434 -1.244 0 CA-C-O 121.476 0.655 . . . . 0.0 110.015 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.531 ' CG2' ' HB2' ' B' ' 18' ' ' GLN . 7.6 mt -109.25 142.77 20.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -99.72 138.89 36.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.293 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.15 160.71 39.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.911 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.01 124.35 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.174 0.512 . . . . 0.0 110.626 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 85.6 t80 -80.19 99.74 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.543 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 73.1 mt-10 -122.74 144.75 48.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 66.37 10.72 7.46 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.434 0.458 . . . . 0.0 111.656 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 86.78 18.93 57.43 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.991 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.0 t -122.12 151.39 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.058 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.6 m-85 -98.58 115.62 29.02 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' B' ' 10' ' ' GLU . 49.1 mtmt -118.16 116.48 35.71 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.914 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 15.7 Cg_endo -61.25 165.96 11.85 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 121.688 1.592 . . . . 0.0 113.531 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.0 -66.06 0.96 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.283 -2.689 . . . . 0.0 104.945 162.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.531 ' HB2' ' CG2' ' B' ' 5' ' ' ILE . 14.7 mp0 -59.67 158.63 9.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.276 -1.783 . . . . 0.0 111.134 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -76.83 128.39 34.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 110.531 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.463 HG12 ' H ' ' B' ' 22' ' ' LEU . 8.7 t -124.44 150.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.374 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.15 15.2 7.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.916 0.865 . . . . 0.0 110.88 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.489 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 94.9 mt -71.25 163.99 26.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.58 -173.63 2.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.354 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 7.2 mp0 -63.15 141.97 58.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.321 0.581 . . . . 0.0 111.806 -175.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.584 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 45.9 64.55 2.38 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.218 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 4.1 mm-40 -103.81 134.42 47.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.521 -0.839 . . . . 0.0 110.032 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.1 mmm-85 -82.64 115.98 21.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.336 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 14' ' ' PHE . 30.0 m -140.42 152.04 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.585 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 59.4 mttm -115.32 141.83 47.51 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.204 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.5 mm -118.94 142.44 33.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.562 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.466 ' HD2' HG22 ' A' ' 4' ' ' ILE . 62.0 tttm -155.3 126.45 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.244 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.601 ' HG ' HG12 ' A' ' 28' ' ' VAL . 1.3 mp . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.167 0.508 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.44 171.29 5.8 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.422 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.65 171.87 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.752 1.634 . . . . 0.0 111.873 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.5 176.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.83 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -114.12 147.99 37.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.174 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.685 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.4 pt? -113.32 144.64 42.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.122 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.58 122.04 7.29 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.808 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.1 pt-20 -55.92 141.73 66.29 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.999 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 3.0 Cg_exo -75.18 -170.63 0.82 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.062 2.508 . . . . 0.0 112.269 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.98 156.25 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.297 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -83.32 172.21 12.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.62 148.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.643 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -50.57 119.85 4.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.329 0.585 . . . . 0.0 111.917 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -85.91 -26.04 25.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.179 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.347 -174.122 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.775 0.322 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -129.2 133.22 47.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.216 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 1.2 tpt -114.07 127.45 55.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.767 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -88.68 167.62 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 26.5 t -81.7 20.22 0.96 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.075 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 70.3 mt 62.9 -165.74 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.272 0.629 . . . . 0.0 111.205 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -123.64 134.25 53.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -93.35 120.22 33.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.954 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -57.26 137.58 55.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.491 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -79.79 139.58 37.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.021 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -131.61 117.99 19.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -81.43 123.38 28.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.941 176.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.443 -0.8 0 CA-C-O 121.383 0.611 . . . . 0.0 112.495 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.623 HG21 HG22 ' A' ' 20' ' ' VAL . 22.8 mm -106.14 168.93 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 46.5 mt-10 -124.76 160.03 29.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.318 0.508 . . . . 0.0 110.706 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' B' ' 30' ' ' ILE . . . -158.65 158.56 34.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.782 0.433 . . . . 0.0 110.259 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.5 117.86 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.635 0.731 . . . . 0.0 110.44 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.733 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 51.3 t80 -82.69 113.05 20.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.131 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HG2' ' HB3' ' B' ' 24' ' ' GLU . 0.4 OUTLIER -137.97 146.14 42.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.994 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 57.59 26.31 12.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 80.31 20.96 65.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.008 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.6 t -130.59 152.84 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.227 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 91.4 m-85 -104.64 114.01 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -104.79 106.39 54.78 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.429 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -39.83 168.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.963 3.109 . . . . 0.0 117.758 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.897 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 96.5 mt -131.72 96.99 4.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 111.621 -2.536 . . . . 0.0 105.518 168.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.897 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 4.4 pp0? 77.66 -176.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.476 2.31 . . . . 0.0 112.02 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.88 137.78 44.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -159.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 5' ' ' ILE . 2.5 t -141.6 134.18 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.103 170.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -131.14 87.76 2.51 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.829 1.3 . . . . 0.0 108.6 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 HD22 ' B' ' 32' ' ' LEU . 57.2 mt -123.11 -179.05 4.15 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 112.178 -2.283 . . . . 0.0 110.967 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.603 ' HG3' ' HG2' ' A' ' 26' ' ' GLU . 18.9 pttp -114.28 162.65 16.31 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 46.3 mt-10 -65.76 133.7 51.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 122.025 0.917 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.61 64.93 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.082 -165.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 2.0 mm-40 -114.82 139.87 49.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.208 -0.996 . . . . 0.0 109.708 168.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -100.17 124.87 46.09 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 123.008 1.385 . . . . 0.0 112.354 -175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' B' ' 30' ' ' ILE . 33.5 m -133.6 150.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.107 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -105.43 138.5 41.53 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.577 0.703 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.476 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.6 mm -110.2 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.98 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.1 156.29 34.05 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.543 HD13 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.2 pm0 -90.59 148.81 39.5 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 173.43 11.96 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.165 1.91 . . . . 0.0 112.149 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.24 153.18 24.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.67 72.04 0.96 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.6 tp -91.04 135.65 33.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.659 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.7 111.34 3.8 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.5 tt0 -93.42 113.06 59.13 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.525 -0.838 . . . . 0.0 110.469 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 6.3 Cg_exo -73.78 113.82 3.88 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.863 2.375 . . . . 0.0 112.204 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 46' ' ' SER . 8.4 p -114.14 163.15 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.526 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 45' ' ' VAL . 4.3 m -66.67 160.17 26.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.258 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.99 134.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.115 0.483 . . . . 0.0 110.577 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.658 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 31.7 mt-10 -126.0 121.57 33.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.966 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 49' ' ' GLU . 6.9 pt-20 -85.2 -25.57 27.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.695 -174.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -88.43 1.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.669 0.747 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.658 ' HE2' ' HB2' ' A' ' 48' ' ' GLU . 25.1 ttmm . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.986 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.426 -1.626 0 CA-C-O 121.245 0.545 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 18' ' ' GLN . 4.4 mt -114.84 168.07 6.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -132.41 136.4 46.74 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -133.83 155.76 49.25 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.374 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.679 HG13 HD11 ' B' ' 17' ' ' LEU . 7.1 m -110.06 121.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.316 0.579 . . . . 0.0 111.006 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 21.3 t80 -61.02 111.23 1.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.982 171.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -136.11 129.3 31.61 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.969 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 1.2 t-20 55.02 27.84 9.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.77 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.97 -68.27 0.22 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 117.688 -2.196 . . . . 0.0 111.26 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.67 154.96 3.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.522 -1.339 . . . . 0.0 111.678 -157.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 89.3 m-85 -88.72 122.16 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 0.0 112.031 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.73 119.03 51.64 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 34.1 Cg_endo -66.13 168.71 15.12 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.462 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.679 HD11 HG13 ' B' ' 8' ' ' VAL . 4.9 mp -113.21 -5.72 13.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' B' ' 5' ' ' ILE . 18.8 mp0 -116.68 143.35 45.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.356 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -72.57 126.75 30.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.9 t -88.27 145.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.244 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -111.52 14.98 21.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.008 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' B' ' 26' ' ' GLU . 80.2 mt -90.57 -168.62 2.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.314 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 15.1 tmtt? -111.81 155.4 23.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.9 mp0 -57.89 133.17 55.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.924 0.869 . . . . 0.0 112.201 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.37 65.5 3.5 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 114.106 -1.407 . . . . 0.0 110.381 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' B' ' 22' ' ' LEU . 10.0 tp10 -92.92 149.13 21.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.686 -0.757 . . . . 0.0 110.958 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.55 104.94 17.19 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.532 1.158 . . . . 0.0 111.376 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 32' ' ' LEU . 34.9 m -124.7 154.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.407 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 41.4 mttp -119.43 148.0 43.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.495 0.664 . . . . 0.0 110.076 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 28' ' ' VAL . 7.8 mt -128.55 153.38 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.129 -170.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -150.88 159.33 44.62 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.584 HD22 HD11 ' A' ' 22' ' ' LEU . 8.3 mt . . . . . 0 C--N 1.315 -0.926 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -173.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.7 mt-10 -60.16 141.93 90.11 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 32.8 Cg_exo -61.88 174.39 2.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.186 2.591 . . . . 0.0 113.773 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.413 HG13 ' H ' ' B' ' 39' ' ' ILE . 2.0 pp -82.09 171.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.127 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -93.4 -151.57 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.493 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.77 -170.53 2.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.42 141.41 10.4 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.46 155.06 85.82 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 120.573 0.225 . . . . 0.0 110.896 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.25 164.72 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.44 2.093 . . . . 0.0 110.11 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.67 134.99 8.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 122.001 0.905 . . . . 0.0 112.099 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -86.51 172.44 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.021 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.78 131.54 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.97 118.9 20.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.0 110.747 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -85.61 -25.47 26.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.588 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 tt . . . . . 0 C--N 1.317 -0.816 0 CA-C-O 121.616 0.722 . . . . 0.0 110.8 -175.065 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -110.45 135.74 50.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.739 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.39 148.7 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.483 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.1 p -142.54 149.52 39.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.032 0.444 . . . . 0.0 111.207 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 46.1 t -95.3 13.91 24.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.65 94.39 9.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.425 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.07 86.55 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -98.81 58.22 1.16 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.239 0.542 . . . . 0.0 111.624 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -68.92 116.24 9.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.23 102.57 14.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.63 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -78.81 112.94 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -109.94 129.88 55.6 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.055 -174.322 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.946 HG22 ' HG2' ' B' ' 31' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.605 HD11 HD11 ' A' ' 22' ' ' LEU . 4.6 mt -106.1 148.18 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.926 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.594 ' H ' ' NE2' ' A' ' 18' ' ' GLN . 44.9 mt-10 -102.52 123.08 45.61 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -143.07 168.52 19.55 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 17' ' ' LEU . 10.6 m -129.68 129.73 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.018 0.437 . . . . 0.0 110.785 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 20.0 t80 -59.77 128.85 38.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 37.7 tt0 -139.79 109.04 6.1 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.496 0.665 . . . . 0.0 111.494 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.455 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 31.0 t30 55.7 27.33 10.5 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.324 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.9 -70.01 0.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 118.158 -1.972 . . . . 0.0 110.731 -165.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.608 ' HB ' ' CG1' ' B' ' 13' ' ' VAL . 23.2 m -94.34 145.36 8.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 113.649 -1.276 . . . . 0.0 112.201 -160.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.5 m-85 -86.82 116.76 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.333 0.587 . . . . 0.0 110.169 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HE3' ' CG2' ' A' ' 13' ' ' VAL . 34.5 mmtp -105.12 116.58 60.34 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.153 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 13.6 Cg_endo -59.93 169.0 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.41 1.407 . . . . 0.0 111.997 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.523 HD11 HG13 ' A' ' 8' ' ' VAL . 7.4 mp -102.23 -8.73 21.04 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' NE2' ' H ' ' A' ' 6' ' ' GLU . 4.5 pm0 -145.47 170.49 16.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.433 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -63.49 128.01 33.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.061 0.934 . . . . 0.0 112.204 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 ' HZ ' ' B' ' 14' ' ' PHE . 4.9 p -132.87 141.36 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.714 173.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -148.14 87.85 1.63 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.358 -1.746 . . . . 0.0 108.867 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.826 HD13 HD11 ' B' ' 32' ' ' LEU . 67.4 mt -106.63 0.72 24.63 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.853 -1.976 . . . . 0.0 109.647 171.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 85.14 171.99 0.07 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 113.191 173.022 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.7 mp0 -78.43 134.92 37.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.502 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 51.94 63.87 4.43 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -166.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.646 ' HG2' ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp10 -113.56 137.7 51.21 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.803 -1.199 . . . . 0.0 107.927 170.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -100.53 117.8 35.41 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 123.124 1.44 . . . . 0.0 112.996 -164.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.622 HG12 HD13 ' B' ' 32' ' ' LEU . 16.0 m -134.84 158.07 41.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 112.149 -2.296 . . . . 0.0 109.483 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.748 ' HD3' HG13 ' B' ' 4' ' ' ILE . 87.3 mttt -120.95 138.38 54.16 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 122.047 0.927 . . . . 0.0 111.101 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 14' ' ' PHE . 8.8 mm -103.57 149.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.204 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -156.3 162.37 40.11 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.742 HD23 HG12 ' B' ' 28' ' ' VAL . 52.3 mt . . . . . 0 C--N 1.308 -1.223 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.723 -171.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.94 137.18 22.34 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-O 121.21 0.529 . . . . 0.0 112.152 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.28 177.34 7.23 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.772 2.315 . . . . 0.0 111.117 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.4 pp -87.82 147.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.119 0.485 . . . . 0.0 111.952 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -99.03 172.08 7.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.096 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.807 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.8 pt? -98.56 130.57 45.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.41 -154.57 17.65 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.844 -170.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.86 153.65 60.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.718 -173.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.36 171.03 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.736 2.291 . . . . 0.0 112.565 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.71 148.94 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.598 . . . . 0.0 110.465 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.537 ' O ' HG12 ' A' ' 47' ' ' VAL . 45.5 m -120.81 175.92 5.8 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.18 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 64.57 154.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.477 1.111 . . . . 0.0 113.029 177.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.6 mm-40 66.27 -36.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.663 1.185 . . . . 0.0 113.928 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.75 -26.02 62.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.492 0.663 . . . . 0.0 109.704 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mm -90.24 -4.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.053 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.329 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.748 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 121.339 0.59 . . . . 0.0 110.457 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.573 HD13 HG21 ' B' ' 20' ' ' VAL . 6.9 mt -101.44 151.8 5.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 42.9 mt-10 -113.55 134.24 54.81 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.27 151.08 40.13 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.538 0.523 . . . . 0.0 109.98 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.7 m -116.19 125.81 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.477 0.656 . . . . 0.0 110.377 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 43.4 t80 -75.99 121.97 23.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.44 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.37 135.98 34.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.57 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t30 63.04 20.61 12.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 91.08 13.06 59.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.743 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 9.1 t -120.69 153.24 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.337 0.255 . . . . 0.0 110.408 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.4 m-85 -109.0 115.34 29.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.054 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -109.05 115.95 56.18 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.99 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 41.8 Cg_endo -68.81 168.14 21.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.832 1.021 . . . . 0.0 112.186 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.436 HD11 HG13 ' B' ' 8' ' ' VAL . 5.3 mp -112.08 -12.6 13.66 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' B' ' 5' ' ' ILE . 0.8 OUTLIER -102.59 139.45 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.484 171.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -80.31 132.76 35.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 110.396 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -127.47 136.36 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.466 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.77 87.34 2.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.828 1.299 . . . . 0.0 108.186 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.581 ' HG ' HG12 ' B' ' 20' ' ' VAL . 47.2 mt -122.43 -178.44 3.9 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.533 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' B' ' 26' ' ' GLU . 29.9 mttp -102.62 161.96 13.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 mp0 -71.87 119.11 15.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 14.93 38.22 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.884 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' B' ' 22' ' ' LEU . 5.3 mm-40 -71.4 133.42 45.93 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 120.77 35.24 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 123.298 1.523 . . . . 0.0 112.819 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 32' ' ' LEU . 32.8 m -138.95 162.65 28.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 112.291 -2.231 . . . . 0.0 110.489 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.414 ' HD3' HG13 ' A' ' 4' ' ' ILE . 46.8 mttp -122.3 139.46 53.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.689 0.757 . . . . 0.0 109.246 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 28' ' ' VAL . 6.2 mt -102.9 136.34 35.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.98 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.946 ' HG2' HG22 ' A' ' 4' ' ' ILE . 19.8 mttt -137.02 147.14 46.03 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.634 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.826 HD11 HD13 ' A' ' 22' ' ' LEU . 4.3 mm? . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.372 -169.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.45 114.84 7.35 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.087 0.47 . . . . 0.0 111.917 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.76 -173.12 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.947 2.431 . . . . 0.0 112.128 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -90.14 155.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.965 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -92.71 159.95 15.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.149 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.65 165.77 26.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.193 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.41 -136.7 5.56 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.557 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -112.9 161.87 24.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 122.282 0.233 . . . . 0.0 110.953 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.88 167.66 24.85 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.402 2.068 . . . . 0.0 111.848 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.05 151.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -98.81 170.18 8.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.016 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.89 138.0 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -119.62 -23.37 6.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.232 0.539 . . . . 0.0 111.123 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.21 -25.23 65.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.983 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.408 ' O ' HG12 ' B' ' 50' ' ' ILE . 13.1 tt . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 121.194 0.521 . . . . 0.0 111.919 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.091 0.472 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -83.33 171.29 13.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.4 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 19.3 ptp -84.69 169.56 14.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.852 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -73.38 -177.15 2.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.8 m -105.32 4.06 30.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.741 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 67.4 mt 59.01 -171.23 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.392 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.51 136.11 50.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.127 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -118.2 85.1 2.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.786 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.21 127.76 32.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.114 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' B' ' 67' ' ' HIS . 52.5 m80 -96.04 147.67 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 66' ' ' HIS . 60.6 m170 72.16 157.61 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.881 0.738 . . . . 0.0 109.465 -168.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -91.29 0.75 57.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.418 0.627 . . . . 0.0 109.781 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 C--O 1.247 0.95 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.888 178.584 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.629 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.182 0.515 . . . . 0.0 111.623 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -105.1 146.76 11.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -103.02 137.2 41.53 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.82 160.33 40.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.838 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.4 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.555 0.693 . . . . 0.0 110.425 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.6 t80 -72.92 110.41 7.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.668 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 36.9 mt-10 -134.2 144.46 48.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.398 177.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 62.62 22.4 13.3 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.441 0.463 . . . . 0.0 111.374 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 79.43 18.55 73.51 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.914 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 9.8 t -127.42 150.72 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 63.4 m-85 -95.55 115.0 26.81 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.287 168.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 50.8 mtpt -113.99 108.64 50.6 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.594 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 27.7 Cg_endo -62.52 169.22 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.35 1.366 . . . . 0.0 112.781 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.2 -16.29 14.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -107.68 137.37 45.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.558 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -75.96 124.58 27.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.644 0.735 . . . . 0.0 109.98 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.655 ' HB ' ' CE2' ' B' ' 9' ' ' TYR . 3.6 t -103.12 147.48 9.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.591 -175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.76 16.1 13.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.121 0.962 . . . . 0.0 110.345 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.585 HD13 ' HG2' ' A' ' 26' ' ' GLU . 96.7 mt -73.84 -174.37 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.773 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -110.97 171.86 7.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.341 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -73.29 141.74 47.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.459 0.647 . . . . 0.0 110.575 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.739 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 54.52 64.77 4.02 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.703 -167.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' HG2' HD13 ' A' ' 22' ' ' LEU . 7.8 tp10 -105.98 123.15 47.52 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.478 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -77.88 111.3 13.58 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 122.654 1.216 . . . . 0.0 112.747 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.641 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.1 m -133.32 155.55 40.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.603 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.964 ' HD3' HG13 ' B' ' 4' ' ' ILE . 64.3 mttm -113.03 149.05 33.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.551 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.0 mm -104.59 130.25 55.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.277 0.561 . . . . 0.0 109.627 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HE3' HG21 ' B' ' 4' ' ' ILE . 75.2 mttt -132.81 134.45 44.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.545 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.707 ' HB3' HG12 ' B' ' 28' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.913 -169.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 mm-40 -81.27 123.05 81.78 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.848 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.3 Cg_exo -77.79 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.543 2.829 . . . . 0.0 113.256 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.2 pt -68.05 165.3 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.89 149.54 52.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.05 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.9 tp -100.52 135.12 42.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 111.379 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 156.38 24.51 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.039 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.44 150.7 73.95 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.36 -0.92 . . . . 0.0 111.868 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 159.03 35.5 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.761 2.307 . . . . 0.0 111.951 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.28 155.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -90.28 174.09 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.43 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.63 164.67 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.37 121.0 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.567 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -85.56 -28.83 24.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.133 0.492 . . . . 0.0 111.088 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.9 tt -93.65 -0.77 10.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.604 0.716 . . . . 0.0 110.774 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 tptm . . . . . 0 C--N 1.319 -0.75 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.726 -176.277 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.964 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.872 0 CA-C-O 120.985 0.421 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB2' ' B' ' 18' ' ' GLN . 6.6 mt -97.78 144.24 11.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 51.4 mp0 -104.9 141.32 36.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -139.87 166.26 25.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.108 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.739 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.4 m -121.36 123.48 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.612 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.655 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.2 t80 -61.55 126.16 26.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.831 173.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 81.1 mt-10 -137.09 111.52 8.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.018 0.437 . . . . 0.0 111.294 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 55.5 29.12 12.78 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.032 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.04 -69.78 0.48 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 118.215 -1.945 . . . . 0.0 110.845 -168.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.15 145.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.784 -1.208 . . . . 0.0 111.823 -161.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -92.83 116.74 29.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.63 120.77 56.68 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.561 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 28.8 Cg_endo -64.82 170.05 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.316 1.344 . . . . 0.0 112.533 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.598 HD11 HG13 ' B' ' 8' ' ' VAL . 6.0 mp -108.92 -10.67 15.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' B' ' 5' ' ' ILE . 47.0 mt-30 -115.48 145.26 42.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.866 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -73.42 151.57 41.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.953 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' B' ' 22' ' ' LEU . 2.5 t -112.54 145.25 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.67 16.61 9.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.36 1.076 . . . . 0.0 109.519 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 88.6 mt -86.36 -165.93 1.4 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.188 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.564 ' HG2' ' HG2' ' B' ' 26' ' ' GLU . 23.6 pttp -116.32 155.08 29.06 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.379 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.1 132.5 45.16 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.885 0.85 . . . . 0.0 109.836 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.02 65.03 2.75 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.617 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 1.9 mm-40 -112.06 132.96 54.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.254 -0.973 . . . . 0.0 109.221 170.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -90.41 119.48 30.73 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.704 0.764 . . . . 0.0 110.869 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 32' ' ' LEU . 29.8 m -140.11 166.81 19.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.467 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HD3' HG13 ' A' ' 4' ' ' ILE . 60.9 mttm -122.03 153.93 37.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.23 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 28' ' ' VAL . 5.8 mm -115.44 142.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -151.34 125.05 9.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.2 mp . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -143.63 89.08 7.56 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.527 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.65 -161.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.304 2.669 . . . . 0.0 112.712 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.34 156.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -91.81 -51.28 5.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.801 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 45.1 tp 68.8 116.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.278 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.77 -142.5 10.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.969 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.83 158.19 38.39 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 122.252 0.221 . . . . 0.0 111.177 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.09 174.27 12.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.025 2.483 . . . . 0.0 112.253 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.69 154.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 10.4 m -89.32 171.84 9.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.39 138.17 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.405 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.02 -30.67 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.692 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' B' ' 49' ' ' GLU . 1.6 pm0 -66.84 -24.49 66.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.957 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.375 0.607 . . . . 0.0 110.944 -178.444 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.683 0.278 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . 0.409 ' O ' ' HB2' ' B' ' 59' ' ' MET . 1.3 m-90 -110.56 -168.77 1.35 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.343 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' B' ' 58' ' ' TRP . 66.6 mtt 73.64 172.42 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.831 0.853 . . . . 0.0 110.31 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m 57.09 26.18 11.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.076 0.465 . . . . 0.0 111.735 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.8 p -82.22 16.93 1.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.003 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 45.43 99.89 0.01 OUTLIER 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.119 0.967 . . . . 0.0 113.223 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -82.83 172.4 12.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.09 123.74 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.263 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -97.23 141.22 30.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -71.14 129.92 40.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 111.639 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -71.83 86.78 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -83.77 73.92 10.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.5 0.667 . . . . 0.0 111.167 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.8 m170 . . . . . 0 C--O 1.246 0.891 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.538 177.011 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.196 0 CA-C-O 121.249 0.547 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 20' ' ' VAL . 4.6 mt -105.59 152.65 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.109 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 30.1 mt-10 -112.94 108.05 16.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -110.16 167.14 10.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.41 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 3.8 m -118.02 117.39 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.642 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 73.5 t80 -70.38 114.85 8.9 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.868 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 11.6 tt0 -88.05 -170.69 3.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.324 -2.216 . . . . 0.0 107.402 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 10.9 t30 -67.44 49.75 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.713 0.805 . . . . 0.0 112.135 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.69 4.58 11.65 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.2 t -117.32 155.12 19.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.298 -175.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 1.097 ' HB2' ' HB3' ' B' ' 14' ' ' PHE . 81.2 m-85 -122.81 119.15 29.72 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.306 164.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.07 121.02 37.52 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -67.07 167.58 19.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.105 1.203 . . . . 0.0 111.23 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.04 -2.65 14.99 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' A' ' 5' ' ' ILE . 40.5 mt-30 -119.24 144.17 46.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.683 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.8 141.19 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 5' ' ' ILE . 4.1 p -132.56 161.77 40.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.843 0.83 . . . . 0.0 112.028 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 20' ' ' VAL . 31.0 t70 -104.9 12.84 32.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.198 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 20' ' ' VAL . 6.9 mp -66.8 135.61 54.2 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.427 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.7 mmpt? -93.67 -172.26 2.84 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.523 -176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -61.63 160.52 11.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.895 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -19.72 72.63 0.0 OUTLIER Glycine 0 CA--C 1.495 -1.217 0 O-C-N 124.997 1.435 . . . . 0.0 114.132 -151.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.11 147.51 40.49 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 111.526 -2.337 . . . . 0.0 108.602 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HG3' HD23 ' B' ' 32' ' ' LEU . 13.2 tpt180 -88.14 119.17 28.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.879 ' HA ' ' CB ' ' B' ' 32' ' ' LEU . 0.0 OUTLIER -144.61 149.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.255 -174.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HB2' HD13 ' B' ' 32' ' ' LEU . 13.6 mttt -115.21 143.96 44.43 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.365 0.602 . . . . 0.0 110.286 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.696 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 1.5 mt -107.34 135.12 47.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HG2' ' HB2' ' B' ' 29' ' ' LYS . 7.5 ptmm? -106.82 143.79 34.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.736 HD21 HD21 ' B' ' 22' ' ' LEU . 21.9 tp . . . . . 0 C--N 1.293 -1.872 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.234 0.253 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.74 138.22 22.91 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.38 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.62 -174.34 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.718 2.279 . . . . 0.0 110.657 171.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.32 151.61 27.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.923 0.392 . . . . 0.0 111.179 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tt -67.99 110.26 3.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.137 0.494 . . . . 0.0 110.902 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.34 114.5 0.71 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -131.89 161.72 60.82 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 122.462 0.305 . . . . 0.0 110.475 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.69 164.84 31.61 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.686 2.257 . . . . 0.0 111.515 173.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.86 148.37 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.4 m -103.59 176.89 5.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.103 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.6 156.92 43.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.03 130.07 39.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.085 0.469 . . . . 0.0 110.227 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -85.43 -25.98 26.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.257 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -70.9 -16.1 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.533 0.682 . . . . 0.0 111.206 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.436 -1.131 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.873 179.087 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 18' ' ' GLN . 10.4 mm -113.14 146.43 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -109.39 131.21 55.28 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' B' ' 14' ' ' PHE . . . -143.12 164.33 30.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 0.0 111.248 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.22 128.87 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.282 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 41.2 t80 -84.76 100.85 11.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -115.12 120.42 39.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.859 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.32 33.29 9.19 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.965 0.79 . . . . 0.0 111.35 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' B' ' 9' ' ' TYR . . . 83.56 14.28 73.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.211 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.5 t -120.12 146.7 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 1.097 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -99.93 114.94 28.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -119.0 108.96 39.91 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.637 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 39.2 Cg_endo -68.85 168.27 20.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.467 1.445 . . . . 0.0 112.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.36 -9.55 17.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.504 ' HB2' HG23 ' B' ' 5' ' ' ILE . 72.4 mt-30 -102.38 145.69 29.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.205 173.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -84.39 124.19 31.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 163.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.7 t -90.57 148.93 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.431 -161.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.42 16.38 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.027 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.736 HD21 HD21 ' A' ' 32' ' ' LEU . 22.1 mt -99.76 -174.62 2.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.089 -173.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 26' ' ' GLU . 37.8 tttm -116.28 155.12 28.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.267 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 1.5 mp0 -62.64 123.46 18.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.049 0.452 . . . . 0.0 109.955 175.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.73 22.92 34.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.036 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' HD22 ' B' ' 22' ' ' LEU . 16.9 mm-40 -84.02 143.02 30.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' B' ' 27' ' ' ARG . 4.3 tpp180 -86.28 120.51 27.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.4 1.095 . . . . 0.0 112.442 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.696 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 34.6 m -136.07 151.55 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.832 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.741 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 47.7 mmtt -117.35 144.63 44.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 18.7 mt -133.12 137.08 54.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.807 0.813 . . . . 0.0 111.967 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -158.16 135.85 10.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.155 169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.879 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 8.8 tp . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 165.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -131.34 114.82 16.03 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 120.876 0.37 . . . . 0.0 110.889 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.11 -175.83 2.37 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.158 2.572 . . . . 0.0 112.289 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt 69.27 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.435 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.468 ' OD2' ' HG ' ' B' ' 41' ' ' LEU . 36.2 t70 -155.4 -69.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.862 -173.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' B' ' 40' ' ' ASP . 94.3 mt -100.04 168.0 10.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.274 0.559 . . . . 0.0 112.147 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 120.93 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.693 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 36.1 mm-40 -97.11 144.18 27.44 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.579 0.228 . . . . 0.0 111.123 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.71 156.15 64.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.98 2.453 . . . . 0.0 112.279 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.49 158.79 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.936 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -87.27 168.24 13.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.88 162.4 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.353 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.36 122.95 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.965 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.13 25.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.023 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 C--N 1.319 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.721 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -95.9 143.14 27.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 120.991 0.424 . . . . 0.0 111.1 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.52 124.65 48.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.61 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.1 t -79.86 148.52 31.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 110.424 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 2.8 p -94.82 -0.09 54.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' B' ' 61' ' ' SER . 1.0 OUTLIER 39.7 84.58 0.02 OUTLIER 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.651 1.219 . . . . 0.0 112.947 -178.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 100.91 0.16 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.244 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -85.01 57.91 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.17 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -70.29 108.18 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.138 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 134.31 22.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -120.2 117.27 27.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -78.57 142.21 37.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.453 178.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.884 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 CA-C-O 121.262 0.553 . . . . 0.0 112.235 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' HZ ' ' B' ' 14' ' ' PHE . 2.0 mt -93.54 145.54 7.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -99.54 109.72 22.23 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.195 -169.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.943 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -115.68 156.97 24.95 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -166.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.623 HG22 HH12 ' B' ' 27' ' ' ARG . 0.1 OUTLIER -123.31 123.62 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.709 171.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.5 t80 -80.37 105.63 11.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 50.0 mt-10 -126.83 139.69 52.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.569 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' CG ' ' B' ' 24' ' ' GLU . 4.6 t30 65.36 20.37 11.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 111.554 172.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 84.25 15.62 68.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.5 t -122.48 154.08 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.7 m-85 -99.43 114.64 27.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 165.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 37.7 mtpt -116.97 108.92 43.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.108 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.943 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 14.4 Cg_endo -72.75 169.17 22.63 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 113.491 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.36 -12.37 59.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.681 ' HG2' ' HG2' ' A' ' 16' ' ' PRO . 6.2 mm-40 75.1 -134.05 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.0 116.731 160.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.0 mttt 59.07 -161.25 0.26 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.454 -141.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' HG ' ' A' ' 22' ' ' LEU . 22.0 t 67.01 147.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.484 0.659 . . . . 0.0 110.435 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.03 26.74 3.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.684 0.754 . . . . 0.0 111.252 -171.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.43 ' HG ' ' CG1' ' A' ' 20' ' ' VAL . 94.7 mt -56.85 174.81 0.14 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.832 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -103.84 162.68 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 1.5 pm0 -83.62 149.57 26.45 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.82 73.06 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.695 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 21.5 tt0 -93.1 155.4 17.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -96.33 137.45 35.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.747 0.784 . . . . 0.0 112.465 -171.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.913 HG12 ' HA ' ' B' ' 32' ' ' LEU . 4.4 m -147.97 171.39 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.601 ' HD3' HG13 ' B' ' 4' ' ' ILE . 62.5 mttm -127.0 144.74 50.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.188 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.66 HG22 ' HB ' ' B' ' 28' ' ' VAL . 1.3 mm -113.05 131.55 64.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.765 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -121.57 124.29 44.01 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.801 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 37' ' ' GLU . 39.5 t . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 36' ' ' VAL . 12.4 pt-20 41.83 84.23 0.19 Allowed Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 124.298 1.039 . . . . 0.0 111.591 -171.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.24 174.39 8.16 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.465 2.776 . . . . 0.0 113.631 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mt -73.89 149.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.095 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -99.28 101.66 13.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.773 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 19.7 tp -83.13 -177.58 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -172.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' ' HG ' ' A' ' 41' ' ' LEU . . . -150.05 156.42 26.73 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.7 mp0 -54.6 124.1 47.71 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 123.785 0.344 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.37 128.25 29.28 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.497 2.131 . . . . 0.0 111.521 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.1 p -70.85 143.93 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.886 0.85 . . . . 0.0 111.661 -175.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -114.47 162.15 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.77 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.561 0.696 . . . . 0.0 111.456 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.31 -14.42 25.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.811 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.0 -27.22 68.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.537 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -93.12 -14.84 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt . . . . . 0 C--N 1.319 -0.718 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -174.635 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.601 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.444 -0.77 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.479 ' O ' HG12 ' A' ' 30' ' ' ILE . 9.0 mm -98.13 143.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -104.86 134.98 47.07 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.668 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -137.27 156.29 48.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.536 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.487 HG13 HD11 ' B' ' 17' ' ' LEU . 2.0 m -117.17 114.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.688 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 14.1 p90 -103.52 141.88 35.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.186 0.993 . . . . 0.0 113.25 -170.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -87.58 -170.98 3.24 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.582 172.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.7 63.45 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 O-C-N 124.504 1.127 . . . . 0.0 111.722 -171.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 113.06 -5.71 25.46 Favored Glycine 0 C--N 1.301 -1.413 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.382 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' B' ' 9' ' ' TYR . 0.2 OUTLIER -104.37 139.02 26.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.437 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 42.5 m-85 -118.68 123.87 45.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.188 0.904 . . . . 0.0 111.353 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -122.79 117.32 28.75 Favored Pre-proline 0 N--CA 1.455 -0.184 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.527 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.4 Cg_endo -67.83 169.14 16.83 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.984 1.789 . . . . 0.0 113.74 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.487 HD11 HG13 ' B' ' 8' ' ' VAL . 4.7 mp -120.58 -17.81 7.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.432 171.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.42 146.97 24.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -62.96 148.54 47.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.438 0.637 . . . . 0.0 110.559 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' B' ' 22' ' ' LEU . 2.3 p -145.17 134.53 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 122.338 1.066 . . . . 0.0 111.818 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -121.13 15.08 11.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.709 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 32' ' ' LEU . 85.7 mt -66.39 167.22 10.92 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.09 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -112.68 160.4 17.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -173.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 2.3 mp0 -62.77 120.23 10.87 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.905 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.2 36.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.974 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -75.89 136.4 40.12 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.942 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.623 HH12 HG22 ' A' ' 8' ' ' VAL . 18.3 tpp180 -93.39 117.39 30.02 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.567 1.175 . . . . 0.0 112.522 -171.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 30' ' ' ILE . 19.8 m -141.79 158.25 21.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.459 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.884 ' HD3' HG13 ' A' ' 4' ' ' ILE . 52.5 mttp -120.76 147.2 45.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.823 HG21 ' CE2' ' B' ' 14' ' ' PHE . 1.3 mm -110.68 132.26 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.145 0.498 . . . . 0.0 110.976 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 4' ' ' ILE . 10.5 mtmt -118.56 136.86 53.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 171.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HA ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.08 -174.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 80.0 t . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 122.115 0.959 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -119.75 139.41 28.0 Favored Pre-proline 0 N--CA 1.435 -1.215 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.749 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.4 174.19 12.54 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 111.769 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.508 ' O ' HD12 ' B' ' 39' ' ' ILE . 1.9 pp -81.4 137.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -107.08 119.26 38.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.2 mt -134.32 168.89 18.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.262 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 118.14 2.64 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.7 mp0 -51.93 139.8 31.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 123.174 0.59 . . . . 0.0 111.572 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 130.2 37.33 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.637 2.225 . . . . 0.0 111.761 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.24 151.95 8.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.065 0.459 . . . . 0.0 110.476 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -94.3 169.71 10.03 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.884 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 132.84 65.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.503 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -72.46 120.01 17.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.264 0.554 . . . . 0.0 110.841 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.84 -23.33 48.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.365 -173.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -132.17 135.91 46.69 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.8 ptp -106.18 159.18 16.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.009 0.433 . . . . 0.0 111.066 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -71.14 173.59 7.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.112 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -90.25 -6.51 55.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.828 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 tp 51.1 30.58 5.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.8 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.44 129.62 50.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.03 0.443 . . . . 0.0 110.587 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -133.28 85.87 2.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.546 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -75.05 74.79 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.129 0.966 . . . . 0.0 110.759 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -104.06 111.82 24.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.818 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.55 141.63 51.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.499 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -105.76 137.94 42.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.523 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 9.7 p80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 120.878 0.37 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.574 ' HB ' HD12 ' B' ' 30' ' ' ILE . 19.4 mt -119.87 152.2 22.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 169.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.57 134.91 48.99 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.678 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.43 165.79 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.44 -175.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.474 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 10.5 m -118.42 127.98 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.27 0.557 . . . . 0.0 110.512 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.687 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 86.5 t80 -89.42 105.15 17.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.834 0.826 . . . . 0.0 110.637 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 8.5 pt-20 -91.86 -168.33 1.99 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.79 168.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.78 67.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.436 1.112 . . . . 0.0 112.43 -160.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . 105.38 0.4 40.58 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.012 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 1.9 t -115.16 141.97 29.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.262 -173.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.5 m-85 -108.31 115.59 30.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 166.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HE3' HG11 ' A' ' 13' ' ' VAL . 96.9 mttt -121.2 119.11 29.78 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.619 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -52.48 166.57 0.75 Allowed 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.382 2.055 . . . . 0.0 114.741 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.3 -67.4 0.99 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 110.215 -3.175 . . . . 0.0 103.655 167.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -71.44 141.73 50.26 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.08 -2.327 . . . . 0.0 108.628 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 13.8 mtpt -60.6 149.63 34.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.697 0.76 . . . . 0.0 112.395 -173.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 m -77.1 166.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.527 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.42 15.21 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.719 0.771 . . . . 0.0 110.148 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.527 HD11 HD22 ' B' ' 32' ' ' LEU . 79.0 mt -122.5 -169.91 1.99 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.378 -172.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 18.3 pttp -124.03 155.12 38.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.974 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.2 pm0 -66.19 134.28 52.41 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.21 0.528 . . . . 0.0 111.002 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.17 10.58 48.22 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.802 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 5.7 tp10 -84.46 146.56 27.56 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.807 -0.231 . . . . 0.0 110.757 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -102.5 125.08 49.1 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.557 1.17 . . . . 0.0 112.334 -175.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.512 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.3 m -134.15 156.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.414 -174.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.627 ' HB3' HD12 ' B' ' 4' ' ' ILE . 64.0 mttm -115.33 144.79 43.23 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.0 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.514 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.5 mm -115.79 144.3 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 -175.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -151.3 123.78 8.41 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' B' ' 28' ' ' VAL . 2.7 pt? . . . . . 0 C--N 1.31 -1.126 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.349 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.1 115.6 27.29 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.369 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.86 172.14 11.26 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.211 1.941 . . . . 0.0 112.298 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.57 165.24 32.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.062 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.64 118.37 15.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.903 0.382 . . . . 0.0 110.297 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 pt? -148.82 133.93 18.24 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.875 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.3 -155.07 31.15 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.227 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 49.0 mt-10 -118.13 143.08 32.17 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-O 120.527 0.204 . . . . 0.0 110.704 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 21.5 Cg_exo -65.94 142.44 68.8 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.943 2.429 . . . . 0.0 112.112 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.84 146.29 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.914 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -95.73 158.19 15.56 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.054 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.9 t -140.72 132.01 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.234 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -118.99 122.3 41.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.856 0.836 . . . . 0.0 110.954 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.48 -22.98 26.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.104 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.07 -3.51 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.532 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.713 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.427 -1.581 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' B' ' 20' ' ' VAL . 1.9 mt -124.45 157.94 31.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 mt-10 -109.59 139.99 43.93 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.4 157.52 44.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.041 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . 0.659 HG13 HD11 ' B' ' 17' ' ' LEU . 6.0 m -104.26 117.35 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.602 0.715 . . . . 0.0 110.822 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 52.7 t80 -76.57 111.25 11.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.21 1.005 . . . . 0.0 111.181 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.696 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 36.6 mt-10 -88.51 -169.12 2.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.163 170.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.55 55.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.236 1.014 . . . . 0.0 112.349 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 112.65 6.72 23.01 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.8 t -116.08 149.59 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.885 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.8 m-85 -119.18 114.87 23.11 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 166.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.468 ' HE2' HG11 ' B' ' 13' ' ' VAL . 65.1 mttm -114.26 113.77 45.93 Favored Pre-proline 0 CA--C 1.506 -0.717 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.23 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -43.56 169.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.318 2.678 . . . . 0.0 116.642 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.946 ' O ' ' HG3' ' B' ' 18' ' ' GLN . 2.5 mt -131.17 103.91 6.76 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.753 167.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.946 ' HG3' ' O ' ' B' ' 17' ' ' LEU . 5.1 pp0? 79.38 178.58 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.068 2.547 . . . . 0.0 112.922 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.23 141.28 35.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -162.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' B' ' 5' ' ' ILE . 3.2 t -137.79 135.06 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.279 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.511 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -128.08 87.56 2.62 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 123.015 1.388 . . . . 0.0 109.149 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.434 HD13 ' HG2' ' B' ' 26' ' ' GLU . 60.6 mt -129.99 -169.95 2.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.032 -1.894 . . . . 0.0 111.119 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -91.1 -174.72 4.07 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -103.45 122.08 44.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.753 0.787 . . . . 0.0 110.24 170.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 93.02 15.16 53.16 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.409 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.434 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.8 tp10 -60.93 138.46 58.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.604 0.361 . . . . 0.0 110.524 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 0.1 OUTLIER -89.76 115.09 26.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.376 1.084 . . . . 0.0 111.662 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 32' ' ' LEU . 27.4 m -132.33 162.7 39.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.575 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -117.66 147.12 43.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.281 0.562 . . . . 0.0 109.598 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.574 HD12 ' HB ' ' A' ' 5' ' ' ILE . 2.1 mt -106.7 128.45 61.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.81 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -125.92 134.09 51.67 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 122.556 1.169 . . . . 0.0 108.852 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 22' ' ' LEU . 41.3 tp . . . . . 0 C--N 1.279 -2.488 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.03 -162.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.321 0.581 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -86.93 136.02 34.65 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.47 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.91 174.37 9.74 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.415 2.077 . . . . 0.0 111.657 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.22 144.81 8.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.91 -177.07 6.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.5 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.38 143.07 26.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 111.0 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 -123.59 5.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.026 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.3 OUTLIER -101.36 153.47 37.81 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 120.774 0.321 . . . . 0.0 111.055 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 1.8 Cg_endo -87.0 -159.57 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.551 2.834 . . . . 0.0 111.654 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 t -115.04 156.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -75.21 169.68 17.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.844 0.354 . . . . 0.0 111.312 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.04 136.92 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.8 -22.35 21.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.245 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.12 -28.19 67.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.518 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 110.945 -174.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.199 0.523 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.07 178.98 4.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.363 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t 74.91 137.23 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.139 0.899 . . . . 0.0 112.424 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -105.47 18.63 21.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.034 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 67.96 179.05 0.23 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.094 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 65' ' ' HIS . 40.7 tt0 -124.21 121.61 35.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.353 0.596 . . . . 0.0 111.83 -172.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -96.36 74.52 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . 0.513 ' HB2' ' HG2' ' B' ' 63' ' ' GLU . 2.2 t-160 -95.07 -8.91 35.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.736 -170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -99.25 127.49 45.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -139.26 115.57 10.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -73.68 -74.83 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.696 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.937 HG13 ' HD2' ' B' ' 29' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.709 0 CA-C-O 121.228 0.537 . . . . 0.0 111.876 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.42 147.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.76 128.51 52.91 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.47 151.57 44.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 6.6 m -115.87 119.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 121.381 0.61 . . . . 0.0 111.063 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.724 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 87.2 t80 -72.71 99.71 2.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -119.28 130.95 55.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.397 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.56 23.64 13.89 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.649 0.593 . . . . 0.0 112.035 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.515 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 92.1 10.43 61.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.354 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.9 t -122.92 142.83 38.03 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' B' ' 28' ' ' VAL . 48.7 m-85 -88.89 114.19 25.24 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 166.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -119.75 116.16 33.23 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.193 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.1 Cg_endo -58.27 166.38 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.33 1.353 . . . . 0.0 111.965 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -98.23 -13.67 20.71 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -122.37 155.36 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.728 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.28 131.85 35.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -111.26 150.05 13.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.0 14.7 20.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.279 1.038 . . . . 0.0 110.145 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.53 HD13 ' HG2' ' A' ' 26' ' ' GLU . 70.4 mt -79.06 176.75 9.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.577 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HG2' ' OE1' ' A' ' 26' ' ' GLU . 17.5 pttm -124.95 163.11 23.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 111.537 -172.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.9 pt-20 -66.24 116.92 7.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.85 14.91 14.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.646 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 3.9 tp10 -80.61 132.49 35.63 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -103.18 127.81 50.35 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 122.356 1.074 . . . . 0.0 111.534 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' B' ' 32' ' ' LEU . 35.7 m -135.19 162.09 38.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.719 -167.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.93 141.88 47.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.793 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 14.7 mt -122.21 137.49 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.569 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -158.04 167.48 29.76 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.108 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 162.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 37' ' ' GLU . 7.5 p . . . . . 0 C--O 1.235 0.311 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 36' ' ' VAL . 1.4 mp0 -61.75 164.57 9.54 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 122.924 0.489 . . . . 0.0 111.239 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.46 179.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.624 2.216 . . . . 0.0 112.856 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.92 174.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.622 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.84 153.74 43.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.697 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.83 148.04 33.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.92 -144.62 5.93 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.813 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.6 mp0 -53.03 117.91 12.49 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.114 0.538 . . . . 0.0 110.716 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.94 124.31 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.43 2.087 . . . . 0.0 112.258 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.51 150.11 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.26 157.92 16.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.345 0.593 . . . . 0.0 111.481 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.46 96.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.78 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 15.8 pt-20 -84.3 1.07 46.61 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.553 -172.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.8 -25.07 10.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.441 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.3 pt -77.77 13.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.365 0.603 . . . . 0.0 111.301 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 32.5 tttt . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.831 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.416 ' N ' HD12 ' B' ' 4' ' ' ILE . 3.3 mp . . . . . 0 N--CA 1.444 -0.759 0 CA-C-O 121.997 0.903 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.594 HD13 HG12 ' B' ' 20' ' ' VAL . 9.9 mt -114.46 151.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.65 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 137.73 52.66 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.66 168.97 18.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.1 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.64 141.58 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 83.7 t80 -100.3 114.09 27.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.053 0.93 . . . . 0.0 109.958 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.714 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 44.7 mt-10 -87.58 -170.63 3.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.126 -1.852 . . . . 0.0 108.552 169.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 52.64 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.096 0.958 . . . . 0.0 112.07 -172.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 117.48 4.67 15.26 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.3 t -114.32 145.54 19.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.554 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' B' ' 9' ' ' TYR . 46.5 m-85 -117.68 115.45 25.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 166.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.87 114.33 46.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.709 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 9.5 Cg_endo -59.93 165.47 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-O 123.472 1.363 . . . . 0.0 113.2 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 -66.03 0.93 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.048 -2.796 . . . . 0.0 104.675 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.508 ' HB2' HG23 ' B' ' 5' ' ' ILE . 50.7 mt-30 -65.55 132.13 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.629 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -61.24 124.16 19.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.02 0.914 . . . . 0.0 110.47 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.594 HG12 HD13 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -101.82 132.95 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.177 -176.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.36 88.4 2.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.426 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.555 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 72.5 mt -130.57 -165.0 1.49 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.348 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -92.59 161.58 14.53 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -88.23 128.28 35.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.4 65.11 3.16 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 113.725 -1.579 . . . . 0.0 109.878 -160.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.93 142.8 29.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.646 -0.777 . . . . 0.0 109.864 173.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' B' ' 27' ' ' ARG . 1.0 OUTLIER -100.84 105.57 16.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.684 1.231 . . . . 0.0 111.768 -176.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 14' ' ' PHE . 33.8 m -123.96 164.83 21.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.979 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.937 ' HD2' HG13 ' A' ' 4' ' ' ILE . 31.7 mtmm -123.44 139.77 53.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.598 0.714 . . . . 0.0 110.935 177.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.465 HG21 ' CE1' ' B' ' 14' ' ' PHE . 10.7 mm -111.11 143.98 19.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.816 -171.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -147.42 161.22 41.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 113.84 -1.527 . . . . 0.0 107.377 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.67 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.2 pt? . . . . . 0 C--N 1.301 -1.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 121.676 0.75 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.0 112.15 26.88 Favored Pre-proline 0 N--CA 1.433 -1.312 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.876 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.28 173.53 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.416 2.077 . . . . 0.0 111.981 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.1 pt -95.81 155.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.31 123.78 28.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.863 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.36 115.54 28.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.28 113.67 2.39 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.55 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.86 155.51 80.41 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.551 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.21 145.21 77.72 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.474 2.116 . . . . 0.0 111.604 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.99 152.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.095 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -77.36 173.42 11.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.69 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 25.5 t -82.92 116.5 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.339 0.59 . . . . 0.0 110.354 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.73 155.49 18.54 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.924 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.94 -24.36 66.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.798 0.332 . . . . 0.0 111.672 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.41 ' N ' HD12 ' B' ' 50' ' ' ILE . 3.0 mp . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.815 0.817 . . . . 0.0 109.837 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.884 0.373 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -82.75 150.72 26.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.368 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 43.5 tpp -116.13 154.11 30.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.313 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 74.26 -0.58 3.31 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.589 0.556 . . . . 0.0 110.767 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -85.28 5.74 29.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.269 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.93 136.66 52.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.115 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 145.85 26.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -146.73 78.15 1.49 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.675 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -145.19 157.83 43.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -153.68 138.57 17.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -121.02 77.86 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -179.74 97.52 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.499 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.2 t60 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.791 -176.663 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.918 ' HG3' HD11 ' B' ' 34' ' ' LEU . 96.2 Cg_endo -86.7 137.61 4.88 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.954 2.436 . . . . 0.0 113.21 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -97.49 167.22 11.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.695 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.614 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -101.86 127.15 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' B' ' 29' ' ' LYS . 11.6 mm -93.99 147.81 5.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 39.6 mt-10 -113.77 134.75 54.58 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.51 156.54 48.45 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.231 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 11.5 m -110.27 115.16 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-O 121.747 0.784 . . . . 0.0 110.577 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.767 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 64.7 t80 -73.62 101.45 3.62 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.564 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' OE1' ' HG3' ' A' ' 15' ' ' LYS . 40.2 mt-10 -108.24 119.24 38.91 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.063 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.73 21.13 12.56 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 170.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.629 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 102.73 7.68 44.33 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.026 -1.083 . . . . 0.0 112.367 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.767 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.2 t -120.37 142.7 34.98 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.923 0 CA-C-O 119.588 -0.244 . . . . 0.0 110.436 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 76.1 m-85 -93.0 115.58 28.25 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 119.576 -0.85 . . . . 0.0 109.976 170.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HG3' ' OE1' ' A' ' 10' ' ' GLU . 29.1 mmtp -107.57 108.75 62.03 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.464 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 17.9 Cg_endo -60.84 167.41 8.69 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 119.979 1.028 . . . . 0.0 112.501 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.2 mt -102.74 -6.05 23.06 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' A' ' 5' ' ' ILE . 7.9 pt20 -138.41 111.97 8.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.472 -1.695 . . . . 0.0 109.631 173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 12.7 tmtt? -60.91 133.25 55.91 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.752 -171.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.507 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.8 t -113.6 140.99 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 114.561 -1.2 . . . . 0.0 110.114 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -116.33 87.49 2.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.789 1.281 . . . . 0.0 109.047 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' A' ' 26' ' ' GLU . 76.0 mt -127.11 -158.65 0.88 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.162 -2.29 . . . . 0.0 110.671 176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -85.67 176.75 7.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 2.0 mp0 -89.7 123.31 33.61 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.97 0.891 . . . . 0.0 109.446 168.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.041 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 69.59 64.75 2.82 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 113.785 -1.552 . . . . 0.0 110.395 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.652 ' HG2' HD13 ' A' ' 22' ' ' LEU . 5.6 tp10 -94.4 144.53 25.47 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.212 -0.994 . . . . 0.0 108.887 169.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.72 120.76 34.4 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 122.568 1.175 . . . . 0.0 114.013 -167.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.794 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.2 m -138.79 154.64 26.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.827 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -115.06 140.01 49.4 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.594 HD12 ' HB ' ' B' ' 5' ' ' ILE . 1.8 mt -103.73 140.97 20.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.27 -173.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -125.58 138.06 53.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.773 174.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -105.87 119.18 38.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -64.27 126.61 28.31 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.475 0.655 . . . . 0.0 109.876 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.3 pt? -114.68 160.25 19.57 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.214 -169.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.872 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 10.9 mmpt? -100.86 152.52 20.42 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.582 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.88 141.79 13.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.472 0.653 . . . . 0.0 111.184 -176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.98 123.65 50.52 Favored Pre-proline 0 N--CA 1.44 -0.937 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.023 177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.45 173.73 13.33 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.585 2.19 . . . . 0.0 112.444 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 pt -116.19 164.96 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.42 -172.3 2.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 32.8 tp -85.48 143.02 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.45 -142.3 5.47 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.866 -177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.9 161.41 63.54 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.606 -0.297 . . . . 0.0 111.001 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.15 -174.87 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.827 2.351 . . . . 0.0 112.536 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.56 155.71 4.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.734 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 p -97.0 -178.43 4.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 53' ' ' ILE . 7.1 p -110.53 123.81 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.522 0.677 . . . . 0.0 110.892 175.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -103.5 179.65 4.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.99 -178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.16 -36.6 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.254 0.55 . . . . 0.0 111.777 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.1 mt -88.85 1.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.713 0.768 . . . . 0.0 110.361 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -92.47 -4.6 53.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.374 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.16 104.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.976 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 ' HA ' HG21 ' A' ' 47' ' ' VAL . 42.3 mt -74.85 -39.07 45.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.73 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -139.67 -166.95 2.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.13 151.51 22.45 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.216 0.532 . . . . 0.0 111.419 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -126.93 47.1 1.04 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.072 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.71 129.39 56.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.751 0.31 . . . . 0.0 110.445 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.62 154.21 48.66 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 ttm -86.01 123.67 31.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.114 0.483 . . . . 0.0 111.613 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.6 t -84.5 133.01 34.48 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 172.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -81.69 1.91 32.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.892 0.377 . . . . 0.0 110.305 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.4 mt 62.18 -171.67 0.16 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.478 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -96.61 128.31 43.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.063 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -115.4 -18.32 11.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.23 174.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' HB3' ' H ' ' A' ' 66' ' ' HIS . 6.0 m-70 58.09 -159.02 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.819 177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.464 ' H ' ' HB3' ' A' ' 65' ' ' HIS . 48.1 m80 -128.99 152.03 49.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.679 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -128.43 131.44 48.44 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -131.27 177.8 7.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.923 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 m80 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.633 175.061 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.411 ' HG2' HD13 ' A' ' 34' ' ' LEU . 14.3 Cg_exo -69.62 88.17 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.23 1.954 . . . . 0.0 109.329 167.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -83.59 147.29 27.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -168.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.458 ' N ' HD12 ' B' ' 4' ' ' ILE . 2.7 mp -94.64 139.34 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.224 167.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.594 ' HB ' HD12 ' A' ' 30' ' ' ILE . 29.7 mt -125.22 153.69 32.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -97.57 148.32 23.39 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.83 150.06 42.81 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 1.041 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.6 m -109.6 113.75 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-O 121.713 0.768 . . . . 0.0 110.531 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' B' ' 14' ' ' PHE . 37.5 t80 -67.47 100.87 0.9 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.84 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 92.2 mt-10 -102.46 112.59 25.37 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t30 63.09 13.45 6.81 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.24 169.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 119.71 2.36 12.98 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 119.886 -1.149 . . . . 0.0 112.479 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.451 HG12 ' HD3' ' A' ' 15' ' ' LYS . 26.9 m -132.1 142.52 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.105 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 1.05 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 98.2 m-85 -86.85 116.31 24.84 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.955 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -105.84 111.15 64.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.144 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -44.93 168.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.333 -0.263 0 C-N-CA 123.126 2.55 . . . . 0.0 117.183 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.761 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -126.15 97.24 5.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.141 -2.299 . . . . 0.0 104.95 163.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.7 pt20 85.53 148.38 0.07 Allowed 'General case' 0 C--N 1.323 -0.565 0 O-C-N 125.717 1.886 . . . . 0.0 109.326 -167.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.41 157.95 34.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.279 -167.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.565 HG12 ' HG ' ' B' ' 22' ' ' LEU . 5.4 t -116.34 147.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.143 -177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -88.37 18.58 4.36 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.796 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.565 ' HG ' HG12 ' B' ' 20' ' ' VAL . 90.8 mt -92.29 162.86 14.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.069 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 175.0 5.91 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.105 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.6 mp0 -65.96 125.0 24.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.482 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.557 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.2 15.11 67.52 Favored Glycine 0 N--CA 1.441 -1.004 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.068 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 mm-40 -69.93 136.24 50.34 Favored 'General case' 0 CA--C 1.51 -0.561 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.794 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -100.63 137.35 39.14 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 122.37 1.081 . . . . 0.0 112.303 -176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.3 m -150.12 172.2 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.865 -1.971 . . . . 0.0 110.135 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 87.0 mttt -125.04 139.23 53.98 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.345 0.593 . . . . 0.0 109.925 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.794 HG22 ' HB ' ' A' ' 28' ' ' VAL . 4.0 mt -140.48 149.51 21.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.551 -171.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.44 157.21 44.36 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.609 HD23 HG12 ' A' ' 28' ' ' VAL . 42.3 mt -77.05 124.55 27.95 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.55 145.03 54.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.665 0.745 . . . . 0.0 112.001 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.918 HD11 ' HG3' ' A' ' 2' ' ' PRO . 77.1 mt -109.68 178.36 4.45 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.275 -1.33 . . . . 0.0 111.696 -171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.559 ' O ' HG12 ' B' ' 36' ' ' VAL . 13.7 mptt -134.76 -170.22 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.007 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.559 HG12 ' O ' ' B' ' 35' ' ' LYS . 0.4 OUTLIER 61.53 161.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.043 1.337 . . . . 0.0 113.899 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -112.15 169.27 6.52 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.176 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -75.25 -166.48 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.648 2.232 . . . . 0.0 112.344 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.436 ' N ' HD12 ' B' ' 39' ' ' ILE . 3.9 mp -93.66 150.45 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.931 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.11 143.34 51.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.363 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tt -134.33 132.83 39.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.91 155.44 17.19 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.1 pm0 -70.74 127.67 91.63 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.044 -0.578 . . . . 0.0 110.515 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 26.5 Cg_exo -62.73 160.55 32.28 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.063 2.509 . . . . 0.0 112.225 -177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.416 ' H ' HG12 ' B' ' 45' ' ' VAL . 1.5 p -63.73 138.72 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.855 0.836 . . . . 0.0 111.768 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 58.1 m -115.52 177.04 4.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.008 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' B' ' 51' ' ' LYS . 51.2 t -79.83 124.45 37.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -100.91 160.31 14.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.747 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -58.96 -25.9 63.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.911 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 tt -76.42 -7.46 10.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.256 0.55 . . . . 0.0 111.395 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.487 ' HD2' HG13 ' B' ' 47' ' ' VAL . 19.2 ttmt -80.71 151.66 28.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.187 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -71.44 106.37 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.363 0.602 . . . . 0.0 110.854 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -112.42 130.95 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.314 174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -76.72 144.77 39.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.637 0.256 . . . . 0.0 110.589 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.2 166.12 11.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.111 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.5 61.63 0.31 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.888 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.1 p -82.6 103.26 12.0 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 111.592 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.94 150.41 22.17 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.843 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.9 ttt -142.24 124.97 15.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.648 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 5.3 p -116.06 164.19 14.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -99.53 -5.49 29.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 mp 45.99 84.85 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.864 0.727 . . . . 0.0 112.439 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 139.93 42.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.872 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -142.87 31.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -94.09 168.93 10.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.908 0.385 . . . . 0.0 110.905 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -149.63 118.64 6.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.631 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -62.82 126.96 29.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -98.32 167.59 10.75 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.719 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.402 -0.809 . . . . 0.0 109.505 175.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -88.13 131.21 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.46 2.106 . . . . 0.0 113.552 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -133.61 143.01 48.37 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 4' ' ' ILE . 3.8 mp -81.28 127.25 39.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.147 0.975 . . . . 0.0 112.73 -173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' B' ' 30' ' ' ILE . 18.0 mt -110.97 158.26 11.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.042 169.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' HG2' ' CD ' ' B' ' 29' ' ' LYS . 44.5 mt-10 -123.47 134.61 53.89 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.396 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -131.44 165.98 22.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.456 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.605 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 4.8 m -110.96 121.16 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.408 0.623 . . . . 0.0 110.01 171.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.652 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 65.8 t80 -83.18 115.7 22.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.518 1.152 . . . . 0.0 110.677 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HB2' ' HB ' ' A' ' 13' ' ' VAL . 61.3 mt-10 -86.7 -169.82 2.8 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 112.158 -2.292 . . . . 0.0 109.064 173.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.21 45.13 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.166 0.986 . . . . 0.0 111.829 -171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.462 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 122.52 5.16 8.64 Favored Glycine 0 N--CA 1.439 -1.166 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' HB2' ' A' ' 10' ' ' GLU . 2.4 t -115.67 142.88 27.09 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 C-N-CA 120.624 -0.431 . . . . 0.0 111.481 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 35.2 m-85 -111.72 114.89 28.19 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.846 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -119.95 116.37 32.85 Favored Pre-proline 0 C--N 1.318 -0.797 0 O-C-N 122.407 -0.183 . . . . 0.0 111.188 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 20.0 Cg_endo -64.0 168.08 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 121.818 1.678 . . . . 0.0 112.088 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -112.65 -14.25 13.18 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HB2' HG23 ' A' ' 5' ' ' ILE . 63.6 mt-30 -104.24 128.52 51.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.11 -1.405 . . . . 0.0 108.871 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -71.32 140.15 50.15 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.739 0.781 . . . . 0.0 110.071 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 22' ' ' LEU . 6.0 p -133.17 140.94 45.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.372 -164.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -97.04 85.87 3.84 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.46 -1.7 . . . . 0.0 107.937 172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.607 HD21 ' CD1' ' B' ' 9' ' ' TYR . 0.0 OUTLIER -116.97 173.92 6.38 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.759 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.671 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 5.1 mptp? -114.06 150.34 34.14 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.486 170.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.4 132.52 47.82 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.211 0.529 . . . . 0.0 111.197 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.92 23.03 51.16 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.119 -175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.671 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 25.3 tt0 -74.02 117.97 16.42 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 27' ' ' ARG . 28.4 ttt180 -84.97 126.49 33.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.562 -175.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG12 HD23 ' B' ' 32' ' ' LEU . 35.5 m -132.5 166.89 27.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.25 -173.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.713 ' HG2' ' HG2' ' B' ' 33' ' ' GLU . 11.4 mmmm -116.37 138.23 51.51 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 2.4 mm -120.84 140.58 44.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.308 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' B' ' 2' ' ' PRO . 85.9 tttt -156.05 149.92 25.17 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD21 HG12 ' B' ' 28' ' ' VAL . 44.9 mt -92.7 118.73 31.37 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.29 -179.83 7.53 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.5 mt 56.42 -161.57 0.19 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.235 -171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -87.81 164.1 16.1 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.749 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -97.78 136.48 28.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.027 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.67 151.03 43.43 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.374 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.83 173.68 13.09 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.119 1.879 . . . . 0.0 112.095 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.88 136.27 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 41' ' ' LEU . 20.7 t70 56.24 -158.88 0.23 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.18 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.512 ' H ' ' CG ' ' A' ' 40' ' ' ASP . 3.2 pp -103.28 167.3 9.91 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.091 -0.381 . . . . 0.0 111.185 -177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.74 -131.91 5.45 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.441 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -106.79 108.69 62.35 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-O 120.652 0.263 . . . . 0.0 111.661 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 114.86 3.61 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.889 2.393 . . . . 0.0 111.408 173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 46' ' ' SER . 7.6 p -102.21 158.47 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.264 0.554 . . . . 0.0 110.782 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 45' ' ' VAL . 1.2 m -100.7 162.72 12.73 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.788 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.83 121.48 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.704 0.764 . . . . 0.0 111.237 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -144.73 -36.77 0.31 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.253 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.76 -25.52 26.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.501 0.667 . . . . 0.0 110.756 -176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.04 1.69 3.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.005 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -98.1 135.05 40.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 0.0 110.575 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -123.57 135.24 53.88 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 tt -105.89 141.93 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 54' ' ' ARG . 42.0 ttm180 -127.53 141.14 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.26 164.38 24.48 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.904 0.383 . . . . 0.0 111.381 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.34 147.75 16.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.977 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.68 130.61 36.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.758 0.313 . . . . 0.0 111.055 -175.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' MET . 2.2 p-90 -100.46 172.99 6.78 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.118 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' TRP . 44.7 mmm 75.16 161.92 0.25 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.725 0.774 . . . . 0.0 112.224 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.0 t -129.81 177.56 7.16 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.165 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 50.2 m -81.69 19.77 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 123.216 0.322 . . . . 0.0 111.019 -179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 61' ' ' SER . 7.7 mp 69.57 137.06 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.006 0.922 . . . . 0.0 111.776 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -105.14 113.52 27.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.22 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -113.8 117.75 32.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.843 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -75.74 100.92 4.85 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 169.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -54.34 121.6 8.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.067 -176.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -77.92 80.92 4.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.86 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -112.9 130.03 56.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.88 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.162 174.394 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.58 ' N ' HD21 ' B' ' 22' ' ' LEU . 1.5 mpt? . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.44 ' O ' ' HE3' ' A' ' 31' ' ' LYS . 43.2 Cg_endo -70.7 -19.79 31.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.311 2.007 . . . . 0.0 111.292 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.87 165.88 24.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.903 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.78 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -93.14 128.92 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.382 0.61 . . . . 0.0 110.43 176.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.617 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 15.5 mm -90.48 154.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.561 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 29' ' ' LYS . 45.9 mt-10 -124.79 130.53 52.58 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.94 163.43 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 26' ' ' GLU . 3.9 m -128.61 116.87 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 112.013 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.644 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 0.6 OUTLIER -65.31 106.34 1.33 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.591 0.71 . . . . 0.0 110.398 175.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.611 ' HB2' ' HD3' ' B' ' 15' ' ' LYS . 34.7 mt-10 -129.95 133.79 47.04 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.887 175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.91 32.32 22.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.402 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.08 -68.3 0.39 Allowed Glycine 0 N--CA 1.431 -1.656 0 C-N-CA 117.432 -2.318 . . . . 0.0 111.92 -168.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 4.8 m -106.21 155.93 7.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.264 -0.968 . . . . 0.0 112.153 -156.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.777 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -84.85 113.69 21.55 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.611 ' HD3' ' HB2' ' B' ' 10' ' ' GLU . 39.9 mtpt -97.94 113.65 64.04 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.744 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.9 Cg_endo -62.09 167.28 11.0 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.122 1.215 . . . . 0.0 111.931 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.56 -12.13 12.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -120.83 161.67 21.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.176 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -77.83 132.12 37.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.232 0.539 . . . . 0.0 112.035 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 1.8 t -132.74 144.26 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.044 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -149.72 87.54 1.5 Allowed 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.405 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.602 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 87.9 mt -109.91 -2.66 17.05 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 113.093 -1.867 . . . . 0.0 110.452 172.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 57.6 mttp 77.17 157.77 0.19 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 113.391 -1.731 . . . . 0.0 112.506 172.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.92 133.49 55.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.102 -164.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.605 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.6 64.93 3.5 Favored Glycine 0 N--CA 1.433 -1.511 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.429 -169.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.602 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 0.0 OUTLIER -101.47 135.09 43.55 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.88 -0.66 . . . . 0.0 110.56 167.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -77.14 117.21 18.47 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.107 0.956 . . . . 0.0 111.395 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.56 HG12 HD21 ' A' ' 32' ' ' LEU . 28.2 m -130.2 156.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.694 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.485 ' CD ' ' HG2' ' A' ' 6' ' ' GLU . 33.2 mmtp -109.36 134.75 51.43 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.321 0.581 . . . . 0.0 110.487 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 5' ' ' ILE . 3.5 mm -112.54 143.82 21.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.987 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.07 160.51 39.77 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.319 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.438 HD23 HG12 ' A' ' 28' ' ' VAL . 83.5 mt -99.82 135.75 40.77 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.734 -172.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.713 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 23.0 mm-40 -101.49 145.47 28.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 122.179 0.99 . . . . 0.0 112.305 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.98 153.73 30.0 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.489 -1.687 . . . . 0.0 107.737 172.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -112.07 154.01 26.03 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.112 0.482 . . . . 0.0 111.008 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.27 160.55 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.317 178.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' B' ' 37' ' ' GLU . 7.1 pt-20 -50.6 110.93 1.91 Allowed Pre-proline 0 N--CA 1.45 -0.45 0 O-C-N 123.558 0.536 . . . . 0.0 111.676 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -89.45 172.89 3.95 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.334 2.022 . . . . 0.0 111.851 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 pt -137.12 150.0 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.754 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -91.44 141.24 28.96 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.56 HD22 ' H ' ' B' ' 41' ' ' LEU . 2.7 mm? -61.16 116.82 4.86 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 123.326 0.391 . . . . 0.0 110.779 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.63 114.03 4.55 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.498 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.4 pm0 -75.56 147.92 82.34 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 114.621 -0.789 . . . . 0.0 110.37 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.14 130.11 29.51 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.304 2.003 . . . . 0.0 111.833 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -77.99 150.32 5.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -101.04 169.74 8.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.987 0.423 . . . . 0.0 110.87 -177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.89 135.31 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' B' ' 51' ' ' LYS . 41.9 mt-10 -98.51 149.36 22.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.896 -175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.92 -28.73 43.88 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.682 0.753 . . . . 0.0 109.287 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.15 13.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.595 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.627 ' HB2' ' HB2' ' B' ' 48' ' ' GLU . 38.5 tptt -72.65 136.58 45.7 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.071 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' B' ' 52' ' ' LYS . 30.7 mmtp -83.22 162.92 21.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp 57.25 86.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 121.539 0.685 . . . . 0.0 110.549 -169.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 46.5 ttt85 70.68 94.49 0.08 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.04 150.78 32.68 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.91 124.81 8.25 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.055 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -166.49 175.75 7.86 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -95.95 134.33 39.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.9 ttt -104.13 146.82 28.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.162 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 25.6 t 75.73 128.62 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 O-C-N 124.218 0.949 . . . . 0.0 110.994 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.0 m -97.52 1.59 49.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.057 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp 53.35 83.72 0.06 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.507 0.67 . . . . 0.0 111.417 -175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.69 159.71 15.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.006 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -85.72 35.04 0.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.562 0.696 . . . . 0.0 109.347 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -78.79 72.4 5.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.348 0.594 . . . . 0.0 110.465 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -77.78 123.48 26.77 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.625 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -100.92 126.58 47.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.836 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -118.81 136.51 53.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.478 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 20.4 t60 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.401 -0.809 . . . . 0.0 110.023 177.736 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.507 0.194 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.15 99.08 1.06 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.791 2.327 . . . . 0.0 111.563 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpp -146.4 172.9 12.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.019 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER -113.19 143.56 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 168.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.909 HD13 HG21 ' A' ' 20' ' ' VAL . 1.4 mt -99.2 145.98 9.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -101.33 132.86 46.67 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.15 155.85 49.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.324 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 m -114.33 117.06 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.416 0.626 . . . . 0.0 110.346 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 77.5 t80 -73.54 119.33 17.62 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.708 176.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 41.3 tt0 -144.96 130.19 18.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.424 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 t30 70.77 22.76 4.72 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.829 0.705 . . . . 0.0 110.802 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 83.04 17.96 66.14 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.656 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 14.6 t -122.68 149.59 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 82.5 m-85 -97.69 115.28 27.64 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 166.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.0 mmmt -116.38 107.91 46.38 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.044 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.7 Cg_endo -59.8 167.89 6.35 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.213 1.275 . . . . 0.0 112.825 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.66 -8.6 20.78 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.211 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.622 ' N ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -138.37 140.05 39.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.083 176.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 20' ' ' VAL . 7.9 tmtt? -76.94 132.4 39.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.558 0.694 . . . . 0.0 110.551 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.909 HG21 HD13 ' A' ' 5' ' ' ILE . 2.9 t -122.49 141.43 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.195 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -100.74 87.94 3.46 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 122.702 1.239 . . . . 0.0 108.148 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' B' ' 9' ' ' TYR . 69.0 mt -111.25 -175.43 2.7 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.383 -2.189 . . . . 0.0 110.61 174.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.975 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 47.9 mtpt -93.41 165.86 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.559 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.35 129.77 34.79 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.644 0.735 . . . . 0.0 109.589 177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.157 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.74 64.65 3.56 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.738 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.975 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 1.9 mm-40 -89.93 150.24 22.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.943 -0.629 . . . . 0.0 110.463 171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -89.75 104.48 17.04 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.929 1.347 . . . . 0.0 112.527 -173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.611 HG12 HD13 ' B' ' 32' ' ' LEU . 35.3 m -126.99 154.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.41 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.911 ' HD3' HG13 ' B' ' 4' ' ' ILE . 54.8 mttm -111.56 144.68 40.41 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.516 HG21 ' CE1' ' A' ' 14' ' ' PHE . 11.8 mm -104.36 133.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-O 121.945 0.878 . . . . 0.0 109.234 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -140.69 161.28 38.13 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HG ' HG12 ' B' ' 28' ' ' VAL . 6.8 mp -112.62 149.45 32.8 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.9 -166.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -66.69 124.74 23.73 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 168.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.17 153.17 22.83 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.573 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.55 157.46 16.18 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 168.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -85.18 137.35 20.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 121.043 0.449 . . . . 0.0 110.29 -172.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -118.03 85.0 22.65 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.937 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -90.71 -154.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.417 2.744 . . . . 0.0 110.278 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mt -95.79 139.1 19.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -111.99 116.37 30.46 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.557 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.2 pt? -86.24 128.52 34.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.904 -175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.05 114.26 1.24 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.108 -0.568 . . . . 0.0 111.981 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.44 124.39 30.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.46 125.1 14.37 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.81 2.34 . . . . 0.0 112.266 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -87.12 148.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.348 0.594 . . . . 0.0 110.863 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.9 m -101.02 173.99 6.22 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.277 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 t -120.32 147.8 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.76 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 24.2 mt-10 -86.93 119.48 27.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.342 . . . . 0.0 111.297 -178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -86.42 -31.35 21.47 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.693 0.758 . . . . 0.0 109.363 170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 pt -84.29 12.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.423 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 41.4 tttp -71.23 133.0 45.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -141.12 117.74 10.94 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -169.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 pt -108.14 97.75 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.255 169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -128.78 139.67 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 112.282 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.8 153.89 33.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.482 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.63 134.92 8.27 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.978 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.1 t -150.07 140.9 22.76 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.136 0.493 . . . . 0.0 110.629 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.7 t90 -156.04 135.61 12.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.953 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -160.62 148.26 15.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.157 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -128.39 119.33 24.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.748 0.309 . . . . 0.0 110.213 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.9 p -105.51 19.11 21.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.04 0.448 . . . . 0.0 110.722 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -73.46 71.48 1.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.739 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -73.84 118.91 17.36 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -160.85 140.46 10.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.144 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -112.33 126.83 55.69 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -140.98 116.99 10.5 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 112.019 -168.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -124.47 -55.87 1.63 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -142.62 -24.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 . . . . . 0 C--O 1.243 0.713 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.792 172.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 39.2 mtt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 120.707 0.289 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 8.7 Cg_exo -73.19 139.94 30.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.498 2.132 . . . . 0.0 110.513 171.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' B' ' 4' ' ' ILE . 20.3 ttmt -110.52 154.02 24.27 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.123 0.487 . . . . 0.0 110.235 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.911 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -79.84 135.91 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.171 172.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 33.2 pt -108.85 134.21 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.542 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 19.8 mp0 -86.08 142.65 28.56 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.532 -176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -135.05 164.38 27.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.163 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 1.157 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 8.5 m -122.48 130.81 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-O 121.276 0.56 . . . . 0.0 110.819 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 91.8 t80 -72.05 112.76 8.41 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 123.08 1.419 . . . . 0.0 111.55 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 1.038 ' HB3' ' HB ' ' B' ' 13' ' ' VAL . 10.6 tp10 -87.81 -176.48 5.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.241 -2.254 . . . . 0.0 106.919 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.445 ' H ' ' HG3' ' B' ' 10' ' ' GLU . 1.2 t-20 -66.86 61.28 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 122.266 1.031 . . . . 0.0 111.93 -172.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 109.31 8.25 27.33 Favored Glycine 0 C--N 1.299 -1.482 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.023 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 1.038 ' HB ' ' HB3' ' B' ' 10' ' ' GLU . 2.5 t -118.75 156.88 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 114.769 -0.716 . . . . 0.0 111.419 -174.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.652 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 71.1 m-85 -118.37 115.15 24.09 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 161.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.581 ' HE3' ' HG2' ' B' ' 10' ' ' GLU . 98.2 mttt -108.48 117.49 54.31 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.638 178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 26.1 Cg_endo -64.43 168.73 12.31 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.109 1.206 . . . . 0.0 111.701 176.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.723 HD11 HG13 ' B' ' 8' ' ' VAL . 6.1 mp -110.05 -10.46 14.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -101.67 155.41 18.12 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.105 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -74.99 141.77 43.94 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.655 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.462 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.0 t -118.82 146.03 24.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.317 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -126.09 15.27 7.89 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.187 0.994 . . . . 0.0 109.454 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.562 HD13 ' HG2' ' B' ' 26' ' ' GLU . 94.1 mt -83.46 -172.79 4.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.357 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -128.28 177.88 6.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.635 0.255 . . . . 0.0 111.016 -178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 2.5 mp0 -66.08 140.36 58.24 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.04 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 16.79 70.73 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.606 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.562 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.3 tp10 -79.8 126.2 30.67 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' B' ' 27' ' ' ARG . 15.3 mmm180 -85.0 129.57 34.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.21 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.712 HG12 ' HG ' ' A' ' 32' ' ' LEU . 30.2 m -142.0 166.36 16.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.724 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.419 ' HD3' HG13 ' A' ' 4' ' ' ILE . 41.8 mttp -116.58 145.21 43.53 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.433 HG21 ' CE1' ' B' ' 14' ' ' PHE . 6.6 mm -117.45 143.97 26.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.685 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' A' ' 4' ' ' ILE . 29.6 tptp -154.55 128.2 8.66 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.569 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.611 HD13 HG12 ' A' ' 28' ' ' VAL . 3.4 mm? -66.14 125.49 25.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -68.35 153.26 44.09 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.659 0.742 . . . . 0.0 112.757 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' B' ' 35' ' ' LYS . 16.1 tp -128.21 159.77 34.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.456 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.442 ' N ' ' HG ' ' B' ' 34' ' ' LEU . 92.3 mttt -98.16 159.14 15.13 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.909 0.385 . . . . 0.0 110.796 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -111.87 149.78 14.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.071 172.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -151.36 126.41 4.73 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.971 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.96 174.13 11.93 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.418 2.079 . . . . 0.0 112.75 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 32.8 pt -87.41 160.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.15 135.53 36.6 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 pp -148.16 164.65 33.29 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.871 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.79 -156.44 22.8 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -137.41 127.45 15.6 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.698 0.285 . . . . 0.0 110.426 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -68.93 117.48 5.06 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.854 2.369 . . . . 0.0 112.726 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -124.72 152.43 30.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.54 149.4 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.32 0.581 . . . . 0.0 111.471 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -155.78 150.16 10.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.326 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.11 115.09 24.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.225 1.012 . . . . 0.0 112.707 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -86.68 -26.62 24.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.584 171.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 23.3 mm -80.01 -10.38 12.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.702 -171.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' B' ' 52' ' ' LYS . 5.0 tmtt? -135.93 135.09 39.35 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.045 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.527 ' N ' ' HD3' ' B' ' 51' ' ' LYS . 74.8 tttt -139.27 169.36 17.92 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.339 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.472 HD12 ' HG2' ' B' ' 52' ' ' LYS . 4.4 mp 54.85 102.42 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.804 0.812 . . . . 0.0 111.646 -171.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -143.66 124.17 13.99 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.714 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -84.17 168.95 15.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.243 0.544 . . . . 0.0 111.268 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' B' ' 57' ' ' THR . . . -173.5 -172.61 39.09 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.027 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' B' ' 56' ' ' GLY . 60.4 m 72.09 145.49 0.07 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.229 0.538 . . . . 0.0 111.36 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -110.1 134.9 51.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.583 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 47.3 ttm -79.36 128.73 33.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.4 m -66.83 106.9 2.01 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.305 0.574 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.3 m -99.52 3.44 45.54 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.368 176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 61.48 179.11 0.12 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.528 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.23 144.25 50.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.395 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -78.78 88.84 4.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.638 0.732 . . . . 0.0 110.173 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -88.12 117.43 27.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.334 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -127.29 127.5 44.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.601 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' B' ' 68' ' ' HIS . 25.7 t-80 -87.13 -103.96 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.608 ' HB2' ' O ' ' B' ' 67' ' ' HIS . 44.9 t-80 156.65 146.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 . . . . . 0 C--O 1.244 0.814 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.402 173.597 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -74.22 44.83 1.08 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.433 2.755 . . . . 0.0 112.832 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -149.5 158.94 44.62 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.685 0.755 . . . . 0.0 111.325 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.404 HG22 ' HD3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -127.09 129.36 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.249 166.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.82 HG13 ' HB ' ' B' ' 30' ' ' ILE . 3.7 pt -90.52 137.1 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -99.45 142.38 31.0 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.928 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -136.21 164.31 28.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.168 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 11.8 m -120.0 126.11 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.197 0.522 . . . . 0.0 110.665 175.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.8 t80 -94.65 111.28 23.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.057 -177.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 5.9 pt-20 -130.67 141.29 50.41 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.785 176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.8 t30 60.83 21.4 11.53 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.982 0.42 . . . . 0.0 111.945 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 87.86 13.08 65.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.863 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 12.5 t -119.53 143.75 30.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-N 115.741 -0.23 . . . . 0.0 110.633 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 49.0 m-85 -103.41 115.62 30.88 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 166.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -106.67 114.87 61.4 Favored Pre-proline 0 C--N 1.316 -0.865 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.7 Cg_endo -62.81 168.69 9.9 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 120.634 0.89 . . . . 0.0 111.939 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -102.43 -4.46 25.42 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -128.26 127.71 43.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.169 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -74.53 131.27 40.85 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -124.2 137.74 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.647 0.737 . . . . 0.0 110.628 -177.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.42 87.82 5.3 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.38 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.5 mt -121.54 -171.94 2.32 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.073 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -98.7 -176.18 3.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.956 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 5.3 mp0 -89.22 138.46 31.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 121.3 0.571 . . . . 0.0 110.162 171.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.747 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 50.3 65.25 3.05 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.378 -168.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.582 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 9.1 tp10 -93.27 128.24 39.18 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.635 -0.783 . . . . 0.0 109.344 171.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -81.62 114.95 20.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.71 1.243 . . . . 0.0 111.569 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 HD23 ' B' ' 32' ' ' LEU . 35.2 m -131.5 164.23 35.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.059 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.817 ' HE2' ' HG3' ' B' ' 33' ' ' GLU . 52.3 mttm -119.92 143.02 48.19 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.23 0.538 . . . . 0.0 110.08 176.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.513 HD12 HD12 ' B' ' 30' ' ' ILE . 3.7 mm -110.65 140.46 29.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.144 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -147.4 165.82 29.06 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.667 0.746 . . . . 0.0 110.294 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD21 HD22 ' B' ' 22' ' ' LEU . 74.9 mt -113.87 129.24 56.61 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 33' ' ' GLU . 4.6 tp10 -64.13 147.46 52.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.667 0.746 . . . . 0.0 112.739 -166.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 mt -147.01 -172.66 4.05 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.225 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -109.51 170.93 7.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.511 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -97.66 144.11 11.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.332 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.3 mm-40 -85.83 131.47 47.06 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.178 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.6 Cg_exo -79.88 -166.85 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.09 2.527 . . . . 0.0 111.854 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 pt -101.39 168.65 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.306 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.4 142.42 24.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.991 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.2 tp -124.11 153.98 40.67 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.98 -143.29 14.5 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.926 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.0 pt-20 -111.78 147.06 36.02 Favored Pre-proline 0 C--N 1.321 -0.644 0 C-N-CA 122.203 0.201 . . . . 0.0 111.001 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 20.0 Cg_exo -67.33 170.96 12.37 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.118 2.545 . . . . 0.0 111.382 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 t -68.92 153.29 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 110.158 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 p -122.52 162.1 22.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.33 0.586 . . . . 0.0 111.608 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 52.6 t -131.17 135.57 59.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.669 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.13 133.62 52.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.389 0.614 . . . . 0.0 111.477 -177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.1 pm0 -80.86 -21.13 40.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.428 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.5 mt -63.63 -13.66 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.705 0.764 . . . . 0.0 110.009 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB2' ' HE3' ' A' ' 51' ' ' LYS . 30.1 ttmt -93.39 131.82 38.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.87 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 16.3 ptpt -158.75 -165.2 1.59 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.566 0.222 . . . . 0.0 111.51 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 67.2 mt 73.65 100.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 122.137 0.97 . . . . 0.0 111.571 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -130.53 143.06 50.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.611 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -122.41 153.51 38.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.527 0.68 . . . . 0.0 111.174 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.57 80.29 0.33 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.338 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 118.83 6.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.108 0.48 . . . . 0.0 111.501 -172.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -147.21 150.21 34.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.212 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.86 -163.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.419 -175.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.9 m 62.57 21.4 12.63 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.367 0.604 . . . . 0.0 111.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -87.47 19.03 3.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.015 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -114.05 154.86 26.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.91 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -125.91 136.14 52.7 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.6 m80 -117.74 93.35 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -130.01 124.16 32.28 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.883 -174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -108.12 -174.45 2.52 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -137.0 31.3 2.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 175.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' HIS . 55.9 t-80 -174.96 -91.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.314 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 68' ' ' HIS . 17.7 t-80 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.403 -1.284 . . . . 0.0 107.933 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.87 -173.48 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.953 2.435 . . . . 0.0 112.852 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -127.38 153.7 45.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.243 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.485 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -124.04 144.3 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.058 177.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 11.2 mt -104.2 144.81 13.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.573 ' H ' HE21 ' B' ' 18' ' ' GLN . 12.7 mp0 -105.95 130.75 53.83 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.379 0.609 . . . . 0.0 110.422 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.48 154.92 46.78 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.623 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.747 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 3.6 m -110.97 115.37 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 121.507 0.67 . . . . 0.0 110.926 176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.788 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 47.4 t80 -75.23 111.46 10.5 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.274 175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 44.9 tt0 -120.13 116.83 26.45 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.694 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 62.27 19.59 11.12 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.876 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 109.59 5.57 29.56 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.215 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.788 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 3.5 t -118.06 142.43 32.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.856 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.794 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.888 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 74.0 m-85 -97.97 116.63 30.57 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.109 -0.637 . . . . 0.0 109.621 171.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.727 ' HE3' HG11 ' B' ' 13' ' ' VAL . 33.8 mmtp -117.54 111.49 39.73 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.766 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 18.7 Cg_endo -60.49 167.97 7.3 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.299 1.333 . . . . 0.0 111.994 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.695 HD11 HG13 ' B' ' 8' ' ' VAL . 6.7 mp -111.51 -21.92 11.53 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.573 HE21 ' H ' ' B' ' 6' ' ' GLU . 5.0 pt20 -115.46 3.72 14.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.053 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' B' ' 16' ' ' PRO . 54.8 mtmt 55.65 167.71 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.263 -1.79 . . . . 0.0 113.534 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.613 HG12 ' HG ' ' B' ' 22' ' ' LEU . 3.5 t -144.12 154.22 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.788 -175.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -136.7 86.81 2.24 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 123.139 1.447 . . . . 0.0 109.605 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' B' ' 20' ' ' VAL . 0.4 OUTLIER -132.52 104.68 6.81 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 112.132 -2.303 . . . . 0.0 110.196 166.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.727 ' HD2' ' HG2' ' B' ' 26' ' ' GLU . 96.0 mttt 33.95 -163.07 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.448 1.499 . . . . 0.0 114.4 -174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -115.47 127.12 55.1 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.697 163.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.615 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 53.96 65.19 3.63 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.497 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.727 ' HG2' ' HD2' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -99.03 145.52 27.01 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 167.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -95.71 123.33 39.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 122.477 1.132 . . . . 0.0 112.391 -168.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.3 m -131.04 174.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.973 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -112.91 142.22 45.83 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.82 ' HB ' HG13 ' A' ' 5' ' ' ILE . 4.3 mm -119.16 141.08 40.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.224 177.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.404 ' HD3' HG22 ' A' ' 4' ' ' ILE . 56.5 tptt -143.66 125.91 15.59 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.492 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.758 HD23 HG12 ' A' ' 28' ' ' VAL . 27.9 mt -59.77 135.96 57.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.817 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 41.8 tt0 -61.12 142.55 56.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.955 0.883 . . . . 0.0 113.03 -169.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.66 167.33 21.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.02 -1.446 . . . . 0.0 109.139 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -124.45 168.82 12.53 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.328 0.585 . . . . 0.0 110.872 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 t -109.36 127.51 66.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -111.47 119.64 44.63 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 120.917 0.389 . . . . 0.0 111.136 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -87.32 -176.52 1.85 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.96 2.44 . . . . 0.0 111.839 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.4 HD12 ' O ' ' B' ' 39' ' ' ILE . 1.8 pp -103.99 152.59 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.496 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -134.08 103.99 6.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.893 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 50.0 tp -135.04 139.09 44.53 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.562 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.86 114.25 2.58 Favored Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.404 ' HB3' ' HD2' ' B' ' 44' ' ' PRO . 45.9 mt-10 -92.26 162.26 30.62 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.739 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 43' ' ' GLU . 76.7 Cg_exo -49.8 142.18 26.23 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.42 2.747 . . . . 0.0 113.968 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.82 164.74 3.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.6 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -78.77 164.08 24.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.032 0.444 . . . . 0.0 111.234 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -118.57 164.76 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.519 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 51' ' ' LYS . 13.8 mt-10 -62.45 110.56 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.912 0.387 . . . . 0.0 110.431 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.41 -29.61 22.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.373 0.606 . . . . 0.0 110.386 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 mt -91.69 13.62 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.391 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' B' ' 48' ' ' GLU . 21.2 tptm -82.07 132.78 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -158.4 147.63 19.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.265 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 71.8 mt -81.25 115.34 23.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.288 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -110.12 98.04 7.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.363 0.602 . . . . 0.0 110.617 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -133.89 163.55 29.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.03 145.86 14.22 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.694 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 14.2 t -160.65 158.57 29.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -130.02 146.39 51.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.825 0.345 . . . . 0.0 110.336 -176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.3 mtt -94.85 178.36 5.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.046 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.7 t -135.04 122.93 22.49 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -94.22 -6.43 44.67 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.547 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 tt 54.86 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.304 1.002 . . . . 0.0 112.132 175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.43 115.72 16.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 111.087 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -99.24 110.55 23.08 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.377 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.83 116.93 20.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.831 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.27 77.19 0.63 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.258 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -96.23 94.12 7.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -81.99 129.62 34.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.697 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.427 174.719 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.64 112.22 3.32 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.907 2.405 . . . . 0.0 111.429 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -157.22 148.19 21.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.486 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.35 144.71 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.815 174.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 18' ' ' GLN . 16.9 mt -98.77 155.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' HB2' HD12 ' A' ' 17' ' ' LEU . 7.0 mp0 -113.1 144.14 43.15 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -144.14 161.04 39.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.454 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.892 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.6 m -121.95 115.22 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.679 0.752 . . . . 0.0 110.493 174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 63.8 t80 -75.2 114.74 14.06 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.737 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 5.5 pt-20 -105.64 132.24 52.03 Favored 'General case' 0 CA--C 1.483 -1.629 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 164.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.529 ' H ' HD22 ' A' ' 11' ' ' ASN . 0.1 OUTLIER -74.0 63.55 0.95 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -149.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . -142.96 -7.08 0.62 Allowed Glycine 0 C--N 1.27 -3.094 0 CA-C-N 110.899 -2.864 . . . . 0.0 107.743 149.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 19.0 m -160.76 150.11 5.36 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -155.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.6 m-85 -99.48 116.52 31.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 165.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.701 ' HD3' ' HG2' ' A' ' 10' ' ' GLU . 23.3 mtpp -109.18 111.61 60.08 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.402 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.7 Cg_endo -53.8 165.12 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.592 1.528 . . . . 0.0 113.978 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.436 HD12 ' HB2' ' A' ' 6' ' ' GLU . 93.1 mt -93.06 -66.43 0.92 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 111.168 -2.742 . . . . 0.0 104.436 165.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.51 ' HB2' HG23 ' A' ' 5' ' ' ILE . 71.0 mt-30 -61.33 132.63 54.18 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 112.982 -1.917 . . . . 0.0 108.636 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -65.67 139.25 58.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.571 0.701 . . . . 0.0 110.436 -177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 22' ' ' LEU . 2.4 p -106.56 146.82 12.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.575 -167.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -133.85 13.76 3.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.099 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 20' ' ' VAL . 86.7 mt -72.93 -176.63 2.11 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.853 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 14.8 pttp -125.18 165.41 18.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.192 -174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 3.8 mp0 -66.47 143.29 57.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.694 0.759 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.52 65.47 3.39 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.299 -168.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 8.5 tp10 -106.82 124.39 49.54 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.06 110.36 21.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 123.499 1.619 . . . . 0.0 113.266 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.955 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.8 m -122.81 149.35 26.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 112.03 -2.35 . . . . 0.0 109.986 -176.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HD3' ' HG3' ' B' ' 6' ' ' GLU . 47.0 mmtm -103.3 138.73 39.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mm -92.6 130.26 41.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HG3' HG22 ' B' ' 4' ' ' ILE . 9.7 tttt -136.45 134.67 37.92 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.171 -171.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD21 HG12 ' B' ' 28' ' ' VAL . 89.5 mt -102.62 128.49 49.28 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.396 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 33' ' ' GLU . 7.7 pt-20 -69.74 138.18 52.61 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -165.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 32' ' ' LEU . 5.1 mp -127.82 -172.64 2.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.765 172.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -114.59 164.89 13.38 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.743 0.306 . . . . 0.0 110.743 177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.18 154.16 4.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.04 159.42 65.54 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.237 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -74.78 178.21 7.49 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.709 2.273 . . . . 0.0 112.373 174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 31.1 pt -80.01 174.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.78 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.36 121.57 14.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.556 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -131.95 154.4 49.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.706 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.79 131.83 2.07 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.337 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.26 135.77 44.0 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 120.884 0.374 . . . . 0.0 111.014 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.3 -173.8 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.047 2.498 . . . . 0.0 112.565 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.07 153.59 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.687 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -106.09 -171.77 1.96 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.975 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.2 p -66.13 157.52 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.989 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.704 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.5 mp0 -61.89 128.0 34.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.383 . . . . 0.0 110.548 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -73.18 -35.19 66.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.283 0.563 . . . . 0.0 111.05 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 tt -80.43 -3.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.769 . . . . 0.0 110.742 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 64.7 tttt -81.69 134.32 35.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.472 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 54' ' ' ARG . 19.3 ptmt -109.91 158.46 18.18 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.339 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.3 mt -79.6 110.71 15.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 168.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.489 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 3.8 ppt_? -65.7 135.08 54.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 111.132 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.32 144.6 29.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.155 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 57' ' ' THR . . . -153.7 170.3 32.41 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.904 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 44.8 m 69.89 145.25 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.137 0.551 . . . . 0.0 110.775 -177.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.5 t90 -122.78 147.18 46.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.862 0.363 . . . . 0.0 110.343 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.1 mtt -86.43 139.74 30.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -75.34 166.79 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.517 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 m -105.31 19.21 20.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.133 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 50.45 82.64 0.05 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.955 0.883 . . . . 0.0 110.647 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.1 114.59 2.94 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.743 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 62.14 69.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.103 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -88.2 36.44 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.805 0.812 . . . . 0.0 110.361 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -136.88 134.26 36.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.171 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -129.42 105.29 8.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.499 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -100.8 -33.8 10.09 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.248 0.987 0 CA-C-N 114.363 -1.29 . . . . 0.0 108.709 175.603 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.757 0.313 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 75.89 4.81 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.638 2.226 . . . . 0.0 112.415 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -79.07 147.95 32.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.738 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.563 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.1 OUTLIER -74.57 126.47 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.581 ' HB ' ' HG3' ' B' ' 18' ' ' GLN . 19.6 pt -101.21 134.1 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.499 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -87.4 138.98 31.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.227 0.537 . . . . 0.0 111.079 -175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.81 152.15 51.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.308 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.608 HG13 HD11 ' B' ' 17' ' ' LEU . 3.6 m -115.33 118.24 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.714 0.769 . . . . 0.0 110.621 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.738 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 45.6 t80 -70.9 131.42 43.72 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.72 174.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.523 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 35.1 tt0 -151.75 129.76 11.81 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.469 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 30.6 t30 66.51 20.23 10.87 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.623 0.577 . . . . 0.0 111.907 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' OH ' ' B' ' 9' ' ' TYR . . . 95.26 10.49 57.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.008 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.2 t -122.85 148.51 26.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.72 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 92.8 m-85 -102.11 114.38 28.47 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 166.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' B' ' 15' ' ' LYS . 48.8 mtmt -110.49 116.55 52.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.523 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.714 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 31.9 Cg_endo -65.55 168.14 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.233 1.288 . . . . 0.0 112.317 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.608 HD11 HG13 ' B' ' 8' ' ' VAL . 5.6 mp -115.13 -5.59 12.44 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 172.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.581 ' HG3' ' HB ' ' B' ' 5' ' ' ILE . 25.0 mm-40 -94.76 -1.58 52.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.544 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 48.8 mttp 34.27 123.17 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 O-C-N 125.311 1.632 . . . . 0.0 114.244 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.677 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -125.42 139.92 49.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.338 -1.301 . . . . 0.0 112.599 -164.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -115.84 88.13 2.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.975 170.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' B' ' 20' ' ' VAL . 71.3 mt -110.81 -161.97 0.78 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 112.639 -2.073 . . . . 0.0 109.967 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -89.27 -174.69 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 35.3 mt-10 -106.3 123.56 48.23 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.378 0.609 . . . . 0.0 109.653 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.892 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 85.04 24.53 44.25 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -170.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.6 tp10 -63.55 132.9 52.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.029 0.531 . . . . 0.0 110.831 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -83.25 113.22 20.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.847 0.832 . . . . 0.0 111.733 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.519 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.8 m -138.41 161.5 30.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.969 -177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.409 ' HE2' ' HG2' ' A' ' 6' ' ' GLU . 33.0 mmtp -115.66 144.51 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.178 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.576 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -118.34 126.22 74.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.355 0.598 . . . . 0.0 110.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -134.08 124.65 26.52 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.638 175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.955 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.9 mp -72.47 113.77 9.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -158.68 162.3 37.19 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.451 -159.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 61.7 mt -98.08 -150.39 0.35 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.573 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -113.02 155.85 24.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.053 0.454 . . . . 0.0 110.991 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -120.51 163.93 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.239 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.15 156.36 35.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 122.616 0.367 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -89.03 -179.32 2.07 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.291 2.661 . . . . 0.0 113.212 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 24.5 pt -120.21 169.42 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.844 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -125.89 -173.59 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.603 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.5 pt? -125.33 172.44 9.59 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.42 -150.05 6.08 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.035 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.777 ' HB2' ' HD2' ' B' ' 44' ' ' PRO . 8.3 pt-20 -98.27 175.07 2.7 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.777 ' HD2' ' HB2' ' B' ' 43' ' ' GLU . 37.7 Cg_endo -67.18 -162.58 0.07 OUTLIER 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.266 1.977 . . . . 0.0 111.9 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.41 151.48 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -91.82 173.01 8.08 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.89 140.04 24.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.477 ' CD ' ' HG2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -126.61 -169.4 2.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.981 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.2 -27.51 63.56 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.437 ' H ' HD12 ' B' ' 50' ' ' ILE . 3.6 mp -93.54 -15.5 7.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.214 0.531 . . . . 0.0 110.321 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.582 ' O ' ' HD2' ' B' ' 52' ' ' LYS . 47.0 mmtm -88.33 132.47 34.4 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.105 176.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.582 ' HD2' ' O ' ' B' ' 51' ' ' LYS . 12.7 mptt -130.38 135.12 47.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.897 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 53' ' ' ILE . 4.2 mp -93.99 -39.38 10.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.09 0.472 . . . . 0.0 110.134 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -79.41 133.6 36.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -104.17 169.66 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.02 172.61 45.23 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 10.6 t -156.99 165.01 37.37 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -91.95 133.87 35.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.3 ttt -132.82 137.92 46.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.5 m 67.52 121.01 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.384 1.053 . . . . 0.0 112.386 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -103.44 0.54 31.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.634 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp 52.45 79.74 0.11 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.795 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.0 136.36 48.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.31 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -89.16 72.53 8.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.538 0.685 . . . . 0.0 110.672 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.16 128.04 34.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.723 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -93.14 138.46 31.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.061 -171.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -77.56 -156.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.606 174.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -145.47 89.05 1.89 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.635 176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.508 177.401 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpp? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.25 106.39 2.26 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.547 2.165 . . . . 0.0 111.243 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -84.01 144.96 28.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.042 0.449 . . . . 0.0 110.281 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.669 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -91.87 143.48 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.1 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 18' ' ' GLN . 24.8 mm -100.93 156.12 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.583 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 28.3 mt-10 -116.0 145.82 42.65 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -147.55 166.27 27.83 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.101 0.477 . . . . 0.0 110.891 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.04 122.6 65.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.935 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 90.2 t80 -78.33 99.46 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.394 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 32.9 mt-10 -120.55 135.79 54.98 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.968 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.5 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 42.3 m-80 63.25 21.69 12.96 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.587 0.555 . . . . 0.0 111.496 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 86.9 11.48 70.29 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.131 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 16.1 t -125.14 148.67 29.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 110.456 -0.201 . . . . 0.0 110.456 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 83.6 m-85 -96.36 114.87 26.58 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.194 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 29.9 mtmt -112.5 114.07 50.43 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.74 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 24.3 Cg_endo -63.15 168.77 10.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 121.449 1.433 . . . . 0.0 112.981 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.8 mt -108.33 -20.62 13.07 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' HB2' HG23 ' A' ' 5' ' ' ILE . 42.8 mt-30 -99.6 143.34 29.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.965 -1.471 . . . . 0.0 109.554 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -84.81 124.38 31.51 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.265 0.555 . . . . 0.0 109.674 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.3 t -132.47 134.87 58.57 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.72 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.36 88.63 4.47 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.365 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.441 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.8 mt -113.05 171.56 7.47 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 112.508 -2.133 . . . . 0.0 110.093 174.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -107.39 158.85 16.84 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.473 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 8.1 mp0 -67.24 114.84 6.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 121.374 0.606 . . . . 0.0 110.199 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.8 14.88 25.92 Favored Glycine 0 C--N 1.31 -0.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.058 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 3.9 mm-40 -74.11 133.96 42.86 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -100.82 121.88 42.45 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 123.968 1.842 . . . . 0.0 113.417 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD23 ' B' ' 32' ' ' LEU . 34.7 m -132.93 160.28 42.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 111.828 -2.442 . . . . 0.0 110.156 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' B' ' 5' ' ' ILE . 65.6 mttm -117.26 140.78 49.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.235 0.54 . . . . 0.0 110.452 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' HB3' ' B' ' 7' ' ' ALA . 1.3 mm -116.57 149.44 18.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.781 -175.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -156.94 164.56 37.89 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 164.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD21 HD13 ' B' ' 22' ' ' LEU . 9.2 mt -87.55 114.56 24.27 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HG2' ' HD2' ' B' ' 29' ' ' LYS . 3.7 tp10 -69.75 141.86 53.35 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.845 0.831 . . . . 0.0 111.457 -164.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.08 163.25 22.17 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.921 -168.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -103.66 162.13 13.33 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.108 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.2 138.96 19.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 mt-10 -66.75 120.94 75.09 Favored Pre-proline 0 N--CA 1.444 -0.725 0 CA-C-O 120.721 0.296 . . . . 0.0 110.45 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 21.1 Cg_exo -66.35 -175.16 0.5 Allowed 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.383 2.722 . . . . 0.0 112.933 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 42.2 pt -70.27 165.64 2.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.77 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.42 104.53 10.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.587 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' H ' ' HG ' ' A' ' 41' ' ' LEU . 2.8 pp -84.1 176.39 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.402 -174.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.95 -125.21 1.91 Allowed Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.787 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -112.27 127.93 26.19 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 120.543 0.211 . . . . 0.0 111.142 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.12 173.35 14.05 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.539 2.159 . . . . 0.0 111.433 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' SER . 14.4 p -131.21 166.58 28.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.217 0.532 . . . . 0.0 110.768 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' VAL . 17.6 m -88.3 170.06 11.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.66 3.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.304 0.574 . . . . 0.0 111.528 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -79.59 104.03 9.91 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.464 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -87.28 -30.26 21.01 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.687 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.5 tt -69.75 -7.25 7.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.621 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -87.35 133.64 33.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.831 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -101.36 141.23 34.55 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.294 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.5 mp -79.23 -45.81 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -147.38 160.43 42.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.412 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -81.04 156.16 25.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.21 -50.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 119.714 -1.231 . . . . 0.0 113.628 -175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -75.84 138.87 41.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.052 0.453 . . . . 0.0 111.265 -173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -114.69 134.19 55.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.415 176.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 97.2 mmm -84.98 161.26 19.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.735 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 m 61.45 25.26 15.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.229 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.2 m -79.38 -0.39 32.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.958 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -85.38 123.34 30.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.916 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.37 113.54 27.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -100.34 -46.87 5.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.285 0.564 . . . . 0.0 110.162 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -99.08 93.51 6.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.585 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -169.93 131.05 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.53 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.8 147.24 52.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.045 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -99.59 148.35 24.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.726 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.6 p80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.869 -0.586 . . . . 0.0 110.245 175.384 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.457 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 7.2 Cg_exo -73.5 86.57 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.789 2.326 . . . . 0.0 111.832 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -92.37 175.02 6.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.007 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.539 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -67.29 139.93 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -174.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 15.0 mt -109.2 154.31 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 164.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mp0 -109.21 135.99 49.41 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.515 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.96 164.24 30.61 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.494 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.707 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -126.49 124.93 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-O 121.472 0.653 . . . . 0.0 111.369 176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.647 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 20.2 t80 -62.15 112.42 2.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.86 172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -131.35 128.83 40.48 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 120.943 0.401 . . . . 0.0 110.712 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 51.22 34.32 11.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.794 176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.04 -69.33 0.26 Allowed Glycine 0 N--CA 1.432 -1.587 0 C-N-CA 117.653 -2.213 . . . . 0.0 111.634 -169.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 32.9 m -93.37 154.33 3.26 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 114.116 -1.042 . . . . 0.0 111.997 -158.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.787 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -88.23 115.85 26.01 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.09 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -105.67 120.9 47.76 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.583 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 11.3 Cg_endo -58.6 168.71 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.453 1.435 . . . . 0.0 112.391 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.707 HD11 HG13 ' B' ' 8' ' ' VAL . 7.0 mp -102.27 -11.25 18.86 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' B' ' 16' ' ' PRO . 13.3 pm0 -133.17 143.52 49.26 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.496 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -61.42 149.25 39.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.503 0.668 . . . . 0.0 112.138 -173.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.451 HG12 ' H ' ' B' ' 22' ' ' LEU . 11.3 t -123.76 150.39 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.353 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.02 25.14 3.93 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.079 0.942 . . . . 0.0 109.878 -171.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.658 HD13 HD21 ' A' ' 32' ' ' LEU . 97.9 mt -78.59 -166.23 0.84 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.874 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.694 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 10.1 mtmp? -97.1 162.32 13.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.5 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.4 mp0 -74.55 136.54 42.11 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 121.337 0.589 . . . . 0.0 109.416 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.6 65.4 3.2 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.416 -165.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.694 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 1.7 mm-40 -96.34 148.8 22.39 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.618 -0.791 . . . . 0.0 109.551 170.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' B' ' 27' ' ' ARG . 2.1 tpt180 -98.02 105.66 17.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.652 1.215 . . . . 0.0 112.167 -169.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.479 HG21 ' CD1' ' A' ' 14' ' ' PHE . 34.0 m -124.68 156.87 33.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 113.045 -1.888 . . . . 0.0 111.408 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.583 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 45.0 mttp -120.79 143.46 48.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.201 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.476 HG23 HD13 ' A' ' 30' ' ' ILE . 17.1 mt -130.02 147.55 33.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.884 -172.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.663 ' HG3' ' HG3' ' B' ' 33' ' ' GLU . 10.2 ptpt -156.88 165.13 37.06 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.705 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.877 HD23 HG12 ' A' ' 28' ' ' VAL . 24.2 mt -89.97 115.11 27.02 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -177.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.663 ' HG3' ' HG3' ' B' ' 31' ' ' LYS . 23.7 mt-10 -125.8 149.25 48.75 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.38 1.086 . . . . 0.0 113.911 -168.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -149.36 -169.85 3.48 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 113.116 -1.856 . . . . 0.0 108.417 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.414 ' HG3' ' N ' ' B' ' 36' ' ' VAL . 49.4 tptt -123.77 163.55 20.94 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.414 ' N ' ' HG3' ' B' ' 35' ' ' LYS . 8.6 t -86.33 132.27 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HB2' ' HD3' ' B' ' 38' ' ' PRO . 45.3 mt-10 -81.21 -57.18 0.57 Allowed Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' B' ' 37' ' ' GLU . 37.9 Cg_endo -65.12 174.6 4.71 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 122.035 1.823 . . . . 0.0 113.184 -173.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.1 pp -101.97 172.95 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.373 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.66 129.61 39.05 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.245 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 49.3 tp 68.37 112.44 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.749 0.656 . . . . 0.0 112.04 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -175.91 114.53 0.49 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.813 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 10.9 mp0 -108.84 130.0 23.25 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 6.0 Cg_exo -78.78 114.38 3.43 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.704 2.269 . . . . 0.0 111.508 175.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -73.9 156.6 6.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.185 0.517 . . . . 0.0 110.461 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.6 p -83.2 160.35 21.81 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.802 -176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.0 p -150.85 142.35 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.202 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.0 105.19 4.81 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.08 0.943 . . . . 0.0 110.879 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -88.78 -27.73 20.94 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.147 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tp -76.79 -15.51 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.525 -172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -151.2 137.99 18.92 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.408 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 tptt -151.6 158.62 43.75 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 4.1 tp -69.87 133.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' B' ' 54' ' ' ARG . 42.0 ttp180 -107.07 133.72 51.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.05 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -149.6 163.44 37.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -1.35 49.5 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.395 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.11 140.17 45.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.846 0.355 . . . . 0.0 111.342 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -124.44 139.99 53.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.584 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.6 140.19 31.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.681 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -73.73 152.03 40.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.063 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 11.5 m -93.51 -5.79 48.27 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.075 -177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' B' ' 61' ' ' SER . 2.9 pp 46.63 111.02 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.032 1.333 . . . . 0.0 114.539 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -119.86 111.74 18.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.347 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -135.4 110.33 8.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.346 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.33 151.3 48.94 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -75.85 99.64 4.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.735 0.779 . . . . 0.0 110.484 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -84.54 82.17 8.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.613 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -138.54 112.37 8.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.096 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.318 -0.793 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.637 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.27 111.89 2.84 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.414 2.076 . . . . 0.0 111.114 176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -71.28 144.05 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.022 0.439 . . . . 0.0 111.298 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' B' ' 31' ' ' LYS . 0.2 OUTLIER -130.83 146.17 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.754 -175.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' CD1' HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -126.56 169.68 17.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 164.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HB2' HD12 ' A' ' 17' ' ' LEU . 37.0 mt-10 -103.85 158.45 16.39 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 169.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.453 ' HB2' HD11 ' B' ' 30' ' ' ILE . . . -150.68 154.4 37.38 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 31.1 m -110.08 116.43 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.841 0.829 . . . . 0.0 110.329 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 57.1 t80 -79.98 102.91 9.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.644 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.55 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.4 pt-20 -118.48 136.95 53.51 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.158 177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 3.3 t-20 65.44 9.25 5.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.133 0.492 . . . . 0.0 111.836 173.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.537 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 96.5 12.51 50.83 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.905 -176.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 10' ' ' GLU . 2.4 m -124.52 142.67 40.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.371 177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 93.5 m-85 -90.79 116.41 28.62 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.652 174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.18 111.82 61.65 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 41.9 Cg_exo -46.18 169.79 0.04 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.633 0 C-N-CA 123.045 2.496 . . . . 0.0 115.357 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.923 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 63.3 mt -107.02 113.79 27.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 166.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.923 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 1.1 pp0? 77.11 143.21 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 127.99 2.516 . . . . 0.0 111.862 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -60.64 127.83 33.62 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.172 -172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 5' ' ' ILE . 14.7 p -127.26 146.97 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.652 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -102.91 86.59 2.75 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.321 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.526 ' HB2' ' CE2' ' B' ' 9' ' ' TYR . 67.3 mt -103.45 -176.56 3.12 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 112.113 -2.312 . . . . 0.0 110.51 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.47 148.83 26.01 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.41 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 12.4 pt-20 -82.74 121.56 27.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.579 0.704 . . . . 0.0 110.034 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.16 14.97 31.87 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.823 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.84 116.69 17.74 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.37 119.58 27.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 122.095 0.95 . . . . 0.0 110.415 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -124.2 161.15 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 114.055 -1.43 . . . . 0.0 111.228 -168.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HG3' ' CD ' ' B' ' 33' ' ' GLU . 13.7 mmmm -118.56 134.97 54.68 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.957 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.742 HG12 HG23 ' B' ' 30' ' ' ILE . 9.8 mt -133.44 148.67 30.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.694 -170.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -139.66 165.51 27.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.638 172.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.2 mt -94.99 146.71 24.07 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 123.445 0.466 . . . . 0.0 111.464 -166.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.17 145.9 55.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.0 mt -71.37 154.57 41.47 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.101 0.953 . . . . 0.0 113.073 -168.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 mptt -129.19 175.14 8.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.638 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.63 142.85 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.035 0.445 . . . . 0.0 110.264 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -91.03 130.06 41.69 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.588 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 174.06 12.35 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.302 2.001 . . . . 0.0 112.083 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.7 mt -89.31 150.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.836 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.59 135.56 53.22 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.13 176.11 9.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.009 0.433 . . . . 0.0 111.253 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.29 155.26 16.45 Favored Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -67.23 140.79 95.69 Favored Pre-proline 0 C--N 1.304 -1.382 0 CA-C-N 114.825 -0.688 . . . . 0.0 111.44 -175.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 27.8 Cg_exo -63.17 119.73 6.92 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.476 2.117 . . . . 0.0 111.363 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 p -76.45 148.03 7.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.512 0.672 . . . . 0.0 111.32 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 67.2 m -92.98 -171.84 2.81 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.176 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 46' ' ' SER . 25.0 t 68.37 139.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 111.67 -177.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -93.6 113.51 25.63 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.7 -176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.45 -26.28 26.42 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.517 0.675 . . . . 0.0 109.47 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mt -80.33 -15.21 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' NZ ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.25 132.51 45.58 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.57 ' HG2' HG13 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -105.63 -150.24 0.43 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.401 -173.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.57 HG13 ' HG2' ' A' ' 52' ' ' LYS . 89.7 mt 76.2 98.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.358 0.663 . . . . 0.0 111.089 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -122.96 123.7 41.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.336 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.53 173.4 8.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.75 38.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.675 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.5 t -66.52 148.69 51.53 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.953 0.406 . . . . 0.0 110.689 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -147.34 144.24 28.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.908 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 24.9 ttt -109.49 124.65 51.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 t -84.14 136.53 33.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.834 0.349 . . . . 0.0 110.914 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.2 m -105.8 18.32 22.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.53 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.62 90.92 3.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.54 115.89 28.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.603 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.45 134.17 55.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.603 -174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -121.57 157.74 30.08 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.646 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -160.78 90.05 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.453 171.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.8 131.51 35.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.563 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -101.49 -29.5 11.95 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.828 171.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 121.161 0.505 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -90.77 111.48 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.912 2.408 . . . . 0.0 112.372 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -129.9 152.77 49.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.086 0.47 . . . . 0.0 111.427 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.746 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -115.97 144.24 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.561 174.113 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.27 148.59 9.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.556 ' HB2' HD13 ' B' ' 17' ' ' LEU . 2.4 mp0 -121.81 145.78 47.72 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -153.47 165.17 36.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.61 0.243 . . . . 0.0 111.191 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 m -117.22 122.62 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.777 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 69.9 t80 -84.27 102.92 13.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.196 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.42 125.6 50.29 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.741 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 63.34 21.26 12.71 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.012 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.692 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 101.49 4.93 52.48 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 119.857 -1.163 . . . . 0.0 112.115 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.777 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.6 t -119.69 142.64 34.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.081 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.977 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.8 m-85 -98.23 115.59 28.67 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 168.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -102.17 113.2 65.95 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 38.6 Cg_exo -56.86 169.72 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.63 1.553 . . . . 0.0 113.041 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 6' ' ' GLU . 7.8 mp -83.53 -74.69 0.36 Allowed 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.782 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -84.69 151.82 24.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.894 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -67.95 137.97 55.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.539 . . . . 0.0 111.507 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.513 HG12 ' HG ' ' B' ' 22' ' ' LEU . 2.5 t -122.1 135.07 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.178 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.597 177.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -110.65 87.81 2.62 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 123.163 1.458 . . . . 0.0 109.012 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.516 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 92.0 mt -111.7 -172.84 2.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.044 -2.344 . . . . 0.0 110.096 173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.738 ' HB2' ' HG2' ' B' ' 26' ' ' GLU . 92.3 mttt -82.19 159.86 23.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 2.7 mp0 -72.97 126.31 29.66 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.57 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 60.46 65.59 3.25 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.565 -165.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.738 ' HG2' ' HB2' ' B' ' 23' ' ' LYS . 0.7 OUTLIER -96.23 149.97 21.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.478 -0.861 . . . . 0.0 108.97 165.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -104.42 131.35 51.88 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.451 0.644 . . . . 0.0 111.198 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.446 HG21 ' CE1' ' A' ' 14' ' ' PHE . 34.2 m -142.15 164.79 17.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.252 -172.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -119.59 134.47 55.21 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.31 0.576 . . . . 0.0 109.717 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.742 HG23 HG12 ' A' ' 30' ' ' ILE . 3.8 mt -118.39 147.9 21.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.581 -172.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 4' ' ' ILE . 3.0 ptpp? -155.6 166.19 34.28 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.441 0.638 . . . . 0.0 110.648 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.437 ' N ' HD22 ' B' ' 32' ' ' LEU . 3.2 mm? -101.9 128.73 48.16 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.284 173.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.461 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 68.9 mt-10 -89.18 147.99 23.88 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 97.6 mt -109.06 -172.24 2.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.741 0.781 . . . . 0.0 112.311 -169.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' B' ' 35' ' ' LYS . 24.4 mtmt -85.36 155.85 21.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.338 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.3 135.7 33.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 164.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 5.5 pt-20 -77.7 143.75 67.92 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.285 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 11.6 Cg_exo -71.73 -156.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.818 3.012 . . . . 0.0 114.191 -170.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.34 178.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.628 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -92.06 129.67 37.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.502 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 40.4 tp -109.9 144.65 38.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.083 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.6 -145.27 11.35 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.028 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 7.2 pt-20 -124.02 122.24 26.24 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 120.784 0.326 . . . . 0.0 110.692 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 38.9 Cg_exo -61.83 128.38 24.22 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.571 2.181 . . . . 0.0 111.816 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.06 150.77 4.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.816 0.817 . . . . 0.0 111.444 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -106.12 -176.52 3.1 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.219 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.81 141.76 17.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.552 ' HB2' HG22 ' B' ' 50' ' ' ILE . 1.6 pm0 -66.76 129.76 40.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.446 0.641 . . . . 0.0 111.628 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.64 -25.08 44.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.423 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.552 HG22 ' HB2' ' B' ' 48' ' ' GLU . 13.7 tt -69.94 -1.19 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.951 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.486 ' HB2' ' HG2' ' B' ' 48' ' ' GLU . 14.0 tptm -59.15 134.01 56.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.916 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -128.71 138.8 52.33 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.044 -170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.2 pp -114.45 162.9 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.107 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -149.83 148.69 29.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.016 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -158.31 -163.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.14 124.39 1.0 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.088 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.75 127.04 43.42 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -82.11 154.72 25.41 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.033 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -144.6 154.75 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.241 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -79.74 133.61 36.34 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 56.4 p -82.85 14.2 3.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.575 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 96.0 mt -62.9 103.08 0.41 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -101.89 155.46 18.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.932 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -84.76 100.26 11.4 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -125.93 135.12 51.51 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.978 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -129.8 153.4 48.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.296 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -147.52 130.39 16.17 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -133.66 140.08 46.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.558 -176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.568 175.793 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 2.0 mpt? . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.68 ' HA ' HD13 ' B' ' 32' ' ' LEU . 14.7 Cg_endo -58.47 99.55 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.406 2.071 . . . . 0.0 112.295 177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -157.27 154.67 29.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.483 -0.781 . . . . 0.0 108.926 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.5 mp -64.49 135.79 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.715 0.769 . . . . 0.0 110.744 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.578 ' HB ' HD12 ' B' ' 30' ' ' ILE . 11.7 mt -131.2 150.84 34.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 175.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -100.99 126.44 47.66 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.82 166.53 18.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.522 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 m -123.26 114.27 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 121.465 0.65 . . . . 0.0 110.131 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 68.3 t80 -67.06 119.44 12.01 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.709 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 22.7 tt0 -148.2 142.57 26.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.395 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.45 18.03 10.76 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 0.0 111.458 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.506 ' HA2' ' OH ' ' A' ' 9' ' ' TYR . . . 83.43 18.99 63.06 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.819 -176.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.744 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 11.6 t -129.09 154.66 40.36 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.054 0 C-N-CA 122.858 0.463 . . . . 0.0 110.048 -177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.2 m-85 -97.84 115.11 27.42 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.309 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 41.6 mtmt -109.74 113.08 57.99 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.667 -0.206 . . . . 0.0 110.478 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 31.4 Cg_exo -56.87 166.28 4.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.171 1.248 . . . . 0.0 113.593 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.21 -68.5 0.79 Allowed 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 112.069 -2.332 . . . . 0.0 105.405 165.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HB2' HG23 ' A' ' 5' ' ' ILE . 57.9 mt-30 -60.04 144.89 48.31 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.467 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -68.74 149.62 48.83 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.143 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' LEU . 3.4 p -123.6 155.83 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 122.162 0.982 . . . . 0.0 111.397 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -120.83 12.63 11.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.834 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.711 HD13 HD21 ' B' ' 32' ' ' LEU . 97.0 mt -90.57 -174.83 4.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.27 . . . . 0.0 112.368 -172.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -92.93 -172.96 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.25 -169.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.678 ' HB3' ' H ' ' B' ' 11' ' ' ASN . 0.0 OUTLIER -93.15 -169.89 2.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 164.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . -21.95 71.66 0.0 OUTLIER Glycine 0 C--N 1.342 0.897 0 CA-C-O 122.847 1.248 . . . . 0.0 114.686 -152.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 44.3 tt0 -96.65 139.78 32.22 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 111.956 -2.122 . . . . 0.0 108.105 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -93.69 128.44 39.88 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.755 0.788 . . . . 0.0 112.354 -166.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.673 HG12 ' HA ' ' B' ' 32' ' ' LEU . 16.5 m -145.74 171.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.72 -173.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' B' ' 6' ' ' GLU . 58.7 mttm -128.45 138.84 52.5 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.822 HG22 ' HB ' ' B' ' 28' ' ' VAL . 0.1 OUTLIER -119.14 134.32 63.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.0 -171.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.623 ' HG2' HG22 ' B' ' 4' ' ' ILE . 51.9 mttp -110.24 148.92 30.92 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.029 0.442 . . . . 0.0 110.075 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 ' HB2' ' HD2' ' B' ' 2' ' ' PRO . 3.5 mm? -102.6 146.54 28.01 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.843 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -88.96 154.74 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.694 HD21 ' HG3' ' B' ' 2' ' ' PRO . 34.5 mt -125.85 -174.17 3.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.894 0.854 . . . . 0.0 113.08 -171.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 36' ' ' VAL . 69.3 tttt -128.33 -137.4 0.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.089 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.416 ' H ' ' HG2' ' A' ' 35' ' ' LYS . 40.3 t -102.05 148.17 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.2 pt-20 -63.76 148.01 95.12 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 122.189 0.196 . . . . 0.0 110.877 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 23.2 Cg_exo -65.53 -169.46 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.197 2.598 . . . . 0.0 113.741 -174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.9 mt -96.51 154.29 3.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.09 -153.7 0.48 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.5 tp -69.47 147.67 50.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.91 -113.62 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.868 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.2 pm0 -63.99 141.64 98.07 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.286 -0.457 . . . . 0.0 111.196 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 14.8 Cg_exo -68.32 157.11 63.22 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.824 2.349 . . . . 0.0 112.592 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.05 149.0 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.786 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.7 m -117.51 -170.94 1.95 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.862 -175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.32 147.1 10.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.02 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -77.94 169.8 17.67 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 111.785 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -71.27 -25.18 62.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -170.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 tt -68.8 -13.37 17.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -82.19 132.45 35.24 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.737 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -147.78 156.5 42.8 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.8 mt -80.12 154.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -71.65 110.47 6.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.007 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -98.95 158.5 15.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.51 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.95 113.37 0.47 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.448 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.8 t -136.8 174.86 10.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -117.43 148.61 41.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.059 0.457 . . . . 0.0 110.879 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.5 ttm -114.75 128.26 56.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.475 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.0 m 62.05 109.34 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 124.196 0.935 . . . . 0.0 112.086 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.844 ' HB2' ' HG3' ' A' ' 63' ' ' GLU . 1.7 m -88.28 18.67 4.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.133 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.8 mt 58.41 30.43 19.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.53 -175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.844 ' HG3' ' HB2' ' A' ' 61' ' ' SER . 34.6 mt-10 -76.14 107.68 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.111 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -111.09 93.7 4.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.392 0.615 . . . . 0.0 109.66 173.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -95.8 104.92 16.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.477 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -86.15 134.64 33.79 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.011 -173.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -98.97 133.46 43.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.37 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -89.87 108.32 19.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.033 0.444 . . . . 0.0 111.104 -175.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--O 1.242 0.7 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.156 177.454 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.431 ' HG2' ' HD3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.694 ' HG3' HD21 ' A' ' 34' ' ' LEU . 26.9 Cg_endo -89.19 -69.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.519 2.146 . . . . 0.0 112.149 174.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -123.25 161.81 23.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.641 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.623 HG22 ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -115.22 136.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.039 0.447 . . . . 0.0 110.364 175.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.831 HD11 HD12 ' B' ' 22' ' ' LEU . 25.1 mt -98.72 160.17 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.546 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 40.6 mt-10 -125.61 136.94 53.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -151.07 168.37 24.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.089 0.471 . . . . 0.0 111.845 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.665 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.5 m -128.19 137.15 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.142 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.574 ' H ' ' HD1' ' B' ' 9' ' ' TYR . 2.8 m-85 -58.05 156.73 8.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.084 0.945 . . . . 0.0 112.075 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' B' ' 13' ' ' VAL . 16.2 tp10 -144.29 98.05 3.14 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.678 ' H ' ' HB3' ' A' ' 24' ' ' GLU . 1.9 t30 56.14 30.99 17.41 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.023 -1.444 . . . . 0.0 110.115 -176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.65 -69.56 0.51 Allowed Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 118.279 -1.915 . . . . 0.0 111.708 -163.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 13' ' ' VAL . 28.3 m -92.78 141.7 14.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.888 -1.156 . . . . 0.0 111.848 -155.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 1.081 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -88.53 125.39 34.75 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -165.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.39 112.59 65.44 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.9 Cg_endo -76.23 169.75 21.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 CA-C-O 122.016 0.757 . . . . 0.0 113.428 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.415 ' N ' HD12 ' B' ' 17' ' ' LEU . 4.5 mp -89.15 -23.61 22.41 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 166.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' B' ' 19' ' ' LYS 0.283 4.2 tt0 43.05 -119.8 0.57 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.343 166.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.682 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 47.1 tttp 69.01 -128.05 0.1 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -143.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' B' ' 19' ' ' LYS . 50.9 t 68.82 171.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 119.613 1.097 . . . . 0.0 109.946 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . 0.43 ' N ' HG12 ' B' ' 20' ' ' VAL . 30.0 t70 -122.96 17.05 10.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 122.226 1.012 . . . . 0.0 111.227 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.831 HD12 HD11 ' B' ' 5' ' ' ILE . 93.6 mt -83.53 169.55 15.33 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.607 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' B' ' 21' ' ' ASP . 18.9 mttt -136.35 -179.73 5.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -164.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -77.3 145.17 37.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.348 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 57.9 65.25 3.67 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -164.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -120.13 139.82 52.02 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.497 -0.852 . . . . 0.0 111.05 173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' B' ' 27' ' ' ARG . 0.3 OUTLIER -88.95 125.89 35.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.862 -174.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.822 ' HB ' HG22 ' A' ' 30' ' ' ILE . 34.3 m -136.99 148.15 26.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.825 -172.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -117.35 138.25 51.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.018 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 3.9 mt -117.26 148.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.289 0.566 . . . . 0.0 111.376 -169.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.435 ' HB2' ' HE2' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -137.25 161.76 35.33 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 167.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 22' ' ' LEU . 6.6 mp -115.05 137.16 52.33 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.739 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -94.94 142.73 27.14 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 25.6 mt -130.08 162.25 29.2 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.159 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -85.91 159.89 19.55 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.178 176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.6 150.39 7.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.132 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -66.08 110.84 5.22 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.09 173.03 15.17 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.544 2.163 . . . . 0.0 113.439 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 39' ' ' ILE . 0.2 OUTLIER -76.64 173.89 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.953 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -88.68 137.03 32.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.302 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 55.4 tp -111.41 143.7 41.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.329 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.54 115.3 3.48 Favored Glycine 0 N--CA 1.44 -1.073 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 0.7 OUTLIER -71.75 125.52 91.65 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 115.319 -0.44 . . . . 0.0 110.92 -178.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.8 172.57 16.02 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.709 2.273 . . . . 0.0 112.356 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.81 152.16 25.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -125.11 168.5 13.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.91 127.34 51.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -102.6 102.78 13.04 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -86.67 -25.98 24.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.136 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt -84.49 0.05 5.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.316 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -79.33 131.81 36.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.598 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 3.0 mptm? -135.84 155.4 50.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.85 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.78 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' B' ' 54' ' ' ARG . 10.1 ptm180 -92.12 155.43 18.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.618 -177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.24 155.13 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.954 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.12 143.64 15.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.666 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -125.13 168.34 13.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.886 0.343 . . . . 0.0 110.602 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -128.98 141.55 51.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.167 -177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 49.7 ttm -123.45 124.75 43.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -79.66 140.26 37.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.773 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 7.3 t -101.89 20.55 16.23 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.34 0.59 . . . . 0.0 109.689 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp 66.33 -169.16 0.2 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.644 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 169.4 18.77 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -176.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -75.13 147.17 40.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.101 0.477 . . . . 0.0 111.17 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -141.62 156.31 45.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.845 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -132.95 100.71 4.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.004 0.43 . . . . 0.0 111.465 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -106.92 100.12 9.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -51.39 -47.62 62.83 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.145 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.97 177.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 28.0 ttt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 1' ' ' MET . 79.8 Cg_exo -43.24 119.41 1.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.206 2.604 . . . . 0.0 112.887 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -80.15 162.32 24.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.447 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.769 HG13 ' HE3' ' B' ' 29' ' ' LYS . 0.3 OUTLIER -87.2 143.83 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 167.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 20' ' ' VAL . 24.0 mt -85.94 150.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 38.9 mt-10 -124.33 126.12 45.48 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.12 169.5 17.48 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.907 0.384 . . . . 0.0 111.406 -171.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.522 HG12 ' HD3' ' B' ' 27' ' ' ARG . 12.1 m -129.66 131.45 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.621 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.686 ' HB2' ' CE2' ' A' ' 14' ' ' PHE . 70.6 t80 -74.79 118.26 17.55 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 171.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 34.1 tt0 -155.44 138.47 15.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.905 1.378 . . . . 0.0 108.813 -175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 t30 65.06 25.72 12.58 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.394 0.616 . . . . 0.0 110.35 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 71.01 20.99 78.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.026 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 54.7 t -132.92 159.13 43.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 54.9 m-85 -108.18 115.03 29.37 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 169.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -112.97 125.9 29.09 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.908 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 28.0 Cg_endo -64.21 170.01 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.228 1.286 . . . . 0.0 112.112 177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -104.47 -5.44 21.6 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 17.6 pt20 -135.18 129.33 33.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.163 -1.835 . . . . 0.0 109.161 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -68.87 129.45 39.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 110.739 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.571 HG12 ' HG ' ' A' ' 22' ' ' LEU . 13.8 t -117.01 149.32 19.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.306 177.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -105.74 25.27 11.03 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.155 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HG ' HG12 ' A' ' 20' ' ' VAL . 55.4 mt -66.75 177.69 1.55 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.456 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 8.9 mtpm? -96.13 170.86 8.97 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 0.6 OUTLIER -77.01 133.86 39.0 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.779 -1.101 . . . . 0.0 109.289 175.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 76.96 16.78 80.48 Favored Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.465 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 23' ' ' LYS . 6.8 mm-40 -68.68 135.4 51.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.95 0.405 . . . . 0.0 110.585 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.41 103.68 15.73 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 122.775 1.274 . . . . 0.0 112.534 -167.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.731 ' HB ' HG22 ' B' ' 30' ' ' ILE . 29.4 m -129.16 152.41 37.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 113.109 -1.86 . . . . 0.0 110.426 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.69 ' HE2' ' HG3' ' B' ' 33' ' ' GLU . 46.6 mttm -129.67 135.26 48.29 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.682 0.753 . . . . 0.0 110.019 175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 HD13 ' B' ' 30' ' ' ILE . 9.1 mt -103.9 143.03 16.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.041 -168.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.829 ' HG3' HG22 ' B' ' 4' ' ' ILE . 10.4 mptt -137.93 157.34 46.59 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.113 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.784 HD11 HD22 ' B' ' 22' ' ' LEU . 94.1 mt -86.27 114.18 22.87 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 171.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 1.062 ' HG3' ' HB2' ' B' ' 29' ' ' LYS . 16.7 mm-40 -92.05 144.17 25.71 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -160.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -106.61 -166.16 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 113.229 -1.805 . . . . 0.0 110.301 -178.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HG2' ' N ' ' A' ' 36' ' ' VAL . 87.5 tttt -125.56 166.11 17.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' N ' ' HG2' ' A' ' 35' ' ' LYS . 2.1 p -64.48 125.41 21.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.49 0.662 . . . . 0.0 111.029 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 48.4 mt-10 -101.85 148.88 35.93 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.904 -174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -75.93 -165.88 0.33 Allowed 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.982 2.455 . . . . 0.0 111.636 175.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 39' ' ' ILE . 1.4 pp -70.79 144.58 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.229 0.538 . . . . 0.0 111.706 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -128.17 -10.09 5.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.343 0.592 . . . . 0.0 110.201 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.68 -176.19 3.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.557 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.35 130.7 3.33 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.9 mt-10 -79.1 136.07 57.82 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.7 0.286 . . . . 0.0 111.303 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 17.0 Cg_exo -67.73 166.03 25.66 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.397 2.731 . . . . 0.0 113.128 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.15 158.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.009 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.6 m -85.16 167.87 15.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.719 0.295 . . . . 0.0 111.102 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.2 p -68.57 134.14 30.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.252 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.04 -35.58 18.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.997 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.12 -25.59 67.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.442 -170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -75.89 -9.33 12.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.725 -173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.2 ttpp -88.86 -5.68 57.85 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.622 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? 65.2 157.83 0.1 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.85 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.446 HG12 ' N ' ' A' ' 54' ' ' ARG . 11.4 tt -67.5 165.29 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 122.908 0.483 . . . . 0.0 110.905 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' N ' HG12 ' A' ' 53' ' ' ILE . 57.3 mtt180 -72.19 -67.74 0.52 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.152 0.501 . . . . 0.0 110.936 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.47 176.83 8.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.224 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.34 35.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.461 -174.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.0 t -99.51 -166.67 1.37 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -71.04 161.08 31.74 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 121.154 0.502 . . . . 0.0 111.248 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 45.4 tpp -131.78 129.46 40.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.714 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.0 t -93.36 144.3 25.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.129 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.2 p -85.71 3.58 40.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt 63.74 106.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.786 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.33 103.25 1.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.278 0.561 . . . . 0.0 110.393 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -82.5 140.23 33.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -64.34 107.31 1.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.719 0.295 . . . . 0.0 110.294 -174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -61.55 139.27 58.28 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -149.59 145.64 26.9 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.606 -175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -99.16 15.17 26.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.197 0.522 . . . . 0.0 110.741 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.243 0.757 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.082 177.151 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.684 0.278 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 112.25 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.824 2.35 . . . . 0.0 110.923 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -70.69 152.1 44.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.381 0.61 . . . . 0.0 110.73 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.829 HG22 ' HG3' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -103.46 143.34 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.202 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.403 ' CD1' HG23 ' B' ' 20' ' ' VAL . 10.5 mt -87.81 151.07 3.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.674 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.22 118.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -134.0 165.02 25.99 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.568 0.542 . . . . 0.0 110.741 -174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.489 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 4.9 m -127.23 133.57 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.598 173.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.65 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 1.3 t80 -65.1 100.03 0.41 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.793 ' HB3' ' HD3' ' B' ' 15' ' ' LYS . 0.5 OUTLIER -120.17 119.92 34.65 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.059 -170.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 52.05 33.58 12.29 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.145 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.85 -70.7 0.44 Allowed Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 117.842 -2.123 . . . . 0.0 112.028 -169.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.53 HG23 ' HG3' ' B' ' 15' ' ' LYS . 32.0 m -100.37 171.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.33 -0.935 . . . . 0.0 112.555 -155.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.722 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 93.7 m-85 -87.76 115.0 24.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.793 ' HD3' ' HB3' ' B' ' 10' ' ' GLU . 50.5 mtpt -115.32 111.18 44.58 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.757 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.3 Cg_endo -64.24 166.67 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 121.265 1.31 . . . . 0.0 112.113 -178.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.413 HD11 HG13 ' B' ' 8' ' ' VAL . 17.6 mt -129.19 -22.7 3.09 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.444 -1.707 . . . . 0.0 108.107 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -96.54 143.82 27.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.959 169.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.52 154.06 33.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.816 0.341 . . . . 0.0 110.35 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.757 HG22 ' H ' ' B' ' 22' ' ' LEU . 4.3 p -98.75 153.74 4.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.994 0.902 . . . . 0.0 110.07 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.3 13.42 7.69 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.875 -1.511 . . . . 0.0 107.906 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.784 HD22 HD11 ' A' ' 32' ' ' LEU . 29.8 mt -106.47 -170.11 1.67 Allowed 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 113.63 -1.623 . . . . 0.0 110.08 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.492 ' HG3' ' HG2' ' B' ' 26' ' ' GLU . 63.5 pttt -120.35 160.84 22.24 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.049 0.452 . . . . 0.0 110.92 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.29 135.52 42.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.497 176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.37 19.51 32.57 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -171.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.492 ' HG2' ' HG3' ' B' ' 23' ' ' LYS . 0.1 OUTLIER -94.2 145.01 25.01 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.13 0.49 . . . . 0.0 112.222 -175.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.522 ' HD3' HG12 ' A' ' 8' ' ' VAL . 2.9 mpp_? -98.57 112.92 24.81 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 123.334 1.54 . . . . 0.0 112.787 -171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.652 HG12 HD23 ' A' ' 32' ' ' LEU . 35.5 m -131.0 162.13 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 112.711 -2.041 . . . . 0.0 111.228 -173.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 1.062 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 36.3 mtpt -132.78 152.12 51.85 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.531 0.681 . . . . 0.0 109.632 173.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.731 HG22 ' HB ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -126.94 139.86 50.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.4 -169.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.2 165.46 27.78 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.573 171.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt -94.97 122.37 37.54 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.813 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.69 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 70.4 mm-40 -72.59 144.12 47.99 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.732 -171.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.4 mt -99.89 179.84 4.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.926 0.87 . . . . 0.0 111.892 -173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -80.1 172.18 14.11 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.834 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.55 149.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 36.5 mt-10 -92.88 151.5 40.8 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.509 -178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 21.0 Cg_exo -65.41 173.75 6.03 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.659 2.239 . . . . 0.0 113.072 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 pt -96.2 172.2 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.881 -177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -85.34 134.27 34.11 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.661 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 pp -136.64 169.59 17.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.403 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.22 -146.61 15.88 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.093 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.0 OUTLIER -93.28 142.81 25.77 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-O 121.049 0.452 . . . . 0.0 111.477 -174.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 5.0 Cg_exo -77.99 130.34 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.932 2.421 . . . . 0.0 111.535 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.86 144.46 12.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.403 0.62 . . . . 0.0 111.443 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -104.92 171.07 7.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.602 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -135.61 148.31 28.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.187 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -85.22 128.05 34.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.18 -24.99 27.68 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.563 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.96 -4.8 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.289 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -71.36 132.74 45.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.104 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -151.28 103.49 3.01 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.174 175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 67.5 mt -141.33 114.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.344 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' B' ' 54' ' ' ARG . 7.2 tpt180 -91.6 -52.31 4.83 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.19 169.84 16.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.025 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.53 -104.29 0.99 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.961 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.4 t -158.09 142.9 16.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.248 0.547 . . . . 0.0 110.811 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -157.08 135.36 11.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.241 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 26.0 ptm -115.11 170.77 8.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.33 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -148.89 -174.19 4.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m -85.31 5.93 28.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.849 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 85.1 mt 61.17 -166.27 0.21 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.317 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -99.76 145.44 27.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.868 0.366 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -168.0 110.21 0.6 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.833 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -113.6 132.77 55.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' B' ' 67' ' ' HIS . 43.3 t-80 -158.31 98.53 1.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.262 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' B' ' 66' ' ' HIS . 19.4 p-80 178.38 159.14 0.52 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -130.65 -99.92 0.31 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.741 0.305 . . . . 0.0 110.302 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 6.8 p80 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 119.149 -0.453 . . . . 0.0 109.973 178.565 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.593 0.235 . . . . 0.0 110.618 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -89.76 96.82 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.759 2.306 . . . . 0.0 112.059 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -129.77 149.56 51.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 110.428 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.625 ' CG2' ' HD3' ' B' ' 31' ' ' LYS . 0.1 OUTLIER -115.01 139.83 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' O ' HG12 ' B' ' 30' ' ' ILE . 10.2 mt -100.33 156.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 41.3 mt-10 -99.19 154.75 17.9 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.926 -178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -149.67 143.98 25.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.009 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.1 t -110.86 131.86 60.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.468 0.652 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.731 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 47.4 t80 -88.6 113.08 23.8 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.374 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 39.4 mt-10 -138.07 138.29 38.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.388 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 68.25 19.71 8.98 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.692 0.62 . . . . 0.0 111.136 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.52 16.12 64.73 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.031 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 10.5 t -125.34 148.61 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 C-N-CA 122.512 0.325 . . . . 0.0 110.598 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 50.5 m-85 -95.29 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 165.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.57 108.32 59.71 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.729 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' B' ' 14' ' ' PHE . 47.2 Cg_exo -47.14 168.68 0.06 OUTLIER 'Trans proline' 0 CA--C 1.514 -0.498 0 C-N-CA 123.1 2.534 . . . . 0.0 115.707 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 90.6 mt -114.22 87.36 2.61 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 112.907 -1.951 . . . . 0.0 105.915 165.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 2.5 pp0? 81.58 149.15 0.09 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.773 2.429 . . . . 0.0 110.932 -172.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -68.31 152.29 45.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.993 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG13 HD12 ' A' ' 5' ' ' ILE . 3.0 t -114.26 135.95 52.37 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.039 176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -89.48 87.8 7.21 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 123.07 1.415 . . . . 0.0 108.154 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.4 mt -128.69 173.93 9.87 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 112.003 -2.362 . . . . 0.0 109.838 174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.732 ' HG2' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -101.2 153.43 19.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 173.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 40.5 mt-10 -61.67 129.9 43.26 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 121.806 0.812 . . . . 0.0 110.865 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.815 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 60.55 65.26 3.46 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.72 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -103.59 142.84 33.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.365 -0.918 . . . . 0.0 109.107 166.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -93.93 127.75 39.87 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 124.036 1.874 . . . . 0.0 113.981 -174.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' B' ' 14' ' ' PHE . 21.4 m -136.08 155.14 34.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-N 111.35 -2.659 . . . . 0.0 108.341 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' B' ' 33' ' ' GLU . 38.7 mtpt -118.87 146.24 45.05 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.944 0.878 . . . . 0.0 111.287 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mm -113.0 142.85 24.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.804 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -155.38 151.52 27.97 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 114.126 -1.397 . . . . 0.0 108.357 174.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.56 125.18 42.13 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.579 -170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.958 ' HG3' ' HG3' ' B' ' 29' ' ' LYS . 5.2 mm-40 -89.1 150.65 22.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.238 0.542 . . . . 0.0 112.435 -167.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -114.41 -172.01 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.053 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -92.46 171.9 8.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.094 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.12 156.21 14.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.778 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -88.14 132.49 39.51 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.758 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 3.3 Cg_exo -80.25 -170.83 1.09 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.573 2.849 . . . . 0.0 113.045 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 39' ' ' ILE . 2.2 pp -84.99 164.5 2.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.459 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -97.27 166.58 11.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.03 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.04 166.4 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.912 0.386 . . . . 0.0 111.693 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.72 -145.06 15.81 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -135.79 156.89 77.05 Favored Pre-proline 0 C--N 1.323 -0.578 0 C-N-CA 122.375 0.27 . . . . 0.0 111.147 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -75.48 -179.16 4.83 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.657 2.238 . . . . 0.0 112.773 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 t -104.03 155.97 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.832 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.8 m -101.45 -172.91 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.882 0.372 . . . . 0.0 110.947 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.4 t -110.64 127.83 67.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.297 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.697 ' H ' ' HD2' ' A' ' 51' ' ' LYS . 8.7 mp0 -97.39 171.79 8.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.859 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -85.08 -23.29 28.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.338 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.1 mm -70.18 -15.49 19.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.399 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.697 ' HD2' ' H ' ' A' ' 48' ' ' GLU . 87.5 mttt -79.67 152.7 29.81 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.155 175.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -58.97 122.93 14.91 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.762 0.791 . . . . 0.0 112.487 -167.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -129.21 142.5 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.017 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -103.64 -175.83 2.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.786 0.327 . . . . 0.0 111.601 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.18 -172.46 0.14 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.389 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.84 -146.64 4.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.247 -0.977 . . . . 0.0 113.055 -175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 14.4 t -158.68 173.42 16.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.727 0.299 . . . . 0.0 110.293 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -100.67 142.86 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.879 0.371 . . . . 0.0 110.379 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 67.0 mtm -109.66 149.33 29.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.93 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.3 m -89.51 107.5 19.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.5 m -94.13 19.76 8.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.877 -175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.4 mt 66.6 174.97 0.24 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.222 0.609 . . . . 0.0 111.503 -176.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.0 -167.51 1.71 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.676 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -119.0 108.66 15.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.849 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 62.46 95.56 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.573 0.546 . . . . 0.0 111.638 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -83.1 3.84 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.948 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -79.79 88.84 5.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.0 t60 -136.18 113.33 10.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.729 -173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.954 175.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.59 0.234 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.75 143.36 23.64 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.259 1.973 . . . . 0.0 111.366 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -97.52 146.44 25.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.024 0.44 . . . . 0.0 110.203 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.793 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -91.49 140.12 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.63 HD13 ' HB ' ' B' ' 20' ' ' VAL . 37.8 pt -101.63 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.45 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.535 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 82.9 mt-10 -113.9 157.49 22.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.923 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.84 155.95 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.635 0.255 . . . . 0.0 110.508 177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.815 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 12.0 m -114.81 126.55 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-O 121.417 0.627 . . . . 0.0 110.571 176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.755 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 66.0 t80 -92.1 109.35 20.7 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.593 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 8.4 pt-20 -130.3 135.24 47.88 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.162 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.48 14.45 9.47 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.486 0.491 . . . . 0.0 111.891 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 94.84 10.84 57.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.755 -176.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.9 t -114.0 143.97 22.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.461 -0.37 . . . . 0.0 110.362 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 44.8 m-85 -106.01 116.35 31.79 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 167.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -115.99 117.81 39.01 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.875 ' HB2' ' HA ' ' B' ' 19' ' ' LYS . 16.8 Cg_exo -58.37 170.55 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.81 1.674 . . . . 0.0 113.721 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.804 ' O ' ' HG2' ' B' ' 18' ' ' GLN . 6.3 mp -111.04 105.82 14.7 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.804 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 6.2 pt20 85.44 6.89 0.43 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 126.535 2.397 . . . . 0.0 110.171 -175.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.875 ' HA ' ' HB2' ' B' ' 16' ' ' PRO . 27.6 mtpp 53.56 -159.75 0.14 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.173 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' B' ' 5' ' ' ILE . 6.3 p -151.12 164.71 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-O 121.304 0.573 . . . . 0.0 110.408 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -99.85 12.98 35.36 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.738 1.256 . . . . 0.0 109.389 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.641 ' O ' ' HD2' ' B' ' 23' ' ' LYS . 93.6 mt -79.12 156.49 28.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.327 170.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.641 ' HD2' ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -132.57 -170.55 2.46 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.453 -170.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 6.2 mp0 -53.14 137.4 33.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.266 -172.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.93 11.1 83.13 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.737 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' B' ' 22' ' ' LEU . 10.0 tp10 -77.89 134.19 37.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 117.092 0.446 . . . . 0.0 110.068 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -117.84 119.71 35.71 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 122.835 1.303 . . . . 0.0 112.318 -171.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.15 168.62 22.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 113.129 -1.851 . . . . 0.0 109.838 -174.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.958 ' HG3' ' HG3' ' A' ' 33' ' ' GLU . 15.3 mtmm -126.45 139.88 52.91 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.586 0.708 . . . . 0.0 111.036 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -91.02 128.03 43.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.224 -170.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 4' ' ' ILE . 1.9 tppt? -121.52 124.45 44.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.614 172.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -73.69 111.88 9.26 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 14.8 mt-10 -135.72 171.83 13.89 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -160.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.465 HD23 ' H ' ' B' ' 34' ' ' LEU . 2.6 pt? -136.1 176.94 8.23 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.764 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -93.88 159.99 14.94 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 120.556 0.217 . . . . 0.0 110.473 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.84 152.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.229 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -69.18 131.96 90.27 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.272 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' B' ' 39' ' ' ILE . 63.0 Cg_endo -72.93 -154.24 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.127 2.551 . . . . 0.0 111.652 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 38' ' ' PRO . 71.2 mt 74.32 161.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.407 ' N ' HG22 ' B' ' 39' ' ' ILE . 27.2 t70 56.16 64.88 1.58 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.291 1.043 . . . . 0.0 110.457 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 80.1 mt -126.97 125.56 41.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.46 -1.246 . . . . 0.0 108.847 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.32 112.75 4.12 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.19 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 9.2 pt-20 -85.37 116.89 67.41 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 114.215 -0.993 . . . . 0.0 109.535 174.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 21.5 Cg_exo -64.36 114.78 2.83 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.655 2.236 . . . . 0.0 112.037 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -72.29 146.75 10.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.454 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -103.37 159.6 15.43 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.177 -176.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -118.41 151.86 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.691 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.53 114.15 5.95 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.767 0.794 . . . . 0.0 111.44 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -85.2 -25.73 27.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.481 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.24 -15.04 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.815 0.817 . . . . 0.0 110.956 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -74.18 133.43 42.74 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.871 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.463 ' HD2' ' H ' ' B' ' 52' ' ' LYS . 0.0 OUTLIER -124.79 156.95 36.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 120.868 0.366 . . . . 0.0 111.272 -175.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 tt -99.28 145.54 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.811 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 54' ' ' ARG . 12.8 mmt180 -72.0 137.96 47.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.261 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -128.96 -179.25 4.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.451 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.17 29.16 6.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.949 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 2.2 p -90.64 102.08 14.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.146 0.498 . . . . 0.0 111.641 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -100.22 -179.46 4.14 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.344 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.41 151.39 6.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.992 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.2 t -98.75 132.84 43.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.985 0.421 . . . . 0.0 110.095 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 19.9 m -105.7 2.36 27.97 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.57 113.5 18.8 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.767 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.1 92.25 2.77 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -86.99 71.0 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.536 0.684 . . . . 0.0 111.814 -174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 131.91 52.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.809 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -90.54 145.52 24.82 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.648 -175.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -141.99 145.19 34.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -115.6 -168.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.245 0.851 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 174.279 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.552 0.215 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' HB2' ' HD2' ' B' ' 31' ' ' LYS . 30.4 Cg_endo -65.71 108.42 1.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.269 1.979 . . . . 0.0 110.694 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -71.12 153.09 42.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.521 -174.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.74 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.1 OUTLIER -117.98 138.21 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.273 170.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 18' ' ' GLN . 9.3 mm -108.08 143.74 17.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.557 ' HG3' ' HG2' ' B' ' 29' ' ' LYS . 5.2 mp0 -97.67 121.13 39.22 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -129.81 165.72 21.39 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.056 -175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.694 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 6.0 m -117.32 115.05 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-O 121.58 0.705 . . . . 0.0 110.69 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.641 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 79.1 t80 -71.88 106.03 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.092 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.65 131.75 54.28 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.156 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.448 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 3.9 m-20 54.86 24.88 6.13 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 172.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 99.82 2.04 56.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.182 -1.008 . . . . 0.0 113.059 177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.97 143.25 41.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 117.252 0.526 . . . . 0.0 111.176 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 96.9 m-85 -94.1 115.62 27.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -105.04 115.25 62.67 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.884 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 36.1 Cg_endo -66.2 167.81 17.41 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.034 1.156 . . . . 0.0 112.352 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.2 mt -112.91 -17.42 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.561 ' HB2' HG23 ' A' ' 5' ' ' ILE . 76.5 mt-30 -92.91 171.63 8.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.058 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -75.94 132.39 40.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 162.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 22' ' ' LEU . 2.3 t -96.42 135.45 30.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-O 121.519 0.676 . . . . 0.0 110.349 -174.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -103.93 14.44 30.75 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.236 -174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD22 ' HG2' ' A' ' 26' ' ' GLU . 91.1 mt -99.27 -174.31 2.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.098 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -143.55 163.04 34.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.261 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' HG3' ' HA ' ' B' ' 10' ' ' GLU . 16.5 mp0 -56.49 141.44 42.65 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.919 0.866 . . . . 0.0 111.524 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 60.27 65.3 3.45 Favored Glycine 0 N--CA 1.435 -1.398 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.535 -169.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.538 ' HG2' HD22 ' A' ' 22' ' ' LEU . 10.9 tp10 -116.76 128.5 55.36 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 114.403 -0.898 . . . . 0.0 109.634 169.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -85.97 120.34 27.26 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.603 1.192 . . . . 0.0 111.189 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.772 ' HB ' HG22 ' B' ' 30' ' ' ILE . 31.0 m -137.02 148.74 26.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.129 -173.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -119.76 137.32 54.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.524 0.678 . . . . 0.0 110.374 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.673 HD13 HG23 ' B' ' 30' ' ' ILE . 3.6 mm -102.85 138.02 28.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.362 -176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -155.92 165.04 37.67 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.533 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 32' ' ' LEU . 2.4 mm? -97.92 127.15 43.69 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.98 ' HB3' ' HE2' ' B' ' 29' ' ' LYS . 30.0 tt0 -141.81 151.74 43.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.453 0.644 . . . . 0.0 112.516 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.9 mt -127.57 157.88 38.99 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.434 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 68.2 mttm -127.62 -173.16 2.85 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.362 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 35' ' ' LYS . 29.8 t 65.7 149.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.868 0.842 . . . . 0.0 112.726 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 154.18 37.51 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.317 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.64 173.23 14.24 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.193 1.929 . . . . 0.0 112.012 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 pt -102.55 178.05 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.341 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.16 137.35 43.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.95 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.863 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.9 pt? -89.37 -165.04 1.24 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.137 -175.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.48 141.03 12.99 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.5 pt-20 -67.09 139.86 95.54 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.04 -0.58 . . . . 0.0 111.511 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 2.3 Cg_endo -84.93 166.88 11.27 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.289 2.659 . . . . 0.0 111.951 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.47 150.71 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.169 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -95.89 -168.8 1.82 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.269 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.46 142.66 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.5 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.94 126.58 29.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.737 0.78 . . . . 0.0 111.923 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -88.27 -24.14 23.3 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.114 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mt -64.92 -12.72 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.547 -169.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.51 133.89 33.71 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.46 137.94 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.629 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.0 tt -80.9 132.93 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -87.34 132.23 34.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.892 0.377 . . . . 0.0 111.024 -172.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.44 -179.09 3.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.959 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.03 19.8 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.435 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 p -81.74 97.83 8.14 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.246 0.546 . . . . 0.0 110.793 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -103.27 142.97 33.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.661 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 21.1 ptm -104.6 136.82 43.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.555 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.6 m -75.75 96.77 3.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.188 0.518 . . . . 0.0 109.78 174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -83.58 10.45 9.06 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.311 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.02 98.12 6.35 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.523 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -116.12 112.59 21.93 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -107.25 147.49 30.13 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -102.58 157.25 17.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.898 0.38 . . . . 0.0 110.579 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -119.26 91.17 3.49 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.392 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -120.31 116.7 26.06 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.346 -176.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 71.31 125.42 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 124.127 0.892 . . . . 0.0 111.538 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 . . . . . 0 C--O 1.243 0.741 0 CA-C-O 118.091 -0.956 . . . . 0.0 109.74 174.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -94.3 161.86 2.02 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.993 2.462 . . . . 0.0 111.934 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -74.48 152.02 39.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.706 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -109.19 137.02 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-O 121.236 0.541 . . . . 0.0 109.797 173.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 30' ' ' ILE . 24.1 mm -94.83 152.18 3.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.501 ' O ' HD12 ' B' ' 17' ' ' LEU . 38.0 mt-10 -124.58 113.02 17.5 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -125.16 169.14 12.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.65 128.8 73.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.703 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 48.5 t80 -82.0 126.86 32.46 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.127 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 25.3 tt0 -152.19 128.28 10.42 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.608 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 67.35 23.16 9.31 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.708 0.63 . . . . 0.0 111.682 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' B' ' 9' ' ' TYR . . . 88.22 15.33 60.81 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.76 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 5.1 t -122.03 150.11 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 1.07 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.0 m-85 -104.56 114.46 28.7 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 165.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -109.63 113.63 57.69 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.512 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 27.5 Cg_endo -63.61 168.51 11.46 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.636 1.557 . . . . 0.0 112.577 -175.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.501 HD12 ' O ' ' B' ' 6' ' ' GLU . 1.3 mt -114.63 -2.43 13.09 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.778 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.45 ' NE2' ' H ' ' B' ' 6' ' ' GLU . 2.2 pm0 -132.39 159.81 38.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.153 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -72.97 130.53 40.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.47 HG12 ' H ' ' B' ' 22' ' ' LEU . 3.3 t -107.24 145.58 14.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.468 -173.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -108.95 14.28 24.21 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.459 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.487 HD13 ' HG2' ' B' ' 26' ' ' GLU . 85.7 mt -75.51 -175.76 2.95 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.587 177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -115.87 168.38 10.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.696 0.284 . . . . 0.0 111.234 -176.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 11' ' ' ASN . 3.5 mp0 -71.4 136.31 47.67 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.487 0.661 . . . . 0.0 110.659 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.694 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 51.48 65.56 3.08 Favored Glycine 0 N--CA 1.438 -1.228 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.074 -165.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' B' ' 23' ' ' LYS . 13.0 tp10 -90.14 134.48 34.25 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.562 -0.819 . . . . 0.0 109.382 172.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' B' ' 27' ' ' ARG . 3.5 tpt180 -83.75 104.07 13.56 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.441 1.115 . . . . 0.0 110.413 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.62 HG21 ' CD1' ' A' ' 14' ' ' PHE . 30.8 m -129.32 154.84 40.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.685 -172.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.98 ' HE2' ' HB3' ' A' ' 33' ' ' GLU . 22.1 mtmm -123.42 138.54 54.57 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.277 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.772 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -105.49 121.98 58.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.116 -172.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 2' ' ' PRO . 3.1 tppp? -105.87 124.71 50.01 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.749 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 9.7 mt -74.22 111.87 9.81 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.72 155.02 42.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.534 0.683 . . . . 0.0 112.139 -169.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 14.5 mt -143.97 161.8 37.8 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.677 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.41 165.92 11.01 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.387 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -79.27 143.07 13.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.551 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 10.2 pt-20 -60.68 125.91 83.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 5.1 Cg_exo -74.63 174.93 11.8 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.08 2.52 . . . . 0.0 112.494 -177.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.44 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -85.03 164.75 2.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.99 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -122.28 157.98 30.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -145.85 153.64 41.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.094 0.473 . . . . 0.0 111.415 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.29 115.92 0.68 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.395 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.428 ' HG3' ' HD2' ' B' ' 44' ' ' PRO . 34.8 tt0 -102.39 140.14 20.86 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.36 0.124 . . . . 0.0 110.908 -173.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' B' ' 43' ' ' GLU . 81.8 Cg_exo -46.78 146.88 5.14 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.959 3.106 . . . . 0.0 113.977 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.21 157.27 5.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.609 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 6.0 m -84.17 -176.58 6.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.3 0.572 . . . . 0.0 112.239 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.8 146.99 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.087 176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.881 ' HG2' ' HB2' ' B' ' 51' ' ' LYS . 0.4 OUTLIER -79.12 136.4 37.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.426 0.631 . . . . 0.0 111.284 -173.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -85.49 -25.56 26.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.009 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.558 ' H ' HD12 ' B' ' 50' ' ' ILE . 4.4 mp -75.85 -4.89 6.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 122.0 0.905 . . . . 0.0 109.901 -176.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.881 ' HB2' ' HG2' ' B' ' 48' ' ' GLU . 15.7 tptm -59.76 133.72 56.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.159 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -134.27 120.63 20.22 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.456 ' N ' HD12 ' B' ' 53' ' ' ILE . 3.4 mp -116.04 92.75 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -112.02 146.64 37.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.276 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -108.17 161.12 15.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.386 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -129.87 112.22 1.28 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.654 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.4 m -105.64 121.68 44.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.383 0.611 . . . . 0.0 111.429 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -116.07 141.24 48.39 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.068 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 24.4 ttt -133.32 124.52 27.41 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.285 0.565 . . . . 0.0 111.453 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 31.3 p -82.72 145.31 29.66 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 25.3 m -76.76 3.14 12.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.59 0.233 . . . . 0.0 110.848 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 88.3 mt 55.54 41.4 30.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.03 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' B' ' 63' ' ' GLU . 1.9 pm0 -63.84 92.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.819 0.819 . . . . 0.0 110.549 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -75.79 102.5 5.49 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.29 -176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -75.57 113.5 13.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.521 0.676 . . . . 0.0 109.717 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -105.85 139.59 40.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.168 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -106.99 147.58 29.71 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.698 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -79.82 112.92 17.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 111.654 -175.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m170 . . . . . 0 C--O 1.248 1.004 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.087 171.167 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 22.0 ptp . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.221 0.534 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.8 Cg_exo -79.61 146.41 19.04 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.838 2.358 . . . . 0.0 111.863 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -115.1 160.48 19.6 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.163 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.728 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -102.03 120.78 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' LYS . 5.0 pt -109.72 155.89 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.728 -175.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.579 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 51.0 mt-10 -103.63 141.3 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -163.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.1 161.73 36.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.712 -1.586 . . . . 0.0 108.071 172.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -129.88 136.82 58.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.417 0.627 . . . . 0.0 110.286 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 81.2 t80 -81.68 103.97 11.76 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.289 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -122.58 122.65 39.36 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.683 -173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.49 ' H ' ' HB3' ' B' ' 24' ' ' GLU . 1.1 m-80 55.76 36.36 27.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.061 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 85.84 16.9 62.54 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.987 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.4 t -134.42 149.29 29.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 94.2 m-85 -93.04 115.38 28.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 170.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -109.25 112.81 59.26 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.968 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 3.1 Cg_endo -61.66 168.64 8.11 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 120.752 0.968 . . . . 0.0 112.154 174.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.52 -71.88 0.44 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 113.339 -1.755 . . . . 0.0 107.166 165.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HG3' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -141.93 7.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 112.993 -1.912 . . . . 0.0 109.76 -169.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.715 ' HB3' HD12 ' A' ' 5' ' ' ILE . 70.5 mmtt -91.25 155.0 18.88 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.222 -1.808 . . . . 0.0 114.292 -159.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 22' ' ' LEU . 40.8 t 61.1 142.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.765 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -145.92 14.74 1.35 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.779 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.616 ' CB ' ' HG2' ' A' ' 26' ' ' GLU . 58.2 mt -89.43 5.74 43.88 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.124 -169.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 83.7 tttt 81.85 163.74 0.15 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.122 -1.854 . . . . 0.0 113.756 156.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -48.91 129.71 17.48 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.048 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.57 12.47 69.45 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.884 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.616 ' HG2' ' CB ' ' A' ' 22' ' ' LEU . 5.0 tp10 -81.36 134.65 35.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.613 0.244 . . . . 0.0 110.439 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -90.18 115.85 27.73 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 123.258 1.504 . . . . 0.0 113.419 -168.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG21 ' CE1' ' B' ' 14' ' ' PHE . 31.8 m -123.81 157.43 30.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 112.473 -2.148 . . . . 0.0 108.794 177.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' ' OE2' ' B' ' 33' ' ' GLU . 59.6 mttm -124.44 135.56 53.35 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.413 HG21 ' CE1' ' A' ' 14' ' ' PHE . 10.7 mm -90.45 132.06 36.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.073 -172.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' CE ' HG21 ' B' ' 4' ' ' ILE . 12.6 mptt -121.27 132.5 54.84 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.288 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD13 HG12 ' B' ' 28' ' ' VAL . 2.8 mm? -81.81 126.71 32.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -61.22 138.18 58.23 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.748 -176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.0 mt -83.17 155.33 23.81 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.069 -170.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' H ' ' HG3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -124.02 148.37 47.07 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.165 178.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -93.8 132.41 38.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 121.438 0.637 . . . . 0.0 110.157 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.95 103.34 55.24 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.631 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -87.41 -171.52 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.878 2.385 . . . . 0.0 111.838 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 39' ' ' ILE . 3.8 mp -91.36 144.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -113.41 123.54 50.31 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.737 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -83.52 154.07 24.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.652 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.87 115.38 2.09 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.957 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.91 122.57 86.45 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.272 -0.464 . . . . 0.0 110.708 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.13 148.03 26.97 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.679 2.253 . . . . 0.0 112.086 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 t -100.69 156.56 4.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -86.82 171.46 10.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.865 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.0 p -97.93 141.81 15.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -135.94 -26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.269 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -66.16 -23.87 66.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -171.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -65.66 -15.63 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -71.89 133.99 45.77 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.103 0.477 . . . . 0.0 111.618 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -133.43 163.96 28.19 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.265 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.5 mt -127.61 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.477 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.18 176.21 6.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.873 0.368 . . . . 0.0 110.495 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -115.73 158.85 22.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.077 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.81 116.61 5.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 p -96.81 102.49 14.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 120.997 0.427 . . . . 0.0 111.607 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 -84.8 152.67 23.48 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 44.2 ttm -143.25 165.34 27.73 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.88 0.371 . . . . 0.0 111.585 -171.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 m 61.78 83.85 0.15 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.113 0.965 . . . . 0.0 112.8 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 m -106.83 16.05 24.8 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.075 172.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.1 tp -88.26 125.9 34.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.693 -172.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -152.82 109.94 3.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -153.58 142.37 21.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.834 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 71.4 101.94 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.792 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -125.14 -179.15 4.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.835 176.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -97.35 149.29 22.26 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -113.33 136.12 53.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.319 0.581 . . . . 0.0 110.855 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.191 -175.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.19 97.5 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.688 2.259 . . . . 0.0 112.881 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -82.66 144.49 30.23 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.456 175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.577 HG21 ' CE ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -118.75 144.28 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.053 -177.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.604 HG23 ' HB3' ' B' ' 18' ' ' GLN . 7.1 mt -89.62 148.29 4.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -102.67 131.08 49.7 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -140.81 154.34 46.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.604 0.24 . . . . 0.0 110.942 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.715 HG13 HD11 ' B' ' 17' ' ' LEU . 4.4 m -111.4 132.52 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.843 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 68.3 t80 -82.2 108.37 15.61 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.021 0.915 . . . . 0.0 110.585 176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.721 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 5.6 mt-10 -86.58 -170.68 3.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 113.304 -1.771 . . . . 0.0 108.391 169.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.15 62.82 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 O-C-N 124.342 1.026 . . . . 0.0 111.301 -171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 105.27 5.55 40.09 Favored Glycine 0 C--N 1.304 -1.218 0 CA-C-N 113.408 -1.724 . . . . 0.0 109.677 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.5 t -112.78 145.92 18.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.221 -0.489 . . . . 0.0 111.432 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.874 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 55.4 m-85 -115.67 114.67 25.18 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 162.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -121.2 123.62 27.68 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.758 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.65 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 19.4 Cg_endo -65.19 168.0 15.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.708 1.605 . . . . 0.0 112.925 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.715 HD11 HG13 ' B' ' 8' ' ' VAL . 4.2 mp -118.45 -13.66 9.74 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' B' ' 5' ' ' ILE . 8.9 tt0 -91.53 164.11 13.91 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.593 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -78.15 142.65 37.88 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.88 139.82 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 122.973 1.368 . . . . 0.0 113.012 -173.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -141.81 87.46 2.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.379 -2.191 . . . . 0.0 108.301 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . . . . . . . . . 78.2 mt -129.3 -179.43 5.14 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 112.423 -2.171 . . . . 0.0 109.986 175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.666 ' HD2' ' OE2' ' B' ' 24' ' ' GLU . 30.0 mmtt -110.06 161.92 15.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.338 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.666 ' OE2' ' HD2' ' B' ' 23' ' ' LYS . 1.1 pm0 -77.16 124.12 27.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.437 0.637 . . . . 0.0 109.532 177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.29 15.28 30.67 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.784 -173.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 9' ' ' TYR . 7.6 tp10 -78.77 121.22 24.5 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -87.46 122.28 30.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.356 1.074 . . . . 0.0 111.278 -173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.47 HG12 HD13 ' A' ' 32' ' ' LEU . 29.7 m -129.46 151.15 35.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.219 -173.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.638 ' HE3' HG13 ' A' ' 4' ' ' ILE . 25.9 mtpp -121.57 134.56 55.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 122.443 1.116 . . . . 0.0 111.086 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 7' ' ' ALA . 9.6 mm -106.16 144.54 15.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 112.708 -2.042 . . . . 0.0 111.151 -164.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.535 ' HE3' HG22 ' A' ' 4' ' ' ILE . 6.1 ptpp? -156.16 163.98 38.94 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.657 -1.61 . . . . 0.0 107.018 173.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.603 ' CD2' HD12 ' A' ' 22' ' ' LEU . 1.7 mp -107.62 120.53 42.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.575 ' OE2' ' HB2' ' A' ' 29' ' ' LYS . 14.3 mt-10 -117.46 163.84 15.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.718 0.771 . . . . 0.0 112.597 -166.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 81.2 mt -97.95 178.57 5.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.275 -170.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -108.11 162.39 14.09 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.002 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.448 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 7.6 p -95.14 138.69 20.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -105.65 104.45 48.54 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.229 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 36' ' ' VAL . 77.2 Cg_endo -92.81 175.29 1.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 123.249 2.632 . . . . 0.0 111.528 172.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 pt -124.77 114.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.01 0.433 . . . . 0.0 111.09 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.23 137.33 34.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.52 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 32.1 tp -102.75 167.62 9.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.029 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.4 -155.18 25.52 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.852 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 40.2 mt-10 -129.44 139.02 34.44 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.64 165.19 31.66 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.059 2.506 . . . . 0.0 112.42 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.449 HG22 ' N ' ' B' ' 46' ' ' SER . 10.6 p -95.15 161.0 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.289 0.566 . . . . 0.0 110.88 -177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . 0.57 ' O ' ' HB ' ' B' ' 47' ' ' VAL . 6.4 p -122.62 -164.54 1.19 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.564 -176.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' B' ' 46' ' ' SER . 23.0 t 77.28 137.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 123.79 0.836 . . . . 0.0 111.915 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -100.07 138.19 37.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.798 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.95 -32.38 21.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.469 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.31 -12.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -166.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -81.86 129.48 34.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.157 0.504 . . . . 0.0 111.055 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -164.87 170.84 14.88 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.795 178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -83.7 157.73 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.741 -175.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -131.76 159.52 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -119.92 -171.56 2.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.4 26.53 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.75 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 9.3 m -126.59 144.9 50.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -122.11 134.06 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.898 0.38 . . . . 0.0 110.458 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.52 125.38 54.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.204 0.526 . . . . 0.0 111.232 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t -77.05 160.22 29.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.304 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.9 t -84.29 19.31 1.91 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.476 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 55.66 -176.42 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.551 0.74 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -111.35 167.39 10.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.876 -177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -152.53 135.66 15.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -143.94 101.42 3.73 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.984 0.421 . . . . 0.0 110.258 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -103.52 165.46 11.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.897 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -135.54 143.28 45.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -75.53 -75.08 0.19 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.87 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 . . . . . 0 C--O 1.244 0.79 0 CA-C-O 118.291 -0.861 . . . . 0.0 110.237 -179.092 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.451 0.167 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.33 131.4 21.76 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.108 1.872 . . . . 0.0 110.738 171.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -70.36 152.03 44.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.431 0.634 . . . . 0.0 111.929 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.786 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -99.59 142.17 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.4 170.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.7 mt -99.31 156.99 3.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' B' ' 29' ' ' LYS . 25.4 mt-10 -124.26 139.45 53.9 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.073 173.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.23 165.23 25.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.071 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.584 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 3.1 m -117.08 114.37 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-O 121.57 0.7 . . . . 0.0 109.512 170.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' B' ' 26' ' ' GLU . 19.2 t80 -60.87 124.76 21.41 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.483 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.597 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 28.2 mt-10 -149.4 134.3 17.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.16 0.287 . . . . 0.0 111.167 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 59.03 28.36 17.6 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 124.152 0.908 . . . . 0.0 111.465 168.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.23 -69.37 0.32 Allowed Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 117.406 -2.33 . . . . 0.0 111.626 -167.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' HG3' ' A' ' 15' ' ' LYS . 22.3 m -95.58 165.46 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.382 -0.909 . . . . 0.0 113.397 -157.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.3 m-85 -88.68 116.74 27.16 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 171.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.597 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 51.8 mtpt -113.44 112.05 49.13 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 119.598 -0.239 . . . . 0.0 110.395 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 19.1 Cg_endo -60.19 168.13 6.62 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.333 1.355 . . . . 0.0 112.527 -175.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 8' ' ' VAL . 97.2 mt -95.84 1.28 53.01 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 16' ' ' PRO . 11.5 pt20 -146.89 156.53 43.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.193 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 23.0 mtpp -81.49 145.08 30.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.551 172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG12 ' HG ' ' A' ' 22' ' ' LEU . 2.5 t -125.0 139.84 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.947 0.88 . . . . 0.0 111.853 -171.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.37 87.44 5.19 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.208 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HG ' HG12 ' A' ' 20' ' ' VAL . 62.2 mt -131.01 -165.59 1.58 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.27 -2.241 . . . . 0.0 109.448 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -129.27 156.79 43.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.042 174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.743 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 34.2 mt-10 -69.5 128.93 38.25 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.209 0.528 . . . . 0.0 110.812 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 14.39 57.72 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.918 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 26' ' ' GLU . 1.5 mm-40 -75.39 139.72 42.54 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -92.53 114.7 27.32 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 123.335 1.541 . . . . 0.0 112.507 -173.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' B' ' 30' ' ' ILE . 28.7 m -124.45 148.63 28.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 112.216 -2.266 . . . . 0.0 109.825 -175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' B' ' 34' ' ' LEU . 61.1 mttm -111.59 139.9 46.65 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mm -105.77 138.89 28.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.304 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -137.32 153.4 50.27 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 169.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' O ' ' B' ' 27' ' ' ARG . 17.3 tp -108.4 133.26 52.83 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.835 -156.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -96.67 142.68 28.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.733 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.5 mt -156.62 175.19 14.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.965 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -104.79 167.74 9.52 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.43 141.79 17.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 33.8 mt-10 -58.04 129.41 82.47 Favored Pre-proline 0 N--CA 1.446 -0.659 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 46.6 Cg_exo -56.25 174.3 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.47 2.78 . . . . 0.0 114.028 -173.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.0 pt -76.4 146.45 8.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.845 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.96 95.22 7.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.254 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.784 HD23 ' H ' ' A' ' 41' ' ' LEU . 2.5 pt? -95.69 177.77 5.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.038 -173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.71 114.48 5.03 Favored Glycine 0 N--CA 1.438 -1.219 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.8 mt-10 -75.01 138.24 72.73 Favored Pre-proline 0 C--N 1.308 -1.217 0 CA-C-N 114.526 -0.837 . . . . 0.0 111.338 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 12.6 Cg_exo -70.0 118.06 5.46 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.482 2.121 . . . . 0.0 110.594 175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.16 147.09 11.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.845 0.355 . . . . 0.0 110.612 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.1 m -98.09 171.78 8.03 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.94 147.34 19.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.335 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.568 ' O ' ' HD2' ' A' ' 51' ' ' LYS . 41.8 mt-10 -74.96 138.03 42.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.807 0.337 . . . . 0.0 110.598 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 -25.19 24.29 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.386 0.612 . . . . 0.0 110.05 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.2 pt -77.57 -0.4 3.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.875 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' HD2' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -65.62 140.01 58.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.05 0.452 . . . . 0.0 110.635 -179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 18.4 ptmt -122.16 159.79 26.47 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' A' ' 52' ' ' LYS . 51.5 mt 73.27 130.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 124.006 0.816 . . . . 0.0 112.755 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.764 ' HG2' ' H ' ' A' ' 55' ' ' ASP . 37.6 ttp180 -140.93 -168.94 2.71 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.764 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 7.5 p-10 -64.95 146.1 55.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.566 0.698 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -177.14 91.15 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.955 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 m -67.29 130.87 44.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.965 0.412 . . . . 0.0 110.843 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -113.06 134.03 54.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.198 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.5 ttm -83.97 146.5 27.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.671 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.06 111.79 3.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.662 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 m -80.6 -5.4 56.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.213 0.53 . . . . 0.0 110.886 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.6 tp -79.05 -21.64 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.535 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.55 101.68 3.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.338 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -114.64 -171.35 1.91 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.267 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -150.22 137.32 19.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.799 0.333 . . . . 0.0 110.889 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 -86.0 154.49 21.41 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -130.4 101.82 5.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.923 0.392 . . . . 0.0 111.029 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -168.19 127.53 1.23 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.857 175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.846 -0.597 . . . . 0.0 109.7 -179.099 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.15 99.77 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.437 2.091 . . . . 0.0 111.116 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.55 167.37 19.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.249 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.777 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -83.21 131.91 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-O 121.476 0.655 . . . . 0.0 110.015 174.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.531 ' CG2' ' HB2' ' B' ' 18' ' ' GLN . 7.6 mt -109.25 142.77 20.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -99.72 138.89 36.17 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.293 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.15 160.71 39.91 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.911 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 m -117.01 124.35 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 121.174 0.512 . . . . 0.0 110.626 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.766 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 85.6 t80 -80.19 99.74 7.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.124 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.543 ' HB2' ' HE2' ' B' ' 15' ' ' LYS . 73.1 mt-10 -122.74 144.75 48.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 66.37 10.72 7.46 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.434 0.458 . . . . 0.0 111.656 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 86.78 18.93 57.43 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.991 -173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.766 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 13.0 t -122.12 151.39 25.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.058 -178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.992 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 97.6 m-85 -98.58 115.62 29.02 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.543 ' HE2' ' HB2' ' B' ' 10' ' ' GLU . 49.1 mtmt -118.16 116.48 35.71 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.914 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 15.7 Cg_endo -61.25 165.96 11.85 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 121.688 1.592 . . . . 0.0 113.531 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 mp -89.0 -66.06 0.96 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 111.283 -2.689 . . . . 0.0 104.945 162.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.531 ' HB2' ' CG2' ' B' ' 5' ' ' ILE . 14.7 mp0 -59.67 158.63 9.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.276 -1.783 . . . . 0.0 111.134 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -76.83 128.39 34.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 110.531 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.463 HG12 ' H ' ' B' ' 22' ' ' LEU . 8.7 t -124.44 150.1 29.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.374 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -127.15 15.2 7.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.916 0.865 . . . . 0.0 110.88 -170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.489 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 94.9 mt -71.25 163.99 26.56 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.613 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -118.58 -173.63 2.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.354 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 7.2 mp0 -63.15 141.97 58.56 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.321 0.581 . . . . 0.0 111.806 -175.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.584 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 45.9 64.55 2.38 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.218 -169.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 4.1 mm-40 -103.81 134.42 47.14 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.521 -0.839 . . . . 0.0 110.032 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 32' ' ' LEU . 19.1 mmm-85 -82.64 115.98 21.83 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.336 -172.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.79 HG21 ' HD1' ' A' ' 14' ' ' PHE . 30.0 m -140.42 152.04 21.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.585 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 59.4 mttm -115.32 141.83 47.51 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.204 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 28' ' ' VAL . 1.5 mm -118.94 142.44 33.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.562 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.466 ' HD2' HG22 ' A' ' 4' ' ' ILE . 62.0 tttm -155.3 126.45 7.16 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.244 174.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.601 ' HG ' HG12 ' A' ' 28' ' ' VAL . 1.3 mp -65.12 113.28 3.83 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -154.85 146.01 22.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.232 -160.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.507 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 3.4 pp -158.28 171.91 19.32 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.855 -1.521 . . . . 0.0 108.137 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -123.33 147.54 46.92 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 t -94.72 139.32 18.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.865 -171.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.44 171.29 5.8 Favored Pre-proline 0 N--CA 1.441 -0.886 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.422 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.65 171.87 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 121.752 1.634 . . . . 0.0 111.873 174.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.5 176.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.83 -174.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -114.12 147.99 37.91 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.174 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.685 ' H ' HD23 ' B' ' 41' ' ' LEU . 2.4 pt? -113.32 144.64 42.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.122 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.58 122.04 7.29 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.808 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 8.1 pt-20 -55.92 141.73 66.29 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.999 177.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 3.0 Cg_exo -75.18 -170.63 0.82 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.062 2.508 . . . . 0.0 112.269 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.98 156.25 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.297 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.0 m -83.32 172.21 12.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.62 148.76 11.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.643 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -50.57 119.85 4.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.329 0.585 . . . . 0.0 111.917 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -85.91 -26.04 25.81 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.179 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 35.6 pt -87.68 0.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 112.347 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.72 134.01 35.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -105.43 150.51 25.21 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.407 . . . . 0.0 110.951 -171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.28 144.46 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.83 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' B' ' 55' ' ' ASP . 87.4 mtm180 -103.16 178.1 4.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.802 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' B' ' 54' ' ' ARG . 12.6 t70 71.02 153.68 0.12 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.907 0.754 . . . . 0.0 110.676 -172.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.68 131.34 1.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.81 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -60.21 135.33 57.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.775 0.322 . . . . 0.0 110.411 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -129.2 133.22 47.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.216 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 1.2 tpt -114.07 127.45 55.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.767 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 13.4 m -88.68 167.62 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 26.5 t -81.7 20.22 0.96 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.075 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 70.3 mt 62.9 -165.74 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.272 0.629 . . . . 0.0 111.205 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -123.64 134.25 53.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -93.35 120.22 33.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.954 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -57.26 137.58 55.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.491 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -79.79 139.58 37.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.021 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -131.61 117.99 19.46 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -81.43 123.38 28.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.527 -0.749 . . . . 0.0 109.941 176.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HB2' ' HB2' ' B' ' 32' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.81 -59.81 0.65 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.509 2.806 . . . . 0.0 114.427 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -93.39 171.25 9.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.027 0.442 . . . . 0.0 111.247 -171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.27 145.26 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.495 -174.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.623 HG21 HG22 ' A' ' 20' ' ' VAL . 22.8 mm -106.14 168.93 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 46.5 mt-10 -124.76 160.03 29.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 118.318 0.508 . . . . 0.0 110.706 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' B' ' 30' ' ' ILE . . . -158.65 158.56 34.04 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 122.782 0.433 . . . . 0.0 110.259 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.5 117.86 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 121.635 0.731 . . . . 0.0 110.44 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.733 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 51.3 t80 -82.69 113.05 20.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.131 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.435 ' HG2' ' HB3' ' B' ' 24' ' ' GLU . 0.4 OUTLIER -137.97 146.14 42.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.994 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 57.59 26.31 12.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 80.31 20.96 65.77 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.008 -178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.6 t -130.59 152.84 38.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.227 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 91.4 m-85 -104.64 114.01 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 169.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -104.79 106.39 54.78 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.429 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -39.83 168.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 123.963 3.109 . . . . 0.0 117.758 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.897 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 96.5 mt -131.72 96.99 4.08 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 111.621 -2.536 . . . . 0.0 105.518 168.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.897 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 4.4 pp0? 77.66 -176.11 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 127.476 2.31 . . . . 0.0 112.02 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -54.88 137.78 44.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -159.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 5' ' ' ILE . 2.5 t -141.6 134.18 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.095 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.103 170.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -131.14 87.76 2.51 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 122.829 1.3 . . . . 0.0 108.6 176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 HD22 ' B' ' 32' ' ' LEU . 57.2 mt -123.11 -179.05 4.15 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 112.178 -2.283 . . . . 0.0 110.967 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.603 ' HG3' ' HG2' ' A' ' 26' ' ' GLU . 18.9 pttp -114.28 162.65 16.31 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.101 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.661 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 46.3 mt-10 -65.76 133.7 51.58 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-O 122.025 0.917 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.61 64.93 3.24 Favored Glycine 0 N--CA 1.434 -1.436 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.082 -165.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' B' ' 8' ' ' VAL . 2.0 mm-40 -114.82 139.87 49.39 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.208 -0.996 . . . . 0.0 109.708 168.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -100.17 124.87 46.09 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 123.008 1.385 . . . . 0.0 112.354 -175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' B' ' 30' ' ' ILE . 33.5 m -133.6 150.02 31.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.107 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.754 ' HG3' ' HG3' ' B' ' 33' ' ' GLU . 59.5 mttm -105.43 138.5 41.53 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.577 0.703 . . . . 0.0 110.136 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.476 HG21 ' CE1' ' A' ' 14' ' ' PHE . 20.6 mm -110.2 146.97 14.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.98 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.1 156.29 34.05 Favored 'General case' 0 N--CA 1.421 -1.911 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.543 HD13 HG12 ' B' ' 28' ' ' VAL . 3.5 mm? -69.45 148.1 50.03 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -50.45 124.82 11.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.779 0.8 . . . . 0.0 112.265 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 44.7 mt 51.47 157.97 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 112.817 -1.992 . . . . 0.0 115.144 -176.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -98.51 175.76 5.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.603 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.1 p -90.33 152.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.691 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 37' ' ' GLU . 1.2 pm0 -90.59 148.81 39.5 Favored Pre-proline 0 N--CA 1.441 -0.895 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 173.43 11.96 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.165 1.91 . . . . 0.0 112.149 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mt -121.24 153.18 24.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.549 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -152.67 72.04 0.96 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 57.6 tp -91.04 135.65 33.61 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.659 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.7 111.34 3.8 Favored Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 41.5 tt0 -93.42 113.06 59.13 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.525 -0.838 . . . . 0.0 110.469 -177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 6.3 Cg_exo -73.78 113.82 3.88 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.863 2.375 . . . . 0.0 112.204 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' N ' ' A' ' 46' ' ' SER . 8.4 p -114.14 163.15 11.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.526 176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.445 ' N ' HG22 ' A' ' 45' ' ' VAL . 4.3 m -66.67 160.17 26.11 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.258 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.99 134.22 56.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 121.115 0.483 . . . . 0.0 110.577 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.658 ' HB2' ' HE2' ' A' ' 51' ' ' LYS . 31.7 mt-10 -126.0 121.57 33.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.966 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 49' ' ' GLU . 6.9 pt-20 -85.2 -25.57 27.28 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.695 -174.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.2 mm -88.43 1.63 6.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.669 0.747 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.658 ' HE2' ' HB2' ' A' ' 48' ' ' GLU . 25.1 ttmm -72.52 133.87 44.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.986 -177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 60.19 104.75 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.804 0.811 . . . . 0.0 112.619 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 tp -78.75 127.78 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.62 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -112.52 117.11 31.45 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.608 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.18 153.37 25.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -112.41 35.66 4.53 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.325 -173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.4 t -79.46 150.6 31.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.389 0.614 . . . . 0.0 111.024 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -150.82 134.27 16.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.24 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -88.1 123.85 33.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.015 0.436 . . . . 0.0 110.06 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.9 m -96.39 116.38 28.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.254 0.55 . . . . 0.0 110.29 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.5 m -85.42 21.76 1.69 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.864 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.2 tp -63.47 107.58 1.15 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.182 0.515 . . . . 0.0 110.287 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.61 160.2 28.99 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.911 -176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -126.12 92.93 3.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.294 0.569 . . . . 0.0 109.706 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -134.5 125.39 27.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.325 -174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -139.94 -50.5 0.49 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.375 0.607 . . . . 0.0 109.707 171.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.5 m170 58.92 23.11 11.06 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.872 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -96.11 114.95 26.7 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.214 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 28.0 ttt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 52.1 Cg_exo -55.12 103.45 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.125 2.55 . . . . 0.0 113.34 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -109.66 159.01 17.49 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.899 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.647 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -99.76 138.64 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-O 121.245 0.545 . . . . 0.0 110.605 176.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.552 HG23 ' HB2' ' B' ' 18' ' ' GLN . 4.4 mt -114.84 168.07 6.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 175.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -132.41 136.4 46.74 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -133.83 155.76 49.25 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.374 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.679 HG13 HD11 ' B' ' 17' ' ' LEU . 7.1 m -110.06 121.68 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-O 121.316 0.579 . . . . 0.0 111.006 176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 24' ' ' GLU . 21.3 t80 -61.02 111.23 1.6 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.982 171.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -136.11 129.3 31.61 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.969 -175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 24' ' ' GLU . 1.2 t-20 55.02 27.84 9.88 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.77 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.97 -68.27 0.22 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 117.688 -2.196 . . . . 0.0 111.26 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.67 154.96 3.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 113.522 -1.339 . . . . 0.0 111.678 -157.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.87 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 89.3 m-85 -88.72 122.16 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.137 0.494 . . . . 0.0 112.031 -175.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -107.73 119.03 51.64 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.674 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.713 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 34.1 Cg_endo -66.13 168.71 15.12 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.092 1.195 . . . . 0.0 112.462 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.679 HD11 HG13 ' B' ' 8' ' ' VAL . 4.9 mp -113.21 -5.72 13.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.552 ' HB2' HG23 ' B' ' 5' ' ' ILE . 18.8 mp0 -116.68 143.35 45.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.356 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -72.57 126.75 30.63 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.9 t -88.27 145.48 7.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.244 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -111.52 14.98 21.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.008 -169.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.595 HD13 ' HG2' ' B' ' 26' ' ' GLU . 80.2 mt -90.57 -168.62 2.14 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.314 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' B' ' 26' ' ' GLU . 15.1 tmtt? -111.81 155.4 23.63 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' B' ' 24' ' ' GLU . 1.9 mp0 -57.89 133.17 55.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.924 0.869 . . . . 0.0 112.201 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.37 65.5 3.5 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 114.106 -1.407 . . . . 0.0 110.381 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' B' ' 22' ' ' LEU . 10.0 tp10 -92.92 149.13 21.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.686 -0.757 . . . . 0.0 110.958 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.55 104.94 17.19 Favored 'General case' 0 C--O 1.247 0.96 0 CA-C-O 122.532 1.158 . . . . 0.0 111.376 -177.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 32' ' ' LEU . 34.9 m -124.7 154.69 32.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.407 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' A' ' 6' ' ' GLU . 41.4 mttp -119.43 148.0 43.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.495 0.664 . . . . 0.0 110.076 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 28' ' ' VAL . 7.8 mt -128.55 153.38 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.129 -170.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -150.88 159.33 44.62 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 8.3 mt -91.25 114.1 26.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -173.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.754 ' HG3' ' HG3' ' A' ' 29' ' ' LYS . 4.6 mm-40 -94.62 152.04 18.82 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.175 0.512 . . . . 0.0 111.916 -168.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 -170.55 3.54 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.771 -175.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -90.96 166.03 13.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.429 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.63 156.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 50.7 mt-10 -60.16 141.93 90.11 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.642 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 37' ' ' GLU . 32.8 Cg_exo -61.88 174.39 2.41 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.186 2.591 . . . . 0.0 113.773 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.413 HG13 ' H ' ' B' ' 39' ' ' ILE . 2.0 pp -82.09 171.6 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.127 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -93.4 -151.57 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.493 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 90.5 mt -89.77 -170.53 2.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.801 0.334 . . . . 0.0 110.59 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.42 141.41 10.4 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.46 155.06 85.82 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 120.573 0.225 . . . . 0.0 110.896 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.25 164.72 32.95 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.44 2.093 . . . . 0.0 110.11 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.7 p -49.67 134.99 8.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 122.001 0.905 . . . . 0.0 112.099 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 4.4 m -86.51 172.44 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.021 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -93.78 131.54 40.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -77.97 118.9 20.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.0 110.747 -178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -85.61 -25.47 26.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.588 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.4 tt -93.29 5.87 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.616 0.722 . . . . 0.0 110.8 -175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -87.19 148.34 25.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.97 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -80.33 143.82 33.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.944 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 65.6 mt -116.58 -49.36 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.372 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 64.3 mtt-85 63.43 147.98 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.855 0.862 . . . . 0.0 112.796 -176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.92 169.69 19.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.903 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.45 80.67 0.87 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.057 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 8.9 t -91.79 152.45 20.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -110.45 135.74 50.67 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.739 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.39 148.7 27.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.483 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 36.1 p -142.54 149.52 39.19 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.032 0.444 . . . . 0.0 111.207 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 46.1 t -95.3 13.91 24.07 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.65 94.39 9.88 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.425 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -115.07 86.55 2.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -98.81 58.22 1.16 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.239 0.542 . . . . 0.0 111.624 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -68.92 116.24 9.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -93.23 102.57 14.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.63 -172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -78.81 112.94 16.47 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -109.94 129.88 55.6 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.055 -174.322 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptm . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.3 111.25 3.24 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.398 2.065 . . . . 0.0 111.86 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -147.76 173.37 12.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.4 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.946 HG22 ' HG2' ' B' ' 31' ' ' LYS . 0.3 OUTLIER -109.41 144.51 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.778 176.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.605 HD11 HD11 ' A' ' 22' ' ' LEU . 4.6 mt -106.1 148.18 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.926 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.594 ' H ' ' NE2' ' A' ' 18' ' ' GLN . 44.9 mt-10 -102.52 123.08 45.61 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -143.07 168.52 19.55 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 17' ' ' LEU . 10.6 m -129.68 129.73 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.018 0.437 . . . . 0.0 110.785 175.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.498 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 20.0 t80 -59.77 128.85 38.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 172.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 37.7 tt0 -139.79 109.04 6.1 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.496 0.665 . . . . 0.0 111.494 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.455 ' H ' ' HG3' ' B' ' 24' ' ' GLU . 31.0 t30 55.7 27.33 10.5 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.207 -1.36 . . . . 0.0 111.324 174.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.9 -70.01 0.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 118.158 -1.972 . . . . 0.0 110.731 -165.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.608 ' HB ' ' CG1' ' B' ' 13' ' ' VAL . 23.2 m -94.34 145.36 8.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 113.649 -1.276 . . . . 0.0 112.201 -160.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 90.5 m-85 -86.82 116.76 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.333 0.587 . . . . 0.0 110.169 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HE3' ' CG2' ' A' ' 13' ' ' VAL . 34.5 mmtp -105.12 116.58 60.34 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.153 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 13.6 Cg_endo -59.93 169.0 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.41 1.407 . . . . 0.0 111.997 177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.523 HD11 HG13 ' A' ' 8' ' ' VAL . 7.4 mp -102.23 -8.73 21.04 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' NE2' ' H ' ' A' ' 6' ' ' GLU . 4.5 pm0 -145.47 170.49 16.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.433 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -63.49 128.01 33.88 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.061 0.934 . . . . 0.0 112.204 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 ' HZ ' ' B' ' 14' ' ' PHE . 4.9 p -132.87 141.36 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.714 173.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -148.14 87.85 1.63 Allowed 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 113.358 -1.746 . . . . 0.0 108.867 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.826 HD13 HD11 ' B' ' 32' ' ' LEU . 67.4 mt -106.63 0.72 24.63 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.853 -1.976 . . . . 0.0 109.647 171.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' LEU . 0.0 OUTLIER 85.14 171.99 0.07 Allowed 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 113.191 173.022 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.7 mp0 -78.43 134.92 37.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.502 -172.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 51.94 63.87 4.43 Favored Glycine 0 N--CA 1.436 -1.316 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -166.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.646 ' HG2' ' HB3' ' A' ' 22' ' ' LEU . 7.4 tp10 -113.56 137.7 51.21 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.803 -1.199 . . . . 0.0 107.927 170.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -100.53 117.8 35.41 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 123.124 1.44 . . . . 0.0 112.996 -164.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.622 HG12 HD13 ' B' ' 32' ' ' LEU . 16.0 m -134.84 158.07 41.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 112.149 -2.296 . . . . 0.0 109.483 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.748 ' HD3' HG13 ' B' ' 4' ' ' ILE . 87.3 mttt -120.95 138.38 54.16 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 122.047 0.927 . . . . 0.0 111.101 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.586 HG21 ' CE1' ' A' ' 14' ' ' PHE . 8.8 mm -103.57 149.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.545 -1.661 . . . . 0.0 109.204 -175.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -156.3 162.37 40.11 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 173.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.742 HD23 HG12 ' B' ' 28' ' ' VAL . 52.3 mt -95.21 117.08 29.63 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.723 -171.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.811 ' HG3' ' HG3' ' B' ' 29' ' ' LYS . 45.2 mm-40 -88.22 132.08 34.5 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.962 -172.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.25 -167.1 2.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.472 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -117.66 171.75 7.82 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.425 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.38 130.17 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.94 137.18 22.34 Favored Pre-proline 0 N--CA 1.439 -1.014 0 CA-C-O 121.21 0.529 . . . . 0.0 112.152 -173.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.28 177.34 7.23 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.772 2.315 . . . . 0.0 111.117 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 39' ' ' ILE . 2.4 pp -87.82 147.37 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.119 0.485 . . . . 0.0 111.952 -178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -99.03 172.08 7.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.096 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.807 HD23 ' H ' ' A' ' 41' ' ' LEU . 1.8 pt? -98.56 130.57 45.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.41 -154.57 17.65 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.844 -170.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.86 153.65 60.44 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 114.53 -0.835 . . . . 0.0 110.718 -173.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.36 171.03 1.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.736 2.291 . . . . 0.0 112.565 175.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.71 148.94 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.357 0.598 . . . . 0.0 110.465 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.537 ' O ' HG12 ' A' ' 47' ' ' VAL . 45.5 m -120.81 175.92 5.8 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.18 -175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 46' ' ' SER . 0.3 OUTLIER 64.57 154.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.477 1.111 . . . . 0.0 113.029 177.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 48' ' ' GLU . 5.6 mm-40 66.27 -36.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.663 1.185 . . . . 0.0 113.928 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.75 -26.02 62.29 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.492 0.663 . . . . 0.0 109.704 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mm -90.24 -4.6 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.053 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -98.38 176.7 5.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.58 103.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.705 0.764 . . . . 0.0 110.572 -168.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.0 tt -107.42 148.9 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.581 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -53.36 126.65 21.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.901 0.381 . . . . 0.0 110.192 175.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.81 149.02 26.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.978 0.418 . . . . 0.0 110.108 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.02 31.1 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.454 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.4 p -65.16 121.32 14.49 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.143 0.497 . . . . 0.0 110.902 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -87.35 134.12 33.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 13.7 tpt -62.83 124.59 21.43 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.3 m -72.39 108.11 5.32 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -93.34 15.85 14.71 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.937 -173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -69.74 97.49 1.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -174.91 2.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.506 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -129.91 116.39 18.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.1 175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -69.72 92.1 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -99.79 4.27 45.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.3 -169.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -103.98 96.88 6.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.633 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -175.62 122.99 0.2 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 t60 . . . . . 0 C--O 1.25 1.118 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.314 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.513 0.197 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.48 106.96 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.444 2.096 . . . . 0.0 112.436 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -115.82 152.2 33.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.554 175.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.748 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -127.53 143.09 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.457 177.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.573 HD13 HG21 ' B' ' 20' ' ' VAL . 6.9 mt -101.44 151.8 5.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 42.9 mt-10 -113.55 134.24 54.81 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.67 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -143.27 151.08 40.13 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.538 0.523 . . . . 0.0 109.98 -175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.438 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 16.7 m -116.19 125.81 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-O 121.477 0.656 . . . . 0.0 110.377 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.734 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 43.4 t80 -75.99 121.97 23.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.44 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -139.37 135.98 34.26 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.57 174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t30 63.04 20.61 12.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 171.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' B' ' 9' ' ' TYR . . . 91.08 13.06 59.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.743 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 9.1 t -120.69 153.24 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 122.337 0.255 . . . . 0.0 110.408 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.851 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.4 m-85 -109.0 115.34 29.89 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.054 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -109.05 115.95 56.18 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.99 -176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.67 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 41.8 Cg_endo -68.81 168.14 21.1 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.832 1.021 . . . . 0.0 112.186 -178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.436 HD11 HG13 ' B' ' 8' ' ' VAL . 5.3 mp -112.08 -12.6 13.66 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 170.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' B' ' 5' ' ' ILE . 0.8 OUTLIER -102.59 139.45 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.484 171.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -80.31 132.76 35.87 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 110.396 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' HG ' ' B' ' 22' ' ' LEU . 1.5 t -127.47 136.36 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.466 -178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -102.77 87.34 2.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.828 1.299 . . . . 0.0 108.186 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.581 ' HG ' HG12 ' B' ' 20' ' ' VAL . 47.2 mt -122.43 -178.44 3.9 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 112.541 -2.118 . . . . 0.0 111.533 178.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.405 ' H ' ' CG ' ' B' ' 26' ' ' GLU . 29.9 mttp -102.62 161.96 13.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.021 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 1.5 mp0 -71.87 119.11 15.58 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 14.93 38.22 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.884 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' B' ' 22' ' ' LEU . 5.3 mm-40 -71.4 133.42 45.93 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 120.77 35.24 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 123.298 1.523 . . . . 0.0 112.819 -168.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.742 HG12 HD23 ' A' ' 32' ' ' LEU . 32.8 m -138.95 162.65 28.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 112.291 -2.231 . . . . 0.0 110.489 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.811 ' HG3' ' HG3' ' A' ' 33' ' ' GLU . 46.8 mttp -122.3 139.46 53.78 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.689 0.757 . . . . 0.0 109.246 172.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 28' ' ' VAL . 6.2 mt -102.9 136.34 35.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.98 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.946 ' HG2' HG22 ' A' ' 4' ' ' ILE . 19.8 mttt -137.02 147.14 46.03 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.634 -176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.826 HD11 HD13 ' A' ' 22' ' ' LEU . 4.3 mm? -86.59 128.36 34.98 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.372 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.549 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 38.4 mm-40 -94.46 124.18 38.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -135.37 -169.64 2.43 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.755 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 153.37 29.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.485 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.0 147.4 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.45 114.84 7.35 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.087 0.47 . . . . 0.0 111.917 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.76 -173.12 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.947 2.431 . . . . 0.0 112.128 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.434 ' H ' HG13 ' B' ' 39' ' ' ILE . 2.7 pp -90.14 155.09 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 120.989 0.423 . . . . 0.0 110.965 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -92.71 159.95 15.2 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.149 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.65 165.77 26.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.193 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.41 -136.7 5.56 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.557 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -112.9 161.87 24.52 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 122.282 0.233 . . . . 0.0 110.953 -176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.88 167.66 24.85 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.402 2.068 . . . . 0.0 111.848 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.9 t -89.05 151.81 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.223 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 8.0 m -98.81 170.18 8.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.016 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.89 138.0 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -119.62 -23.37 6.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.232 0.539 . . . . 0.0 111.123 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -60.21 -25.23 65.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.983 -172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.408 ' O ' HG12 ' B' ' 50' ' ' ILE . 13.1 tt -84.14 -6.24 10.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.194 0.521 . . . . 0.0 111.919 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -74.18 138.55 43.86 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.824 0.345 . . . . 0.0 110.565 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -85.94 126.94 34.47 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 65.8 mt -89.72 123.97 42.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.449 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -60.93 115.64 3.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.316 0.579 . . . . 0.0 111.041 -175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -87.54 172.29 9.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.281 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 128.61 11.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.278 -0.487 . . . . 0.0 112.4 -176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 4.4 t -90.95 144.16 25.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.091 0.472 . . . . 0.0 110.688 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -83.33 171.29 13.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.4 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 19.3 ptp -84.69 169.56 14.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.852 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -73.38 -177.15 2.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.8 m -105.32 4.06 30.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.741 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 67.4 mt 59.01 -171.23 0.12 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.392 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.51 136.11 50.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.167 0.508 . . . . 0.0 110.127 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -118.2 85.1 2.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.786 177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.21 127.76 32.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.114 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' B' ' 67' ' ' HIS . 52.5 m80 -96.04 147.67 23.47 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 66' ' ' HIS . 60.6 m170 72.16 157.61 0.18 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.881 0.738 . . . . 0.0 109.465 -168.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -91.29 0.75 57.47 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.418 0.627 . . . . 0.0 109.781 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 67.0 t60 . . . . . 0 C--O 1.247 0.95 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.888 178.584 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.583 0.23 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.5 130.89 23.25 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.814 2.342 . . . . 0.0 111.743 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -136.31 149.03 48.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.831 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -71.12 144.28 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.182 0.515 . . . . 0.0 111.623 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.8 mt -105.1 146.76 11.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -103.02 137.2 41.53 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.318 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.82 160.33 40.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.838 -177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.4 m -121.4 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 CA-C-O 121.555 0.693 . . . . 0.0 110.425 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.634 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 72.6 t80 -72.92 110.41 7.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 175.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.668 ' HB2' ' HD3' ' A' ' 15' ' ' LYS . 36.9 mt-10 -134.2 144.46 48.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.398 177.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.6 t30 62.62 22.4 13.3 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.441 0.463 . . . . 0.0 111.374 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 79.43 18.55 73.51 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.914 -177.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 9.8 t -127.42 150.72 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 63.4 m-85 -95.55 115.0 26.81 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.287 168.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 50.8 mtpt -113.99 108.64 50.6 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.594 -174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 27.7 Cg_endo -62.52 169.22 8.6 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 121.35 1.366 . . . . 0.0 112.781 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -107.2 -16.29 14.45 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -107.68 137.37 45.82 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.558 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -75.96 124.58 27.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.644 0.735 . . . . 0.0 109.98 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.655 ' HB ' ' CE2' ' B' ' 9' ' ' TYR . 3.6 t -103.12 147.48 9.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.591 -175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.76 16.1 13.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.121 0.962 . . . . 0.0 110.345 -172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.585 HD13 ' HG2' ' A' ' 26' ' ' GLU . 96.7 mt -73.84 -174.37 1.79 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.773 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -110.97 171.86 7.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.341 -174.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 3.3 mp0 -73.29 141.74 47.17 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.459 0.647 . . . . 0.0 110.575 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.739 ' HA2' ' HB ' ' B' ' 8' ' ' VAL . . . 54.52 64.77 4.02 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.703 -167.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' HG2' HD13 ' A' ' 22' ' ' LEU . 7.8 tp10 -105.98 123.15 47.52 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.478 171.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -77.88 111.3 13.58 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 122.654 1.216 . . . . 0.0 112.747 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG12 ' HG ' ' B' ' 32' ' ' LEU . 27.1 m -133.32 155.55 40.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.48 -1.691 . . . . 0.0 110.603 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.964 ' HD3' HG13 ' B' ' 4' ' ' ILE . 64.3 mttm -113.03 149.05 33.89 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.551 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.0 mm -104.59 130.25 55.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.277 0.561 . . . . 0.0 109.627 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HE3' HG21 ' B' ' 4' ' ' ILE . 75.2 mttt -132.81 134.45 44.68 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.545 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.707 ' HB3' HG12 ' B' ' 28' ' ' VAL . 0.1 OUTLIER -103.75 141.83 35.42 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.913 -169.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.22 158.3 20.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.255 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt -133.93 160.04 38.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.013 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -96.22 166.94 11.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.653 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.14 138.84 32.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 mm-40 -81.27 123.05 81.78 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.848 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 37' ' ' GLU . 5.3 Cg_exo -77.79 -160.61 0.12 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.543 2.829 . . . . 0.0 113.256 -174.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.2 pt -68.05 165.3 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -132.89 149.54 52.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.05 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.9 tp -100.52 135.12 42.45 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.046 0.451 . . . . 0.0 111.379 -175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 156.38 24.51 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.039 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -79.44 150.7 73.95 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.36 -0.92 . . . . 0.0 111.868 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -76.67 159.03 35.5 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.761 2.307 . . . . 0.0 111.951 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 t -91.28 155.99 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.182 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.9 m -90.28 174.09 7.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.43 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.63 164.67 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -74.37 121.0 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.773 0.32 . . . . 0.0 110.567 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -85.56 -28.83 24.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.133 0.492 . . . . 0.0 111.088 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.9 tt -93.65 -0.77 10.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.604 0.716 . . . . 0.0 110.774 -172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -73.54 132.94 43.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.726 -176.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -123.92 141.71 51.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.063 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -99.63 90.76 2.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.424 0.631 . . . . 0.0 110.197 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -87.56 110.72 20.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.941 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -120.46 163.21 18.26 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.21 105.2 3.01 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.434 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.3 m -84.94 131.19 34.52 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -98.24 142.67 29.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 -172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -101.13 144.65 29.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.196 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.7 m -77.86 107.18 10.19 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.204 0.526 . . . . 0.0 110.439 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.9 m -95.8 3.51 53.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.795 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.3 tp -107.01 123.43 48.18 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.895 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -91.59 150.23 21.28 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -78.03 66.67 3.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 0.0 109.754 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -86.91 141.54 28.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.648 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 73.14 69.37 0.12 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.511 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -117.09 87.09 2.63 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 166.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -82.61 115.02 21.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.162 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 -179.298 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.606 0.241 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.05 146.72 20.46 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.319 2.013 . . . . 0.0 111.691 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -121.3 162.78 19.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.729 0.299 . . . . 0.0 110.363 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.964 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -105.71 144.99 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.463 -177.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.54 HG23 ' HB2' ' B' ' 18' ' ' GLN . 6.6 mt -97.78 144.24 11.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 29' ' ' LYS . 51.4 mp0 -104.9 141.32 36.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -139.87 166.26 25.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.108 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.739 ' HB ' ' HA2' ' A' ' 25' ' ' GLY . 5.4 m -121.36 123.48 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.612 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.655 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.2 t80 -61.55 126.16 26.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.831 173.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 81.1 mt-10 -137.09 111.52 8.58 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.018 0.437 . . . . 0.0 111.294 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t30 55.5 29.12 12.78 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.032 172.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.04 -69.78 0.48 Allowed Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 118.215 -1.945 . . . . 0.0 110.845 -168.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.15 145.5 7.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 113.784 -1.208 . . . . 0.0 111.823 -161.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.754 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 96.5 m-85 -92.83 116.74 29.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.687 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.63 120.77 56.68 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.561 173.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 28.8 Cg_endo -64.82 170.05 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.316 1.344 . . . . 0.0 112.533 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.598 HD11 HG13 ' B' ' 8' ' ' VAL . 6.0 mp -108.92 -10.67 15.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.54 ' HB2' HG23 ' B' ' 5' ' ' ILE . 47.0 mt-30 -115.48 145.26 42.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.866 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -73.42 151.57 41.09 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.953 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.516 HG12 ' H ' ' B' ' 22' ' ' LEU . 2.5 t -112.54 145.25 18.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.038 -169.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.67 16.61 9.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.36 1.076 . . . . 0.0 109.519 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.57 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 88.6 mt -86.36 -165.93 1.4 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.188 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.564 ' HG2' ' HG2' ' B' ' 26' ' ' GLU . 23.6 pttp -116.32 155.08 29.06 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.379 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -71.1 132.5 45.16 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.885 0.85 . . . . 0.0 109.836 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.02 65.03 2.75 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 113.932 -1.485 . . . . 0.0 109.617 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' B' ' 22' ' ' LEU . 1.9 mm-40 -112.06 132.96 54.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.254 -0.973 . . . . 0.0 109.221 170.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -90.41 119.48 30.73 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.704 0.764 . . . . 0.0 110.869 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 32' ' ' LEU . 29.8 m -140.11 166.81 19.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.467 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.629 ' HD3' HG13 ' A' ' 4' ' ' ILE . 60.9 mttm -122.03 153.93 37.95 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.23 176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' A' ' 28' ' ' VAL . 5.8 mm -115.44 142.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -151.34 125.05 9.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.641 ' HG ' HG12 ' A' ' 28' ' ' VAL . 3.2 mp -71.14 114.54 9.3 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -146.12 171.68 14.55 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.181 0.515 . . . . 0.0 111.594 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.471 HD23 ' H ' ' B' ' 34' ' ' LEU . 1.7 pt? -123.55 165.72 16.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.997 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.507 ' HG2' ' N ' ' B' ' 36' ' ' VAL . 37.6 ttmt -120.64 159.47 25.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.507 ' N ' ' HG2' ' B' ' 35' ' ' LYS . 7.7 p -92.44 138.75 19.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.4 0.619 . . . . 0.0 111.018 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -143.63 89.08 7.56 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.527 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.65 -161.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.304 2.669 . . . . 0.0 112.712 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.34 156.15 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.138 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -91.81 -51.28 5.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.801 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 45.1 tp 68.8 116.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.278 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.77 -142.5 10.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.969 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -112.83 158.19 38.39 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 122.252 0.221 . . . . 0.0 111.177 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.09 174.27 12.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.025 2.483 . . . . 0.0 112.253 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 t -86.69 154.76 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.769 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 10.4 m -89.32 171.84 9.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.39 138.17 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.405 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.02 -30.67 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.692 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' B' ' 49' ' ' GLU . 1.6 pm0 -66.84 -24.49 66.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.957 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 tt -77.69 -4.03 6.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.375 0.607 . . . . 0.0 110.944 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -70.55 134.24 47.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.178 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -108.21 150.6 27.05 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.98 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -118.23 132.33 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.636 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -78.28 120.71 23.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -93.92 147.97 22.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.432 0.634 . . . . 0.0 110.89 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.75 76.88 0.41 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.211 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 5.0 m -70.05 135.56 49.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.683 0.278 . . . . 0.0 110.666 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . 0.409 ' O ' ' HB2' ' B' ' 59' ' ' MET . 1.3 m-90 -110.56 -168.77 1.35 Allowed 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.343 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' B' ' 58' ' ' TRP . 66.6 mtt 73.64 172.42 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.831 0.853 . . . . 0.0 110.31 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m 57.09 26.18 11.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.076 0.465 . . . . 0.0 111.735 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 9.8 p -82.22 16.93 1.8 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.003 -173.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 45.43 99.89 0.01 OUTLIER 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.119 0.967 . . . . 0.0 113.223 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -82.83 172.4 12.89 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.986 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -131.09 123.74 29.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.093 0.473 . . . . 0.0 111.263 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -97.23 141.22 30.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -71.14 129.92 40.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 111.639 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -71.83 86.78 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -83.77 73.92 10.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.5 0.667 . . . . 0.0 111.167 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.8 m170 . . . . . 0 C--O 1.246 0.891 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.538 177.011 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' B' ' 32' ' ' LEU . 74.4 Cg_endo -93.2 108.28 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.097 2.531 . . . . 0.0 115.656 -166.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.452 ' HG2' HD13 ' A' ' 4' ' ' ILE . 23.8 ttpp -120.17 158.56 26.67 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 161.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.676 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 0.3 OUTLIER -70.49 127.1 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.451 -178.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 20' ' ' VAL . 4.6 mt -105.59 152.65 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.109 177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 30.1 mt-10 -112.94 108.05 16.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.659 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -110.16 167.14 10.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.41 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 3.8 m -118.02 117.39 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.642 ' CZ ' ' HB ' ' B' ' 20' ' ' VAL . 73.5 t80 -70.38 114.85 8.9 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.868 174.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 13' ' ' VAL . 11.6 tt0 -88.05 -170.69 3.08 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 112.324 -2.216 . . . . 0.0 107.402 170.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' HG2' ' A' ' 10' ' ' GLU . 10.9 t30 -67.44 49.75 0.05 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.713 0.805 . . . . 0.0 112.135 -170.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.69 4.58 11.65 Favored Glycine 0 C--N 1.306 -1.098 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 2.2 t -117.32 155.12 19.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 CA-C-N 114.904 -0.648 . . . . 0.0 111.298 -175.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 1.097 ' HB2' ' HB3' ' B' ' 14' ' ' PHE . 81.2 m-85 -122.81 119.15 29.72 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.306 164.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -114.07 121.02 37.52 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 173.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 7.5 Cg_exo -67.07 167.58 19.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 121.105 1.203 . . . . 0.0 111.23 178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.8 mt -112.04 -2.65 14.99 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.56 ' HB2' HG23 ' A' ' 5' ' ' ILE . 40.5 mt-30 -119.24 144.17 46.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.683 176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.8 141.19 42.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 5' ' ' ILE . 4.1 p -132.56 161.77 40.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-O 121.843 0.83 . . . . 0.0 112.028 -172.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' H ' HG22 ' A' ' 20' ' ' VAL . 31.0 t70 -104.9 12.84 32.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.198 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 20' ' ' VAL . 6.9 mp -66.8 135.61 54.2 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.427 172.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.7 mmpt? -93.67 -172.26 2.84 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.523 -176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -61.63 160.52 11.33 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.895 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -19.72 72.63 0.0 OUTLIER Glycine 0 CA--C 1.495 -1.217 0 O-C-N 124.997 1.435 . . . . 0.0 114.132 -151.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -75.11 147.51 40.49 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 111.526 -2.337 . . . . 0.0 108.602 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HG3' HD23 ' B' ' 32' ' ' LEU . 13.2 tpt180 -88.14 119.17 28.27 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.5 0.667 . . . . 0.0 110.356 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.879 ' HA ' ' CB ' ' B' ' 32' ' ' LEU . 0.0 OUTLIER -144.61 149.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.255 -174.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.634 ' HB2' HD13 ' B' ' 32' ' ' LEU . 13.6 mttt -115.21 143.96 44.43 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.365 0.602 . . . . 0.0 110.286 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.696 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 1.5 mt -107.34 135.12 47.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HG2' ' HB2' ' B' ' 29' ' ' LYS . 7.5 ptmm? -106.82 143.79 34.4 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.736 HD21 HD21 ' B' ' 22' ' ' LEU . 21.9 tp -100.87 128.06 47.07 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' OE2' ' HE3' ' B' ' 29' ' ' LYS . 3.7 tp10 -72.38 133.64 45.03 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 122.414 1.102 . . . . 0.0 113.38 -162.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -157.07 -179.5 8.27 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.005 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -126.09 158.53 35.23 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 173.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.03 137.13 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.782 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -93.74 138.22 22.91 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.38 -175.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.62 -174.34 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.718 2.279 . . . . 0.0 110.657 171.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.6 pp -123.32 151.61 27.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.923 0.392 . . . . 0.0 111.179 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 tt -67.99 110.26 3.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.137 0.494 . . . . 0.0 110.902 -174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.34 114.5 0.71 Allowed Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -131.89 161.72 60.82 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 122.462 0.305 . . . . 0.0 110.475 -175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.69 164.84 31.61 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.686 2.257 . . . . 0.0 111.515 173.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.86 148.37 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.4 m -103.59 176.89 5.0 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.103 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.6 156.92 43.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.03 130.07 39.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.085 0.469 . . . . 0.0 110.227 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -85.43 -25.98 26.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.257 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.1 mt -70.9 -16.1 19.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.533 0.682 . . . . 0.0 111.206 -175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.75 132.29 54.11 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.873 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.773 ' HG2' HG12 ' A' ' 53' ' ' ILE . 85.5 tttt -173.69 149.61 1.62 Allowed 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.091 0.244 . . . . 0.0 110.381 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.773 HG12 ' HG2' ' A' ' 52' ' ' LYS . 43.0 mm 58.98 104.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.93 152.05 25.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.417 176.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -70.51 155.93 40.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.652 0.739 . . . . 0.0 112.835 -172.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.97 75.13 0.24 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.047 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.2 m -94.29 142.6 27.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.164 0.507 . . . . 0.0 111.922 -172.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.2 t-105 -125.89 134.62 51.53 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 ttm -94.02 124.95 38.35 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.6 t -81.41 150.73 28.24 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 171.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.9 p -104.32 -6.03 21.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp 38.69 79.56 0.03 OUTLIER 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.09 0.869 . . . . 0.0 112.21 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.78 156.3 34.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.873 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -145.68 82.42 1.63 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.094 171.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -108.13 99.75 9.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.212 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -143.33 143.2 31.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.936 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -146.12 138.09 25.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.854 0.359 . . . . 0.0 110.496 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -109.42 108.73 19.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.917 177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 t60 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.376 178.244 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.421 ' O ' ' HD3' ' B' ' 3' ' ' LYS . 27.0 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -46.74 109.91 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.054 2.503 . . . . 0.0 112.659 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' B' ' 3' ' ' LYS . 3.7 mppt? -73.2 156.94 38.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.054 -177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.577 ' H ' HD13 ' B' ' 4' ' ' ILE . 0.2 OUTLIER -89.22 143.96 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.263 170.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB2' ' B' ' 18' ' ' GLN . 10.4 mm -113.14 146.43 17.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -109.39 131.21 55.28 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.628 ' HB3' ' CE2' ' B' ' 14' ' ' PHE . . . -143.12 164.33 30.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.06 0.457 . . . . 0.0 111.248 -173.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -119.22 128.87 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.282 174.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.713 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 41.2 t80 -84.76 100.85 11.79 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.837 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -115.12 120.42 39.73 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.859 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.32 33.29 9.19 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.965 0.79 . . . . 0.0 111.35 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.426 ' HA2' ' CE2' ' B' ' 9' ' ' TYR . . . 83.56 14.28 73.87 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.211 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.713 ' O ' ' HA ' ' B' ' 9' ' ' TYR . 6.5 t -120.12 146.7 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 1.097 ' HB3' ' HB2' ' A' ' 14' ' ' PHE . 1.0 OUTLIER -99.93 114.94 28.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 172.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -119.0 108.96 39.91 Favored Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.637 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.608 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 39.2 Cg_endo -68.85 168.27 20.82 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 121.467 1.445 . . . . 0.0 112.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.36 -9.55 17.52 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.504 ' HB2' HG23 ' B' ' 5' ' ' ILE . 72.4 mt-30 -102.38 145.69 29.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.173 -1.376 . . . . 0.0 109.205 173.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -84.39 124.19 31.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 163.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.642 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 15.7 t -90.57 148.93 4.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.431 -161.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.42 16.38 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.027 -174.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.736 HD21 HD21 ' A' ' 32' ' ' LEU . 22.1 mt -99.76 -174.62 2.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 113.089 -173.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 26' ' ' GLU . 37.8 tttm -116.28 155.12 28.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.267 -178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 1.5 mp0 -62.64 123.46 18.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.049 0.452 . . . . 0.0 109.955 175.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.73 22.92 34.83 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.036 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.57 ' HG3' HD22 ' B' ' 22' ' ' LEU . 16.9 mm-40 -84.02 143.02 30.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' B' ' 27' ' ' ARG . 4.3 tpp180 -86.28 120.51 27.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.4 1.095 . . . . 0.0 112.442 -175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.696 ' HB ' ' CG2' ' A' ' 30' ' ' ILE . 34.6 m -136.07 151.55 29.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.832 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.741 ' HB2' ' HG2' ' A' ' 31' ' ' LYS . 47.7 mmtt -117.35 144.63 44.72 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 18.7 mt -133.12 137.08 54.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.807 0.813 . . . . 0.0 111.967 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -158.16 135.85 10.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.599 -1.637 . . . . 0.0 108.155 169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.879 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 8.8 tp -153.01 162.22 41.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 165.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -164.36 157.22 17.3 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.021 -168.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' B' ' 34' ' ' LEU . 2.9 pp -78.73 173.63 12.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.806 177.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.481 ' HB3' ' NZ ' ' B' ' 35' ' ' LYS . 9.1 mtpm? -84.12 153.24 23.84 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.491 0.662 . . . . 0.0 111.795 -176.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.7 137.95 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -131.34 114.82 16.03 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 120.876 0.37 . . . . 0.0 110.889 -174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.11 -175.83 2.37 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.158 2.572 . . . . 0.0 112.289 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 57.3 mt 69.27 148.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.435 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.468 ' OD2' ' HG ' ' B' ' 41' ' ' LEU . 36.2 t70 -155.4 -69.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.862 -173.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' B' ' 40' ' ' ASP . 94.3 mt -100.04 168.0 10.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.274 0.559 . . . . 0.0 112.147 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.01 120.93 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.693 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 36.1 mm-40 -97.11 144.18 27.44 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-O 120.579 0.228 . . . . 0.0 111.123 -177.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 14.3 Cg_exo -69.71 156.15 64.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.98 2.453 . . . . 0.0 112.279 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.49 158.79 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.936 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 2.0 p -87.27 168.24 13.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -134.88 162.4 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.353 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -84.36 122.95 29.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.965 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -25.13 25.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.023 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 17.9 tt -72.29 -12.02 15.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.422 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.445 ' HB2' ' HE2' ' B' ' 51' ' ' LYS . 6.1 tppt? -79.37 132.38 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -147.42 107.46 4.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 120.903 0.382 . . . . 0.0 111.574 -176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tp -100.85 101.86 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.421 0.629 . . . . 0.0 109.449 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -122.73 126.29 47.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.499 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.58 159.28 30.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.112 0.482 . . . . 0.0 110.963 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.48 5.05 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.479 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.7 t -115.98 167.62 10.8 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -95.9 143.14 27.36 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 120.991 0.424 . . . . 0.0 111.1 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtt -118.52 124.65 48.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.61 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 41.1 t -79.86 148.52 31.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 0.0 110.424 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 2.8 p -94.82 -0.09 54.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.012 175.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' B' ' 61' ' ' SER . 1.0 OUTLIER 39.7 84.58 0.02 OUTLIER 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.651 1.219 . . . . 0.0 112.947 -178.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 100.91 0.16 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.244 176.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -85.01 57.91 4.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.17 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -70.29 108.18 4.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.138 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -145.1 134.31 22.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.051 0.453 . . . . 0.0 111.453 -178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -120.2 117.27 27.44 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.402 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -78.57 142.21 37.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 . . . . . 0 C--O 1.244 0.787 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.453 178.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 100.35 1.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.877 2.385 . . . . 0.0 110.898 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 156.32 21.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.061 0.458 . . . . 0.0 110.906 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.884 HG13 ' HD3' ' B' ' 29' ' ' LYS . 0.1 OUTLIER -92.99 144.07 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.235 -170.028 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 ' HZ ' ' B' ' 14' ' ' PHE . 2.0 mt -93.54 145.54 7.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 165.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -99.54 109.72 22.23 Favored 'General case' 0 CA--C 1.509 -0.628 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.195 -169.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.943 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -115.68 156.97 24.95 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -166.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.623 HG22 HH12 ' B' ' 27' ' ' ARG . 0.1 OUTLIER -123.31 123.62 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 114.138 -1.392 . . . . 0.0 108.709 171.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.729 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.5 t80 -80.37 105.63 11.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 50.0 mt-10 -126.83 139.69 52.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.569 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.483 ' H ' ' CG ' ' B' ' 24' ' ' GLU . 4.6 t30 65.36 20.37 11.8 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.198 0.523 . . . . 0.0 111.554 172.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.578 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 84.25 15.62 68.8 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.096 -1.049 . . . . 0.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 7.5 t -122.48 154.08 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -177.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 98.7 m-85 -99.43 114.64 27.69 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 165.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 10' ' ' GLU . 37.7 mtpt -116.97 108.92 43.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.108 -176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.943 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 14.4 Cg_endo -72.75 169.17 22.63 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 120.963 1.109 . . . . 0.0 113.491 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.36 -12.37 59.01 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.681 ' HG2' ' HG2' ' A' ' 16' ' ' PRO . 6.2 mm-40 75.1 -134.05 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.0 116.731 160.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.0 mttt 59.07 -161.25 0.26 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.454 -141.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' CG1' ' HG ' ' A' ' 22' ' ' LEU . 22.0 t 67.01 147.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.484 0.659 . . . . 0.0 110.435 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -135.03 26.74 3.57 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 121.684 0.754 . . . . 0.0 111.252 -171.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.43 ' HG ' ' CG1' ' A' ' 20' ' ' VAL . 94.7 mt -56.85 174.81 0.14 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.832 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -103.84 162.68 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -166.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 10' ' ' GLU . 1.5 pm0 -83.62 149.57 26.45 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.237 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.51 17.82 73.06 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.695 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 21.5 tt0 -93.1 155.4 17.51 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -96.33 137.45 35.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.747 0.784 . . . . 0.0 112.465 -171.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.913 HG12 ' HA ' ' B' ' 32' ' ' LEU . 4.4 m -147.97 171.39 2.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.522 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.601 ' HD3' HG13 ' B' ' 4' ' ' ILE . 62.5 mttm -127.0 144.74 50.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.188 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.66 HG22 ' HB ' ' B' ' 28' ' ' VAL . 1.3 mm -113.05 131.55 64.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.765 -178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -121.57 124.29 44.01 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.801 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.0 mp -74.03 117.45 15.83 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.8 158.13 32.47 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.354 0.597 . . . . 0.0 112.43 -170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -164.03 1.48 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.756 -173.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -99.03 157.51 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.95 0.405 . . . . 0.0 110.753 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 37' ' ' GLU . 39.5 t -70.14 164.92 2.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.546 178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 36' ' ' VAL . 12.4 pt-20 41.83 84.23 0.19 Allowed Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 124.298 1.039 . . . . 0.0 111.591 -171.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.24 174.39 8.16 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.465 2.776 . . . . 0.0 113.631 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.4 mt -73.89 149.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.095 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -99.28 101.66 13.03 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.773 ' HG ' ' H ' ' A' ' 42' ' ' GLY . 19.7 tp -83.13 -177.58 6.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -172.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.773 ' H ' ' HG ' ' A' ' 41' ' ' LEU . . . -150.05 156.42 26.73 Favored Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.7 mp0 -54.6 124.1 47.71 Favored Pre-proline 0 C--N 1.315 -0.9 0 O-C-N 123.785 0.344 . . . . 0.0 111.06 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.37 128.25 29.28 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.497 2.131 . . . . 0.0 111.521 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 45' ' ' VAL . 2.1 p -70.85 143.93 14.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.886 0.85 . . . . 0.0 111.661 -175.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 m -114.47 162.15 17.06 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.77 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.561 0.696 . . . . 0.0 111.456 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -94.31 -14.42 25.44 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.811 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.0 -27.22 68.16 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.537 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.5 tt -93.12 -14.84 8.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.287 0.565 . . . . 0.0 111.667 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -139.09 130.78 27.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -151.88 139.3 19.5 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.446 -0.501 . . . . 0.0 110.669 -173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -92.24 115.49 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.559 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -103.61 104.4 14.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -76.79 148.66 36.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.277 0.56 . . . . 0.0 111.688 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.34 104.86 0.83 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.195 -176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.1 p -81.83 127.93 33.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.902 0.382 . . . . 0.0 111.404 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -144.65 140.14 28.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.031 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.1 ttm -159.6 145.12 15.74 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -101.01 159.29 15.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.169 177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m -77.39 -0.31 25.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.761 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 tp 57.91 -163.95 0.19 Allowed 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.19 0.596 . . . . 0.0 111.343 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.95 115.67 5.2 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -97.04 102.29 14.04 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.456 0.646 . . . . 0.0 110.484 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.74 135.78 40.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.359 -176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -146.5 -179.07 6.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.893 0.377 . . . . 0.0 110.945 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -135.69 164.04 28.78 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -125.95 97.47 5.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.648 0.737 . . . . 0.0 110.3 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.8 t60 . . . . . 0 C--O 1.249 1.028 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.544 -178.703 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.413 ' HA ' ' HD3' ' B' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 1' ' ' MET . 6.2 Cg_endo -86.48 97.9 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.973 2.449 . . . . 0.0 113.103 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -144.54 161.94 37.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.362 174.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.601 HG13 ' HD3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -109.21 145.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.658 173.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.479 ' O ' HG12 ' A' ' 30' ' ' ILE . 9.0 mm -98.13 143.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -104.86 134.98 47.07 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.668 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -137.27 156.29 48.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.536 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.487 HG13 HD11 ' B' ' 17' ' ' LEU . 2.0 m -117.17 114.17 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.688 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 14.1 p90 -103.52 141.88 35.24 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 122.186 0.993 . . . . 0.0 113.25 -170.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -87.58 -170.98 3.24 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 112.797 -2.002 . . . . 0.0 108.582 172.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.7 63.45 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 O-C-N 124.504 1.127 . . . . 0.0 111.722 -171.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 113.06 -5.71 25.46 Favored Glycine 0 C--N 1.301 -1.413 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.382 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' B' ' 9' ' ' TYR . 0.2 OUTLIER -104.37 139.02 26.56 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.253 0 CA-C-N 114.988 -0.606 . . . . 0.0 109.437 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.879 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 42.5 m-85 -118.68 123.87 45.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 119.188 0.904 . . . . 0.0 111.353 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -122.79 117.32 28.75 Favored Pre-proline 0 N--CA 1.455 -0.184 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.527 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.668 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 35.4 Cg_endo -67.83 169.14 16.83 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 121.984 1.789 . . . . 0.0 113.74 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.487 HD11 HG13 ' B' ' 8' ' ' VAL . 4.7 mp -120.58 -17.81 7.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.432 171.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -96.42 146.97 24.3 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.034 177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -62.96 148.54 47.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.438 0.637 . . . . 0.0 110.559 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.424 HG23 ' HG ' ' B' ' 22' ' ' LEU . 2.3 p -145.17 134.53 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 122.338 1.066 . . . . 0.0 111.818 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -121.13 15.08 11.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.098 -1.864 . . . . 0.0 109.709 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.449 HD21 HD21 ' A' ' 32' ' ' LEU . 85.7 mt -66.39 167.22 10.92 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.09 175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -112.68 160.4 17.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.058 0.456 . . . . 0.0 112.003 -173.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 2.3 mp0 -62.77 120.23 10.87 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.905 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.2 36.9 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.974 -175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -75.89 136.4 40.12 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.942 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.623 HH12 HG22 ' A' ' 8' ' ' VAL . 18.3 tpp180 -93.39 117.39 30.02 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.567 1.175 . . . . 0.0 112.522 -171.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 30' ' ' ILE . 19.8 m -141.79 158.25 21.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.459 -174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.884 ' HD3' HG13 ' A' ' 4' ' ' ILE . 52.5 mttp -120.76 147.2 45.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.823 HG21 ' CE2' ' B' ' 14' ' ' PHE . 1.3 mm -110.68 132.26 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 CA-C-O 121.145 0.498 . . . . 0.0 110.976 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.523 ' HG3' HG22 ' A' ' 4' ' ' ILE . 10.5 mtmt -118.56 136.86 53.61 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 171.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HA ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -93.17 113.38 25.59 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.08 -174.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.561 ' O ' ' HG ' ' B' ' 34' ' ' LEU . 49.6 mm-40 -122.37 135.35 54.69 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -162.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' B' ' 33' ' ' GLU . 18.3 mt -151.58 144.81 24.68 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 112.409 -2.178 . . . . 0.0 106.728 156.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -153.03 179.27 8.85 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.356 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 80.0 t 65.73 143.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.983 171.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -119.75 139.41 28.0 Favored Pre-proline 0 N--CA 1.435 -1.215 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.749 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.4 174.19 12.54 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 111.769 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.508 ' O ' HD12 ' B' ' 39' ' ' ILE . 1.9 pp -81.4 137.29 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -107.08 119.26 38.88 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.2 mt -134.32 168.89 18.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.262 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 118.14 2.64 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.429 ' H ' ' CD ' ' B' ' 43' ' ' GLU . 1.7 mp0 -51.93 139.8 31.87 Favored Pre-proline 0 C--N 1.318 -0.777 0 C-N-CA 123.174 0.59 . . . . 0.0 111.572 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.79 130.2 37.33 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.637 2.225 . . . . 0.0 111.761 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.24 151.95 8.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.065 0.459 . . . . 0.0 110.476 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.9 m -94.3 169.71 10.03 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.884 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 132.84 65.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.503 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -72.46 120.01 17.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.264 0.554 . . . . 0.0 110.841 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.84 -23.33 48.97 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.387 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 30.3 mt -64.2 -15.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.365 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -76.12 131.97 39.75 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.745 ' HG2' HG13 ' B' ' 53' ' ' ILE . 46.6 tttp -160.09 141.73 12.72 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.981 -164.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.745 HG13 ' HG2' ' B' ' 52' ' ' LYS . 77.3 mt 70.11 112.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.868 0.842 . . . . 0.0 112.588 172.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -99.94 17.29 21.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.794 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -82.83 175.49 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.075 -178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.24 63.46 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.247 -0.501 . . . . 0.0 111.952 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 11.9 t -158.47 164.72 35.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.823 -0.222 . . . . 0.0 110.417 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -132.17 135.91 46.69 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 23.8 ptp -106.18 159.18 16.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.009 0.433 . . . . 0.0 111.066 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 3.0 m -71.14 173.59 7.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.112 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 13.9 m -90.25 -6.51 55.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.971 0.415 . . . . 0.0 110.828 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 tp 51.1 30.58 5.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.8 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.44 129.62 50.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.03 0.443 . . . . 0.0 110.587 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -133.28 85.87 2.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.546 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -75.05 74.79 2.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.129 0.966 . . . . 0.0 110.759 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -104.06 111.82 24.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.818 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.55 141.63 51.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.499 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -105.76 137.94 42.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.523 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.4 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 9.7 p80 . . . . . 0 C--O 1.247 0.957 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' B' ' 32' ' ' LEU . 15.7 ptm . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.77 -41.53 2.14 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.092 2.528 . . . . 0.0 112.446 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -149.94 160.38 43.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.347 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.747 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.08 144.84 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.184 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.574 ' HB ' HD12 ' B' ' 30' ' ' ILE . 19.4 mt -119.87 152.2 22.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 169.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.57 134.91 48.99 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.678 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -142.43 165.79 26.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.44 -175.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.474 ' HB ' ' HA2' ' B' ' 25' ' ' GLY . 10.5 m -118.42 127.98 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 121.27 0.557 . . . . 0.0 110.512 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.687 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 86.5 t80 -89.42 105.15 17.61 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.834 0.826 . . . . 0.0 110.637 177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 24' ' ' GLU . 8.5 pt-20 -91.86 -168.33 1.99 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 113.812 -1.54 . . . . 0.0 107.79 168.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.78 67.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 122.436 1.112 . . . . 0.0 112.43 -160.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 10' ' ' GLU . . . 105.38 0.4 40.58 Favored Glycine 0 C--N 1.297 -1.597 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.012 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 1.9 t -115.16 141.97 29.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.262 -173.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' B' ' 14' ' ' PHE . 60.5 m-85 -108.31 115.59 30.39 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 166.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.628 ' HE3' HG11 ' A' ' 13' ' ' VAL . 96.9 mttt -121.2 119.11 29.78 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.619 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -52.48 166.57 0.75 Allowed 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 122.382 2.055 . . . . 0.0 114.741 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.1 mt -109.3 -67.4 0.99 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 110.215 -3.175 . . . . 0.0 103.655 167.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -71.44 141.73 50.26 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.08 -2.327 . . . . 0.0 108.628 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 13.8 mtpt -60.6 149.63 34.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.697 0.76 . . . . 0.0 112.395 -173.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.9 m -77.1 166.48 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.527 -177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -152.42 15.21 0.6 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.719 0.771 . . . . 0.0 110.148 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.527 HD11 HD22 ' B' ' 32' ' ' LEU . 79.0 mt -122.5 -169.91 1.99 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.378 -172.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 18.3 pttp -124.03 155.12 38.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.974 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.2 pm0 -66.19 134.28 52.41 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.21 0.528 . . . . 0.0 111.002 -177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.17 10.58 48.22 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.802 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 5.7 tp10 -84.46 146.56 27.56 Favored 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 122.807 -0.231 . . . . 0.0 110.757 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' HD3' ' N ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -102.5 125.08 49.1 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 122.557 1.17 . . . . 0.0 112.334 -175.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.512 ' HB ' HG22 ' B' ' 30' ' ' ILE . 30.3 m -134.15 156.25 40.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.414 -174.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.627 ' HB3' HD12 ' B' ' 4' ' ' ILE . 64.0 mttm -115.33 144.79 43.23 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.0 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.514 HG21 ' CE1' ' A' ' 14' ' ' PHE . 4.5 mm -115.79 144.3 23.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.014 -175.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -151.3 123.78 8.41 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.774 ' HB3' HG12 ' B' ' 28' ' ' VAL . 2.7 pt? -89.85 145.67 24.99 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -94.18 123.93 37.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.405 1.097 . . . . 0.0 110.782 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 34' ' ' LEU . 2.0 mm? -101.48 -164.9 1.14 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.372 -1.74 . . . . 0.0 109.783 177.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -134.64 160.31 38.51 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.49 127.41 14.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.355 0.598 . . . . 0.0 111.037 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.1 115.6 27.29 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.369 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.86 172.14 11.26 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.211 1.941 . . . . 0.0 112.298 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.2 pt -131.57 165.24 32.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.062 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -136.64 118.37 15.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.903 0.382 . . . . 0.0 110.297 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 pt? -148.82 133.93 18.24 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.875 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.3 -155.07 31.15 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.227 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 49.0 mt-10 -118.13 143.08 32.17 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-O 120.527 0.204 . . . . 0.0 110.704 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 43' ' ' GLU . 21.5 Cg_exo -65.94 142.44 68.8 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.943 2.429 . . . . 0.0 112.112 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.84 146.29 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.43 0.633 . . . . 0.0 110.914 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -95.73 158.19 15.56 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.054 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.9 t -140.72 132.01 29.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.234 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -118.99 122.3 41.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.856 0.836 . . . . 0.0 110.954 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.48 -22.98 26.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.104 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mm -65.07 -3.51 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.532 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -78.43 133.19 37.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 153.15 23.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 120.961 0.41 . . . . 0.0 111.451 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -105.53 -158.34 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.123 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' H ' ' HB ' ' A' ' 53' ' ' ILE . 27.9 ttm105 -107.23 160.47 15.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.905 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -65.43 153.82 40.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.776 0.322 . . . . 0.0 110.296 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -96.68 156.42 21.05 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.855 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.5 m -68.39 130.76 43.83 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -119.63 175.17 5.99 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.081 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.0 ttt -63.31 130.56 45.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.864 0.364 . . . . 0.0 111.022 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.6 m -64.41 154.88 34.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.402 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -87.11 15.24 6.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mp 60.22 -171.03 0.14 Allowed 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.374 0.67 . . . . 0.0 111.62 -178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 64' ' ' HIS . 2.8 mp0 -97.22 -22.92 16.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.249 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 28.6 t-80 72.95 -17.94 0.38 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.695 0.622 . . . . 0.0 112.66 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.466 ' HB2' ' O ' ' A' ' 64' ' ' HIS . 3.8 m170 68.74 -178.08 0.22 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 122.735 0.414 . . . . 0.0 110.535 -172.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -109.56 109.97 20.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.509 0.671 . . . . 0.0 110.726 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -94.83 96.74 9.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.356 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -96.52 -7.13 35.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.294 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 16.6 p80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.903 170.32 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.561 0.22 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.67 102.81 1.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.012 2.475 . . . . 0.0 111.707 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -124.16 171.5 9.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.369 0.604 . . . . 0.0 111.894 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.627 HD12 ' HB3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -136.83 144.28 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.125 173.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' B' ' 20' ' ' VAL . 1.9 mt -124.45 157.94 31.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 29' ' ' LYS . 50.7 mt-10 -109.59 139.99 43.93 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.4 157.52 44.31 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.041 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.659 HG13 HD11 ' B' ' 17' ' ' LEU . 6.0 m -104.26 117.35 49.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.602 0.715 . . . . 0.0 110.822 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 52.7 t80 -76.57 111.25 11.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.21 1.005 . . . . 0.0 111.181 177.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.696 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 36.6 mt-10 -88.51 -169.12 2.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.298 -1.774 . . . . 0.0 109.163 170.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -65.55 55.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.236 1.014 . . . . 0.0 112.349 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 112.65 6.72 23.01 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.8 t -116.08 149.59 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 114.917 -0.642 . . . . 0.0 109.885 -174.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.716 ' HB2' ' HB2' ' A' ' 14' ' ' PHE . 91.8 m-85 -119.18 114.87 23.11 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 166.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.468 ' HE2' HG11 ' B' ' 13' ' ' VAL . 65.1 mttm -114.26 113.77 45.93 Favored Pre-proline 0 CA--C 1.506 -0.717 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.23 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -43.56 169.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.508 -0.8 0 C-N-CA 123.318 2.678 . . . . 0.0 116.642 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.946 ' O ' ' HG3' ' B' ' 18' ' ' GLN . 2.5 mt -131.17 103.91 6.76 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 111.392 -2.64 . . . . 0.0 105.753 167.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.946 ' HG3' ' O ' ' B' ' 17' ' ' LEU . 5.1 pp0? 79.38 178.58 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 128.068 2.547 . . . . 0.0 112.922 177.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -55.23 141.28 35.95 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -162.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' B' ' 5' ' ' ILE . 3.2 t -137.79 135.06 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.279 0 CA-C-N 113.644 -1.616 . . . . 0.0 108.511 173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -128.08 87.56 2.62 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 123.015 1.388 . . . . 0.0 109.149 172.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.434 HD13 ' HG2' ' B' ' 26' ' ' GLU . 60.6 mt -129.99 -169.95 2.22 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 113.032 -1.894 . . . . 0.0 111.119 176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -91.1 -174.72 4.07 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -103.45 122.08 44.14 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.753 0.787 . . . . 0.0 110.24 170.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . 0.474 ' HA2' ' HB ' ' A' ' 8' ' ' VAL . . . 93.02 15.16 53.16 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.409 -173.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.434 ' HG2' HD13 ' B' ' 22' ' ' LEU . 8.8 tp10 -60.93 138.46 58.16 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 122.604 0.361 . . . . 0.0 110.524 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 0.1 OUTLIER -89.76 115.09 26.85 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.376 1.084 . . . . 0.0 111.662 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' A' ' 32' ' ' LEU . 27.4 m -132.33 162.7 39.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.575 -174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -117.66 147.12 43.19 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.281 0.562 . . . . 0.0 109.598 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.574 HD12 ' HB ' ' A' ' 5' ' ' ILE . 2.1 mt -106.7 128.45 61.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.81 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -125.92 134.09 51.67 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 122.556 1.169 . . . . 0.0 108.852 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.527 HD22 HD11 ' A' ' 22' ' ' LEU . 41.3 tp -103.15 131.17 50.37 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.03 -162.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -97.25 140.08 32.26 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.943 0.877 . . . . 0.0 112.173 -170.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 18.0 mt -155.59 158.91 39.15 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.348 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.78 177.3 7.35 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.705 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.17 141.18 16.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -86.93 136.02 34.65 Favored Pre-proline 0 N--CA 1.443 -0.796 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.47 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.91 174.37 9.74 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.415 2.077 . . . . 0.0 111.657 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 pt -93.22 144.81 8.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.749 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.91 -177.07 6.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.5 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.38 143.07 26.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.963 0.411 . . . . 0.0 111.0 -176.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 -123.59 5.3 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.026 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 44' ' ' PRO . 0.3 OUTLIER -101.36 153.47 37.81 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-O 120.774 0.321 . . . . 0.0 111.055 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 43' ' ' GLU . 1.8 Cg_endo -87.0 -159.57 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.551 2.834 . . . . 0.0 111.654 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 t -115.04 156.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -75.21 169.68 17.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.844 0.354 . . . . 0.0 111.312 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.04 136.92 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.8 -22.35 21.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.245 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.12 -28.19 67.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.518 -171.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.27 2.33 7.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.246 0.546 . . . . 0.0 110.945 -174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -111.71 -154.84 0.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.136 -178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.443 ' HB2' ' HE3' ' B' ' 52' ' ' LYS . 1.5 ttmt 60.31 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.613 0.721 . . . . 0.0 111.974 -172.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.4 ' N ' HD12 ' B' ' 53' ' ' ILE . 4.3 mp -86.81 102.98 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.696 -174.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -157.56 116.12 3.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.144 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -125.25 166.02 17.26 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.74 -36.87 93.88 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.783 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 42.6 m 70.0 148.4 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.292 0.637 . . . . 0.0 111.67 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.07 178.98 4.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.363 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.9 t 74.91 137.23 0.06 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 124.139 0.899 . . . . 0.0 112.424 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -105.47 18.63 21.92 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.034 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp 67.96 179.05 0.23 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.094 -173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 65' ' ' HIS . 40.7 tt0 -124.21 121.61 35.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.353 0.596 . . . . 0.0 111.83 -172.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -96.36 74.52 2.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . 0.513 ' HB2' ' HG2' ' B' ' 63' ' ' GLU . 2.2 t-160 -95.07 -8.91 35.26 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.736 -170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -99.25 127.49 45.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.534 -174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -139.26 115.57 10.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 170.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -73.68 -74.83 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.696 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.246 0.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 1' ' ' MET . 20.5 ptm . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.25 0.547 . . . . 0.0 111.503 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -93.43 119.81 0.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.771 2.314 . . . . 0.0 111.104 172.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -88.23 143.56 26.97 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.937 HG13 ' HD2' ' B' ' 29' ' ' LYS . 0.2 OUTLIER -76.12 129.79 36.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.876 -174.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -89.42 147.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -104.76 128.51 52.91 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.47 151.57 44.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.697 -174.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' GLU . 6.6 m -115.87 119.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 CA-C-O 121.381 0.61 . . . . 0.0 111.063 175.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.724 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 87.2 t80 -72.71 99.71 2.66 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -119.28 130.95 55.68 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.397 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 61.56 23.64 13.89 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 123.649 0.593 . . . . 0.0 112.035 174.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.515 ' HA2' ' CZ ' ' A' ' 9' ' ' TYR . . . 92.1 10.43 61.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.354 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 3.9 t -122.92 142.83 38.03 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' B' ' 28' ' ' VAL . 48.7 m-85 -88.89 114.19 25.24 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 166.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -119.75 116.16 33.23 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.193 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 11.1 Cg_endo -58.27 166.38 5.98 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.33 1.353 . . . . 0.0 111.965 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -98.23 -13.67 20.71 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -122.37 155.36 36.19 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.728 -177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.28 131.85 35.06 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG12 ' HG ' ' A' ' 22' ' ' LEU . 3.8 t -111.26 150.05 13.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -95.0 14.7 20.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 122.279 1.038 . . . . 0.0 110.145 -177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.53 HD13 ' HG2' ' A' ' 26' ' ' GLU . 70.4 mt -79.06 176.75 9.37 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.577 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HG2' ' OE1' ' A' ' 26' ' ' GLU . 17.5 pttm -124.95 163.11 23.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.676 0.274 . . . . 0.0 111.537 -172.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' B' ' 9' ' ' TYR . 1.9 pt-20 -66.24 116.92 7.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.117 175.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.85 14.91 14.06 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.646 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' B' ' 9' ' ' TYR . 3.9 tp10 -80.61 132.49 35.63 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -103.18 127.81 50.35 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 122.356 1.074 . . . . 0.0 111.534 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' B' ' 32' ' ' LEU . 35.7 m -135.19 162.09 38.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 113.927 -1.488 . . . . 0.0 112.719 -167.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -114.93 141.88 47.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.793 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' B' ' 5' ' ' ILE . 14.7 mt -122.21 137.49 55.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.569 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -158.04 167.48 29.76 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.108 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -87.52 114.86 24.52 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 162.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.705 ' HB2' ' HE2' ' B' ' 29' ' ' LYS . 8.5 tp10 -58.14 147.85 28.65 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -154.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.689 ' HG ' ' HG3' ' A' ' 33' ' ' GLU . 85.0 mt 55.23 -166.0 0.11 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.025 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -116.13 171.37 7.85 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.49 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 37' ' ' GLU . 7.5 p -85.81 164.27 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 36' ' ' VAL . 1.4 mp0 -61.75 164.57 9.54 Favored Pre-proline 0 C--N 1.326 -0.452 0 C-N-CA 122.924 0.489 . . . . 0.0 111.239 178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.46 179.6 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.624 2.216 . . . . 0.0 112.856 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.6 pt -76.92 174.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.622 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.84 153.74 43.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.697 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 pp -78.83 148.04 33.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.92 -144.62 5.93 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.813 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.6 mp0 -53.03 117.91 12.49 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.114 0.538 . . . . 0.0 110.716 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.94 124.31 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.43 2.087 . . . . 0.0 112.258 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.51 150.11 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.26 157.92 16.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.345 0.593 . . . . 0.0 111.481 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.46 96.9 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.78 175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 15.8 pt-20 -84.3 1.07 46.61 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.553 -172.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -52.8 -25.07 10.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.441 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.3 pt -77.77 13.7 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.365 0.603 . . . . 0.0 111.301 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 48' ' ' GLU . 32.5 tttt -65.35 140.08 58.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.831 -177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -136.35 147.98 47.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 169.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 tt -81.74 132.83 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 120.936 0.398 . . . . 0.0 110.575 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 54' ' ' ARG . 22.6 ttt85 -74.83 85.57 2.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.18 148.27 23.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.751 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.46 116.98 1.61 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.36 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.0 t -129.72 156.78 43.73 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.667 0.27 . . . . 0.0 110.421 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -77.71 159.23 29.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.007 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -59.25 159.49 7.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.932 0.396 . . . . 0.0 110.846 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.434 ' O ' HD22 ' A' ' 62' ' ' LEU . 2.3 p -66.63 171.01 5.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 m -76.47 8.19 3.73 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 60' ' ' SER . 2.6 mm? 60.1 142.12 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.906 0.882 . . . . 0.0 113.133 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.02 111.58 4.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.497 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.85 -16.54 56.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.699 -175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 59.4 t60 71.91 126.54 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.879 0.737 . . . . 0.0 110.552 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -85.61 144.79 27.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.676 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 74.84 121.53 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 124.412 1.07 . . . . 0.0 111.58 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -60.24 137.33 58.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.071 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.8 p80 . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.368 -0.825 . . . . 0.0 109.557 173.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.91 139.11 15.18 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.633 2.222 . . . . 0.0 113.665 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -157.25 158.85 36.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.416 ' N ' HD12 ' B' ' 4' ' ' ILE . 3.3 mp -77.93 130.83 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 121.997 0.903 . . . . 0.0 111.734 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.594 HD13 HG12 ' B' ' 20' ' ' VAL . 9.9 mt -114.46 151.07 16.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.65 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 137.73 52.66 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.221 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' B' ' 16' ' ' PRO . . . -142.66 168.97 18.46 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.1 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.64 141.58 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' B' ' 13' ' ' VAL . 83.7 t80 -100.3 114.09 27.3 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.053 0.93 . . . . 0.0 109.958 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.714 ' HB2' ' HB ' ' B' ' 13' ' ' VAL . 44.7 mt-10 -87.58 -170.63 3.1 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 113.126 -1.852 . . . . 0.0 108.552 169.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.33 52.64 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.096 0.958 . . . . 0.0 112.07 -172.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 10' ' ' GLU . . . 117.48 4.67 15.26 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.714 ' HB ' ' HB2' ' B' ' 10' ' ' GLU . 2.3 t -114.32 145.54 19.99 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.249 -0.476 . . . . 0.0 111.554 -175.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.53 ' CE1' ' HB2' ' B' ' 9' ' ' TYR . 46.5 m-85 -117.68 115.45 25.07 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 166.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -113.87 114.33 46.7 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.709 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' B' ' 7' ' ' ALA . 9.5 Cg_endo -59.93 165.47 10.21 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-O 123.472 1.363 . . . . 0.0 113.2 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -96.72 -66.03 0.93 Allowed 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 111.048 -2.796 . . . . 0.0 104.675 164.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.508 ' HB2' HG23 ' B' ' 5' ' ' ILE . 50.7 mt-30 -65.55 132.13 48.11 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 112.86 -1.973 . . . . 0.0 109.629 -174.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -61.24 124.16 19.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 122.02 0.914 . . . . 0.0 110.47 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.594 HG12 HD13 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -101.82 132.95 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.177 -176.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -121.36 88.4 2.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.426 169.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.555 ' HB3' ' HG3' ' B' ' 26' ' ' GLU . 72.5 mt -130.57 -165.0 1.49 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.348 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -92.59 161.58 14.53 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -88.23 128.28 35.46 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 169.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.4 65.11 3.16 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 113.725 -1.579 . . . . 0.0 109.878 -160.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.628 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.93 142.8 29.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.646 -0.777 . . . . 0.0 109.864 173.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' B' ' 27' ' ' ARG . 1.0 OUTLIER -100.84 105.57 16.87 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.684 1.231 . . . . 0.0 111.768 -176.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 14' ' ' PHE . 33.8 m -123.96 164.83 21.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 113.128 -1.851 . . . . 0.0 108.979 -179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.937 ' HD2' HG13 ' A' ' 4' ' ' ILE . 31.7 mtmm -123.44 139.77 53.68 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.598 0.714 . . . . 0.0 110.935 177.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.465 HG21 ' CE1' ' B' ' 14' ' ' PHE . 10.7 mm -111.11 143.98 19.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.816 -171.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -147.42 161.22 41.47 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 113.84 -1.527 . . . . 0.0 107.377 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.67 ' HB3' HG12 ' A' ' 28' ' ' VAL . 1.2 pt? -121.73 154.05 37.42 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -68.51 142.49 55.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.511 0.672 . . . . 0.0 112.107 -173.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -115.57 153.9 30.38 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.957 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -124.14 147.33 48.04 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.069 0.462 . . . . 0.0 110.423 175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.65 130.61 63.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.676 0.75 . . . . 0.0 110.302 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -125.0 112.15 26.88 Favored Pre-proline 0 N--CA 1.433 -1.312 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.876 177.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.28 173.53 10.42 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.416 2.077 . . . . 0.0 111.981 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 26.1 pt -95.81 155.36 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -80.31 123.78 28.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.863 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 93.1 mt -92.36 115.54 28.18 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.28 113.67 2.39 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.55 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.86 155.51 80.41 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.551 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.21 145.21 77.72 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.474 2.116 . . . . 0.0 111.604 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -76.99 152.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.095 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 16.2 m -77.36 173.42 11.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.69 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 25.5 t -82.92 116.5 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.339 0.59 . . . . 0.0 110.354 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.73 155.49 18.54 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.924 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.94 -24.36 66.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.798 0.332 . . . . 0.0 111.672 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.41 ' N ' HD12 ' B' ' 50' ' ' ILE . 3.0 mp -69.91 -16.79 20.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.815 0.817 . . . . 0.0 109.837 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -92.67 132.98 36.44 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.263 174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' B' ' 52' ' ' LYS . 50.4 tptt -132.71 107.94 8.7 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.43 0.633 . . . . 0.0 111.228 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -87.31 136.8 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.34 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.849 ' HG3' ' H ' ' B' ' 55' ' ' ASP . 6.4 tpt180 55.63 -166.73 0.11 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.102 0.561 . . . . 0.0 112.015 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.849 ' H ' ' HG3' ' B' ' 54' ' ' ARG . 11.2 p-10 -108.51 -176.46 3.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.638 -176.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.19 126.85 2.0 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.943 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.38 119.44 31.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.884 0.373 . . . . 0.0 111.06 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -82.75 150.72 26.51 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.368 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' MET . . . . . . . . . . . . . 43.5 tpp -116.13 154.11 30.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.313 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 74.26 -0.58 3.31 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.589 0.556 . . . . 0.0 110.767 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 15.8 m -85.28 5.74 29.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.269 176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.93 136.66 52.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.115 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.01 145.85 26.64 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -146.73 78.15 1.49 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.675 -174.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -145.19 157.83 43.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.208 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -153.68 138.57 17.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -121.02 77.86 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 171.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -179.74 97.52 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.499 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 18.2 t60 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.791 -176.663 . . . . . . . . 0 0 . 1 stop_ save_